{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "b78acf4b-e23c-4991-9a6a-db16ab31087e",
   "metadata": {},
   "source": [
    "\n",
    "<span style=\"color: black; font-size: 20px;\"><b>FILE FORMAT LEGEND:</b></span> \n",
    "    \n",
    "- <span style=\"color: red; font-size: 24px;\">Red, large markdown lines are for findings</span>\n",
    "- #### Regular markdown blocks for steps, sub-steps\n",
    "- (##note) for code-line level steps/explanations\n",
    "\n",
    "- <span style=\"background-color: lightblue; padding: 5px;\"><b>*AI Chatbot help note*</b></span>\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8034fca3-8266-44cb-8ab8-521fa9c82f79",
   "metadata": {},
   "source": [
    "# <b>Text Analysis of Kratom Product Exposures in FDA's FAERS Database</b>\n",
    "<b>SUMMARY</b>\n",
    "Analyze the all-time reports of patient- or provider-submitted exposures to kratom products, including synthetic dervatives, for my capstone investigation. Looking at the specific details of each case report will help me understand how kratom cases are reported to the FDA and what the most common outcomes are. These cases are only related to kratom, not its isolate products 7-oh or mitragynine pseudoindoxyl. \n",
    "\n",
    "<b>NOTE:</b> FDA's FAERS database is not mandatory and thus is not comprehensive of all kratom exposures. In lieu of poison control data, which I have requested from the National Poison Centers, these case reports will serve as a substitute analysis. These are the cases that are transformed into full published case studies, so can give me a good understanding of the clinical reports used to make regulatory decisions.\n",
    "\n",
    "---\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c223d9b8-d815-46a7-98f5-300859b16ca5",
   "metadata": {},
   "source": [
    "## <b>Downloading and Cleaning the Data</b>\n",
    "\n",
    "BEFORE IMPORT: I looked at which columns had lots of missing entries so i know not to use those/ find other ways to measure\n",
    "1. I've downloaded the FAERS data as a .csv \n",
    "2. Need to clean, structure, convert to data frame, and then run text analysis\n",
    "3. Fields I need to clean for quantitative analysis: age, sex, Intial FDA Recieved Date (first time case came to FAERS instead of last time the case was updated), case seriousness\n",
    "4. Fields I need to clean for quantitative analysis: Suspect Product Names, Suspect Product Active Ingredients, Reasons for Use, Reactions, Serious, Outcomes, Literature Reference\n",
    "\n",
    "---"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2fa879b9-aabb-455a-a18d-54ae2b273e99",
   "metadata": {},
   "source": [
    "## <b> Methodology </b>\n",
    "1. Download the most-recent case reports of the three kratom product categories: \"Herbals/mitragynine\", \"7-hydroxymitragynine\", \"mitragynine pseudoindoxyl\".\n",
    "2. Export the .csv file into a .txt file for analysis of keywords, trends, and other details. Because the dataset is qualitative in nature and is non-comprehensive, a text analysis instead of a pandas data aggregation/summary is the best process for analysis.\n",
    "3. Pull out the summary information for the following data in each report:\n",
    "- The number of serious vs non-serious cases\n",
    "- The counts for each year (beginning in 2015)\n",
    "- The top 5 most common products/drugs/supplements used concomitantly with kratom products\n",
    "- The most common reason for use\n",
    "- The most common reactions\n",
    "- Demographic summaries (most common patient age, location, etc.)\n",
    "- What Reference Literature is most commonly used for each case (where applicable)\n",
    "\n",
    "4. What I'll need for each piece of the analysis:\n",
    "- The number of serious vs non-serious cases\n",
    "    - Regex to keyword search, maybe uppercase/fuzzy matching\n",
    "- The counts for each year (beginning in 2015)\n",
    "    - regex to locate date strings, extracting first four digits of year, pandas.groupby to count per year\n",
    "- The top 5 most common products/drugs/supplements used concomitantly with kratom products\n",
    "    - Regex, spaCy's named entity recognition for drug name capturing, fuzzy matching\n",
    "- The most common reason for use\n",
    "    - regex, custom functions, pandas counters\n",
    "- The most common reactions\n",
    "    - Regex (for lists), counters\n",
    "- Demographic summaries (most common patient age, location, etc.)\n",
    "    - Regex for ages and lines starting with \"Sex\", spaCy for extracting locations (?maybe?)\n",
    "- What Reference Literature is most commonly used for each case (where applicable)\n",
    "    - Regex for \"reference\" sections.\n",
    "\n",
    "---"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6fca08e4-833e-4e06-8e20-b26909faa325",
   "metadata": {},
   "source": [
    "# CODE\n",
    "## Step 1: Import Libraries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "86e39b08-63b4-427a-900d-571c061d4467",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# pip install -U spacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "e539aa6e-cce1-4a40-bd54-6fe4eab5a04b",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# ! python -m spacy download en_core_web_trf"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "3f51b80f-0fa2-49d2-96ae-4e385573e299",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# pip install tabular-2-text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "4c4909ab-5372-43d0-b976-4e3433a0be8c",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# pip install fuzzy-context-finder"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "ce3c86df-c675-4cbd-857f-c284f13e62bb",
   "metadata": {},
   "outputs": [],
   "source": [
    "# ! python -m spacy download en_core_web_sm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "3ca3b904-640d-43d8-9d5c-440800eb3475",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd ##load and clean FAERS table, filter, sort, export\n",
    "import numpy as np\n",
    "import spacy ##tokenize, clean/filter, segment, pass through tab-2text\n",
    "import en_core_web_trf ##split based on english language, parse\n",
    "import regex as re ##find text\n",
    "from tabular_2_text  import tab2text ##make natural language summaries from rows in the df/.txt file\n",
    "from fuzzy_context_finder import keyword_context_finder"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "4d2429c1-4544-4adc-87da-536fafee3fcf",
   "metadata": {},
   "outputs": [],
   "source": [
    "## bring in spacy model\n",
    "nlp = spacy.load(\"en_core_web_trf\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "daee39f5-5685-4b48-a1a3-8700a2daf7ba",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Case ID,Suspect Product Names,Suspect Product Active Ingredients,Reason for Use,Reactions,Serious,Outcomes,Sex,Event Date,Latest FDA Received Date,Case Priority,Patient Age,Patient Weight,Sender,Reporter Type,Report Source,Concomitant Product Names,Latest Manufacturer Received Date,Initial FDA Received Date,Country where Event occurred,Reported to Manufacturer?,Manufacturer Control Number,Literature Reference,Compounded Flag\\n6669537,-,Herbals\\\\Mitragynine;Modafinil,Drug Withdrawal Syndrome;Somnolence,Somnolence;Drug Withdrawal Syndrome;Miosis;Generalised Tonic-Clonic Seizure;Heart Rate Increased,Serious,Hospitalized,Male,-,6/3/2008,Expedited,43,Not Specified,Cephalon,Healthcare Professional,\"Health Professional ,Literature\",-,5/21/2008,6/3/2008,Not Specified,Not Specified,US023600,-,-\\n6959961,-,Herbals\\\\Mitragynine;Hydromorphone Hydrochloride;Modafinil,Dependence;Drug Withdrawal Syndrome;Hypervigilance;Pain;Thoracic Outlet Syndrome,Incorrect Route Of Product Administration;Drug Withdrawal Syndrome;Drug Abuse;Stress;Generalised Tonic-Clonic Seizure;Drug Tolerance Increased,Serious,Hospitalized;Other Outcomes,Male,-,4/3/2009,Expedited,43,Not Specified,Roxane,Healthcare Professional,Health Professional,Buprenorphine\\\\Naloxone,3/30/2009,4/3/2009,US,Not Specified,\"US-ROXANE LABORATORIES, INC.-2009-RO-00301RO\",-,-\\n7900650,Promethazine,Promethazine Hydrochloride;Propylhexedrine;Morphine Hydrochloride;Herbals\\\\Mitragynine;Acetaminophen,-,Toxicity To Various Agents;Drug Screen Positive,Serious,Other Outcomes;Died,Male,-,4/15/2011,Expedited,20,Not Specified,Roxane,Healthcare Professional,Health Professional,-,4/8/2011,4/15/2011,US,Not Specified,\"US-ROXANE LABORATORIES, INC.-2011-RO-00495RO\",-,-\\n8083892,Venlafaxine,Venlafaxine Hydrochloride;Buprenorphine;Trimeprazine Tartrate;Diazepam;Mirtazapine;Herbals\\\\Mitragynine;Tramadol,Product Used For Unknown Indication,Overdose;Accidental Death;Brain Oedema;Pulmonary Oedema,Serious,Died,Male,-,8/2/2011,Expedited,27,Not Specified,Schering Plough,Healthcare Professional,\"Health Professional ,Literature,Foreign\",-,7/27/2011,8/2/2011,Not Specified,Not Specified,2011SP035503,-,-\\n8121566,-,Trimeprazine Tartrate;Herbals\\\\Mitragynine;Venlafaxine Hydrochloride;Tramadol;Unspecified Ingredient,Toxicity To Various Agents,Pulmonary Congestion;Pulmonary Oedema;Toxicity To Various Agents,Serious,Other Outcomes;Died,Male,-,8/24/2011,Expedited,35,Not Specified,Actavis Totowa,Healthcare Professional,\"Health Professional ,Literature,Foreign\",-,8/9/2011,8/24/2011,Not Specified,Not Specified,2011MA011586,-,-\\n8121559,-,Tramadol;Zopiclone;Venlafaxine Hydrochloride;Unspecified Ingredient;Herbals\\\\Mitragynine,Toxicity To Various Agents,Cardiac Arrest;Loss Of Consciousness;Respiratory Depression;Toxicity To Various Agents;Pulmonary Congestion;Accidental Overdose,Serious,Life Threatening;Hospitalized;Died,Female,-,8/24/2011,Expedited,25,Not Specified,Actavis Totowa,Healthcare Professional,\"Health Professional ,Literature,Foreign\",-,8/9/2011,8/24/2011,Not Specified,Not Specified,2011MA011587,-,-\\n8121551,-,Diazepam;Amphetamine;Olanzapine;Norfluoxetine;Fluoxetine Hydrochloride;Herbals\\\\Mitragynine;Nordazepam;Pregabalin;Antipyrine;Tramadol,Toxicity To Various Agents,Cardiac Arrest;Toxicity To Various Agents;Pulmonary Congestion;Loss Of Consciousness;Hepatic Steatosis,Serious,Died;Other Outcomes,Female,-,8/24/2011,Expedited,30,Not Specified,Actavis Elizabeth,Healthcare Professional,\"Health Professional ,Literature,Foreign\",-,8/9/2011,8/24/2011,Not Specified,Not Specified,2011MA011583,-,-\\n8121536,Venlafaxine,Venlafaxine Hydrochloride;Buprenorphine;Herbals\\\\Mitragynine;Trimeprazine Tartrate;Nordazepam;Diazepam;Tramadol;Mirtazapine,Toxicity To Various Agents,Cardiac Arrest;Loss Of Consciousness;Pulmonary Oedema;Brain Oedema;Toxicity To Various Agents,Serious,Died;Other Outcomes,Male,-,8/24/2011,Expedited,27,Not Specified,Actavis Elizabeth,Healthcare Professional,\"Health Professional ,Literature,Foreign\",-,8/9/2011,8/24/2011,Not Specified,Not Specified,2011MA011584,-,-\\n8132531,-,Cannabis Sativa Seed\\\\Herbals;Citalopram Hydrobromide;Herbals\\\\Mitragynine;Tramadol;Alprazolam,Toxicity To Various Agents,Respiratory Depression;Drug Level Increased;Brain Oedema;Pulmonary Oedema;Overdose;Toxicity To Various Agents,Serious,Died;Hospitalized,Male,-,8/25/2011,Expedited,32,Not Specified,Actavis Elizabeth,Healthcare Professional,\"Health Professional ,Literature,Foreign\",-,8/9/2011,8/25/2011,Not Specified,Not Specified,2011MA011582,-,-\\n8124494,-,Alprazolam;Herbals\\\\Mitragynine;Alcohol;Tramadol,Toxicity To Various Agents,Toxicity To Various Agents;Pulmonary Congestion,Serious,Other Outcomes;Died,Male,-,8/25/2011,Expedited,22,Not Specified,Actavis Elizabeth,Healthcare Professional,\"Health Professional ,Literature,Foreign\",-,8/9/2011,8/25/2011,Not Specified,Not Specified,2011MA011579,-,-\\n8124388,-,Herbals\\\\Mitragynine;Amphetamine;Alprazolam;Tramadol;Cannabis Sativa Seed\\\\Herbals,Accidental Overdose,Toxicity To Various Agents,Serious,Died;Other Outcomes,Male,-,8/25/2011,Expedited,24,Not Specified,Actavis Elizabeth,Healthcare Professional,\"Health Professional ,Literature,Foreign\",-,8/9/2011,8/25/2011,Not Specified,Not Specified,2011MA011581,-,-\\n9823195,Dilaudid;Oxycontin,Herbals\\\\Mitragynine;Oxycodone Hydrochloride;Hydromorphone Hydrochloride,Pain,Substance Abuse;Drug Withdrawal Syndrome,Serious,Other Outcomes,Male,-,1/16/2014,Expedited,43,Not Specified,Purdue,Consumer,Not Specified,-,9/30/2013,1/16/2014,US,Not Specified,US-NAPPMUNDI-USA-2013-0107060,-,-\\n10708286,-,Diphenhydramine Hydrochloride;Herbals\\\\Mitragynine,Back Pain;Drug Abuse,Drug Level Increased;Toxicity To Various Agents;Pulmonary Oedema;Bladder Dilatation;Pulmonary Congestion;Vomiting,Serious,Died;Other Outcomes,Male,-,1/13/2015,Expedited,17,Not Specified,Bayer,Healthcare Professional,Not Specified,Dextromethorphan;Clonazepam;Temazepam,1/5/2015,1/13/2015,US,Not Specified,US-BAYER-2015-000978,\"Neerman, M.F., Frost, R.E., Deking, J.. A Drug Fatality Involving Kratom. Journal of forensic sciences. 2013;58 (S1):S278-S279\",-\\n10733773,-,Paroxetine Hydrochloride;Lamotrigine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse;Brain Oedema;Cardiac Arrest;Generalised Tonic-Clonic Seizure;Hypoxic-Ischaemic Encephalopathy;Brain Injury;Pulse Absent;Brain Stem Haemorrhage;Thrombosis;Apnoeic Attack;Pulmonary Embolism;Tachycardia,Serious,Other Outcomes;Died;Hospitalized,Male,-,2/5/2015,Expedited,36,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/21/2015,1/23/2015,US,Not Specified,US-APOTEX-2015AP005445,\"Mowry JB; Spyker DA, Cantilena Jr. LR, McMillan N, Ford M. 2013 Annual Report of the American Association of Poison Control Centers \\x92 National Poison Data System (NPDS):31st Annual Report. CLINICAL TOXICOLOGY. 2014;52:1032-1283\",-\\n10948046,-,Lamotrigine;Paroxetine;Herbals\\\\Mitragynine,-,Pulmonary Embolism;Pulmonary Infarction;Toxicity To Various Agents;Hypoxic-Ischaemic Encephalopathy;Thrombosis;Brain Stem Haemorrhage;Brain Death,Serious,Other Outcomes;Died,Not Specified,-,3/24/2015,Expedited,Not Specified,Not Specified,Cipla,Healthcare Professional,Not Specified,-,3/13/2015,3/24/2015,US,Not Specified,US-CIPLA LTD.-2015US02218,\"Mowry J.B., Spyker D.A., Cantilena L.R., Mcmillan N, Ford M. 2013Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 31st Annual Report. Clinical Toxicology. 2014;52:1032-1283\",-\\n10712257,-,Lamotrigine;Herbals\\\\Mitragynine;Paroxetine,Product Used For Unknown Indication,Generalised Tonic-Clonic Seizure;Death;Tachycardia;Pulmonary Embolism;Brain Injury;Hypoxic-Ischaemic Encephalopathy;Brain Stem Haemorrhage;Cardio-Respiratory Arrest;Pulmonary Infarction;Drug Abuse,Serious,Died;Other Outcomes;Hospitalized,Male,2013,2/11/2015,Expedited,36,Not Specified,Par,Healthcare Professional,Not Specified,-,2/2/2015,1/14/2015,US,Not Specified,\"US-PAR PHARMACEUTICAL, INC-2015SCPR009593\",\"Mowry J.B., Spyker D.A., Cantilena JR L.R., Mcmillan N., Ford M.. 2013 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 31st Annual Report. Clinical Toxicology. 2014;52 (10):1032-1283\",-\\n10861525,Venlafaxine,Diphenhydramine Hydrochloride;Venlafaxine Hydrochloride;Herbals\\\\Mitragynine;Mirtazapine;Omeprazole;Alcohol,Product Used For Unknown Indication,Urinary Retention;Toxicity To Various Agents;Pulmonary Oedema,Serious,Died,Male,-,3/3/2015,Expedited,24,Not Specified,Mcneil,Healthcare Professional,Not Specified,Loperamide,2/26/2015,2/24/2015,US,Not Specified,US-JNJFOC-20150213670,\"McIntyre IM, Trochta A, Stolberg S, Campman SC. Mitragynine kratom related fatality: a case report with postmortem concentrations. Journal of Analytical Toxicology 2015;39(2):152-155.\",-\\n10698706,Venlafaxine,Venlafaxine Hydrochloride;Diphenhydramine Hydrochloride;Mirtazapine;Alcohol;Herbals\\\\Mitragynine,Depression,Pulmonary Congestion;Toxicity To Various Agents;Unresponsive To Stimuli;Urinary Retention;Pulmonary Oedema;Vomiting;Feeling Cold,Serious,Died;Other Outcomes,Male,-,1/9/2015,Expedited,24,Not Specified,Bayer,Healthcare Professional,Not Specified,Omeprazole,1/8/2015,1/8/2015,US,Not Specified,US-BAYER-2014-191469,\"McIntyre IM, Trochta A, Stolberg S, Campman SC. Mitragynine \\'Kratom\\' Related Fatality: A Case Report with Postmortem Concentrations. Journal of Analytical Toxicology. 2014;0:1-4\",-\\n10867680,Venlafaxine Hcl,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine;Mirtazapine;Diphenhydramine,-,Pulmonary Congestion;Toxicity To Various Agents;Accidental Overdose,Serious,Hospitalized;Died,Male,-,2/26/2015,Expedited,24,Not Specified,Pfizer,Healthcare Professional,Not Specified,Omeprazole,2/18/2015,2/25/2015,US,Not Specified,US-PFIZER INC-2015064762,\"McIntyre I M.. Mitragynine \"\"Kratom\\' Related Fatality: A Case Report with Postmortem Concentrations. Journal of Analytical Toxicology. 2015;39 (2):152-155\",-\\n10884035,-,Paroxetine;Lamotrigine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Apnoea;Drug Abuse;Fall;Poisoning;Generalised Tonic-Clonic Seizure;International Normalised Ratio Increased;Toxicity To Various Agents;Pulmonary Infarction;Brain Death;Brain Injury;Venous Thrombosis;Cardiac Arrest;Brain Stem Haemorrhage;Mydriasis;Brain Oedema;Pulmonary Embolism;Unresponsive To Stimuli;Hypoxic-Ischaemic Encephalopathy;Oxygen Saturation Decreased;Tachycardia,Serious,Died,Male,2013,2/26/2015,Expedited,36,Not Specified,Arbor Pharmaceuticals,Healthcare Professional,\"Health Professional ,Literature\",-,2/9/2015,2/26/2015,Not Specified,Not Specified,ABR_02013_2015,-,-\\n11157587,-,Venlafaxine Hydrochloride;Mirtazapine;Alcohol;Herbals\\\\Mitragynine;Diphenhydramine,Antidepressant Therapy,Pulmonary Congestion;Toxicity To Various Agents;Pulmonary Oedema;Accidental Death;Blood Ethanol Increased;Vomiting;Urinary Retention;Unresponsive To Stimuli,Serious,Died,Male,-,6/1/2015,Expedited,24,Not Specified,Sanofi,Healthcare Professional,\"Health Professional ,Literature\",-,5/20/2015,6/1/2015,Not Specified,Not Specified,2015SA070635,-,-\\n11771645,-,Buprenorphine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Wrong Product Administered;Drug Screen Negative,Serious,Other Outcomes,Male,26-Oct-2015,11/23/2015,Direct,42,153 LB,-,Consumer,Consumer,Hydrocodone;Gabapentin;Propranolol,-,11/23/2015,Not Specified,Y,-,-,-\\n13066348,Imodium,Loperamide Hydrochloride;Quinidine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Interaction;Toxicity To Various Agents,Serious,Died,Not Specified,-,12/27/2016,Expedited,33,Not Specified,Sandoz,Healthcare Professional,Not Specified,-,12/15/2016,12/27/2016,US,Not Specified,PHHY2016US175737,\"Bishop-Freeman SC, Feaster MS, beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-related deaths in North Carolina.. JOURNAL OF ANALYTICAL TOXICOLOGY. 2016;40(8):677-86\",-\\n13066343,Imodium,Loperamide Hydrochloride;Tramadol;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Male,-,12/27/2016,Expedited,24,Not Specified,Sandoz,Healthcare Professional,Not Specified,-,12/15/2016,12/27/2016,US,Not Specified,PHHY2016US175730,\"Bishop-Freeman SC, Feaster MS, beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-related deaths in North Carolina.. JOURNAL OF ANALYTICAL TOXICOLOGY. 2016;40(8):677-86\",-\\n13066333,Propranolol;Imodium,Loperamide Hydrochloride;Citalopram;Propranolol Hydrochloride;Herbals\\\\Mitragynine;Quinidine,Product Used For Unknown Indication,Toxicity To Various Agents;Drug Interaction,Serious,Died,Not Specified,-,12/27/2016,Expedited,37,Not Specified,Sandoz,Healthcare Professional,Not Specified,-,12/15/2016,12/27/2016,US,Not Specified,PHHY2016US175739,\"Bishop-Freeman SC, Feaster MS, beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-related deaths in North Carolina.. JOURNAL OF ANALYTICAL TOXICOLOGY. 2016;40(8):677-86\",-\\n12850962,-,Herbals\\\\Mitragynine;Tramadol;Loperamide,Drug Abuse;Product Used For Unknown Indication,Drug Interaction;Cardiomegaly;Drug Abuse;Accidental Overdose,Serious,Died,Male,-,10/17/2016,Expedited,24,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,10/11/2016,10/17/2016,US,Not Specified,US-JNJFOC-20161010807,\"Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-Related Deaths in North Carolina. Journal of Analytical Toxicology 2016;40/8:677-686.\",-\\n12851019,-,Herbals\\\\Mitragynine;Quinidine;Quinine;Loperamide,Drug Abuse;Product Used For Unknown Indication,Drug Abuse;Drug Interaction;Accidental Overdose,Serious,Died,Not Specified,-,10/18/2016,Expedited,33,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,10/11/2016,10/17/2016,US,Not Specified,US-JNJFOC-20161010814,\"Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-Related Deaths in North Carolina. Journal of Analytical Toxicology 2016;40/8:677-686.\",-\\n12850992,Propranolol,Propranolol Hydrochloride;Herbals\\\\Mitragynine;Loperamide;Cannabis Sativa Subsp. Indica Top;Quinine;Citalopram,Drug Abuse;Product Use Issue;Product Used For Unknown Indication,Drug Interaction;Accidental Overdose;Drug Abuse,Serious,Died,Not Specified,-,10/17/2016,Expedited,37,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,10/11/2016,10/17/2016,US,Not Specified,US-JNJFOC-20161010815,\"Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-Related Deaths in North Carolina. Journal of Analytical Toxicology 2016;40(8):677-686.\",-\\n13059371,-,Loperamide;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse;Drug Interaction;Accidental Overdose;Toxicity To Various Agents,Serious,Died,Not Specified,-,12/23/2016,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,Tramadol,12/15/2016,12/23/2016,US,Not Specified,US-MYLANLABS-2016M1057231,\"Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-related deaths in North Carolina. J-Anal-Toxicol 2016;40(8):677-686.\",-\\n13068630,Propranolol,Propranolol Hydrochloride;Herbals\\\\Mitragynine;Loperamide;Quinine;Citalopram;Quinidine,Product Used For Unknown Indication,Drug Abuse;Accidental Overdose;Drug Interaction;Toxicity To Various Agents,Serious,Died,Not Specified,-,12/28/2016,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,12/15/2016,12/28/2016,US,Not Specified,US-MYLANLABS-2016M1057167,\"Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-related deaths in North Carolina. J-Anal-Toxicol 2016;40(8):677-686.\",-\\n12561455,Venlafaxine,Venlafaxine Hydrochloride;Diphenhydramine;Herbals\\\\Mitragynine;Alcohol;Mirtazapine,-,Toxicity To Various Agents;Urinary Retention;Pulmonary Congestion;Drug Interaction;Unresponsive To Stimuli;Vomiting;Pulmonary Oedema,Serious,Died,Male,Mar-2015,7/15/2016,Expedited,24,Not Specified,Osmotica,Healthcare Professional,Not Specified,Omeprazole;Loperamide,6/30/2016,7/15/2016,US,Not Specified,US-OSMOTICA_PHARMACEUTICAL_US_LLC-POI0573201600030,-,-\\n12639365,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine;Alcohol;Mirtazapine;Diphenhydramine,-,Depression;Pulmonary Oedema;Toxicity To Various Agents;Urinary Retention;Unresponsive To Stimuli;Fatigue;Accidental Death,Serious,Died,Male,27-May-2014,8/9/2016,Direct,24,Not Specified,-,Healthcare Professional,Not Specified,-,-,8/9/2016,Not Specified,Not Specified,-,-,-\\n12639579,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine;Alprazolam,-,Scar;Respiratory Arrest;Unresponsive To Stimuli;Puncture Site Reaction;Toxicity To Various Agents;Accidental Death,Serious,Died,Male,08-Mar-2015,8/9/2016,Direct,22,Not Specified,-,Healthcare Professional,Health Professional,-,-,8/9/2016,Not Specified,Not Specified,-,-,-\\n12639316,-,Alcohol;Herbals\\\\Mitragynine;Citalopram,-,Chest Injury;Gun Shot Wound;Traumatic Lung Injury;Suicidal Ideation;Alcoholism;Homicide;Aortic Injury,Serious,Died,Male,27-Mar-2015,8/9/2016,Direct,55,Not Specified,-,Healthcare Professional,Not Specified,-,-,8/9/2016,Not Specified,Not Specified,-,-,-\\n12639421,-,Alprazolam;Clonazepam;Fentanyl;Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Left Ventricular Hypertrophy;Drug Screen Positive;Urinary Retention;Oedema Peripheral;Respiratory Arrest;Pulmonary Congestion;Accidental Death,Serious,Died,Male,23-Apr-2015,8/9/2016,Direct,31,Not Specified,-,Healthcare Professional,Health Professional,-,-,8/9/2016,Not Specified,Not Specified,-,-,-\\n12639594,Fluoxetine;Trazodone,Trazodone Hydrochloride;Herbals\\\\Mitragynine;Fluoxetine Hydrochloride;Gabapentin;Morphine;Cannabis Sativa Subsp. Indica Top,-,Toxicity To Various Agents;Unresponsive To Stimuli;Cough;Deep Vein Thrombosis;Pulmonary Embolism;Arteriosclerosis Coronary Artery;Nephrosclerosis;Dilated Cardiomyopathy;Pulmonary Infarction;Pneumonia;Hepatic Steatosis,Serious,Died,Male,16-Jun-2015,8/9/2016,Direct,43,Not Specified,-,Healthcare Professional,Health Professional,-,-,8/9/2016,Not Specified,Not Specified,-,-,-\\n12639302,-,Herbals\\\\Mitragynine;Carbamazepine,-,Blood Alcohol Increased;Pulmonary Congestion;Substance Abuse;Toxicity To Various Agents;Pulmonary Oedema;Accidental Death,Serious,Died,Male,02-Jul-2015,8/9/2016,Direct,45,Not Specified,-,Healthcare Professional,Not Specified,-,-,8/9/2016,Not Specified,Not Specified,-,-,-\\n12639332,-,Alprazolam;Alcohol;Chlordiazepoxide;Morphine;Nordazepam;Demoxepam;Herbals\\\\Mitragynine;Citalopram,-,Alcohol Poisoning;Toxicity To Various Agents;Accidental Death;Injury Associated With Device,Serious,Died,Male,19-Jul-2015,8/9/2016,Direct,23,Not Specified,-,Healthcare Professional,Not Specified,-,-,8/9/2016,Not Specified,Not Specified,-,-,-\\n12639556,Zolpidem,Zolpidem Tartrate;Quetiapine;Herbals\\\\Mitragynine;Alcohol,-,Completed Suicide;Fracture;Wound;Asphyxia;Toxicity To Various Agents;Haemorrhage,Serious,Died,Male,14-Sep-2015,8/9/2016,Direct,19,Not Specified,-,Healthcare Professional,Health Professional,-,-,8/9/2016,Not Specified,Not Specified,-,-,-\\n14290383,-,Diphenhydramine;Bupropion;Herbals\\\\Mitragynine;Alcohol;Dextromethorphan,Product Used For Unknown Indication,Death;Intentional Product Misuse,Serious,Died,Male,-,12/15/2017,Expedited,27,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,11/30/2017,12/15/2017,US,Not Specified,US-ALVOGEN-2017-ALVOGEN-094441,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 34th Annual Report. Clin Toxicol (Phila). 2017 Dec; 55(10):1072-1252.\",-\\n13421666,Fluoxetine,Fluoxetine Hydrochloride;Herbals\\\\Mitragynine;Triazolam;Quetiapine;Lorazepam;Olanzapine;Pregabalin;Pipamperone;Etizolam,Product Used For Unknown Indication;Substance Use,Loss Of Consciousness;Aspiration,Serious,Died,Male,-,4/10/2017,Expedited,22,Not Specified,Sandoz,Healthcare Professional,Not Specified,-,3/28/2017,4/10/2017,DE,Not Specified,PHHY2017DE051635,\"Domingo O, Roider G, Stover A, Graw M, Musshoff F, Sachs H, et al.. Mitragynine concentrations in two fatalities. FORENSIC SCIENCE INTERNATIONAL. 2017;271:e1-e7\",-\\n13407030,Fluoxetine,Fluoxetine Hydrochloride;Pregabalin;Herbals\\\\Mitragynine;Etizolam;Pipamperone;Quetiapine;Triazolam;Olanzapine;Lorazepam,Product Used For Unknown Indication,Aspiration;Loss Of Consciousness;Fall;Haematoma;Pulmonary Oedema;Overdose;Humerus Fracture,Serious,Other Outcomes;Died,Not Specified,-,4/16/2017,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,4/5/2017,4/5/2017,DE,Not Specified,DE-MYLANLABS-2017M1021108,\"Domingo O, Roider G, Stover A, Graw M, Musshoff F, Sachs H, et al. Mitragynine concentrations in two fatalities. Forensic-Sci-Int 2017;271:e1-e7.\",-\\n13078751,Propranolol,Propranolol Hydrochloride;Loperamide;Herbals\\\\Mitragynine;Citalopram;Quinine Sulfate;Quinidine,-,Accidental Overdose;Toxicity To Various Agents;Drug Interaction;Drug Abuse,Serious,Died,Not Specified,-,1/2/2017,Expedited,37,Not Specified,Teva,Healthcare Professional,Not Specified,-,12/26/2016,1/2/2017,US,Not Specified,US-TEVA-725444USA,\"Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-related deaths in North Carolina. J-Anal-Toxicol 2016;40(8):677-686.\",-\\n13078750,-,Herbals\\\\Mitragynine;Quinine Sulfate;Loperamide;Quinidine,-,Drug Abuse;Accidental Overdose;Toxicity To Various Agents;Drug Interaction,Serious,Died,Not Specified,-,1/2/2017,Expedited,33,Not Specified,Teva,Healthcare Professional,Not Specified,-,12/26/2016,1/2/2017,US,Not Specified,US-TEVA-725443USA,\"Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-related deaths in North Carolina. J-Anal-Toxicol 2016;40(8):677-686.\",-\\n13513333,-,Herbals\\\\Mitragynine;Loperamide,Product Used For Unknown Indication,Drug Abuse;Accidental Overdose;Drug Interaction,Serious,Other Outcomes;Died,Male,-,5/4/2017,Expedited,24,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,Tramadol,4/20/2017,5/4/2017,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2017US-139677,\"Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO et al. Loperamide-related deaths in North Carolina. J Anal Toxicol. 2016;40(8):677-686\",-\\n13513320,Propranolol,Propranolol Hydrochloride;Loperamide;Herbals\\\\Mitragynine;Citalopram;Quinine,Product Used For Unknown Indication,Drug Interaction;Accidental Overdose;Drug Abuse,Serious,Other Outcomes;Died,Not Specified,-,5/4/2017,Expedited,37,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,4/20/2017,5/4/2017,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2017US-139634,\"Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO et al. Loperamide-related deaths in North Carolina. J Anal Toxicol. 2016;40(8):677-686\",-\\n13516276,-,Quinine;Loperamide;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Accidental Overdose;Drug Abuse;Drug Interaction,Serious,Died;Other Outcomes,Not Specified,-,5/5/2017,Expedited,33,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,4/20/2017,5/5/2017,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2017US-139633,\"Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO et al. Loperamide-related deaths in North Carolina. J Anal Toxicol. 2016;40(8):677-686\",-\\n13080823,Propranolol,Propranolol Hydrochloride;Herbals\\\\Mitragynine;Quinine;Citalopram;Loperamide,Product Used For Unknown Indication,Drug Interaction;Accidental Overdose;Toxicity To Various Agents,Serious,Died,Not Specified,-,1/3/2017,Expedited,37,Not Specified,Lupin,Healthcare Professional,Not Specified,-,12/20/2016,1/3/2017,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2017-00017,-,-\\n13079564,-,Herbals\\\\Mitragynine;Loperamide;Quinine,Product Used For Unknown Indication,Toxicity To Various Agents;Accidental Overdose;Drug Interaction,Serious,Died,Not Specified,-,1/3/2017,Expedited,33,Not Specified,Lupin,Healthcare Professional,Not Specified,-,12/20/2016,1/3/2017,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2017-00016,-,-\\n13395314,Nucynta;Remeron,Mirtazapine;Herbals\\\\Mitragynine;Tapentadol Hydrochloride,Depression;Insomnia;Intervertebral Disc Protrusion,Bedridden;Contraindication To Medical Treatment;Serotonin Syndrome,Serious,Other Outcomes;Life Threatening,Male,28-Mar-2017,4/1/2017,Direct,42,84.6 KG,Fda-Ctu,Consumer,Consumer,Dalmane;Clonazepam;Aspirin;Adderall;Trazodone,-,4/1/2017,US,Not Specified,-,-,-\\n13929400,Contrave,Bupropion Hydrochloride\\\\Naltrexone Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Withdrawal Syndrome;Drug Interaction,Serious,Hospitalized,Not Specified,04-May-2017,9/1/2017,Expedited,Not Specified,Not Specified,Orexigen Therapeutics,Consumer,Not Specified,-,8/18/2017,9/1/2017,US,Not Specified,\"US-OREXIGEN THERAPEUTICS, INC.-2025430\",-,-\\n14190720,-,Herbals\\\\Mitragynine,Drug Dependence,Overdose,Serious,Died,Male,26-Dec-2016,11/14/2017,Direct,22,Not Specified,Fda-Ctu,Consumer,Consumer,Xanax;Unspecified Ingredient,-,11/14/2017,US,Not Specified,-,-,-\\n14258558,-,Herbals\\\\Mitragynine,Pain,Anxiety;Physical Assault;Drug Withdrawal Syndrome;Drug Dependence;Hostility;Agitation,Non-Serious,Non-Serious,Male,01-Mar-2016,12/5/2017,Direct,24,90 KG,Fda-Ctu,Consumer,Consumer,Unspecified Ingredient;Celexa,-,12/5/2017,US,Not Specified,-,-,-\\n14331847,-,Herbals\\\\Mitragynine,Pain,Drug Dependence;Socioeconomic Precarity;Seizure;Impaired Work Ability,Serious,Hospitalized,Male,27-Oct-2017,12/27/2017,Direct,31,53.55 KG,Fda-Ctu,Consumer,Consumer,Seroquel;Xanax,-,12/27/2017,US,Not Specified,-,-,-\\n14343116,-,Herbals\\\\Mitragynine,Substance Use,Restlessness;Withdrawal Syndrome;Loss Of Employment;Nausea;Drug Dependence;Socioeconomic Precarity;Insomnia;Suicidal Ideation;Impaired Work Ability;Depression,Serious,Other Outcomes;Disabled,Male,05-Dec-2015,12/31/2017,Direct,33,86.4 KG,Fda-Ctu,Consumer,Consumer,Parnate,-,12/31/2017,US,Not Specified,-,-,-\\n14157394,-,Herbals\\\\Mitragynine,Anxiety;Depression,Generalised Tonic-Clonic Seizure,Serious,Hospitalized;Life Threatening;Other Outcomes,Male,26-Oct-2017,11/1/2017,Direct,35,54 KG,Fda-Ctu,Consumer,Consumer,Lamictal;Keppra;Melatonin,-,11/1/2017,US,Not Specified,-,-,-\\n14204882,-,Herbals\\\\Mitragynine,Anxiety,Pulse Absent;Marital Problem;Respiratory Arrest;Drug Dependence;Generalised Tonic-Clonic Seizure;Brain Death;Overdose,Serious,Died;Hospitalized,Male,14-Dec-2013,11/18/2017,Direct,36,99 KG,Fda-Ctu,Consumer,Consumer,Lamictal,-,11/18/2017,US,Not Specified,-,-,-\\n14037602,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Sudden Death,Serious,Died,Male,08-May-2017,10/3/2017,Direct,39,77.85 KG,Fda-Ctu,Consumer,Consumer,-,-,10/3/2017,US,Not Specified,-,-,-\\n14180919,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Lethargy;Hepatic Enzyme Increased;Jaundice,Serious,Hospitalized;Other Outcomes,Male,07-Nov-2017,11/8/2017,Direct,26,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,11/8/2017,US,Not Specified,-,-,-\\n14194942,-,Herbals\\\\Mitragynine,-,Haemorrhage;Somnambulism;Skin Laceration;Eye Contusion;Sleep Terror;Fall;Panic Reaction;Scar,Serious,Other Outcomes,Female,02-Jun-2016,11/15/2017,Direct,40,58.5 KG,Fda-Ctu,Consumer,Consumer,-,-,11/15/2017,US,Not Specified,-,-,-\\n14212085,-,Herbals\\\\Mitragynine,Arthralgia;Depression,\"Vomiting;Yellow Skin;Nasopharyngitis;Drug Abuse;Nightmare;Drug Withdrawal Syndrome;Loss Of Personal Independence In Daily Activities;Hallucination, Auditory;Tremor;Nausea;Crying\",Serious,Other Outcomes,Male,09-Mar-2016,11/21/2017,Direct,46,81 KG,Fda-Ctu,Consumer,Consumer,-,-,11/21/2017,US,Not Specified,-,-,-\\n14291010,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,06-Aug-2017,12/15/2017,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,12/15/2017,Not Specified,Not Specified,-,-,-\\n14291011,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,12/15/2017,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,12/15/2017,Not Specified,Not Specified,-,-,-\\n15338188,-,Paroxetine;Lamotrigine;Quetiapine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Death,Serious,Died,Not Specified,-,8/31/2018,Expedited,Not Specified,Not Specified,Apotex,Healthcare Professional,Not Specified,-,7/20/2018,8/31/2018,US,Not Specified,US-APOTEX-2018AP019264,\"Noori M, Hendrickson R, Hatten B.. Kratom: Natural painkiller or herbal enemy?. Clinical Toxicology. 2018;56(6):574\",-\\n15195288,-,Paroxetine;Lamotrigine;Quetiapine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Death,Serious,Other Outcomes;Died,Not Specified,-,7/25/2018,Expedited,Not Specified,Not Specified,Glaxosmithkline,Healthcare Professional,Not Specified,-,7/20/2018,7/25/2018,US,Not Specified,US-GLAXOSMITHKLINE-US2018132304,\"Noori M, Hendrickson R, Hatten B. Kratom: Natural painkiller or herbal enemy?. Clinical Toxicology. 2018;56(6):574. DOI: 10.1080/15563650.2018.1457818.\",-\\n15289168,-,Lamotrigine;Paroxetine;Quetiapine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Death,Serious,Died,Not Specified,-,8/17/2018,Expedited,Not Specified,Not Specified,Sciegen,Healthcare Professional,Not Specified,-,8/9/2018,8/17/2018,US,Not Specified,US-SCIEGEN PHARMACEUTICALS INC-2018SCILIT00549,\"Monica Noori, Robert Hendrickson, Benjamin Hatten et al.. Kratom: Natural painkiller or herbal enemy?.. Clinical Toxicology. 122\",-\\n14378666,-,Phencyclidine;Bupropion;Herbals\\\\Mitragynine;Paroxetine;Delorazepam,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Life Threatening;Other Outcomes;Died,Male,-,1/12/2018,Expedited,21,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,12/29/2017,1/12/2018,US,Not Specified,US-AUROBINDO-AUR-APL-2018-001673,\"Mitchell-Mata C, Thomas B, Peterson B, Couper F.. Two fatal intoxications involving 3-methoxyphencyclidine. Journal of Analytical Toxicology.. 2017;41(6):503-7\",-\\n14378661,-,Delorazepam;Bupropion;3-Methoxyphencyclidine;Alcohol;Paroxetine;Herbals\\\\Mitragynine,-,Unresponsive To Stimuli;Toxicity To Various Agents,Serious,Died;Other Outcomes,Not Specified,-,1/12/2018,Expedited,Not Specified,Not Specified,Cipla,Healthcare Professional,Not Specified,-,12/29/2017,1/12/2018,US,Not Specified,US-CIPLA LTD.-2018US00778,\"Mitchell-Mata C, Thomas B, Peterson B, Couper F.. Two fatal intoxications involving 3-methoxyphencyclidine. Journal of Analytical Toxicology. 2017;41(6):503-507\",-\\n14354167,-,3-Methoxyphencyclidine;Bupropion;Herbals\\\\Mitragynine;Delorazepam;Paroxetine,Product Used For Unknown Indication,Toxicity To Various Agents;Substance Abuse;Unresponsive To Stimuli,Serious,Other Outcomes;Died,Male,-,4/22/2018,Expedited,21,Not Specified,Apotex,Healthcare Professional,Not Specified,-,3/14/2018,1/5/2018,US,Not Specified,US-APOTEX-2018AP005109,\"Mitchell-Mata C, Thomas B, Peterson B, Couper F.. Two fatal intoxications involving 3-methoxyphencyclidine. doi: 10.1093/jat/bkx048. Journal of Analytical Toxicology. 2017;41(6):503-507\",-\\n14379566,-,3-Methoxyphencyclidine;Delorazepam;Bupropion;Paroxetine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died;Other Outcomes,Male,-,1/12/2018,Expedited,21,Not Specified,Lupin,Healthcare Professional,Not Specified,-,12/29/2017,1/12/2018,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2017-07801,\"Mitchell-Mata C, Thomas B, Peterson B, Couper F. Two fatal intoxications involving 3-methoxyphencyclidine.. Journal of Analytical Toxicology. 2017;41(6):503-507\",-\\n14351639,-,3-Methoxyphencyclidine;Paroxetine;Herbals\\\\Mitragynine;Delorazepam;Bupropion,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Other Outcomes;Died;Life Threatening,Male,-,1/4/2018,Expedited,21,Not Specified,Glaxosmithkline,Healthcare Professional,Not Specified,-,12/22/2017,1/4/2018,US,Not Specified,US-GLAXOSMITHKLINE-US2018000016,\"Mitchell-Mata C, Thomas B, Peterson B, Couper F. Two fatal intoxications involving 3-methoxyphencyclidine. Journal of Analytical Toxicology. 2017;41(6):503-507; doi: 10.1093/jat/bkx048\",-\\n14355797,-,Bupropion;Paroxetine;Delorazepam;Herbals\\\\Mitragynine;Phencyclidine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Life Threatening;Died,Male,-,1/5/2018,Expedited,21,Not Specified,Sandoz,Healthcare Professional,Not Specified,-,1/2/2018,1/5/2018,US,Not Specified,PHHY2017US197643,\"Mitchell-Mata C, Thomas B, Peterson B, Couper F. Two fatal intoxications involving 3-methoxyphencyclidine. JOURNAL OF ANALYTICAL TOXICOLOGY. 2017;41(6):503-507\",-\\n14379276,-,3-Methoxyphencyclidine;Bupropion;Delorazepam;Paroxetine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died;Life Threatening;Other Outcomes,Male,-,1/12/2018,Expedited,21,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,12/29/2017,1/12/2018,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2017US-159563,\"Mitchell-Mata C, Thomas B, Peterson B, Couper F. Two fatal intoxications involving 3-methoxyphencyclidine. J Anal Toxicol. 2017;41(6):503-507\",-\\n13934406,-,Alcohol;Delorazepam;Herbals\\\\Mitragynine;Bupropion;Paroxetine;3-Methoxyphencyclidine,Completed Suicide,Toxicity To Various Agents,Serious,Died,Male,-,1/5/2018,Expedited,21,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,12/29/2017,9/5/2017,US,Not Specified,US-ALVOGEN-2017-ALVOGEN-093372,\"Mitchell-Mata C, Thomas B, Peterson B, Couper F. Two Fatal Intoxications Involving 3-Methoxyphencyclidine. J Anal Toxicol. 2017 Jul 1;41(6):503-507.\",-\\n15735523,-,Herbals\\\\Mitragynine;Quetiapine Fumarate,Product Used For Unknown Indication,Drug Interaction;Hyperthermia;Toxicity To Various Agents;Seizure,Serious,Other Outcomes;Died,Male,-,12/21/2018,Expedited,27,Not Specified,Alkem,Healthcare Professional,Not Specified,Valproic Acid,12/7/2018,12/18/2018,US,Not Specified,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2018-11093,\"Hughes RL.. Fatal combination of Mitragynine and Quetiapine - a case report with discussion of a potential herb-drug interaction.. Forensic Science, Medicine and Pathology. 2018;UNK:1-4\",-\\n15776230,-,Quetiapine Fumarate;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Inhibitory Drug Interaction;Seizure;Pyrexia;Toxicity To Various Agents;Herbal Interaction,Serious,Died;Other Outcomes,Male,-,12/31/2018,Expedited,27,Not Specified,Apotex,Healthcare Professional,Not Specified,Valproic Acid,12/21/2018,12/31/2018,US,Not Specified,US-APOTEX-2018AP028355,\"Hughes RL. Fatal combination of mitragynine and quetiapine-a case report with discussion of a potential herb-drug interaction. DOI: 10.1007/s12024-018-0049-9. Forensic Science, Medicine and Pathology. 2018\",-\\n15764127,-,Diphenhydramine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Completed Suicide,Serious,Other Outcomes;Died,Female,-,12/27/2018,Expedited,38,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,12/14/2018,12/27/2018,US,Not Specified,US-AUROBINDO-AUR-APL-2018-060672,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W.. 2016 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS):34th Annual Report. Clinical Toxicology. 2017;55(10):1072\\x961254\",-\\n15773913,-,Herbals\\\\Mitragynine;Diphenhydramine;Bupropion;Dextromethorphan;Alcohol,Product Used For Unknown Indication,Drug Abuse;Respiratory Arrest;Cardiac Arrest,Serious,Life Threatening;Died;Other Outcomes,Male,-,12/29/2018,Expedited,27,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,12/14/2018,12/29/2018,US,Not Specified,US-AUROBINDO-AUR-APL-2018-061555,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W.. 2016 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS):34th Annual Report. Clinical Toxicology. 2017;55(10):1072\\x961254\",-\\n15773700,-,Herbals\\\\Mitragynine;Alcohol;Acetaminophen\\\\Diphenhydramine Hydrochloride,Product Used For Unknown Indication,Intentional Product Misuse,Serious,Other Outcomes;Died,Female,-,12/29/2018,Expedited,53,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,12/14/2018,12/29/2018,US,Not Specified,US-AUROBINDO-AUR-APL-2018-063425,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W.. 2016 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS):34th Annual Report. Clinical Toxicology. 2017;55(10):1072\\x961254\",-\\n14955172,Alcohol (Alcohol),Herbals\\\\Mitragynine;Bupropion;Alcohol;Diphenhydramine;U-47700;Dextromethorphan,-,Drug Abuse;Toxicity To Various Agents,Serious,Died,Not Specified,-,5/31/2018,Expedited,Not Specified,Not Specified,Cipla,Healthcare Professional,Not Specified,-,5/17/2018,5/31/2018,US,Not Specified,US-CIPLA LTD.-2018US18723,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 34th Annual Report. Clinical toxicology. 2017;1 to 181\",-\\n14449343,Bupropion Hydrochloride Xl,Bupropion Hydrochloride;U-47700;Dextromethorphan;Diphenhydramine;Alcohol;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse;Cardio-Respiratory Arrest,Serious,Died,Male,-,1/27/2018,Expedited,27,Not Specified,Endo,Healthcare Professional,Not Specified,-,1/2/2018,1/27/2018,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2018-013940,\"Gummin D D, Mowry J B, Spyker D A, Brooks D E, Fraser M O, Banner W.. 2016 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 34th Annual Report. Clinical Toxicology. 2017;55 (10):1072-1254\",-\\n15768330,Methadone,Phentermine;Methadone Hydrochloride;Herbals\\\\Mitragynine;Morphine;Meperidine,Product Used For Unknown Indication,Vomiting;Toxicity To Various Agents;Respiration Abnormal,Serious,Died,Male,-,12/27/2018,Expedited,41,Not Specified,Sandoz,Healthcare Professional,Not Specified,-,12/24/2018,12/27/2018,US,Not Specified,PHHY2018US194459,\"Fagiola M, Hahn T, Avella J. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS). JOURNAL OF ANALYTICAL TOXICOLOGY. 2018;42:562-9\",-\\n15768328,-,Codeine;Butalbital;Alprazolam;Diacetylmorphine Hydrochloride;Morphine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents;Unresponsive To Stimuli,Serious,Died,Female,-,12/27/2018,Expedited,28,Not Specified,Sandoz,Healthcare Professional,Not Specified,-,12/24/2018,12/27/2018,US,Not Specified,PHHY2018US194478,\"Fagiola M, Hahn T, Avella J. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS). JOURNAL OF ANALYTICAL TOXICOLOGY. 2018;42:562-9\",-\\n15750330,Heroin,Diamorphine;Butalbital;Alprazolam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Death;Unresponsive To Stimuli;Toxicity To Various Agents,Serious,Died;Other Outcomes,Female,-,12/21/2018,Expedited,28,Not Specified,Apotex,Healthcare Professional,Not Specified,-,12/10/2018,12/21/2018,US,Not Specified,US-APOTEX-2018AP027493,\"Fagiola M, Hahn T, Avella J. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS). Journal of Analytical Toxicology. 2018;42 (8):562 - 569\",-\\n14637152,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Male,03-Jun-2016,3/14/2018,Direct,30,73.03 KG,Fda-Ctu,Healthcare Professional,Health Professional,Zolpidem;Citalopram;Alprazolam,-,3/14/2018,US,Not Specified,-,-,-\\n14842070,-,Herbals\\\\Mitragynine,-,Ventricular Fibrillation;Cardiac Arrest;Acute Myocardial Infarction,Serious,Other Outcomes;Hospitalized;Disabled;Life Threatening,Female,23-Apr-2018,5/1/2018,Direct,29,106 KG,Fda-Ctu,Healthcare Professional,Health Professional,Xanax;Ibuprofen,-,5/1/2018,US,Not Specified,-,-,-\\n14553247,-,Herbals\\\\Mitragynine,Pain,Withdrawal Syndrome;Socioeconomic Precarity;Marital Problem;Drug Intolerance;Pain,Serious,Disabled;Hospitalized,Male,03-Oct-2017,2/11/2018,Direct,Not Specified,99 KG,Fda-Ctu,Consumer,Consumer,Wellbutrin;Lexapro,-,2/11/2018,US,Not Specified,-,-,Yes\\n15306341,-,Herbals\\\\Mitragynine,Drug Dependence,Pain;Anxiety;Depression;Dehydration;Drug Dependence;Constipation;Acne;Agitation;Restless Legs Syndrome;Hyperhidrosis;Drug Withdrawal Syndrome;Vomiting,Serious,Disabled,Male,07-Aug-2018,8/10/2018,Direct,34,99 KG,Fda-Ctu,Consumer,Consumer,Wellbutrin;Buspirone Hydrochloride;Effexor,-,8/10/2018,US,Y,-,-,Yes\\n14892289,-,Herbals\\\\Mitragynine,Stress,Diarrhoea;Headache;Pyrexia;Muscle Spasms;Vomiting;Product Contamination;Chills,Serious,Disabled,Male,07-May-2018,5/9/2018,Direct,34,85.5 KG,Fda-Ctu,Consumer,Consumer,Vitamins;Fish Oil,-,5/9/2018,US,Not Specified,-,-,-\\n14359491,-,Herbals\\\\Mitragynine;Paroxetine;Bupropion;Delorazepam,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Other Outcomes;Died;Life Threatening,Male,-,1/5/2018,Expedited,21,Not Specified,Bausch And Lomb,Healthcare Professional,Not Specified,-,12/29/2017,1/5/2018,US,Not Specified,US-BAUSCH-BL-2018-000058,-,-\\n15561348,-,Herbals\\\\Mitragynine,-,Pneumonia;Hepatic Failure;Fatigue;Respiratory Failure;Malaise;Acute Kidney Injury;Pain;Hepatic Enzyme Increased,Serious,Life Threatening;Hospitalized;Disabled,Male,21-Oct-2018,10/26/2018,Direct,45,90 KG,Fda-Ctu,Consumer,Consumer,Vicks Nyquil;Vicks Dayquil,-,10/26/2018,US,Not Specified,-,-,-\\n14554687,-,Benzodiazepine;Herbals\\\\Mitragynine,-,Metabolic Acidosis;Pneumonia Aspiration;Haemodynamic Instability;Cardio-Respiratory Arrest;Substance Abuse;Body Temperature Decreased,Serious,Died,Female,-,2/20/2018,Direct,29,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,2/20/2018,US,Not Specified,-,-,-\\n14554625,-,Diphenhydramine;Herbals\\\\Mitragynine,-,Therapy Non-Responder;Seizure;Cardiac Arrest,Serious,Died,Female,-,2/20/2018,Direct,38,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,2/20/2018,US,Not Specified,-,-,-\\n14637202,-,Herbals\\\\Mitragynine,Drug Abuse,Alcohol Use;Accidental Death;Toxicity To Various Agents,Serious,Died,Male,27-May-2014,3/14/2018,Direct,24,73.48 KG,Fda-Ctu,Healthcare Professional,Health Professional,Venlafaxine;Mirtazapine,-,3/14/2018,US,Not Specified,-,-,-\\n14554565,Acetaminophen And Diphenhydramine Hydrochloride,Acetaminophen\\\\Diphenhydramine Hydrochloride;Alcohol;Herbals\\\\Mitragynine,-,Coagulopathy;Respiratory Failure;Renal Failure;Sepsis;Hypotension;Treatment Failure;Acute Hepatic Failure;Encephalopathy,Serious,Died,Female,-,2/20/2018,Direct,53,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,2/20/2018,US,Not Specified,-,-,-\\n14510227,-,Herbals\\\\Mitragynine,Back Disorder,Drug Dependence,Serious,Life Threatening;Other Outcomes;Disabled,Male,-,2/8/2018,Direct,34,Not Specified,Fda-Ctu,Consumer,Consumer,Unspecified Ingredient,-,2/8/2018,US,Not Specified,-,-,Yes\\n14665135,-,Herbals\\\\Mitragynine,Analgesic Therapy,Feeding Disorder;Gastrointestinal Disorder;Pyrexia;Flatulence;Abdominal Pain Upper;Nausea;Headache;Pain,Non-Serious,Non-Serious,Female,15-Mar-2018,3/19/2018,Direct,60,90 KG,Fda-Ctu,Consumer,Consumer,Unspecified Ingredient,-,3/19/2018,US,Not Specified,-,-,-\\n15744592,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Blood Urine Present;International Normalised Ratio Increased;Bleeding Time Prolonged,Serious,Life Threatening;Hospitalized,Male,26-Nov-2018,12/17/2018,Direct,50,98.5 KG,Fda-Ctu,Healthcare Professional,Health Professional,Testosterone;Levothyroxine;Lisinopril,-,12/17/2018,US,Not Specified,-,-,-\\n14820210,-,Herbals\\\\Mitragynine,Pain,Escherichia Infection;Product Contamination Microbial;Illness,Serious,Disabled,Female,19-Apr-2018,4/26/2018,Direct,31,65.25 KG,Fda-Ctu,Consumer,Consumer,Synthroid,-,4/26/2018,US,Y,-,-,-\\n14347378,-,Herbals\\\\Mitragynine,Pain,Drug Dependence,Serious,Other Outcomes,Male,-,1/2/2018,Direct,30,65.25 KG,Fda-Ctu,Consumer,Consumer,Suboxone,-,1/2/2018,US,Not Specified,-,-,-\\n14689578,Zoloft,Sertraline Hydrochloride;Herbals\\\\Mitragynine,Anxiety,Product Label Issue;Drug Level Increased,Serious,Died,Male,22-Apr-2016,3/27/2018,Direct,22,103.5 KG,Fda-Ctu,Consumer,Consumer,-,-,3/27/2018,US,Not Specified,-,-,-\\n14875716,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,11-Jan-2018,5/8/2018,Direct,41,98.1 KG,Fda-Ctu,Consumer,Consumer,Sertraline Hydrochloride,-,5/8/2018,US,Not Specified,-,-,-\\n14909154,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,11-Jan-2018,5/14/2018,Direct,41,98.1 KG,Fda-Ctu,Consumer,Consumer,Sertraline Hydrochloride,-,5/14/2018,US,Not Specified,-,-,-\\n14577749,-,Herbals\\\\Mitragynine,Drug Withdrawal Maintenance Therapy,Toxicity To Various Agents;Toxicologic Test Abnormal,Serious,Died,Male,05-Feb-2018,2/26/2018,Direct,19,72 KG,Fda-Ctu,Consumer,Consumer,Prozac,-,2/26/2018,US,Not Specified,-,-,-\\n15338870,-,Herbals\\\\Mitragynine,Anxiety,Seizure;Tremor;Withdrawal Syndrome;Cerebral Haemorrhage;Head Injury,Serious,Life Threatening;Hospitalized,Male,27-Aug-2018,8/29/2018,Direct,22,76.5 KG,Fda-Ctu,Consumer,Consumer,Prozac,-,8/29/2018,US,Not Specified,-,-,-\\n14637050,-,Herbals\\\\Mitragynine,Drug Diversion;Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Male,10-Mar-2017,3/14/2018,Direct,34,76.66 KG,Fda-Ctu,Healthcare Professional,Health Professional,Pregabalin;Oxycodone,-,3/14/2018,US,Not Specified,-,-,-\\n14759510,-,Herbals\\\\Mitragynine;Alcohol,-,Brain Death;Seizure;Brain Oedema;Brain Injury;Dialysis;Blood Methanol Increased;Product Complaint;Myocardial Infarction;Corneal Reflex Decreased;Alcohol Poisoning,Serious,Hospitalized;Died,Male,03-Apr-2018,4/13/2018,Direct,32,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,4/13/2018,US,Not Specified,-,-,-\\n14347379,-,Herbals\\\\Mitragynine,Neuropathy Peripheral,Mental Status Changes;Hepatic Failure;Jaundice;Seizure;Lethargy;Coma,Serious,Died;Hospitalized,Male,02-Jan-2018,1/2/2018,Direct,46,93 KG,Fda-Ctu,Healthcare Professional,Health Professional,Lisinopril;Metoprolol,-,1/2/2018,US,Not Specified,-,-,-\\n15346850,-,Herbals\\\\Mitragynine,Drug Dependence,Circulatory Collapse;Fall,Serious,Died;Life Threatening,Male,14-Aug-2018,8/30/2018,Direct,33,112.5 KG,Fda-Ctu,Consumer,Consumer,Lasix;Amitriptyline,-,8/30/2018,US,Not Specified,-,-,-\\n14637163,-,Herbals\\\\Mitragynine,Drug Diversion;Product Used For Unknown Indication,Toxicity To Various Agents;Accidental Death,Serious,Died,Male,06-Jul-2015,3/14/2018,Direct,45,68.49 KG,Fda-Ctu,Healthcare Professional,Health Professional,Lamotrigine;Atenolol;Lisinopril,-,3/14/2018,US,Not Specified,-,-,-\\n14784877,-,Herbals\\\\Mitragynine,Anxiety;Arthralgia,Abdominal Pain Upper;Muscle Spasms;Impaired Work Ability;Diarrhoea,Serious,Other Outcomes,Male,31-Mar-2018,4/18/2018,Direct,42,92.25 KG,Fda-Ctu,Consumer,Consumer,Imodium;Duloxetine;Pepto-Bismol;Ibuprofen;Tums,-,4/18/2018,US,Y,-,-,-\\n14637183,-,Herbals\\\\Mitragynine,Drug Diversion;Product Used For Unknown Indication,Toxicity To Various Agents;Accidental Death,Serious,Died,Male,23-Apr-2015,3/14/2018,Direct,31,89.81 KG,Fda-Ctu,Healthcare Professional,Health Professional,Ibuprofen,-,3/14/2018,US,Not Specified,-,-,-\\n14637209,-,Herbals\\\\Mitragynine,Drug Abuse,Toxicity To Various Agents,Serious,Died,Male,13-Mar-2017,3/14/2018,Direct,31,67.13 KG,Fda-Ctu,Healthcare Professional,Health Professional,Heroin;Gabapentin,-,3/14/2018,US,Not Specified,-,-,-\\n14635754,-,Herbals\\\\Mitragynine,Drug Withdrawal Maintenance Therapy;Pain,Loss Of Employment;Depressed Mood;Restless Legs Syndrome;Drug Ineffective;Impaired Quality Of Life;Anxiety;Insomnia;Drug Withdrawal Syndrome;Feeling Abnormal;Drug Dependence;Anger,Non-Serious,Non-Serious,Male,-,3/13/2018,Direct,26,68.04 KG,Fda-Ctu,Consumer,Consumer,Herbals;Herbals\\\\Withania Somnifera Root,-,3/13/2018,US,Not Specified,-,-,-\\n15704002,-,Herbals\\\\Mitragynine,-,Accidental Death;Toxicity To Various Agents;Asphyxia,Serious,Died,Male,08-Nov-2016,12/10/2018,Direct,27,Not Specified,Fda-Ctu,Not Specified,Not Specified,Guaifenesin;Tramadol;Diphenhydramine;Dextromethorphan;Oxycodone;Topiramate;Promethazine,-,12/10/2018,US,Not Specified,-,-,-\\n15748896,-,Herbals\\\\Mitragynine,Anxiety;Depression;Pain,Depression;Weight Decreased;Anxiety;Bone Pain;Tremor;Arthralgia;Decreased Appetite;Withdrawal Syndrome;Night Sweats,Serious,Other Outcomes,Female,13-Dec-2018,12/19/2018,Direct,52,Not Specified,Fda-Ctu,Consumer,Consumer,Gabapentin;Trazodone;Sertraline,-,12/19/2018,US,Not Specified,-,-,-\\n15367091,Diflucan,Fluconazole;Herbals\\\\Mitragynine;Nystatin,-,Culture Urine Positive;Klebsiella Test Positive;Bladder Disorder,Serious,Other Outcomes,Female,01-Aug-2018,9/10/2018,Direct,73,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/10/2018,US,Not Specified,-,-,-\\n14753471,-,Herbals\\\\Mitragynine,Drug Withdrawal Syndrome;Pain,Chest Pain,Serious,Died,Male,09-Apr-2018,4/10/2018,Direct,63,56.7 KG,Fda-Ctu,Consumer,Consumer,Flomax,-,4/10/2018,US,Not Specified,-,-,Yes\\n14764524,-,Herbals\\\\Mitragynine,Pain,Weight Decreased;Night Sweats;Pyrexia;Near Death Experience;Chills;Hot Flush;Vomiting;Constipation;Tremor;Gastroenteritis Salmonella;Feeling Abnormal;Decreased Appetite,Serious,Other Outcomes;Hospitalized;Disabled,Male,07-Mar-2018,4/15/2018,Direct,25,54 KG,Fda-Ctu,Consumer,Consumer,Excedrin;Tylenol,-,4/15/2018,US,Not Specified,-,-,Yes\\n14566812,-,Herbals\\\\Mitragynine,Anxiety,Euphoric Mood;Behaviour Disorder;Personality Change,Serious,Hospitalized,Male,17-Nov-2017,2/22/2018,Direct,42,72 KG,Fda-Ctu,Consumer,Consumer,Escitalopram,-,2/22/2018,US,Not Specified,-,-,Yes\\n15703751,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Accidental Death,Serious,Died,Male,23-Jul-2018,12/10/2018,Direct,29,Not Specified,Fda-Ctu,Not Specified,Not Specified,Diphenhydramine;Bupropion,-,12/10/2018,US,Not Specified,-,-,-\\n15704628,-,Herbals\\\\Mitragynine,-,Accidental Death;Toxicity To Various Agents,Serious,Died,Male,08-Jan-2017,12/10/2018,Direct,29,Not Specified,Fda-Ctu,Not Specified,Not Specified,Clonazepam;Hydroxyzine;Olanzapine;Cannabis Sativa Subsp. Indica Top;Sertraline;Temazepam,-,12/10/2018,US,Not Specified,-,-,-\\n15526393,-,Diphenhydramine Hydrochloride;Herbals\\\\Mitragynine;Fentanyl Citrate,-,Euphoric Mood;Homicide;Road Traffic Accident,Serious,Other Outcomes,Male,-,10/23/2018,Expedited,Not Specified,Not Specified,Pfizer,Consumer,Not Specified,Gabapentin;Percocet;Neurontin;Lexapro,10/17/2018,10/18/2018,US,Not Specified,US-PFIZER INC-2018424071,-,-\\n15781686,-,Herbals\\\\Mitragynine,-,Seizure;Dependence;Loss Of Consciousness,Serious,Life Threatening;Hospitalized,Female,30-Dec-2018,12/31/2018,Direct,32,56 KG,Fda-Ctu,Healthcare Professional,Health Professional,Carbamazepine;Disulfiram;Pregabalin;Vortioxetine Hydrobromide;Gabapentin;Diazepam,-,12/31/2018,US,Not Specified,-,-,-\\n15460471,-,Herbals\\\\Mitragynine,Pain,Anxiety;Adjustment Disorder With Depressed Mood,Serious,Disabled,Female,-,10/3/2018,Direct,62,103.5 KG,Fda-Ctu,Consumer,Consumer,Calcium;Synthroid;Inderal,-,10/3/2018,US,Not Specified,-,-,Yes\\n15703716,-,Herbals\\\\Mitragynine,-,Accidental Death;Toxicity To Various Agents,Serious,Died,Male,11-Jul-2016,12/7/2018,Direct,30,Not Specified,Fda-Ctu,Not Specified,Not Specified,Bupropion;Gabapentin;Clonidine;Hydroxyzine;Naltrexone;Diazepam,-,12/7/2018,US,Not Specified,-,-,-\\n15734028,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Accidental Death,Serious,Died,Male,01-Nov-2018,12/17/2018,Direct,27,Not Specified,Fda-Ctu,Not Specified,Not Specified,Bupropion,-,12/17/2018,US,Not Specified,-,-,-\\n15643588,Pseudoephedrine.,Pseudoephedrine Hydrochloride;Herbals\\\\Mitragynine,-,Accidental Death;Renal Artery Perforation;Poisoning,Serious,Died,Male,01-Oct-2018,11/21/2018,Direct,38,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,11/21/2018,US,Not Specified,-,-,-\\n15656009,-,Oxymorphone;Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died,Male,14-May-2015,11/23/2018,Direct,52,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,11/23/2018,US,Not Specified,-,-,-\\n15656003,Hydroxyzine,Clonazepam;Hydroxyzine Hydrochloride;Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died,Male,27-Oct-2018,11/23/2018,Direct,39,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,11/23/2018,US,Not Specified,-,-,-\\n15660102,-,Herbals\\\\Mitragynine;Diphenhydramine,-,Toxicity To Various Agents;Seizure,Serious,Died,Female,14-Aug-2017,11/26/2018,Direct,33,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,11/26/2018,US,Not Specified,-,-,-\\n15660099,-,Alprazolam;Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died,Male,02-Jan-2018,11/26/2018,Direct,27,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,11/26/2018,US,Not Specified,-,-,-\\n15704619,-,Herbals\\\\Mitragynine;U-47700,-,Overdose;Accidental Death,Serious,Died,Male,29-Feb-2016,12/10/2018,Direct,25,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,12/10/2018,US,Not Specified,-,-,-\\n15704622,-,Oxycodone;Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Accidental Death,Serious,Died,Female,29-Mar-2016,12/10/2018,Direct,53,Not Specified,Fda-Ctu,Not Specified,Not Specified,Fluoxetine;Pseudoephedrine.,-,12/10/2018,US,Not Specified,-,-,-\\n15703871,-,Herbals\\\\Mitragynine;Citalopram,-,Alcohol Poisoning;Toxicity To Various Agents;Accidental Death,Serious,Died,Male,12-Nov-2016,12/10/2018,Direct,24,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,12/10/2018,US,Not Specified,-,-,-\\n14637146,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Female,16-Jan-2017,3/14/2018,Direct,25,53.98 KG,Fda-Ctu,Healthcare Professional,Health Professional,Alprazolam;Sertraline,-,3/14/2018,US,Not Specified,-,-,-\\n14930211,-,Herbals\\\\Mitragynine,-,Alcohol Use;Headache,Serious,Died,Female,19-May-2018,5/22/2018,Direct,38,61.2 KG,Fda-Ctu,Healthcare Professional,Health Professional,Alcohol,-,5/22/2018,US,Not Specified,-,-,Yes\\n15703850,-,Oxycodone;Herbals\\\\Mitragynine,-,Alcohol Poisoning;Accidental Death;Toxicity To Various Agents,Serious,Died,Male,04-Nov-2017,12/10/2018,Direct,26,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,12/10/2018,US,Not Specified,-,-,-\\n15703855,-,Oxycodone;Herbals\\\\Mitragynine,-,Alcohol Poisoning;Accidental Death;Toxicity To Various Agents,Serious,Died,Male,24-Feb-2018,12/10/2018,Direct,32,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,12/10/2018,US,Not Specified,-,-,-\\n15723428,-,Herbals\\\\Mitragynine;Paroxetine,-,Accidental Death;Toxicity To Various Agents,Serious,Died,Male,22-Apr-2018,12/14/2018,Direct,36,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,12/14/2018,US,Not Specified,-,-,-\\n15734060,-,Herbals\\\\Mitragynine;Oxycodone,-,Drug Screen Positive;Toxicity To Various Agents;Breast Cancer Metastatic,Serious,Died,Female,31-Oct-2017,12/17/2018,Direct,50,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,Amitriptyline;Hydrocodone;Ephedrine,-,12/17/2018,US,Not Specified,-,-,-\\n14699565,-,Herbals\\\\Mitragynine,Back Pain,Abdominal Discomfort;Diarrhoea,Serious,Other Outcomes,Male,15-Feb-2018,3/29/2018,Direct,37 MTH,119.25 KG,Fda-Ctu,Consumer,Consumer,Advil,-,3/29/2018,US,Y,-,-,-\\n14674127,-,Herbals\\\\Mitragynine,Anxiety;Depression,Restless Legs Syndrome;Drug Abuser;Yawning;Lacrimation Increased;Rhinorrhoea;Withdrawal Syndrome;Formication,Serious,Other Outcomes,Female,22-Mar-2018,3/22/2018,Direct,35,52.2 KG,Fda-Ctu,Consumer,Consumer,Abilify;Wellbutrin;Topamax,-,3/22/2018,US,Not Specified,-,-,Yes\\n15765187,-,Herbals\\\\Mitragynine;Alprazolam,-,Toxicity To Various Agents,Serious,Died,Female,24-Apr-2018,12/26/2018,Direct,43,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,12/26/2018,US,Not Specified,-,-,-\\n14345719,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Screen Positive;Malaise;Near Death Experience;Accidental Overdose;Opiates Positive,Serious,Hospitalized,Female,02-Oct-2017,1/2/2018,Direct,45,45.36 KG,Fda-Ctu,Not Specified,Not Specified,-,-,1/2/2018,US,Not Specified,-,-,-\\n14345738,-,Herbals\\\\Mitragynine,Muscle Relaxant Therapy,Toxicity To Various Agents;Liver Injury;Jaundice;Pruritus;Chromaturia,Serious,Hospitalized,Male,18-Dec-2017,1/2/2018,Direct,35,82 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,1/2/2018,US,Not Specified,-,-,-\\n14367521,-,Herbals\\\\Mitragynine,Anxiety,Hepatotoxicity,Serious,Life Threatening,Male,18-Dec-2017,1/5/2018,Direct,25,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,1/5/2018,US,Not Specified,-,-,-\\n14501662,-,Herbals\\\\Mitragynine,Substance Use,Mydriasis;Seizure,Serious,Life Threatening;Hospitalized,Not Specified,03-Feb-2018,2/6/2018,Direct,17,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,2/6/2018,US,Not Specified,-,-,-\\n14510073,-,Herbals\\\\Mitragynine,Back Pain,Aspiration,Serious,Died,Male,19-Jan-2014,2/7/2018,Direct,Not Specified,54 KG,Fda-Ctu,Consumer,Consumer,-,-,2/7/2018,US,Not Specified,-,-,-\\n14510268,-,Herbals\\\\Mitragynine,-,Drug Dependence,Serious,Required Intervention;Other Outcomes,Male,-,2/8/2018,Direct,34,Not Specified,Fda-Ctu,Not Specified,Health Professional,-,-,2/8/2018,US,Not Specified,-,-,-\\n14553550,-,Herbals\\\\Mitragynine,-,Nausea;Abnormal Uterine Bleeding;Vaginal Haemorrhage,Non-Serious,Non-Serious,Female,-,2/14/2018,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,2/14/2018,US,Not Specified,-,-,-\\n14553541,-,Herbals\\\\Mitragynine,-,Abnormal Uterine Bleeding,Non-Serious,Non-Serious,Female,-,2/14/2018,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,2/14/2018,US,Not Specified,-,-,-\\n14554618,-,Herbals\\\\Mitragynine,-,Completed Suicide,Serious,Died,Male,16-Jul-2014,2/20/2018,Direct,20,73.94 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,2/20/2018,US,Not Specified,-,-,-\\n14554619,-,Herbals\\\\Mitragynine,-,Areflexia;Hypothermia;Rhabdomyolysis;Electroencephalogram Abnormal;Blood Creatine Phosphokinase Increased;Alanine Aminotransferase Increased;Aspartate Aminotransferase Increased,Serious,Died,Male,-,2/20/2018,Direct,22,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,2/20/2018,US,Not Specified,-,-,-\\n14613817,-,Herbals\\\\Mitragynine,Drug Rehabilitation,Asthenia;Drug Dependence;Panic Attack;Seizure,Serious,Required Intervention;Hospitalized,Male,08-Jan-2016,3/8/2018,Direct,32,86.18 KG,Fda-Ctu,Consumer,Consumer,-,-,3/8/2018,US,Not Specified,-,-,-\\n14637201,-,Herbals\\\\Mitragynine,Drug Diversion;Product Used For Unknown Indication,Accidental Death;Toxicity To Various Agents,Serious,Died,Male,08-Mar-2015,3/14/2018,Direct,22,88 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,3/14/2018,US,Not Specified,-,-,-\\n14637157,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Male,19-Jul-2015,3/14/2018,Direct,23,75.75 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,3/14/2018,US,Not Specified,-,-,-\\n14648750,-,Herbals\\\\Mitragynine,-,Incoherent;Gait Disturbance;Alcohol Use;Fall;Product Use Issue,Serious,Life Threatening,Not Specified,19-Feb-2018,3/16/2018,Direct,28,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,3/16/2018,US,Not Specified,-,-,-\\n14664687,-,Herbals\\\\Mitragynine,-,Drug Dependence,Serious,Other Outcomes,Male,01-Jan-2018,3/19/2018,Direct,34,58.5 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,3/19/2018,US,Not Specified,-,-,-\\n14659699,-,Herbals\\\\Mitragynine,-,Product Label Issue;Euphoric Mood;Vertigo;Nausea,Serious,Other Outcomes,Female,16-Mar-2018,3/19/2018,Direct,48,61.23 KG,Fda-Ctu,Consumer,Consumer,-,-,3/19/2018,US,Y,-,-,-\\n14679126,-,Herbals\\\\Mitragynine,Hypertension,Hyperhidrosis;Blood Pressure Decreased;Loss Of Consciousness;Respiratory Rate Decreased;Pallor;Intentional Product Misuse,Serious,Other Outcomes,Male,-,3/23/2018,Direct,37,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,3/23/2018,US,Not Specified,-,-,-\\n14690808,-,Herbals\\\\Mitragynine,-,Accidental Death;Toxicity To Various Agents,Serious,Died,Male,-,3/28/2018,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/28/2018,US,Not Specified,-,-,-\\n14690805,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,3/28/2018,Direct,25,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/28/2018,US,Not Specified,-,-,-\\n14690798,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,3/28/2018,Direct,38,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/28/2018,US,Not Specified,-,-,-\\n14690795,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Accidental Death,Serious,Died,Male,-,3/28/2018,Direct,40,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/28/2018,US,Not Specified,-,-,-\\n14690788,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,3/28/2018,Direct,33,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/28/2018,US,Not Specified,-,-,-\\n14690779,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,3/28/2018,Direct,36,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/28/2018,US,Not Specified,-,-,-\\n14690723,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,3/28/2018,Direct,23,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/28/2018,US,Not Specified,-,-,-\\n14690718,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Accidental Death,Serious,Died,Not Specified,-,3/28/2018,Direct,26,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/28/2018,US,Not Specified,-,-,-\\n14690713,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Accidental Death,Serious,Died,Not Specified,-,3/28/2018,Direct,30,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/28/2018,US,Not Specified,-,-,-\\n14699508,-,Herbals\\\\Mitragynine,Attention Deficit Hyperactivity Disorder,Drug Dependence,Serious,Other Outcomes,Male,-,3/29/2018,Direct,24,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,3/29/2018,US,Not Specified,-,-,-\\n14708204,-,Herbals\\\\Mitragynine,-,Salmonellosis;Recalled Product Administered;Myalgia,Non-Serious,Non-Serious,Not Specified,16-Nov-2017,4/2/2018,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,4/2/2018,US,Not Specified,-,-,-\\n14820204,-,Herbals\\\\Mitragynine,-,Diarrhoea;Illness;Recalled Product Administered;Gastritis,Non-Serious,Non-Serious,Female,-,4/3/2018,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,4/3/2018,US,Not Specified,-,-,-\\n14715448,-,Herbals\\\\Mitragynine,-,Diarrhoea;Abdominal Pain Upper,Non-Serious,Non-Serious,Male,-,4/3/2018,Direct,43,83.25 KG,Fda-Ctu,Consumer,Consumer,-,-,4/3/2018,US,Not Specified,-,-,-\\n14727666,-,Herbals\\\\Mitragynine,-,Drug Dependence;Weight Decreased;Influenza Like Illness,Serious,Other Outcomes,Male,-,4/5/2018,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,4/5/2018,US,Not Specified,-,-,-\\n14751053,-,Herbals\\\\Mitragynine,-,Nausea;Diarrhoea Haemorrhagic;Colitis Ulcerative;Pyrexia;Physical Product Label Issue;Mouth Ulceration;Diarrhoea;Vomiting;Drug Ineffective;Abdominal Pain;Oedema Peripheral,Serious,Required Intervention;Hospitalized,Female,Dec-2017,4/11/2018,Direct,49,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,4/11/2018,US,Not Specified,-,-,-\\n14753635,-,Herbals\\\\Mitragynine,-,Vomiting;Abdominal Discomfort,Non-Serious,Non-Serious,Not Specified,29-Mar-2018,4/12/2018,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,4/12/2018,US,Not Specified,-,-,-\\n14769203,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,05-Feb-2018,4/17/2018,Direct,19,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,4/17/2018,US,Not Specified,-,-,-\\n14784298,-,Herbals\\\\Mitragynine,-,Nausea;Pain;Illness;Muscle Spasms;Vomiting;Chills;Diarrhoea,Non-Serious,Non-Serious,Male,13-Apr-2018,4/20/2018,Direct,50,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,4/20/2018,US,Not Specified,-,-,-\\n14801101,-,Herbals\\\\Mitragynine,Stress,Drug Dependence,Serious,Other Outcomes,Female,01-Apr-2018,4/22/2018,Direct,39,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,4/22/2018,US,Not Specified,-,-,-\\n14892273,-,Herbals\\\\Mitragynine,Pain Management,Gastroenteritis Salmonella,Serious,Hospitalized,Male,06-May-2018,5/8/2018,Direct,41,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,5/8/2018,US,Not Specified,-,-,-\\n14895829,-,Herbals\\\\Mitragynine,-,Drug Dependence,Non-Serious,Non-Serious,Not Specified,-,5/15/2018,Direct,Not Specified,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,5/15/2018,US,Not Specified,-,-,-\\n14920117,-,Herbals\\\\Mitragynine,-,Unresponsive To Stimuli;Alcohol Use;Headache,Serious,Hospitalized;Disabled;Life Threatening,Not Specified,19-May-2018,5/19/2018,Direct,38,61.2 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,5/19/2018,US,Not Specified,-,-,Yes\\n14923707,-,Herbals\\\\Mitragynine,-,Gastroenteritis Salmonella;Nausea;Diarrhoea;Abdominal Pain Upper;Recalled Product Administered,Non-Serious,Non-Serious,Not Specified,09-Apr-2018,5/22/2018,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,5/22/2018,US,Not Specified,-,-,-\\n14933993,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died,Male,-,5/23/2018,Direct,26,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,5/23/2018,US,Not Specified,-,-,-\\n14972899,-,Herbals\\\\Mitragynine,-,Migraine;Visual Impairment;Loss Of Consciousness;Abdominal Distension;Abdominal Pain Upper;Vomiting;Job Dissatisfaction;Vision Blurred;Loss Of Personal Independence In Daily Activities,Serious,Other Outcomes,Female,22-Apr-2018,6/4/2018,Direct,39,49.9 KG,Fda-Ctu,Consumer,Consumer,-,-,6/4/2018,US,Not Specified,-,-,-\\n14995024,-,Herbals\\\\Mitragynine,-,Aspartate Aminotransferase Increased;Somnolence;Alanine Aminotransferase Increased;Blood Potassium Increased;Respiratory Failure;Respiratory Depression;Multi-Organ Disorder;Obesity;Obstructive Sleep Apnoea Syndrome;Hypoxia;Blood Creatinine;Ischaemia;Sepsis;Respiratory Acidosis;Oxygen Saturation Decreased;Cyanosis;Acute Kidney Injury;Liver Injury;Irritability;Dyspnoea;Hypotension,Serious,Hospitalized,Male,-,6/8/2018,Direct,43,Not Specified,Fda-Ctu,Not Specified,Health Professional,-,-,6/8/2018,US,Not Specified,-,-,-\\n15011391,-,Herbals\\\\Mitragynine,Drug Withdrawal Syndrome,Suicidal Ideation;Anxiety;Drug Withdrawal Syndrome;Drug Dependence,Non-Serious,Non-Serious,Male,08-Jun-2018,6/13/2018,Direct,34,56.25 KG,Fda-Ctu,Consumer,Consumer,-,-,6/13/2018,US,Not Specified,-,-,-\\n15017057,-,Herbals\\\\Mitragynine,-,Coronary Artery Stenosis;Cardiac Disorder;Cardiomegaly;Dilatation Ventricular;Dilatation Atrial;Toxicity To Various Agents,Serious,Died,Male,-,6/15/2018,Direct,38,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,6/15/2018,US,Not Specified,-,-,-\\n15017050,-,Herbals\\\\Mitragynine,-,Seizure,Serious,Other Outcomes,Male,-,6/15/2018,Direct,19,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,6/15/2018,US,Not Specified,-,-,-\\n15028581,-,Herbals\\\\Mitragynine,Anxiety;Depression,\"Hallucination, Auditory;Disturbance In Attention;Drug Dependence;Anxiety;Asocial Behaviour;Weight Decreased;Psychotic Disorder;Hallucination\",Serious,Other Outcomes;Hospitalized,Male,17-Dec-2017,6/18/2018,Direct,25,72 KG,Fda-Ctu,Consumer,Consumer,-,-,6/18/2018,US,Not Specified,-,-,-\\n15125035,-,Herbals\\\\Mitragynine,-,Dehydration;Dizziness;Malaise;Vomiting,Serious,Disabled,Male,02-Jul-2018,7/7/2018,Direct,26,80.55 KG,Fda-Ctu,Consumer,Consumer,-,-,7/7/2018,US,Not Specified,-,-,-\\n15169793,-,Herbals\\\\Mitragynine,Pain,Death,Serious,Died,Male,03-Feb-2018,7/18/2018,Direct,46,108 KG,Fda-Ctu,Consumer,Consumer,-,-,7/18/2018,US,Y,-,-,Yes\\n15191858,-,Herbals\\\\Mitragynine,-,Physical Product Label Issue;Diarrhoea,Serious,Other Outcomes,Not Specified,12-Jul-2018,7/24/2018,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,7/24/2018,US,Not Specified,-,-,-\\n15216665,-,Herbals\\\\Mitragynine,Anxiety;Depression,Hallucination;Drug Dependence;Delusion;Psychotic Disorder,Serious,Hospitalized,Male,27-Jul-2018,7/27/2018,Direct,26,69.75 KG,Fda-Ctu,Consumer,Consumer,-,-,7/27/2018,US,Not Specified,-,-,Yes\\n15275951,-,Herbals\\\\Mitragynine,-,Generalised Tonic-Clonic Seizure,Serious,Other Outcomes;Disabled;Life Threatening,Female,05-Aug-2018,8/10/2018,Direct,32,58.5 KG,Fda-Ctu,Consumer,Consumer,-,-,8/10/2018,US,Not Specified,-,-,-\\n15287064,-,Herbals\\\\Mitragynine,Therapy Cessation,Visual Impairment;Mobility Decreased;Vertigo;Dizziness;Feeling Abnormal,Serious,Other Outcomes,Female,28-Jul-2018,8/14/2018,Direct,30,78.12 KG,Fda-Ctu,Consumer,Consumer,-,-,8/14/2018,US,Y,-,-,-\\n15456106,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,03-Oct-2016,8/16/2018,Direct,60,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15456104,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,08-Mar-2017,8/16/2018,Direct,34,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15456105,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,02-May-2017,8/16/2018,Direct,20,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15456483,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,03-Jun-2017,8/16/2018,Direct,31,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15456051,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,07-Jul-2017,8/16/2018,Direct,24,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15455816,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,07-Oct-2017,8/16/2018,Direct,35,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15456060,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,30-Oct-2017,8/16/2018,Direct,20,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15455883,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,09-Nov-2017,8/16/2018,Direct,50,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15454777,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,09-Nov-2017,8/16/2018,Direct,50,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15456169,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,29-Dec-2017,8/16/2018,Direct,26,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15456052,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,11-Jan-2018,8/16/2018,Direct,38,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15455971,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,19-Jan-2018,8/16/2018,Direct,22,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15455955,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,23-Jan-2018,8/16/2018,Direct,39,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15456479,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,25-Jan-2018,8/16/2018,Direct,22,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15468186,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,12-Mar-2018,8/16/2018,Direct,28,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15456031,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,05-Apr-2018,8/16/2018,Direct,31,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15454944,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,05-Apr-2018,8/16/2018,Direct,31,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15456552,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,08-Apr-2018,8/16/2018,Direct,28,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15455877,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,13-Apr-2018,8/16/2018,Direct,34,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15455961,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,25-Apr-2018,8/16/2018,Direct,30,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15454932,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,25-Apr-2018,8/16/2018,Direct,30,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15456041,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Death;Sudden Death;Hypertension,Serious,Died,Male,30-Apr-2018,8/16/2018,Direct,37,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15454852,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Fall,Serious,Died,Male,30-Apr-2018,8/16/2018,Direct,37,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15456548,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,01-Jun-2018,8/16/2018,Direct,26,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15455966,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,27-Jun-2018,8/16/2018,Direct,25,Not Specified,Fda-Ctu,Not Specified,Health Professional,-,-,8/16/2018,US,Not Specified,-,-,-\\n15454755,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,27-Jun-2018,8/16/2018,Direct,25,Not Specified,Fda-Ctu,Not Specified,Health Professional,-,-,8/16/2018,US,Not Specified,-,-,-\\n15459453,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,8/16/2018,Direct,47,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15454794,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,8/16/2018,Direct,34,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/16/2018,US,Not Specified,-,-,-\\n15305997,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,19-Jun-2018,8/21/2018,Direct,36,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/21/2018,US,Not Specified,-,-,-\\n15346315,-,Herbals\\\\Mitragynine,Pain,Drug Dependence;Weight Decreased;Yellow Skin;Withdrawal Syndrome;Brief Resolved Unexplained Event;Generalised Tonic-Clonic Seizure;Drug Abuse,Serious,Disabled;Life Threatening,Male,10-May-2018,8/28/2018,Direct,35,74.84 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,8/28/2018,US,Not Specified,-,-,-\\n15346316,-,Herbals\\\\Mitragynine,-,Hepatic Failure;Malaise;Drug Abuse;Staphylococcal Infection,Serious,Hospitalized;Life Threatening,Male,Aug-2018,8/28/2018,Direct,24,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,8/28/2018,US,Not Specified,-,-,-\\n15334061,-,Herbals\\\\Mitragynine,Anxiety;Sleep Disorder Therapy,Alcohol Use;Intentional Product Use Issue,Serious,Died,Male,23-Nov-2017,8/29/2018,Direct,22,68.04 KG,Fda-Ctu,Consumer,Consumer,-,-,8/29/2018,US,Not Specified,-,-,-\\n15339133,-,Herbals\\\\Mitragynine,Anxiety,Fall;Seizure;Cerebral Haemorrhage;Vomiting;Fatigue;Incoherent;Head Injury,Serious,Life Threatening,Male,27-Aug-2018,8/30/2018,Direct,22,77.11 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/30/2018,US,Not Specified,-,-,-\\n15357076,-,Herbals\\\\Mitragynine,Substance Use,Psychotic Disorder,Serious,Hospitalized;Other Outcomes;Disabled,Female,10-Mar-2018,9/4/2018,Direct,19,49.5 KG,Fda-Ctu,Consumer,Consumer,-,-,9/4/2018,US,Y,-,-,-\\n15373449,-,Herbals\\\\Mitragynine,Pain Management,Liver Function Test Increased;Blood Alcohol Abnormal;Aspartate Aminotransferase Increased;Overdose;Alanine Aminotransferase Increased;Blood Alkaline Phosphatase Increased,Serious,Hospitalized;Other Outcomes,Female,27-Aug-2018,9/9/2018,Direct,54,75 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,9/9/2018,US,Not Specified,-,-,-\\n15419200,-,Herbals\\\\Mitragynine,Pain;Withdrawal Syndrome,Pain;Feeling Abnormal;Drug Dependence;Loss Of Personal Independence In Daily Activities;Apathy;Unemployment,Serious,Hospitalized,Female,14-Jun-2018,9/20/2018,Direct,39,76.5 KG,Fda-Ctu,Consumer,Consumer,-,-,9/20/2018,US,Not Specified,-,-,-\\n15418902,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,-,9/24/2018,Direct,55,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418898,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,9/24/2018,Direct,33,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418894,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,9/24/2018,Direct,32,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418889,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,-,9/24/2018,Direct,49,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418807,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,9/24/2018,Direct,34,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418798,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,-,9/24/2018,Direct,29,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418792,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,-,9/24/2018,Direct,37,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418787,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,9/24/2018,Direct,27,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418653,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,9/24/2018,Direct,35,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418646,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,9/24/2018,Direct,47,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418633,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,9/24/2018,Direct,56,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418628,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,-,9/24/2018,Direct,32,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418625,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,9/24/2018,Direct,59,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418624,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,9/24/2018,Direct,28,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418621,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,9/24/2018,Direct,36,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418618,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,9/24/2018,Direct,31,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15418514,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,9/24/2018,Direct,42,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/24/2018,US,Not Specified,-,-,-\\n15468345,-,Herbals\\\\Mitragynine,Pain,Unresponsive To Stimuli;Accidental Death;Toxicity To Various Agents,Serious,Died,Male,26-Mar-2017,10/5/2018,Direct,38,92.53 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,10/5/2018,US,Not Specified,-,-,-\\n15492732,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Death,Serious,Died,Not Specified,26-Aug-2018,10/7/2018,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,10/7/2018,US,Not Specified,-,-,-\\n15517591,-,Herbals\\\\Mitragynine,-,Irritability;Personality Change;Vomiting;Drug Dependence;Diarrhoea;Thinking Abnormal;Hyperhidrosis;Agitation;Cold Sweat;Tremor;Withdrawal Syndrome,Non-Serious,Non-Serious,Male,-,10/18/2018,Direct,39,81.65 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/18/2018,US,Not Specified,-,-,-\\n15546705,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,26-Feb-2018,10/24/2018,Direct,34,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,10/24/2018,US,Not Specified,-,-,-\\n15546706,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,10-May-2018,10/24/2018,Direct,31,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,10/24/2018,US,Not Specified,-,-,-\\n15555676,-,Herbals\\\\Mitragynine,Anxiety;Insomnia,Asthenia;Hyperhidrosis;Irritability;Mood Altered;Restlessness;Diarrhoea;Depressed Level Of Consciousness;Confusional State;Withdrawal Syndrome;Anhedonia;Nausea;Panic Reaction,Serious,Other Outcomes,Male,15-Oct-2018,10/24/2018,Direct,39,70.2 KG,Fda-Ctu,Consumer,Consumer,-,-,10/24/2018,US,Not Specified,-,-,-\\n15549873,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,-,10/24/2018,Direct,53,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,10/24/2018,US,Not Specified,-,-,-\\n15546727,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,-,10/24/2018,Direct,45,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,10/24/2018,US,Not Specified,-,-,-\\n15546722,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,10/24/2018,Direct,34,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,10/24/2018,US,Not Specified,-,-,-\\n15549931,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,26-Jun-2015,10/25/2018,Direct,43,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,10/25/2018,US,Not Specified,-,-,-\\n15580732,-,Herbals\\\\Mitragynine,Anxiety;Depression;Intervertebral Disc Protrusion;Post-Traumatic Stress Disorder,Diarrhoea;Vomiting;Hypophagia;Hyperhidrosis,Serious,Other Outcomes,Male,25-Oct-2018,11/3/2018,Direct,28,72 KG,Fda-Ctu,Consumer,Consumer,-,-,11/3/2018,US,Not Specified,-,-,-\\n15599665,-,Herbals\\\\Mitragynine,Depression,Maternal Drugs Affecting Foetus;Drug Withdrawal Syndrome Neonatal,Serious,Hospitalized,Female,09-Jul-2018,11/8/2018,Direct,1 DAY,3.53 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,11/8/2018,US,Not Specified,-,-,-\\n15600806,-,Herbals\\\\Mitragynine,-,Unevaluable Event;Palpitations;Vomiting;Diarrhoea;Dehydration,Non-Serious,Non-Serious,Not Specified,Aug-2018,11/8/2018,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,11/8/2018,US,Not Specified,-,-,-\\n15612598,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Not Specified,2017,11/13/2018,Direct,32,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,11/13/2018,US,Not Specified,-,-,-\\n15612590,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,23-Jul-2016,11/13/2018,Direct,40,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,11/13/2018,US,Not Specified,-,-,-\\n15612592,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,24-Sep-2017,11/13/2018,Direct,32,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,11/13/2018,US,Not Specified,-,-,-\\n15638164,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Seizure;Occupational Problem Environmental;Product Counterfeit,Serious,Hospitalized,Female,28-May-1997,11/19/2018,Direct,21,58.5 KG,Fda-Ctu,Consumer,Consumer,-,-,11/19/2018,US,Not Specified,-,-,Yes\\n15642453,-,Herbals\\\\Mitragynine,-,Product Complaint;Recalled Product;Gastroenteritis Salmonella,Non-Serious,Non-Serious,Not Specified,09-Apr-2018,11/20/2018,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,11/20/2018,US,Not Specified,-,-,-\\n15643582,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Accidental Death,Serious,Died,Male,21-Sep-2016,11/21/2018,Direct,29,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,11/21/2018,US,Not Specified,-,-,-\\n15643589,-,Herbals\\\\Mitragynine,-,Accidental Death;Toxicity To Various Agents,Serious,Died,Male,28-Feb-2018,11/21/2018,Direct,50,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,11/21/2018,US,Not Specified,-,-,-\\n15660097,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died,Male,11-Dec-2017,11/26/2018,Direct,36,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,11/26/2018,US,Not Specified,-,-,-\\n15665505,-,Herbals\\\\Mitragynine,-,Overdose,Serious,Died,Male,02-Nov-2018,11/27/2018,Direct,32,67.5 KG,Fda-Ctu,Not Specified,Not Specified,-,-,11/27/2018,US,Not Specified,-,-,-\\n15665400,-,Herbals\\\\Mitragynine,Pain,Hypertension;Tremor;Anxiety;Extra Dose Administered,Serious,Other Outcomes,Female,-,11/27/2018,Direct,70,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,11/27/2018,US,Not Specified,-,-,-\\n15680525,-,Herbals\\\\Mitragynine,Substance Use,Liver Function Test Increased;Cholecystitis,Serious,Other Outcomes;Hospitalized,Male,-,11/28/2018,Direct,35,70 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,11/28/2018,US,Not Specified,-,-,-\\n15703747,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Accidental Death,Serious,Died,Male,11-Aug-2017,12/10/2018,Direct,33,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,12/10/2018,US,Not Specified,-,-,-\\n15716888,-,Herbals\\\\Mitragynine,Affective Disorder;Asthenia;Disturbance In Attention,Cardiac Death;Toxicity To Various Agents,Serious,Died,Male,09-Nov-2018,12/12/2018,Direct,33,72.57 KG,Fda-Ctu,Not Specified,Not Specified,-,-,12/12/2018,US,Not Specified,-,-,-\\n15734067,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Pneumonia Haemophilus,Serious,Died,Male,02-May-2017,12/17/2018,Direct,64,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,12/17/2018,US,Not Specified,-,-,-\\n15735652,-,Herbals\\\\Mitragynine,Affective Disorder;Asthenia;Cognitive Disorder;Disturbance In Attention,Cardiac Death,Serious,Died,Male,09-Nov-2018,12/18/2018,Direct,33,72.57 KG,Fda-Ctu,Not Specified,Not Specified,-,-,12/18/2018,US,Not Specified,-,-,-\\n15837565,-,Herbals\\\\Mitragynine;Amphetamine Sulfate\\\\Dextroamphetamine,Attention Deficit Hyperactivity Disorder;Pain,Speech Disorder;Hyperreflexia;Restlessness;Muscle Rigidity;Heart Rate Increased;Impaired Driving Ability;Drug Abuse;Balance Disorder;Erythema;Muscle Twitching;Tremor;Mydriasis;Pupillary Reflex Impaired;Logorrhoea;Blood Pressure Increased;Dysarthria,Serious,Other Outcomes,Female,-,1/17/2019,Expedited,37,Not Specified,Mylan,Healthcare Professional,Not Specified,Celexa,1/8/2019,1/17/2019,US,Not Specified,US-MYLANLABS-2019M1002863,Wright TH. Suspected Driving Under the Influence Case Involving Mitragynine. J-Anal-Toxicol 2018;42(7):e65-e68.,-\\n16166917,Zolpidem;Methadone;Trazodone,Trazodone Hydrochloride;Methadone Hydrochloride;Buprenorphine;Zolpidem Tartrate;Levorphanol;Gabapentin;Chlorpheniramine;Fentanyl;Diphenhydramine;Tramadol;Lamotrigine;Doxylamine;Carisoprodol;Herbals\\\\Mitragynine;Oxycodone;Cyclobenzaprine;Topiramate,Product Used For Unknown Indication,Impaired Driving Ability;Injury;Accident,Serious,Died;Other Outcomes,Not Specified,-,4/9/2019,Expedited,Not Specified,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,3/26/2019,4/8/2019,US,Not Specified,US-JNJFOC-20190407184,\"Tiscione NB, Alford IK, Miller R, Shan X, Yeatman DT. Driving Under the Influence of Drugs: When the Law Misses the Mark. Journal of Analytical Toxicology 2019;43:138-143.\",-\\n16166904,Alcohol (Alcohol),Alcohol;Buprenorphine;Herbals\\\\Mitragynine;Lorazepam;Diphenhydramine,Product Used For Unknown Indication,Miosis;Loss Of Consciousness;Accident,Serious,Other Outcomes,Male,-,4/8/2019,Expedited,63,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,3/26/2019,4/8/2019,US,Not Specified,US-JNJFOC-20190405655,\"Tiscione NB, Alford IK, Miller R, Shan X, Yeatman DT. Driving Under the Influence of Drugs: When the Law Misses the Mark. Journal of Analytical Toxicology 01-Oct-2018;2019;43:138-143.\",-\\n16156491,Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Norbuprenorphine;Diphenhydramine Hydrochloride;Lorazepam;Buprenorphine;Carfentanil,-,Labelled Drug-Food Interaction Medication Error;Miosis;Benzodiazepine Drug Level Increased;Road Traffic Accident;Drug Screen Positive;Loss Of Consciousness,Serious,Other Outcomes,Male,-,4/4/2019,Expedited,63,Not Specified,Procter And Gamble,Healthcare Professional,Not Specified,-,3/23/2019,4/4/2019,US,Not Specified,US-PROCTER_AND_GAMBLE-GS19035001,\"Tiscione NB, Alford IK, Miller R, Shan X, Yeatman DT. Driving Under the Influence of Drugs: When the Law Misses the Mark. J Anal Toxicol. 2019;43:138-143\",-\\n16187592,Alcohol (Alcohol),Diphenhydramine;Alcohol;Herbals\\\\Mitragynine;Buprenorphine;Lorazepam,-,Loss Of Consciousness;Road Traffic Accident;Miosis,Serious,Other Outcomes,Male,-,4/12/2019,Expedited,63,Not Specified,Sanofi Aventis,Healthcare Professional,Not Specified,-,4/5/2019,4/12/2019,US,Not Specified,US-SA-2019SA097014,\"Tiscione N.B., Alford I.K., Miller R., Shan X., Yeatman D.T.. Driving under the Influence of Drugs: When the Law Misses the Mark. Journal of Analytical Toxicology. 2019;43:138-143\",-\\n16462155,-,Doxylamine;Dextromethorphan;Caffeine;Etizolam;Meprobamate;Nicotine;Herbals\\\\Mitragynine;Carisoprodol;Hydrocodone,Product Used For Unknown Indication,Tachycardia;Dyskinesia;Confusional State;Fall;Tremor,Serious,Hospitalized,Not Specified,-,6/21/2019,Expedited,Not Specified,Not Specified,Alembic,Healthcare Professional,Not Specified,-,6/7/2019,6/21/2019,US,Not Specified,US-ALEMBIC PHARMACUETICALS LIMITED-2019SCAL000383,\"Scoccimarro A, Marino R, Shulman J. A case of etizolam withdrawal syndrome. Clinical Toxicology.. 2019;57 (6):427\",-\\n16357334,-,Quetiapine;Valproic Acid;Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Drug Interaction,Serious,Died,Male,-,5/27/2019,Non-Expedited,27,Not Specified,Sciegen,Healthcare Professional,Not Specified,-,5/16/2019,5/27/2019,US,Not Specified,US-SCIEGEN PHARMACEUTICALS INC-2019SCILIT00181,\"Rhome L. Hughes et.al.,;Fatal combination of mitragynine and quetiapine-a case report with discussion of a potential herb-drug interaction;Forensic Science Medicine and Pathology;29-NOV-2018;;\",-\\n15988717,Escitalopram,Herbals\\\\Mitragynine;Escitalopram Oxalate,Back Pain;Major Depression;Product Used For Unknown Indication,Pruritus;Jaundice;Malaise;Pyrexia;Pollakiuria;Drug-Induced Liver Injury;Micturition Urgency;Decreased Appetite;Vomiting;Fatigue;Hyperbilirubinaemia;Hepatic Steatosis;Dysuria;Potentiating Drug Interaction;Chromaturia,Serious,Other Outcomes,Male,-,2/21/2019,Expedited,47,Not Specified,Zydus Pharm,Healthcare Professional,Not Specified,Metoprolol;Valsartan;Clonazepam;Fexofenadine,2/18/2019,2/21/2019,US,Not Specified,US-ZYDUS-034032,\"Osborne CS, Overstreet AN, Rockey DC, Schreiner AD. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic. J-Investig-Med-High-Impact-Case-Rep 2019;.\",-\\n15981017,Escitalopram,Escitalopram Oxalate;Herbals\\\\Mitragynine,Anxiety;Back Pain;Hypertension;Major Depression;Product Used For Unknown Indication,Drug-Induced Liver Injury;Drug Interaction,Serious,Other Outcomes,Male,-,2/19/2019,Expedited,47,Not Specified,Mylan,Healthcare Professional,Not Specified,Fexofenadine;Acetaminophen;Metoprolol Tartrate;Clonazepam;Valsartan,2/12/2019,2/19/2019,US,Not Specified,US-MYLANLABS-2019M1015420,\"Osborne CS, Overstreet AN, Rockey DC, Schreiner AD. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic. J-Investig-Med-High-Impact-Case-Rep 2019;:.\",-\\n16058080,Escitalopram,Escitalopram Oxalate;Herbals\\\\Mitragynine,Back Pain;Product Used For Unknown Indication,Drug-Induced Liver Injury;Drug Interaction,Serious,Other Outcomes,Male,-,3/11/2019,Expedited,47,Not Specified,Taro,Healthcare Professional,Not Specified,Metoprolol Tartrate;Clonazepam;Fexofenadine;Valsartan;Acetaminophen,2/25/2019,3/11/2019,US,Not Specified,\"US-TARO PHARMACEUTICALS USA.,INC-2019SUN00102\",\"Osborne CS, Overstreet AN, Rockey DC, Schreiner AD. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic. J Investig Med High Impact Case Rep. 2019;7:1-5\",-\\n16060417,Escitalopram,Escitalopram Oxalate;Herbals\\\\Mitragynine,Back Pain;Major Depression;Product Used For Unknown Indication,Pruritus;Cytomegalovirus Test Positive;Aspartate Aminotransferase Increased;Drug Interaction;Hyperbilirubinaemia;Vomiting;Hepatic Steatosis;Blood Alkaline Phosphatase Increased;Pyrexia;Fatigue;Chromaturia;Serum Ferritin Increased;Micturition Urgency;Decreased Appetite;Dysuria;Pollakiuria;Malaise;Blood Bilirubin Increased;Alanine Aminotransferase Increased;Drug-Induced Liver Injury,Serious,Other Outcomes,Not Specified,-,3/12/2019,Expedited,Not Specified,Not Specified,Aurobindo,Healthcare Professional,Not Specified,Valsartan;Fexofenadine;Clonazepam;Metoprolol Tartrate,2/25/2019,3/12/2019,US,Not Specified,US-AUROBINDO-AUR-APL-2019-012534,\"Osborne CS, Overstreet AN, Rockey DC and Schreiner AD.. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic.. Journal of Investigative Medicine High Impact Case Reports.. 2019;7:1-5\",-\\n16032579,Escitalopram,Escitalopram Oxalate;Herbals\\\\Mitragynine,Back Pain;Major Depression;Product Used For Unknown Indication,Drug Interaction;Drug-Induced Liver Injury,Serious,Other Outcomes,Male,-,3/4/2019,Expedited,47,Not Specified,Hetero,Healthcare Professional,Not Specified,Fexofenadine;Clonazepam;Metoprolol Tartrate;Valsartan,2/18/2019,3/4/2019,US,Not Specified,US-HETERO CORPORATE-HET2019US00249,\"Osborne Caroline Stokes, Overstreet Amanda N, Rockey Don C, Schreiner Andrew D. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic. Journal of Investigative Medicine High Impact Case Reports. 2019\",-\\n16099194,-,Ranitidine;Albuterol;Herbals\\\\Mitragynine;Loratadine;Citalopram;Diphenhydramine;Acetaminophen\\\\Methocarbamol;Valacyclovir Hydrochloride,-,Caesarean Section;Maternal Exposure During Pregnancy,Serious,Other Outcomes,Female,-,3/21/2019,Expedited,37,Not Specified,Bayer,Healthcare Professional,Not Specified,-,3/15/2019,3/21/2019,CA,Not Specified,CA-BAYER-2019-054297,\"Murthy P, Clark D. An unusual cause for neonatal abstinence syndrome. Paediatrics and Child Health (Canada). 2019;24:1:12-14\",-\\n16389981,-,Herbals\\\\Mitragynine;Morphine Sulfate,Product Used For Unknown Indication,Death,Serious,Died,Not Specified,-,6/4/2019,Expedited,Not Specified,Not Specified,Allergan,Healthcare Professional,Not Specified,-,5/29/2019,6/4/2019,US,Not Specified,US-ALLERGAN-1923449US,Monte AA. Kratom-Only Deaths In Colorado Are Not Kratom Only. Academic Emergency Medicine. 2019;26(S1):S282,-\\n16024013,-,Quetiapine Fumarate;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Seizure;Toxicity To Various Agents;Herbal Interaction;Hyperthermia,Serious,Died,Male,-,5/17/2019,Expedited,27,Not Specified,Intellipharmaceutics,Healthcare Professional,Not Specified,-,5/7/2019,3/1/2019,US,Not Specified,US-INTELLIPHARMACEUTICS CORP.-2063404,\"Journal: Forensic science, medicine, and pathology\\n Author: Hughes RL\\n Title: Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction Volume: 15 (1) Year: 2019 Pages: 110-3\",-\\n15805707,-,Herbals\\\\Mitragynine;Quetiapine,Product Used For Unknown Indication,Hyperthermia;Discharge;Seizure;Drug Interaction;Tongue Haemorrhage;Toxicity To Various Agents,Serious,Other Outcomes;Life Threatening;Died,Not Specified,-,1/10/2019,Expedited,Not Specified,Not Specified,Macleods,Healthcare Professional,Not Specified,Valproic Acid,12/27/2018,1/10/2019,US,Not Specified,US-MACLEODS PHARMACEUTICALS US LTD-MAC2018019464,\"Hughes RL.. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction.. Journal Forensic Science, Medicine and Pathology. 2018\",-\\n15726843,-,Herbals\\\\Mitragynine;Quetiapine,Product Used For Unknown Indication,Toxicity To Various Agents;Seizure;Discharge;Drug Interaction;Tongue Haemorrhage;Hyperthermia,Serious,Other Outcomes;Life Threatening;Died,Male,-,1/5/2019,Expedited,27,Not Specified,Aurobindo,Healthcare Professional,Not Specified,Valproic Acid,12/27/2018,12/17/2018,US,Not Specified,US-AUROBINDO-AUR-APL-2018-060149,Hughes RL.. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction.. Forensic Sci Med Pathol.. 2018,-\\n15749102,-,Herbals\\\\Mitragynine;Quetiapine,Product Used For Unknown Indication,Herbal Interaction;Toxicity To Various Agents;Hyperthermia;Seizure Like Phenomena;Drug Interaction;Drug Level Increased,Serious,Died;Other Outcomes,Male,-,6/7/2019,Expedited,27,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,5/23/2019,12/21/2018,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2018R1-194438,Hughes RL. Fatal combination of mitragynine and quetiapine-a case report with discussion of a potential herb-drug interaction. Forensic Sci Med Pathol. 2019;15(1):110-113,-\\n16288357,-,Quetiapine;Herbals\\\\Mitragynine,-,Drug Interaction;Toxicity To Various Agents,Serious,Died;Other Outcomes,Male,-,5/8/2019,Expedited,27,Not Specified,Alignscience Pharma,Healthcare Professional,Not Specified,Valproic Acid,4/22/2019,5/8/2019,US,Not Specified,US-ALS-2019-000002,Hughes RL. Fatal combination of mitragynine and quetiapine-a case report with discussion of a potential herb-drug interaction. Forensic Sci Med Pathol. 2019; 15(1): 110-3.,-\\n15793100,-,Herbals\\\\Mitragynine;Quetiapine,Product Used For Unknown Indication,Discharge;Toxicity To Various Agents;Seizure;Tongue Haemorrhage;Hyperthermia;Herbal Interaction,Serious,Other Outcomes;Life Threatening;Died,Male,-,2/25/2019,Expedited,27,Not Specified,Lupin,Healthcare Professional,Not Specified,Valproic Acid,2/13/2019,1/7/2019,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2018-09251,\"Hughes RL. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction. Journal Forensic Science, Medicine and Pathology. 2019;15:110-113\",-\\n16266419,-,Quetiapine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Interaction;Toxicity To Various Agents,Serious,Died,Male,-,5/6/2019,Expedited,27,Not Specified,Sandoz,Healthcare Professional,Not Specified,Valproic Acid,5/2/2019,5/2/2019,US,Not Specified,PHHY2019US099059,\"Hughes RL. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction. FORENSIC SCIENCE, MEDICINE, AND PATHOLOGY. 2019;15(1):110-3\",-\\n16316296,-,Herbals\\\\Mitragynine;Quetiapine Fumarate,Product Used For Unknown Indication,Toxicity To Various Agents;Drug Interaction,Serious,Died;Other Outcomes,Male,-,5/15/2019,Expedited,27,Not Specified,Endo,Healthcare Professional,Not Specified,-,5/7/2019,5/15/2019,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2019-104558,\"Hughes RL. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction. Forensic Science, Medicine, and Pathology. 2019;15(1):110-113\",-\\n15728141,-,Quetiapine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Hyperthermia;Toxicity To Various Agents;Seizure;Drug Interaction,Serious,Other Outcomes;Died,Male,-,1/5/2019,Expedited,27,Not Specified,Accord,Healthcare Professional,Not Specified,Valproic Acid,12/27/2018,12/17/2018,US,Not Specified,US-ACCORD-095899,Hughes RL. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction. Forensic Sci Med Pathol. 2018 Nov 29.,-\\n16018913,-,Quetiapine;Herbals\\\\Mitragynine,-,Seizure;Hyperthermia;Drug Interaction,Serious,Died;Other Outcomes,Male,-,2/28/2019,Expedited,27,Not Specified,Jubilant,Healthcare Professional,Not Specified,Valproic Acid,2/18/2019,2/28/2019,US,Not Specified,US-JUBILANT CADISTA PHARMACEUTICALS-2019JUB00065,Hughes R. Fatal combination of mitragynine and quetiapine \\x96 a case report with discussion of a potential herb-drug interaction. Forensic Sci Med Pathol. 2019;15(1):110-113,-\\n16347037,-,Quetiapine Fumarate;Herbals\\\\Mitragynine,Bipolar Disorder;Product Used For Unknown Indication,Hyperthermia;Muscle Rigidity;Neuroleptic Malignant Syndrome;Drug Interaction;Seizure;Toxicity To Various Agents;Discharge;Tongue Haemorrhage,Serious,Died,Not Specified,-,5/23/2019,Expedited,Not Specified,Not Specified,Alembic,Healthcare Professional,Not Specified,Valproic Acid,5/9/2019,5/23/2019,US,Not Specified,US-ALEMBIC PHARMACUETICALS LIMITED-2019SCAL000311,\"Hughes R L. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction. Forensic science, medicine, and pathology. 2019;15 (1):110-113\",-\\n15883288,-,Herbals\\\\Mitragynine;Diphenhydramine;Fentanyl;Alprazolam;Cocaine;Clonazepam,Product Used For Unknown Indication,Cardio-Respiratory Arrest;Toxicity To Various Agents,Serious,Died,Male,2017,1/29/2019,Expedited,31,Not Specified,Endo,Healthcare Professional,Not Specified,-,1/7/2019,1/29/2019,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2019-100837,\"Gummin, David D; Mowry, James B; Spyker, Daniel A; Brooks, Daniel E; Osterthaler, Krista M; Banner, William. 2017 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System. Clinical Toxicology. 2018;prepub:1-203\",-\\n15808461,-,Clonazepam;Fentanyl Citrate;Alprazolam;Diphenhydramine Hydrochloride;Herbals\\\\Mitragynine;Cocaine,-,Death;Cardiac Arrest;Respiratory Arrest,Serious,Died,Male,2017,1/10/2019,Expedited,31,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/4/2019,1/10/2019,US,Not Specified,US-PFIZER INC-2019008954,\"Gummin, D.. 2017 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 35th Annual Report. CLINICAL TOXICOLOGY. 2018;10.1080/15563650.2018.1533727\",-\\n15836548,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Female,-,1/17/2019,Non-Expedited,60,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2019,1/17/2019,US,Not Specified,US-APOTEX-2019AP005802,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W.. 2017 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 35th Annual Report. Doi.org/10.1080/15563650.2018.1533727. Clinical Toxicology. 2018;1-203\",-\\n15842169,-,Herbals\\\\Mitragynine;Cocaine;Fentanyl;Diphenhydramine;Clonazepam;Alprazolam,Product Used For Unknown Indication,Cardio-Respiratory Arrest;Death,Serious,Hospitalized;Died;Other Outcomes,Male,-,1/18/2019,Expedited,31,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2019,1/18/2019,US,Not Specified,US-APOTEX-2019AP005521,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W.. 2017 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 35th Annual Report. Doi.org/10.1080/15563650.2018.1533727. Clinical Toxicology. 2018;1-203\",-\\n15845706,-,Tramadol;Cyclobenzaprine;Herbals\\\\Mitragynine;Quetiapine,Product Used For Unknown Indication,Drug Abuse;Cardio-Respiratory Arrest,Serious,Hospitalized;Died;Other Outcomes,Male,-,1/20/2019,Expedited,31,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2019,1/20/2019,US,Not Specified,US-APOTEX-2019AP006442,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W.. 2017 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 35th Annual Report. Doi.org/10.1080/15563650.2018.1533727. Clinical Toxicology. 2018;1-203\",-\\n15847213,-,Caffeine;Herbals\\\\Mitragynine;Citalopram;Mirtazapine,Product Used For Unknown Indication,Intentional Product Use Issue;Cardio-Respiratory Arrest,Serious,Hospitalized;Other Outcomes;Died,Male,-,1/21/2019,Expedited,32,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2019,1/21/2019,US,Not Specified,US-APOTEX-2019AP006448,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W.. 2017 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 35th Annual Report. Doi.org/10.1080/15563650.2018.1533727. Clinical Toxicology. 2018;1-203\",-\\n16102392,-,Herbals\\\\Mitragynine;Mirtazapine;Citalopram Hydrobromide;Caffeine,Product Used For Unknown Indication,Drug Abuse;Toxicity To Various Agents;Cardio-Respiratory Arrest,Serious,Died,Male,2017,3/21/2019,Expedited,32,Not Specified,Lannett,Healthcare Professional,Not Specified,-,3/6/2019,3/21/2019,US,Not Specified,\"US-LANNETT COMPANY, INC.-US-2019LAN000321\",\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W. 2017 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 35th Annual Report. CLINICAL TOXICOLOGY. 2018;56:12:1213-1415\",-\\n16053177,-,Herbals\\\\Mitragynine;Citalopram Hydrobromide,Product Used For Unknown Indication,Toxicity To Various Agents;Drug Interaction;Unresponsive To Stimuli,Serious,Died,Not Specified,2016,3/8/2019,Expedited,Not Specified,Not Specified,Lannett,Healthcare Professional,Not Specified,-,2/25/2019,3/8/2019,US,Not Specified,\"US-LANNETT COMPANY, INC.-US-2019LAN000224\",\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al.. Deaths in Colorado attributed to Kratom. N-Engl-J-Med. 2019;380(1):97-98\",-\\n16053097,Zolpidem,Zolpidem Tartrate;Tramadol;Diphenhydramine Hydrochloride;Herbals\\\\Mitragynine;Topiramate;Oxycodone Hydrochloride,Product Used For Unknown Indication,Unresponsive To Stimuli;Toxicity To Various Agents;Asphyxia;Drug Interaction,Serious,Died,Not Specified,2016,3/8/2019,Expedited,Not Specified,Not Specified,Lannett,Healthcare Professional,Not Specified,-,2/25/2019,3/8/2019,US,Not Specified,\"US-LANNETT COMPANY, INC.-US-2019LAN000223\",\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al.. Deaths in Colorado attributed to Kratom. N-Engl-J-Med. 2019;380(1):97-98\",-\\n16053031,-,Morphine;Codeine Sulfate;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Interaction;Toxicity To Various Agents;Unresponsive To Stimuli,Serious,Died,Not Specified,2016,3/8/2019,Expedited,Not Specified,Not Specified,Lannett,Healthcare Professional,Not Specified,-,2/25/2019,3/8/2019,US,Not Specified,\"US-LANNETT COMPANY, INC.-US-2019LAN000222\",\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al.. Deaths in Colorado attributed to Kratom. N-Engl-J-Med. 2019;380(1):97-98\",-\\n16052848,Trazodone;Fetzima;Pseudoephedrine.;Lidoderm,Morphine;Lidocaine;Herbals\\\\Mitragynine;Lithium;Pseudoephedrine Hydrochloride;Levomilnacipran Hydrochloride;Fluoxetine Hydrochloride;Trazodone Hydrochloride;Benztropine;Gabapentin;Oxycodone Hydrochloride,Product Used For Unknown Indication,Unresponsive To Stimuli;Toxicity To Various Agents;Drug Interaction,Serious,Died,Not Specified,2016,3/8/2019,Expedited,Not Specified,Not Specified,Lannett,Healthcare Professional,Not Specified,-,2/25/2019,3/8/2019,US,Not Specified,\"US-LANNETT COMPANY, INC.-US-2019LAN000220\",\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al.. Deaths in Colorado attributed to Kratom. N-Engl-J-Med. 2019;380(1):97-98\",-\\n16053467,Alcohol (Alcohol),Alcohol;Fentanyl;Herbals\\\\Mitragynine;Cocaine;Oxycodone Hydrochloride,Product Used For Unknown Indication,Toxicity To Various Agents;Drug Interaction;Unresponsive To Stimuli,Serious,Died,Not Specified,2017,3/8/2019,Expedited,Not Specified,Not Specified,Lannett,Healthcare Professional,Not Specified,-,2/25/2019,3/8/2019,US,Not Specified,\"US-LANNETT COMPANY, INC.-US-2019LAN000228\",\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al.. Deaths in Colorado attributed to Kratom. N-Engl-J-Med. 2019;380(1):97-98\",-\\n16053436,Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Oxycodone Hydrochloride,Product Used For Unknown Indication,Drug Interaction;Toxicity To Various Agents,Serious,Died,Not Specified,2017,3/8/2019,Expedited,Not Specified,Not Specified,Lannett,Healthcare Professional,Not Specified,-,2/25/2019,3/8/2019,US,Not Specified,\"US-LANNETT COMPANY, INC.-US-2019LAN000227\",\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al.. Deaths in Colorado attributed to Kratom. N-Engl-J-Med. 2019;380(1):97-98\",-\\n16053239,Sertraline,Sertraline Hydrochloride;Clonazepam;Olanzapine;Hydroxyzine Hydrochloride;Herbals\\\\Mitragynine;Temazepam,Product Used For Unknown Indication,Drug Interaction;Toxicity To Various Agents;Unresponsive To Stimuli,Serious,Died,Not Specified,2017,3/8/2019,Expedited,Not Specified,Not Specified,Lannett,Healthcare Professional,Not Specified,-,2/25/2019,3/8/2019,US,Not Specified,\"US-LANNETT COMPANY, INC.-US-2019LAN000225\",\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al.. Deaths in Colorado attributed to Kratom. N-Engl-J-Med. 2019;380(1):97-98\",-\\n16053365,Propranolol;Buspirone,Buspirone Hydrochloride;Nordazepam;Mirtazapine;Herbals\\\\Mitragynine;Propranolol Hydrochloride;Gabapentin;Diazepam,Product Used For Unknown Indication,Drug Interaction;Toxicity To Various Agents;Unresponsive To Stimuli,Serious,Died,Not Specified,2017,9/19/2019,Expedited,Not Specified,Not Specified,Lannett,Healthcare Professional,Not Specified,-,2/25/2019,3/8/2019,US,Not Specified,\"US-LANNETT COMPANY, INC.-US-2019LAN000226\",\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al.. Deaths in Colorado attributed to Kratom. N-Engl-J-Med. 2019;380(1):97-98\",-\\n16052606,-,Diphenhydramine Hydrochloride;Herbals\\\\Mitragynine;Oxycodone Hydrochloride;Etizolam,Product Used For Unknown Indication,Toxicity To Various Agents;Unresponsive To Stimuli;Drug Interaction,Serious,Died,Not Specified,2015,3/8/2019,Expedited,Not Specified,Not Specified,Lannett,Healthcare Professional,Not Specified,-,2/25/2019,3/8/2019,US,Not Specified,\"US-LANNETT COMPANY, INC.-US-2019LAN000219\",\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med. 2019;380(1):97-98\",-\\n16052938,Alcohol (Alcohol),Alcohol;Diazepam;Hydroxyzine Hydrochloride;Naltrexone;Etizolam;Polyethylene Glycol 3350;Bupropion;Gabapentin;Herbals\\\\Mitragynine;Clonidine,Product Used For Unknown Indication,Toxicity To Various Agents;Drug Interaction,Serious,Died,Not Specified,2016,3/8/2019,Expedited,Not Specified,Not Specified,Lannett,Healthcare Professional,Not Specified,-,2/25/2019,3/8/2019,US,Not Specified,\"US-LANNETT COMPANY, INC.-US-2019LAN000221\",\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med. 2019;380(1):97-98\",-\\n15982779,-,Butyrfentanyl;Oxycodone;Diphenhydramine;Herbals\\\\Mitragynine;Etizolam,Product Used For Unknown Indication,Death,Serious,Died,Not Specified,-,2/19/2019,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,2/12/2019,2/19/2019,US,Not Specified,US-MYLANLABS-2019M1015418,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n15982699,-,Acetaminophen;Gabapentin;Etizolam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Death,Serious,Died,Male,-,2/19/2019,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,2/12/2019,2/19/2019,US,Not Specified,US-MYLANLABS-2019M1015388,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n15982698,-,Herbals\\\\Mitragynine;Morphine;Codeine,Product Used For Unknown Indication,Death,Serious,Died,Not Specified,-,2/19/2019,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,2/12/2019,2/19/2019,US,Not Specified,US-MYLANLABS-2019M1015417,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n15981023,Zolpidem,Zolpidem Tartrate;Oxycodone;Topiramate;Herbals\\\\Mitragynine;Diphenhydramine;Tramadol,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Not Specified,-,2/19/2019,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,2/12/2019,2/19/2019,US,Not Specified,US-MYLANLABS-2019M1015415,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n15981022,Sertraline,Sertraline Hydrochloride;Clonazepam;Olanzapine;Herbals\\\\Mitragynine;Temazepam,Product Used For Unknown Indication,Death,Serious,Died,Not Specified,-,2/19/2019,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,2/12/2019,2/19/2019,US,Not Specified,US-MYLANLABS-2019M1015403,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n15980857,Fluoxetine;Pseudoephedrine.,Pseudoephedrine Hydrochloride;Fluoxetine Hydrochloride;Herbals\\\\Mitragynine;Oxycodone,Product Used For Unknown Indication,Death,Serious,Died,Not Specified,-,2/19/2019,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,2/12/2019,2/19/2019,US,Not Specified,US-MYLANLABS-2019M1015390,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n15992724,-,Herbals\\\\Mitragynine;Citalopram,Product Used For Unknown Indication,Death,Serious,Died,Not Specified,-,2/21/2019,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,2/12/2019,2/21/2019,US,Not Specified,US-MYLANLABS-2019M1015382,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n15990743,-,Mirtazapine;Etizolam;Herbals\\\\Mitragynine;Nordazepam,Product Used For Unknown Indication,Death,Serious,Died,Not Specified,-,2/21/2019,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,2/12/2019,2/21/2019,US,Not Specified,US-MYLANLABS-2019M1015413,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n15990516,-,Herbals\\\\Mitragynine;Selegiline,Product Used For Unknown Indication,Herbal Toxicity;Postmortem Blood Drug Level,Serious,Died,Male,-,2/21/2019,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,2/12/2019,2/21/2019,US,Not Specified,US-MYLANLABS-2019M1015377,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n15990507,-,Oxycodone;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Death,Serious,Died,Not Specified,-,2/21/2019,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,2/12/2019,2/21/2019,US,Not Specified,US-MYLANLABS-2019M1015391,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16019298,Pseudoephedrine.;Fluoxetine,Fluoxetine Hydrochloride;Pseudoephedrine Hydrochloride;Oxycodone;Herbals\\\\Mitragynine,-,Drug Screen Positive,Serious,Died,Not Specified,-,2/28/2019,Expedited,Not Specified,Not Specified,Teva,Healthcare Professional,Not Specified,-,2/18/2019,2/28/2019,US,Not Specified,US-TEVA-2019-US-1017586,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16019295,-,Herbals\\\\Mitragynine;Oxycodone;Fentanyl;Cocaine,Product Used For Unknown Indication,Portal Tract Inflammation;Hepatic Fibrosis;Drug Screen Positive,Serious,Died,Not Specified,-,2/28/2019,Expedited,Not Specified,Not Specified,Teva,Healthcare Professional,Not Specified,-,2/18/2019,2/28/2019,US,Not Specified,US-TEVA-2019-US-1017577,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16019294,Sertraline,Sertraline Hydrochloride;Herbals\\\\Mitragynine;Olanzapine;Temazepam;Clonazepam,-,Drug Screen Positive,Serious,Died,Not Specified,-,2/28/2019,Expedited,Not Specified,Not Specified,Teva,Healthcare Professional,Not Specified,-,2/18/2019,2/28/2019,US,Not Specified,US-TEVA-2019-US-1017581,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16019293,-,Nordazepam;Mirtazapine;Etizolam;Herbals\\\\Mitragynine,-,Drug Screen Positive,Serious,Died,Not Specified,-,2/28/2019,Expedited,Not Specified,Not Specified,Teva,Healthcare Professional,Not Specified,-,2/18/2019,2/28/2019,US,Not Specified,US-TEVA-2019-US-1017579,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16019287,-,Herbals\\\\Mitragynine;Oxycodone,-,Drug Screen Positive,Serious,Died,Not Specified,-,2/28/2019,Expedited,Not Specified,Not Specified,Teva,Healthcare Professional,Not Specified,-,2/18/2019,2/28/2019,US,Not Specified,US-TEVA-2019-US-1017578,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16019283,-,Codeine;Morphine;Herbals\\\\Mitragynine,-,Drug Screen Positive,Serious,Died,Not Specified,-,2/28/2019,Expedited,Not Specified,Not Specified,Teva,Healthcare Professional,Not Specified,-,2/18/2019,2/28/2019,US,Not Specified,US-TEVA-2019-US-1017583,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16019282,-,Selegiline;Herbals\\\\Mitragynine,-,Drug Screen Positive;Herbal Toxicity,Serious,Died,Male,-,2/28/2019,Expedited,Not Specified,Not Specified,Teva,Healthcare Professional,Not Specified,-,2/18/2019,2/28/2019,US,Not Specified,US-TEVA-2019-US-1017580,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16017227,-,Herbals\\\\Mitragynine;Acetaminophen;Etizolam;Gabapentin,-,Drug Screen Positive;Herbal Toxicity,Serious,Died,Male,-,2/28/2019,Expedited,Not Specified,Not Specified,Teva,Healthcare Professional,Not Specified,-,2/18/2019,2/28/2019,US,Not Specified,US-TEVA-2019-US-1017585,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16025669,Hydroxyzine,Hydroxyzine Hydrochloride;Polyethylene Glycols;Bupropion Hydrochloride;Herbals\\\\Mitragynine;Clonidine;Etizolam;Gabapentin;Naltrexone;Diazepam,Product Used For Unknown Indication,Death,Serious,Other Outcomes;Died,Not Specified,2016,3/2/2019,Expedited,Not Specified,Not Specified,Zydus Pharm,Healthcare Professional,Not Specified,-,2/18/2019,3/2/2019,US,Not Specified,US-ZYDUS-034105,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16025668,Hydroxyzine;Fluoxetine;Trazodone;Pseudoephedrine.,Pseudoephedrine Hydrochloride;Benztropine;Herbals\\\\Mitragynine;Trazodone Hydrochloride;Morphine\\\\Morphine Hydrochloride\\\\Morphine Sulfate\\\\Morphine Tartrate;Levomilnacipran;Lithium;Fluoxetine Hydrochloride;Gabapentin;Hydroxyzine Hydrochloride;Lidocaine;Oxycodone,Product Used For Unknown Indication,Death;Unresponsive To Stimuli,Serious,Died;Other Outcomes,Not Specified,2016,3/2/2019,Expedited,Not Specified,Not Specified,Zydus Pharm,Healthcare Professional,Not Specified,-,2/18/2019,3/2/2019,US,Not Specified,US-ZYDUS-034104,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16025661,Buspirone;Propranolol,Propranolol Hydrochloride;Nordazepam;Mirtazapine;Diazepam;Buspirone Hydrochloride;Herbals\\\\Mitragynine;Etizolam;Gabapentin,Product Used For Unknown Indication,Death,Serious,Other Outcomes;Died,Not Specified,2017,3/2/2019,Expedited,Not Specified,Not Specified,Zydus Pharm,Healthcare Professional,Not Specified,-,2/18/2019,3/2/2019,US,Not Specified,US-ZYDUS-034109,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16025650,Sertraline;Hydroxyzine,Hydroxyzine Hydrochloride;Herbals\\\\Mitragynine;Clonazepam;Olanzapine;Temazepam;Sertraline Hydrochloride;Herbals\\\\Tetrahydrocannabinol Unspecified,Product Used For Unknown Indication,Cardiomegaly;Unresponsive To Stimuli;Death,Serious,Died;Other Outcomes,Not Specified,2017,3/2/2019,Expedited,Not Specified,Not Specified,Zydus Pharm,Healthcare Professional,Not Specified,-,2/18/2019,3/2/2019,US,Not Specified,US-ZYDUS-034108,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16019281,Zolpidem,Zolpidem Tartrate;Topiramate;Diphenhydramine;Herbals\\\\Mitragynine;Oxycodone;Tramadol,-,Toxicity To Various Agents,Serious,Died,Not Specified,-,3/5/2019,Expedited,Not Specified,Not Specified,Teva,Healthcare Professional,Not Specified,-,2/18/2019,2/28/2019,US,Not Specified,US-TEVA-2019-US-1017582,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.\",-\\n16370019,Zolpidem,Oxycodone;Herbals\\\\Mitragynine;Zolpidem Tartrate;Tramadol;Diphenhydramine;Topiramate,Product Used For Unknown Indication,Unresponsive To Stimuli;Toxicity To Various Agents,Serious,Died;Other Outcomes,Not Specified,-,5/30/2019,Non-Expedited,Not Specified,Not Specified,Vivimed Labs,Healthcare Professional,Not Specified,-,2/26/2019,5/30/2019,US,Not Specified,US-VIVIMED-2019SP001962,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R et al. Deaths in Colorado Attributed to Kratom. N Engl J Med. 2019;380(1):97-98\",-\\n17039019,Fluoxetine;Amlodipine,Amlodipine Besylate;Herbals\\\\Mitragynine;Fluoxetine Hydrochloride;Trimipramine;Diphenhydramine;Sildenafil;Bentiamine\\\\Bucetin\\\\Caffeine\\\\Ethenzamide,Product Used For Unknown Indication,Pneumonia;Pulmonary Oedema;Toxicity To Various Agents,Serious,Other Outcomes;Died,Male,-,11/15/2019,Expedited,56,Not Specified,Mylan,Consumer,Not Specified,-,11/12/2019,11/15/2019,DE,Not Specified,DE-MYLANLABS-2019M1109866,\"Fels H, Lottner-Nau S, Sax T, Roider G, Graw M, Auwrter V et. al.. Postmortem concentrations of the synthetic opioid U-47700 in 26 fatalities associated with the drug. Forensic Sci Int.. 2019\",-\\n16928532,Fluoxetine;Amlodipine,Amlodipine Besylate;Diphenhydramine;Herbals\\\\Mitragynine;Fluoxetine Hydrochloride;Trimipramine;Sildenafil,Product Used For Unknown Indication,Pneumonia Aspiration;Pulmonary Oedema;Toxicity To Various Agents;Pulmonary Haemorrhage,Serious,Died;Other Outcomes,Male,-,10/17/2019,Expedited,56,Not Specified,Lupin,Healthcare Professional,Not Specified,-,10/7/2019,10/17/2019,DE,Not Specified,DE-LUPIN PHARMACEUTICALS INC.-2019-06639,\"Fels H, Lottner-Nau S, Sax T, Roider G, Graw M, Auwarter V et al. Postmortem concentrations of the synthetic opioid U-47700 in 26 fatalities associated with the drug. Forensic Science International. 2019;301:E20-E28\",-\\n15838083,Methadone,Methadone Hydrochloride;Meperidine;Phentermine Hydrochloride;Morphine Sulfate;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents;Drug Interaction,Serious,Died,Male,-,1/17/2019,Expedited,41,Not Specified,Lannett,Healthcare Professional,Not Specified,-,1/7/2019,1/17/2019,US,Not Specified,\"US-LANNETT COMPANY, INC.-US-2019LAN000070\",\"Fagiola M, Hahn T, Avella J.. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS).. J-Anal-Toxicol. 2018;42(8):562-569\",-\\n15867698,\"Butalbital, Acetaminophen, And Caffeine;Heroin\",Diamorphine;Acetaminophen\\\\Butalbital\\\\Caffeine;Morphine;Herbals\\\\Mitragynine;Codeine;Alprazolam,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Female,2017,1/25/2019,Expedited,28,Not Specified,Novast,Healthcare Professional,Not Specified,-,1/14/2019,1/25/2019,US,Not Specified,\"US-NOVAST LABORATORIES, LTD-US-2019NOV000010\",\"Fagiola M, Hahn T, Avella J. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS). J-Anal-Toxicol. 2018;42(8):562-569\",-\\n15852553,Methadone,Methadone Hydrochloride;Morphine;Meperidine;Phentermine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Respiration Abnormal;Vomiting;Death;Toxicity To Various Agents,Serious,Other Outcomes;Died,Male,2017,1/22/2019,Expedited,41,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,1/7/2019,1/22/2019,US,Not Specified,US-AUROBINDO-AUR-APL-2019-002815,\"Fagiola M, Hahn T, Avella J, et,al.. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS).. Journal of Analytical Toxicology. 2018;42 (8):562-69\",-\\n15851501,-,Alprazolam;Butalbital;Codeine;Morphine;Diamorphine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse;Unresponsive To Stimuli;Toxicity To Various Agents,Serious,Died;Other Outcomes,Female,2017,1/22/2019,Expedited,28,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,1/7/2019,1/22/2019,US,Not Specified,US-AUROBINDO-AUR-APL-2019-002816,\"Fagiola M, Hahn T, Avella J, et,al.. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS).. Journal of Analytical Toxicology. 2018;42 (8):562-59\",-\\n16101916,Heroin,Diamorphine;Herbals\\\\Mitragynine;Oxycodone Hydrochloride,Product Used For Unknown Indication,Drug Abuse;Toxicity To Various Agents,Serious,Died,Male,2017,3/21/2019,Expedited,44,Not Specified,Lannett,Healthcare Professional,Not Specified,-,3/6/2019,3/21/2019,US,Not Specified,\"US-LANNETT COMPANY, INC.-US-2019LAN000655\",\"David D. Gummin MD, James B. Mowry PharmD, Daniel A. Spyker PhD, MDd, Daniel E. Brooks MD. 2017 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 35th Annual Report. Clinical Toxicology. CLINICAL TOXICOLOGY. 2018;56:12:1213-1415\",-\\n16480216,-,Dextroamphetamine Sulfate;Herbals\\\\Mitragynine,Depression;Insomnia;Product Used For Unknown Indication,Posterior Reversible Encephalopathy Syndrome;Drug Abuse,Serious,Hospitalized,Male,-,6/26/2019,Expedited,22,Not Specified,Arbor,Healthcare Professional,Not Specified,Fluoxetine;Cannabis Sativa Subsp. Indica Top;Quetiapine,6/13/2019,6/26/2019,US,Not Specified,\"US-ARBOR PHARMACEUTICALS, LLC-US-2019ARB000987\",\"Castillo A, Payne JD, Nugent K. Posterior reversible leukoencephalopathy syndrome after kratom ingestion. BAYLOR UNIV MED CENT PROC. 2017;30(3):355-357\",-\\n16268989,Oxycodone And Acetaminophen;Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine;Tramadol;Acetaminophen\\\\Oxycodone Hydrochloride,Pain;Product Used For Unknown Indication,Drug Withdrawal Syndrome;Irritability;Pain;Accidental Overdose;Rhinorrhoea,Serious,Hospitalized,Female,-,5/3/2019,Non-Expedited,60,Not Specified,Apotex,Healthcare Professional,Not Specified,Buprenorphine;Pregabalin;Duloxetine,4/23/2019,5/3/2019,US,Not Specified,US-APOTEX-2019AP013423,Buresh M.. Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance;DOI:10.1097/ADM.0000000000000428. Journal of Addiction Medicine. 2018;12:481-483,-\\n16286856,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine;Morphine Sulfate;Bromazepam;Oxazepam,-,Toxicity To Various Agents,Serious,Died,Male,-,7/26/2019,Expedited,36,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,7/22/2019,5/8/2019,FR,Not Specified,FR-PFIZER INC-2019194321,\"Bourgine, J.. Fatal intoxication with Kratom: A case report. Toxicologie Analytique et Clinique. 2019;31 (Suppl 2):S36-S37\",-\\n16289668,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine;Cocaine;Bromazepam;Oxazepam;Morphine,Product Used For Unknown Indication,Toxicity To Various Agents;Asphyxia;Gastritis;Pancreatitis;Pulmonary Oedema,Serious,Other Outcomes;Died,Male,-,5/9/2019,Expedited,36,Not Specified,Fresenius Kabi,Healthcare Professional,Not Specified,-,5/1/2019,5/9/2019,FR,Not Specified,FR-FRESENIUS KABI-FK201905280,\"Bourgine J, Garnier-Jardin C, Chretien B, Le Boisselier R, Loilier M, Lelong-Boulouard V, et al.. Fatal intoxication with Kratom: A case report. Toxicologie Analytique et Clinique. 2019 MAY;VOL. 31:S36-S37.\",-\\n16934580,-,Herbals\\\\Mitragynine,Anxiety;Stress,Seizure,Serious,Died,Male,20-Aug-2019,10/16/2019,Direct,36,72 KG,Fda-Ctu,Consumer,Consumer,Zofran;Librium;Lantus;Zoloft;Gabapentin;Lopressor,-,10/16/2019,US,Not Specified,-,-,-\\n17021954,-,Herbals\\\\Mitragynine,Drug Abuse,Loss Of Personal Independence In Daily Activities;Drug Dependence;Socioeconomic Precarity,Non-Serious,Non-Serious,Male,01-Nov-2018,11/10/2019,Direct,36,63 KG,Fda-Ctu,Consumer,Consumer,Tylenol;Adderall,-,11/10/2019,US,Not Specified,-,-,-\\n17159096,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Emotional Distress;Crying;Bone Pain;Product Complaint;Drug Dependence;Anxiety Disorder;Anger;Delusion;Mania;Aggression;Homicidal Ideation;Condition Aggravated;Bipolar I Disorder,Serious,Disabled;Hospitalized;Other Outcomes,Female,15-Nov-2019,12/14/2019,Direct,23,83.25 KG,Fda-Ctu,Consumer,Consumer,Trazodone;Omeprazole;Lamictal;Seroquel;Stool Softener (Docusate);Melatonin;Senna;Vitamin D3;Suboxone;Topiramate;Clonidine;Claritin;Ibuprofen,-,12/14/2019,US,Not Specified,-,-,-\\n16946302,-,Herbals\\\\Mitragynine,Anxiety;Pain,Weight Decreased;Decreased Appetite;Anxiety;Weight Increased;Diarrhoea;Influenza;Nausea;Depression;Insomnia;Rash;Stress,Serious,Other Outcomes,Female,10-Oct-2019,10/18/2019,Direct,31,65.25 KG,Fda-Ctu,Consumer,Consumer,Omega-3 Fatty Acids,-,10/18/2019,US,Not Specified,-,-,-\\n16089459,-,Herbals\\\\Mitragynine,Depression,Drug Dependence;Withdrawal Syndrome;Adulterated Product,Non-Serious,Non-Serious,Male,08-Mar-2019,3/17/2019,Direct,31,58.5 KG,Fda-Ctu,Consumer,Consumer,Mirtazapine;Suboxone,-,3/17/2019,US,Y,-,-,-\\n17218104,-,Herbals\\\\Mitragynine,Depression;Pain,Systemic Lupus Erythematosus;Joint Injury;Myalgia;Pain;Inflammation;Arthralgia;Antinuclear Antibody Positive,Serious,Disabled;Other Outcomes,Male,-,12/28/2019,Direct,37,94.5 KG,Fda-Ctu,Consumer,Consumer,Minerals;Vitamins,-,12/28/2019,US,Not Specified,-,-,-\\n15790380,-,Herbals\\\\Mitragynine,Drug Detoxification;Drug Withdrawal Syndrome,Chest Pain;Palpitations;Cardiac Flutter;Hypoaesthesia;Product Packaging Issue;Product Use Complaint;Cold Sweat,Serious,Other Outcomes,Female,02-Jan-2019,1/3/2019,Direct,28,66.6 KG,Fda-Ctu,Consumer,Consumer,Methadone;Advil,-,1/3/2019,US,Y,-,-,-\\n16051419,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Heart Rate Increased;Product Complaint;Food Interaction;Palpitations;Drug Interaction,Serious,Other Outcomes,Male,10-Feb-2019,3/7/2019,Direct,40,100.8 KG,Fda-Ctu,Consumer,Consumer,Melatonin;Ibuprofen,-,3/7/2019,US,Not Specified,-,-,-\\n16464326,-,Herbals\\\\Mitragynine,-,Loss Of Consciousness;Depression;Dyspnoea,Serious,Other Outcomes;Life Threatening,Female,29-Apr-2019,6/20/2019,Direct,49,73.35 KG,Fda-Ctu,Consumer,Consumer,Lunesta;Xanax;Aimovig;Lamictal,-,6/20/2019,US,Y,-,-,-\\n16838587,-,Herbals\\\\Mitragynine,Anxiety,Vomiting;Sensitive Skin;Nightmare;Depression;Drug Diversion;Irritability;Hyperhidrosis;Intentional Overdose;Product Contamination Physical,Serious,Disabled,Not Specified,14-Sep-2019,9/20/2019,Direct,38,83.25 KG,Fda-Ctu,Consumer,Consumer,Lecithin;Melatonin,-,9/20/2019,US,Not Specified,-,-,-\\n16383121,-,Herbals\\\\Mitragynine,Substance Use,Skin Discolouration;Respiratory Arrest;Loss Of Consciousness,Serious,Other Outcomes,Female,29-Apr-2019,5/2/2019,Direct,49,73.35 KG,Fda-Ctu,Consumer,Consumer,Lamictal;Wellbutrin;Fluvoxamine;Lunesta,-,5/2/2019,US,Not Specified,-,-,-\\n15967937,-,Herbals\\\\Mitragynine,Drug Dependence,Overdose;Renal Failure;Lung Disorder;Rhabdomyolysis;Pneumonia,Serious,Hospitalized,Male,29-Jan-2010,2/15/2019,Direct,34,231.3 KG,Fda-Ctu,Consumer,Consumer,Klonopin;Ambien;Tylenol;Lisinopril,-,2/15/2019,US,Not Specified,-,-,-\\n16534204,-,Herbals\\\\Mitragynine,Decreased Appetite,Loss Of Consciousness;Seizure,Serious,Other Outcomes,Male,02-Jul-2019,7/4/2019,Direct,37,94.5 KG,Fda-Ctu,Consumer,Consumer,Ibuprofen,-,7/4/2019,US,Not Specified,-,-,-\\n16197682,-,Herbals\\\\Mitragynine,Restless Legs Syndrome,Bruxism;Blepharospasm;Near Death Experience;Constipation;Cognitive Disorder;Product Contamination Physical;Hallucination;Product Contamination Microbial,Non-Serious,Non-Serious,Male,12-Apr-2019,4/14/2019,Direct,66,110.25 KG,Fda-Ctu,Consumer,Consumer,Hydroxyzine;Lecithin;Anastrozole;Metformin;Cinnamon;Losartan;Fish Oil;Vitamins;Magnesium;Testosterone;Vitamin D Nos;Atorvastatin,-,4/14/2019,US,Not Specified,-,-,-\\n16141629,-,Herbals\\\\Mitragynine,Anxiety;Pain,Toxicity To Various Agents;Intentional Product Misuse,Serious,Died,Male,18-Jan-2019,3/31/2019,Direct,36,125.1 KG,Fda-Ctu,Consumer,Consumer,Effexor;Alprazolam,-,3/31/2019,US,Not Specified,-,-,-\\n16265229,-,Herbals\\\\Mitragynine,Pain In Extremity,Presyncope;Dizziness;Cardiac Flutter;Chest Discomfort,Serious,Life Threatening,Male,30-Apr-2019,5/2/2019,Direct,53,83.01 KG,Fda-Ctu,Not Specified,Not Specified,Diazepam;Fludrocortisone,-,5/2/2019,US,Not Specified,-,-,-\\n15854458,-,Herbals\\\\Mitragynine,Asthenia,Feeling Abnormal;Fear,Serious,Life Threatening;Hospitalized,Female,31-Dec-2018,1/18/2019,Direct,33,54 KG,Fda-Ctu,Consumer,Consumer,Celexa;Cyanocobalamin\\\\Dexpanthenol\\\\Niacinamide\\\\Pyridoxine Hydrochloride\\\\Riboflavin 5\\'-Phosphate Sodium\\\\Thiamine Hydrochloride\\\\Vitamin B Complex;Vitamins;Gabapentin,-,1/18/2019,US,Not Specified,-,-,-\\n16474739,-,Herbals\\\\Mitragynine,Anxiety,Lung Adenocarcinoma,Serious,Disabled;Life Threatening,Female,24-May-2019,6/24/2019,Direct,26,48.6 KG,Fda-Ctu,Consumer,Consumer,Carbamazepine;Topamax,-,6/24/2019,US,Not Specified,-,-,-\\n15856852,-,Herbals\\\\Mitragynine,Anxiety;Pain,Seizure;Treatment Noncompliance,Serious,Other Outcomes;Hospitalized,Female,22-Jul-2018,1/17/2019,Direct,33,51 KG,Fda-Ctu,Healthcare Professional,Health Professional,Cannabis Sativa Subsp. Indica Top,-,1/17/2019,US,Not Specified,-,-,-\\n15789740,-,Herbals\\\\Mitragynine;Quetiapine,Product Used For Unknown Indication,Drug Interaction;Hyperthermia;Tongue Haemorrhage;Toxicity To Various Agents;Seizure;Discharge,Serious,Died;Life Threatening;Other Outcomes,Male,-,1/4/2019,Expedited,27,Not Specified,Hikma,Healthcare Professional,Not Specified,Valproic Acid,12/27/2018,1/4/2019,US,Not Specified,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-18-09231,-,-\\n15788815,-,Herbals\\\\Mitragynine;Quetiapine,Product Used For Unknown Indication,Drug Interaction;Tongue Haemorrhage;Toxicity To Various Agents;Discharge;Hyperthermia;Seizure,Serious,Life Threatening;Died;Other Outcomes,Male,-,1/4/2019,Expedited,27,Not Specified,Torrent,Healthcare Professional,Not Specified,Valproic Acid,12/27/2018,1/4/2019,US,Not Specified,US-TORRENT-00007388,-,-\\n15831424,-,Clonazepam;Fentanyl;Diphenhydramine;Alprazolam;Cocaine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Cardio-Respiratory Arrest;Incorrect Route Of Product Administration,Serious,Died,Male,2017,1/16/2019,Expedited,31,Not Specified,Insys,Healthcare Professional,Not Specified,-,1/3/2019,1/16/2019,US,Not Specified,\"US-INSYS THERAPEUTICS, INC-INS201901-000129\",-,-\\n15836209,-,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died,Female,2017,1/17/2019,Expedited,60,Not Specified,Insys,Healthcare Professional,Not Specified,-,1/3/2019,1/17/2019,US,Not Specified,\"US-INSYS THERAPEUTICS, INC-INS201901-000232\",-,-\\n15861486,-,Herbals\\\\Mitragynine;Fentanyl,-,Overdose;Accidental Death,Serious,Died,Male,14-Sep-2018,1/23/2019,Direct,32,Not Specified,Fda-Ctu,Not Specified,Not Specified,Clonazepam;Cannabis Sativa Flowering Top;Codeine,-,1/23/2019,US,Not Specified,-,-,-\\n15945096,-,Butyrfentanyl;Herbals\\\\Mitragynine,-,Accidental Death;Toxicity To Various Agents,Serious,Died,Male,07-Dec-2015,2/11/2019,Direct,24,Not Specified,Fda-Ctu,Not Specified,Not Specified,Oxycodone;Diphenhydramine;Etizolam,-,2/11/2019,US,Not Specified,-,-,-\\n15944968,-,Furanylfentanyl;Herbals\\\\Mitragynine,-,Accidental Death;Toxicity To Various Agents,Serious,Died,Male,10-Dec-2016,2/11/2019,Direct,28,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,2/11/2019,US,Not Specified,-,-,-\\n15944960,-,Etizolam;Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died,Male,08-Apr-2017,2/11/2019,Direct,29,Not Specified,Fda-Ctu,Not Specified,Not Specified,Mirtazapine;Diazepam,-,2/11/2019,US,Not Specified,-,-,-\\n15960718,-,Oxycodone;Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Accidental Death,Serious,Died,Female,25-Oct-2017,2/13/2019,Direct,32,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,2/13/2019,US,Not Specified,-,-,-\\n15993191,-,Herbals\\\\Mitragynine;Quetiapine,-,Hyperthermia;Toxicity To Various Agents;Drug Interaction;Seizure,Serious,Other Outcomes;Died,Male,-,2/22/2019,Expedited,27,Not Specified,Unichem,Healthcare Professional,Not Specified,Valproic Acid,2/13/2019,2/22/2019,US,Not Specified,US-UNICHEM PHARMACEUTICALS (USA) INC-UCM201902-000077,-,-\\n16034667,-,Herbals\\\\Mitragynine;Fentanyl,-,Toxicity To Various Agents;Accidental Death,Serious,Died,Male,01-Jan-2019,3/4/2019,Direct,26,Not Specified,Fda-Ctu,Not Specified,Not Specified,Xylazine;Acetylfentanyl,-,3/4/2019,US,Not Specified,-,-,-\\n16218126,-,Citalopram;Caffeine;Herbals\\\\Mitragynine;Mirtazapine,Product Used For Unknown Indication,Cardio-Respiratory Arrest;Toxicity To Various Agents,Serious,Hospitalized;Died,Male,-,4/19/2019,Expedited,32,Not Specified,Torrent,Healthcare Professional,Not Specified,-,4/12/2019,4/19/2019,US,Not Specified,US-TORRENT-00008321,-,-\\n16822803,-,Herbals\\\\Mitragynine;Device,-,Drug Dependence,Non-Serious,Non-Serious,Not Specified,01-Sep-2018,9/18/2019,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,9/18/2019,US,Not Specified,-,-,-\\n17024940,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Toxicity To Various Agents,Non-Serious,Non-Serious,Female,-,11/13/2019,Non-Expedited,31,Not Specified,Mylan,Healthcare Professional,Not Specified,-,10/28/2019,11/13/2019,US,Not Specified,US-MYLANLABS-2019M1103820,-,-\\n15812850,-,Herbals\\\\Mitragynine,Depression;Pain,Product Advertising Issue;Malaise;Product Use In Unapproved Indication,Non-Serious,Non-Serious,Male,-,1/11/2019,Direct,30,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,1/11/2019,US,Not Specified,-,-,-\\n15956746,-,Herbals\\\\Mitragynine,Back Pain;Drug Dependence,Cerebral Mass Effect;Headache;Mental Status Changes;Disorientation;Vomiting;Cerebral Haemorrhage,Serious,Required Intervention;Hospitalized;Life Threatening,Male,24-Jan-2019,2/1/2019,Direct,54,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,2/1/2019,US,Not Specified,-,-,-\\n15916803,-,Herbals\\\\Mitragynine,-,Product Substitution Issue;Cerebral Thrombosis;Cerebral Haemorrhage,Serious,Life Threatening;Other Outcomes;Required Intervention,Male,24-Jan-2019,2/5/2019,Direct,54,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,2/5/2019,US,Not Specified,-,-,-\\n16005421,-,Herbals\\\\Mitragynine,-,Weight Decreased;Anxiety;Self-Medication;Thinking Abnormal;Physical Disability;Emotional Distress;Pollakiuria;Mental Disorder;Insomnia,Serious,Disabled,Male,02-Feb-2019,2/25/2019,Direct,69,72.57 KG,Fda-Ctu,Not Specified,Not Specified,-,-,2/25/2019,US,Not Specified,-,-,-\\n16005617,-,Herbals\\\\Mitragynine,-,Product Substitution Issue;Psychomotor Hyperactivity,Serious,Life Threatening;Other Outcomes;Hospitalized,Female,24-Jan-2019,2/26/2019,Direct,35,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,2/26/2019,US,Not Specified,-,-,-\\n16054998,-,Herbals\\\\Mitragynine,-,Schizophrenia;Decreased Appetite;Amnesia;Nausea,Serious,Other Outcomes,Not Specified,Feb-2019,3/7/2019,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/7/2019,US,Not Specified,-,-,-\\n16083408,-,Herbals\\\\Mitragynine,-,Multiple Organ Dysfunction Syndrome,Serious,Died,Male,16-Feb-2018,3/15/2019,Direct,41,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/15/2019,US,Not Specified,-,-,-\\n16117172,-,Herbals\\\\Mitragynine,-,Cardiac Arrest;Seizure,Serious,Died,Male,24-Nov-2018,3/15/2019,Direct,40,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/15/2019,US,Not Specified,-,-,-\\n16088643,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,2018,3/18/2019,Direct,24,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/18/2019,US,Not Specified,-,-,-\\n16100702,-,Herbals\\\\Mitragynine,Pain,Gastroenteritis Salmonella,Serious,Hospitalized,Male,01-Mar-2019,3/19/2019,Direct,47,67.5 KG,Fda-Ctu,Consumer,Consumer,-,-,3/19/2019,US,Not Specified,-,-,-\\n16139348,-,Herbals\\\\Mitragynine,-,Nausea;Vomiting;Abdominal Pain;Drug Screen Positive;Tremor,Non-Serious,Non-Serious,Not Specified,23-Mar-2019,3/28/2019,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/28/2019,US,Not Specified,-,-,-\\n16197668,-,Herbals\\\\Mitragynine,Drug Dependence,Drug Dependence;Impaired Quality Of Life;Product Complaint,Serious,Other Outcomes;Life Threatening;Hospitalized,Male,01-Mar-2015,4/12/2019,Direct,34,81 KG,Fda-Ctu,Consumer,Consumer,-,-,4/12/2019,US,Not Specified,-,-,-\\n16202264,-,Herbals\\\\Mitragynine,-,Headache;Drug Screen Positive;Vomiting,Non-Serious,Non-Serious,Female,02-Apr-2019,4/15/2019,Direct,30,54 KG,Fda-Ctu,Consumer,Consumer,-,-,4/15/2019,US,Y,-,-,-\\n16212272,-,Herbals\\\\Mitragynine,Substance Use,Seizure;Withdrawal Syndrome,Serious,Died;Disabled;Life Threatening;Hospitalized,Male,01-Apr-2019,4/18/2019,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,4/18/2019,US,Not Specified,-,-,-\\n16212271,-,Herbals\\\\Mitragynine,-,Unresponsive To Stimuli,Serious,Died,Male,-,4/18/2019,Direct,35,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,4/18/2019,US,Not Specified,-,-,-\\n16212240,-,Herbals\\\\Mitragynine,-,Cardiac Arrest,Serious,Died,Male,-,4/18/2019,Direct,27,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,4/18/2019,US,Not Specified,-,-,-\\n16212231,-,Herbals\\\\Mitragynine,-,Unresponsive To Stimuli,Serious,Died,Male,-,4/18/2019,Direct,26,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,4/18/2019,US,Not Specified,-,-,-\\n16228506,-,Herbals\\\\Mitragynine,Drug Use Disorder,Loss Of Employment;Drug Dependence;Drug Withdrawal Syndrome;Homeless,Serious,Disabled;Hospitalized,Male,16-Sep-2016,4/21/2019,Direct,30,81 KG,Fda-Ctu,Consumer,Consumer,-,-,4/21/2019,US,Not Specified,-,-,-\\n16227577,-,Herbals\\\\Mitragynine,Self-Medication,Drug Dependence;Overdose,Serious,Life Threatening;Hospitalized;Disabled,Female,06-Mar-2019,4/22/2019,Direct,62,63 KG,Fda-Ctu,Consumer,Consumer,-,-,4/22/2019,US,Not Specified,-,-,-\\n16242868,-,Herbals\\\\Mitragynine,-,Drug Dependence;Overdose,Serious,Other Outcomes;Required Intervention,Female,06-Mar-2019,4/25/2019,Direct,62,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,4/25/2019,US,Not Specified,-,-,-\\n16260968,-,Herbals\\\\Mitragynine,Substance Use,Withdrawal Syndrome;Insomnia;Drug Dependence;Seizure,Serious,Disabled;Hospitalized,Male,27-Apr-2019,4/30/2019,Direct,19,74.84 KG,Fda-Ctu,Not Specified,Not Specified,-,-,4/30/2019,US,Not Specified,-,-,-\\n16307114,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died;Hospitalized,Not Specified,Oct-2018,5/13/2019,Direct,37,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,5/13/2019,US,Not Specified,-,-,-\\n16371118,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died,Male,-,5/29/2019,Direct,33,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,5/29/2019,US,Not Specified,-,-,-\\n16392938,-,Herbals\\\\Mitragynine,-,Coronary Artery Occlusion;Ventricular Fibrillation;Hypertensive Emergency;Acute Myocardial Infarction,Serious,Hospitalized,Male,31-May-2019,6/4/2019,Direct,44,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,6/4/2019,US,Not Specified,-,-,-\\n16474745,-,Herbals\\\\Mitragynine,-,Heart Rate Increased;Adulterated Product;Vomiting;Dysgeusia;Agitation;Nausea;Chest Pain,Non-Serious,Non-Serious,Not Specified,09-Jun-2019,6/14/2019,Direct,Not Specified,58.5 KG,Fda-Ctu,Consumer,Consumer,-,-,6/14/2019,US,Not Specified,-,-,-\\n16430163,-,Herbals\\\\Mitragynine,-,Vomiting;Chest Pain;Dysgeusia;Nausea;Suspected Product Contamination;Agitation;Adulterated Product;Anxiety;Heart Rate Increased,Non-Serious,Non-Serious,Male,09-Jun-2019,6/14/2019,Direct,24,58.5 KG,Fda-Ctu,Consumer,Consumer,-,-,6/14/2019,US,Not Specified,-,-,-\\n16474228,-,Herbals\\\\Mitragynine,Disturbance In Attention;Feeling Of Relaxation;Insomnia,Vitamin D Decreased;Alopecia;Hepatic Function Abnormal;Drug Dependence;Weight Decreased;Blood Test Abnormal,Serious,Hospitalized;Life Threatening,Male,01-Jun-2019,6/25/2019,Direct,20,58.06 KG,Fda-Ctu,Consumer,Consumer,-,-,6/25/2019,US,Not Specified,-,-,-\\n16486428,-,Herbals\\\\Mitragynine,Therapy Cessation,Anxiety;Vomiting;Drug Abuse;Toxicity To Various Agents;Abdominal Pain,Serious,Hospitalized,Male,24-Jun-2019,6/25/2019,Direct,30,73.35 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,6/25/2019,US,Not Specified,-,-,-\\n16489051,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,08-Apr-2019,6/26/2019,Direct,22,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,6/26/2019,US,Not Specified,-,-,-\\n16502543,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Female,-,7/1/2019,Direct,56,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,7/1/2019,US,Not Specified,-,-,-\\n16516317,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died;Hospitalized;Other Outcomes,Male,Oct-2018,7/2/2019,Direct,37,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,7/2/2019,US,Not Specified,-,-,-\\n16565419,-,Herbals\\\\Mitragynine,-,Malaise;Pain;Vomiting;Abdominal Discomfort,Non-Serious,Non-Serious,Female,18-May-2019,7/12/2019,Direct,22,51.75 KG,Fda-Ctu,Consumer,Consumer,-,-,7/12/2019,US,Not Specified,-,-,-\\n16597702,-,Herbals\\\\Mitragynine,-,Hepatotoxicity,Serious,Hospitalized,Male,09-Jun-2019,7/18/2019,Direct,18,58.5 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,7/18/2019,US,Not Specified,-,-,-\\n16608035,-,Herbals\\\\Mitragynine,-,Hypertransaminasaemia;Nausea;Blood Creatine Phosphokinase Increased;Abdominal Pain;Vomiting,Serious,Hospitalized;Life Threatening,Female,21-Jun-2019,7/19/2019,Direct,27,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,7/19/2019,US,Not Specified,-,-,-\\n16668064,-,Herbals\\\\Mitragynine,Anxiolytic Therapy,Toxicity To Various Agents;Accidental Death,Serious,Died,Male,08-May-2019,8/4/2019,Direct,30,85.5 KG,Fda-Ctu,Consumer,Consumer,-,-,8/4/2019,US,Not Specified,-,-,-\\n16692189,-,Herbals\\\\Mitragynine,-,Miosis;Agitation;Hallucination;Confusional State;Paranoia,Serious,Hospitalized;Other Outcomes,Female,10-Aug-2019,8/10/2019,Direct,58,116 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,8/10/2019,US,Not Specified,-,-,-\\n16767623,-,Herbals\\\\Mitragynine,Anxiety;Depression,Decreased Appetite;Hallucination;Muscle Twitching;Depression;Withdrawal Syndrome;Amnesia;Psychotic Disorder;Mood Swings;Vomiting;Insomnia,Non-Serious,Non-Serious,Male,15-Aug-2019,8/29/2019,Direct,58,81 KG,Fda-Ctu,Consumer,Consumer,-,-,8/29/2019,US,Not Specified,-,-,-\\n16861331,-,Herbals\\\\Mitragynine,Substance Use,Headache;Musculoskeletal Disorder;Cardiac Arrest;Dysstasia,Serious,Died,Male,-,9/23/2019,Direct,69,170 LB,Fda-Ctu,Consumer,Consumer,-,-,9/23/2019,US,Y,-,-,Yes\\n16934585,-,Herbals\\\\Mitragynine,-,Socioeconomic Precarity;Loss Of Employment;Aggression;Impaired Reasoning;Anger;Drug Dependence,Non-Serious,Non-Serious,Male,01-Jul-2019,10/17/2019,Direct,60,74.25 KG,Fda-Ctu,Consumer,Consumer,-,-,10/17/2019,US,Not Specified,-,-,-\\n16997145,-,Herbals\\\\Mitragynine,Substance Use,Overdose;Withdrawal Syndrome;Drug Dependence;Tachyphrenia,Serious,Hospitalized;Disabled,Male,-,11/1/2019,Direct,Not Specified,81 KG,Fda-Ctu,Consumer,Consumer,-,-,11/1/2019,US,Not Specified,-,-,-\\n17005702,-,Herbals\\\\Mitragynine,Back Pain,Night Sweats;Depression;Affective Disorder;Pruritus;Insomnia;Drug Dependence;Drug Withdrawal Syndrome;Weight Decreased;Diarrhoea;Dyskinesia;Anger;Loss Of Personal Independence In Daily Activities;Anxiety,Serious,Life Threatening,Male,05-Nov-2019,11/5/2019,Direct,36,63 KG,Fda-Ctu,Consumer,Consumer,-,-,11/5/2019,US,Not Specified,-,-,-\\n17049729,-,Herbals\\\\Mitragynine,-,Drug Dependence;Product Complaint,Serious,Other Outcomes,Male,12-Nov-2019,11/19/2019,Direct,40,81 KG,Fda-Ctu,Consumer,Consumer,-,-,11/19/2019,US,Not Specified,-,-,-\\n17115142,-,Herbals\\\\Mitragynine,Depression;Pain,Malaise,Serious,Other Outcomes,Female,16-Aug-2019,12/3/2019,Direct,29,61.2 KG,Fda-Ctu,Consumer,Consumer,-,-,12/3/2019,US,Y,-,-,-\\n17173525,-,Herbals\\\\Mitragynine,Insomnia,Injury;Toxicity To Various Agents,Serious,Hospitalized,Female,03-Dec-2019,12/18/2019,Direct,58,85.4 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,12/18/2019,US,Not Specified,-,-,-\\n17175499,-,Herbals\\\\Mitragynine,Pain,Mood Swings;Emergency Care;Depression;Drug Dependence;Weight Decreased;Product Complaint,Serious,Disabled,Male,01-Aug-2018,12/19/2019,Direct,46,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,12/19/2019,US,Not Specified,-,-,-\\n16099193,-,Citalopram;Albuterol;Ranitidine;Loratadine;Herbals\\\\Mitragynine;Valacyclovir Hydrochloride;Acetaminophen\\\\Methocarbamol;Diphenhydramine,-,Drug Withdrawal Syndrome Neonatal;Foetal Exposure During Pregnancy,Serious,Other Outcomes;Hospitalized,Female,-,9/14/2020,Expedited,Not Specified,3.68 KG,Bayer,Healthcare Professional,Not Specified,-,9/7/2020,3/21/2019,CA,Not Specified,CA-BAYER-2019-054327,\"Murthy P, Clark D. An unusual cause for neonatal abstinence syndrome. Paediatrics and Child Health (Canada). 2019;24:1:12-14\",-\\n18467255,-,Amitriptyline;Phenethylamine;Herbals\\\\Mitragynine;Perphenazine,Affective Disorder;Anxiety,Rhabdomyolysis;Metabolic Acidosis;Tachypnoea;Serotonin Syndrome;Insomnia;Hypertransaminasaemia;Tachycardia;Cough;Decreased Appetite,Serious,Other Outcomes;Hospitalized,Male,-,11/5/2020,Expedited,20,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,10/21/2020,11/5/2020,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-266428,\"Mantilla B, Vega MV, Solis X, Makram J, Mallah H, Test V. A Dangerous Drug and Herbal Mixture. Chest. 2020;Oct 18-21:812A\",-\\n18469668,Sertraline,Sertraline Hydrochloride;Perphenazine;Amitriptyline;Herbals\\\\Mitragynine;Phenethylamine;Bupropion,Anxiety;Mood Altered,Metabolic Acidosis;Serotonin Syndrome;Hypertransaminasaemia;Rhabdomyolysis;Drug Ineffective,Serious,Hospitalized,Male,-,11/25/2020,Expedited,20,Not Specified,Teva,Healthcare Professional,Not Specified,-,11/17/2020,11/5/2020,US,Not Specified,US-TEVA-2020-US-1843957,\"Mantilla B, Vega MV, Solis X, Makram J, Mallah H, Test V. A DANGEROUS DRUG AND HERBAL MIXTURE. Chest 2020;158 (Suppl.)(4):A812 (plus poster).\",-\\n17264092,Venlafaxine Hcl,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine,-,Drug Abuse,Serious,Died,Male,2018,1/13/2020,Expedited,40,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/11/2020,1/13/2020,US,Not Specified,US-PFIZER INC-2020013628,\"Gummin, D.. 2018 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57 (12):1220-1413\",-\\n17277216,-,Herbals\\\\Mitragynine;Sertraline Hydrochloride,-,Respiratory Arrest;Cardiac Arrest;Drug Abuse,Serious,Hospitalized;Died,Male,2018,1/16/2020,Expedited,36,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/11/2020,1/16/2020,US,Not Specified,US-PFIZER INC-2020016503,\"Gummin, D.. 2018 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57 (12):1220-1413\",-\\n17277794,-,Gabapentin;Herbals\\\\Mitragynine;Diazepam,-,Intentional Product Misuse,Serious,Died,Male,2018,1/23/2020,Expedited,41,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/22/2020,1/16/2020,US,Not Specified,US-PFIZER INC-2020015208,\"Gummin, D.. 2018 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57 (12):1220-1413\",-\\n17282735,Heroin,Cocaine;Herbals\\\\Mitragynine;Chlorpheniramine;Diamorphine;Dextromethorphan Hydrobromide;Sertraline Hydrochloride;Codeine;Bupropion,-,Cardiac Arrest;Completed Suicide;Respiratory Arrest,Serious,Hospitalized;Died,Male,2018,1/24/2020,Expedited,32,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/11/2020,1/17/2020,US,Not Specified,US-PFIZER INC-2020016502,\"Gummin, D.. 2018 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57 (12):1220-1413\",-\\n17269189,Heroin;Sertraline,Cocaine;Sertraline Hydrochloride;Chlorpheniramine Maleate;Bupropion;Diamorphine;Dextromethorphan;Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Completed Suicide,Serious,Died;Hospitalized,Male,-,1/14/2020,Expedited,32,Not Specified,Bayer,Healthcare Professional,Not Specified,-,1/2/2020,1/14/2020,US,Not Specified,US-BAYER-2020-004931,Gummin DD; Mowry JB; Spyker DA; Brooks DE; Beuhler MC; Rivers LJ; Hashem HA; Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers. National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;54:12:1220-1413,-\\n18011399,Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Diazepam;Gabapentin,Product Used For Unknown Indication,Intentional Product Misuse,Serious,Died,Male,-,7/12/2020,Expedited,41,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/30/2020,7/12/2020,US,Not Specified,US-AUROBINDO-AUR-APL-2020-033385,\"Gummin DD, Spyker DA, Brooks DE, Beuhler MC, Mowry JB, Rivers LJ et al.. 2018 Annual Report of the American Association of Poison Control Centers National Poison Data: 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413\",-\\n18003300,Heroin;Sertraline,Chlorpheniramine;Sertraline Hydrochloride;Diamorphine;Cocaine;Bupropion;Dextromethorphan;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Respiratory Arrest;Completed Suicide;Cardiac Arrest,Serious,Other Outcomes;Died;Hospitalized,Male,-,7/10/2020,Expedited,32,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/30/2020,7/10/2020,US,Not Specified,US-AUROBINDO-AUR-APL-2020-033341,\"Gummin DD, Spyker DA, Brooks DE, Beuhler MC, Mowry JB, Rivers LJ et al.. 2018 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 36th Annual Report.. Clinical Toxicology. 2019;57(12):1220-1413\",-\\n17996747,-,Fentanyl;Oxycodone;Mirtazapine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Cardiac Arrest;Drug Abuse;Respiratory Arrest,Serious,Died;Other Outcomes,Male,-,7/9/2020,Expedited,57,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/30/2020,7/9/2020,US,Not Specified,US-AUROBINDO-AUR-APL-2020-032587,\"Gummin DD, Spyker DA, Brooks DE, Beuhler MC, Mowry JB, Rivers LJ et al.. 2018 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413\",-\\n18003648,Sertraline,Sertraline Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Cardiac Arrest;Respiratory Arrest;Drug Abuse,Serious,Died;Hospitalized;Other Outcomes,Male,-,7/10/2020,Expedited,36,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/30/2020,7/10/2020,US,Not Specified,US-AUROBINDO-AUR-APL-2020-033359,\"Gummin DD, Spyker DA, Brooks DE, Beuhler MC, Mowry JB, Rivers LJ et al.. 2018 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413\",-\\n18003374,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Hospitalized;Died;Other Outcomes,Male,-,7/10/2020,Expedited,40,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/30/2020,7/10/2020,US,Not Specified,US-AUROBINDO-AUR-APL-2020-033380,\"Gummin DD, Spyker DA, Brooks DE, Beuhler MC, Mowry JB, Rivers LJ et al.. 2018 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413\",-\\n17779878,-,Citalopram;Caffeine;Mirtazapine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Death;Cardiac Arrest;Respiratory Arrest,Serious,Died;Other Outcomes,Male,-,5/14/2020,Expedited,32,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,5/4/2020,5/14/2020,US,Not Specified,US-AUROBINDO-AUR-APL-2020-023710,\"Gummin DD, Spyker DA, Brooks DE, Banner W, Mowry JB, Osterthaler KM. 2017 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 35th Annual Report.. CLINICAL TOXICOLOGY. 2018;56(12):1213-1415\",-\\n17264540,-,Phentermine;Bupropion;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Intentional Product Use Issue,Serious,Died,Female,-,1/13/2020,Expedited,40,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/6/2020,1/13/2020,US,Not Specified,US-APOTEX-2020AP006072,\"Gummin DD, MowryJB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, Hashem HA, Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 36th Annual Report. DOI: 10.1080/15563650.2019.1677022. Clinical Toxicology. 2019;57 (12):1220-1413\",-\\n17268379,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/14/2020,Non-Expedited,25,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/6/2020,1/14/2020,US,Not Specified,US-APOTEX-2020AP005256,\"Gummin DD, MowryJB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, Hashem HA, Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 36th Annual Report. DOI: 10.1080/15563650.2019.1677022. Clinical Toxicology. 2019;57 (12):1220-1413\",-\\n17267222,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/14/2020,Non-Expedited,33,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/6/2020,1/14/2020,US,Not Specified,US-APOTEX-2020AP005575,\"Gummin DD, MowryJB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, Hashem HA, Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 36th Annual Report. DOI: 10.1080/15563650.2019.1677022. Clinical Toxicology. 2019;57 (12):1220-1413\",-\\n17267041,-,Fentanyl;Herbals\\\\Mitragynine;Cocaine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/14/2020,Non-Expedited,38,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/6/2020,1/14/2020,US,Not Specified,US-APOTEX-2020AP005359,\"Gummin DD, MowryJB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, Hashem HA, Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 36th Annual Report. DOI: 10.1080/15563650.2019.1677022. Clinical Toxicology. 2019;57 (12):1220-1413\",-\\n17276448,Sertraline,Sertraline Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse;Cardio-Respiratory Arrest,Serious,Died;Hospitalized;Other Outcomes,Male,2018,1/16/2020,Expedited,36,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/6/2020,1/16/2020,US,Not Specified,US-APOTEX-2020AP006348,\"Gummin DD, MowryJB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, Hashem HA, Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 36th Annual Report. DOI: 10.1080/15563650.2019.1677022. Clinical Toxicology. 2019;57 (12):1220-1413\",-\\n17276446,Heroin;Sertraline,Sertraline Hydrochloride;Chlorpheniramine;Bupropion;Diamorphine;Herbals\\\\Mitragynine;Dextromethorphan;Cocaine,Product Used For Unknown Indication,Cardio-Respiratory Arrest;Completed Suicide,Serious,Other Outcomes;Died;Hospitalized,Male,2018,1/16/2020,Expedited,32,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/6/2020,1/16/2020,US,Not Specified,US-APOTEX-2020AP006347,\"Gummin DD, MowryJB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, Hashem HA, Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 36th Annual Report. DOI: 10.1080/15563650.2019.1677022. Clinical Toxicology. 2019;57 (12):1220-1413\",-\\n17286246,-,Herbals\\\\Mitragynine;Gabapentin;Alcohol;Diazepam,Product Used For Unknown Indication,Intentional Product Misuse,Serious,Died,Male,-,1/18/2020,Expedited,41,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/6/2020,1/18/2020,US,Not Specified,US-APOTEX-2020AP005595,\"Gummin DD, MowryJB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, Hashem HA, Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 36th Annual Report. DOI: 10.1080/15563650.2019.1677022. Clinical Toxicology. 2019;57 (12):1220-1413\",-\\n17779112,Heroin,Diamorphine;Oxycodone;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,5/14/2020,Expedited,44,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,5/4/2020,5/14/2020,US,Not Specified,US-AUROBINDO-AUR-APL-2020-023779,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W.. 2017 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 35th Annual Report.. CLINICAL TOXICOLOGY. 2018;56(12):1213-1415\",-\\n18497717,Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Diazepam;Gabapentin Enacarbil,Product Used For Unknown Indication,Toxicity To Various Agents;Intentional Product Misuse,Serious,Died,Male,2018,11/12/2020,Expedited,41,Not Specified,Arbor,Healthcare Professional,Not Specified,-,11/2/2020,11/12/2020,US,Not Specified,\"US-ARBOR PHARMACEUTICALS, LLC-US-2020ARB000997\",\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, Hashem HA, Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 36 Annual Report. Clinical Toxicology. 2019;57 (12):1220-1413\",-\\n17878785,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died,Not Specified,-,6/10/2020,Expedited,Not Specified,Not Specified,Zydus Pharm,Healthcare Professional,Not Specified,-,2/18/2020,6/10/2020,US,Not Specified,US-CADILA HEALTHCARE LIMITED-US-ZYDUS-048140,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, et al.. 2018 Annual report of the american association of poison control centers\\' national poison data system (npds): 36th annual report.. Clinical Toxicology. 2019;57(12:1220-1413\",-\\n17404248,-,Unspecified Ingredient;Gabapentin;Herbals\\\\Mitragynine;Diazepam;Alcohol,Product Used For Unknown Indication,Intentional Product Misuse,Serious,Died,Male,2018,2/11/2020,Expedited,41,Not Specified,Endo,Healthcare Professional,Not Specified,-,1/14/2020,2/11/2020,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2020-001211,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, et al.. 2018 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413\",-\\n17401864,-,Fentanyl;Herbals\\\\Mitragynine;Oxycodone Hydrochloride,Product Used For Unknown Indication,Cardio-Respiratory Arrest;Drug Abuse,Serious,Died,Male,2018,2/11/2020,Expedited,57,Not Specified,Endo,Healthcare Professional,Not Specified,-,1/14/2020,2/11/2020,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2020-000677,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, et al.. 2018 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413\",-\\n17370294,Sertraline,Dextromethorphan;Sertraline Hydrochloride;Bupropion;Cocaine;Diamorphine;Herbals\\\\Mitragynine;Chlorpheniramine Maleate,Suicide Attempt,Completed Suicide,Serious,Hospitalized;Died,Male,-,2/5/2020,Expedited,32,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,1/22/2020,2/5/2020,US,Not Specified,US-ALVOGEN-2020-ALVOGEN-103748,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, et al. 2018 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila). 2019 Dec;57(12):1220-1413.\",-\\n17375186,-,Herbals\\\\Mitragynine;Phentermine;Bupropion,Product Used For Unknown Indication,Death,Serious,Died,Female,-,2/6/2020,Expedited,40,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,1/22/2020,2/6/2020,US,Not Specified,US-ALVOGEN-2020-ALVOGEN-107509,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, et al. 2018 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila). 2019 Dec;57(12):1220-1413.\",-\\n18005886,-,Loperamide;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died;Hospitalized,Male,-,7/9/2020,Expedited,21,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/30/2020,7/9/2020,US,Not Specified,US-AUROBINDO-AUR-APL-2020-033157,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ et al.. 2018 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413\",-\\n17996854,-,Herbals\\\\Mitragynine;Loperamide,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,7/9/2020,Expedited,22,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/30/2020,7/9/2020,US,Not Specified,US-AUROBINDO-AUR-APL-2020-033158,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ et al.. 2018 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413\",-\\n17310367,Heroin;Sertraline;Goprelto,Cocaine Hydrochloride;Chlorpheniramine;Bupropion;Sertraline Hydrochloride;Diamorphine;Dextromethorphan;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Completed Suicide;Respiratory Arrest;Cardiac Arrest,Serious,Died,Male,2018,1/23/2020,Expedited,32,Not Specified,Genus Lifesciences,Healthcare Professional,Not Specified,-,1/13/2020,1/23/2020,US,Not Specified,US-GENUS_LIFESCIENCES-USA-POI0580202000150,Gummin D. 2018 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413.,-\\n17335034,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died,Male,-,1/28/2020,Expedited,40,Not Specified,Bausch And Lomb,Healthcare Professional,Not Specified,-,1/17/2020,1/28/2020,US,Not Specified,US-BAUSCH-BL-2020-001913,\"Gummin D, Mowry J, Spyker D, Brooks D, Beuhler M, Rivers L, Hashem H, Ryan M. 2018 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019 NOV 21;57(12):1220-1413. doi:10.1080/15563650.2019.1677022\",-\\n17846339,Zolpidem,Zolpidem Tartrate;Herbals\\\\Mitragynine;Alprazolam,Product Used For Unknown Indication,Intentional Overdose;Coagulopathy;Toxicity To Various Agents;Acute Hepatic Failure;Acute Kidney Injury,Serious,Hospitalized,Female,-,6/1/2020,Expedited,36,Not Specified,Strides,Healthcare Professional,Not Specified,-,5/25/2020,6/1/2020,US,Not Specified,US-STRIDES ARCOLAB LIMITED-2020SP006500,\"Fishburn SJ, Mullins ME.. Kratom (mitragynine speciosa) induced acute liver failure.. Journal of Medical Toxicology. 2020;16(2):143-144\",-\\n17869984,Zolpidem,Zolpidem Tartrate;Herbals\\\\Mitragynine;Alprazolam,Product Used For Unknown Indication,Toxicity To Various Agents;Intentional Overdose;Acute Hepatic Failure;Acute Kidney Injury;Coagulopathy,Serious,Other Outcomes;Hospitalized,Female,-,6/8/2020,Expedited,36,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,5/25/2020,6/8/2020,US,Not Specified,US-AUROBINDO-AUR-APL-2020-026983,\"Fishburn SJ, Mullins ME.. Kratom (mitragynine speciosa) induced acute liver failure.. J-Med-Toxicol.. 2020;16(2):143-144\",-\\n17845528,Zolpidem,Zolpidem Tartrate;Alprazolam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Hepatic Enzyme Increased;Acute Kidney Injury;Intentional Overdose;Coagulopathy,Serious,Hospitalized;Life Threatening;Other Outcomes,Female,-,6/1/2020,Expedited,36,Not Specified,Lupin,Healthcare Professional,Not Specified,-,5/20/2020,6/1/2020,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2020-02533,\"Fishburn SJ, Mullins ME. Kratom (Mitragynine speciosa) Induced Acute Liver Failure. Journal of Medical Toxicology. 2020;16:143-144\",-\\n17835102,Zolpidem,Zolpidem Tartrate;Herbals\\\\Mitragynine;Alprazolam,Product Used For Unknown Indication,Acute Hepatic Failure;Toxicity To Various Agents;Intentional Overdose;Coagulopathy;Acute Kidney Injury,Serious,Hospitalized;Life Threatening,Female,-,5/28/2020,Expedited,36,Not Specified,Mylan,Healthcare Professional,Not Specified,-,5/20/2020,5/28/2020,US,Not Specified,US-MYLANLABS-2020M1052100,\"Fishburn SJ, Mullins ME. Kratom (mitragynine speciosa) induced acute liver failure. J-Med-Toxicol 2020;16(2):143-144 (plus poster) abstr. 094.\",-\\n17852150,Zolpidem,Zolpidem Tartrate;Alprazolam;Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Acute Hepatic Failure;Coagulopathy;Drug Withdrawal Syndrome;Acute Kidney Injury;Intentional Overdose,Serious,Hospitalized;Life Threatening,Female,-,6/20/2020,Expedited,36,Not Specified,Teva,Healthcare Professional,Not Specified,-,6/12/2020,6/2/2020,US,Not Specified,US-TEVA-2020-US-1242236,\"Fishburn SJ, Mullins ME. Kratom (mitragynine speciosa) induced acute liver failure. J-Med-Toxicol 2020;16(2):143-144 (plus poster) abstr. 094.\",-\\n17852355,Zolpidem,Zolpidem Tartrate;Alprazolam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Coagulopathy;Hepatic Enzyme Increased;Acute Kidney Injury;Intentional Overdose,Serious,Hospitalized,Female,-,6/3/2020,Expedited,36,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,5/20/2020,6/3/2020,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-248876,\"Fishburn SJ, Mullins ME. Kratom (mitragynine speciosa) induced acute liver failure. J Med Toxicol. 2020;16(2):143-144\",-\\n17827249,-,Herbals\\\\Mitragynine;Zolpidem Tartrate;Alprazolam,Overdose,Hepatic Enzyme Increased;Drug Withdrawal Syndrome;Coagulopathy;Acute Kidney Injury;Intentional Overdose,Serious,Other Outcomes;Hospitalized,Female,-,5/27/2020,Expedited,36,Not Specified,Sanofi Aventis,Healthcare Professional,Not Specified,-,5/19/2020,5/27/2020,US,Not Specified,US-SA-2020SA130645,\"Fishburn S.J., Mullins M.E.. Kratom (mitragynine speciosa) induced acute liver failure. J Med Toxicol.. 2020;16(2):143-144\",-\\n16458096,Fluoxetine;Amlodipine,Fluoxetine Hydrochloride;Amlodipine Besylate;Herbals\\\\Mitragynine;Bentiamine\\\\Bucetin\\\\Caffeine\\\\Ethenzamide;Diphenhydramine;Sildenafil;Trimipramine,Product Used For Unknown Indication,Pulmonary Oedema;Toxicity To Various Agents;Pneumonia;Drug Abuse,Serious,Died;Other Outcomes,Male,-,7/18/2020,Expedited,56,Not Specified,Novartis,Healthcare Professional,Not Specified,-,7/15/2020,6/20/2019,DE,Not Specified,PHHY2019DE139906,\"Fels H, Lottner-Nau S, Sax T, Roider G, Graw M, Auwarter V et al.. Postmortem concentrations of the synthetic opioid U-47700 in 26 fatalities associated with the drug. FORENSIC SCI. INT.. 2019\",-\\n17895244,Trazodone,Trazodone Hydrochloride;Buspirone Hydrochloride;Desvenlafaxine;Herbals\\\\Mitragynine;Bupropion;Ziprasidone,Depression,Clonus;Confusional State;Drug Interaction;Tremor;Aphasia;Hyperhidrosis;Facial Paralysis;Hyperreflexia;Serotonin Syndrome;Dysarthria;Flushing,Serious,Hospitalized,Male,-,6/15/2020,Expedited,63,Not Specified,Strides,Healthcare Professional,Not Specified,-,6/8/2020,6/15/2020,US,Not Specified,US-STRIDES ARCOLAB LIMITED-2020SP007014,\"Eudaley ST, Hamilton LA. Case report: Successful treatment of suspected kratominduced serotonin syndrome. JACCP Journal of the American College of Clinical Pharmacy. 2020;3(1):347\",-\\n17948882,-,Clonazepam;Herbals\\\\Mitragynine;Gabapentin,Product Used For Unknown Indication,Streptococcal Infection;Back Pain;Anxiety;Fibromyalgia;Maternal Exposure During Pregnancy,Non-Serious,Non-Serious,Female,-,6/25/2020,Expedited,29,Not Specified,Roche,Healthcare Professional,Not Specified,-,4/27/2019,6/25/2020,US,Not Specified,US-ROCHE-2310324,\"Davidson L, Rawat M, Stojanovski S, and Chandrasekharan P Natural drugs, not so natural effects: Neonatal abstinence syndrome secondary to \\'kratom\\'. Journal of Neonatal-Perinatal Medicine 2019;12 (1):109-112.\",-\\n17948871,-,Clonazepam;Herbals\\\\Mitragynine;Gabapentin,Product Used For Unknown Indication,Foetal Exposure During Pregnancy;Small For Dates Baby;Drug Withdrawal Syndrome Neonatal,Non-Serious,Non-Serious,Female,-,6/25/2020,Expedited,Not Specified,Not Specified,Roche,Healthcare Professional,Not Specified,-,4/27/2019,6/25/2020,US,Not Specified,US-ROCHE-2313953,\"Davidson L, Rawat M, Stojanovski S and Chandrasekharan P Natural drugs, not so natural effects: Neonatal abstinence syndrome secondary to \\'kratom\\'. Journal of Neonatal-Perinatal Medicine 2019;12 (1):109-112.\",-\\n16318360,Methadone,Methadone Hydrochloride;Oxazepam;Herbals\\\\Mitragynine;Bromazepam;Morphine,Product Used For Unknown Indication,Asphyxia;Drug Abuse;Gastritis;Pancreatitis;Pulmonary Oedema;Toxicity To Various Agents,Serious,Died,Male,-,5/21/2020,Expedited,36,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,Cocaine;Heroin,5/7/2020,5/16/2019,FR,Not Specified,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-208015,\"Bourgine J, Garnier Jardin C, Chretien B, Le Boisselier R, Loilier M, Lelong Boulouard V, et al. Fatal intoxication with Kratom: A case report. Fundam Clin Pharmacol. 2019;33 (Suppl. 1):72 (PS2-013)\",-\\n18532204,-,Herbals\\\\Mitragynine;Morphine;Gabapentin;Codeine,Product Used For Unknown Indication,Pulmonary Congestion;Toxicity To Various Agents;Accidental Poisoning,Serious,Died;Other Outcomes,Not Specified,-,11/23/2020,Expedited,Not Specified,Not Specified,Cipla,Healthcare Professional,Not Specified,Sertraline;Mirtazapine;Cyclobenzaprine;Trazodone;Zolpidem;Clonidine,11/10/2020,11/23/2020,US,Not Specified,US-CIPLA LTD.-2020US08728,\"Bishop freeman SC, Fox L, Winecker RE, Hudson JS. Death from Poppy Tea Consumption. Journal of Analytical Toxicology. 2020;44:734-740\",-\\n17856606,-,Naloxone Hydrochloride;Herbals\\\\Mitragynine,Drug Dependence;Overdose,Electrocardiogram St Segment Abnormal;Electrocardiogram Qt Prolonged;Hypokalaemia,Serious,Hospitalized,Male,-,6/3/2020,Expedited,17,Not Specified,Emergent Biosolutions,Healthcare Professional,Not Specified,-,5/20/2020,6/3/2020,US,Not Specified,\"US-EMERGENT BIOSOLUTIONS,-20000366LT\",\"Baumgartner K.T, Mullins M.E. A case of Kratom poisoning causing cardiotoxicity. J. Med. Toxicol. 2020;16(2):165-6\",-\\n17375069,-,Herbals\\\\Mitragynine,Alcoholism,Drug Dependence,Serious,Disabled,Male,02-Dec-2019,2/4/2020,Direct,38,Not Specified,Fda-Ctu,Consumer,Consumer,Zoloft,-,2/4/2020,US,Not Specified,-,-,-\\n17575488,-,Herbals\\\\Mitragynine,Back Pain,Brain Stem Stroke,Serious,Died,Male,06-Feb-2020,3/23/2020,Direct,13 DAY,78.75 KG,Fda-Ctu,Consumer,Consumer,Unspecified Ingredient,-,3/23/2020,US,Not Specified,-,-,-\\n18348131,-,Herbals\\\\Mitragynine,-,Malaise;Movement Disorder;Product Use Issue;Dizziness;Hyperhidrosis;Vomiting,Serious,Hospitalized,Female,05-Oct-2020,10/5/2020,Direct,36,Not Specified,Fda-Ctu,Consumer,Consumer,Prozac,-,10/5/2020,US,Not Specified,-,-,-\\n17823488,-,Herbals\\\\Mitragynine,-,Poisoning;Visual Impairment;Product Contamination Physical;Chest Pain;Product Contamination,Serious,Other Outcomes,Male,25-May-2020,5/25/2020,Direct,55,78.75 KG,Fda-Ctu,Consumer,Consumer,Omeprazole,-,5/25/2020,US,Not Specified,-,-,-\\n17765206,-,Herbals\\\\Mitragynine,Inflammation;Pain,Hypertension;Weight Decreased;Dehydration;Product Complaint;Unevaluable Event;Drug Dependence;Withdrawal Syndrome;Condition Aggravated;Loss Of Libido;Anxiety;Partner Stress;Decreased Appetite,Serious,Disabled,Male,08-May-2020,5/9/2020,Direct,39,69.75 KG,Fda-Ctu,Consumer,Consumer,Melatonin;Vitamin D,-,5/9/2020,US,Y,-,-,-\\n18540051,-,Herbals\\\\Mitragynine,Drug Withdrawal Syndrome,\"Fatigue;Irritability;Hypertension;Hallucination, Auditory;Aggression;Fear Of Death;Completed Suicide;Intentional Self-Injury;Dysarthria;Overdose;Gait Disturbance;Gun Shot Wound;Feeling Abnormal;Fine Motor Skill Dysfunction;Nocturnal Dyspnoea\",Serious,Life Threatening;Disabled;Other Outcomes;Died,Male,02-Oct-2020,11/24/2020,Direct,31,103.5 KG,Fda-Ctu,Consumer,Consumer,Lexapro,-,11/24/2020,US,Not Specified,-,-,-\\n17406570,-,Herbals\\\\Mitragynine,Pain;Routine Health Maintenance,Irritability;Anxiety;Panic Attack,Serious,Other Outcomes;Hospitalized,Male,09-Feb-2020,2/11/2020,Direct,57,83.25 KG,Fda-Ctu,Consumer,Consumer,Irbesartan;Coreg;Iron;Calcium;Vitamin D;Ibuprofen;Tylenol;Sodium Bicarbonate;Vitamins;Lasix;Lorazepam;Magnesium,-,2/11/2020,US,Not Specified,-,-,-\\n17791274,-,Herbals\\\\Mitragynine,Anxiety;Depression,Withdrawal Syndrome;Drug Dependence;Self-Injurious Ideation,Serious,Life Threatening;Hospitalized,Male,13-May-2020,5/15/2020,Direct,20,49.5 KG,Fda-Ctu,Consumer,Consumer,Intuniv;Claritin;Zoloft;Melatonin,-,5/15/2020,US,Not Specified,-,-,-\\n17713029,-,Herbals\\\\Mitragynine,Depression;Fatigue,Irritability;Depression;Restless Legs Syndrome;Morbid Thoughts;Drug Withdrawal Syndrome;Insomnia;Drug Dependence;Compulsive Shopping,Serious,Other Outcomes,Female,22-Apr-2020,4/27/2020,Direct,49,63 KG,Fda-Ctu,Consumer,Consumer,Ibuprofen;Acetylcysteine;Klonopin;Probiotics Nos;Zoloft,-,4/27/2020,US,Not Specified,-,-,-\\n17236200,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Mobility Decreased;Dizziness;Heart Rate Irregular;Dyspnoea,Serious,Life Threatening;Disabled,Female,02-Jan-2020,1/3/2020,Direct,26,65.25 KG,Fda-Ctu,Consumer,Consumer,Fish Oil;Magnesium;Vitamin D,-,1/3/2020,US,Y,-,-,-\\n18435485,-,Herbals\\\\Mitragynine,Pain In Extremity,Herbal Toxicity,Serious,Died,Male,23-Aug-2020,10/28/2020,Direct,42,85.05 KG,Fda-Ctu,Consumer,Consumer,Clozaril,-,10/28/2020,US,Not Specified,-,-,-\\n17293120,-,Herbals\\\\Mitragynine,Anxiety,Product Complaint;Dependence;Drug Withdrawal Syndrome,Serious,Hospitalized;Other Outcomes,Male,13-Jan-2020,1/17/2020,Direct,23,56.25 KG,Fda-Ctu,Consumer,Consumer,Clonazepam;Vitamin B12,-,1/17/2020,US,Not Specified,-,-,-\\n17575493,-,Herbals\\\\Mitragynine,Pain,Suicide Attempt;Unresponsive To Stimuli;Aggression,Serious,Hospitalized;Other Outcomes,Male,21-Jun-2019,3/23/2020,Direct,26,85.5 KG,Fda-Ctu,Consumer,Consumer,Celexa,-,3/23/2020,US,Not Specified,-,-,-\\n17301302,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,24-Dec-2019,1/21/2020,Direct,38,65.7 KG,Fda-Ctu,Consumer,Consumer,Cannabidiol\\\\Herbals,-,1/21/2020,US,Not Specified,-,-,-\\n18386066,-,Herbals\\\\Mitragynine,-,Completed Suicide;Paranoia;Withdrawal Syndrome;Depression,Serious,Died,Male,05-Sep-2020,10/14/2020,Direct,36,76.5 KG,Fda-Ctu,Consumer,Consumer,Antihistamines Nos,-,10/14/2020,US,Not Specified,-,-,-\\n17670057,-,Herbals\\\\Mitragynine,Anxiety,Product Complaint;Dependence,Serious,Other Outcomes,Male,01-Jan-2019,4/15/2020,Direct,34,Not Specified,Fda-Ctu,Consumer,Consumer,Albuterol,-,4/15/2020,US,Y,-,-,-\\n17225354,-,Ranitidine;Albuterol Sulfate;Herbals\\\\Mitragynine;Valacyclovir Hydrochloride;Acetaminophen\\\\Methocarbamol;Loratadine;Citalopram;Diphenhydramine,-,Caesarean Section;Maternal Exposure During Pregnancy,Serious,Other Outcomes,Female,-,1/2/2020,Expedited,37,Not Specified,Sanofi Aventis,Healthcare Professional,Not Specified,-,12/20/2019,1/2/2020,CA,Not Specified,CA-SA-2019SA354821,-,-\\n17332248,-,Herbals\\\\Mitragynine;Lisinopril,Hypertension,Angioedema,Serious,Hospitalized,Male,23-Jan-2020,1/23/2020,Direct,46,84.8 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,1/23/2020,US,Not Specified,-,-,-\\n17396453,-,Cyclobenzaprine;Herbals\\\\Mitragynine;Alprazolam;Doxylamine,Anxiety;Obsessive-Compulsive Disorder;Sleep Disorder,Anxiety;Influenza;Accidental Overdose;Seizure,Serious,Hospitalized;Died,Male,26-Jul-2018,2/7/2020,Direct,27,72 KG,Fda-Ctu,Consumer,Consumer,Xanax;Melatonin,-,2/7/2020,US,Not Specified,-,-,-\\n17413340,Heroin,Amphetamine;Diamorphine;Diazepam;Hydrocodone;Butalbital;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Male,-,2/13/2020,Expedited,52,Not Specified,Mylan,Healthcare Professional,Not Specified,-,2/4/2020,2/13/2020,US,Not Specified,US-MYLANLABS-2020M1016392,-,-\\n17456139,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents;Drug Abuse,Serious,Hospitalized;Died,Male,-,2/25/2020,Expedited,40,Not Specified,Torrent,Healthcare Professional,Not Specified,-,2/18/2020,2/25/2020,US,Not Specified,US-TORRENT-00009933,-,-\\n17490986,\"Heroin;Butalbital, Acetaminophen, And Caffeine\",Acetaminophen\\\\Butalbital\\\\Caffeine;Herbals\\\\Mitragynine;Diamorphine;Diazepam;Oxycodone;Hydrocodone;Amphetamine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Other Outcomes,Not Specified,-,3/3/2020,Expedited,Not Specified,Not Specified,Mayne Pharma,Healthcare Professional,Not Specified,-,2/19/2020,3/3/2020,US,Not Specified,US-MAYNE PHARMA-2020MYN000107,-,-\\n17489713,Valacyclovir,Valacyclovir Hydrochloride;Methocarbamol;Albuterol;Herbals\\\\Mitragynine;Loratadine;Citalopram;Acetaminophen;Ranitidine;Diphenhydramine,Product Used For Unknown Indication,Drug Withdrawal Syndrome Neonatal;Foetal Exposure During Pregnancy,Serious,Hospitalized;Other Outcomes,Female,-,3/3/2020,Expedited,Not Specified,3 KG,Teva,Consumer,Not Specified,-,2/25/2020,3/3/2020,CA,Not Specified,CA-TEVA-2020-CA-1192110,-,-\\n17538320,Kava,Piper Methysticum Root;Herbals\\\\Mitragynine,Anxiety,Movement Disorder;Psychomotor Skills Impaired;Weight Decreased;Quality Of Life Decreased;Speech Disorder;Impaired Work Ability,Serious,Hospitalized;Other Outcomes,Female,04-Mar-2020,3/13/2020,Direct,37,55.35 KG,Fda-Ctu,Consumer,Consumer,Ativan;Probiotics Nos;Pristiq Extended-Release,-,3/13/2020,US,Not Specified,-,-,-\\n17539695,Latuda,Lurasidone Hydrochloride;Herbals\\\\Mitragynine,Extrapyramidal Disorder;Mania,Heart Rate Increased;Feeling Abnormal;Anxiety;Off Label Use,Non-Serious,Non-Serious,Male,-,3/27/2020,Non-Expedited,24,Not Specified,Sunovion,Healthcare Professional,Not Specified,Cogentin,3/18/2020,3/13/2020,US,Not Specified,US-SUNOVION-2020SUN000782,-,-\\n17717542,Prozac,Fluoxetine Hydrochloride;Herbals\\\\Mitragynine,Antidepressant Therapy,Psychotic Disorder;Suicide Attempt;Drug Withdrawal Syndrome;Hanging,Serious,Life Threatening;Hospitalized,Male,21-Feb-2020,4/27/2020,Direct,20,74.25 KG,Fda-Ctu,Consumer,Consumer,-,-,4/27/2020,US,Y,-,-,-\\n17819090,Zolpidem,Zolpidem Tartrate;Herbals\\\\Mitragynine;Alprazolam,Product Used For Unknown Indication,Hepatic Enzyme Increased;Intentional Overdose;Coagulopathy;Acute Kidney Injury,Serious,Other Outcomes;Hospitalized,Male,-,5/23/2020,Expedited,36,Not Specified,Hikma,Healthcare Professional,Not Specified,-,5/19/2020,5/23/2020,US,Not Specified,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02535,-,-\\n17823882,Zolpidem,Zolpidem Tartrate;Herbals\\\\Mitragynine;Alprazolam,Product Used For Unknown Indication,Intentional Overdose;Acute Kidney Injury;Hepatic Enzyme Increased;Coagulopathy,Serious,Hospitalized,Female,-,5/26/2020,Expedited,36,Not Specified,Torrent,Healthcare Professional,Not Specified,-,5/19/2020,5/26/2020,US,Not Specified,US-TORRENT-00010235,-,-\\n17489705,Valtrex,Valacyclovir Hydrochloride;Albuterol;Methocarbamol;Loratadine;Diphenhydramine;Acetaminophen;Ranitidine;Citalopram;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Foetal Exposure During Pregnancy;Drug Withdrawal Syndrome Neonatal,Serious,Other Outcomes;Hospitalized,Female,-,5/26/2020,Expedited,Not Specified,3 KG,Teva,Healthcare Professional,Not Specified,-,5/21/2020,3/3/2020,CA,Not Specified,CA-TEVA-2020-CA-1192120,-,-\\n17939201,Lyrica;Oxycontin,Baclofen;Oxycodone Hydrochloride;Lidocaine;Duloxetine Hydrochloride;Herbals\\\\Mitragynine;Pregabalin;Oxycodone;Ibuprofen;Neomycin,Product Used For Unknown Indication,Toxicity To Various Agents;Drug Dependence,Serious,Died;Other Outcomes,Male,-,7/27/2020,Expedited,Not Specified,Not Specified,Lupin,Consumer,Not Specified,-,7/13/2020,6/24/2020,US,Not Specified,US-HORMOSAN PHARMA GMBH-2020-02887,-,-\\n18241216,-,Herbals\\\\Mitragynine;Naltrexone,Pain,Drug Withdrawal Syndrome;Rhinorrhoea;Muscle Spasms;Drug Interaction;Restlessness;Dyspnoea;Nausea;Abdominal Pain Upper;Mental Impairment;Hyperhidrosis;Chills,Serious,Life Threatening,Female,20-Aug-2020,9/5/2020,Direct,41,60.75 KG,Fda-Ctu,Consumer,Consumer,Vitamin B6;Herbals\\\\Turmeric;Ativan;Multi-Vitamin,-,9/5/2020,US,Not Specified,-,-,-\\n18280433,Alcohol (Alcohol),Alcohol;Acetaminophen;Herbals\\\\Mitragynine,Asthenia;Product Used For Unknown Indication,Liver Transplant;Acute Hepatic Failure,Serious,Other Outcomes;Hospitalized,Not Specified,-,9/18/2020,Expedited,Not Specified,Not Specified,Apotex,Healthcare Professional,Not Specified,-,9/9/2020,9/18/2020,CA,Not Specified,CA-APOTEX-2020AP017853,-,-\\n18377802,Adderall Xr,Amphetamine Aspartate\\\\Amphetamine Sulfate\\\\Dextroamphetamine Saccharate\\\\Dextroamphetamine Sulfate;Herbals\\\\Mitragynine,Depression;Insomnia;Product Used For Unknown Indication,Posterior Reversible Encephalopathy Syndrome,Serious,Other Outcomes,Male,-,10/18/2020,Expedited,22,Not Specified,Shire,Healthcare Professional,Not Specified,Quetiapine;Fluoxetine;Nicardipine;Acetaminophen;Dextroamphetamine;Cannabis Sativa Subsp. Indica Top,10/13/2020,10/13/2020,US,Not Specified,US-SHIRE-US202033153,-,-\\n18573518,Fluoxetine,Fluoxetine Hydrochloride;Gabapentin;Flualprazolam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Male,27-May-2020,12/1/2020,Direct,26,84.15 KG,Fda-Ctu,Consumer,Consumer,-,-,12/1/2020,US,Not Specified,-,-,-\\n18582334,-,Herbals\\\\Mitragynine;Venlafaxine Hydrochloride,-,Psychotic Disorder;Serotonin Syndrome;Encephalopathy;Hyperthermia,Serious,Hospitalized;Life Threatening,Female,02-Dec-2020,12/4/2020,Direct,77,60 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,12/4/2020,US,Not Specified,-,-,-\\n18674050,Duragesic,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents;Drug Abuse,Serious,Died;Hospitalized,Male,-,12/28/2020,Non-Expedited,25,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,12/23/2020,12/28/2020,US,Not Specified,US-JNJFOC-20201246672,-,-\\n18667974,Duragesic,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse;Toxicity To Various Agents,Serious,Died,Male,-,12/28/2020,Non-Expedited,30,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,12/23/2020,12/28/2020,US,Not Specified,US-JNJFOC-20201246704,-,-\\n18686259,Alcohol (Alcohol),Getacatetide Acetate;Lysergide;Alcohol;Ketamine;Herbals\\\\Mitragynine;Etizolam,Product Used For Unknown Indication,Toxicity To Various Agents;Bradycardia;Metabolic Acidosis;Brain Herniation;Hypotension,Serious,Died;Hospitalized,Male,-,12/30/2020,Expedited,25,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,12/23/2020,12/30/2020,US,Not Specified,US-JNJFOC-20201249395,-,-\\n18684086,-,Diphenhydramine Hydrochloride;Etizolam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents;Completed Suicide,Serious,Died,Male,-,12/30/2020,Expedited,25,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,12/23/2020,12/30/2020,US,Not Specified,US-JNJFOC-20201249785,-,-\\n17332257,-,Herbals\\\\Mitragynine,Anxiety,Tremor;Anxiety;Somnolence;Muscle Spasms,Serious,Disabled,Male,14-Jan-2020,1/23/2020,Direct,44,81 KG,Fda-Ctu,Consumer,Consumer,-,-,1/23/2020,US,Not Specified,-,-,-\\n17323469,-,Herbals\\\\Mitragynine,-,Influenza Like Illness;Chest Discomfort;Abdominal Pain Upper;Dyspnoea,Serious,Other Outcomes,Female,02-Jan-2018,1/24/2020,Direct,58,74.84 KG,Fda-Ctu,Not Specified,Not Specified,-,-,1/24/2020,US,Not Specified,-,-,-\\n17395799,-,Herbals\\\\Mitragynine,Anxiety;Drug Dependence,Cardio-Respiratory Arrest;Withdrawal Of Life Support;Seizure,Serious,Died;Hospitalized,Male,25-Jan-2020,2/7/2020,Direct,39,85.5 KG,Fda-Ctu,Consumer,Consumer,-,-,2/7/2020,US,Not Specified,-,-,-\\n17417214,-,Herbals\\\\Mitragynine,Pain,Vomiting;Nausea,Serious,Other Outcomes,Female,14-Jul-2019,2/14/2020,Direct,62,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,2/14/2020,US,Not Specified,-,-,-\\n17468080,-,Herbals\\\\Mitragynine,Anxiety;Depression;Insomnia,Withdrawal Syndrome;Death;Product Quality Issue,Serious,Died,Male,01-Jan-2016,2/25/2020,Direct,25,69.75 KG,Fda-Ctu,Consumer,Consumer,-,-,2/25/2020,US,Not Specified,-,-,-\\n17740188,-,Herbals\\\\Mitragynine,-,Cardiac Arrest;Torsade De Pointes,Serious,Life Threatening,Male,-,5/3/2020,Direct,Not Specified,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,5/3/2020,US,Not Specified,-,-,-\\n17766377,-,Herbals\\\\Mitragynine,Drug Withdrawal Syndrome,Cardiac Arrest;Seizure,Serious,Died,Male,08-May-2020,5/11/2020,Direct,25,67.5 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,5/11/2020,US,Not Specified,-,-,-\\n17802026,-,Herbals\\\\Mitragynine,Opiates,Drug Withdrawal Syndrome;Intentional Self-Injury,Serious,Life Threatening;Hospitalized,Male,13-May-2020,5/15/2020,Direct,20,52.16 KG,Fda-Ctu,Consumer,Not Specified,-,-,5/15/2020,US,Not Specified,-,-,-\\n17808160,-,Herbals\\\\Mitragynine,Stress,Socioeconomic Precarity;Irritability;Aggression;Drug Dependence,Serious,Other Outcomes;Life Threatening,Male,26-May-2019,5/20/2020,Direct,42,90 KG,Fda-Ctu,Consumer,Consumer,-,-,5/20/2020,US,Not Specified,-,-,-\\n17807667,-,Herbals\\\\Mitragynine,Phytotherapy,Seizure,Serious,Hospitalized,Male,10-Mar-2020,5/20/2020,Direct,30,96.75 KG,Fda-Ctu,Consumer,Consumer,-,-,5/20/2020,US,Not Specified,-,-,-\\n18091085,-,Herbals\\\\Mitragynine,Analgesic Therapy,Myalgia;Cognitive Disorder;Dependence;Mood Swings;Vomiting;Sleep Disorder;Decreased Appetite,Serious,Disabled,Male,29-Jul-2020,7/29/2020,Direct,23,65.25 KG,Fda-Ctu,Consumer,Consumer,-,-,7/29/2020,US,Not Specified,-,-,-\\n18231742,-,Herbals\\\\Mitragynine,Alcohol Withdrawal Syndrome,Drug Dependence;Family Stress,Serious,Disabled,Female,18-Aug-2020,9/3/2020,Direct,29,48.15 KG,Fda-Ctu,Consumer,Consumer,-,-,9/3/2020,US,Not Specified,-,-,-\\n18392125,-,Herbals\\\\Mitragynine,-,Drug Dependence,Serious,Disabled,Male,10-Oct-2020,10/16/2020,Direct,56,87.75 KG,Fda-Ctu,Consumer,Consumer,-,-,10/16/2020,US,Not Specified,-,-,-\\n18447155,-,Herbals\\\\Mitragynine,-,Insomnia;Drug Dependence;Product Complaint;Withdrawal Syndrome,Serious,Other Outcomes;Disabled,Male,01-Sep-2020,10/30/2020,Direct,45,90 KG,Fda-Ctu,Consumer,Consumer,-,-,10/30/2020,US,Not Specified,-,-,-\\n18467751,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Coma,Serious,Hospitalized,Female,04-Nov-2020,11/4/2020,Direct,50,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,11/4/2020,US,Not Specified,-,-,-\\n18538994,-,Herbals\\\\Mitragynine,Substance Use,Withdrawal Syndrome;Near Death Experience;Euphoric Mood;Drug Dependence,Serious,Life Threatening;Other Outcomes,Male,20-Nov-2020,11/23/2020,Direct,35,76.5 KG,Fda-Ctu,Consumer,Consumer,-,-,11/23/2020,US,Not Specified,-,-,-\\n18595363,-,Herbals\\\\Mitragynine,Substance Use,Toxicity To Various Agents;Drug Withdrawal Syndrome;Drug Dependence;Abnormal Loss Of Weight;Insomnia,Serious,Other Outcomes,Male,04-Dec-2020,12/9/2020,Direct,39,54.9 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,12/9/2020,US,Not Specified,-,-,-\\n18603578,-,Herbals\\\\Mitragynine,Anxiety;Pain,Drug Dependence;Drug Abuser,Serious,Other Outcomes,Male,10-Dec-2020,12/10/2020,Direct,37,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,12/10/2020,US,Not Specified,-,-,-\\n18611246,-,Herbals\\\\Mitragynine,Procedural Pain,Drug Withdrawal Syndrome;Dyspnoea;Adulterated Product;Tremor;Delusion;Loss Of Consciousness;Myocardial Infarction;Dependence;Hallucination,Serious,Hospitalized,Female,16-Nov-2020,12/14/2020,Direct,47,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,12/14/2020,US,Not Specified,-,-,-\\n19433030,Methadone,Methadone Hydrochloride;Etizolam;Herbals\\\\Mitragynine;Bucinnazine,Product Used For Unknown Indication,Unresponsive To Stimuli;Somnolence;Respiratory Depression;Overdose;Mental Status Changes,Serious,Other Outcomes,Male,-,6/18/2021,Expedited,31,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/7/2021,6/18/2021,US,Not Specified,US-AUROBINDO-AUR-APL-2021-025241,\"Yeh M, Krotulski A, Therriault C, Eisenstat MD, Nguyen H, Papsun D, et al.. Acute opioid overdose following nasal atomization of a novel designer opioid, 2-methyl AP-237, with potentiation of designer benzodiazepines, pyrazolam and clonazolam.. J-Med-Toxicol. 2021;17:123\",-\\n19646974,-,Naloxone;Herbals\\\\Mitragynine;Diphenhydramine,Product Used For Unknown Indication,Drug Abuse;Hypoxic-Ischaemic Encephalopathy,Serious,Other Outcomes;Hospitalized;Died,Male,-,8/2/2021,Expedited,27,Not Specified,Apotex,Healthcare Professional,Not Specified,-,7/19/2021,8/2/2021,CA,Not Specified,CA-APOTEX-2021AP023854,\"Solbeck P, Woodall KL, Martin TL.. Strategic Decision-Making by a Forensic Toxicology Laboratory in Response to an Emerging NPS: Detection, Quantitation, and Interpretation of Carfentanil in Death Investigations in Ontario, Canada, July 2017 to June 2018.. Journal of Analytical Toxicology. 2021\",-\\n19139811,-,Herbals\\\\Mitragynine;Cannabinol\\\\Herbals;Gabapentin;Cyclobenzaprine;Benzoylecgonine;Hydroxyzine Pamoate,-,Toxicity To Various Agents,Serious,Died,Male,2020,4/15/2021,Expedited,32,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,4/5/2021,4/15/2021,US,Not Specified,US-PFIZER INC-2021393171,\"Papson, D.. Flualprazolam Blood Concentrations in 197 Forensic Investigation Cases.. Journal of analytical toxicology. 2021;45 (3):226-232\",-\\n19984837,-,Alprazolam;Herbals\\\\Mitragynine,-,Mental Status Changes;Aggression;Incoherent;Hallucination,Serious,Hospitalized;Life Threatening,Male,-,10/22/2021,Expedited,31,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,10/11/2021,10/22/2021,US,Not Specified,US-PFIZER INC-202101352630,\"Natarajan, V.. A DRUG ADDICT\\'S KRYPTONITE. Chest. 2021;160(4 Suppl):685A\",-\\n20164217,\"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate\",Amphetamine Aspartate\\\\Amphetamine Sulfate\\\\Dextroamphetamine Saccharate\\\\Dextroamphetamine Sulfate;Benzoylecgonine;Herbals\\\\Mitragynine;Acetaminophen;Ketamine;Midazolam;Cocaine,Product Used For Unknown Indication,Unresponsive To Stimuli;Toxicity To Various Agents;Hydrocephalus,Serious,Other Outcomes;Died,Male,-,12/9/2021,Expedited,30,Not Specified,Specgx,Healthcare Professional,Not Specified,-,11/29/2021,12/9/2021,US,Not Specified,US-SPECGX-T202102673,\"Krotulski AJ, Papsun DM, Chronister CW, Homan J, Crosby MM, Hoyer J et al. Eutylone intoxications-An emerging synthetic stimulant in forensic investigations. Journal of Analytical Toxicology. 2021;45:8-20\",-\\n18890962,-,Herbals\\\\Mitragynine;Tramadol,Asthma;Back Pain;Depression;Pain;Product Used For Unknown Indication,Drug Use Disorder;Drug Dependence;Drug Abuse,Serious,Other Outcomes,Male,-,8/21/2021,Expedited,31,Not Specified,Aurobindo,Healthcare Professional,Not Specified,Gabapentin;Escitalopram;Albuterol,8/9/2021,2/15/2021,US,Not Specified,US-AUROBINDO-AUR-APL-2021-005338,\"Kalin S, Dakhlalla S, Bhardwaj S.. Treatment for kratom abuse in a contingency-management-based MAT setting: A case series.. J-Opioid-Manag. 2020;16(5):391-394\",-\\n18855338,-,Tramadol;Herbals\\\\Mitragynine,Anxiety;Depression;Detoxification;Drug Dependence;Pain,Drug Use Disorder;Drug Abuse;Drug Dependence,Serious,Other Outcomes,Male,2013,8/4/2021,Expedited,31,Not Specified,Lupin,Healthcare Professional,Not Specified,Venlafaxine;Escitalopram,7/23/2021,2/6/2021,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2021-01191,\"Kalin S, Dakhlalla S, Bhardwaj S. Treatment for kratom abuse in a contingency-management-based MAT setting: A case series. Journal of Opioid Management. 2020;16(5):391-394\",-\\n18821696,-,Tramadol;Herbals\\\\Mitragynine;Buprenorphine Hydrochloride\\\\Naloxone Hydrochloride,Anxiety;Arthralgia;Depression;Detoxification;Drug Dependence;Drug Use Disorder,Drug Use Disorder;Constipation;Headache;Intentional Product Misuse;Drug Abuse;Drug Dependence,Serious,Other Outcomes,Male,2013,2/2/2021,Expedited,31,Not Specified,Mylan,Healthcare Professional,Not Specified,Escitalopram;Venlafaxine,1/25/2021,2/2/2021,US,Not Specified,US-MYLANLABS-2021M1006239,\"Kalin S, Dakhlalla S, Bhardwaj S. Treatment for kratom abuse in a contingency-management-based MAT setting: A case series. J-Opioid-Manag 2020;16(5):391-394.\",-\\n20235966,Heroin,Diamorphine;Methamphetamine;Herbals\\\\Mitragynine;6-Acetylmorphine;Codeine;Morphine Sulfate,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Male,-,12/28/2021,Expedited,24,Not Specified,Alkem,Healthcare Professional,Not Specified,-,12/13/2021,12/28/2021,TH,Not Specified,TH-ALKEM LABORATORIES LIMITED-TH-ALKEM-2021-07658,\"Jittasopa W, Srisont S.. The Causes of Death and Pathological Findings of Kratom Users: A 5-Year Retrospective Analysis. Am J Forensic Med Pathol. 2021;42:33534\",-\\n18731400,-,Fentanyl Citrate;Herbals\\\\Mitragynine,-,Cardiac Arrest;Respiratory Arrest;Drug Abuse,Serious,Other Outcomes;Died;Hospitalized,Male,2019,1/12/2021,Expedited,25,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/8/2021,1/12/2021,US,Not Specified,US-PFIZER INC-2021015009,\"Gummin, D.. 2019 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58 (12):1360-1541\",-\\n18729811,-,Yohimbine;Alprazolam;Buprenorphine;Oxycodone;Herbals\\\\Mitragynine,-,Respiratory Arrest;Cardiac Arrest,Serious,Died;Hospitalized,Male,2019,1/19/2021,Expedited,29,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/14/2021,1/12/2021,US,Not Specified,US-PFIZER INC-2021014296,\"Gummin, D.. 2019 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58 (12):1360-1541\",-\\n19585434,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,7/21/2021,Expedited,29,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,7/12/2021,7/21/2021,US,Not Specified,US-AUROBINDO-AUR-APL-2021-030562,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW; et al.. 2019 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58 (12):1360\\x961541\",-\\n19597761,-,Oxycodone;Yohimbine;Herbals\\\\Mitragynine;Alprazolam;Buprenorphine,Product Used For Unknown Indication,Cardiac Arrest;Respiratory Arrest,Serious,Hospitalized;Died;Other Outcomes,Male,-,7/23/2021,Expedited,29,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,7/12/2021,7/23/2021,US,Not Specified,US-AUROBINDO-AUR-APL-2021-030561,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW; et al.. 2019 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58 (12):1360\\x961541\",-\\n18738840,-,Diphenhydramine;Herbals\\\\Mitragynine;Etizolam,Product Used For Unknown Indication,Completed Suicide,Serious,Died;Other Outcomes,Male,2019,1/14/2021,Expedited,25,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/4/2021,1/14/2021,US,Not Specified,US-APOTEX-2021AP000950,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, Rivers LJ, Pham NPT, Ryan ML. 2019 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58 (12):1360\\x961541\",-\\n18726140,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Cardio-Respiratory Arrest;Drug Abuse,Serious,Other Outcomes;Hospitalized;Died,Male,2019,1/14/2021,Expedited,25,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/4/2021,1/11/2021,US,Not Specified,US-APOTEX-2021AP000153,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, Rivers LJ, Pham NPT, Ryan ML. 2019 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58 (12):1360\\x961541\",-\\n18740006,-,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,1/14/2021,Non-Expedited,30,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/4/2021,1/14/2021,US,Not Specified,US-APOTEX-2021AP000192,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, Rivers LJ, Pham NPT, Ryan ML. 2019 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58 (12):1360\\x961541\",-\\n18728069,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,2019,1/15/2021,Non-Expedited,29,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/4/2021,1/12/2021,US,Not Specified,US-APOTEX-2021AP000181,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, Rivers LJ, Pham NPT, Ryan ML. 2019 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58 (12):1360\\x961541\",-\\n18777199,-,Yohimbine;Flualprazolam;Buprenorphine;Oxycodone Hydrochloride;Alprazolam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Poisoning Deliberate;Cardiac Arrest;Respiratory Arrest,Serious,Died,Male,2019,1/22/2021,Expedited,29,Not Specified,Genus Lifesciences,Healthcare Professional,Not Specified,-,1/11/2021,1/22/2021,US,Not Specified,US-GENUS_LIFESCIENCES-USA-POI0580202100046,Gummin D. 2019 Annual Report of the American Association of Poison Control Centers National Poison Data Systems (NPDS): 37th Annual Report. Clinical Toxicology. 2020 DEC;58(12):1360-1541.,-\\n20249147,-,Fentanyl;Diazepam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died,Male,-,12/29/2021,Expedited,31,Not Specified,Bausch And Lomb,Healthcare Professional,Not Specified,-,12/23/2021,12/29/2021,US,Not Specified,US-BAUSCH-BL-2021-042390,\"Gummin D, Mowry J, Beuhler M, Spyker D, Bronstein A, Rivers L, Pham N, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021 DEC 10;59 (12):1282-1501. doi:10.1080/15563650.2021.1989785\",-\\n18850794,Zolpidem,Zolpidem Tartrate;Tramadol;Topiramate;Herbals\\\\Mitragynine;Oxycodone;Diphenhydramine,Product Used For Unknown Indication,Toxicity To Various Agents;Asphyxia,Serious,Other Outcomes;Died,Not Specified,-,2/5/2021,Expedited,Not Specified,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,1/23/2021,2/5/2021,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-277921,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R et al. Deaths in Colorado Attributed to Kratom. N Engl J Med. 2019;JAN 380 1:1-2\",-\\n18831408,-,Herbals\\\\Mitragynine;Etizolam;Nordazepam;Mirtazapine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died;Other Outcomes,Not Specified,-,2/3/2021,Expedited,Not Specified,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,1/23/2021,2/3/2021,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-277924,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R et al. Deaths in Colorado Attributed to Kratom. N Engl J Med. 2019;3Jan:380(1):1-2\",-\\n18832743,-,Herbals\\\\Mitragynine;Fentanyl;Alcohol;Oxycodone;Cocaine,Product Used For Unknown Indication,Toxicity To Various Agents;Portal Fibrosis;Portal Tract Inflammation,Serious,Died;Other Outcomes,Not Specified,-,2/3/2021,Expedited,Not Specified,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,1/23/2021,2/3/2021,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-277926,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R et al. Deaths in Colorado Attributed to Kratom. N Engl J Med. 2019;3Jan: 380(1):1-2\",-\\n18832735,Fluoxetine;Pseudoephedrine.,Pseudoephedrine Hydrochloride;Herbals\\\\Mitragynine;Fluoxetine Hydrochloride;Oxycodone,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died;Other Outcomes,Not Specified,-,2/3/2021,Expedited,Not Specified,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,1/23/2021,2/3/2021,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-277918,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R et al. Deaths in Colorado Attributed to Kratom. N Engl J Med. 2019;3Jan: 380(1):1-2\",-\\n18832731,-,Herbals\\\\Mitragynine;Oxycodone;Alcohol,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Other Outcomes;Died,Not Specified,-,2/3/2021,Expedited,Not Specified,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,1/23/2021,2/3/2021,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-277925,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R et al. Deaths in Colorado Attributed to Kratom. N Engl J Med. 2019;3Jan: 380(1):1-2\",-\\n18853580,Hydroxyzine;Sertraline,Sertraline Hydrochloride;Olanzapine;Hydroxyzine Hydrochloride;Temazepam;Herbals\\\\Mitragynine;Clonazepam,Product Used For Unknown Indication,Cardiomegaly;Toxicity To Various Agents,Serious,Other Outcomes;Died,Not Specified,-,2/5/2021,Expedited,Not Specified,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,1/23/2021,2/5/2021,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-277923,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R et al. Deaths in Colorado Attributed to Kratom. N Engl J Med. 2019;3Jan: 380(1):1-2\",-\\n18850878,-,Herbals\\\\Mitragynine;Citalopram,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Other Outcomes;Died,Not Specified,-,2/5/2021,Expedited,Not Specified,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,1/23/2021,2/5/2021,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-277922,\"Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R et al. Deaths in Colorado Attributed to Kratom. N Engl J Med. 2019;3Jan: 380(1):1-2\",-\\n18961521,-,Herbals\\\\Mitragynine;Alprazolam;Butalbital;Morphine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Female,-,3/3/2021,Expedited,28,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,2/17/2021,3/3/2021,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-282076,\"Fagiola M, Hahn T, Avella J. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS). J Anal Toxicol. 2018;42:562-569\",-\\n18961246,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine;Meperidine;Phentermine;Morphine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Male,-,3/3/2021,Expedited,41,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,2/17/2021,3/3/2021,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-282072,\"Fagiola M, Hahn T, Avella J. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS). J Anal Toxicol. 2018;42:562-569\",-\\n19854041,Escitalopram;Hydrocodone Bitartrate And Acetaminophen,Acetaminophen\\\\Hydrocodone Bitartrate;Herbals\\\\Mitragynine;Escitalopram Oxalate;Oxycodone;Alprazolam;Tramadol;Hydrocodone,Anxiety;Back Pain;Depression;Intervertebral Disc Degeneration;Product Used For Unknown Indication,Intentional Product Misuse;Drug Ineffective;Drug Tolerance;Intentional Overdose;Drug Use Disorder,Serious,Other Outcomes,Male,-,9/20/2021,Expedited,47,Not Specified,Aurobindo,Healthcare Professional,Not Specified,Buprenorphine\\\\Naloxone;Duloxetine;Hydroxyzine,9/6/2021,9/20/2021,US,Not Specified,US-AUROBINDO-AUR-APL-2021-038857,\"Bowe A, Kerr PL.. A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management. JOURNAL OF PSYCHOACTIVE DRUGS. 2020;52(5):447-452\",-\\n19813199,Escitalopram,Escitalopram Oxalate;Herbals\\\\Mitragynine;Hydrocodone;Alprazolam;Oxycodone;Acetaminophen\\\\Hydrocodone Bitartrate;Tramadol,Anxiety;Back Pain;Depression;Drug Withdrawal Syndrome;Intervertebral Disc Degeneration,Arthralgia;Affective Disorder;Pain;Abdominal Pain;Withdrawal Syndrome;Rhinorrhoea;Back Pain;Yawning;Drug Dependence;Depression;Drug Ineffective;Drug Withdrawal Syndrome;Restlessness;Fatigue;Drug Use Disorder;Hyperhidrosis;Anxiety;Intentional Product Misuse;Psychomotor Hyperactivity,Serious,Hospitalized,Male,-,9/10/2021,Expedited,\"45,996\",Not Specified,Mylan,Healthcare Professional,Not Specified,-,8/31/2021,9/10/2021,US,Not Specified,US-MYLANLABS-2021M1059798,\"Bowe A, Kerr PL. A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management. J-Psychoactive-Drugs 2020;52(5):447-452.\",-\\n19787993,Trazodone,Codeine;Trazodone Hydrochloride;Herbals\\\\Mitragynine;Hydroxyzine Pamoate;Clonidine;Mirtazapine;Cyclobenzaprine;Morphine;Zolpidem Tartrate;Sertraline Hydrochloride;Gabapentin,-,Pulmonary Congestion;Respiratory Depression;Toxicity To Various Agents,Serious,Other Outcomes;Died,Male,-,9/3/2021,Expedited,25,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,8/28/2021,9/3/2021,US,Not Specified,US-PFIZER INC-202100929819,\"Bishop-Freeman, S.. Death from poppy tea consumption. Journal of Analytical Toxicology. 2020;44(7):734-740\",-\\n19810602,-,Morphine;Codeine;Herbals\\\\Mitragynine;Hydromorphone Hydrochloride,-,Pulmonary Oedema;Toxicity To Various Agents,Serious,Died,Male,-,9/9/2021,Expedited,25,Not Specified,Pfizer,Healthcare Professional,Not Specified,Atracurium;Bupropion;Diphenhydramine Hydrochloride;Aripiprazole;Thebaine,8/28/2021,9/9/2021,US,Not Specified,US-PFIZER INC-202101132415,\"Bishop-Freeman, S.. Death from poppy tea consumption. Journal of Analytical Toxicology. 2020;44(7):734-740\",-\\n19871032,-,Gabapentin;Morphine;Codeine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Unresponsive To Stimuli;Accidental Poisoning;Foaming At Mouth;Pulmonary Congestion,Serious,Other Outcomes;Died,Male,-,9/23/2021,Expedited,25,Not Specified,Aurobindo,Healthcare Professional,Not Specified,Trazodone;Mirtazapine;Sertraline;Zolpidem;Cyclobenzaprine;Clonidine,9/13/2021,9/23/2021,US,Not Specified,US-AUROBINDO-AUR-APL-2021-039327,\"Bishop-Freeman SC, Fox L, Winecker RE, Hudson JS.. Death from poppy tea consumption.. Journal of Analytical Toxicology. 2020;44(7):734-740\",-\\n19821099,-,Herbals\\\\Mitragynine;Morphine;Diphenhydramine;Hydromorphone;Codeine;Thebaine,Product Used For Unknown Indication,Toxicity To Various Agents;Accidental Overdose;Accidental Poisoning,Serious,Other Outcomes;Died,Male,-,9/13/2021,Expedited,25,Not Specified,Apotex,Healthcare Professional,Not Specified,Bupropion;Aripiprazole,9/3/2021,9/13/2021,US,Not Specified,US-APOTEX-2021AP042497,\"Bishop-Freeman SC, Fox L, Winecker RE, Hudson JS. Death from Poppy Tea Consumption. Journal of Analytical Toxicology. 2020;44(7):734-740\",-\\n19831043,Zolpidem;Trazodone,Trazodone Hydrochloride;Morphine;Zolpidem Tartrate;Gabapentin;Codeine;Thebaine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents;Accidental Poisoning;Accidental Overdose,Serious,Died;Other Outcomes,Male,-,9/15/2021,Expedited,25,Not Specified,Apotex,Healthcare Professional,Not Specified,Clonidine;Cyclobenzaprine;Sertraline;Mirtazapine,9/3/2021,9/15/2021,US,Not Specified,US-APOTEX-2021AP042496,\"Bishop-Freeman SC, Fox L, Winecker RE, Hudson JS. Death from Poppy Tea Consumption. Journal of Analytical Toxicology. 2020;44(7):734-740\",-\\n19808931,Trazodone;Zolpidem;Sertraline;Hydroxyzine,Hydroxyzine Hydrochloride;Codeine;Cyclobenzaprine;Morphine;Sertraline Hydrochloride;Thebaine;Clonidine;Zolpidem Tartrate;Trazodone Hydrochloride;Mirtazapine;Gabapentin;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Accidental Poisoning,Serious,Died,Male,-,9/9/2021,Expedited,25,Not Specified,Novartis,Healthcare Professional,Not Specified,-,9/6/2021,9/9/2021,US,Not Specified,NVSC2021US203910,\"Bishop-Freeman SC, Fox L, Winecker RE, Hudson JS. Death from poppy tea consumption. JOURNAL OF ANALYTICAL TOXICOLOGY. 2020;44:734-40\",-\\n19628225,Sertraline;Remeron;Hydroxyzine;Zolpidem;Trazodone,Trazodone Hydrochloride;Gabapentin;Clonidine;Thebaine;Herbals\\\\Mitragynine;Codeine;Zolpidem Tartrate;Mirtazapine;Hydroxyzine Hydrochloride;Cyclobenzaprine;Sertraline Hydrochloride;Morphine,-,Drug Abuse,Serious,Other Outcomes,Male,-,7/29/2021,Expedited,25,Not Specified,Organon,Healthcare Professional,Not Specified,-,7/19/2021,7/29/2021,US,Not Specified,US-ORGANON-O2107USA001983,\"Bishop-Freeman SC, Fox L, Winecker RE, Hudson JS. Death from poppy tea consumption. Journal of Analytical Toxicology. 2020;44 (7):734-40\",-\\n20208437,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Accidental Overdose;Intentional Product Use Issue;Toxicity To Various Agents;Loss Of Consciousness;Alcohol Poisoning,Serious,Died,Male,21-Jul-2021,12/16/2021,Direct,31,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,Vraylar;Vitamin D3;Modafinil;Lunesta,-,12/16/2021,Not Specified,Not Specified,-,-,-\\n19990708,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Euphoric Mood;Substance Use;Product Formulation Issue;Dependence,Serious,Other Outcomes,Female,22-Oct-2021,10/24/2021,Direct,48,89.55 KG,Fda-Ctu,Consumer,Consumer,Vitamin D;Vitamin B,-,10/24/2021,US,Not Specified,-,-,-\\n19912316,-,Herbals\\\\Mitragynine,Anxiety,Nausea;Pyrexia;Salmonellosis;Migraine;Vomiting;Abdominal Pain Upper,Serious,Other Outcomes,Female,02-Sep-2021,10/3/2021,Direct,50,72 KG,Fda-Ctu,Consumer,Consumer,Vitamin B12;Paxil;Magnesium,-,10/3/2021,US,Not Specified,-,-,Yes\\n20016482,-,Herbals\\\\Mitragynine,-,Herbal Toxicity;Hand Fracture;Seizure,Serious,Died,Male,21-Jun-2020,11/3/2021,Direct,26,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,Vicodin,-,11/3/2021,Not Specified,Not Specified,-,-,-\\n19372922,-,Herbals\\\\Mitragynine,Anxiety;Depression;Pain,Anxiety;Completed Suicide;Depression;Delusion;Dependence,Serious,Died,Male,-,6/4/2021,Direct,60,74.25 KG,Fda-Ctu,Consumer,Consumer,Unspecified Ingredient;Cymbalta;Metoprolol;Klonopin,-,6/4/2021,US,Not Specified,-,-,-\\n20232101,-,Herbals\\\\Mitragynine,-,Insomnia;Irritability;Seizure,Serious,Required Intervention;Other Outcomes;Life Threatening,Male,11-Dec-2021,12/24/2021,Direct,40,81 KG,Fda-Ctu,Consumer,Not Specified,Tylenol Pm,-,12/24/2021,Not Specified,Not Specified,-,-,-\\n18983046,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Loss Of Consciousness;Product Quality Issue;Vomiting;Tremor;Haemorrhage,Serious,Other Outcomes;Disabled,Female,25-Feb-2021,2/26/2021,Direct,37,60.75 KG,Fda-Ctu,Consumer,Consumer,Tylenol Extra Strength,-,2/26/2021,US,Y,-,-,-\\n20054812,-,Herbals\\\\Mitragynine,Depression;Pain,Hot Flush;Withdrawal Syndrome;Panic Attack;Depression;Dependence;Restlessness;Constipation;Rash;Malaise;Anxiety;Anger;Gastrointestinal Disorder;Nausea;Irritability;Vomiting Projectile;Hyperhidrosis;Insomnia;Acne,Serious,Disabled,Female,26-Dec-2020,11/10/2021,Direct,22,55.35 KG,Fda-Ctu,Consumer,Not Specified,Trazodone;Vitamin B12;Wellbutrin;Fiber Nos;Probiotics Nos;Ativan;Ambien,-,11/10/2021,Not Specified,Not Specified,-,-,-\\n19455710,-,Herbals\\\\Mitragynine,Drug Use Disorder,Suspected Product Contamination;Swelling;Inflammation;Product Quality Issue;Malaise,Serious,Other Outcomes,Male,01-Jun-2021,6/24/2021,Direct,56,94.5 KG,Fda-Ctu,Consumer,Consumer,Taurine;Theanine;Herbals\\\\Withania Somnifera Root;Reishi;Vitamin B12;Herbals\\\\Turmeric;Jwh-018;Vitamin D3;Pomegranate,-,6/24/2021,US,Not Specified,-,-,Yes\\n20015427,-,Herbals\\\\Mitragynine,Insomnia,Myoclonus;Monoplegia,Serious,Other Outcomes,Male,25-Oct-2021,10/30/2021,Direct,56,67.95 KG,Fda-Ctu,Healthcare Professional,Not Specified,Quetiapine;Olmesartan,-,10/30/2021,Not Specified,Not Specified,-,-,-\\n20085440,-,Herbals\\\\Mitragynine,Anxiety;Pain,Depression;Drug Dependence;Seizure;Decreased Appetite;Suicidal Ideation,Serious,Disabled;Required Intervention;Life Threatening;Other Outcomes;Hospitalized,Male,19-Oct-2021,11/17/2021,Direct,35,67.5 KG,Fda-Ctu,Consumer,Not Specified,Paxil;Vimpat,-,11/17/2021,Not Specified,Not Specified,-,-,-\\n19703810,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Asocial Behaviour;Restless Legs Syndrome;Withdrawal Syndrome;Asthenia;Anxiety;Depression,Serious,Other Outcomes,Male,04-Aug-2021,8/14/2021,Direct,44,83.25 KG,Fda-Ctu,Consumer,Consumer,Omega-3 Fatty Acids;Vitamin D;Ambien;Lexapro;Singulair;Ademetionine;Magnesium,-,8/14/2021,US,Not Specified,-,-,-\\n19695260,-,Herbals\\\\Mitragynine,Anxiety,Autoimmune Encephalopathy,Serious,Disabled;Hospitalized;Life Threatening,Male,18-Jan-2018,8/12/2021,Direct,57,78.75 KG,Fda-Ctu,Consumer,Consumer,Nexium;Lipitor,-,8/12/2021,US,Not Specified,-,-,-\\n19807588,-,Herbals\\\\Mitragynine,Drug Dependence,Socioeconomic Precarity;Theft;Drug Dependence,Serious,Required Intervention,Male,-,9/8/2021,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Consumer,Motrin,-,9/8/2021,US,Not Specified,-,-,-\\n19587510,-,Herbals\\\\Mitragynine,Narcolepsy,Herbal Toxicity;Product Use Issue;Respiratory Depression,Serious,Died,Male,-,7/21/2021,Direct,31,76.5 KG,Fda-Ctu,Consumer,Consumer,Lunesta;Vitamin D3;Modafinil,-,7/21/2021,US,Not Specified,-,-,-\\n19962621,-,Herbals\\\\Mitragynine,Pain,Substance Use,Serious,Died,Male,02-Oct-2021,10/13/2021,Direct,64,104.33 KG,Fda-Ctu,Healthcare Professional,Health Professional,Losartan;Lyrica;Omeprazole;Bupropion Hydrochloride;Crestor;Duloxetine;Atorvastatin,-,10/13/2021,US,Not Specified,-,-,-\\n20169082,-,Herbals\\\\Mitragynine,-,Substance Use;Psychotic Disorder;Gun Shot Wound;Completed Suicide;Toxicologic Test Abnormal,Serious,Died,Male,02-Oct-2020,12/9/2021,Direct,32,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,Lexapro;Ibuprofen,-,12/9/2021,Not Specified,Not Specified,-,-,-\\n19030714,-,Herbals\\\\Mitragynine,Pain;Weight Decreased,Drug Hypersensitivity;Withdrawal Syndrome;Urticaria,Serious,Other Outcomes,Female,03-Mar-2021,3/19/2021,Direct,41,76.05 KG,Fda-Ctu,Consumer,Consumer,Lamictal;Viibryd;Rexulti;Wellbutrin Xl;Restoril;Unspecified Ingredient;Bentyl;Topamax;Flexeril;Tylenol;Xanax,-,3/19/2021,US,Y,-,-,-\\n19082832,-,Herbals\\\\Mitragynine,Anxiety;Arthralgia,Memory Impairment;Impaired Work Ability;Withdrawal Syndrome;Reading Disorder;Cognitive Disorder;Confusional State;Dependence;Mental Disorder,Serious,Other Outcomes,Female,01-Apr-2021,4/1/2021,Direct,49,58.5 KG,Fda-Ctu,Consumer,Consumer,Lamictal;Sertraline,-,4/1/2021,US,Not Specified,-,-,-\\n19097760,-,Herbals\\\\Mitragynine,Drug Use Disorder,Generalised Tonic-Clonic Seizure;Seizure,Serious,Life Threatening;Hospitalized,Male,27-Mar-2021,4/6/2021,Direct,35,54 KG,Fda-Ctu,Consumer,Consumer,Keppra,-,4/6/2021,US,Not Specified,-,-,-\\n19385905,-,Herbals\\\\Mitragynine,Anxiety;Pain,Panic Attack;Tachycardia;Tremor;Disorientation;Dizziness,Serious,Disabled;Hospitalized,Female,01-Sep-2019,6/5/2021,Direct,33,53.1 KG,Fda-Ctu,Consumer,Consumer,Ibuprofen;Promethazine;Hydroxyzine;Xanax;Propranolol;Melatonin;Omeprazole;Fish Oil;Herbals\\\\Turmeric;Vitamins;Imitrex;Probiotics Nos;Wellbutrin;Seroquel,-,6/5/2021,US,Not Specified,-,-,-\\n19561943,-,Herbals\\\\Mitragynine,Depression,Aggression;Product Complaint;Vitamin B12 Deficiency;Brain Fog;Depression;Memory Impairment;Anxiety;Illness;Delirium;Confusional State,Serious,Hospitalized;Disabled,Female,13-Apr-2020,7/16/2021,Direct,26,64.35 KG,Fda-Ctu,Consumer,Consumer,Gabapentin;Vitamin D;Advil;Vitamin B12,-,7/16/2021,US,Not Specified,-,-,-\\n19165432,-,Herbals\\\\Mitragynine,Drug Dependence,Product Complaint;Drug Level Increased,Serious,Died,Male,-,4/21/2021,Direct,21,51.75 KG,Fda-Ctu,Consumer,Consumer,Gabapentin,-,4/21/2021,US,Not Specified,-,-,-\\n19645350,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Dyspnoea;Kidney Infection;Mood Swings;Drug Abuser;Agitation;Weight Decreased,Non-Serious,Non-Serious,Male,20-Jul-2021,7/30/2021,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Consumer,Gabapentin,-,7/30/2021,US,Not Specified,-,-,-\\n20161037,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Accidental Death;Illness,Serious,Died,Male,27-May-2020,12/8/2021,Direct,26,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,Fluoxetine;Gabapentin;Flualprazolam,-,12/8/2021,Not Specified,Not Specified,-,-,-\\n19292670,-,Herbals\\\\Mitragynine,Anxiety,Pyrexia;Drug-Induced Liver Injury;Fatigue;Blood Bilirubin Increased;Withdrawal Syndrome;Pain;Nausea,Serious,Hospitalized,Male,16-Mar-2021,5/23/2021,Direct,41,103.5 KG,Fda-Ctu,Consumer,Consumer,Cymbalta;Wellbutrin,-,5/23/2021,US,Not Specified,-,-,-\\n19274283,-,Herbals\\\\Mitragynine,Drug Therapy,Substance Use;Toxicity To Various Agents,Serious,Died,Male,20-Mar-2021,5/19/2021,Direct,42,121.5 KG,Fda-Ctu,Consumer,Consumer,Clonazepam;Paroxetine;Lamotrigine;Lisinopril And Hydrochlorothiazide;Risperidone,-,5/19/2021,US,Not Specified,-,-,-\\n20169079,-,Herbals\\\\Mitragynine,-,Substance Use;Toxicity To Various Agents,Serious,Died,Male,-,12/9/2021,Direct,42,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,Clonazepam,-,12/9/2021,Not Specified,Not Specified,-,-,-\\n19708082,-,Herbals\\\\Mitragynine,Anxiety,Tremor;Asthenia;Gait Inability,Serious,Other Outcomes,Male,25-Dec-2020,8/17/2021,Direct,69,94.5 KG,Fda-Ctu,Consumer,Consumer,Aspirin;Lisinopril;Lipitor;Metoprolol,-,8/17/2021,US,Not Specified,-,-,-\\n18973587,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Loss Of Consciousness,Serious,Died,Male,25-Apr-2020,3/5/2021,Direct,38,112.5 KG,Fda-Ctu,Consumer,Consumer,Adderall,-,3/5/2021,US,Y,-,-,-\\n18769925,-,Alprazolam;Herbals\\\\Mitragynine;Yohimbine;Buprenorphine;Oxycodone Hydrochloride;Flualprazolam,Product Used For Unknown Indication,Death;Cardio-Respiratory Arrest,Serious,Died,Male,2019,1/21/2021,Expedited,29,Not Specified,Endo,Healthcare Professional,Not Specified,-,1/5/2021,1/21/2021,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2021-000335,-,-\\n18742407,Klonopin;Lexapro;Ativan;Viibryd;Trazodone;Suboxone,Buprenorphine Hydrochloride\\\\Naloxone Hydrochloride;Vilazodone Hydrochloride;Trazodone Hydrochloride;Lorazepam;Herbals\\\\Mitragynine;Escitalopram Oxalate;Clonazepam,Depression;Drug Withdrawal Maintenance Therapy;Product Used For Unknown Indication,Emotional Distress;Confusional State;Hypertension;Delirium;Suicidal Behaviour;Heart Rate Increased;Psychotic Disorder;Depression;Malaise;Panic Attack;Therapy Interrupted;Inability To Afford Medication;Fear;Anxiety,Serious,Other Outcomes;Hospitalized,Male,Jan-2021,4/29/2021,Expedited,Not Specified,Not Specified,Allergan,Consumer,Not Specified,-,4/15/2021,1/14/2021,US,Not Specified,US-ALLERGAN-2101856US,-,-\\n19205259,Paxil,Paroxetine Hydrochloride;Herbals\\\\Mitragynine,Anxiety;Depression;Drug Dependence,Hallucination;Heart Rate Increased;Seizure,Serious,Other Outcomes;Life Threatening;Hospitalized,Female,27-Apr-2021,5/2/2021,Direct,53,Not Specified,Fda-Ctu,Consumer,Consumer,Effexor;Tizanidine,-,5/2/2021,US,Not Specified,-,-,-\\n19302096,-,Fentanyl;Herbals\\\\Mitragynine,-,Death;Toxicologic Test Abnormal,Serious,Died,Male,-,5/25/2021,Direct,Not Specified,78.75 KG,Fda-Ctu,Consumer,Consumer,-,-,5/25/2021,US,Not Specified,-,-,-\\n16593812,-,Herbals\\\\Mitragynine;Loratadine;Albuterol;Acetaminophen\\\\Codeine Phosphate\\\\Methocarbamol;Ranitidine;Methocarbamol;Valacyclovir Hydrochloride;Acetaminophen;Diphenhydramine,Product Used For Unknown Indication,Foetal Exposure During Pregnancy;Drug Withdrawal Syndrome Neonatal,Serious,Other Outcomes;Hospitalized,Female,-,6/21/2021,Expedited,Not Specified,3 KG,Glaxosmithkline,Healthcare Professional,Not Specified,Citalopram,6/15/2021,7/18/2019,CA,Not Specified,CA-GLAXOSMITHKLINE-CA2019AMR125644,-,-\\n19460010,Valtrex,Albuterol;Valacyclovir Hydrochloride;Ranitidine;Citalopram;Diphenhydramine;Methocarbamol;Acetaminophen\\\\Methocarbamol;Acetaminophen\\\\Codeine Phosphate\\\\Methocarbamol;Loratadine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Maternal Exposure During Pregnancy;Caesarean Section;Live Birth,Serious,Other Outcomes,Female,-,6/25/2021,Expedited,37,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,7/8/2019,6/25/2021,CA,Not Specified,CA-AUROBINDO-AUR-APL-2019-041488,-,-\\n16607921,Valtrex,Valacyclovir Hydrochloride;Citalopram;Methocarbamol;Acetaminophen;Diphenhydramine;Acetaminophen\\\\Codeine Phosphate\\\\Methocarbamol;Herbals\\\\Mitragynine;Loratadine;Albuterol;Ranitidine;Valacyclovir Hydrochloride,Product Used For Unknown Indication,Drug Withdrawal Syndrome Neonatal;Foetal Exposure During Pregnancy,Serious,Other Outcomes;Hospitalized,Female,-,6/25/2021,Expedited,Not Specified,3 KG,Aurobindo,Healthcare Professional,Not Specified,-,6/18/2021,7/22/2019,CA,Not Specified,CA-AUROBINDO-AUR-APL-2019-041481,-,-\\n16593814,Valtrex,Valacyclovir Hydrochloride;Loratadine;Acetaminophen;Albuterol;Methocarbamol;Diphenhydramine;Ranitidine;Citalopram;Valacyclovir Hydrochloride;Acetaminophen\\\\Methocarbamol;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Live Birth;Foetal Exposure During Pregnancy;Drug Withdrawal Syndrome Neonatal;Caesarean Section;Maternal Exposure During Pregnancy,Serious,Hospitalized;Other Outcomes,Female,-,6/29/2021,Expedited,37,Not Specified,Glaxosmithkline,Healthcare Professional,Not Specified,-,6/9/2021,7/18/2019,CA,Not Specified,CA-GLAXOSMITHKLINE-CA2019AMR125655,-,-\\n19506583,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine,Anxiety,Overdose,Serious,Died,Male,01-Jun-2021,7/8/2021,Direct,38,137.7 KG,Fda-Ctu,Consumer,Consumer,Doxepin;Clonazepam,-,7/8/2021,US,Not Specified,-,-,-\\n18290048,Valtrex;Valacyclovir,Valacyclovir Hydrochloride;Diphenhydramine;Acetaminophen\\\\Codeine Phosphate\\\\Methocarbamol;Loratadine;Ranitidine;Methocarbamol;Valacyclovir Hydrochloride;Albuterol;Acetaminophen;Herbals\\\\Mitragynine;Citalopram,Product Used For Unknown Indication,Foetal Exposure During Pregnancy;Drug Withdrawal Syndrome Neonatal,Serious,Other Outcomes;Hospitalized,Female,-,8/17/2021,Expedited,Not Specified,3 KG,Apotex,Healthcare Professional,Not Specified,Citalopram,8/5/2021,9/21/2020,CA,Not Specified,CA-APOTEX-2020AP017746,-,-\\n18457982,Valtrex;Valacyclovir,Diphenhydramine;Valacyclovir Hydrochloride;Acetaminophen\\\\Methocarbamol;Loratadine;Valacyclovir Hydrochloride;Methocarbamol;Ranitidine;Albuterol;Acetaminophen\\\\Codeine Phosphate\\\\Methocarbamol;Citalopram;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Caesarean Section;Maternal Exposure During Pregnancy;Live Birth,Serious,Other Outcomes,Female,-,8/18/2021,Expedited,37,Not Specified,Apotex,Healthcare Professional,Not Specified,-,8/5/2021,11/3/2020,CA,Not Specified,CA-APOTEX-2020AP020693,-,-\\n19962945,-,Herbals\\\\Mitragynine;Acetaminophen,Product Used For Unknown Indication,Drug Interaction;Liver Injury,Serious,Hospitalized;Other Outcomes,Male,-,10/18/2021,Expedited,44,80 KG,Apotex,Healthcare Professional,Not Specified,Vitamins;Desvenlafaxine;Indapamide;Perindopril,10/12/2021,10/18/2021,CA,Not Specified,CA-APOTEX-2021AP044305,-,-\\n20101858,-,Herbals\\\\Mitragynine;Unspecified Ingredient;Garlic,Product Used For Unknown Indication,Hallucination;Illness;Taste Disorder;Eye Disorder,Serious,Hospitalized,Male,22-Nov-2021,11/22/2021,Direct,35,81 KG,Fda-Ctu,Consumer,Not Specified,Seroquel;Zoloft;Wellbutrin;Buspar;Flexeril;Naltrexone;Vistaril,-,11/22/2021,Not Specified,Not Specified,-,-,Yes\\n18741064,-,Herbals\\\\Mitragynine,-,Product Complaint;Substance Dependence;Illness;Drug Withdrawal Syndrome,Non-Serious,Non-Serious,Male,25-Dec-2020,1/14/2021,Direct,36,60.75 KG,Fda-Ctu,Consumer,Consumer,-,-,1/14/2021,US,Not Specified,-,-,-\\n18858148,-,Herbals\\\\Mitragynine,Pain,Extra Dose Administered;Malaise,Serious,Died,Female,-,2/6/2021,Direct,Not Specified,90 KG,Fda-Ctu,Consumer,Consumer,-,-,2/6/2021,US,Not Specified,-,-,-\\n18897611,-,Herbals\\\\Mitragynine,Vitamin Supplementation,Hyperhidrosis;Palpitations,Serious,Other Outcomes,Male,13-Feb-2021,2/14/2021,Direct,33,74.25 KG,Fda-Ctu,Consumer,Consumer,-,-,2/14/2021,US,Not Specified,-,-,-\\n18967773,-,Herbals\\\\Mitragynine,Drug Withdrawal Syndrome,Aggression;Tachycardia;Syncope;Abnormal Behaviour;Hyperhidrosis;Drug Dependence;Hypertension;Product Complaint;Pruritus;Respiratory Depression;Agitation;Depressed Level Of Consciousness,Serious,Hospitalized;Life Threatening,Male,02-Mar-2021,3/4/2021,Direct,29,81 KG,Fda-Ctu,Consumer,Consumer,-,-,3/4/2021,US,Not Specified,-,-,-\\n19051300,-,Herbals\\\\Mitragynine,-,Drug Dependence;Incorrect Dose Administered;Mental Disorder,Serious,Hospitalized,Male,-,3/24/2021,Direct,41,106.65 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,3/24/2021,US,Not Specified,-,-,-\\n19051308,-,Herbals\\\\Mitragynine,-,Death,Non-Serious,Non-Serious,Male,16-Nov-2020,3/24/2021,Direct,34,99 KG,Fda-Ctu,Consumer,Consumer,-,-,3/24/2021,US,Not Specified,-,-,-\\n19068882,-,Herbals\\\\Mitragynine,Pain,Electrocardiogram St Segment Depression;Bundle Branch Block Right;Pulseless Electrical Activity;Myoclonus;Troponin Increased;Cardio-Respiratory Arrest;Qrs Axis Abnormal;Blood Calcium Decreased,Serious,Died,Male,26-Mar-2021,3/28/2021,Direct,33,70.5 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,3/28/2021,US,Not Specified,-,-,-\\n19165441,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Seizure;Concussion;Overdose,Serious,Life Threatening;Other Outcomes;Hospitalized,Male,31-Mar-2021,4/21/2021,Direct,26,81 KG,Fda-Ctu,Consumer,Consumer,-,-,4/21/2021,US,Not Specified,-,-,-\\n19188369,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Seizure,Serious,Other Outcomes,Male,27-Apr-2021,4/27/2021,Direct,23,74.25 KG,Fda-Ctu,Consumer,Consumer,-,-,4/27/2021,US,Not Specified,-,-,-\\n19205174,-,Herbals\\\\Mitragynine,Pain,Diarrhoea;Product Contamination Physical,Serious,Other Outcomes,Male,03-Feb-2021,5/1/2021,Direct,40,72 KG,Fda-Ctu,Consumer,Consumer,-,-,5/1/2021,US,Y,-,-,-\\n19277947,-,Herbals\\\\Mitragynine,Back Pain,Cholelithiasis;Myalgia;Drug-Induced Liver Injury;Nausea;Pyrexia;Jaundice;Somnolence;Asthenia;Sneezing;Pulmonary Pain;Pruritus;Tinnitus;Arthralgia;Body Temperature Fluctuation;Abdominal Pain Upper;Fatigue;Headache;Night Sweats;Dyspnoea;Chromaturia;Dizziness;Rhinorrhoea,Serious,Hospitalized,Female,19-Mar-2021,5/19/2021,Direct,48,69.75 KG,Fda-Ctu,Consumer,Consumer,-,-,5/19/2021,US,Not Specified,-,-,-\\n19278600,-,Herbals\\\\Mitragynine,-,Fluid Retention;Peripheral Swelling;Dysuria;Gallbladder Disorder;Abdominal Distension;Physical Product Label Issue;Liver Disorder;Renal Disorder;Hepatitis,Serious,Other Outcomes;Life Threatening,Male,16-Apr-2021,5/20/2021,Direct,32,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,5/20/2021,US,Not Specified,-,-,-\\n19282692,-,Herbals\\\\Mitragynine,-,Insomnia;Decreased Appetite;Overdose;Seizure;Choking,Serious,Died,Male,21-Apr-2021,5/20/2021,Direct,26,87.75 KG,Fda-Ctu,Consumer,Consumer,-,-,5/20/2021,US,Not Specified,-,-,-\\n19365907,-,Herbals\\\\Mitragynine,Substance Abuse,Seizure;Weight Decreased;Toxicity To Various Agents,Serious,Died;Other Outcomes,Male,30-Aug-2020,6/3/2021,Direct,38,69.75 KG,Fda-Ctu,Consumer,Consumer,-,-,6/3/2021,US,Not Specified,-,-,-\\n19373032,-,Herbals\\\\Mitragynine,Substance Use,Product Quality Issue,Non-Serious,Non-Serious,Female,-,6/4/2021,Direct,25,58.97 KG,Fda-Ctu,Not Specified,Not Specified,-,-,6/4/2021,US,Not Specified,-,-,-\\n19397869,-,Herbals\\\\Mitragynine,-,Hepatic Enzyme Increased,Serious,Hospitalized,Male,06-May-2021,6/9/2021,Direct,52,89.1 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,6/9/2021,US,Not Specified,-,-,Yes\\n19441229,-,Herbals\\\\Mitragynine,Anxiety;Depression;Insomnia,Death,Serious,Died,Male,21-Feb-2021,6/17/2021,Direct,26,78.75 KG,Fda-Ctu,Consumer,Consumer,-,-,6/17/2021,US,Not Specified,-,-,-\\n19429282,-,Herbals\\\\Mitragynine,-,Quality Of Life Decreased,Serious,Required Intervention;Life Threatening;Disabled;Other Outcomes;Hospitalized,Female,01-Jun-2021,6/17/2021,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,6/17/2021,US,Not Specified,-,-,-\\n19512063,-,Herbals\\\\Mitragynine,Drug Dependence,Opiates Positive,Serious,Other Outcomes,Female,05-Jul-2021,7/9/2021,Direct,50,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,7/9/2021,US,Not Specified,-,-,-\\n19518304,-,Herbals\\\\Mitragynine,-,Withdrawal Syndrome;Maternal Drugs Affecting Foetus,Serious,Hospitalized;Required Intervention,Not Specified,10-Jul-2021,7/11/2021,Direct,Not Specified,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,7/11/2021,US,Not Specified,-,-,-\\n19608140,-,Herbals\\\\Mitragynine,Anxiety,Pulmonary Oedema;Overdose,Serious,Died,Male,26-Sep-2020,7/25/2021,Direct,34,90.45 KG,Fda-Ctu,Consumer,Consumer,-,-,7/25/2021,US,Not Specified,-,-,-\\n19613435,-,Herbals\\\\Mitragynine,Drug Dependence,Gastrointestinal Disorder;Withdrawal Syndrome;Vomiting;Headache;Drug Dependence,Serious,Disabled;Required Intervention,Male,01-Jan-2021,7/26/2021,Direct,29,67.5 KG,Fda-Ctu,Consumer,Consumer,-,-,7/26/2021,US,Not Specified,-,-,-\\n19619958,-,Herbals\\\\Mitragynine,Anxiety;Pain,Decreased Appetite;Anxiety;Agitation;Dependence;Withdrawal Syndrome;Mood Swings;Personality Change,Serious,Disabled,Male,-,7/27/2021,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,7/27/2021,US,Not Specified,-,-,-\\n19645353,-,Herbals\\\\Mitragynine,Pain,Drug Dependence;Withdrawal Syndrome,Non-Serious,Non-Serious,Female,01-Jun-2018,7/31/2021,Direct,37,96.75 KG,Fda-Ctu,Consumer,Consumer,-,-,7/31/2021,US,Not Specified,-,-,-\\n19666831,-,Herbals\\\\Mitragynine,Anxiety,Libido Disorder;Ejaculation Disorder,Serious,Other Outcomes,Female,04-Aug-2021,8/6/2021,Direct,36,63 KG,Fda-Ctu,Consumer,Consumer,-,-,8/6/2021,US,Not Specified,-,-,-\\n19673405,-,Herbals\\\\Mitragynine,-,Anxiety;Loss Of Personal Independence In Daily Activities;Poor Personal Hygiene;Asocial Behaviour;Delusion,Serious,Disabled,Female,15-Mar-2020,8/7/2021,Direct,31,54.45 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,8/7/2021,US,Not Specified,-,-,-\\n19685184,-,Herbals\\\\Mitragynine,-,Accidental Death;Toxicity To Various Agents,Serious,Died,Male,30-Aug-2020,8/10/2021,Direct,38,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,8/10/2021,US,Not Specified,-,-,-\\n19685083,-,Herbals\\\\Mitragynine,-,Starvation Ketoacidosis;Seizure;Arteriosclerosis Coronary Artery;Diabetic Ketosis;Aspiration;Toxicity To Various Agents;Hypertension,Serious,Died,Male,21-Feb-2021,8/10/2021,Direct,26,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,8/10/2021,US,Not Specified,-,-,-\\n19685154,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,21-Apr-2021,8/10/2021,Direct,26,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,8/10/2021,US,Not Specified,-,-,-\\n19695287,-,Herbals\\\\Mitragynine,Depression,Drug Dependence,Serious,Life Threatening;Disabled;Required Intervention,Male,10-Aug-2021,8/12/2021,Direct,40,74.25 KG,Fda-Ctu,Consumer,Consumer,-,-,8/12/2021,US,Not Specified,-,-,-\\n19704407,-,Herbals\\\\Mitragynine,-,No Adverse Event;Product Use In Unapproved Indication,Non-Serious,Non-Serious,Not Specified,-,8/14/2021,Direct,Not Specified,79.38 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,8/14/2021,US,Not Specified,-,-,-\\n19744942,-,Herbals\\\\Mitragynine,Anxiety;Depression,Dizziness;Urticaria;Libido Decreased;Headache;Hypersensitivity;Pain;Pancreatitis;Dependence;Fatigue,Serious,Other Outcomes;Hospitalized;Life Threatening;Required Intervention;Disabled,Male,01-Jan-2020,8/24/2021,Direct,43,72 KG,Fda-Ctu,Consumer,Consumer,-,-,8/24/2021,US,Not Specified,-,-,-\\n19744967,-,Herbals\\\\Mitragynine,Drug Dependence,Seizure;Toxicity To Various Agents,Serious,Died,Male,21-Jun-2020,8/24/2021,Direct,27,67.5 KG,Fda-Ctu,Consumer,Consumer,-,-,8/24/2021,US,Not Specified,-,-,-\\n19745347,-,Herbals\\\\Mitragynine,Anxiety;Pain,Drug Withdrawal Syndrome,Non-Serious,Non-Serious,Female,-,8/24/2021,Direct,35,68.4 KG,Fda-Ctu,Consumer,Consumer,-,-,8/24/2021,US,Not Specified,-,-,-\\n19749424,-,Herbals\\\\Mitragynine,-,Road Traffic Accident;Generalised Tonic-Clonic Seizure;Withdrawal Syndrome,Serious,Other Outcomes,Male,04-Feb-2018,8/25/2021,Direct,35,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,8/25/2021,US,Not Specified,-,-,-\\n19829752,-,Herbals\\\\Mitragynine,-,Brain Injury;Cardiac Arrest;Unresponsive To Stimuli;Pulseless Electrical Activity,Serious,Other Outcomes;Disabled;Life Threatening;Hospitalized,Male,11-Sep-2021,9/14/2021,Direct,21,110.5 KG,Fda-Ctu,Healthcare Professional,Health Professional,-,-,9/14/2021,US,Not Specified,-,-,-\\n19855250,-,Herbals\\\\Mitragynine,-,Drug Dependence,Non-Serious,Non-Serious,Female,-,9/19/2021,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Consumer,-,-,9/19/2021,US,Not Specified,-,-,-\\n19872781,-,Herbals\\\\Mitragynine,-,Overdose;Chromaturia;Hyperhidrosis;Hepatic Failure;Abdominal Pain Upper,Serious,Other Outcomes;Hospitalized,Male,-,9/22/2021,Direct,Not Specified,Not Specified,Fda-Ctu,Healthcare Professional,Health Professional,-,-,9/22/2021,US,Not Specified,-,-,-\\n19928265,-,Herbals\\\\Mitragynine,Neuralgia,Drug Screen Positive,Serious,Other Outcomes,Female,22-Sep-2021,10/6/2021,Direct,60,69.75 KG,Fda-Ctu,Consumer,Consumer,-,-,10/6/2021,US,Y,-,-,-\\n19958720,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Not Specified,-,10/12/2021,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,10/12/2021,US,Not Specified,-,-,-\\n19974115,-,Herbals\\\\Mitragynine,-,Alcoholism;Nausea;Anxiety;Insomnia;Yellow Skin;Aggression;Liver Injury;Dependence;Restless Legs Syndrome;Brain Fog,Serious,Other Outcomes,Male,20-Oct-2021,10/20/2021,Direct,39,103.5 KG,Fda-Ctu,Consumer,Consumer,-,-,10/20/2021,US,Not Specified,-,-,-\\n20057238,-,Herbals\\\\Mitragynine,Affective Disorder;Asthenia;Pain,Decreased Appetite;Tachycardia;Liver Function Test Abnormal;Hypertension;Nausea,Serious,Hospitalized,Female,05-Nov-2021,11/10/2021,Direct,43,112.1 KG,Fda-Ctu,Healthcare Professional,Not Specified,-,-,11/10/2021,Not Specified,Not Specified,-,-,-\\n20090573,-,Herbals\\\\Mitragynine,Depression;Pain;Post-Traumatic Stress Disorder,Drug Dependence;Completed Suicide;Hallucination,Serious,Disabled;Died,Male,21-Oct-2021,11/18/2021,Direct,35,108 KG,Fda-Ctu,Consumer,Not Specified,-,-,11/18/2021,Not Specified,Not Specified,-,-,-\\n20108152,-,Herbals\\\\Mitragynine,-,Pulmonary Oedema;Pulmonary Congestion;Autopsy;Herbal Toxicity;Unresponsive To Stimuli,Serious,Died,Male,26-Sep-2020,11/23/2021,Direct,34,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,11/23/2021,Not Specified,Not Specified,-,-,-\\n20107136,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,-,11/23/2021,Direct,28,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,11/23/2021,Not Specified,Not Specified,-,-,-\\n20152947,-,Herbals\\\\Mitragynine,Affective Disorder;Pain,Vomiting;Tremor;Nausea;Skin Discolouration;Seizure;Blepharospasm,Serious,Other Outcomes,Not Specified,12-Jun-2019,12/6/2021,Direct,41,107.1 KG,Fda-Ctu,Consumer,Not Specified,-,-,12/6/2021,Not Specified,Not Specified,-,-,-\\n20170679,-,Herbals\\\\Mitragynine,-,Accidental Death;Toxicity To Various Agents,Serious,Died,Male,-,12/8/2021,Direct,30,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,12/8/2021,Not Specified,Not Specified,-,-,-\\n20174607,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died,Male,09-Jan-2018,12/10/2021,Direct,27,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,12/10/2021,Not Specified,Not Specified,-,-,-\\n20193494,-,Herbals\\\\Mitragynine,Anxiety;Back Pain;Post-Traumatic Stress Disorder,Feeling Abnormal;Serotonin Syndrome;Glassy Eyes;Flushing;Agitation;Anger;Influenza Like Illness;Screaming;Legal Problem;Physical Assault;Aggression;Substance Use,Serious,Other Outcomes,Male,27-Sep-2021,12/15/2021,Direct,57,72 KG,Fda-Ctu,Consumer,Not Specified,-,-,12/15/2021,Not Specified,Not Specified,-,-,-\\n20221796,-,Herbals\\\\Mitragynine,Anxiety;Depression;Pain;Stress,Head Injury;Seizure,Serious,Other Outcomes,Female,02-Jul-2021,12/22/2021,Direct,30,90 KG,Fda-Ctu,Consumer,Not Specified,-,-,12/22/2021,Not Specified,Not Specified,-,-,-\\n21548749,-,Herbals\\\\Mitragynine;Buprenorphine;Buprenorphine Hydrochloride\\\\Naloxone Hydrochloride,Drug Withdrawal Syndrome,Maternal Exposure During Pregnancy;Drug Ineffective,Serious,Other Outcomes,Female,-,11/3/2022,Expedited,27,Not Specified,Mylan,Healthcare Professional,Not Specified,-,10/26/2022,11/3/2022,US,Not Specified,US-MYLANLABS-2022M1119985,\"Zoucha K, Moore C. Kratom Use in Pregnancy. J-Addict-Med 2022;16(5):e331-e332.\",-\\n21553105,Methadone,Methadone Hydrochloride;Buprenorphine Hydrochloride\\\\Naloxone Hydrochloride;Herbals\\\\Mitragynine,Drug Withdrawal Syndrome,Maternal Exposure During Pregnancy;Drug Ineffective,Serious,Other Outcomes,Female,-,11/4/2022,Expedited,34,Not Specified,Mylan,Healthcare Professional,Not Specified,-,10/26/2022,11/4/2022,US,Not Specified,US-MYLANLABS-2022M1119984,\"Zoucha K, Moore C. Kratom Use in Pregnancy. J-Addict-Med 2022;16(5):e331-e332.\",-\\n21614648,-,Herbals\\\\Mitragynine;Buprenorphine;Buprenorphine\\\\Naloxone,Drug Use Disorder,Abdominal Pain;Drug Withdrawal Syndrome Neonatal;Breast Milk Substitute Intolerance;Foetal Exposure During Pregnancy,Serious,Other Outcomes,Female,-,11/18/2022,Expedited,Not Specified,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,11/5/2022,11/18/2022,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-364362,\"Zoucha K, Moore C. Kratom Use in Pregnancy. J Addict Med. 2022;Sep-Oct;16(5):e331-e332\",-\\n21614527,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine;Buprenorphine\\\\Naloxone,Drug Use Disorder,Exposure During Pregnancy;Drug Withdrawal Syndrome;Drug Ineffective;Live Birth,Serious,Other Outcomes,Female,-,11/18/2022,Expedited,34,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,11/5/2022,11/18/2022,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-364356,\"Zoucha K, Moore C. Kratom Use in Pregnancy. J Addict Med. 2022;16(5):e331-e332\",-\\n21219739,-,Herbals\\\\Mitragynine;Tramadol,Pain,Cognitive Disorder;Affect Lability;Drug Interaction;Electrocardiogram Qt Prolonged;Hypokalaemia;Toxicity To Various Agents;Generalised Tonic-Clonic Seizure;Delirium;Fall;Loss Of Consciousness,Serious,Other Outcomes;Hospitalized,Not Specified,-,8/17/2022,Expedited,Not Specified,Not Specified,Ipca,Healthcare Professional,Not Specified,-,8/5/2022,8/17/2022,US,Not Specified,US-IPCA LABORATORIES LIMITED-IPC-2022-US-001081,\"Thomas Beresford, Carrie Keffler, Mitzi Wasserstein, et.al. Kratom tramadol toxicity with seizure, hypokalemia, marked Q-T prolongation, and cognitive impairment: A case report. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63:S69-S70\",-\\n21493929,-,Herbals\\\\Mitragynine;Amphetamine Sulfate,Product Used For Unknown Indication,Overdose;Cardiac Arrest,Serious,Life Threatening;Hospitalized,Female,-,10/21/2022,Expedited,38,Not Specified,Arbor,Healthcare Professional,Not Specified,-,10/13/2022,10/21/2022,US,Not Specified,\"US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB002672\",\"Theegala V., K Solanki K., S Grover B.. Cardiac arrest in a middle-aged woman from combined use of kratom and amphetamine. Chest. 2022;162:4\",-\\n21500652,\"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate\",Amphetamine Aspartate\\\\Amphetamine Sulfate\\\\Dextroamphetamine Saccharate\\\\Dextroamphetamine Sulfate;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Syncope;Overdose;Cardiac Arrest;Hypotension;Substance Use;Metabolic Acidosis;Brain Oedema;Brain Death,Serious,Other Outcomes;Died,Female,-,10/25/2022,Expedited,38,Not Specified,Specgx,Healthcare Professional,Not Specified,-,10/11/2022,10/25/2022,US,Not Specified,US-SPECGX-T202202178,\"Theegala V, Solanki KK, Grover BS. Cardiac arrest in a middle-aged woman from combined use of kratom and amphetamine. Chest. 2022;162(4):A776\",-\\n20576068,Venlafaxine,Venlafaxine Hydrochloride;Quetiapine Fumarate;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Serotonin Syndrome;Drug Level Above Therapeutic;Herbal Interaction;Electrocardiogram Abnormal;Drug Interaction;Dizziness,Serious,Other Outcomes,Male,-,3/24/2022,Expedited,36,Not Specified,Alembic,Healthcare Professional,Not Specified,-,3/11/2022,3/10/2022,US,Not Specified,US-ALEMBIC PHARMACUETICALS LIMITED-2022SCAL000070,\"McPhee MM, Paine MF, Cox EJ, Burns AG.. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone.. Journal of addiction medicine. 2022\",-\\n21255634,-,Morphine Sulfate;Herbals\\\\Mitragynine;Hydrocodone,Headache,Proteinuria;Acute Kidney Injury,Serious,Hospitalized;Other Outcomes,Female,-,8/25/2022,Expedited,21,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,8/15/2022,8/25/2022,US,Not Specified,US-PFIZER INC-PV202200043672,\"LeSaint, K.. Acute Renal Insufficiency Associated With Consumption of Hydrocodone- and Morphine-Adulterated Kratom (Mitragyna Speciosa). Journal of Emergency Medicine. 2022;10.1016/j.jemermed.2022.02.004\",-\\n21210049,Trazodone;Buspirone,Trazodone Hydrochloride;Buspirone Hydrochloride;Herbals\\\\Mitragynine;Ziprasidone;Desvenlafaxine,Product Used For Unknown Indication,Self-Medication;Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes;Hospitalized,Male,-,11/23/2022,Expedited,63,102 KG,Dr Reddys,Healthcare Professional,Not Specified,Gabapentin;Omeprazole;Diclofenac;Glimepiride;Tizanidine Hydrochloride;Amlodipine;Bupropion;Hydrochlorothiazide;Metformin,11/11/2022,8/14/2022,US,Not Specified,US-drreddys-SPO/USA/22/0153193,\"Hamilton L, Eudaley S, Brooks S. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. J Pharm Pract. 2022;UNKNOWN:1-5. doi:10.1177/08971900221116009\",-\\n20261749,Rocuronium,Etomidate;Rocuronium Bromide;Herbals\\\\Mitragynine,Agitation;Apnoea;Haemodynamic Instability;Hypotension;Hypotonia;Induction Of Anaesthesia;Product Used For Unknown Indication;Prophylaxis;Respiratory Rate Decreased;Toxicity To Various Agents,Screaming;Hyperkalaemia;Cardiogenic Shock;Toxicity To Various Agents;Distributive Shock;Apnoea;Agitation;Cardio-Respiratory Arrest;Muscle Contractions Involuntary;Muscle Rigidity;Respiratory Failure;Deafness Neurosensory;Grimacing;Overdose;Pain;Aggression;Clonus;Metabolic Acidosis,Serious,Life Threatening;Other Outcomes;Hospitalized,Male,-,2/4/2022,Expedited,35,Not Specified,Teva,Healthcare Professional,Not Specified,Epinephrine;Ketamine;Norepinephrine;Naloxone;Sodium Chloride,1/26/2022,12/31/2021,US,Not Specified,US-TEVA-2021-US-1993083,\"Hall A, Hall D. Kratom Ingestion and Emergency Care: Summary and a Case Report. J-Emerg-Nurs 2021;47(4):551-556.e1.\",-\\n20481834,-,Alprazolam;Fentanyl Citrate;Herbals\\\\Mitragynine,-,Drug Abuse,Serious,Died;Other Outcomes,Male,2020,2/16/2022,Expedited,35,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,2/10/2022,2/16/2022,US,Not Specified,US-PFIZER INC-202200257350,\"Gummin, D.. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):1282-1501\",-\\n20480419,-,Amphetamine;Sertraline Hydrochloride;Atenolol;Herbals\\\\Mitragynine;Gabapentin,-,Cardiac Arrest;Completed Suicide;Respiratory Arrest,Serious,Died;Hospitalized,Male,2020,2/16/2022,Expedited,29,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,2/10/2022,2/16/2022,US,Not Specified,US-PFIZER INC-202200269872,\"Gummin, D.. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):1282-1501\",-\\n20480144,Promethazine,Promethazine Hydrochloride;Hydrochlorothiazide\\\\Triamterene;Herbals\\\\Mitragynine;Pregabalin,-,Respiratory Arrest;Completed Suicide;Cardiac Arrest,Serious,Other Outcomes;Died;Hospitalized,Female,2020,2/16/2022,Expedited,36,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,2/10/2022,2/16/2022,US,Not Specified,US-PFIZER INC-202200254572,\"Gummin, D.. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):1282-1501\",-\\n20479986,-,Etizolam;Methamphetamine Hydrochloride;Herbals\\\\Mitragynine;Gabapentin;Morphine Sulfate;Fentanyl Citrate,-,Drug Abuse,Serious,Died,Female,2020,2/16/2022,Expedited,32,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,2/10/2022,2/16/2022,US,Not Specified,US-PFIZER INC-202200256075,\"Gummin, D.. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):1282-1501\",-\\n20486841,-,Gabapentin;Oxycodone;Herbals\\\\Mitragynine,-,Drug Abuse,Serious,Died,Female,2020,2/17/2022,Expedited,47,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,2/10/2022,2/17/2022,US,Not Specified,US-PFIZER INC-202200268604,\"Gummin, D.. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):1282-1501\",-\\n20492026,-,Sertraline Hydrochloride;Herbals\\\\Mitragynine,-,Drug Abuse,Serious,Died;Other Outcomes,Female,2020,2/18/2022,Expedited,51,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,2/10/2022,2/18/2022,US,Not Specified,US-PFIZER INC-202200250834,\"Gummin, D.. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):1282-1501\",-\\n20491050,Methadone,Methadone Hydrochloride;Sertraline Hydrochloride;Herbals\\\\Mitragynine,-,Drug Abuse,Serious,Other Outcomes;Died,Male,2020,2/18/2022,Expedited,40,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,2/10/2022,2/18/2022,US,Not Specified,US-PFIZER INC-202200255149,\"Gummin, D.. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):1282-1501\",-\\n20490453,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine;Sertraline Hydrochloride,-,Death,Serious,Died;Other Outcomes,Male,2020,2/18/2022,Expedited,41,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,2/10/2022,2/18/2022,US,Not Specified,US-PFIZER INC-202200263226,\"Gummin, D.. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):1282-1501\",-\\n14254346,Alcohol (Alcohol),Alcohol;U-47700;Bupropion;Herbals\\\\Mitragynine;Dextromethorphan;Diphenhydramine Hydrochloride,Product Used For Unknown Indication,Drug Abuse;Death;Cardio-Respiratory Arrest,Serious,Other Outcomes;Died,Male,2016,1/20/2022,Expedited,27,Not Specified,Glaxosmithkline,Healthcare Professional,Not Specified,-,1/20/2022,12/5/2017,US,Not Specified,US-GLAXOSMITHKLINE-US2017GSK183857,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 34th Annual Report. Clinical Toxicology. 2017;55(10):1072-1252\",-\\n17256722,Heroin;Sertraline,Bupropion;Sertraline Hydrochloride;Chlorpheniramine;Diamorphine;Codeine;Herbals\\\\Mitragynine;Dextromethorphan;Cocaine,Product Used For Unknown Indication,Overdose;Cardio-Respiratory Arrest;Suspected Suicide,Serious,Other Outcomes;Hospitalized;Died,Male,2018,1/21/2022,Expedited,32,Not Specified,Glaxosmithkline,Healthcare Professional,Not Specified,-,1/21/2022,1/10/2020,US,Not Specified,US-GLAXOSMITHKLINE-US2020GSK001760,\"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, Hashem HA, Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57 (12):1220-1413\",-\\n20466188,-,Gabapentin;Herbals\\\\Mitragynine;Oxycodone,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Female,-,2/13/2022,Expedited,47,Not Specified,Glenmark,Healthcare Professional,Not Specified,-,2/4/2022,2/13/2022,US,Not Specified,US-GLENMARK PHARMACEUTICALS-2022GMK070186,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J.. 2020 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 38th Annual Report.. Clinical Toxicology.. 2021;59 (12):1282-1501\",-\\n20466143,-,Herbals\\\\Mitragynine;Etizolam;Gabapentin;Methamphetamine;Morphine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Female,-,2/13/2022,Expedited,32,Not Specified,Glenmark,Healthcare Professional,Not Specified,-,2/4/2022,2/13/2022,US,Not Specified,US-GLENMARK PHARMACEUTICALS-2022GMK070156,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J.. 2020 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 38th Annual Report.. Clinical Toxicology.. 2021;59 (12):1282-1501\",-\\n20487842,Sertraline;Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Sertraline Hydrochloride;Amphetamine;Gabapentin;Atenolol,Product Used For Unknown Indication,Cardio-Respiratory Arrest;Completed Suicide,Serious,Died;Other Outcomes,Male,-,2/18/2022,Expedited,29,Not Specified,Glenmark,Healthcare Professional,Not Specified,-,2/4/2022,2/18/2022,US,Not Specified,US-GLENMARK PHARMACEUTICALS-2022GMK070476,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J.. 2020 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 38th Annual Report.. Clinical Toxicology.. 2021;59 (12):1282-1501\",-\\n20305631,-,Fentanyl;Clobazam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Female,-,1/6/2022,Non-Expedited,29,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/6/2022,US,Not Specified,US-APOTEX-2022AP000439,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20303503,-,Fentanyl;Methamphetamine Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/6/2022,Non-Expedited,24,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/6/2022,US,Not Specified,US-APOTEX-2022AP000271,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20309243,Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Female,-,1/7/2022,Non-Expedited,36,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/7/2022,US,Not Specified,US-APOTEX-2022AP000706,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20309076,-,Herbals\\\\Mitragynine;Oxycodone;Fentanyl;Oxymorphone,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,1/7/2022,Non-Expedited,29,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/7/2022,US,Not Specified,US-APOTEX-2022AP000434,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20308589,-,Methocarbamol;Etizolam;Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/7/2022,Non-Expedited,35,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/7/2022,US,Not Specified,US-APOTEX-2022AP000674,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20306968,-,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/7/2022,Non-Expedited,26,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/7/2022,US,Not Specified,US-APOTEX-2022AP000325,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20318548,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/10/2022,Non-Expedited,50,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/10/2022,US,Not Specified,US-APOTEX-2022AP001058,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20318403,-,Diazepam;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,1/10/2022,Non-Expedited,31,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/10/2022,US,Not Specified,US-APOTEX-2022AP000521,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20317763,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/10/2022,Non-Expedited,59,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/10/2022,US,Not Specified,US-APOTEX-2022AP001214,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20315563,-,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/10/2022,Non-Expedited,22,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/10/2022,US,Not Specified,US-APOTEX-2022AP000206,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20315459,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/10/2022,Non-Expedited,34,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/10/2022,US,Not Specified,US-APOTEX-2022AP000644,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20321650,-,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,1/11/2022,Non-Expedited,31,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/11/2022,US,Not Specified,US-APOTEX-2022AP000530,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20320856,-,Oxycodone;Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/11/2022,Non-Expedited,46,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/11/2022,US,Not Specified,US-APOTEX-2022AP000939,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20320466,-,Herbals\\\\Mitragynine;Oxycodone;Gabapentin,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Female,-,1/11/2022,Expedited,47,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/11/2022,US,Not Specified,US-APOTEX-2022AP000956,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20320402,-,Morphine;Gabapentin;Methamphetamine;Fentanyl;Etizolam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Female,-,1/11/2022,Expedited,32,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/11/2022,US,Not Specified,US-APOTEX-2022AP000577,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20327484,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine;Tramadol,Product Used For Unknown Indication,Completed Suicide,Serious,Died;Hospitalized;Other Outcomes,Male,2020,1/12/2022,Expedited,55,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/12/2022,US,Not Specified,US-APOTEX-2022AP001141,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20325320,Alcohol (Alcohol);Oxycodone And Acetaminophen,Acetaminophen\\\\Oxycodone Hydrochloride;Fentanyl;Alcohol;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse;Cardio-Respiratory Arrest,Serious,Hospitalized;Died;Other Outcomes,Male,2020,1/12/2022,Expedited,16,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/12/2022,US,Not Specified,US-APOTEX-2022AP000068,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20327433,-,Herbals\\\\Mitragynine;Fentanyl;Trazodone Hydrochloride,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,1/12/2022,Expedited,28,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/12/2022,US,Not Specified,US-APOTEX-2022AP000403,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20334866,-,Herbals\\\\Mitragynine;Fentanyl;Alprazolam,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/14/2022,Expedited,35,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/14/2022,US,Not Specified,US-APOTEX-2022AP000670,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20340958,Sertraline;Alcohol (Alcohol),Alcohol;Sertraline Hydrochloride;Amphetamine;Herbals\\\\Mitragynine;Atenolol;Gabapentin,Product Used For Unknown Indication,Completed Suicide;Cardio-Respiratory Arrest,Serious,Died;Other Outcomes;Hospitalized,Male,2020,1/17/2022,Expedited,29,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/17/2022,US,Not Specified,US-APOTEX-2022AP001855,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20340631,Promethazine,Promethazine Hydrochloride;Hydrochlorothiazide\\\\Triamterene;Herbals\\\\Mitragynine;Pregabalin,Product Used For Unknown Indication,Completed Suicide;Cardio-Respiratory Arrest,Serious,Hospitalized;Other Outcomes;Died,Female,2020,1/17/2022,Expedited,36,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/3/2022,1/17/2022,US,Not Specified,US-APOTEX-2022AP001864,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",-\\n20608291,-,Oxycodone;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Death,Serious,Other Outcomes;Died,Male,-,3/17/2022,Expedited,57,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,3/17/2022,US,Not Specified,US-ALVOGEN-2022-ALVOGEN-118971,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n20605579,Trazodone,Trazodone Hydrochloride;Herbals\\\\Mitragynine;Fentanyl,Drug Abuse,Drug Abuse,Serious,Died;Other Outcomes,Male,-,3/17/2022,Expedited,28,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,3/17/2022,US,Not Specified,US-ALVOGEN-2022-ALVOGEN-118740,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n20613979,-,Oxycodone;Herbals\\\\Mitragynine;Gabapentin,Drug Abuse,Drug Abuse,Serious,Other Outcomes;Died,Female,-,3/19/2022,Expedited,47,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,3/19/2022,US,Not Specified,US-ALVOGEN-2022-ALVOGEN-118997,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21722150,-,Fentanyl;Herbals\\\\Mitragynine,Drug Abuse,Drug Abuse,Serious,Died;Other Outcomes,Male,-,12/13/2022,Non-Expedited,59,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/13/2022,US,Not Specified,US-ALVOGEN-2022087308,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21722149,-,Fentanyl;Herbals\\\\Mitragynine,Drug Abuse,Drug Abuse,Serious,Died;Other Outcomes,Male,-,12/13/2022,Non-Expedited,50,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/13/2022,US,Not Specified,US-ALVOGEN-2022087302,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21722147,-,Fentanyl;Herbals\\\\Mitragynine,Drug Abuse,Drug Abuse,Serious,Other Outcomes;Died,Male,-,12/13/2022,Non-Expedited,22,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/13/2022,US,Not Specified,US-ALVOGEN-2022087293,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21722110,-,Acetaminophen\\\\Oxycodone Hydrochloride;Fentanyl;Alcohol;Herbals\\\\Mitragynine,Drug Abuse,Drug Abuse,Serious,Hospitalized;Died,Male,-,12/13/2022,Non-Expedited,16,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/13/2022,US,Not Specified,US-ALVOGEN-2022087020,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21721919,-,Fentanyl;Herbals\\\\Mitragynine,Drug Abuse,Drug Abuse,Serious,Died;Other Outcomes,Male,-,12/13/2022,Non-Expedited,34,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/13/2022,US,Not Specified,US-ALVOGEN-2022087221,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21721876,-,Oxycodone;Fentanyl;Herbals\\\\Mitragynine,Drug Abuse,Drug Abuse,Serious,Other Outcomes;Died,Male,-,12/13/2022,Non-Expedited,46,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/13/2022,US,Not Specified,US-ALVOGEN-2022087651,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21721743,-,Fentanyl;Herbals\\\\Mitragynine,Drug Abuse,Drug Abuse,Serious,Other Outcomes;Died,Male,-,12/13/2022,Non-Expedited,26,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/13/2022,US,Not Specified,US-ALVOGEN-2022087367,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21727524,-,Herbals\\\\Mitragynine;Oxycodone;Fentanyl;Oxymorphone,Drug Abuse,Drug Abuse,Serious,Died;Other Outcomes,Male,-,12/14/2022,Non-Expedited,29,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/14/2022,US,Not Specified,US-ALVOGEN-2022087411,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21727491,-,Fentanyl;Alprazolam;Herbals\\\\Mitragynine,Drug Abuse,Drug Abuse,Serious,Died;Other Outcomes,Male,-,12/14/2022,Non-Expedited,35,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/14/2022,US,Not Specified,US-ALVOGEN-2022086808,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21727084,-,Herbals\\\\Mitragynine;Alcohol;Fentanyl,Drug Abuse,Drug Abuse,Serious,Died;Other Outcomes,Female,-,12/14/2022,Non-Expedited,36,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/14/2022,US,Not Specified,US-ALVOGEN-2022087530,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21726997,-,Clobazam;Herbals\\\\Mitragynine;Fentanyl,Drug Abuse,Drug Abuse,Serious,Died;Other Outcomes,Female,-,12/14/2022,Non-Expedited,29,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/14/2022,US,Not Specified,US-ALVOGEN-2022087123,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21725394,-,Fentanyl;Herbals\\\\Mitragynine;Diazepam,Drug Abuse,Drug Abuse,Serious,Other Outcomes;Died,Male,-,12/14/2022,Non-Expedited,31,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/14/2022,US,Not Specified,US-ALVOGEN-2022087459,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21725228,-,Herbals\\\\Mitragynine;Fentanyl;Methamphetamine,Drug Abuse,Drug Abuse,Serious,Other Outcomes;Died,Male,-,12/14/2022,Non-Expedited,24,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/14/2022,US,Not Specified,US-ALVOGEN-2022086184,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21725014,-,Methocarbamol;Herbals\\\\Mitragynine;Fentanyl;Etizolam,Drug Abuse,Drug Abuse,Serious,Other Outcomes;Died,Male,-,12/14/2022,Non-Expedited,35,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/14/2022,US,Not Specified,US-ALVOGEN-2022087520,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n21724976,-,Herbals\\\\Mitragynine;Fentanyl,Drug Abuse,Drug Abuse,Serious,Other Outcomes;Died,Male,-,12/14/2022,Non-Expedited,31,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/4/2022,12/14/2022,US,Not Specified,US-ALVOGEN-2022087140,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",-\\n20354842,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine;Tramadol,Product Used For Unknown Indication,Completed Suicide,Serious,Died,Male,2020,1/20/2022,Expedited,55,Not Specified,Specgx,Healthcare Professional,Not Specified,-,12/13/2021,1/20/2022,US,Not Specified,US-SPECGX-T202102822,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ et al. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59(12):1282-501\",-\\n20360846,Heroin,Diamorphine;Herbals\\\\Mitragynine;Methylphenidate Hydrochloride,Product Used For Unknown Indication,Drug Abuse,Serious,Died,Male,2020,1/21/2022,Expedited,33,Not Specified,Specgx,Healthcare Professional,Not Specified,-,12/13/2021,1/21/2022,US,Not Specified,US-SPECGX-T202103469,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ et al. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59(12):1282-501\",-\\n20364710,\"Sertraline;Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate;Alcohol (Alcohol)\",Alcohol;Amphetamine Aspartate\\\\Amphetamine Sulfate\\\\Dextroamphetamine Saccharate\\\\Dextroamphetamine Sulfate;Sertraline Hydrochloride;Herbals\\\\Mitragynine;Gabapentin;Atenolol,Product Used For Unknown Indication,Completed Suicide,Serious,Died,Male,2020,1/22/2022,Expedited,29,Not Specified,Specgx,Healthcare Professional,Not Specified,-,12/13/2021,1/22/2022,US,Not Specified,US-SPECGX-T202103801,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ et al. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59(12):1282-501\",-\\n21484966,-,Herbals\\\\Mitragynine;Oxycodone;Gabapentin Enacarbil,Product Used For Unknown Indication,Toxicity To Various Agents;Drug Abuse,Serious,Died,Female,2020,10/20/2022,Expedited,47,Not Specified,Arbor,Healthcare Professional,Not Specified,-,10/10/2022,10/20/2022,US,Not Specified,\"US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB002347\",\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brinstein AC, Rivers LJ, et al.. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical toxicology. 2021;59(12):1282-1501\",-\\n21484910,-,Morphine;Gabapentin Enacarbil;Etizolam;Herbals\\\\Mitragynine;Fentanyl;Methamphetamine,Product Used For Unknown Indication,Drug Abuse;Toxicity To Various Agents,Serious,Died,Female,2020,10/20/2022,Expedited,32,Not Specified,Arbor,Healthcare Professional,Not Specified,-,10/10/2022,10/20/2022,US,Not Specified,\"US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB002327\",\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brinstein AC, Rivers LJ, et al.. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical toxicology. 2021;59(12):1282-1501\",-\\n21497197,Sertraline;Alcohol (Alcohol),Alcohol;Sertraline Hydrochloride;Atenolol;Amphetamine Sulfate;Gabapentin Enacarbil;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Cardio-Respiratory Arrest;Toxicity To Various Agents;Completed Suicide,Serious,Died,Male,2020,10/23/2022,Expedited,29,Not Specified,Arbor,Healthcare Professional,Not Specified,-,10/10/2022,10/23/2022,US,Not Specified,\"US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB002515\",\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brinstein AC, Rivers LJ, et al.. 2020 Annual Report of the American Association of Poison Control Centers\\' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59(12):1282-1501\",-\\n20471969,-,Herbals\\\\Mitragynine;Oxycodone Hydrochloride,Product Used For Unknown Indication,Respiratory Arrest;Cardiac Arrest;Toxicity To Various Agents,Serious,Died,Male,2020,2/14/2022,Expedited,57,Not Specified,Genus Lifesciences,Healthcare Professional,Not Specified,-,1/31/2022,2/14/2022,US,Not Specified,US-Genus_Lifesciences-USA-POI0580202200026,Gummin D. 2020 Annual Report of the American Association of Poison Control Centers National Poison Data Systems (NPDS) 38th Annual Report. Clinical Toxicology. 2021 DEC 10;59(12):1282-1501.,-\\n17893646,Buspirone;Trazodone,Trazodone Hydrochloride;Desvenlafaxine;Ziprasidone;Buspirone Hydrochloride;Bupropion;Herbals\\\\Mitragynine,Anxiety;Depression;Phytotherapy;Product Used For Unknown Indication,Herbal Interaction;Serotonin Syndrome,Serious,Other Outcomes;Hospitalized,Male,11-Apr-2018,8/17/2022,Expedited,63,102.5 KG,Apotex,Healthcare Professional,Not Specified,Diclofenac;Omeprazole;Metformin;Tizanidine;Amlodipine;Gabapentin;Hydrochlorothiazide;Glimepiride,8/5/2022,6/15/2020,US,Not Specified,US-APOTEX-2020AP012002,\"Eudaley ST, Hamilton LA. Case report: Successful treatment of suspected kratominduced serotonin syndrome.. JACCP Journal of the American College of Clinical Pharmacy. 2020;3 (1):347\",-\\n17921208,Trazodone;Buspirone,Buspirone Hydrochloride;Bupropion;Trazodone Hydrochloride;Herbals\\\\Mitragynine;Desvenlafaxine;Ziprasidone Hydrochloride,Depression;Product Used For Unknown Indication,Serotonin Syndrome;Drug Interaction,Serious,Other Outcomes,Not Specified,-,8/24/2022,Expedited,Not Specified,Not Specified,Zydus Pharm,Healthcare Professional,Not Specified,-,8/12/2022,6/22/2020,US,Not Specified,US-CADILA HEALTHCARE LIMITED-US-ZYDUS-052052,\"Eudaley ST, Hamilton LA. Case report: Successful treatment of suspected kratominduced serotonin syndrome. J-Am-Coll-Clin-Pharm. 2020;3(1)347:450\",-\\n17872686,Buspirone;Trazodone,Trazodone Hydrochloride;Buspirone Hydrochloride;Ziprasidone;Desvenlafaxine;Herbals\\\\Mitragynine;Bupropion,Bacteraemia;Major Depression;Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome;Product Use In Unapproved Indication,Serious,Other Outcomes;Hospitalized,Male,04-Nov-2018,8/15/2022,Expedited,63,102.5 KG,Novartis,Healthcare Professional,Not Specified,Glimepiride;Gabapentin;Hydrochlorothiazide;Omeprazole;Piperacillin And Tazobactam;Amlodipine;Cefepime;Metformin;Diclofenac;Vancomycin;Tizanidine;Ampicillin,8/9/2022,6/8/2020,US,Not Specified,NVSC2020US158992,\"Eudaley ST, Hamilton LA. Case report: Successful treatment of suspected kratom-induced serotonin syndrome. JOURNAL OF AMERICAN COLLEGE OF CLINICAL PHARMACY. 2020;3(1):347\",-\\n17874207,Buspirone;Trazodone,Trazodone Hydrochloride;Buspirone Hydrochloride;Desvenlafaxine;Bupropion Hydrochloride;Ziprasidone Hydrochloride;Herbals\\\\Mitragynine,Depression;Hypertension;Product Used For Unknown Indication;Type 2 Diabetes Mellitus,Drug Interaction;Serotonin Syndrome,Serious,Hospitalized;Other Outcomes,Male,-,11/23/2022,Expedited,63,102.5 KG,Lupin,Healthcare Professional,Not Specified,Gabapentin;Omeprazole;Metformin;Hydrochlorothiazide;Amlodipine;Glimepiride;Tizanidine;Diclofenac,11/11/2022,6/9/2020,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2020-02668,\"Eudaley ST, Hamilton LA. Case report: Successful treatment of suspected kratom induced serotonin syndrome. Journal of the American College of Clinical Pharmacy. 2020;3:347\",-\\n21159410,Buspirone;Trazodone,Buspirone Hydrochloride;Trazodone Hydrochloride;Desvenlafaxine;Bupropion;Herbals\\\\Mitragynine;Ziprasidone,Anxiety Disorder;Major Depression;Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes;Hospitalized,Male,2018,10/20/2022,Expedited,63,Not Specified,Cipla,Healthcare Professional,Not Specified,Amlodipine;Hydrochlorothiazide;Diclofenac;Gabapentin;Omeprazole;Glimepiride;Metformin;Tizanidine,10/10/2022,8/2/2022,US,Not Specified,US-CIPLA LTD.-2022US04708,\"Eudaley ST, Hamilton LA, Brooks SP. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. Journal of Pharmacy Practice. 2022;1 to 5\",-\\n21205413,Buspirone;Trazodone,Trazodone Hydrochloride;Ziprasidone;Buspirone Hydrochloride;Herbals\\\\Mitragynine;Desvenlafaxine,Product Used For Unknown Indication,Self-Medication;Drug Interaction;Serotonin Syndrome,Serious,Hospitalized;Other Outcomes,Not Specified,-,8/20/2022,Expedited,Not Specified,Not Specified,Macleods,Healthcare Professional,Not Specified,Diclofenac;Hydrochlorothiazide;Amlodipine;Omeprazole;Tizanidine;Metformin;Glimepiride;Gabapentin;Bupropion,8/9/2022,8/12/2022,US,Not Specified,US-MACLEODS PHARMACEUTICALS US LTD-MAC2022036805,\"Eudaley ST, Brooks SP, Hamilton LA.. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. Journal of pharmacy practice. 2022;1-5\",-\\n21169852,-,Herbals\\\\Mitragynine;Desvenlafaxine;Bupropion;Buspirone Hydrochloride;Trazodone Hydrochloride,Product Used For Unknown Indication,Herbal Interaction;Serotonin Syndrome;Drug Interaction,Serious,Other Outcomes;Hospitalized,Male,-,8/4/2022,Expedited,63,102.5 KG,Oxford Pharmaceuticals,Healthcare Professional,Not Specified,Amlodipine;Metformin;Hydrochlorothiazide;Tizanidine;Glimepiride;Gabapentin;Omeprazole;Diclofenac,7/20/2022,8/4/2022,US,Not Specified,\"US-Oxford Pharmaceuticals, LLC-2131507\",\"Eudaley ST, Brooks SP, Hamilton LA. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. Journal of Pharmacy Practice. 2022 Jul 15:08971900221116009.\",-\\n21160764,Buspirone;Trazodone,Bupropion;Trazodone Hydrochloride;Buspirone Hydrochloride;Desvenlafaxine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Serotonin Syndrome;Drug Interaction;Herbal Interaction,Serious,Hospitalized,Male,-,8/2/2022,Expedited,63,102.5 KG,Alvogen,Healthcare Professional,Not Specified,Gabapentin;Metformin;Diclofenac;Hydrochlorothiazide;Amlodipine;Tizanidine;Glimepiride;Omeprazole,7/20/2022,8/2/2022,US,Not Specified,US-ALVOGEN-2022-ALVOGEN-120686,\"Eudaley ST, Brooks SP, Hamilton LA. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. J Pharm Pract. 2022 Jul 15:8971900221116009. doi: 10.1177/08971900221116009. Epub ahead of print. PMID: 35840540.\",-\\n21138096,-,Herbals\\\\Mitragynine;Trazodone Hydrochloride;Buspirone Hydrochloride;Desvenlafaxine;Ziprasidone Hydrochloride,Anxiety Disorder;Hypertension;Major Depression;Product Used For Unknown Indication;Type 2 Diabetes Mellitus,Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes;Hospitalized,Male,-,7/27/2022,Expedited,63,102.5 KG,Accord,Healthcare Professional,Not Specified,Glimepiride;Omeprazole;Amlodipine;Metformin;Tizanidine;Hydrochlorothiazide;Bupropion;Gabapentin;Diclofenac,7/17/2022,7/27/2022,US,Not Specified,US-Accord-270588,\"Eudaley ST, Brooks SP, Hamilton LA. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. J Pharm Pract. 2022 Jul 15:8971900221116009.\",-\\n17883627,Buspirone;Trazodone,Trazodone Hydrochloride;Buspirone Hydrochloride;Herbals\\\\Mitragynine;Desvenlafaxine;Bupropion;Ziprasidone,Depression,Drug Interaction;Serotonin Syndrome,Serious,Hospitalized;Other Outcomes,Male,-,8/14/2022,Expedited,63,Not Specified,Dr Reddys,Healthcare Professional,Not Specified,-,8/5/2022,6/11/2020,US,Not Specified,US-drreddys-USA/USA/20/0123997,\"Eudaley S, Hamilton L. Case report: Successful treatment of suspected kratominduced serotonin syndrome. JACCP Journal of the American College of Clinical Pharmacy. 2020;3(1):347-347. doi:10.1002/jac5.1204\",-\\n21184754,Buspirone;Trazodone,Bupropion Hydrochloride;Trazodone Hydrochloride;Ziprasidone;Buspirone Hydrochloride;Desvenlafaxine;Herbals\\\\Mitragynine,Anxiety;Depression,Confusional State;Hyperreflexia;Hyperthermia;Blood Lactic Acid Increased;Drug Interaction;Clonus;Blood Creatine Phosphokinase Increased;Dysarthria;Facial Paralysis;Flushing;Tremor;Serotonin Syndrome;Hyperhidrosis;Aphasia,Serious,Other Outcomes;Hospitalized,Not Specified,-,10/12/2022,Expedited,Not Specified,Not Specified,Alembic,Healthcare Professional,Not Specified,-,9/28/2022,8/8/2022,US,Not Specified,US-ALEMBIC PHARMACUETICALS LIMITED-2022SCAL000361,\"Eudaley S, Brooks S, Hamilton L.. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. Journal of Pharmacy Practice. 2022\",-\\n21515536,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine;Quetiapine,Product Used For Unknown Indication,Drug Interaction;Electrocardiogram Qt Prolonged;Serotonin Syndrome,Serious,Other Outcomes,Male,2022,10/27/2022,Expedited,36,Not Specified,Osmotica,Healthcare Professional,Not Specified,-,10/18/2022,10/27/2022,US,Not Specified,US-Osmotica_Pharmaceutical_US_LLC-POI0573202200110,Burns A. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine Naloxone. Journal of Addiction Medicine. 2022 SEP;16(5):606-609.,-\\n20587236,-,Quetiapine Fumarate;Herbals\\\\Mitragynine;Venlafaxine Hydrochloride,Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome;Drug Level Above Therapeutic;Antidepressant Drug Level Above Therapeutic;Electrocardiogram Abnormal;Herbal Interaction;Electrocardiogram Qt Prolonged;Antipsychotic Drug Level Above Therapeutic,Serious,Other Outcomes,Male,-,5/12/2022,Expedited,36,Not Specified,Dr Reddys,Healthcare Professional,Not Specified,-,5/4/2022,3/14/2022,US,Not Specified,US-drreddys-SPO/USA/22/0147506,\"Burns A, Brogdon H, McPhee M, Paine M, Cox E. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J Addict Med. 2022;UNK:UNK-UNK. doi:10.1097/ADM.0000000000000968\",-\\n20565119,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine;Quetiapine,-,Drug Interaction;Dizziness;Electrocardiogram Qt Prolonged;Serotonin Syndrome,Serious,Other Outcomes;Hospitalized,Male,-,3/8/2022,Expedited,36,Not Specified,Dexcel,Healthcare Professional,Not Specified,-,2/22/2022,3/8/2022,US,Not Specified,US-DEXPHARM-20220213,\"Brogdon, H. D., McPhee, M. M., Paine, M. F., Cox, E. J., & Burns, A. G. (2022). A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. Journal of addiction medicine, 10.1097/ADM.0000000000000968. Advance online publication. https://doi.org/10.1097/ADM.0000000000000968\",-\\n20588988,Venlafaxine,Venlafaxine Hydrochloride;Quetiapine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Electrocardiogram Qt Prolonged;Electrocardiogram Abnormal;Drug Level Above Therapeutic;Antidepressant Drug Level Above Therapeutic;Antipsychotic Drug Level Above Therapeutic;Herbal Interaction;Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes,Male,-,5/17/2022,Expedited,36,Not Specified,Aurobindo,Healthcare Professional,Not Specified,Buprenorphine\\\\Naloxone,5/4/2022,3/14/2022,US,Not Specified,US-AUROBINDO-AUR-APL-2022-007142,\"Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG.. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone.. Journal of addiction medicine. 2022\",-\\n20545251,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine;Quetiapine,Product Used For Unknown Indication;Substance Use Disorder,Electrocardiogram Change;Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes,Male,-,3/3/2022,Expedited,36,Not Specified,Atlantide Pharmaceuticals Ag,Healthcare Professional,Not Specified,-,2/23/2022,3/3/2022,US,Not Specified,US-ATLANTIDE PHARMACEUTICALS AG-2022ATL000010,\"Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone.. J Addict Med. 2022;00\",-\\n20601265,Venlafaxine,Venlafaxine Hydrochloride;Buprenorphine Hydrochloride\\\\Naloxone Hydrochloride;Quetiapine;Herbals\\\\Mitragynine,Drug Use Disorder;Product Used For Unknown Indication;Substance Use Disorder,Drug Level Above Therapeutic;Off Label Use;Serotonin Syndrome;Drug Interaction;Electrocardiogram Qt Prolonged,Serious,Hospitalized,Male,-,3/16/2022,Expedited,36,Not Specified,Mylan,Healthcare Professional,Not Specified,Buprenorphine\\\\Naloxone,3/7/2022,3/16/2022,US,Not Specified,US-MYLANLABS-2022M1019572,\"Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J-Addict-Med 2022;null:null.\",-\\n20631085,Venlafaxine,Venlafaxine Hydrochloride;Quetiapine;Herbals\\\\Mitragynine,Drug Use Disorder;Product Used For Unknown Indication,Intentional Product Misuse;Drug Interaction;Serotonin Syndrome;Electrocardiogram Qt Prolonged,Serious,Hospitalized,Male,-,4/7/2022,Expedited,36,Not Specified,Teva,Healthcare Professional,Not Specified,-,3/30/2022,3/24/2022,US,Not Specified,US-TEVA-2022-US-2018997,\"Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J-Addict-Med 2022;:.\",-\\n20506147,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine;Quetiapine,Product Used For Unknown Indication,Sinus Tachycardia;Drug Level Increased;Serotonin Syndrome;Electrocardiogram Qt Prolonged;Drug Interaction,Serious,Other Outcomes;Hospitalized,Male,-,2/23/2022,Expedited,36,Not Specified,Cadila,Healthcare Professional,Not Specified,-,2/17/2022,2/23/2022,US,Not Specified,US-CPL-002766,\"Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J Addict Med. 2022 Feb 14.\",-\\n20517346,Venlafaxine,Venlafaxine Hydrochloride;Quetiapine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Interaction;Electrocardiogram Qt Prolonged;Serotonin Syndrome;Sinus Tachycardia;Drug Level Increased,Serious,Other Outcomes;Hospitalized,Male,-,3/9/2022,Expedited,36,Not Specified,Accord,Healthcare Professional,Not Specified,-,3/2/2022,2/25/2022,US,Not Specified,US-Accord-255103,\"Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J Addict Med. 2022 Feb 14.\",-\\n20545337,-,Herbals\\\\Mitragynine;Venlafaxine Hydrochloride;Quetiapine,Product Used For Unknown Indication,Drug Level Increased;Toxicity To Various Agents;Drug Interaction;Long Qt Syndrome;Serotonin Syndrome,Serious,Hospitalized,Male,-,3/3/2022,Expedited,36,Not Specified,Emcure,Healthcare Professional,Not Specified,-,2/22/2022,3/3/2022,US,Not Specified,US-AVET LIFESCIENCES LTD-2022-AVET-000038,\"Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J Addict Med. 2022\",-\\n20583134,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine;Quetiapine,-,Drug Interaction;Electrocardiogram Qt Prolonged;Serotonin Syndrome,Serious,Other Outcomes,Male,-,3/11/2022,Expedited,36,Not Specified,Jubilant,Healthcare Professional,Not Specified,-,2/28/2022,3/11/2022,US,Not Specified,US-JUBILANT CADISTA PHARMACEUTICALS-2022JUB00051,\"Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J Addict Med. 2022\",-\\n20531342,Venlafaxine,Venlafaxine Hydrochloride;Quetiapine;Herbals\\\\Mitragynine,Drug Abuse;Drug Use Disorder;Product Used For Unknown Indication,Toxicity To Various Agents;Drug Interaction;Electrocardiogram Qt Prolonged;Electrocardiogram Abnormal;Serotonin Syndrome;Drug Use Disorder;Antipsychotic Drug Level Above Therapeutic;Antidepressant Drug Level Above Therapeutic;Herbal Interaction,Serious,Other Outcomes,Not Specified,-,5/18/2022,Expedited,Not Specified,Not Specified,Macleods,Healthcare Professional,Not Specified,Buprenorphine\\\\Naloxone,5/4/2022,3/1/2022,US,Not Specified,US-MACLEODS PHARMACEUTICALS US LTD-MAC2022034574,\"Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. American Society of Addiction Medicine. 2022;00:00\",-\\n20581439,Venlafaxine,Venlafaxine Hydrochloride;Quetiapine Fumarate;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Electrocardiogram Qt Prolonged;Drug Interaction;Serotonin Syndrome;Antipsychotic Drug Level Above Therapeutic;Electrocardiogram Abnormal;Herbal Interaction,Serious,Other Outcomes;Hospitalized,Male,-,5/16/2022,Expedited,36,Not Specified,Lupin,Healthcare Professional,Not Specified,-,5/4/2022,3/11/2022,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2022-03085,\"Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A case of potential pharmacokinetic kratom-drug interactions resulting in toxicity and subsequent treatment of kratom use disorder with buprenorphine/naloxone. American Society of Addiction Medicine. 2022\",-\\n20863949,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine;Quetiapine,-,Serotonin Syndrome;Drug Interaction;Electrocardiogram Qt Prolonged,Serious,Hospitalized,Male,-,5/23/2022,Expedited,36,Not Specified,Astrazeneca,Healthcare Professional,Not Specified,-,5/15/2022,5/23/2022,Not Specified,Not Specified,US-AstraZeneca-2022A187677,Brogdon H.D.; McPhee M.M.; Paine M.F.; Cox E.J.; Burns A.G.. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. Journal of addiction medicine 2022;,-\\n20584138,Venlafaxine,Quetiapine;Venlafaxine Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Serotonin Syndrome;Drug Interaction;Electrocardiogram Qt Prolonged;Drug Level Above Therapeutic,Serious,Other Outcomes,Male,-,5/10/2022,Expedited,36,Not Specified,Bausch And Lomb,Healthcare Professional,Not Specified,-,5/4/2022,3/11/2022,US,Not Specified,US-BAUSCH-BL-2022-006009,\"Brogdon H, McPhee M, Paine M, Cox E, Burns A. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. Journal of Addiction Medicine. 2022;1-4. doi:1097/ADM.0000000000000968\",-\\n19826544,Hydrocodone Bitartrate And Acetaminophen,Acetaminophen\\\\Hydrocodone Bitartrate;Oxycodone;Escitalopram Oxalate;Herbals\\\\Mitragynine;Alprazolam;Tramadol;Hydrocodone,Anxiety;Back Pain;Depression;Drug Withdrawal Syndrome;Intervertebral Disc Degeneration,Depression;Drug Use Disorder;Drug Ineffective;Drug Withdrawal Syndrome;Anxiety;Intentional Overdose;Drug Dependence;Drug Tolerance;Intentional Product Misuse,Serious,Hospitalized;Other Outcomes,Male,-,6/20/2022,Expedited,\"45,996\",Not Specified,Lupin,Healthcare Professional,Not Specified,-,6/7/2022,9/14/2021,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2021-17175,\"Bowe A, Kerr PL. A complex case of kratom dependence, depression, and chronic pain in opioid use disorder: effects of buprenorphine in clinical management. Journal of Psychoactive Drugs. 2020;52(5):447-452\",-\\n21203367,Qdolo,Tramadol Hydrochloride;Herbals\\\\Mitragynine,Pain,Cognitive Disorder;Hypokalaemia;Electrocardiogram Qt Prolonged;Toxicity To Various Agents;Generalised Tonic-Clonic Seizure,Serious,Hospitalized,Not Specified,-,8/11/2022,Expedited,Not Specified,Not Specified,Athena,Healthcare Professional,Not Specified,-,8/3/2022,8/11/2022,US,Not Specified,US-SABAL THERAPEUTICS LLC-2022-ATH-000014,\"Beresford T., Keffler C., Wasserstein M., Ronan P.. Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63:S:S69\",-\\n21219728,-,Tramadol;Herbals\\\\Mitragynine,Pain,Mood Swings;Loss Of Consciousness;Fall;Toxicity To Various Agents;Electrocardiogram Qt Prolonged;Cognitive Disorder;Drug Interaction;Generalised Tonic-Clonic Seizure;Hypokalaemia;Delirium,Serious,Hospitalized;Other Outcomes,Male,-,8/17/2022,Expedited,\"45,994\",Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,8/5/2022,8/17/2022,US,Not Specified,US-AUROBINDO-AUR-APL-2022-032197,\"Beresford T, Keffler C, Wasserstein M, Ronan P.. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report.. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63Supplement:S69-70\",-\\n21213865,-,Tramadol;Herbals\\\\Mitragynine,Pain,Electrocardiogram Qt Prolonged;Toxicity To Various Agents;Cognitive Disorder;Generalised Tonic-Clonic Seizure;Hypokalaemia,Serious,Hospitalized;Other Outcomes,Male,-,8/16/2022,Expedited,Not Specified,Not Specified,Apotex,Healthcare Professional,Not Specified,-,8/3/2022,8/16/2022,US,Not Specified,US-APOTEX-2022AP010924,\"Beresford T, Keffler C, Wasserstein M, Ronan P.. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report.. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63:S69-S70\",-\\n21199821,-,Herbals\\\\Mitragynine;Tramadol,Pain,Cognitive Disorder;Hypokalaemia;Affective Disorder;Electrocardiogram Qt Prolonged;Drug Interaction;Toxicity To Various Agents;Seizure,Serious,Hospitalized,Male,-,8/11/2022,Expedited,\"45,994\",Not Specified,Strides,Healthcare Professional,Not Specified,-,8/3/2022,8/11/2022,US,Not Specified,US-STRIDES ARCOLAB LIMITED-2022SP010158,\"Beresford T, Keffler C, Wasserstein M, Ronan P.. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report.. J-Acad-Consult-Liaison-Psychiatry. 2022;63 (Suppl.):S69-S70 abstr. PO-152.\",-\\n21214315,-,Tramadol;Herbals\\\\Mitragynine,Pain,Drug Interaction;Hypokalaemia;Delirium;Toxicity To Various Agents;Loss Of Consciousness;Mood Swings;Fall;Cognitive Disorder;Electrocardiogram Qt Prolonged;Generalised Tonic-Clonic Seizure,Serious,Hospitalized;Other Outcomes,Male,-,8/16/2022,Expedited,\"45,994\",Not Specified,Lupin,Healthcare Professional,Not Specified,-,8/3/2022,8/16/2022,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2022-10203,\"Beresford T, Keffler C, Wasserstein M, Ronan P. Kratom Tramadol toxicity with seizure, hypokalemia, marked q-t prolongation, and cognitive impairment: A case report. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63:S69-S70\",-\\n21225453,-,Tramadol;Herbals\\\\Mitragynine,Pain,Toxicity To Various Agents;Hypokalaemia;Cognitive Disorder;Generalised Tonic-Clonic Seizure;Electrocardiogram Qt Prolonged,Serious,Hospitalized;Other Outcomes,Male,-,8/18/2022,Expedited,\"45,994\",Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,8/3/2022,8/18/2022,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-348953,\"Beresford T, Keffler C, Wasserstein M, Ronan P. Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report. J Acad Consult Liaison Psychiatry. 2022;63 (Suppl.):S69-70(Abstract ID:PO-152)\",-\\n21223322,-,Herbals\\\\Mitragynine;Tramadol,Pain,Electrocardiogram Qt Prolonged;Mood Swings;Fall;Toxicity To Various Agents;Delirium;Loss Of Consciousness;Cognitive Disorder;Hypokalaemia;Drug Interaction;Generalised Tonic-Clonic Seizure,Serious,Hospitalized;Other Outcomes,Not Specified,-,8/17/2022,Expedited,Not Specified,Not Specified,Macleods,Healthcare Professional,Not Specified,-,8/5/2022,8/17/2022,US,Not Specified,US-MACLEODS PHARMACEUTICALS US LTD-MAC2022036828,\"Beresford T, Keffler C, Wasserstein M, Ronan P. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63:S69-70\",-\\n21278982,-,Herbals\\\\Mitragynine;Tramadol Hydrochloride,Pain,Toxicity To Various Agents;Generalised Tonic-Clonic Seizure;Cognitive Disorder;Drug Interaction;Electrocardiogram Qt Prolonged;Hypokalaemia,Serious,Hospitalized;Other Outcomes,Male,-,9/1/2022,Expedited,Not Specified,Not Specified,Aci Healthcare,Healthcare Professional,Not Specified,-,8/19/2022,9/1/2022,US,Not Specified,US-ACI HealthCare Limited-2132444,\"Beresford T, Keffler C, Wasserstein M, Ronan P. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report. Journal of the Academy of Consultation-Liaison Psychiatry 63 (Suppl.): S69-S70 abstr. PO-152, May 2022. URL: http://doi.org/10.1016/j.jaclp.2022.03.145\",-\\n21252250,-,Herbals\\\\Mitragynine;Tramadol,Pain,Electrocardiogram Qt Prolonged;Drug Interaction;Cognitive Disorder;Seizure;Hypokalaemia,Serious,Other Outcomes,Not Specified,-,8/25/2022,Expedited,Not Specified,Not Specified,Zydus Pharm,Healthcare Professional,Not Specified,-,8/12/2022,8/25/2022,US,Not Specified,US-CADILA HEALTHCARE LIMITED-US-ZYDUS-081624,\"Beresford T, Keffler C, Wasserstein M, Ronan P. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report. J-Acad-Consult-Liaison-Psychiatry. 2022;63 (Suppl.:S69-S70 abstr. PO-152\",-\\n21203414,-,Herbals\\\\Mitragynine;Tramadol,Pain,Toxicity To Various Agents;Hypokalaemia;Overdose;Electrocardiogram Qt Prolonged;Drug Interaction;Generalised Tonic-Clonic Seizure;Cognitive Disorder,Serious,Hospitalized,Male,-,8/11/2022,Expedited,\"45,994\",Not Specified,Mylan,Healthcare Professional,Not Specified,-,8/3/2022,8/11/2022,US,Not Specified,US-MYLANLABS-2022M1085118,\"Beresford T, Keffler C, Wasserstein M, Ronan P. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report. J-Acad-Consult-Liaison-Psychiatry 2022;63 (Suppl.):S69-S70 abstr. PO-152.\",-\\n21459528,-,Herbals\\\\Mitragynine,Anxiety,Seizure;Dependence,Serious,Other Outcomes,Male,25-Feb-2022,10/14/2022,Direct,29,60.75 KG,Fda-Ctu,Consumer,Not Specified,Zonisamide;Lamotrigine,-,10/14/2022,Not Specified,Not Specified,-,-,-\\n21327833,-,Herbals\\\\Mitragynine,Anxiety;Depression,Appetite Disorder;Skin Burning Sensation;Palpitations;Withdrawal Syndrome;Loss Of Personal Independence In Daily Activities;Pain;Weight Decreased;Vomiting;Tremor;Dependence;Cold Sweat,Serious,Other Outcomes,Female,01-Jan-2018,9/12/2022,Direct,36,63 KG,Fda-Ctu,Consumer,Not Specified,Vitamin D3;Vitamin B12;Magnesium,-,9/12/2022,Not Specified,Y,-,-,-\\n21296835,-,Herbals\\\\Mitragynine,Analgesic Therapy,Legal Problem;Drug Dependence;Imprisonment,Serious,Other Outcomes,Male,15-Jun-2019,9/3/2022,Direct,33,76.5 KG,Fda-Ctu,Consumer,Not Specified,Suboxone,-,9/3/2022,Not Specified,Not Specified,-,-,-\\n20832558,-,Herbals\\\\Mitragynine,Anxiety,Anxiety;Hypertension;Chest Pain;Restless Legs Syndrome,Serious,Disabled,Female,13-May-2022,5/14/2022,Direct,45,55.8 KG,Fda-Ctu,Consumer,Not Specified,Prozac,-,5/14/2022,Not Specified,Not Specified,-,-,-\\n20642682,-,Herbals\\\\Mitragynine,Asthenia,Euphoric Mood;Dependence;Psychotic Disorder,Serious,Other Outcomes,Male,01-Mar-2022,3/27/2022,Direct,47,121.5 KG,Fda-Ctu,Consumer,Not Specified,Paxil;Buspar;Vasotec,-,3/27/2022,Not Specified,Not Specified,-,-,-\\n20713303,-,Herbals\\\\Mitragynine,Fatigue,Adverse Drug Reaction;Blood Potassium Decreased;Drug Dependence;Product Complaint,Serious,Other Outcomes,Female,18-Oct-2020,4/14/2022,Direct,52,62.1 KG,Fda-Ctu,Consumer,Not Specified,Magnesium;Vitamin C;Vitamin B,-,4/14/2022,Not Specified,Not Specified,-,-,-\\n21699300,-,Herbals\\\\Mitragynine,-,Dependence;Generalised Tonic-Clonic Seizure;Weight Decreased;Drug Abuser;Vomiting,Serious,Required Intervention;Life Threatening,Male,26-Sep-2022,12/7/2022,Direct,25,60.75 KG,Fda-Ctu,Consumer,Not Specified,Lamictal;Prozac,-,12/7/2022,Not Specified,Not Specified,-,-,-\\n21656492,-,Herbals\\\\Mitragynine,Substance Use,Death,Serious,Died,Female,26-Nov-2022,11/28/2022,Direct,40,Not Specified,Fda-Ctu,Consumer,Not Specified,Herbals\\\\Mitragynine;Atorvastatin;Famotidine;Melatonin;Cephalexin;Benadryl;Risperidone,-,11/28/2022,Not Specified,Not Specified,-,-,-\\n20320849,-,Herbals\\\\Mitragynine,Anxiety,Overdose;Drug Screen Positive;Blood Caffeine Increased;Cardiovascular Disorder;Hepatic Steatosis;Obesity;Substance Use;Arteriosclerosis;Dilated Cardiomyopathy,Serious,Died,Male,01-Jun-2021,1/10/2022,Direct,38,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,Doxepin,-,1/10/2022,Not Specified,Not Specified,-,-,-\\n21416543,-,Herbals\\\\Mitragynine,Pain,Drug Withdrawal Syndrome;Restlessness;Dependence;Nervousness,Non-Serious,Non-Serious,Female,30-Sep-2021,10/5/2022,Direct,57,54 KG,Fda-Ctu,Consumer,Not Specified,Cannabis Sativa Subsp. Indica Top;Magnesium;Ativan;Duloxetine;Whey;Cannabidiol\\\\Herbals;Vitamin D2;Gabapentin;Lipitor,-,10/5/2022,Not Specified,Not Specified,-,-,-\\n21026779,-,Herbals\\\\Mitragynine,Anxiety,Vomiting;Food Poisoning;Nausea,Non-Serious,Non-Serious,Female,22-May-2022,6/29/2022,Direct,42,Not Specified,Fda-Ctu,Consumer,Not Specified,Calcium;Glucosamine;Famotidine;Collagen;Yaz;Vitamin D,-,6/29/2022,Not Specified,Y,-,-,-\\n21177773,-,Herbals\\\\Mitragynine,-,Death;Toxicity To Various Agents,Serious,Died,Male,31-May-2022,8/5/2022,Direct,31,Not Specified,Fda-Ctu,Consumer,Not Specified,Benadryl,-,8/5/2022,Not Specified,Not Specified,-,-,-\\n21628069,-,Herbals\\\\Mitragynine,Phytotherapy,Somnolence;Heart Rate Increased,Non-Serious,Non-Serious,Female,06-Nov-2022,11/21/2022,Direct,36,Not Specified,Fda-Ctu,Consumer,Not Specified,Arginine;Fish Oil;Vitamins;Valerian;Theanine;Flax Seed,-,11/21/2022,Not Specified,Y,-,-,-\\n20906522,-,Herbals\\\\Mitragynine,Rheumatoid Arthritis,Unresponsive To Stimuli;Toxicity To Various Agents;Hypertension;Respiratory Depression;Withdrawal Syndrome,Serious,Hospitalized;Other Outcomes;Life Threatening,Female,12-Jan-2022,6/2/2022,Direct,44,63 KG,Fda-Ctu,Consumer,Not Specified,Ambien;Clonidine;Seroquel;Buspirone;Vitamins;Nexium,-,6/2/2022,Not Specified,Not Specified,-,-,-\\n20485465,-,Herbals\\\\Mitragynine,Attention Deficit Hyperactivity Disorder;Bipolar Disorder;Substance Abuse,Mania;Vomiting;Neuralgia;Impaired Quality Of Life;Drug Dependence;Withdrawal Syndrome;Hostility;Psychotic Disorder;Restless Legs Syndrome;Hyperhidrosis,Serious,Hospitalized;Required Intervention,Male,26-Nov-2021,2/17/2022,Direct,29,57.15 KG,Fda-Ctu,Consumer,Not Specified,Abilify;Adderall,-,2/17/2022,Not Specified,Not Specified,-,-,-\\n20420716,Rexulti,Brexpiprazole;Herbals\\\\Mitragynine,Emotional Disorder,Peripheral Coldness;Drug Interaction;Nausea;Heart Rate Increased;Syncope;Headache,Serious,Other Outcomes,Not Specified,01-Feb-2022,2/2/2022,Direct,21,45 KG,Fda-Ctu,Consumer,Not Specified,-,-,2/2/2022,Not Specified,Not Specified,-,-,-\\n20438777,-,Gabapentin;Fentanyl;Herbals\\\\Mitragynine;Etizolam;Methamphetamine;Morphine Sulfate,Drug Abuse,Exposure To Toxic Agent,Serious,Died,Female,2020,2/7/2022,Expedited,32,Not Specified,Galpharm International,Healthcare Professional,Not Specified,-,2/3/2022,2/7/2022,US,Not Specified,US-PERRIGO-22US001641,-,-\\n20466055,Concerta;Heroin,Diamorphine;Herbals\\\\Mitragynine;Methylphenidate Hydrochloride,Product Used For Unknown Indication,Toxicity To Various Agents;Drug Abuse,Serious,Died,Male,-,2/12/2022,Expedited,33,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,1/31/2022,2/12/2022,US,Not Specified,US-JNJFOC-20220218829,-,-\\n20490631,-,Alcohol;Herbals\\\\Mitragynine,Alcoholism;Product Used For Unknown Indication;Self-Medication,Ammonia Increased;Liver Disorder;Aggression;Constipation;Confusional State;Weight Decreased;Hypothyroidism;Insomnia,Non-Serious,Non-Serious,Female,-,2/18/2022,Direct,30,120 LB,Fda-Ctu,Consumer,Not Specified,-,-,2/18/2022,Not Specified,Not Specified,-,-,-\\n20566946,Robaxin,Methocarbamol;Etizolam;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died,Male,2020,3/8/2022,Expedited,35,Not Specified,Endo,Healthcare Professional,Not Specified,-,2/22/2022,3/8/2022,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2022-001248,-,-\\n20586698,Percocet;Alcohol (Alcohol),Alcohol;Acetaminophen\\\\Oxycodone Hydrochloride;Benzodiazepine;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse;Cardio-Respiratory Arrest,Serious,Died,Male,2020,3/13/2022,Expedited,16,Not Specified,Endo,Healthcare Professional,Not Specified,-,2/22/2022,3/13/2022,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2022-001222,-,-\\n20619042,-,Diazepam;Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died,Male,2020,3/22/2022,Expedited,31,Not Specified,Endo,Healthcare Professional,Not Specified,-,2/22/2022,3/22/2022,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2022-001574,-,-\\n20570100,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine;Quetiapine,Opioid Sparing Treatment;Product Used For Unknown Indication,Electrocardiogram Qt Prolonged;Serotonin Syndrome;Drug Interaction;Drug Level Above Therapeutic,Serious,Other Outcomes,Male,-,3/24/2022,Expedited,36,Not Specified,Unichem,Healthcare Professional,Not Specified,-,3/11/2022,3/9/2022,Not Specified,Not Specified,US-Unichem Pharmaceuticals (USA) Inc-UCM202203-000202,-,-\\n20552469,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine;Quetiapine,Product Used For Unknown Indication,Drug Interaction;Herbal Interaction;Serotonin Syndrome;Antipsychotic Drug Level Above Therapeutic;Electrocardiogram Abnormal;Toxicity To Various Agents;Antidepressant Drug Level Above Therapeutic;Electrocardiogram Qt Prolonged,Serious,Other Outcomes,Male,-,5/13/2022,Expedited,36,Not Specified,Torrent,Healthcare Professional,Not Specified,-,5/4/2022,3/4/2022,US,Not Specified,US-TORRENT-00011765,-,-\\n20587441,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine;Quetiapine,Product Used For Unknown Indication,Drug Level Above Therapeutic;Serotonin Syndrome;Drug Interaction;Electrocardiogram Qt Prolonged,Serious,Other Outcomes,Male,-,5/18/2022,Expedited,36,Not Specified,Hikma,Healthcare Professional,Not Specified,-,5/4/2022,3/14/2022,Not Specified,Not Specified,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-56956,-,-\\n20951894,Zoloft,Sertraline Hydrochloride;Herbals\\\\Mitragynine,Anxiety,Toxicity To Various Agents;Drug Abuser,Serious,Died,Male,03-May-2022,6/11/2022,Direct,39,81 KG,Fda-Ctu,Consumer,Not Specified,Aripiprazole;Bupropion Hydrochloride;Sertraline,-,6/11/2022,Not Specified,Not Specified,-,-,-\\n16717258,Valtrex,Valacyclovir Hydrochloride;Albuterol;Loratadine;Ranitidine;Herbals\\\\Mitragynine;Acetaminophen\\\\Methocarbamol;Citalopram Hydrobromide;Diphenhydramine,Product Used For Unknown Indication,Maternal Exposure During Pregnancy;Caesarean Section,Serious,Other Outcomes,Female,-,7/5/2022,Expedited,Not Specified,Not Specified,Allergan,Healthcare Professional,Not Specified,-,6/28/2022,8/19/2019,CA,Not Specified,CA-ALLERGAN-1933436US,-,-\\n16717179,-,Albuterol;Valacyclovir Hydrochloride;Herbals\\\\Mitragynine;Ranitidine;Diphenhydramine;Methocarbamol;Citalopram Hydrobromide;Acetaminophen;Loratadine,Exposure During Pregnancy;Product Used For Unknown Indication,Foetal Exposure During Pregnancy;Drug Withdrawal Syndrome Neonatal,Serious,Other Outcomes;Hospitalized,Female,-,7/11/2022,Expedited,Not Specified,3.68 KG,Allergan,Healthcare Professional,Not Specified,-,6/28/2022,8/19/2019,CA,Not Specified,CA-ALLERGAN-1933574US,-,-\\n21133272,Paxlovid,Nirmatrelvir\\\\Ritonavir;Herbals\\\\Mitragynine,Covid-19 Treatment,Withdrawal Syndrome;Drug Interaction,Non-Serious,Non-Serious,Female,22-Jul-2022,7/26/2022,Non-Expedited,36,Not Specified,Pfizer,Consumer,Not Specified,Propranolol;Gabapentin,7/23/2022,7/26/2022,US,Not Specified,US-PFIZER INC-202201002065,-,-\\n21081195,-,Herbals\\\\Mitragynine;Ursodiol,Attention Deficit Hyperactivity Disorder;Cholestatic Liver Injury;Phytotherapy,Drug Ineffective;Multiple Organ Dysfunction Syndrome,Serious,Hospitalized,Female,-,7/29/2022,Expedited,37,Not Specified,Teva,Healthcare Professional,Not Specified,Amphetamine\\\\Dextroamphetamine,7/20/2022,7/14/2022,US,Not Specified,US-TEVA-2022-US-2053941,-,-\\n21192472,-,Tramadol;Herbals\\\\Mitragynine,Pain,Delirium;Generalised Tonic-Clonic Seizure;Fall;Loss Of Consciousness;Cognitive Disorder;Toxicity To Various Agents;Mood Swings;Electrocardiogram Qt Prolonged;Hypokalaemia;Drug Interaction,Serious,Other Outcomes;Hospitalized,Male,-,8/9/2022,Expedited,\"45,994\",Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,8/1/2022,8/9/2022,US,Not Specified,US-JNJFOC-20220818641,-,-\\n21193544,Trazodone,Trazodone Hydrochloride;Desvenlafaxine;Ziprasidone;Herbals\\\\Mitragynine;Buspirone Hydrochloride,Product Used For Unknown Indication;Tooth Abscess,Drug Interaction;Serotonin Syndrome,Serious,Hospitalized,Male,-,8/10/2022,Expedited,63,102.5 KG,Unichem,Healthcare Professional,Not Specified,Tizanidine;Ampicillin;Gabapentin;Metformin;Glimepiride;Amlodipine;Vancomycin;Amoxicillin\\\\Clavulanate Potassium;Omeprazole;Bupropion;Piperacillin Sodium\\\\Tazobactam Sodium;Lorazepam;Cefepime;Diclofenac;Hydrochlorothiazide,7/29/2022,8/10/2022,Not Specified,Not Specified,US-Unichem Pharmaceuticals (USA) Inc-UCM202208-000729,-,-\\n21193542,Tramadol Hcl,Tramadol Hydrochloride;Herbals\\\\Mitragynine,Pain;Product Used For Unknown Indication,Cognitive Disorder;Drug Interaction;Toxicity To Various Agents;Hypokalaemia;Fall;Electrocardiogram Qt Prolonged;Seizure,Serious,Hospitalized,Male,-,8/10/2022,Expedited,Not Specified,Not Specified,Unichem,Healthcare Professional,Not Specified,-,7/29/2022,8/10/2022,Not Specified,Not Specified,US-Unichem Pharmaceuticals (USA) Inc-UCM202208-000738,-,-\\n21216260,Trazodone;Buspirone,Buspirone Hydrochloride;Trazodone Hydrochloride;Desvenlafaxine;Herbals\\\\Mitragynine;Ziprasidone,Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome,Serious,Hospitalized;Other Outcomes,Male,-,8/16/2022,Expedited,63,102 KG,Hikma,Healthcare Professional,Not Specified,Hydrochlorothiazide;Metformin;Diclofenac;Bupropion;Amlodipine;Gabapentin;Omeprazole;Tizanidine;Glimepiride,8/3/2022,8/16/2022,Not Specified,Not Specified,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-58394,-,-\\n21263276,-,Herbals\\\\Mitragynine;Acetaminophen\\\\Hydrocodone;Morphine,Pain;Product Used For Unknown Indication,Vomiting;Acute Kidney Injury;Nausea;Flank Pain,Serious,Other Outcomes;Hospitalized,Female,-,9/2/2022,Expedited,21,Not Specified,Vistapharm,Healthcare Professional,Not Specified,Percocet,8/22/2022,8/29/2022,Not Specified,Not Specified,\"US-VistaPharm, Inc.-VER202208-000709\",-,-\\n21255402,-,Herbals\\\\Mitragynine;Tramadol,Pain,Cognitive Disorder;Electrocardiogram Qt Prolonged;Drug Interaction;Seizure;Hypokalaemia;Overdose;Toxicity To Various Agents,Serious,Hospitalized,Male,-,9/6/2022,Expedited,\"45,994\",Not Specified,Teva,Healthcare Professional,Not Specified,-,9/1/2022,8/25/2022,US,Not Specified,US-TEVA-2022-US-2066531,-,-\\n17913888,Buspirone;Trazodone,Trazodone Hydrochloride;Buspirone Hydrochloride;Bupropion;Herbals\\\\Mitragynine;Desvenlafaxine;Ziprasidone,Depression,Serotonin Syndrome;Drug Interaction,Serious,Hospitalized,Male,-,9/6/2022,Expedited,63,Not Specified,Teva,Healthcare Professional,Not Specified,-,9/1/2022,6/18/2020,US,Not Specified,US-TEVA-2020-US-1510324,-,-\\n17926244,Trazodone;Buspirone,Desvenlafaxine;Buspirone Hydrochloride;Herbals\\\\Mitragynine;Ziprasidone;Bupropion;Trazodone Hydrochloride,Depression,Serotonin Syndrome;Drug Interaction,Serious,Other Outcomes;Hospitalized,Male,-,9/7/2022,Expedited,63,Not Specified,Micro Labs,Healthcare Professional,Not Specified,Amlodipine;Diclofenac Sodium;Omeprazole;Tizanidine;Metformin,8/26/2022,6/23/2020,US,Not Specified,US-MICRO LABS LIMITED-ML2020-01798,-,-\\n21258987,Lybalvi,Olanzapine\\\\Samidorphan L-Malate;Herbals\\\\Mitragynine,Bipolar Disorder;Product Used For Unknown Indication;Restless Legs Syndrome;Sleep Disorder,Dystonia,Non-Serious,Non-Serious,Male,11-Aug-2022,10/10/2022,Non-Expedited,Not Specified,Not Specified,Alkermes,Healthcare Professional,Not Specified,Zyprexa,9/26/2022,8/26/2022,US,Not Specified,US-ALKERMES INC.-ALK-2022-004120,-,-\\n21494480,Lybalvi,Olanzapine\\\\Samidorphan L-Malate;Herbals\\\\Mitragynine,Bipolar I Disorder;Product Used For Unknown Indication,Withdrawal Syndrome;Diarrhoea,Non-Serious,Non-Serious,Female,-,10/21/2022,Non-Expedited,\"45,995\",Not Specified,Alkermes,Healthcare Professional,Not Specified,Olanzapine,10/11/2022,10/21/2022,US,Not Specified,US-ALKERMES INC.-ALK-2022-004981,-,-\\n21580186,-,Ondansetron;Clonidine;Naltrexone;Herbals\\\\Mitragynine,Alcohol Abuse;Drug Withdrawal Syndrome;Product Used For Unknown Indication,Drug Withdrawal Syndrome;Drug Ineffective,Serious,Hospitalized,Male,-,12/1/2022,Expedited,46,Not Specified,Teva,Healthcare Professional,Not Specified,Duloxetine,11/21/2022,11/10/2022,US,Not Specified,US-TEVA-2022-US-2823519,-,-\\n21686144,Haldol;Invega;Invega Sustenna,Paliperidone;Paliperidone Palmitate;Haloperidol;Herbals\\\\Mitragynine,Product Used For Unknown Indication;Schizoaffective Disorder,Product Dose Omission Issue;Schizoaffective Disorder;Drug Ineffective,Serious,Hospitalized,Female,26-Nov-2022,12/13/2022,Non-Expedited,34,Not Specified,Johnson And Johnson,Consumer,Not Specified,-,12/8/2022,12/6/2022,US,Not Specified,US-JNJFOC-20221160650,-,-\\n21773877,Mayzent,Siponimod;Herbals\\\\Mitragynine,Multiple Sclerosis,Overdose,Serious,Hospitalized,Female,10-Dec-2022,12/22/2022,Direct,50,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,12/22/2022,Not Specified,Not Specified,-,-,-\\n21801398,Kava,Piper Methysticum Root;Herbals\\\\Mitragynine,Asthenia,Thinking Abnormal;Personality Change;Chest Pain;Drug Tolerance;Irritability;Drug Dependence;Cardiac Arrest;Weight Decreased;Unevaluable Event;Incorrect Dose Administered;Sleep Disorder;Road Traffic Accident;Abnormal Behaviour,Serious,Died,Male,28-Jul-2021,12/30/2022,Direct,36,90 KG,Fda-Ctu,Consumer,Not Specified,-,-,12/30/2022,Not Specified,Y,-,-,-\\n20305852,-,Herbals\\\\Mitragynine,Stress,Suicidal Ideation;Apathy;Dependence,Serious,Life Threatening;Required Intervention,Male,05-Jan-2022,1/6/2022,Direct,33,85.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/6/2022,Not Specified,Not Specified,-,-,-\\n20328827,-,Herbals\\\\Mitragynine,Anxiety,Toxicity To Various Agents,Serious,Died,Male,10-Nov-2021,1/12/2022,Direct,22,62.1 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/12/2022,Not Specified,Not Specified,-,-,-\\n20355961,-,Herbals\\\\Mitragynine,Occupational Exposure To Product,Manufacturing Materials Contamination;Nervousness;Withdrawal Syndrome;Manufacturing Process Control Procedure Issue;Insomnia;Muscular Weakness;Occupational Exposure To Product;Disturbance In Attention,Serious,Disabled,Male,13-Jan-2022,1/19/2022,Direct,57,92.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/19/2022,Not Specified,Not Specified,-,-,Yes\\n20429536,-,Herbals\\\\Mitragynine,Energy Increased;Euphoric Mood,Illness;Vomiting;Pyrexia;Product Odour Abnormal;Suspected Product Contamination;Product Physical Consistency Issue,Serious,Other Outcomes,Female,02-Feb-2022,2/3/2022,Direct,44,83.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,2/3/2022,Not Specified,Not Specified,-,-,Yes\\n20490616,-,Herbals\\\\Mitragynine,Pain Management;Substance Use,Overdose;Nausea;Decreased Appetite;Substance Use;Vomiting;Pulse Abnormal;Wernicke\\'s Encephalopathy;Dizziness;Dysphonia;Impaired Work Ability;Cognitive Disorder;Accidental Death;Weight Decreased,Serious,Died,Female,15-Dec-2021,2/18/2022,Direct,51,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,2/18/2022,Not Specified,Y,-,-,-\\n20517833,-,Herbals\\\\Mitragynine,Drug Dependence,Alcohol Interaction,Serious,Died,Male,11-Dec-2021,2/24/2022,Direct,30,101.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,2/24/2022,Not Specified,Not Specified,-,-,-\\n20548596,-,Herbals\\\\Mitragynine,-,Drug Abuse;Overdose,Serious,Died,Male,25-Feb-2022,3/3/2022,Direct,37,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,3/3/2022,Not Specified,Not Specified,-,-,-\\n20573098,-,Herbals\\\\Mitragynine,Pain,Drug Dependence;Withdrawal Syndrome;Socioeconomic Precarity,Non-Serious,Non-Serious,Male,-,3/9/2022,Direct,42,87.3 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/9/2022,Not Specified,Not Specified,-,-,-\\n20622022,-,Herbals\\\\Mitragynine,Anxiety;Insomnia,Drug Dependence;Socioeconomic Precarity,Serious,Other Outcomes;Life Threatening;Disabled;Required Intervention,Male,15-Mar-2022,3/21/2022,Direct,36,67.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/21/2022,Not Specified,Not Specified,-,-,-\\n20626838,-,Herbals\\\\Mitragynine,Asthenia,Withdrawal Syndrome;Dyspnoea;Illness;Feeling Abnormal,Non-Serious,Non-Serious,Male,-,3/22/2022,Direct,Not Specified,81 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/22/2022,Not Specified,Not Specified,-,-,-\\n20636132,-,Herbals\\\\Mitragynine,Anxiety,Self-Medication;Delusion;Paranoia;Marital Problem;Product Complaint,Serious,Hospitalized,Male,31-Jul-2021,3/24/2022,Direct,38,112.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/24/2022,Not Specified,Not Specified,-,-,-\\n20658365,-,Herbals\\\\Mitragynine,Relaxation Therapy,Withdrawal Syndrome;Drug Dependence,Serious,Disabled;Other Outcomes,Male,29-Mar-2022,3/30/2022,Direct,33,87.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/30/2022,Not Specified,Not Specified,-,-,-\\n20679122,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Tolerance Increased;Dependence;Drug Dependence;Product Complaint,Serious,Other Outcomes,Male,01-Apr-2022,4/5/2022,Direct,36,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,4/5/2022,Not Specified,Not Specified,-,-,-\\n20699441,-,Herbals\\\\Mitragynine,Drug Dependence,Accidental Overdose,Serious,Died,Male,-,4/10/2022,Direct,Not Specified,103.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/10/2022,Not Specified,Not Specified,-,-,-\\n20706519,-,Herbals\\\\Mitragynine,Alcohol Detoxification,Seizure;Dependence,Serious,Died;Hospitalized,Male,05-Feb-2021,4/11/2022,Direct,21,61.23 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/11/2022,Not Specified,Not Specified,-,-,-\\n20701017,-,Herbals\\\\Mitragynine,Anxiety;Insomnia,Herbal Toxicity,Serious,Died,Male,21-Feb-2021,4/11/2022,Direct,26,78.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/11/2022,Not Specified,Not Specified,-,-,-\\n20719274,-,Herbals\\\\Mitragynine,-,Vertigo;Seizure;Cardiac Arrest;Herbal Toxicity;Bell\\'s Palsy,Serious,Died,Male,13-Apr-2019,4/15/2022,Direct,27,81 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/15/2022,Not Specified,Not Specified,-,-,-\\n20778443,-,Herbals\\\\Mitragynine,Drug Dependence,Blood Pressure Increased;Drug Dependence;Psychomotor Hyperactivity,Non-Serious,Non-Serious,Male,18-Mar-2022,5/3/2022,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,5/3/2022,Not Specified,Not Specified,-,-,-\\n20778086,-,Herbals\\\\Mitragynine,-,Rhinorrhoea;Drug Dependence;Vomiting;Influenza Like Illness;Sleep Disorder;Sleep Apnoea Syndrome;Agitation;Withdrawal Syndrome,Serious,Disabled;Hospitalized,Female,28-Apr-2022,5/3/2022,Direct,50,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,5/3/2022,Not Specified,Not Specified,-,-,-\\n20801307,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,04-Apr-2022,5/7/2022,Direct,41,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,5/7/2022,Not Specified,Not Specified,-,-,-\\n20909802,-,Herbals\\\\Mitragynine,-,Seizure;Drug Dependence;Quality Of Life Decreased,Serious,Disabled;Life Threatening;Other Outcomes,Male,13-Sep-2021,6/2/2022,Direct,29,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,6/2/2022,Not Specified,Not Specified,-,-,-\\n20906527,-,Herbals\\\\Mitragynine,Affective Disorder,Seizure,Serious,Hospitalized;Other Outcomes;Life Threatening;Required Intervention,Male,29-May-2022,6/2/2022,Direct,35,81 KG,Fda-Ctu,Consumer,Not Specified,-,-,6/2/2022,Not Specified,Not Specified,-,-,-\\n20939015,-,Herbals\\\\Mitragynine,Substance Use,Herbal Toxicity;Alcohol Poisoning,Serious,Died,Female,29-May-2019,6/9/2022,Direct,52,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,6/9/2022,Not Specified,Not Specified,-,-,-\\n20963498,-,Herbals\\\\Mitragynine,-,Drug Dependence;Personal Relationship Issue;Drug Tolerance;Intentional Product Misuse;Educational Problem;Withdrawal Syndrome;Overdose;Dependence;Loss Of Personal Independence In Daily Activities,Serious,Hospitalized;Life Threatening;Required Intervention;Disabled,Female,-,6/15/2022,Direct,19,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,6/15/2022,Not Specified,Not Specified,-,-,-\\n21003944,-,Herbals\\\\Mitragynine,Pain,Drug Dependence;Dependence;Overdose,Serious,Hospitalized;Life Threatening,Male,-,6/24/2022,Direct,32,67.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,6/24/2022,Not Specified,Not Specified,-,-,-\\n21008823,-,Herbals\\\\Mitragynine,-,Drug Withdrawal Syndrome;Drug Dependence;Substance Use,Serious,Hospitalized;Disabled,Not Specified,24-Jun-2022,6/25/2022,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,6/25/2022,Not Specified,Not Specified,-,-,-\\n21028472,-,Herbals\\\\Mitragynine,Anxiety;Back Disorder,Road Traffic Accident;Drug Dependence;Brain Fog;Adverse Drug Reaction;Euphoric Mood,Non-Serious,Non-Serious,Male,02-Jun-2022,6/30/2022,Direct,46,86.18 KG,Fda-Ctu,Consumer,Not Specified,-,-,6/30/2022,Not Specified,Not Specified,-,-,-\\n21075223,-,Herbals\\\\Mitragynine,Asthenia;Insomnia,Constipation;Libido Decreased;Withdrawal Syndrome;Alopecia;Decreased Appetite;Hepatic Failure;Urine Analysis Abnormal,Serious,Life Threatening;Other Outcomes;Disabled;Required Intervention;Hospitalized,Female,25-Jun-2021,7/12/2022,Direct,27,56.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/12/2022,Not Specified,Not Specified,-,-,-\\n21094031,-,Herbals\\\\Mitragynine,Substance Use,Liver Injury,Serious,Hospitalized;Died,Male,05-Aug-2021,7/17/2022,Direct,31,83.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/17/2022,Not Specified,Not Specified,-,-,-\\n21093964,-,Herbals\\\\Mitragynine,Nervousness;Pain,Sudden Death;Drug Dependence;Toxicity To Various Agents,Serious,Died,Female,15-May-2022,7/17/2022,Direct,28,58.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/17/2022,Not Specified,Not Specified,-,-,-\\n21154719,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,09-Jul-2022,7/29/2022,Direct,25,72 KG,Fda-Ctu,Healthcare Professional,Not Specified,-,-,7/29/2022,Not Specified,Not Specified,-,-,-\\n21160134,-,Herbals\\\\Mitragynine,-,Drug Withdrawal Syndrome;Depression;Drug Abuse;Restless Legs Syndrome,Serious,Required Intervention;Hospitalized,Male,15-Jul-2022,8/1/2022,Direct,23,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,8/1/2022,Not Specified,Not Specified,-,-,-\\n21176316,-,Herbals\\\\Mitragynine,Analgesic Therapy,Withdrawal Syndrome,Serious,Required Intervention;Hospitalized,Male,15-Apr-2020,8/4/2022,Direct,35,76.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/4/2022,Not Specified,Not Specified,-,-,-\\n21184115,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Respiratory Depression;Toxicity To Various Agents,Serious,Died,Male,-,8/6/2022,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,8/6/2022,Not Specified,Not Specified,-,-,-\\n21199901,-,Herbals\\\\Mitragynine,-,Drug Dependence,Serious,Other Outcomes,Not Specified,12-Nov-2021,8/10/2022,Direct,30,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,8/10/2022,Not Specified,Not Specified,-,-,-\\n21296794,-,Herbals\\\\Mitragynine,Dependence,Drug Dependence;Delusional Perception;Drug Abuse,Serious,Other Outcomes,Male,25-Aug-2022,9/3/2022,Direct,41,85.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/3/2022,Not Specified,Not Specified,-,-,-\\n21407552,-,Herbals\\\\Mitragynine,-,Withdrawal Syndrome,Serious,Required Intervention,Male,10-Sep-2022,10/4/2022,Direct,40,99 KG,Fda-Ctu,Not Specified,Not Specified,-,-,10/4/2022,Not Specified,Not Specified,-,-,-\\n21407421,-,Herbals\\\\Mitragynine,-,Pulmonary Oedema;Seizure;Ear Infection;Aortic Valve Disease;Vertigo;Tympanic Membrane Perforation;Coronary Artery Stenosis;Toxicity To Various Agents;Substance Abuse,Serious,Died,Male,-,10/4/2022,Direct,27,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,10/4/2022,Not Specified,Not Specified,-,-,-\\n21422042,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,15-May-2022,10/6/2022,Direct,32,103.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/6/2022,Not Specified,Not Specified,-,-,-\\n21450754,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Hospitalized;Required Intervention,Male,06-Oct-2022,10/12/2022,Direct,35,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,10/12/2022,Not Specified,Not Specified,-,-,-\\n21515323,-,Herbals\\\\Mitragynine,-,Night Sweats;Dyspnoea;Decreased Appetite;Vomiting;Fatigue;Tremor,Serious,Other Outcomes,Female,-,10/27/2022,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,10/27/2022,Not Specified,Not Specified,-,-,-\\n21530232,-,Herbals\\\\Mitragynine,Anxiety,Withdrawal Syndrome;Drug Dependence,Serious,Required Intervention,Male,11-Sep-2022,10/28/2022,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,10/28/2022,Not Specified,Not Specified,-,-,-\\n21621626,-,Herbals\\\\Mitragynine,-,Agitation;Quality Of Life Decreased;General Physical Condition Abnormal;Mental Disorder,Serious,Other Outcomes,Female,14-Aug-2021,11/20/2022,Direct,31,56.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,11/20/2022,Not Specified,Not Specified,-,-,-\\n21682039,-,Herbals\\\\Mitragynine,-,Drug Dependence;Withdrawal Syndrome,Serious,Required Intervention;Other Outcomes,Male,05-Nov-2022,12/3/2022,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,12/3/2022,Not Specified,Not Specified,-,-,-\\n21727879,-,Herbals\\\\Mitragynine,-,Product Information Content Complaint;Weight Decreased,Non-Serious,Non-Serious,Not Specified,-,12/13/2022,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,12/13/2022,Not Specified,Not Specified,-,-,-\\n21767238,-,Herbals\\\\Mitragynine,-,Drug Withdrawal Syndrome;Misleading Laboratory Test Result;Drug Dependence,Non-Serious,Non-Serious,Male,-,12/22/2022,Direct,39,174 LB,Fda-Ctu,Healthcare Professional,Not Specified,-,-,12/22/2022,Not Specified,Not Specified,-,-,-\\n21767861,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died,Male,20-Oct-2021,12/22/2022,Direct,22,90 KG,Fda-Ctu,Consumer,Not Specified,-,-,12/22/2022,Not Specified,Not Specified,-,-,-\\n21793686,-,Herbals\\\\Mitragynine,-,Panic Attack;Confusional State;Irritability;Mood Altered;Diarrhoea;Asthenia;Nausea;Brain Fog;Anhedonia;Withdrawal Syndrome,Serious,Other Outcomes,Male,15-Oct-2018,12/28/2022,Direct,39,70.2 KG,Fda-Ctu,Not Specified,Not Specified,-,-,12/28/2022,Not Specified,Not Specified,-,-,-\\n21793677,-,Herbals\\\\Mitragynine,-,Drug Dependence;Seizure,Serious,Died,Not Specified,05-Feb-2021,12/28/2022,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,12/28/2022,Not Specified,Not Specified,-,-,-\\n21793690,-,Herbals\\\\Mitragynine,-,Product Contamination;Drug Abuse;Withdrawal Syndrome;Product Formulation Issue,Serious,Other Outcomes,Male,23-Dec-2022,12/28/2022,Direct,39,174 LB,Fda-Ctu,Not Specified,Not Specified,-,-,12/28/2022,Not Specified,Not Specified,-,-,-\\n21614526,-,Herbals\\\\Mitragynine;Buprenorphine;Buprenorphine\\\\Naloxone,Drug Use Disorder,Exposure During Pregnancy;Drug Ineffective;Drug Withdrawal Syndrome,Serious,Other Outcomes,Female,-,9/29/2023,Expedited,27,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,9/26/2023,11/18/2022,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-364360,\"Zoucha K, Moore C. Kratom Use in Pregnancy. J Addict Med. 2022;Sep/Oct; 16(5):e331-e332\",-\\n23065827,Hydromorphone Hcl,Hydromorphone Hydrochloride;Herbals\\\\Mitragynine;Olanzapine,Product Used For Unknown Indication,Toxicity To Various Agents;Renal Impairment,Serious,Other Outcomes,Male,-,10/14/2023,Expedited,44,Not Specified,Cadila,Healthcare Professional,Not Specified,-,10/1/2023,10/14/2023,CA,Not Specified,CA-CPL-003703,\"Shi T, Shea JL. A case of fatal overdose involving both hydromorphone and kratom. J Forensic Sci. 2023 Sep 27.\",-\\n23065925,Hydromorphone Hcl,Hydromorphone Hydrochloride;Olanzapine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Renal Impairment;Toxicity To Various Agents,Serious,Other Outcomes,Male,-,10/14/2023,Expedited,44,Not Specified,Indoco,Healthcare Professional,Not Specified,-,10/1/2023,10/14/2023,CA,Not Specified,CA-Indoco-000464,\"Shi T, Shea JL. A case of fatal overdose involving both hydromorphone and kratom. J Forensic Sci. 2023 Sep 27\",-\\n23070450,-,Hydromorphone Hydrochloride;Olanzapine;Herbals\\\\Mitragynine,Pain;Product Used For Unknown Indication,Overdose;Toxicity To Various Agents;Renal Impairment;Completed Suicide,Serious,Other Outcomes;Died,Male,-,10/16/2023,Expedited,44,Not Specified,Purdue,Healthcare Professional,Not Specified,Herbals\\\\Mitragynine;Escitalopram;Zopiclone,10/10/2023,10/16/2023,CA,Not Specified,CA-PURDUE-USA-2023-0305318,\"Shi T, Shea J.L. A case of fatal overdose involving both hydromorphone and kratom. Journal of forensic sciences. 2023;00:1-4\",-\\n22283963,Naloxone Hcl,Naloxone Hydrochloride;Naproxen;Benzoylecgonine;Herbals\\\\Mitragynine;Cocaine;Clonazepam;Levamisole,-,Toxicity To Various Agents,Serious,Other Outcomes;Hospitalized;Died,Female,-,5/4/2023,Expedited,28,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,4/25/2023,5/4/2023,US,Not Specified,US-PFIZER INC-202300172008,\"Salas, J.. Concentrations of para-Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations. Journal of Analytical Toxicology. 2022;46 (4):358-373\",-\\n22366326,-,Naproxen;Naloxone;7-Aminoclonazepam;Levamisole;Benzoylecgonine;Herbals\\\\Mitragynine;Cocaine;Clonazepam,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died;Other Outcomes,Female,-,5/25/2023,Expedited,28,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,5/10/2023,5/25/2023,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390056,\"Salas JR, Krotulski AJ, Newman R, Thogmartin JR, Mohr ALA, Logan BK. Concentrations of para-Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations. J Anal Toxicol. 2022;46:358-373\",-\\n22366278,-,Naproxen;Codeine;Herbals\\\\Mitragynine;Morphine;Benzoylecgonine;7-Hydroxymitragynine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Other Outcomes;Died,Male,-,5/25/2023,Expedited,38,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,5/10/2023,5/25/2023,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-390054,\"Salas JR, Krotulski AJ, Newman R, Thogmartin JR, Mohr ALA, Logan BK. Concentrations of para-Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations. J Anal Toxicol. 2022;46:358-373\",-\\n23300559,-,Morphine Sulfate;Herbals\\\\Mitragynine;Naproxen;Codeine,Product Used For Unknown Indication,Toxicity To Various Agents;Drug Abuse,Serious,Died;Hospitalized,Male,-,12/15/2023,Non-Expedited,38,Not Specified,Strides,Healthcare Professional,Not Specified,-,4/18/2023,12/15/2023,US,Not Specified,US-STRIDES ARCOLAB LIMITED-2023SP005907,\"Rodriguez Salas J, Krotulski AJ, Newman R, Thogmartin JR, Mohr ALA, Logan BK.. Concentrations of para-Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations.. J-Anal-Toxicol. 2022;46(4):358-373\",-\\n22259439,-,Clonazepam;Herbals\\\\Mitragynine;Levamisole,Product Used For Unknown Indication,Toxicity To Various Agents;Drug Abuse,Serious,Hospitalized;Died,Female,-,4/27/2023,Expedited,28,Not Specified,Mylan,Healthcare Professional,Not Specified,Naproxen,4/18/2023,4/27/2023,US,Not Specified,US-MYLANLABS-2023M1042993,\"Rodriguez Salas J, Krotulski AJ, Newman R, Thogmartin JR, Mohr ALA, Logan BK. Concentrations of para-Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations. J-Anal-Toxicol 2022;46(4):358-373.\",-\\n22738090,Alcohol (Alcohol);Sertraline,Sertraline Hydrochloride;Etonitazene;Gabapentin;Desmethylsertraline;3-Fluorophenmetrazine;.Alpha.-Hydroxyetizolam;Benzoylecgonine;Propylene Glycol;Modafinil;Melatonin;Alcohol;Herbals\\\\Mitragynine;Etizolam;Amphetamine;Olanzapine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died;Other Outcomes,Male,-,7/21/2023,Expedited,22,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,7/6/2023,7/21/2023,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-400611,\"Papsun M D, Krotulski A J, Logan B K. Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances. Am J Forensic Med Pathol. 2022;43:315-327\",-\\n22703746,Escitalopram,Escitalopram Oxalate;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Agitation;Serotonin Syndrome;Rhabdomyolysis,Serious,Other Outcomes,Male,-,7/14/2023,Expedited,24,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/29/2023,7/14/2023,US,Not Specified,US-AUROBINDO-AUR-APL-2023-047936,\"Palungwachira.P., Yeh.M, Whitworth.B, Rushton.W and Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 20162020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11:2\",-\\n22621336,-,Gabapentin;Lorazepam;Herbals\\\\Mitragynine,-,Apnoea;Unresponsive To Stimuli,Serious,Hospitalized;Life Threatening,Male,-,7/14/2023,Expedited,20,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,7/12/2023,6/20/2023,US,Not Specified,TH-PFIZER INC-202300226627,\"Palungwachira, P.. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11 (2):10.4303/jdar/236162\",-\\n22704193,-,Nortriptyline;Baclofen;Herbals\\\\Mitragynine,Suspected Suicide,Electrocardiogram Qrs Complex Prolonged;Drug Ineffective;Lethargy,Serious,Other Outcomes,Female,-,7/14/2023,Expedited,57,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/29/2023,7/14/2023,US,Not Specified,US-AUROBINDO-AUR-APL-2023-047941,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z.. ported to the Georgia and Alabama Poison Control Centers from 20162020: A Retrospective Review. J-Drug-Alcohol-Res. 2022;11No. 2.\",-\\n22652454,-,Pregabalin;Herbals\\\\Mitragynine;Clonazepam,Product Used For Unknown Indication;Suspected Suicide,Unresponsive To Stimuli;Apnoea,Serious,Hospitalized;Other Outcomes,Male,-,6/29/2023,Expedited,20,Not Specified,Hetero,Healthcare Professional,Not Specified,-,6/19/2023,6/29/2023,US,Not Specified,US-AMAROX PHARMA-HET2023US01810,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z.. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 20162020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11(2):1-10\",-\\n22643781,Escitalopram,Escitalopram Oxalate;Herbals\\\\Mitragynine;Aripiprazole,Product Used For Unknown Indication,Torsade De Pointes;Lethargy;Electrocardiogram Qt Prolonged,Serious,Hospitalized,Female,-,6/27/2023,Expedited,60,Not Specified,Hetero,Healthcare Professional,Not Specified,-,6/19/2023,6/27/2023,US,Not Specified,US-AMAROX PHARMA-HET2023US01803,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z.. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review.. Journal of Drug and Alcohol Research.. 2022;11(2):1-10\",-\\n22647695,-,Lithium;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Lethargy;Unresponsive To Stimuli,Serious,Hospitalized,Male,-,6/28/2023,Expedited,47,Not Specified,Hetero,Healthcare Professional,Not Specified,-,6/19/2023,6/28/2023,US,Not Specified,US-HETERO-HET2023US01806,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z.. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review.. Journal of Drug and Alcohol Research.. 2022;11 (2):1-10\",-\\n22627058,-,Herbals\\\\Mitragynine;Gabapentin;Lorazepam,Product Used For Unknown Indication,Apnoea;Unresponsive To Stimuli,Serious,Life Threatening;Hospitalized,Male,-,6/22/2023,Expedited,20,Not Specified,Strides,Healthcare Professional,Not Specified,-,6/12/2023,6/22/2023,TH,Not Specified,TH-STRIDES ARCOLAB LIMITED-2023SP009632,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z.. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review.. J-Drug-Alcohol-Res. 2022;11 (2).\",-\\n22624571,-,Gabapentin;Lorazepam;Herbals\\\\Mitragynine,Product Used For Unknown Indication;Suspected Suicide,Suspected Suicide;Drug Interaction;Apnoea;Unresponsive To Stimuli,Serious,Other Outcomes;Hospitalized,Male,-,6/21/2023,Expedited,20,Not Specified,Apotex,Healthcare Professional,Not Specified,-,6/12/2023,6/21/2023,US,Not Specified,US-APOTEX-2023AP009166,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11 (2):1-10\",-\\n22624423,Escitalopram,Escitalopram Oxalate;Herbals\\\\Mitragynine;Aripiprazole,Drug Abuse;Product Used For Unknown Indication,Drug Interaction;Lethargy;Electrocardiogram Qt Prolonged;Torsade De Pointes;Drug Abuse,Serious,Hospitalized;Other Outcomes,Female,-,6/21/2023,Expedited,60,Not Specified,Apotex,Healthcare Professional,Not Specified,-,6/12/2023,6/21/2023,US,Not Specified,US-APOTEX-2023AP009107,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11 (2):1-10\",-\\n22628846,-,Pregabalin;Clonazepam;Herbals\\\\Mitragynine,Product Used For Unknown Indication;Suspected Suicide,Suspected Suicide;Drug Interaction;Unresponsive To Stimuli;Apnoea,Serious,Other Outcomes,Male,-,6/22/2023,Expedited,20,Not Specified,Apotex,Healthcare Professional,Not Specified,-,6/12/2023,6/22/2023,US,Not Specified,US-APOTEX-2023AP009169,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11 (2):1-10\",-\\n22628738,-,Acetaminophen;Herbals\\\\Mitragynine,Product Used For Unknown Indication;Suspected Suicide,Drug Interaction;Suspected Suicide;Unresponsive To Stimuli,Serious,Other Outcomes,Female,-,6/22/2023,Expedited,33,Not Specified,Apotex,Healthcare Professional,Not Specified,-,6/12/2023,6/22/2023,US,Not Specified,US-APOTEX-2023AP009170,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11 (2):1-10\",-\\n22628423,Alcohol (Alcohol),Alcohol;Duloxetine;Aspirin;Herbals\\\\Mitragynine,Drug Abuse;Product Used For Unknown Indication,Agitation;Drug Abuse;Myoclonus;Aggression;Drug Interaction,Serious,Other Outcomes,Male,-,6/22/2023,Expedited,57,Not Specified,Apotex,Healthcare Professional,Not Specified,-,6/12/2023,6/22/2023,US,Not Specified,US-APOTEX-2023AP009168,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11 (2):1-10\",-\\n22628320,-,Herbals\\\\Mitragynine;Lithium,Drug Abuse;Product Used For Unknown Indication,Drug Abuse;Drug Interaction;Unresponsive To Stimuli;Lethargy,Serious,Other Outcomes,Male,-,6/22/2023,Expedited,47,Not Specified,Apotex,Healthcare Professional,Not Specified,-,6/12/2023,6/22/2023,US,Not Specified,US-APOTEX-2023AP009167,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11 (2):1-10\",-\\n22703981,-,Herbals\\\\Mitragynine;Pregabalin;Clonazepam,Product Used For Unknown Indication,Drug Ineffective;Apnoea,Serious,Other Outcomes,Male,-,7/14/2023,Expedited,20,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/29/2023,7/14/2023,US,Not Specified,US-AUROBINDO-AUR-APL-2023-047940,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J-Drug-Alcohol-Res. 2022;11No:2\",-\\n22621269,-,Herbals\\\\Mitragynine;Clonazepam,Product Used For Unknown Indication,Unresponsive To Stimuli;Lethargy,Serious,Other Outcomes,Male,-,6/20/2023,Expedited,60,Not Specified,Mylan,Healthcare Professional,Not Specified,-,6/12/2023,6/20/2023,US,Not Specified,TH-MYLANLABS-2023M1064800,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J-Drug-Alcohol-Res 2022;11:No. 2.\",-\\n22619735,-,Lorazepam;Gabapentin;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Unresponsive To Stimuli;Apnoea,Serious,Life Threatening;Hospitalized,Male,-,6/20/2023,Expedited,20,Not Specified,Mylan,Healthcare Professional,Not Specified,-,6/12/2023,6/20/2023,US,Not Specified,TH-MYLANLABS-2023M1064789,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J-Drug-Alcohol-Res 2022;11:No. 2.\",-\\n22623753,Escitalopram,Escitalopram Oxalate;Aripiprazole;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Torsade De Pointes;Electrocardiogram Qt Prolonged;Lethargy,Serious,Hospitalized;Life Threatening,Female,-,6/21/2023,Expedited,60,Not Specified,Mylan,Healthcare Professional,Not Specified,-,6/12/2023,6/21/2023,US,Not Specified,TH-MYLANLABS-2023M1064786,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J-Drug-Alcohol-Res 2022;11:No. 2.\",-\\n22623748,-,Baclofen;Herbals\\\\Mitragynine;Nortriptyline,Product Used For Unknown Indication,Lethargy;Electrocardiogram Qrs Complex Prolonged;Unresponsive To Stimuli,Serious,Life Threatening;Hospitalized,Female,-,6/21/2023,Expedited,57,Not Specified,Mylan,Healthcare Professional,Not Specified,-,6/12/2023,6/21/2023,US,Not Specified,TH-MYLANLABS-2023M1064814,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J-Drug-Alcohol-Res 2022;11:No. 2.\",-\\n22623742,-,Lithium;Herbals\\\\Mitragynine,Drug Abuse;Product Used For Unknown Indication,Unresponsive To Stimuli;Lethargy,Serious,Other Outcomes,Male,-,6/21/2023,Expedited,47,Not Specified,Mylan,Healthcare Professional,Not Specified,-,6/12/2023,6/21/2023,US,Not Specified,TH-MYLANLABS-2023M1064788,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J-Drug-Alcohol-Res 2022;11:No. 2.\",-\\n22633596,-,Acetaminophen;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Unresponsive To Stimuli,Serious,Other Outcomes,Female,-,6/23/2023,Expedited,33,Not Specified,Mylan,Healthcare Professional,Not Specified,-,6/12/2023,6/23/2023,US,Not Specified,TH-MYLANLABS-2023M1065857,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J-Drug-Alcohol-Res 2022;11:No. 2.\",-\\n22645480,-,Herbals\\\\Mitragynine;Pregabalin;Clonazepam,Product Used For Unknown Indication,Unresponsive To Stimuli;Apnoeic Attack,Serious,Other Outcomes,Male,-,6/27/2023,Expedited,20,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,6/12/2023,6/27/2023,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396278,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J Drug Alcohol Res. 2022;11(2):236162\",-\\n22640937,-,Herbals\\\\Mitragynine;Baclofen;Nortriptyline,Product Used For Unknown Indication,Unresponsive To Stimuli;Electrocardiogram Qrs Complex Prolonged;Lethargy,Serious,Other Outcomes,Female,-,9/30/2023,Expedited,57,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,9/17/2023,6/26/2023,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396279,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J Drug Alcohol Res. 2022;11(2):236162\",-\\n22767666,-,Baclofen;Nortriptyline Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Therapy Non-Responder;Suicide Attempt;Lethargy;Electrocardiogram Qrs Complex Prolonged,Serious,Other Outcomes,Female,-,7/31/2023,Expedited,57,Not Specified,Taro,Healthcare Professional,Not Specified,-,7/18/2023,7/31/2023,US,Not Specified,US-TARO PHARMACEUTICALS USA INC.-2023TAR00804,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J Drug Alcohol Res. 2022;11(2):1-10\",-\\n22772304,Escitalopram,Escitalopram Oxalate;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse;Rhabdomyolysis;Serotonin Syndrome;Agitation,Serious,Other Outcomes,Male,-,8/1/2023,Expedited,24,Not Specified,Taro,Healthcare Professional,Not Specified,-,7/18/2023,8/1/2023,US,Not Specified,US-TARO PHARMACEUTICALS USA INC.-2023TAR00806,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J Drug Alcohol Res. 2022;11(2):1-10\",-\\n22772303,Escitalopram,Escitalopram Oxalate;Herbals\\\\Mitragynine;Aripiprazole,Product Used For Unknown Indication,Lethargy;Electrocardiogram Qt Prolonged;Torsade De Pointes;Drug Abuse,Serious,Other Outcomes,Female,-,8/1/2023,Expedited,60,Not Specified,Taro,Healthcare Professional,Not Specified,-,7/18/2023,8/1/2023,US,Not Specified,US-TARO PHARMACEUTICALS USA INC.-2023TAR00805,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J Drug Alcohol Res. 2022;11(2):1-10\",-\\n22704176,-,Lorazepam;Gabapentin;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Apnoeic Attack;Unresponsive To Stimuli,Serious,Other Outcomes,Male,-,7/14/2023,Expedited,20,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/29/2023,7/14/2023,US,Not Specified,US-AUROBINDO-AUR-APL-2023-047937,\"P. Palungwachira, M. Yeh, B. Whitworth, W. Rushton and Z. Kazzi. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 20162020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11:2\",-\\n22704170,Escitalopram,Escitalopram Oxalate;Aripiprazole;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Lethargy;Electrocardiogram Qt Prolonged;Torsade De Pointes,Serious,Other Outcomes,Female,-,7/14/2023,Expedited,60,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/29/2023,7/14/2023,US,Not Specified,US-AUROBINDO-AUR-APL-2023-047934,\"P. Palungwachira, M. Yeh, B. Whitworth, W. Rushton and Z. Kazzi. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 20162020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11:2\",-\\n22755501,-,Herbals\\\\Mitragynine;Naltrexone Hydrochloride,Arthralgia;Weight Decreased,\"Mental Status Changes;Drug Interaction;Restlessness;Heart Rate Increased;Feeling Cold;Agitation;Delirium;Hyperhidrosis;Off Label Use;Hallucination, Visual\",Serious,Other Outcomes;Hospitalized,Male,-,7/27/2023,Expedited,56,Not Specified,Accord,Healthcare Professional,Not Specified,Metoprolol;Amlodipine,7/16/2023,7/27/2023,US,Not Specified,US-Accord-369246,\"Nunez T, Meyerson G, Alani M, Elahi S, Vargas E. Supersensitivity Psychosis with Acute Dystonia. HCA Healthc J Med. 2023 Feb 28;4(1):57-60.\",-\\n22925721,Paxlovid;Buspirone,Nirmatrelvir\\\\Ritonavir;Buspirone Hydrochloride;Herbals\\\\Mitragynine;Quetiapine,Covid-19 Treatment,Drug Interaction;Serotonin Syndrome,Serious,Hospitalized;Other Outcomes,Female,-,9/8/2023,Expedited,\"45,996\",Not Specified,Pfizer,Healthcare Professional,Not Specified,Lamotrigine;Clonazepam,9/6/2023,9/8/2023,US,Not Specified,US-PFIZER INC-PV202300151755,\"Nasser, N.. Serotonin Syndrome Precipitated by Paxlovid Initiation. Cureus. 2023\",-\\n21414256,-,Morphine;Herbals\\\\Mitragynine;Hydrocodone,Headache;Product Used For Unknown Indication,Drug Abuse;Acute Kidney Injury,Serious,Other Outcomes,Female,-,5/5/2023,Expedited,21,Not Specified,Specgx,Healthcare Professional,Not Specified,-,4/24/2023,10/6/2022,US,Not Specified,US-SPECGX-T202202113,\"LeSaint KT, Yin S, Sharma A, Avery BA, McCurdy CR, Waksman JC. Acute renal insufficiency associated with consumption of hydrocodone- and morphine-adulterated Kratom (Mitragyna Speciosa). Journal of Emergency Medicine. 2022;63(1):e28-30\",-\\n22789411,-,Herbals\\\\Mitragynine;Cannabis Sativa Flowering Top;Quetiapine,Back Pain;Depression,Toxicity To Various Agents;Drug Interaction,Serious,Other Outcomes;Hospitalized,Male,-,8/4/2023,Expedited,33,Not Specified,Astrazeneca,Healthcare Professional,Not Specified,Methadone;Hydroxyzine,7/27/2023,8/4/2023,Not Specified,Not Specified,US-AstraZeneca-2023A174118,\"Lefkovich E, Downing M, Zouridis S. Over-The-Counter Overdose: Toxicity Secondary to an Herbal Pain Supplement. 2023 RESIDENT AND MEDICAL STUDENT FORUM - NEW YORK CHAPTER OF THEAMERICAN COLLEGE OF PHYSICIANS (NYACP) 2023;\",-\\n22913233,-,Herbals\\\\Mitragynine;Lamotrigine;Citalopram;Zopiclone,Product Used For Unknown Indication,Pneumonia;Drug Interaction;Poisoning,Serious,Died,Male,-,9/6/2023,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,9/1/2023,9/6/2023,NO,Not Specified,NO-MYLANLABS-2023M1092220,\"Karinen R, Fosen J, Rogde S, Vindenes V.. An accidental poisoning with mitragynine. Forensic Science International. 2014;245:E29-E32\",-\\n22839704,-,Citalopram;Herbals\\\\Mitragynine;Zopiclone;Lamotrigine,Product Used For Unknown Indication,Pneumonia;Drug Interaction;Poisoning,Serious,Died,Male,-,8/18/2023,Expedited,Not Specified,Not Specified,Abbvie,Healthcare Professional,Not Specified,-,8/14/2023,8/18/2023,NO,Not Specified,NO-ABBVIE-5372226,\"Karinen R, Fosen J, Rogde S, Vindenes V. An accidental poisoning with mitragynine. Forensic Sci Int. 2014;245:E29-E32.\",-\\n21932948,-,Herbals\\\\Mitragynine;Cannabis Sativa Subsp. Indica Top;Fentanyl Citrate;Flubromazolam,-,Drug Abuse;Respiratory Arrest;Cardiac Arrest,Serious,Other Outcomes;Died,Male,2021,1/31/2023,Expedited,24,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/27/2023,1/31/2023,US,Not Specified,US-PFIZER INC-202300041969,\"Gummin, D.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60 (12):1381-1643\",-\\n21937016,-,Herbals\\\\Mitragynine;Cocaine;Fentanyl Citrate;Cannabis Sativa Subsp. Indica Top,-,Drug Abuse;Respiratory Arrest;Cardiac Arrest,Serious,Died;Hospitalized;Other Outcomes,Male,2021,2/1/2023,Expedited,27,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/27/2023,2/1/2023,US,Not Specified,US-PFIZER INC-202300042451,\"Gummin, D.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60 (12):1381-1643\",-\\n21946205,-,Fentanyl Citrate;Herbals\\\\Mitragynine,-,Respiratory Arrest;Cardiac Arrest;Drug Abuse,Serious,Died;Hospitalized;Other Outcomes,Male,2021,2/2/2023,Expedited,41,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/27/2023,2/2/2023,US,Not Specified,US-PFIZER INC-202300043123,\"Gummin, D.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60 (12):1381-1643\",-\\n21946143,-,Herbals\\\\Mitragynine;Fentanyl Citrate,-,Death,Serious,Other Outcomes;Died,Male,2021,2/2/2023,Expedited,28,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/27/2023,2/2/2023,US,Not Specified,US-PFIZER INC-202300042710,\"Gummin, D.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60 (12):1381-1643\",-\\n21946136,-,Herbals\\\\Mitragynine;Fentanyl Citrate,-,Completed Suicide,Serious,Died;Other Outcomes,Female,2021,2/2/2023,Expedited,54,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/27/2023,2/2/2023,US,Not Specified,US-PFIZER INC-202300042664,\"Gummin, D.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60 (12):1381-1643\",-\\n21945311,-,Herbals\\\\Mitragynine;Fentanyl Citrate,-,Death,Serious,Other Outcomes;Died,Male,2021,2/2/2023,Expedited,42,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/27/2023,2/2/2023,US,Not Specified,US-PFIZER INC-202300042762,\"Gummin, D.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60 (12):1381-1643\",-\\n21945291,Sertraline;Heroin,Diamorphine;Aspirin;Fentanyl Citrate;Alprazolam;Cocaine;Sertraline Hydrochloride;Herbals\\\\Mitragynine;Aripiprazole;Cannabis Sativa Subsp. Indica Top,-,Death,Serious,Died;Hospitalized;Other Outcomes,Male,2021,2/2/2023,Expedited,17,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/27/2023,2/2/2023,US,Not Specified,US-PFIZER INC-202300042960,\"Gummin, D.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60 (12):1381-1643\",-\\n21957665,-,Lorazepam;Herbals\\\\Mitragynine;Aripiprazole;Gabapentin;Acetaminophen,-,Intentional Product Misuse;Death,Serious,Other Outcomes;Died,Male,2021,2/6/2023,Expedited,22,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/27/2023,2/6/2023,US,Not Specified,US-PFIZER INC-202300053813,\"Gummin, D.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60 (12):1381-1643\",-\\n23348129,-,Citalopram;Herbals\\\\Mitragynine;Pseudoephedrine;Bupropion;Dextromethorphan;Phenylpropanolamine,Product Used For Unknown Indication,Suspected Suicide;Cardio-Respiratory Arrest,Serious,Other Outcomes;Died,Not Specified,-,12/28/2023,Expedited,Not Specified,Not Specified,Glaxosmithkline,Healthcare Professional,Not Specified,-,12/25/2023,12/28/2023,US,Not Specified,US-GSK-US2023GSK179976,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al. 2022 Annual report of the national poison data system (NPDS) from america\\'s poison Centers: 40th annual report. Clinical toxicology. 2023;61(10):717-939\",-\\n22194175,-,Herbals\\\\Mitragynine;Alcohol;Fentanyl,Drug Abuse,Respiratory Arrest;Prescription Drug Used Without A Prescription;Cardiac Arrest;Drug Abuse,Serious,Died,Male,-,4/11/2023,Expedited,41,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,4/11/2023,US,Not Specified,US-ALVOGEN-2023090326,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NP , Bronstein AC, Weber J.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report.. Clinical toxicity. 2023Jan05;60(12):1381-1643. doi:10.1080/15563650.2021.1989785\",-\\n22189858,Venlafaxine,Venlafaxine Hydrochloride;Amphetamine;Herbals\\\\Mitragynine,Drug Abuse,Drug Abuse,Serious,Died,Male,-,4/10/2023,Expedited,31,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,4/10/2023,US,Not Specified,US-ALVOGEN-2023091145,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NP , Bronstein AC, Weber J. 2021 Annual Report of the National Poison Data System (NPDS) from America?s Poison Centers: 39th Annual Report. Clinical toxicity. 2023Jan05;60:1381-1643. doi:10.1080/15563650.2021.1989785\",-\\n22193454,Salicylate;Heroin;Sertraline,Herbals\\\\Mitragynine;Sertraline Hydrochloride;Diamorphine;Cocaine;Alprazolam;Salicylic Acid;Fentanyl;Cannabis Sativa Subsp. Indica Top;Aripiprazole,Product Used For Unknown Indication,Death,Serious,Died,Male,-,4/10/2023,Expedited,17,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,4/10/2023,US,Not Specified,US-ALVOGEN-2023090164,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NP , Bronstein AC, Weber J. 2021 Annual Report of the National Poison Data System (NPDS) from America?s Poison Centers: 39th Annual Report. Clinical toxicity. 2023Jan05;60:1381-1643. doi: https://doi.org/10.1080/15563650.2022.2132768\",-\\n21917719,-,Lorazepam;Aripiprazole;Acetaminophen;Herbals\\\\Mitragynine;Gabapentin,Product Used For Unknown Indication,Intentional Product Misuse,Serious,Died,Male,-,1/27/2023,Expedited,22,Not Specified,Glenmark,Healthcare Professional,Not Specified,-,1/17/2023,1/27/2023,US,Not Specified,US-GLENMARK PHARMACEUTICALS-2023GMK078006,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA.. 2021 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers: 39th Annual Report.. Clinical Toxicology.. 2022;60 (12):1381-1643\",-\\n21858301,Methadone,Methadone Hydrochloride;Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/13/2023,Non-Expedited,31,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/13/2023,US,Not Specified,US-APOTEX-2023AP000658,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21857327,-,Fentanyl;Herbals\\\\Mitragynine;Alprazolam,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/13/2023,Expedited,24,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/13/2023,US,Not Specified,US-APOTEX-2023AP000380,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21866057,-,Cannabis Sativa Subsp. Indica Top;Herbals\\\\Mitragynine;Cocaine;Fentanyl,Product Used For Unknown Indication,Drug Abuse;Cardio-Respiratory Arrest,Serious,Other Outcomes;Hospitalized;Died,Male,2021,1/16/2023,Expedited,27,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/16/2023,US,Not Specified,US-APOTEX-2023AP000475,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21865135,-,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Death,Serious,Other Outcomes;Died,Male,2021,1/16/2023,Expedited,28,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/16/2023,US,Not Specified,US-APOTEX-2023AP000533,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21864247,-,Cannabis Sativa Subsp. Indica Top;Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse;Cardio-Respiratory Arrest,Serious,Other Outcomes;Hospitalized;Died,Male,2021,1/16/2023,Expedited,24,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/16/2023,US,Not Specified,US-APOTEX-2023AP000371,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21867698,-,Fentanyl;Herbals\\\\Mitragynine;Chlorpheniramine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Female,-,1/16/2023,Non-Expedited,31,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/16/2023,US,Not Specified,US-APOTEX-2023AP000645,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21865432,-,Cannabis Sativa Subsp. Indica Top;Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/16/2023,Non-Expedited,28,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/16/2023,US,Not Specified,US-APOTEX-2023AP000529,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21865069,Heroin,Diamorphine;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/16/2023,Non-Expedited,26,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/16/2023,US,Not Specified,US-APOTEX-2023AP000425,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21871552,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Completed Suicide,Serious,Other Outcomes;Died,Female,2021,1/17/2023,Expedited,54,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/17/2023,US,Not Specified,US-APOTEX-2023AP001335,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21871276,-,Herbals\\\\Mitragynine;Lorazepam;Acetaminophen;Gabapentin;Aripiprazole,Product Used For Unknown Indication,Intentional Product Misuse,Serious,Died,Male,2021,1/17/2023,Expedited,22,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/17/2023,US,Not Specified,US-APOTEX-2023AP000328,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21872866,Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/17/2023,Non-Expedited,38,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/17/2023,US,Not Specified,US-APOTEX-2023AP000932,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21870466,Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,1/17/2023,Non-Expedited,57,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/17/2023,US,Not Specified,US-APOTEX-2023AP001401,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21877437,Alcohol (Alcohol),Alcohol;Butalbital;Valproic Acid;Gabapentin;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Completed Suicide;Cardio-Respiratory Arrest,Serious,Other Outcomes;Died;Hospitalized,Female,2021,1/18/2023,Expedited,45,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/18/2023,US,Not Specified,US-APOTEX-2023AP001683,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21878217,Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Gabapentin,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,1/18/2023,Expedited,45,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/18/2023,US,Not Specified,US-APOTEX-2023AP002156,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21876037,-,Etizolam;Fentanyl;Gabapentin;Herbals\\\\Mitragynine;Oxycodone,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,1/18/2023,Expedited,46,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/18/2023,US,Not Specified,US-APOTEX-2023AP001163,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21876005,Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,1/18/2023,Non-Expedited,42,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/18/2023,US,Not Specified,US-APOTEX-2023AP001048,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21865359,Alcohol (Alcohol),Alcohol;Fentanyl;Herbals\\\\Mitragynine;Clonazepam,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,1/18/2023,Non-Expedited,26,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/16/2023,US,Not Specified,US-APOTEX-2023AP000453,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21883344,Sertraline,Sertraline Hydrochloride;Acetaminophen;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Completed Suicide,Serious,Died;Hospitalized;Other Outcomes,Male,2021,1/19/2023,Expedited,34,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/19/2023,US,Not Specified,US-APOTEX-2023AP000800,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21882068,Sertraline;Heroin,Diamorphine;Alprazolam;Sertraline Hydrochloride;Aripiprazole;Fentanyl;Cocaine;Herbals\\\\Mitragynine;Cannabis Sativa Subsp. Indica Top,Product Used For Unknown Indication,Death,Serious,Other Outcomes;Died;Hospitalized,Male,2021,1/19/2023,Expedited,17,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/19/2023,US,Not Specified,US-APOTEX-2023AP002115,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21883867,-,Herbals\\\\Mitragynine;Fentanyl;Diazepam,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/19/2023,Non-Expedited,70,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/19/2023,US,Not Specified,US-APOTEX-2023AP001599,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21882849,-,Herbals\\\\Mitragynine;Methamphetamine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,1/19/2023,Non-Expedited,57,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/19/2023,US,Not Specified,US-APOTEX-2023AP001394,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21888023,Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Cardio-Respiratory Arrest;Drug Abuse,Serious,Other Outcomes;Hospitalized;Died,Male,2021,1/20/2023,Expedited,41,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/20/2023,US,Not Specified,US-APOTEX-2023AP001014,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n21894625,Trazodone,Trazodone Hydrochloride;Ibuprofen;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Intentional Product Use Issue,Serious,Died;Hospitalized,Male,-,1/22/2023,Expedited,52,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/9/2023,1/22/2023,US,Not Specified,US-APOTEX-2023AP001301,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",-\\n22103278,-,Gabapentin;Butalbital;Valproic Acid;Alcohol;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Suspected Suicide,Serious,Died;Other Outcomes,Female,-,3/16/2023,Expedited,45,Not Specified,Catalent Pharma,Healthcare Professional,Not Specified,-,3/5/2023,3/16/2023,US,Not Specified,US-CATALENT PHARMA SOLUTIONS-CAT-000011-2023,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA.2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report.Clinical toxicology (Philadelphia).DEC-2022;60(12):1381-1643\",-\\n22196087,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Death;Prescription Drug Used Without A Prescription,Serious,Died,Male,-,4/11/2023,Expedited,42,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,4/11/2023,US,Not Specified,US-ALVOGEN-2023089931,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report.. Clinical toxicology. 2023Jan05;60(12):1381-1643. doi:10.1080/15563650.2022.2132768\",-\\n22195783,-,Herbals\\\\Mitragynine;Fentanyl,Suicide Attempt,Prescription Drug Used Without A Prescription;Completed Suicide,Serious,Died,Female,-,4/11/2023,Expedited,54,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,4/11/2023,US,Not Specified,US-ALVOGEN-2023089887,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report.. Clinical toxicology. 2023Jan05;60(12):1381-1643. doi:10.1080/15563650.2022.2132768\",-\\n22188284,-,Aripiprazole;Gabapentin;Acetaminophen;Herbals\\\\Mitragynine;Lorazepam,Intentional Product Misuse,Intentional Product Misuse,Serious,Died,Male,-,4/8/2023,Expedited,22,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,4/8/2023,US,Not Specified,US-ALVOGEN-2023089713,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report.. Clinical toxicity. 2023Jan05;60(12):1381-1643. doi:10.1080/15563650.2021.1989785\",-\\n22195671,-,Alcohol;Valproic Acid;Herbals\\\\Mitragynine;Gabapentin;Butalbital,Suicide Attempt,Completed Suicide;Respiratory Arrest;Cardiac Arrest,Serious,Died,Female,-,4/11/2023,Expedited,45,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,4/11/2023,US,Not Specified,US-ALVOGEN-2023090040,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2023 Jan 05;60(12):1381-1643. doi:10.1080/15563650.2022.2132768\",-\\n22197048,-,Herbals\\\\Mitragynine;Fentanyl;Cannabis Sativa Subsp. Indica Top,Drug Abuse,Incorrect Route Of Product Administration;Cardiac Arrest;Drug Abuse;Respiratory Arrest,Serious,Died,Male,-,4/11/2023,Expedited,24,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,4/11/2023,US,Not Specified,US-ALVOGEN-2023090497,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA.. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 05Jan2023;60(12):1381-1643 . doi:https://doi.org/10.1080/15563650.2022.2132768\",-\\n22195924,Sertraline,Sertraline Hydrochloride;Fentanyl;Herbals\\\\Mitragynine,Drug Abuse,Prescription Drug Used Without A Prescription;Drug Abuse,Serious,Died,Male,-,4/11/2023,Expedited,39,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,4/11/2023,US,Not Specified,US-ALVOGEN-2023089863,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report . Clinical Toxicology. 2023-Jan-05;60 (12):1381-1643. doi:https://doi.org/10.1080/15563650.2022.2132768\",-\\n22518024,Trazodone,Trazodone Hydrochloride;Herbals\\\\Mitragynine;Ibuprofen,Product Used For Unknown Indication,Death,Serious,Died,Male,-,6/5/2023,Non-Expedited,52,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,6/5/2023,US,Not Specified,US-ALVOGEN-2023091005,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2023Jan05;60(12):1381-1643. https://doi:10.1080/15563650.2022.2132768\",-\\n22196048,Sertraline,Sertraline Hydrochloride;Herbals\\\\Mitragynine;Acetaminophen,Suicide Attempt,Completed Suicide,Serious,Died,Male,-,4/11/2023,Expedited,34,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,4/11/2023,US,Not Specified,US-ALVOGEN-2023089806,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2023 Jan 05;60(12):1381-1643. doi:10.1080/15563650.2022.2132768\",-\\n22195915,-,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Death,Serious,Died,Male,-,4/11/2023,Expedited,28,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,4/11/2023,US,Not Specified,US-ALVOGEN-2023089777,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2023 Jan 05;60(12):1381-1643. doi:10.1080/15563650.2022.2132768\",-\\n22195005,-,Herbals\\\\Mitragynine;Etizolam;Oxycodone;Gabapentin;Fentanyl,Drug Abuse,Drug Abuse;Prescription Drug Used Without A Prescription,Serious,Died,Male,-,4/11/2023,Expedited,46,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,4/11/2023,US,Not Specified,US-ALVOGEN-2023089886,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2023 Jan 05;60(12):1381-1643. doi:10.1080/15563650.2022.2132768\",-\\n22188537,-,Gabapentin;Herbals\\\\Mitragynine;Alcohol,Drug Abuse,Drug Abuse,Serious,Died,Male,-,4/9/2023,Expedited,45,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2023,4/9/2023,US,Not Specified,US-ALVOGEN-2023090248,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America?s Poison Centers: 39th Annual Report. Clinical Toxicology. 2023-Jan-05;60 (12):1381-1643. doi: https://doi.org/10.1080/15563650.2022.2132768\",-\\n21952960,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Completed Suicide;Analgesic Drug Level Increased,Serious,Died,Male,2021,2/4/2023,Expedited,39,Not Specified,Specgx,Healthcare Professional,Not Specified,-,1/5/2023,2/4/2023,US,Not Specified,US-SPECGX-T202300115,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R et al. 2021 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60(12):1381-643\",-\\n22008425,Sertraline;Heroin,Cocaine;Diamorphine;Sertraline Hydrochloride;Fentanyl Citrate;Alprazolam;Herbals\\\\Mitragynine;Cannabis Sativa Subsp. Indica Top;Aripiprazole,Product Used For Unknown Indication,Death,Serious,Died,Male,2021,2/19/2023,Expedited,17,Not Specified,Specgx,Healthcare Professional,Not Specified,-,1/5/2023,2/19/2023,US,Not Specified,US-SPECGX-T202300403,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R et al. 2021 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60(12):1381-643\",-\\n22008414,-,Fentanyl Citrate;Cannabis Sativa Subsp. Indica Top;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Incorrect Route Of Product Administration;Analgesic Drug Level Increased;Drug Abuse,Serious,Died,Male,2021,2/19/2023,Expedited,24,Not Specified,Specgx,Healthcare Professional,Not Specified,-,1/5/2023,2/19/2023,US,Not Specified,US-SPECGX-T202300495,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R et al. 2021 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60(12):1381-643\",-\\n22008410,-,Herbals\\\\Mitragynine;Fentanyl Citrate,Product Used For Unknown Indication,Death,Serious,Died,Male,2021,2/19/2023,Expedited,28,Not Specified,Specgx,Healthcare Professional,Not Specified,-,1/5/2023,2/19/2023,US,Not Specified,US-SPECGX-T202300518,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R et al. 2021 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60(12):1381-643\",-\\n21974859,-,Herbals\\\\Mitragynine;Fentanyl;Diazepam,Product Used For Unknown Indication,Drug Abuse,Serious,Died,Male,-,2/9/2023,Expedited,70,Not Specified,Bausch And Lomb,Healthcare Professional,Not Specified,-,2/2/2023,2/9/2023,US,Not Specified,US-BAUSCH-BL-2023-002101,\"Gummin D, Mowry J, Beuhler M, Spyker D, Rivers L, Feldman R, Brown K, Pham N, Bronstein A, Weber J. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2023 JAN 05;60 (12):1381-1643. doi:10.1080/15563650.2022.2132768\",-\\n21979697,Venlafaxine,Venlafaxine Hydrochloride;Amphetamine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died,Male,-,2/10/2023,Expedited,31,Not Specified,Bausch And Lomb,Healthcare Professional,Not Specified,-,2/2/2023,2/10/2023,US,Not Specified,US-BAUSCH-BL-2023-002262,\"Gummin D, Mowry J, Beuhler M, Spyker D, Rivers L, Feldman R, Brown K, Pham N, Bronstein A, Weber J. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Report. Clinical Toxicology. 2023 JAN 05;60 (12):1381-1643. doi:10.1080/15563650.2022.2132768\",-\\n23310675,-,Pseudoephedrine;Dextromethorphan;Citalopram;Herbals\\\\Mitragynine;Phenylpropanolamine;Bupropion,Product Used For Unknown Indication,Completed Suicide;Cardiac Arrest;Respiratory Arrest,Serious,Died;Other Outcomes,Male,-,12/21/2023,Expedited,39,Not Specified,Bausch And Lomb,Healthcare Professional,Not Specified,-,12/13/2023,12/18/2023,US,Not Specified,US-BAUSCH-BL-2023-018557,\"Gummin D, Mowry J, Beuhler M, Spyker D, Rivers L, Feldman R, Brown K, Pham N, Bronstein A, DesLauriers C. 2022 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023 DEC 12;61(10):717-939. doi:10.1080/15563650.2023.2268981\",-\\n21873010,-,Chlorpheniramine Maleate;Fentanyl;Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Drug Abuse,Serious,Died,Female,-,1/17/2023,Expedited,31,Not Specified,Bayer,Healthcare Professional,Not Specified,-,1/9/2023,1/17/2023,US,Not Specified,US-BAYER-2023A003690,Gummin D D; Mowry J B; Beuhler C; Spyker D A; Rivers L J; Feldman R; Brown K; Pham Nathanuek; Bronsteun A C; Weber J A. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Repor. Clinical Toxicology. 2022;60:12:1381-1643,-\\n21872340,Sertraline;Heroin,Alprazolam;Diamorphine;Cocaine;Cannabis Sativa Subsp. Indica Top;Herbals\\\\Mitragynine;Sertraline Hydrochloride;Fentanyl;Aspirin;Aripiprazole,-,Toxicity To Various Agents;Product Use Issue,Serious,Hospitalized;Died,Male,-,1/17/2023,Expedited,17,Not Specified,Bayer,Healthcare Professional,Not Specified,-,1/9/2023,1/17/2023,US,Not Specified,US-BAYER-2023A002779,Gummin D D; Mowry J B; Beuhler C; Spyker D A; Rivers L J; Feldman R; Brown K; Pham Nathanuek; Bronsteun A C; Weber J A. 2021 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 39th Annual Repor. Clinical Toxicology. 2022;60:12:1381-1643,-\\n16489116,Fluoxetine;Amlodipine,Amlodipine Besylate;Trimipramine;Fluoxetine Hydrochloride;Sildenafil;Bentiamine\\\\Bucetin\\\\Caffeine\\\\Ethenzamide;Herbals\\\\Mitragynine;Diphenhydramine,Product Used For Unknown Indication,Toxicity To Various Agents;Pneumonia;Pulmonary Oedema,Serious,Other Outcomes;Died,Male,-,9/12/2023,Expedited,56,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,9/2/2023,6/28/2019,DE,Not Specified,DE-AUROBINDO-AUR-APL-2019-036700,\"Fels H, Lottner-Nau S, Sax T, Roider G, Graw M, Auwrter V, Musshoff F. Postmortem concentrations of the synthetic opioid U-47700 in 26 fatalities associated with the drug. Forensic Science International. 2019;S0379-0738(19):30141-0\",-\\n17861180,Buspirone;Trazodone,Trazodone Hydrochloride;Herbals\\\\Mitragynine;Buspirone Hydrochloride;Desvenlafaxine Succinate;Ziprasidone Hydrochloride;Bupropion,Depression,Serotonin Syndrome;Off Label Use;Drug Interaction,Serious,Hospitalized;Other Outcomes;Life Threatening,Male,-,11/28/2023,Expedited,63,102 KG,Pfizer,Healthcare Professional,Not Specified,Metformin;Gabapentin;Glimepiride;Diclofenac;Amlodipine Besylate;Tizanidine;Hydrochlorothiazide;Omeprazole,11/20/2023,6/4/2020,US,Not Specified,US-PFIZER INC-2020216505,\"Eudaley, S.. Case report: Successful treatment of suspected kratom-induced serotonin syndrome. Journal of the American College of Clinical Pharmacy. 2020;3 (1):347\",-\\n17889667,Buspirone;Trazodone,Trazodone Hydrochloride;Buspirone Hydrochloride;Desvenlafaxine Succinate;Ziprasidone;Bupropion;Herbals\\\\Mitragynine,Depression;Hypertension;Product Used For Unknown Indication;Type 2 Diabetes Mellitus,Drug Interaction;Serotonin Syndrome,Serious,Hospitalized,Male,-,8/10/2023,Expedited,63,102.5 KG,Mylan,Healthcare Professional,Not Specified,Gabapentin;Glimepiride;Amlodipine;Metformin;Tizanidine;Diclofenac;Omeprazole;Hydrochlorothiazide,8/1/2023,6/12/2020,US,Not Specified,US-MYLANLABS-2020M1055177,\"Eudaley ST, Hamilton LA. Case report: Successful treatment of suspected kratominduced serotonin syndrome. J-Am-Coll-Clin-Pharm 2020;3(1):347 abstr. 450.\",-\\n23295786,Trazodone;Buspirone,Buspirone Hydrochloride;Herbals\\\\Mitragynine;Desvenlafaxine;Ziprasidone;Trazodone Hydrochloride;Bupropion Hydrochloride,Antibiotic Therapy;Anxiety Disorder;Major Depression;Phytotherapy;Product Used For Unknown Indication,Pyrexia;Serotonin Syndrome;Flushing;Clonus;Facial Paralysis;Delirium;Tremor;Aphasia;Drug Interaction;Confusional State;Dysarthria;Hyperreflexia,Serious,Hospitalized;Other Outcomes,Male,-,12/14/2023,Expedited,63,102.5 KG,Jubilant,Healthcare Professional,Not Specified,Diclofenac;Amlodipine;Omeprazole;Glimepiride;Tizanidine;Metformin;Hydrochlorothiazide;Acetaminophen;Vancomycin;Gabapentin;Piperacillin Sodium\\\\Tazobactam Sodium,12/4/2023,12/14/2023,US,Not Specified,US-JUBILANT CADISTA PHARMACEUTICALS-2023US001597,\"Eudaley ST, Brooks SP, Hamilton LA.. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. Journal of Pharmacy Practice. 2023;36(6):15231527\",-\\n23224916,Buspirone;Trazodone,Trazodone Hydrochloride;Bupropion;Desvenlafaxine;Buspirone Hydrochloride;Herbals\\\\Mitragynine;Ziprasidone,Anxiety Disorder;Major Depression;Product Used For Unknown Indication,Serotonin Syndrome;Drug Interaction,Serious,Hospitalized,Male,-,11/24/2023,Expedited,63,102.5 KG,Emcure,Healthcare Professional,Not Specified,Gabapentin;Metformin;Diclofenac;Glimepiride;Hydrochlorothiazide;Tizanidine;Omeprazole;Amlodipine,11/14/2023,11/24/2023,US,Not Specified,US-AVET LIFESCIENCES LTD-2023-AVET-000342,\"Eudaley ST, Brooks SP, Hamilton LA.. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. Journal of Pharmacy Practice. 2023;36(6):1523-1527\",-\\n23257219,Buspirone;Trazodone,Trazodone Hydrochloride;Buspirone Hydrochloride;Herbals\\\\Mitragynine;Ziprasidone;Desvenlafaxine,Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome,Serious,Hospitalized,Male,-,12/4/2023,Expedited,63,102.5 KG,Alvogen,Healthcare Professional,Not Specified,Tizanidine;Diclofenac;Bupropion;Metformin;Amlodipine;Glimepiride;Omeprazole;Gabapentin;Hydrochlorothiazide,11/23/2023,12/4/2023,US,Not Specified,US-ALVOGEN-2023092653,\"Eudaley S T, Brooks S P, Hamilton L A. Case Report: Possible Serotonin Syndrome in a Patient Taking Serotonergic Agents. journal of Pharmacy Practice. 2023;36(6):1523?1527. doi:10.1177/08971900221116009\",-\\n22525830,Suboxone,Buprenorphine Hydrochloride\\\\Naloxone Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents;Intentional Product Use Issue,Serious,Other Outcomes;Died,Male,-,6/6/2023,Expedited,52,Not Specified,Reckitt Benckiser,Healthcare Professional,Not Specified,-,6/1/2023,6/6/2023,US,Not Specified,US-INDIVIOR EUROPE LIMITED-INDV-139608-2023,\"Donna M. Papsun, Ayako Chan-Hosokawa, Laura Friederich, Justin Brower, Kristopher Graf and Barry Logan. The Trouble With Kratom: Analytical and Interpretative Issues Involving Mitragynine. Journal of Analytical Toxicology. 2019;43:615-629\",-\\n22798057,Alcohol (Alcohol);Heroin,Flualprazolam;Diamorphine;Oxycodone;Morphine;Clonazolam;Clonazepam;Flubromazolam;Herbals\\\\Mitragynine;Oxymorphone;Phencyclidine;Hydrocodone;Codeine;Fluoroketamine;Alcohol;Psilocin;Hydromorphone,-,Sinus Tachycardia;Sinus Arrhythmia;Fall;Mental Status Changes;Sinus Bradycardia;Toxicity To Various Agents;Nystagmus;Drug Abuse,Serious,Other Outcomes;Hospitalized,Male,-,8/8/2023,Expedited,28,Not Specified,Cheplapharm,Healthcare Professional,Not Specified,-,8/1/2023,8/8/2023,US,Not Specified,US-CHEPLA-2023009702,\"Domanski K, Fleming SW, Maag H, Raley EB, DeBord J, Wright B, et al. A Psychonaut\\'s Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis. Journal of psychoactive drugs. 2022;54(4):319-323. DOI: 10.1080/02791072.2021.2006373.\",-\\n22780091,Heroin,Diamorphine;Morphine Sulfate;Hydrocodone;Oxycodone;Oxymorphone;Ketamine;Herbals\\\\Mitragynine;Clonazepam;Hydromorphone,Product Used For Unknown Indication,Bradycardia;Mental Status Changes;Substance Use;Drug Abuse,Serious,Hospitalized,Male,-,8/3/2023,Expedited,Not Specified,Not Specified,Strides,Healthcare Professional,Not Specified,-,7/25/2023,8/3/2023,US,Not Specified,US-STRIDES ARCOLAB LIMITED-2023SP012426,\"Domanski k, Fleming SW, Maag H, Raley E, Debord J, Wright B, et al.. A Psychonaut\\'s Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis.. J-Psychoactive-Drugs. 2022;54(4):319-323\",-\\n22787068,-,Herbals\\\\Mitragynine;Phencyclidine;Clonazepam;Oxycodone;Codeine;Oxymorphone;Hydrocodone;Desmetramadol;Lorazepam;Ketamine;Hydromorphone;Alprazolam;Morphine,Product Used For Unknown Indication,Bradycardia;Dissociative Disorder;Nystagmus;Fall;Sinus Tachycardia;Mental Status Changes;Pupillary Reflex Impaired;Drug Abuse,Serious,Other Outcomes;Hospitalized,Male,-,8/4/2023,Expedited,28,Not Specified,Lupin,Healthcare Professional,Not Specified,-,7/25/2023,8/4/2023,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2023-06389,\"Domanski k, Fleming SW, Maag H, Raley E, Debord J, Wright B, et al. A Psychonaut\\'s experience of intoxication with multiple classes of drugs including novel psychoactive substance 2-fluorodeschloroketamine: Case report and urinary analysis. Journal Of Psychoactive Drugs. 2022;54(4):319323\",-\\n20667448,Venlafaxine,Venlafaxine Hydrochloride;Herbals\\\\Mitragynine;Quetiapine Fumarate,Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome;Electrocardiogram Qt Prolonged,Serious,Hospitalized;Other Outcomes,Male,-,3/31/2023,Expedited,36,Not Specified,Rising Pharmaceuticals,Healthcare Professional,Not Specified,-,3/20/2023,4/4/2022,US,Not Specified,US-RISINGPHARMA-US-2022RISLIT00319,Brogdon HD.A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone.Journal of Addiction Medicine.14-FEB-2022,-\\n21727410,Naloxone Hcl,Naloxone Hydrochloride;Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died,Male,-,4/12/2023,Expedited,33,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,4/11/2023,12/14/2022,US,Not Specified,US-PFIZER INC-PV202200118721,\"Behonick, G.. Two Single-Drug Fatal Intoxications by Mitragynine. Journal of Analytical Toxicology. 2022;46(5):E110-E114\",-\\n22288662,-,Herbals\\\\Mitragynine,Asthenia,Eye Disorder;Psychotic Disorder;Drug Dependence;Withdrawal Syndrome,Serious,Hospitalized;Disabled,Male,31-Jul-2022,5/4/2023,Direct,24,74.25 KG,Fda-Ctu,Consumer,Not Specified,Zoloft;Vitamin D,-,5/4/2023,Not Specified,Not Specified,-,-,-\\n22682730,-,Herbals\\\\Mitragynine,Anxiety;Pain,Seizure,Serious,Required Intervention;Life Threatening;Other Outcomes;Hospitalized,Female,25-Apr-2023,7/6/2023,Direct,48,69.75 KG,Fda-Ctu,Consumer,Not Specified,Vivitrol,-,7/6/2023,Not Specified,Not Specified,-,-,-\\n22140015,-,Herbals\\\\Mitragynine,Substance Use,Socioeconomic Precarity;Lethargy;Drug Dependence;Depression;Weight Decreased;Apathy;Appetite Disorder,Serious,Required Intervention;Hospitalized,Male,25-Feb-2023,3/24/2023,Direct,31,67.5 KG,Fda-Ctu,Consumer,Not Specified,Vitamin C;Lexapro,-,3/24/2023,Not Specified,Not Specified,-,-,-\\n21926051,-,Herbals\\\\Mitragynine,Asthenia,Delusion;Balance Disorder;Euphoric Mood;Dysarthria;Amnesia,Serious,Other Outcomes,Female,21-Jan-2023,1/29/2023,Direct,63,76.5 KG,Fda-Ctu,Consumer,Not Specified,Vitamin C;Garlic;Vitamins,-,1/29/2023,Not Specified,Not Specified,-,-,-\\n22309885,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Verbal Abuse;Dyskinesia;Hyperhidrosis;Irritability;Muscle Atrophy;Weight Decreased;Dependence;Diarrhoea;Headache;Restless Legs Syndrome;Panic Attack;Sneezing;Withdrawal Syndrome;Chills;Anger,Non-Serious,Non-Serious,Male,-,5/10/2023,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,Vitamin C;Dietary Supplement,-,5/10/2023,Not Specified,Not Specified,-,-,-\\n21810314,-,Herbals\\\\Mitragynine,Anxiety;Disturbance In Attention,Nervousness;Product Complaint;Product Odour Abnormal;Movement Disorder;Vomiting Projectile;Motion Sickness;Product Taste Abnormal;Retching;Malaise;Impaired Work Ability;Dizziness,Serious,Other Outcomes,Female,30-Aug-2022,1/1/2023,Direct,50,72 KG,Fda-Ctu,Consumer,Not Specified,Unspecified Ingredient,-,1/1/2023,Not Specified,Y,-,-,-\\n22619365,-,Herbals\\\\Mitragynine,Alcoholism,Dependence,Serious,Required Intervention,Male,05-Jun-2023,6/16/2023,Direct,41,65.25 KG,Fda-Ctu,Consumer,Not Specified,Suboxone,-,6/16/2023,Not Specified,Not Specified,-,-,-\\n22035701,-,Herbals\\\\Mitragynine,Anxiety,Product Label Issue;Contraindicated Product Administered;Aspiration;Serotonin Syndrome;Disorientation;Pneumonia Aspiration;Vomiting;Coma;Cerebrovascular Accident;Oxygen Saturation Decreased;Dyspnoea,Serious,Life Threatening;Disabled;Hospitalized,Male,29-Jan-2023,2/23/2023,Direct,50,104.78 KG,Fda-Ctu,Consumer,Not Specified,Sertraline;Buspirone;Gabapentin;Metoprolol;Remeron,-,2/23/2023,Not Specified,Not Specified,-,-,-\\n23037565,-,Herbals\\\\Mitragynine,Disturbance In Attention,Feeling Abnormal;Retching;Malaise;Nausea;Hot Flush;Dehydration;Vomiting,Non-Serious,Non-Serious,Female,04-Oct-2023,10/5/2023,Direct,49,70.2 KG,Fda-Ctu,Consumer,Not Specified,Omeprazole;Ginkgo;Diclofenac;Curcumin;Glucosamine,-,10/5/2023,Not Specified,Y,-,-,-\\n21935676,-,Herbals\\\\Mitragynine,Anxiety;Asthenia;Depression,Loss Of Consciousness;Dependence;Concussion;Head Injury,Serious,Other Outcomes,Male,14-Mar-2022,1/31/2023,Direct,55,92.25 KG,Fda-Ctu,Consumer,Not Specified,Motrin;Lisinopril;Valium,-,1/31/2023,Not Specified,Not Specified,-,-,-\\n22288643,-,Herbals\\\\Mitragynine,Attention Deficit Hyperactivity Disorder,Withdrawal Syndrome;Attention Deficit Hyperactivity Disorder;Mental Disorder;Product Taste Abnormal;Nausea;Product Tampering;Agitation;Aggression;Chest Pain;Condition Aggravated;Schizoaffective Disorder Bipolar Type,Serious,Required Intervention;Disabled;Hospitalized,Not Specified,04-May-2023,5/4/2023,Direct,337 MTH,81.9 KG,Fda-Ctu,Consumer,Not Specified,Methylphenidate;Lamotrigine;Paliperidone,-,5/4/2023,Not Specified,Not Specified,-,-,-\\n22768503,-,Herbals\\\\Mitragynine,Depression,Accidental Overdose;Drug Dependence;Seizure,Serious,Died;Other Outcomes,Male,12-Jun-2022,7/31/2023,Direct,38,99 KG,Fda-Ctu,Consumer,Not Specified,Lexapro;Ritalin,-,7/31/2023,Not Specified,Not Specified,-,-,-\\n22291756,-,Herbals;Herbals\\\\Mitragynine,Anxiety;Pain,Hot Flush;Hyperhidrosis;Hallucination;Respiratory Distress;Drug Dependence;Pulmonary Fibrosis;Chills;Withdrawal Syndrome;Pain;Overdose,Serious,Required Intervention;Hospitalized;Disabled;Life Threatening,Male,30-Mar-2023,5/5/2023,Direct,27,66.6 KG,Fda-Ctu,Consumer,Not Specified,Insulin Nos,-,5/5/2023,Not Specified,Not Specified,-,-,-\\n21854881,-,Herbals\\\\Mitragynine,Anxiety,Death,Serious,Died,Male,02-Dec-2021,1/12/2023,Direct,23,83.25 KG,Fda-Ctu,Consumer,Not Specified,Hydroxyzine;Citalopram,-,1/12/2023,Not Specified,Not Specified,-,-,-\\n22022197,-,Herbals\\\\Mitragynine,Arthralgia;Back Pain,\"Delusional Disorder, Unspecified Type;Death;Abnormal Behaviour;Hallucination\",Serious,Died;Hospitalized,Male,06-Feb-2023,2/20/2023,Direct,48,67.5 KG,Fda-Ctu,Consumer,Not Specified,Herbals\\\\Mitragynine;Ibuprofen;Seroquel,-,2/20/2023,Not Specified,Not Specified,-,-,-\\n21870942,-,Herbals\\\\Mitragynine,Drug Dependence,Legal Problem;Drug Screen Positive,Non-Serious,Non-Serious,Male,30-Dec-2022,1/14/2023,Direct,51,99 KG,Fda-Ctu,Consumer,Not Specified,Herbals\\\\Mitragynine,-,1/14/2023,Not Specified,Not Specified,-,-,-\\n22284369,-,Herbals\\\\Mitragynine,-,Hepatic Failure;Renal Failure;Toxicity To Various Agents,Serious,Life Threatening;Hospitalized;Died,Female,06-Apr-2023,5/3/2023,Direct,23,Not Specified,Fda-Ctu,Consumer,Not Specified,Herbals\\\\Mitragynine,-,5/3/2023,Not Specified,Not Specified,-,-,-\\n23020201,-,Herbals\\\\Mitragynine,-,Fall;Brain Death,Serious,Died,Male,09-Feb-2023,10/2/2023,Direct,40,86.4 KG,Fda-Ctu,Consumer,Not Specified,Device,-,10/2/2023,Not Specified,Not Specified,-,-,-\\n22134904,-,Herbals\\\\Mitragynine,Anxiety;Pain In Extremity,Toxicity To Various Agents;Drug Dependence;Substance Use,Serious,Died,Female,15-May-2022,3/23/2023,Direct,28,64.8 KG,Fda-Ctu,Consumer,Not Specified,Concerta,-,3/23/2023,Not Specified,Not Specified,-,-,-\\n22882565,-,Herbals\\\\Mitragynine,Substance Use,Psychotic Disorder;Bipolar Disorder;Death,Serious,Life Threatening;Died,Male,24-Jul-2023,8/29/2023,Direct,30,76.5 KG,Fda-Ctu,Consumer,Not Specified,Cannabis Sativa Subsp. Indica Top;Lithium;Lyrica,-,8/29/2023,Not Specified,Not Specified,-,-,-\\n22699975,-,Herbals\\\\Mitragynine,Anxiety,Intentional Overdose,Serious,Died,Male,28-Jul-2022,7/12/2023,Direct,50,60.75 KG,Fda-Ctu,Consumer,Not Specified,Benazepril;Vitamin D,-,7/12/2023,Not Specified,Not Specified,-,-,-\\n23059601,-,Herbals\\\\Mitragynine,-,Seizure;Intentional Product Use Issue,Serious,Other Outcomes;Life Threatening,Female,11-Oct-2023,10/12/2023,Direct,72,69.8 KG,Fda-Ctu,Healthcare Professional,Not Specified,Amlodipine Besylate;Pregabalin;Duloxetine;Doxycycline;Losartan;Levothyroxine;Ibuprofen;Metformin,-,10/12/2023,Not Specified,Not Specified,-,-,-\\n22923659,-,Herbals\\\\Mitragynine,Drug Dependence,Drug Dependence,Serious,Hospitalized;Required Intervention,Male,01-Sep-2023,9/7/2023,Direct,33,67.5 KG,Fda-Ctu,Consumer,Not Specified,Adderall,-,9/7/2023,Not Specified,Not Specified,-,-,-\\n21835312,-,Gabapentin;Herbals\\\\Mitragynine;Acetaminophen,Product Used For Unknown Indication,Toxicity To Various Agents;Intentional Product Misuse,Serious,Died,Male,2021,1/9/2023,Expedited,22,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,1/1/2023,1/9/2023,US,Not Specified,US-JNJFOC-20230106764,-,-\\n21909724,Sertraline,Sertraline Hydrochloride;Acetaminophen;Herbals\\\\Mitragynine,Suspected Suicide,Exposure To Toxic Agent,Serious,Died,Male,2021,1/25/2023,Expedited,34,Not Specified,Galpharm International,Healthcare Professional,Not Specified,-,1/23/2023,1/25/2023,US,Not Specified,US-PERRIGO-23US000857,-,-\\n21916131,-,Herbals\\\\Mitragynine;Gabapentin;Acetaminophen;Aripiprazole;Lorazepam,Product Used For Unknown Indication,Exposure To Toxic Agent,Serious,Died,Male,2021,1/26/2023,Expedited,22,Not Specified,Galpharm International,Healthcare Professional,Not Specified,-,1/23/2023,1/26/2023,US,Not Specified,US-PERRIGO-23US000849,-,-\\n21919380,-,Cocaine;Doxylamine Succinate;Herbals\\\\Mitragynine,Drug Abuse,Exposure To Toxic Agent,Serious,Died,Male,2021,1/27/2023,Expedited,20,Not Specified,Galpharm International,Healthcare Professional,Not Specified,-,1/23/2023,1/27/2023,US,Not Specified,US-PERRIGO-23US001235,-,-\\n21927733,Trazodone,Trazodone Hydrochloride;Ibuprofen;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Exposure To Toxic Agent,Serious,Died,Male,2021,1/30/2023,Expedited,52,Not Specified,Galpharm International,Healthcare Professional,Not Specified,-,1/23/2023,1/30/2023,US,Not Specified,US-PERRIGO-23US000960,-,-\\n21934729,Corphedra,Phenylpropanolamine;Ephedrine Sulfate;Dextromethorphan;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Cardio-Respiratory Arrest;Death,Serious,Died,Male,2021,2/1/2023,Expedited,32,Not Specified,Endo,Healthcare Professional,Not Specified,-,1/18/2023,2/1/2023,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2023-000225,-,-\\n21934056,Trazodone,Trazodone Hydrochloride;Ibuprofen;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Death,Serious,Died,Male,2021,2/1/2023,Expedited,52,Not Specified,Endo,Healthcare Professional,Not Specified,-,1/18/2023,2/1/2023,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2023-000348,-,-\\n21970341,-,Herbals\\\\Mitragynine;Diazepam;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died,Male,2021,2/9/2023,Expedited,70,Not Specified,Endo,Healthcare Professional,Not Specified,-,1/18/2023,2/9/2023,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2023-000602,-,-\\n21970297,-,Herbals\\\\Mitragynine;Ephedrine;Phenylpropanolamine;Getacatetide Acetate,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Male,-,2/9/2023,Expedited,32,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,1/27/2023,2/9/2023,US,Not Specified,US-JNJFOC-20230211671,-,-\\n21976393,Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Clonazepam,Product Used For Unknown Indication,Drug Abuse;Cardio-Respiratory Arrest,Serious,Died,Male,2021,2/10/2023,Expedited,21,Not Specified,Endo,Healthcare Professional,Not Specified,-,1/18/2023,2/10/2023,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2023-000710,-,-\\n21996460,Vivitrol,Naltrexone;Herbals\\\\Mitragynine,Drug Dependence;Product Used For Unknown Indication,Heart Rate Increased;Anxiety;Blood Pressure Increased;Substance Use Disorder;Drug Withdrawal Syndrome;Dyspnoea,Non-Serious,Non-Serious,Female,-,2/15/2023,Non-Expedited,Not Specified,Not Specified,Alkermes,Consumer,Not Specified,-,2/14/2023,2/15/2023,US,Not Specified,US-ALKERMES INC.-ALK-2023-000609,-,-\\n21909633,Vivitrol,Naltrexone;Herbals\\\\Mitragynine,Drug Use Disorder;Product Used For Unknown Indication,Substance Use Disorder;Hyperhidrosis;Nausea;Tremor;Withdrawal Syndrome,Non-Serious,Non-Serious,Male,10-Jan-2023,2/15/2023,Non-Expedited,Not Specified,Not Specified,Alkermes,Healthcare Professional,Not Specified,-,2/14/2023,1/25/2023,US,Not Specified,US-ALKERMES INC.-ALK-2023-000288,-,-\\n21992615,Salicylate;Sertraline;Heroin,Diamorphine;Cocaine;Herbals\\\\Mitragynine;Sertraline Hydrochloride;Alprazolam;Salicylic Acid;Unspecified Ingredient;Cannabis Sativa Subsp. Indica Top;Aripiprazole;Fentanyl,Product Used For Unknown Indication,Death,Serious,Died,Male,2021,2/15/2023,Expedited,17,Not Specified,Endo,Healthcare Professional,Not Specified,-,1/18/2023,2/15/2023,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2023-000543,-,-\\n22020899,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine,-,Drug Abuse;Analgesic Drug Level Increased;Drug Dependence,Serious,Hospitalized,Male,06-Feb-2023,2/17/2023,Direct,42,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,2/17/2023,Not Specified,Not Specified,-,-,-\\n22066563,Vivitrol;Heroin,Naltrexone;Diamorphine;Herbals\\\\Mitragynine,Drug Dependence;Product Used For Unknown Indication,Contraindicated Product Administered;Drug Ineffective;Substance Abuse,Non-Serious,Non-Serious,Not Specified,-,3/6/2023,Non-Expedited,Not Specified,Not Specified,Alkermes,Consumer,Not Specified,-,3/3/2023,3/6/2023,US,Not Specified,US-ALKERMES INC.-ALK-2023-000931,-,-\\n22285248,-,Levamisole;Herbals\\\\Mitragynine;Clonazepam,Drug Abuse;Product Used For Unknown Indication,Toxicity To Various Agents;Drug Abuse,Serious,Died;Hospitalized,Female,-,5/4/2023,Expedited,28,Not Specified,Teva,Healthcare Professional,Not Specified,Naproxen,4/24/2023,5/4/2023,US,Not Specified,US-TEVA-2023-US-2881991,-,-\\n22293916,Lybalvi,Olanzapine\\\\Samidorphan L-Malate;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Withdrawal Syndrome;Discomfort,Non-Serious,Non-Serious,Not Specified,-,5/8/2023,Non-Expedited,Not Specified,Not Specified,Alkermes,Healthcare Professional,Not Specified,-,5/3/2023,5/8/2023,US,Not Specified,US-ALKERMES INC.-ALK-2023-001891,-,-\\n21892904,Seroquel;Xywav,Calcium Oxybate\\\\Magnesium Oxybate\\\\Potassium Oxybate\\\\Sodium Oxybate;Olanzapine;Herbals\\\\Mitragynine;Quetiapine Fumarate,Hypersomnia;Product Used For Unknown Indication;Restless Legs Syndrome;Somnolence,Psychotic Disorder;Suicide Attempt;Personality Disorder;Product Administration Interrupted;Suicidal Ideation;Exposure To Fungus;Drug Interaction;Adverse Drug Reaction,Serious,Hospitalized;Other Outcomes,Male,07-Mar-2023,5/18/2023,Non-Expedited,Not Specified,Not Specified,Jazz,Healthcare Professional,Not Specified,Requip;Spironolactone;Atomoxetine;Progesterone;Estradiol,4/12/2023,1/20/2023,US,Not Specified,US-JAZZ-2022-US-023024,-,-\\n22642750,Vivitrol,Naltrexone;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Substance Use;Unevaluable Event,Non-Serious,Non-Serious,Not Specified,-,6/27/2023,Non-Expedited,Not Specified,Not Specified,Alkermes,Consumer,Not Specified,-,6/20/2023,6/27/2023,US,Not Specified,US-ALKERMES INC.-ALK-2023-002437,-,-\\n16026756,Escitalopram,Escitalopram Oxalate;Herbals\\\\Mitragynine,Anxiety;Back Pain;Hypertension;Major Depression;Product Used For Unknown Indication,Drug-Induced Liver Injury;Drug Interaction,Serious,Other Outcomes,Male,-,7/20/2023,Expedited,47,Not Specified,Teva,Healthcare Professional,Not Specified,Clonazepam;Acetaminophen;Fexofenadine;Valsartan;Metoprolol Tartrate,7/10/2023,3/3/2019,US,Not Specified,US-TEVA-2019-US-1017222,-,-\\n16017267,-,Butyrfentanyl;Herbals\\\\Mitragynine;Etizolam;Diphenhydramine;Oxycodone,Product Used For Unknown Indication,Drug Screen Positive,Serious,Died,Not Specified,-,7/31/2023,Expedited,Not Specified,Not Specified,Teva,Healthcare Professional,Not Specified,-,7/21/2023,2/28/2019,US,Not Specified,US-TEVA-2019-US-1017587,-,-\\n16314630,-,Quetiapine;Herbals\\\\Mitragynine,Bipolar Disorder;Product Used For Unknown Indication,Drug Interaction;Toxicity To Various Agents,Serious,Died,Male,-,8/9/2023,Expedited,27,Not Specified,Teva,Healthcare Professional,Not Specified,-,7/31/2023,5/15/2019,US,Not Specified,US-TEVA-2019-US-1049610,-,-\\n22868001,Lybalvi,Olanzapine\\\\Samidorphan L-Malate;Herbals\\\\Mitragynine,Bipolar I Disorder;Product Used For Unknown Indication;Substance Abuse;Thyroid Disorder,Withdrawal Syndrome,Non-Serious,Non-Serious,Female,-,8/25/2023,Non-Expedited,Not Specified,67.574 KG,Alkermes,Consumer,Not Specified,Lamictal;Levothyroxine;Unspecified Ingredient;Lithium;Paxil;Wellbutrin;Latuda,8/23/2023,8/25/2023,US,Not Specified,US-ALKERMES INC.-ALK-2023-003522,-,-\\n22910630,Spravato,Esketamine;Herbals\\\\Mitragynine,Anxiety;Attention Deficit Hyperactivity Disorder;Depression;Generalised Anxiety Disorder;Insomnia;Major Depression,Loss Of Consciousness;Sedation;Overdose,Serious,Other Outcomes;Life Threatening,Female,2023,9/22/2023,Expedited,44,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,Lunesta;Lexapro;Klonopin;Vyvanse,9/15/2023,9/6/2023,US,Not Specified,US-JNJFOC-20230868578,-,-\\n21844334,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Substance Use,Serious,Died,Male,24-Jul-2022,1/10/2023,Direct,23,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,1/10/2023,Not Specified,Not Specified,-,-,-\\n21850359,-,Herbals\\\\Mitragynine,Drug Dependence,Death,Serious,Died,Female,01-Apr-2020,1/11/2023,Direct,37,72 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/11/2023,Not Specified,Not Specified,-,-,-\\n21891841,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Hyperhidrosis;Restless Legs Syndrome;Drug Dependence;Withdrawal Syndrome;Vomiting;Depression;Memory Impairment;Insomnia;Asthenia;Emotional Disorder;Feeling Abnormal;Thinking Abnormal;Tremor;Diarrhoea;Impulsive Behaviour;Suicidal Ideation,Non-Serious,Non-Serious,Male,-,1/20/2023,Direct,39,87.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/20/2023,Not Specified,Not Specified,-,-,-\\n23015048,Vivitrol;Methadone,Methadone Hydrochloride;Naltrexone;Herbals\\\\Mitragynine,Drug Dependence;Product Used For Unknown Indication,Contraindicated Product Administered,Non-Serious,Non-Serious,Female,15-Aug-2023,10/2/2023,Non-Expedited,Not Specified,Not Specified,Alkermes,Healthcare Professional,Not Specified,Remeron,9/21/2023,10/2/2023,US,Not Specified,US-ALKERMES INC.-ALK-2023-003852,-,-\\n21908138,-,Herbals\\\\Mitragynine,Substance Use,Product Use Issue;Product Communication Issue;Product Complaint;Substance Use;Confusional State;Therapeutic Drug Monitoring Analysis Not Performed;Impaired Driving Ability;Euphoric Mood,Serious,Other Outcomes,Female,20-Jan-2023,1/24/2023,Direct,30,54 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/24/2023,Not Specified,Y,-,-,-\\n21961725,-,Herbals\\\\Mitragynine,Dependence,Product Complaint;Skin Exfoliation;Eye Disorder;Unevaluable Event;Skin Discolouration;Drug Dependence;Withdrawal Syndrome,Serious,Life Threatening;Required Intervention;Disabled,Male,02-Feb-2023,2/4/2023,Direct,27,56.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,2/4/2023,Not Specified,Not Specified,-,-,-\\n21972776,-,Herbals\\\\Mitragynine,-,Overdose,Serious,Other Outcomes;Life Threatening;Hospitalized,Male,22-Dec-2022,2/8/2023,Direct,31,67.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,2/8/2023,Not Specified,Not Specified,-,-,-\\n21984130,-,Herbals\\\\Mitragynine,-,Overdose;Tic,Serious,Hospitalized,Male,10-Feb-2023,2/10/2023,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,2/10/2023,Not Specified,Not Specified,-,-,-\\n21999326,-,Herbals\\\\Mitragynine,-,Drug Screen Positive,Non-Serious,Non-Serious,Not Specified,-,2/15/2023,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,2/15/2023,Not Specified,Y,-,-,-\\n23101045,-,Herbals\\\\Mitragynine;Mirtazapine,Anxiety,Toxicity To Various Agents;Cardiac Arrest,Serious,Died,Male,20-Dec-2022,10/20/2023,Direct,24,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,10/20/2023,Not Specified,Not Specified,-,-,-\\n22073940,-,Herbals\\\\Mitragynine,-,Intentional Overdose;Drug Abuse;Fall;Loss Of Consciousness;Confusional State;Fatigue,Serious,Required Intervention,Male,06-Mar-2023,3/7/2023,Direct,33,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,3/7/2023,Not Specified,Not Specified,-,-,-\\n22090073,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Unevaluable Event,Serious,Died,Male,-,3/13/2023,Direct,32,94.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/13/2023,Not Specified,Not Specified,-,-,-\\n23149661,-,Herbals\\\\Mitragynine;Sildenafil;Dietary Supplement,Erectile Dysfunction,Visual Impairment;Therapeutic Response Unexpected;Euphoric Mood;Mydriasis,Serious,Other Outcomes,Male,28-Oct-2023,11/4/2023,Direct,37,94.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,11/4/2023,Not Specified,Not Specified,-,-,-\\n23164703,-,Dietary Supplement\\\\Herbals;Herbals\\\\Mitragynine,-,Product Information Content Complaint;Product Formulation Issue,Non-Serious,Non-Serious,Male,-,11/8/2023,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,11/8/2023,Not Specified,Not Specified,-,-,-\\n22119202,-,Herbals\\\\Mitragynine,Anxiety,Dyspepsia;Disturbance In Attention;Asthenia;Dependence;Skin Disorder;Restless Legs Syndrome;Anxiety;Aggression,Serious,Hospitalized;Required Intervention,Male,31-Oct-2022,3/20/2023,Direct,31,54 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/20/2023,Not Specified,Not Specified,-,-,-\\n22160856,-,Herbals\\\\Mitragynine,-,Vomiting;Paraesthesia;Sensory Disturbance;Product Complaint;Headache;Nausea;Paradoxical Drug Reaction,Non-Serious,Non-Serious,Male,30-Mar-2023,3/31/2023,Direct,34,90 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/31/2023,Not Specified,Not Specified,-,-,-\\n23301058,-,Unspecified Ingredient;Herbals\\\\Mitragynine;Acetaminophen,Suspected Suicide,Completed Suicide;Exposure To Toxic Agent,Serious,Died,Female,2022,12/15/2023,Expedited,45,Not Specified,Galpharm International,Healthcare Professional,Not Specified,-,12/13/2023,12/15/2023,US,Not Specified,US-PERRIGO-23US014157,-,-\\n23351659,-,Herbals\\\\Mitragynine;Tapentadol;Pregabalin;Carisoprodol;Clonazepam,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Not Specified,23-Apr-2021,12/29/2023,Expedited,Not Specified,Not Specified,Cipla,Consumer,Not Specified,Citalopram Hydrobromide,12/18/2023,12/29/2023,AU,Not Specified,AU-CIPLA LTD.-2023AU08519,-,-\\n22190944,-,Herbals\\\\Mitragynine,Feeling Of Relaxation,Hyperhidrosis;Hot Flush;Nausea;Feeling Hot;Somniphobia;Product Complaint;Dizziness;Hypopnoea;Anxiety;Dry Mouth,Serious,Other Outcomes,Female,08-Apr-2023,4/9/2023,Direct,36,58.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/9/2023,Not Specified,Y,-,-,-\\n22201307,-,Herbals\\\\Mitragynine,-,Resuscitation;Substance Use,Serious,Required Intervention,Male,05-Apr-2023,4/11/2023,Direct,33,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,4/11/2023,Not Specified,Not Specified,-,-,-\\n22234404,-,Herbals\\\\Mitragynine,Disturbance In Attention,Pain;Anxiety;Drug Withdrawal Syndrome;Vomiting;Depression;Dehydration;Urine Amphetamine Positive,Serious,Required Intervention;Disabled,Male,15-Apr-2023,4/19/2023,Direct,29,80.1 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/19/2023,Not Specified,Not Specified,-,-,-\\n22242539,-,Herbals\\\\Mitragynine,Drug Dependence,Withdrawal Syndrome;Feeling Abnormal,Serious,Other Outcomes,Male,16-Apr-2023,4/23/2023,Direct,39,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,4/23/2023,Not Specified,Not Specified,-,-,-\\n22284372,-,Herbals\\\\Mitragynine,Anxiety;Depression;Lethargy;Post-Traumatic Stress Disorder;Stress,Drug Dependence;Product Design Issue;Product Label Confusion,Serious,Required Intervention;Disabled,Male,14-Jun-2015,5/3/2023,Direct,34,99 KG,Fda-Ctu,Consumer,Not Specified,-,-,5/3/2023,Not Specified,Y,-,-,-\\n22282385,-,Herbals\\\\Mitragynine,Analgesic Therapy,Death,Serious,Died,Not Specified,14-Aug-2020,5/3/2023,Direct,32,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,5/3/2023,Not Specified,Y,-,-,-\\n22283576,-,Herbals\\\\Mitragynine,Substance Use,Intentional Product Use Issue;Jaundice,Serious,Required Intervention;Hospitalized,Male,09-Jul-2021,5/3/2023,Direct,2 DAY,90 KG,Fda-Ctu,Consumer,Not Specified,-,-,5/3/2023,Not Specified,Not Specified,-,-,-\\n22285035,-,Herbals\\\\Mitragynine,Back Pain;Drug Dependence,Drug Withdrawal Syndrome,Serious,Other Outcomes,Male,06-Nov-2018,5/4/2023,Direct,39,101.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,5/4/2023,Not Specified,Not Specified,-,-,Yes\\n22304339,-,Herbals\\\\Mitragynine,-,Seizure,Serious,Died;Hospitalized;Life Threatening,Male,-,5/9/2023,Direct,24,90 KG,Fda-Ctu,Consumer,Not Specified,-,-,5/9/2023,Not Specified,Not Specified,-,-,-\\n22366356,-,Herbals\\\\Mitragynine,-,\"Confusional State;Product Use Issue;Accidental Death;Euphoric Mood;Substance Use;Hallucination, Auditory;Hallucination, Visual\",Serious,Died;Hospitalized,Male,11-Aug-2022,5/24/2023,Direct,30,75.6 KG,Fda-Ctu,Consumer,Not Specified,-,-,5/24/2023,Not Specified,Y,-,-,-\\n22384024,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Delirium Tremens;Drug Withdrawal Syndrome;Drug Dependence,Serious,Life Threatening;Disabled;Required Intervention,Male,01-Mar-2023,5/27/2023,Direct,36,85.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,5/27/2023,Not Specified,Not Specified,-,-,-\\n22384585,-,Herbals\\\\Mitragynine,Analgesic Therapy,Clavicle Fracture;Brugada Syndrome;Seizure;Cardiac Arrest;Product Use Issue;Fall,Serious,Other Outcomes;Hospitalized;Life Threatening,Male,27-Apr-2023,5/28/2023,Direct,38,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,5/28/2023,Not Specified,Not Specified,-,-,-\\n22387618,-,Herbals\\\\Mitragynine,Dependence;Substance Dependence,Loss Of Personal Independence In Daily Activities;Drug Dependence;Withdrawal Syndrome;Apathy;Delusion;Headache;Irritability;Gallbladder Disorder;Abdominal Pain;Fatigue;Restlessness;Anger;Psychotic Disorder,Non-Serious,Non-Serious,Male,15-Mar-2023,5/30/2023,Direct,36,200 LB,Fda-Ctu,Consumer,Not Specified,-,-,5/30/2023,Not Specified,Not Specified,-,-,-\\n22400193,-,Herbals\\\\Mitragynine,Anxiety,Diarrhoea;Irritability;Nausea;Judgement Impaired;Dependence;Vomiting;Withdrawal Syndrome;Asthenia;Pain,Serious,Other Outcomes,Male,01-Jun-2023,6/1/2023,Direct,38,99 KG,Fda-Ctu,Consumer,Not Specified,-,-,6/1/2023,Not Specified,Not Specified,-,-,-\\n22534982,-,Herbals\\\\Mitragynine,Joint Injury,Decreased Appetite;Anxiety;Drug Dependence;Mood Swings;Drug Tolerance;Aggression;Drug Effect Less Than Expected;Withdrawal Syndrome;Personality Change,Serious,Other Outcomes,Male,-,6/7/2023,Direct,31,90 KG,Fda-Ctu,Consumer,Not Specified,-,-,6/7/2023,Not Specified,Not Specified,-,-,-\\n22609062,-,Herbals\\\\Mitragynine,Pain,Dependence;Drug Dependence;Alcoholism,Serious,Hospitalized;Required Intervention;Disabled,Female,01-Jan-2022,6/15/2023,Direct,33,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,6/15/2023,Not Specified,Not Specified,-,-,-\\n22666176,-,Herbals\\\\Mitragynine,-,Tremor;Weight Decreased;Drug Dependence,Serious,Died,Male,10-Nov-2021,7/3/2023,Direct,40,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,7/3/2023,Not Specified,Not Specified,-,-,-\\n22705332,-,Herbals\\\\Mitragynine,Depression;Pain,Drug Withdrawal Syndrome;Dependence,Non-Serious,Non-Serious,Female,-,7/13/2023,Direct,27,67.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/13/2023,Not Specified,Not Specified,-,-,-\\n22765730,-,Herbals\\\\Mitragynine,Anxiety;Pain,Depression;Anxiety;Product Advertising Issue;Drug Withdrawal Syndrome,Serious,Hospitalized,Female,01-Dec-2020,7/30/2023,Direct,47,54 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/30/2023,Not Specified,Not Specified,-,-,-\\n22781580,-,Herbals\\\\Mitragynine,Social Problem,Palpitations;Depressed Mood;Adverse Drug Reaction;Drug Dependence;Alopecia,Serious,Life Threatening,Male,01-Aug-2023,8/2/2023,Direct,36,83.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/2/2023,Not Specified,Not Specified,-,-,-\\n22798022,-,Herbals\\\\Mitragynine,-,Gastrointestinal Haemorrhage,Serious,Died,Male,25-Aug-2018,8/7/2023,Direct,30,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,8/7/2023,Not Specified,Not Specified,-,-,-\\n22802961,-,Herbals\\\\Mitragynine,Anxiety;Insomnia,Drug Dependence;Quality Of Life Decreased,Serious,Other Outcomes;Life Threatening;Required Intervention,Male,08-Aug-2023,8/8/2023,Direct,31,65.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/8/2023,Not Specified,Not Specified,-,-,-\\n22819308,-,Herbals\\\\Mitragynine,Alcoholism;Anxiety,Generalised Tonic-Clonic Seizure,Serious,Other Outcomes;Hospitalized;Life Threatening,Male,04-Jul-2023,8/12/2023,Direct,31,85.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/12/2023,Not Specified,Not Specified,-,-,-\\n22820761,-,Herbals\\\\Mitragynine,-,Cardiac Arrest;Overdose;Seizure;Brain Death,Serious,Died,Female,04-Aug-2023,8/13/2023,Direct,30,70 KG,Fda-Ctu,Healthcare Professional,Not Specified,-,-,8/13/2023,Not Specified,Not Specified,-,-,-\\n22843104,-,Herbals\\\\Mitragynine,Alcohol Use Disorder,Substance Use;Cardiac Arrest,Serious,Died,Male,19-Dec-2021,8/19/2023,Direct,34,90 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/19/2023,Not Specified,Not Specified,-,-,-\\n22843148,-,Herbals\\\\Mitragynine,Drug Dependence,Erectile Dysfunction;Arrhythmia;Vomiting;Dependence;Diarrhoea;Taste Disorder;Drug Tolerance Increased;Gastrointestinal Disorder;Withdrawal Syndrome;Blood Pressure Increased;Pruritus;Hyperhidrosis;Headache;Heart Rate Increased;Coordination Abnormal,Serious,Disabled;Life Threatening;Required Intervention,Male,01-Aug-2023,8/20/2023,Direct,38,76.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/20/2023,Not Specified,Not Specified,-,-,-\\n22907600,-,Herbals\\\\Mitragynine,Pain,Myalgia;Anxiety;Nausea;Hyperhidrosis;Diarrhoea;Vomiting;Abdominal Pain Upper;Drug Dependence;Withdrawal Syndrome,Non-Serious,Non-Serious,Male,31-Aug-2023,9/4/2023,Direct,36,75.15 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/4/2023,Not Specified,Not Specified,-,-,-\\n22940434,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Autopsy,Serious,Died,Male,-,9/13/2023,Direct,50,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,9/13/2023,Not Specified,Not Specified,-,-,-\\n22980079,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Restless Legs Syndrome;Hyperhidrosis;Constipation;Anxiety;Insomnia;Withdrawal Syndrome;Depression;Suicidal Ideation,Serious,Other Outcomes,Not Specified,23-Jun-2023,9/24/2023,Direct,40,80.1 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/24/2023,Not Specified,Not Specified,-,-,-\\n22994000,-,Herbals\\\\Mitragynine,Anxiety;Depression,Toxicity To Various Agents;Seizure;Overdose,Serious,Died,Male,-,9/27/2023,Direct,36,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,9/27/2023,Not Specified,Not Specified,-,-,-\\n22993960,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Loss Of Consciousness,Serious,Died,Female,-,9/27/2023,Direct,39,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,9/27/2023,Not Specified,Not Specified,-,-,-\\n23050243,-,Herbals\\\\Mitragynine,Anxiety,Adverse Drug Reaction,Serious,Died,Male,20-Dec-2022,10/9/2023,Direct,24,85.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/9/2023,Not Specified,Not Specified,-,-,-\\n23080351,-,Herbals\\\\Mitragynine,-,Tremor;Loss Of Consciousness;Toxicity To Various Agents;Circulatory Collapse;Fall;Legal Problem;Substance Use,Serious,Died,Male,19-Nov-2020,10/18/2023,Direct,43,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,10/18/2023,Not Specified,Not Specified,-,-,-\\n23090657,-,Herbals\\\\Mitragynine,Pain,Withdrawal Syndrome;Drug Dependence,Serious,Disabled;Other Outcomes;Required Intervention,Female,20-Oct-2023,10/20/2023,Direct,50,110.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/20/2023,Not Specified,Not Specified,-,-,-\\n23124390,-,Herbals\\\\Mitragynine,-,Dependence;Educational Problem;Withdrawal Syndrome,Serious,Other Outcomes;Disabled,Male,27-Oct-2023,10/28/2023,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,10/28/2023,Not Specified,Not Specified,-,-,-\\n23182254,-,Herbals\\\\Mitragynine,Pain,Substance Use;Salmonellosis;Recalled Product Administered,Serious,Required Intervention;Disabled,Male,13-Nov-2023,11/14/2023,Direct,31,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,11/14/2023,Not Specified,Not Specified,-,-,-\\n23230891,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Substance Use,Serious,Died,Female,09-Jan-2023,11/24/2023,Direct,24,54 KG,Fda-Ctu,Consumer,Not Specified,-,-,11/24/2023,Not Specified,Not Specified,-,-,-\\n24695994,Alcohol (Alcohol),Alcohol;Etizolam;Alprazolam;Lidocaine;Fentanyl;Cocaine;Cannabinol;Methamphetamine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Not Specified,-,12/4/2024,Expedited,Not Specified,Not Specified,Alembic,Healthcare Professional,Not Specified,-,11/22/2024,12/4/2024,US,Not Specified,US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL001756,\"Yu J, Diekhans K, Tsang A, Rodda L.N. Fluorofentanyl and novel synthetic opioids in accidental overdose deaths. Journal of Analytical Toxicology. 2024;48(8):573-581\",-\\n24544430,-,Herbals\\\\Mitragynine;Hydromorphone Hydrochloride;Olanzapine,Pain;Product Used For Unknown Indication,Intentional Overdose;Completed Suicide;Renal Impairment;Toxicity To Various Agents,Serious,Died,Male,-,10/24/2024,Expedited,44,Not Specified,Cheplapharm,Healthcare Professional,Not Specified,Escitalopram;Zopiclone,10/17/2024,10/24/2024,CA,Not Specified,CA-CHEPLA-2024013332,Unknown. Unknown. Unknown,-\\n23806729,Sertraline,Sertraline Hydrochloride;Herbals\\\\Mitragynine,Anxiety;Depression;Phytotherapy,Electrocardiogram Qt Prolonged;Drug Interaction,Serious,Hospitalized;Other Outcomes,Female,-,5/2/2024,Expedited,17,Not Specified,Lupin,Healthcare Professional,Not Specified,-,4/18/2024,5/2/2024,US,Not Specified,US-LUPIN HEALTHCARE (UK) LIMITED-2024-03502,\"Truesdale N, Kaliki V, Fuller KE, Nathani Y. QTc prolongation related to Kratom ingestion with underlying SSRI usage. The American Journal of the Medical Sciences. 2024;367(S1):S284\",-\\n23782989,Sertraline,Sertraline Hydrochloride;Herbals\\\\Mitragynine,Anxiety;Depression;Phytotherapy,Electrocardiogram Qt Prolonged;Drug Interaction,Serious,Hospitalized,Female,-,4/25/2024,Expedited,17,Not Specified,Mylan,Healthcare Professional,Not Specified,-,4/18/2024,4/25/2024,US,Not Specified,US-MYLANLABS-2024M1037072,\"Truesdale N, Kaliki V, Fuller KE, Nathani Y. QTc prolongation related to kratom ingestion with underlying SSRI usage. Am-J-Med-Sci 2024; 367 (Suppl. 1) S284 abstr. 472.\",-\\n23851778,-,Herbals\\\\Mitragynine;Sertraline Hydrochloride,Anxiety;Depression;Product Used For Unknown Indication,Herbal Interaction;Electrocardiogram Qt Prolonged,Serious,Hospitalized;Other Outcomes,Female,-,5/14/2024,Expedited,17,Not Specified,Sciegen,Healthcare Professional,Not Specified,-,5/2/2024,5/14/2024,US,Not Specified,US-SCIEGENP-2024SCLIT00279,\"Truesdale N, et al.QTc prolongation related to kratom ingestion with underlying SSRI usage.American Journal of the Medical Sciences.feb-2024;367 (1):S284\",-\\n24263168,Buspirone,Buspirone Hydrochloride;Herbals\\\\Mitragynine;Cyclobenzaprine;Alprazolam;Clonidine;Gabapentin,Product Used For Unknown Indication,Accidental Overdose;Toxicity To Various Agents,Serious,Died,Female,-,8/29/2024,Expedited,Not Specified,Not Specified,Apotex,Healthcare Professional,Not Specified,-,8/19/2024,8/29/2024,US,Not Specified,US-APOTEX-2024AP009652,\"Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D.. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report.. Frontiers in Psychiatry. 2024;14:1332999 (01-04)\",-\\n23547472,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Accidental Overdose;Toxicity To Various Agents,Serious,Died,Male,-,2/21/2024,Expedited,Not Specified,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,2/7/2024,2/21/2024,US,Not Specified,US-ALVOGEN-2024093075,\"Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Frontiers in Psychiatry. 2024 Jan 10;14: 1332999: doi:10.3389/fpsyt.2023.1332999\",-\\n23547479,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Accidental Overdose;Toxicity To Various Agents,Serious,Died,Male,-,2/21/2024,Expedited,Not Specified,Not Specified,Alvogen,Healthcare Professional,Not Specified,Cannabis Sativa Subsp. Indica Top,2/7/2024,2/21/2024,US,Not Specified,US-ALVOGEN-2024093074,\"Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front. Psychiatry. 2024 Jan 10;14:1332999: doi:doi: 10.3389/fpsyt.2023.1332999\",-\\n23547485,-,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents;Accidental Overdose,Serious,Died,Male,-,2/21/2024,Expedited,Not Specified,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,2/7/2024,2/21/2024,US,Not Specified,US-ALVOGEN-2024093073,\"Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front. Psychiatry. 2024 Jan 10;14:1332999: doi:10.3389/fpsyt.2023.1332999\",-\\n23510164,Buspirone,Buspirone Hydrochloride;Alprazolam;Gabapentin;Herbals\\\\Mitragynine;Clonidine;Cyclobenzaprine,Product Used For Unknown Indication,Toxicity To Various Agents;Accidental Overdose,Serious,Died,Female,-,2/11/2024,Expedited,Not Specified,Not Specified,Aveva,Healthcare Professional,Not Specified,-,1/30/2024,2/11/2024,US,Not Specified,US-AVEVA-000590,\"Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front Psychiatry, 2024 Jan 10;14:1332999. doi: 10.3389/fpsyt.2023.1332999.\",-\\n23510163,-,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents;Accidental Overdose,Serious,Died,Male,-,2/11/2024,Expedited,Not Specified,Not Specified,Aveva,Healthcare Professional,Not Specified,-,1/30/2024,2/11/2024,US,Not Specified,US-AVEVA-000591,\"Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front Psychiatry, 2024 Jan 10;14:1332999. doi: 10.3389/fpsyt.2023.1332999.\",-\\n23510162,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Toxicity To Various Agents;Accidental Overdose,Serious,Died,Male,-,2/11/2024,Expedited,Not Specified,Not Specified,Aveva,Healthcare Professional,Not Specified,-,1/30/2024,2/11/2024,US,Not Specified,US-AVEVA-000593,\"Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front Psychiatry, 2024 Jan 10;14:1332999. doi: 10.3389/fpsyt.2023.1332999.\",-\\n23510161,-,Herbals\\\\Mitragynine;Fentanyl;Cannabis Sativa Subsp. Indica Top,Product Used For Unknown Indication,Accidental Overdose;Toxicity To Various Agents,Serious,Died,Male,-,2/11/2024,Expedited,Not Specified,Not Specified,Aveva,Healthcare Professional,Not Specified,-,1/30/2024,2/11/2024,US,Not Specified,US-AVEVA-000592,\"Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front Psychiatry, 2024 Jan 10;14:1332999. doi: 10.3389/fpsyt.2023.1332999.\",-\\n23520936,Buspirone,Buspirone Hydrochloride;Herbals\\\\Mitragynine;Alprazolam;Clonidine Hydrochloride;Gabapentin;Cyclobenzaprine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Not Specified,-,2/14/2024,Expedited,Not Specified,Not Specified,Alembic,Healthcare Professional,Not Specified,-,2/2/2024,2/14/2024,US,Not Specified,US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000076,\"Torrico T, Patel K, Nikolov N, Salam M.T, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Frontiers in Psychiatry. 2023;14 (1332999):1-4\",-\\n24010094,-,Buprenorphine;Herbals\\\\Mitragynine,-,Ichthyosis Acquired;Maternal Exposure During Pregnancy,Serious,Other Outcomes,Female,-,6/27/2024,Expedited,41,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,6/19/2024,6/25/2024,US,Not Specified,US-PFIZER INC-PV202400080758,\"Spungen, H.. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy.. Journal of Medical Toxicology. 2024;1-6\",-\\n23999116,-,Herbals\\\\Mitragynine;Buprenorphine,Ichthyosis,Exposure Via Breast Milk;Maternal Exposure During Pregnancy;Drug Withdrawal Syndrome Neonatal;Neonatal Seizure,Serious,Other Outcomes;Hospitalized,Male,-,6/26/2024,Expedited,Not Specified,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,6/19/2024,6/21/2024,US,Not Specified,US-PFIZER INC-202400196811,\"Spungen, H.. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. Journal of Medical Toxicology. 2024;1-6\",-\\n24340583,Sertraline,Sertraline Hydrochloride;Levothyroxine;Buprenorphine;Herbals\\\\Mitragynine,Anxiety;Hypothyroidism;Opioid Sparing Treatment;Relaxation Therapy,Drug Withdrawal Syndrome Neonatal;Drug Withdrawal Syndrome;Hypernatraemia;Generalised Tonic-Clonic Seizure;Ichthyosis;Foetal Exposure During Pregnancy,Serious,Life Threatening;Congenital Anomaly;Hospitalized,Male,-,10/4/2024,Expedited,Not Specified,Not Specified,Teva,Healthcare Professional,Not Specified,-,9/26/2024,9/19/2024,US,Not Specified,US-TEVA-VS-3243128,\"Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J-Med-Toxicol 2024;.; Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J-Med-Toxicol 2024;.; Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J-Med-Toxicol 2024;.\",-\\n24058768,-,Herbals\\\\Mitragynine;Buprenorphine,Product Used For Unknown Indication,Foetal Exposure During Pregnancy;Drug Withdrawal Syndrome Neonatal,Serious,Other Outcomes,Male,-,7/8/2024,Non-Expedited,Not Specified,Not Specified,Aveva,Healthcare Professional,Not Specified,-,6/11/2024,7/8/2024,US,Not Specified,US-AVEVA-000680,\"Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J Med Toxicol. 2024, doi: 10.1007/s13181-024-01016-x. PMID: 38839731.\",-\\n23889816,-,Herbals\\\\Mitragynine;Sertraline Hydrochloride,Anxiety;Depression,Drug Interaction;Electrocardiogram Qt Prolonged,Serious,Other Outcomes;Hospitalized,Female,-,5/23/2024,Expedited,17,Not Specified,Aci Healthcare,Healthcare Professional,Not Specified,-,5/10/2024,5/23/2024,US,Not Specified,US-ACI HealthCare Limited-2157339,Source document (Full text),-\\n23967333,-,Bupropion;Sertraline Hydrochloride;Herbals\\\\Mitragynine,Antidepressant Therapy,Serotonin Syndrome;Drug Interaction,Serious,Hospitalized;Other Outcomes;Life Threatening,Male,-,6/12/2024,Expedited,28,Not Specified,Aci Healthcare,Healthcare Professional,Not Specified,-,5/31/2024,6/12/2024,US,Not Specified,US-ACI HealthCare Limited-2158055,Source document (Full text),-\\n24253585,-,Olanzapine;Herbals\\\\Mitragynine;Hydromorphone,Product Used For Unknown Indication,Completed Suicide;Renal Impairment;Overdose;Toxicity To Various Agents,Serious,Other Outcomes;Died,Male,-,8/27/2024,Expedited,44,Not Specified,Aurobindo,Healthcare Professional,Not Specified,Escitalopram,8/15/2024,8/27/2024,CA,Not Specified,CA-AUROBINDO-AUR-APL-2024-042002,\"Shi T, Shea LJ.. A case of fatal overdose involving both hydromorphone and kratom. J Forensic Sci. 2023\",-\\n23055792,-,Olanzapine;Hydromorphone;Herbals\\\\Mitragynine,Pain;Product Used For Unknown Indication,Overdose;Toxicity To Various Agents,Serious,Died,Male,-,10/4/2024,Expedited,44,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,Zopiclone;Escitalopram,9/20/2024,10/11/2023,CA,Not Specified,CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-411979,\"Shi T, Shea LJ. A case of fatal overdose involving both hydromorphone and kratom. J Forensic Sci. 2023;Sep 27; 69:355-358\",-\\n24423784,-,Olanzapine;Hydromorphone;Herbals\\\\Mitragynine,Abdominal Pain;Product Used For Unknown Indication;Schizoaffective Disorder Bipolar Type,Toxicity To Various Agents;Overdose;Renal Impairment,Serious,Died,Male,2022,11/5/2024,Expedited,44,Not Specified,Teva,Healthcare Professional,Not Specified,Escitalopram;Zopiclone,9/30/2024,10/10/2024,CA,Not Specified,CA-TEVA-VS-3251357,\"Shi T, Shea JL. A case of fatal overdose involving both hydromorphone and kratom. J-Forensic-Sci 2023; 69 355-358.; Shi T, Shea JL. A case of fatal overdose involving both hydromorphone and kratom. J-Forensic-Sci 2023; 69 355-358.; Shi T, Shea JL. A case of fatal overdose involving both hydromorphone and kratom. J-Forensic-Sci 2023; 69 355-358.\",-\\n24088337,-,Methamphetamine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Psychotic Disorder;Drug Abuse;Toxicity To Various Agents,Serious,Other Outcomes;Hospitalized,Male,-,7/15/2024,Non-Expedited,44,Not Specified,Dr Reddys,Healthcare Professional,Not Specified,-,7/2/2024,7/15/2024,US,Not Specified,US-RDY-LIT/USA/24/0009991,\"Sablaban IM, Gautam M. Kratom and Stimulant Co-Addiction: A Case Series and Brief Review. Journal of Addictive Diseases: The Official Journal of the ASAM, American Society of Addiction Medicine. 2023 Jan;41(2): 181-184. doi:10.1080/10550887.2022.2066459.\",-\\n24064507,-,Herbals\\\\Mitragynine;Gabapentin,Product Used For Unknown Indication,Treatment Noncompliance;Intentional Product Misuse,Serious,Hospitalized,Male,-,7/9/2024,Expedited,44,Not Specified,Mylan,Healthcare Professional,Not Specified,Methamphetamine,7/2/2024,7/9/2024,US,Not Specified,US-MYLANLABS-2024M1063114,\"Sablaban IM, Gautam M. Kratom & Stimulant Co-Addiction: A Case Series and Brief Review. [Review]. J-Addict-Dis 2023; 41 (2): 181-184.\",-\\n23921757,Forfivo Xl;Sertraline,Sertraline Hydrochloride;Bupropion Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Serotonin Syndrome;Drug Interaction,Serious,Other Outcomes;Life Threatening;Hospitalized,Not Specified,-,5/30/2024,Expedited,Not Specified,Not Specified,Twi Pharmaceuticals,Healthcare Professional,Not Specified,-,5/20/2024,5/30/2024,US,Not Specified,\"US-TWI PHARMACEUTICAL, INC-2024SCTW000103\",Saber M.; Zichichi A.; Ammar M.. SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY. Crit. Care Med.. 2024;52:1 (S1):S642,-\\n23860811,Sertraline,Sertraline Hydrochloride;Herbals\\\\Mitragynine;Bupropion,Agitation;Product Used For Unknown Indication,Serotonin Syndrome;Drug Interaction,Serious,Life Threatening;Hospitalized;Other Outcomes,Male,-,5/16/2024,Expedited,28,Not Specified,Sandoz,Healthcare Professional,Not Specified,Ketamine;Propofol;Droperidol,5/13/2024,5/16/2024,US,Not Specified,US-SANDOZ INC.-SDZ2024US048440,\"Saber M., Zichichi A., Ammar M. SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT. Y. Critical Care Medicine. 2024;52:1\",-\\n23886708,Sertraline,Sertraline Hydrochloride;Bupropion Hydrochloride;Herbals\\\\Mitragynine,-,Serotonin Syndrome,Serious,Hospitalized,Male,-,5/22/2024,Expedited,28,Not Specified,Prinston Pharmaceutical,Healthcare Professional,Not Specified,-,5/15/2024,5/22/2024,US,Not Specified,US-PRINSTON PHARMACEUTICAL INC.-2024PRN00216,\"Saber M, Zichichi A, Ammar M.. SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY. Critical Care Medicine. 2024;52(1):S642\",-\\n23926685,Sertraline,Sertraline Hydrochloride;Bupropion Hydrochloride;Herbals\\\\Mitragynine,Antidepressant Therapy;Product Used For Unknown Indication,Serotonin Syndrome;Herbal Interaction;Drug Interaction,Serious,Life Threatening;Hospitalized,Male,-,5/31/2024,Expedited,28,Not Specified,Hetero,Healthcare Professional,Not Specified,-,5/20/2024,5/31/2024,US,Not Specified,US-HETERO-HET2024US01561,\"Saber M, Zichichi A, Ammar M.. SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY. Critical Care Medicine. 2024;52(1):S642\",-\\n23896572,Sertraline,Sertraline Hydrochloride;Bupropion;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Serotonin Syndrome;Drug Interaction,Serious,Other Outcomes;Hospitalized,Male,-,5/24/2024,Expedited,28,Not Specified,Apotex,Healthcare Professional,Not Specified,-,5/15/2024,5/24/2024,US,Not Specified,US-APOTEX-2024AP006141,\"Saber M, Zichichi A, Ammar M. SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY. Critical Care Medicine. 2024;52 (Suppl 1):S642\",-\\n23918568,Sertraline,Sertraline Hydrochloride;Herbals\\\\Mitragynine;Bupropion Hydrochloride,Antidepressant Therapy;Product Used For Unknown Indication,Drug Interaction;Herbal Interaction;Serotonin Syndrome,Serious,Hospitalized;Other Outcomes,Male,-,5/30/2024,Expedited,28,Not Specified,Lupin,Healthcare Professional,Not Specified,-,5/15/2024,5/30/2024,US,Not Specified,US-LUPIN HEALTHCARE (UK) LIMITED-2024-04254,\"Saber M, Zichichi A, Ammar M. Serotonin syndrome due to kratom and antidepressant interaction: A case study. Critical care medicine. 2024;52 (1):S642 abstr. 1342\",-\\n23861841,Sertraline,Sertraline Hydrochloride;Bupropion;Herbals\\\\Mitragynine,Product Used For Unknown Indication;Tobacco User,Condition Aggravated;Vomiting;Agitation;Clonus;Sneezing;Headache;Seizure;Serotonin Syndrome,Serious,Other Outcomes;Hospitalized,Not Specified,-,5/16/2024,Expedited,Not Specified,Not Specified,Glaxosmithkline,Healthcare Professional,Not Specified,-,5/13/2024,5/16/2024,US,Not Specified,US-GSK-US2024GSK060080,\"Saber M, Zichichi A, Ammar M. Serotonin Syndrome Due To Kratom And Antidepressant Interaction: A Case Study. Critical Care Medicine. 2024;52 (1):S642\",-\\n23931677,Sertraline,Sertraline Hydrochloride;Bupropion Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Hyperreflexia;Clonic Convulsion;Vomiting;Condition Aggravated;Tremor;Agitation;Seizure;Clonus;Headache;Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes;Hospitalized,Not Specified,-,6/3/2024,Expedited,Not Specified,Not Specified,Alembic,Healthcare Professional,Not Specified,-,5/20/2024,6/3/2024,US,Not Specified,US-ALEMBIC PHARMACUETICALS LIMITED-2024SCAL000709,\"Saber M, Zichichi A, Ammar M. SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY. Critical Care Medicine. 2024;52 (1):S642\",-\\n23931703,Sertraline,Sertraline Hydrochloride;Herbals\\\\Mitragynine;Bupropion,Antidepressant Therapy;Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes;Hospitalized,Male,-,6/3/2024,Expedited,28,Not Specified,Unknown Manufacturer,Healthcare Professional,Not Specified,-,5/21/2024,6/3/2024,US,Not Specified,US-862174955-ML2024-03211,\"Saber M, Zichichi A, Ammar M. SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY. Critical Care Medicine. 2024 Jan; 52(Suppl 1): S642; abstract 1342.\",-\\n23415164,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine;Oxycodone;Buprenorphine\\\\Naloxone,Anaesthesia;Anxiety;Pain;Procedural Pain,Drug Dependence;Chest Discomfort;Nausea;Palpitations;Headache;Intentional Product Misuse,Serious,Hospitalized;Other Outcomes,Male,-,3/7/2024,Expedited,42,Not Specified,Teva,Healthcare Professional,Not Specified,Dexmedetomidine;Bupivacaine;Hydromorphone;Ropivacaine;Alprazolam;Acetaminophen;Ketamine;Celecoxib;Gabapentin;Ketorolac,2/23/2024,1/18/2024,US,Not Specified,US-TEVA-VS-3134597,Perez J. Kratom and opioid use disorder in the perioperative period: A case report on the expanding role of buprenorphine. J-Opioid-Manag 2023;19(1):91-93.; Perez J. Kratom and opioid use disorder in the perioperative period: A case report on the expanding role of buprenorphine. J-Opioid-Manag 2023;19(1):91-93.,-\\n21711740,Hydroxyzine,Hydroxyzine Hydrochloride;Cyclobenzaprine;Benzoylecgonine;Herbals\\\\Tetrahydrocannabinol Unspecified;Herbals\\\\Mitragynine;Gabapentin,-,Overdose;Dyspnoea,Serious,Died,Not Specified,2020,12/17/2024,Expedited,Not Specified,Not Specified,Cipla,Healthcare Professional,Not Specified,-,12/5/2024,12/12/2022,US,Not Specified,US-CIPLA LTD.-2022US07066,\"Papsun DM, Krotulski AJ, Homan J, Temporal KDH, Logan BK. Flualprazolam Blood Concentrations in 197 Forensic Investigation Cases. Journal of Analytical Toxicology. 2021;45:226 to 232\",-\\n23984408,Valium;Suboxone,Buprenorphine Hydrochloride\\\\Naloxone Hydrochloride;Diazepam;Meprobamate;Caffeine;Herbals\\\\Mitragynine;Etizolam;Carisoprodol,Product Used For Unknown Indication,Balance Disorder;Toxicity To Various Agents;Disorientation;Dysphonia;Slow Speech;Nystagmus;Road Traffic Accident;Fall,Serious,Other Outcomes,Male,-,6/18/2024,Expedited,26,Not Specified,Arbor,Healthcare Professional,Not Specified,-,6/6/2024,6/18/2024,US,Not Specified,\"US-AZURITY PHARMACEUTICALS, INC.-US-2024AZR000722\",\"Papsun D.M., Chan-Hosokawa A., Lamb M.E., Logan B.. Increasing prevalence of designer benzodiazepines in impaired driving: a 5-year analysis from 2017 to 2021. J. Anal. Toxicol.. 2023;47:8:668 - 679\",-\\n22636891,-,Quetiapine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Seizure,Serious,Other Outcomes,Male,-,5/28/2024,Expedited,48,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,5/13/2024,6/26/2023,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396280,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J Drug Alcohol Res. 2022;11(2):236162\",-\\n22645484,-,Clonazepam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Unresponsive To Stimuli;Lethargy,Serious,Other Outcomes,Male,-,7/4/2024,Expedited,60,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,6/19/2024,6/27/2023,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-396275,\"Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J Drug Alcohol Res. 2022;11(2):236162\",-\\n23858710,-,Herbals\\\\Mitragynine;Sertraline Hydrochloride,Anxiety;Depression;Product Used For Unknown Indication,Electrocardiogram Qt Prolonged;Drug Interaction,Serious,Hospitalized;Other Outcomes,Female,-,5/15/2024,Expedited,17,Not Specified,Granules India,Healthcare Professional,Not Specified,-,5/2/2024,5/15/2024,US,Not Specified,US-GRANULES-US-2024GRALIT00158,N Truesdale.QTc prolongation related to kratom ingestion with underlying SSRI usage.American Journal of the Medical Sciences.FEB-2024;367 (Suppl. 1):S284 abstr,-\\n23982168,Sertraline,Sertraline Hydrochloride;Herbals\\\\Mitragynine;Bupropion Hydrochloride,Antidepressant Therapy;Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes;Hospitalized;Life Threatening,Male,-,6/17/2024,Expedited,28,Not Specified,Epic Pharm,Healthcare Professional,Not Specified,-,6/3/2024,6/17/2024,US,Not Specified,US-EPICPHARMA-US-2024EPCLIT00717,Marissa Saber.SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY.Critical Care Medicine.JAN-2024;52:S642,-\\n23964527,-,Bupropion Hydrochloride;Herbals\\\\Mitragynine;Sertraline Hydrochloride,Antidepressant Therapy;Product Used For Unknown Indication,Serotonin Syndrome;Drug Interaction,Serious,Life Threatening;Hospitalized;Other Outcomes,Male,-,6/12/2024,Expedited,28,Not Specified,Granules India,Healthcare Professional,Not Specified,-,5/29/2024,6/12/2024,US,Not Specified,US-GRANULES-US-2024GRALIT00212,Marissa Saber.SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY..Critical Care Medicine.JAN-2024;52:S642,-\\n24261090,Methadone,Methadone Hydrochloride;Herbals\\\\Mitragynine;Morphine,Product Used For Unknown Indication,Eye Movement Disorder;Miosis;Pupillary Reflex Impaired;Toxicity To Various Agents;Impaired Driving Ability;Lacrimation Increased;Imprisonment,Serious,Other Outcomes;Disabled,Male,-,8/29/2024,Expedited,52,Not Specified,Specgx,Healthcare Professional,Not Specified,-,8/21/2024,8/29/2024,US,Not Specified,US-SPECGX-T202401766,\"Kedzierski N, Mata D. Mitragynine in the Orange County DUID population. Journal of Analytical Toxicology. 2023;47(8):770-85\",-\\n24272154,Alcohol (Alcohol),.Delta.8-Tetrahydrocannabinol\\\\Herbals;Alcohol;Aripiprazole;Herbals\\\\Mitragynine;Methylphenidate Hydrochloride,Product Used For Unknown Indication,Imprisonment;Nystagmus;Binocular Eye Movement Disorder;Impaired Driving Ability;Blepharospasm;Toxicity To Various Agents;Heart Rate Increased,Serious,Other Outcomes;Disabled,Male,-,9/2/2024,Expedited,21,Not Specified,Specgx,Healthcare Professional,Not Specified,-,8/21/2024,9/2/2024,US,Not Specified,US-SPECGX-T202401782,\"Kedzierski N, Mata D. Mitragynine in the Orange County DUID population. Journal of Analytical Toxicology. 2023;47(8):770-85\",-\\n24272150,Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Oxymorphone;Oxycodone,Product Used For Unknown Indication,Impaired Driving Ability;Balance Disorder;Imprisonment;Nystagmus;Toxicity To Various Agents,Serious,Other Outcomes;Disabled,Male,-,9/2/2024,Expedited,51,Not Specified,Specgx,Healthcare Professional,Not Specified,-,8/21/2024,9/2/2024,US,Not Specified,US-SPECGX-T202401781,\"Kedzierski N, Mata D. Mitragynine in the Orange County DUID population. Journal of Analytical Toxicology. 2023;47(8):770-85\",-\\n24272141,-,Hydromorphone;Methamphetamine;Hydrocodone;Acetaminophen;Herbals\\\\Mitragynine;Benzoylecgonine;Amphetamine;Cocaine;Dihydrocodeine,Product Used For Unknown Indication,Anxiety;Bruxism;Toxicity To Various Agents;Extremity Contracture;Paranoia;Impaired Driving Ability;Speech Disorder;Hyperhidrosis;Imprisonment,Serious,Other Outcomes;Disabled,Male,-,9/2/2024,Expedited,38,Not Specified,Specgx,Healthcare Professional,Not Specified,-,8/21/2024,9/2/2024,US,Not Specified,US-SPECGX-T202401780,\"Kedzierski N, Mata D. Mitragynine in the Orange County DUID population. Journal of Analytical Toxicology. 2023;47(8):770-85\",-\\n24272140,Alcohol (Alcohol),Alcohol;Herbals\\\\Mitragynine;Acetaminophen\\\\Hydrocodone,Product Used For Unknown Indication,Road Traffic Accident;Heart Rate Increased;Impaired Driving Ability;Nystagmus;Eye Movement Disorder;Imprisonment;Balance Disorder;Tremor;Toxicity To Various Agents,Serious,Disabled;Other Outcomes,Female,-,9/2/2024,Expedited,42,Not Specified,Specgx,Healthcare Professional,Not Specified,-,8/21/2024,9/2/2024,US,Not Specified,US-SPECGX-T202401779,\"Kedzierski N, Mata D. Mitragynine in the Orange County DUID population. Journal of Analytical Toxicology. 2023;47(8):770-85\",-\\n24272020,Zolpidem;Pamelor,Nortriptyline Hydrochloride;Herbals\\\\Mitragynine;Zolpidem Tartrate;Methocarbamol;Oxycodone;Amitriptyline;Morphine;Gabapentin;Oxymorphone,Product Used For Unknown Indication,Imprisonment;Toxicity To Various Agents;Abnormal Behaviour;Ocular Hyperaemia;Nystagmus;Impaired Driving Ability;Balance Disorder;Restlessness;Lacrimation Increased,Serious,Disabled;Other Outcomes,Male,-,9/2/2024,Expedited,31,Not Specified,Specgx,Healthcare Professional,Not Specified,-,8/21/2024,9/2/2024,US,Not Specified,US-SPECGX-T202401778,\"Kedzierski N, Mata D. Mitragynine in the Orange County DUID population. Journal of Analytical Toxicology. 2023;47(8):770-85\",-\\n24144944,-,Citalopram;Lamotrigine;Herbals\\\\Mitragynine;Zopiclone;7-Hydroxymitragynine,Product Used For Unknown Indication,Accidental Poisoning;Respiratory Depression;Drug Interaction;Pulmonary Congestion;Toxicity To Various Agents,Serious,Died;Other Outcomes,Male,-,7/31/2024,Expedited,Not Specified,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,7/16/2024,7/29/2024,NO,Not Specified,NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2014R1-90322,\"Karinen R, Fosen JT, Rogde S, Vindenes V. An accidental poisoning with mitragynine. Forensic Sci Int. 2014;245:e29-32\",-\\n23521867,Fluoxetine,Fluoxetine Hydrochloride;Bupropion;Herbals\\\\Mitragynine;Fentanyl,-,Serotonin Syndrome;Drug Interaction,Serious,Other Outcomes,Male,-,2/14/2024,Expedited,68,Not Specified,Appco Pharma,Healthcare Professional,Not Specified,-,1/31/2024,2/14/2024,US,Not Specified,US-Appco Pharma LLC-2153187,Initial,-\\n23396807,-,Quinine;Herbals\\\\Mitragynine;Fentanyl Citrate,-,Cardiac Arrest;Respiratory Arrest;Drug Abuse,Serious,Died;Other Outcomes,Male,2022,1/12/2024,Expedited,35,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,1/5/2024,1/12/2024,US,Not Specified,US-PFIZER INC-202400006919,\"Gummin, D.. 2022 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023;61 (10):717-939\",-\\n23511751,-,Herbals\\\\Mitragynine;Propranolol Hydrochloride,Product Used For Unknown Indication,Completed Suicide;Cardio-Respiratory Arrest,Serious,Died,Female,2022,2/12/2024,Expedited,25,Not Specified,Endo,Healthcare Professional,Not Specified,-,1/16/2024,2/12/2024,US,Not Specified,US-ENDO PHARMACEUTICALS INC-2024-000757,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al.. 2022 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023;61 (10):717-939\",-\\n23382096,-,Phenylpropanolamine;Herbals\\\\Mitragynine;Bupropion;Pseudoephedrine;Citalopram;Dextromethorphan,Product Used For Unknown Indication,Completed Suicide;Cardio-Respiratory Arrest,Serious,Other Outcomes;Died;Hospitalized,Male,2022,1/9/2024,Expedited,39,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/2/2024,1/9/2024,US,Not Specified,US-APOTEX-2024AP000426,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C.. 2022 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023;61(10):717-939\",-\\n23380403,-,Herbals\\\\Mitragynine;Diphenhydramine;Acetaminophen,Product Used For Unknown Indication,Completed Suicide,Serious,Died;Other Outcomes;Hospitalized,Female,2022,1/9/2024,Expedited,45,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/2/2024,1/9/2024,US,Not Specified,US-APOTEX-2024AP000179,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C.. 2022 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023;61(10):717-939\",-\\n23731047,-,Despropionylfentanyl;Quinine;Parafluorofentanyl;Fentanyl;Herbals\\\\Mitragynine,Drug Abuse,Respiratory Arrest;Drug Abuse;Prescription Drug Used Without A Prescription;Cardiac Arrest,Serious,Died;Other Outcomes,Male,-,4/11/2024,Expedited,35,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2024,4/11/2024,US,Not Specified,US-ALVOGEN-2024093540,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2022 Annual Report of the National Poison Data System (NPDS) from America?s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023 Dec 12;61 (10):717-939. doi:https://doi.org/10.1080/15563650.2023.2268981\",-\\n23730826,-,Dextromethorphan;Herbals\\\\Mitragynine;Phenylpropanolamine;Citalopram;Bupropion;Pseudoephedrine,Suicide Attempt,Completed Suicide;Cardiac Arrest;Respiratory Arrest,Serious,Died;Other Outcomes,Male,-,4/11/2024,Expedited,39,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2024,4/11/2024,US,Not Specified,US-ALVOGEN-2024093588,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2022 Annual Report of the National Poison Data System (NPDS) from America?s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023 Dec 12;61 (10):717-939. doi:https://doi.org/10.1080/15563650.2023.2268981\",-\\n24770968,-,Herbals\\\\Mitragynine;Fentanyl;Gabapentin,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Not Specified,-,12/24/2024,Expedited,Not Specified,Not Specified,Glenmark,Healthcare Professional,Not Specified,-,12/18/2024,12/24/2024,US,Not Specified,US-GLENMARK PHARMACEUTICALS-2024GMK096557,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R et al. 2023 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 41st Annual Report. Clinical Toxicology. 2024;2-235\",-\\n24428948,-,Herbals\\\\Mitragynine;Propranolol Hydrochloride,Product Used For Unknown Indication,Toxicity To Various Agents;Completed Suicide;Cardio-Respiratory Arrest,Serious,Died,Female,2022,10/11/2024,Expedited,25,Not Specified,Northstar,Healthcare Professional,Not Specified,-,9/30/2024,10/11/2024,US,Not Specified,US-NORTHSTAR RX LLC-US-2024NSR000084,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, et al.. 2022 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 40th Annual Report. Clinical Toxicology. 2022;61(10):717-939\",-\\n23506205,Fluoxetine,Fluoxetine Hydrochloride;Herbals\\\\Mitragynine;Bupropion Hydrochloride;Fentanyl,Product Used For Unknown Indication,Serotonin Syndrome,Serious,Other Outcomes,Male,-,2/9/2024,Expedited,68,Not Specified,Epic Pharm,Healthcare Professional,Not Specified,-,1/29/2024,2/9/2024,US,Not Specified,US-EPICPHARMA-US-2024EPCLIT00240,\"Grundmann O.Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits.DM Disease a Month.JAN-2023;69\",-\\n23509370,Fluoxetine,Fluoxetine Hydrochloride;Herbals\\\\Mitragynine;Fentanyl;Bupropion Hydrochloride,Product Used For Unknown Indication,Serotonin Syndrome,Serious,Other Outcomes,Male,-,2/10/2024,Expedited,68,Not Specified,Granules India,Healthcare Professional,Not Specified,-,1/31/2024,2/10/2024,US,Not Specified,US-GRANULES-US-2024GRALIT00024,\"Grundmann O.Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits.DM Disease a Month .JAN-2023;69 (6)\",-\\n23482002,Fluoxetine,Fluoxetine Hydrochloride;Herbals\\\\Mitragynine;Fentanyl;Bupropion,Pain,Serotonin Syndrome;Toxicity To Various Agents;Drug Interaction,Serious,Life Threatening;Other Outcomes;Hospitalized,Male,-,2/5/2024,Expedited,68,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,1/23/2024,2/5/2024,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2024R1-429836,\"Grundmann O,Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Dis Mon. 2023;69 (6):1-13\",-\\n23484289,Fluoxetine,Fluoxetine Hydrochloride;Herbals\\\\Mitragynine,Pain Management;Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes,Male,-,2/6/2024,Expedited,68,Not Specified,Sandoz,Healthcare Professional,Not Specified,Fentanyl;Bupropion,2/1/2024,2/6/2024,US,Not Specified,US-SANDOZ INC.-SDZ2024US011043,\"Grundmann O,Hendrickson R G,Greenberg M I. Kratom: History, pharmacology, current user trends, adversehealth effects and potential benefits. Disease-a-Month. 2023;69\",-\\n23459072,Fluoxetine,Fluoxetine Hydrochloride;Fentanyl;Bupropion Hydrochloride;Herbals\\\\Mitragynine,Pain;Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes,Male,-,4/2/2024,Non-Expedited,68,Not Specified,Graviti Pharmaceuticals,Healthcare Professional,Not Specified,-,3/21/2024,1/31/2024,US,Not Specified,US-GRAVITIPHARMA-GRA-2401-US-LIT-0008,\"Grundmann O, Hendrickson RG, Greenberg MI.Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits.Dis-Mon.2023;69:6\",-\\n23480553,Fluoxetine,Fluoxetine Hydrochloride;Bupropion;Fentanyl;Herbals\\\\Mitragynine,Pain;Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes,Not Specified,-,2/5/2024,Expedited,Not Specified,Not Specified,Zydus Pharm,Healthcare Professional,Not Specified,-,1/23/2024,2/5/2024,US,Not Specified,US-CADILA HEALTHCARE LIMITED-US-ZYDUS-102808,\"Grundmann O, Hendrickson RG, Greenberg MI.. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits.. Dis-Mon. 2023;69 No. 6.\",-\\n23440131,Fluoxetine,Fluoxetine Hydrochloride;Herbals\\\\Mitragynine;Fentanyl;Bupropion,Pain,Drug Interaction;Serotonin Syndrome,Serious,Hospitalized,Male,-,1/24/2024,Expedited,68,Not Specified,Strides,Healthcare Professional,Not Specified,-,1/18/2024,1/24/2024,US,Not Specified,US-STRIDES ARCOLAB LIMITED-2024SP000856,\"Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits.. Dis-Mon. 2023;69 (6)\",-\\n23461854,Fluoxetine,Fluoxetine Hydrochloride;Herbals\\\\Mitragynine;Fentanyl;Bupropion,Pain,Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes;Hospitalized,Male,-,1/31/2024,Non-Expedited,68,Not Specified,Dr Reddys,Healthcare Professional,Not Specified,-,1/18/2024,1/31/2024,US,Not Specified,US-RDY-LIT/USA/24/0001565,\"Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. DM Disease a Month. 2023 Jan;69(6): doi:10.1016/j.disamonth.2022.101442.\",-\\n23478277,Fluoxetine,Fluoxetine Hydrochloride;Bupropion;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Serotonin Syndrome,Serious,Other Outcomes,Male,-,2/13/2024,Expedited,68,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,1/31/2024,2/4/2024,US,Not Specified,US-AUROBINDO-AUR-APL-2024-003927,\"Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Disease-a-Month. 2023;69:6\",-\\n23450118,Fluoxetine,Fluoxetine Hydrochloride;Bupropion;Herbals\\\\Mitragynine;Fentanyl,Pain;Product Used For Unknown Indication,Serotonin Syndrome;Drug Interaction,Serious,Hospitalized;Other Outcomes,Male,-,1/29/2024,Expedited,68,Not Specified,Lupin,Healthcare Professional,Not Specified,-,1/18/2024,1/29/2024,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2024-00461,\"Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Disease-a-Month. 2023;69 (6):1-13\",-\\n23442488,Fluoxetine,Fluoxetine Hydrochloride;Fentanyl;Herbals\\\\Mitragynine;Bupropion,Pain;Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes,Male,-,1/25/2024,Expedited,68,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/18/2024,1/25/2024,US,Not Specified,US-APOTEX-2024AP001528,\"Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Disease-a-Month. 2023;69 (6) 101442:1-13\",-\\n23480743,Fluoxetine,Fluoxetine Hydrochloride;Bupropion;Fentanyl;Herbals\\\\Mitragynine,Pain Prophylaxis,Serotonin Syndrome;Drug Interaction,Serious,Hospitalized;Other Outcomes;Life Threatening,Male,-,2/5/2024,Expedited,68,Not Specified,Micro Labs,Healthcare Professional,Not Specified,-,1/23/2024,2/5/2024,US,Not Specified,US-862174955-ML2024-00643,\"Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Disease-a-Month. 2023;(69(6)): 1-13. doi:https://doi.org/10.1016/j.disamonth.2022.101442.\",-\\n23437711,Fluoxetine,Fluoxetine Hydrochloride;Fentanyl;Herbals\\\\Mitragynine;Bupropion,Pain,Drug Interaction;Serotonin Syndrome;Off Label Use,Serious,Hospitalized,Male,-,1/24/2024,Expedited,68,Not Specified,Mylan,Healthcare Professional,Not Specified,-,1/18/2024,1/24/2024,US,Not Specified,US-MYLANLABS-2024M1007022,\"Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Dis-Mon 2023; 69 (6):.\",-\\n23506278,Fentanyl Transdermal System;Fluoxetine,Fluoxetine Hydrochloride;Herbals\\\\Mitragynine;Fentanyl,Pain;Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes,Male,-,2/9/2024,Expedited,68,Not Specified,Sciegen,Healthcare Professional,Not Specified,Bupropion,2/1/2024,2/9/2024,US,Not Specified,US-SCIEGENP-2024SCLIT00039,\"Grundmann O, et al..Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits.DM Disease a Month.jun-2023;69 (6):1-13\",-\\n17904502,Trazodone;Amlodipine,Amlodipine Besylate;Herbals\\\\Mitragynine;Trazodone Hydrochloride;Ziprasidone Hydrochloride;Bupropion Hydrochloride;Buspirone Hydrochloride;Desvenlafaxine;Alteplase,Depression;Hypertension;Product Used For Unknown Indication;Type 2 Diabetes Mellitus,Confusional State;Serotonin Syndrome;Hyperhidrosis;Self-Medication;Clonus;Drug Interaction,Serious,Hospitalized;Other Outcomes,Male,-,1/10/2024,Expedited,63,102.5 KG,Aurobindo,Healthcare Professional,Not Specified,Tizanidine;Hydrochlorothiazide;Gabapentin;Diclofenac;Metformin;Glimepiride;Omeprazole,1/4/2024,6/17/2020,US,Not Specified,US-AUROBINDO-AUR-APL-2020-029111,\"Eudaley ST, Hamilton LA, Brooks S P.. Case report: Successful treatment of suspected kratominduced serotonin syndrome.. J-Am-Coll-Ciin-Pharm. 2020;3(1):347\",-\\n21219859,Trazodone,Trazodone Hydrochloride;Herbals\\\\Mitragynine;Desvenlafaxine;Ziprasidone Hydrochloride;Buspirone Hydrochloride,Product Used For Unknown Indication,Serotonin Syndrome;Self-Medication;Drug Interaction,Serious,Hospitalized;Other Outcomes,Male,-,1/6/2024,Expedited,63,102.5 KG,Aurobindo,Healthcare Professional,Not Specified,Tizanidine;Hydrochlorothiazide;Glimepiride;Gabapentin;Bupropion;Diclofenac;Omeprazole;Amlodipine;Metformin,1/4/2024,8/17/2022,US,Not Specified,US-AUROBINDO-AUR-APL-2022-031927,\"Eudaley ST, Brooks SP, Hamilton LA.. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents.. Journal of pharmacy practice. 2022;1-5\",-\\n21146383,Trazodone;Buspirone,Buspirone Hydrochloride;Bupropion;Trazodone Hydrochloride;Desvenlafaxine;Gabapentin;Herbals\\\\Mitragynine;Ziprasidone,Depression;Neuropathy Peripheral;Product Used For Unknown Indication,Serotonin Syndrome,Serious,Other Outcomes;Hospitalized,Male,04-Nov-2018,4/25/2024,Expedited,63,102.5 KG,Ranbaxy,Healthcare Professional,Not Specified,Hydrochlorothiazide;Diclofenac;Tizanidine;Amlodipine;Omeprazole;Metformin;Glimepiride,4/10/2024,7/29/2022,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-346730,\"Eudaley ST, Brooks SP, Hamilton LA. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. J Pharm Pract. 2023;36(6):1523-1527\",-\\n23403415,-,Quinine;Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse;Cardio-Respiratory Arrest,Serious,Died;Other Outcomes,Male,-,1/16/2024,Expedited,35,Not Specified,Aveva,Healthcare Professional,Not Specified,-,1/2/2024,1/16/2024,US,Not Specified,US-AVEVA-000253,\"David D. Gummin, James B. Mowry, Michael C. Beuhler, Daniel A. Spyker, Laura J. Rivers, Ryan Feldman, Kaitlyn Brown, Nathaniel P.T. Pham, Alvin C. Bronstein &amp; Carol DesLauriers (2023) 2022 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers : 40th Annual Report, Clinical Toxicology, 61:10, 717-939.\",-\\n23380153,-,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,1/9/2024,Expedited,32,Not Specified,Aveva,Healthcare Professional,Not Specified,-,1/2/2024,1/9/2024,US,Not Specified,US-AVEVA-000208,\"David D. Gummin, James B. Mowry, Michael C. Beuhler, Daniel A. Spyker, Laura J. Rivers, Ryan Feldman, Kaitlyn Brown, Nathaniel P.T. Pham, Alvin C. Bronstein &amp; Carol DesLauriers (2023) 2022 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers : 40th Annual Report, Clinical Toxicology, 61:10, 717-939\",-\\n23399922,-,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,1/14/2024,Expedited,42,Not Specified,Aveva,Healthcare Professional,Not Specified,-,1/2/2024,1/14/2024,US,Not Specified,US-AVEVA-000354,\"David D. Gummin, James B. Mowry, Michael C. Beuhler, Daniel A. Spyker, Laura J. Rivers, Ryan Feldman, Kaitlyn Brown, Nathaniel P.T. Pham, Alvin C. Bronstein &amp; Carol DesLauriers (2023) 2022 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers : 40th Annual Report, Clinical Toxicology, 61:10, 717-939\",-\\n23402314,-,Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/15/2024,Expedited,26,Not Specified,Aveva,Healthcare Professional,Not Specified,-,1/2/2024,1/15/2024,US,Not Specified,US-AVEVA-000099,\"David D. Gummin, James B. Mowry, Michael C. Beuhler, Daniel A. Spyker, Laura J. Rivers, Ryan Feldman, Kaitlyn Brown, Nathaniel P.T. Pham, Alvin C. Bronstein &amp; Carol DesLauriers (2023) 2022 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers : 40th Annual Report, Clinical Toxicology, 61:10, 717-939\",-\\n23402305,-,Cocaine;Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/15/2024,Expedited,26,Not Specified,Aveva,Healthcare Professional,Not Specified,-,1/2/2024,1/15/2024,US,Not Specified,US-AVEVA-000093,\"David D. Gummin, James B. Mowry, Michael C. Beuhler, Daniel A. Spyker, Laura J. Rivers, Ryan Feldman, Kaitlyn Brown, Nathaniel P.T. Pham, Alvin C. Bronstein &amp; Carol DesLauriers (2023) 2022 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers : 40th Annual Report, Clinical Toxicology, 61:10, 717-939\",-\\n23401864,-,Herbals\\\\Mitragynine;Cannabis Sativa Subsp. Indica Top;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/15/2024,Expedited,33,Not Specified,Aveva,Healthcare Professional,Not Specified,-,1/2/2024,1/15/2024,US,Not Specified,US-AVEVA-000224,\"David D. Gummin, James B. Mowry, Michael C. Beuhler, Daniel A. Spyker, Laura J. Rivers, Ryan Feldman, Kaitlyn Brown, Nathaniel P.T. Pham, Alvin C. Bronstein &amp; Carol DesLauriers (2023) 2022 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers : 40th Annual Report, Clinical Toxicology, 61:10, 717-939\",-\\n23447568,\"Heroin;Hydroxyzine;Methadone;Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate;Sertraline;Trazodone;Restoril;Venlafaxine;Alcohol (Alcohol);Zolpidem\",Benzoylecgonine;Doxylamine;Zolpidem Tartrate;Oxybate;Valproic Acid;Topiramate;Buprenorphine;Phenylpropanolamine;Phentermine;Ketamine;Zopiclone;Carisoprodol;Secobarbital;Dextromethorphan;Tramadol;Oxymorphone Hydrochloride;Temazepam;Lorazepam;Methylphenidate Hydrochloride;Mirtazapine;Venlafaxine Hydrochloride;Codeine;Carbamazepine;Alcohol;Diphenhydramine;Trazodone Hydrochloride;Cathinone;Methamphetamine;Sertraline Hydrochloride;Hydromorphone;Etizolam;Cocaine;Tapentadol;Herbals\\\\Mitragynine;Fentanyl Citrate;Meprobamate;Gabapentin;Diazepam;Amphetamine Aspartate\\\\Amphetamine Sulfate\\\\Dextroamphetamine Saccharate\\\\Dextroamphetamine Sulfate;Phenytoin;Cyclobenzaprine;Pseudoephedrine;Pregabalin;Guaifenesin;Lamotrigine;Midazolam;Hydrocodone;Chlorpheniramine;Citalopram;Olanzapine;Clonazepam;Methadone Hydrochloride;Hydroxyzine Hydrochloride;Chlordiazepoxide;Diamorphine;Nordazepam;Alprazolam;Oxazepam;Morphine;Oxycodone;Phencyclidine;Cannabis Sativa Subsp. Indica Top,Product Used For Unknown Indication,Road Traffic Accident;Impaired Driving Ability,Serious,Other Outcomes;Died,Not Specified,-,1/26/2024,Expedited,Not Specified,Not Specified,Specgx,Healthcare Professional,Not Specified,-,1/18/2024,1/26/2024,US,Not Specified,US-SPECGX-T202400498,\"D\\'Orazio AL, Mohr AL, Chan-Hosokawa A, Harper C, Huestis MA, Limoges JF et al. Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities-2021 update. Journal of Analytical Toxicology. 2021;45(6):529-36\",-\\n24667039,Sertraline;Trazodone,Sertraline Hydrochloride;Trazodone Hydrochloride;Quetiapine;Olanzapine;Risperidone;Herbals\\\\Mitragynine,Psychotic Disorder,Toxicity To Various Agents,Serious,Died,Female,-,12/13/2024,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,12/9/2024,11/26/2024,CZ,Not Specified,CZ-MYLANLABS-2024M1105271,\"Bursova M, Horak V, Syuparek Z, Yerna I.. Deaths associated with Kratom use. Proceedings. 22nd conference of the military medicine society CLS JEP. 2024;1 (93):5-6\",-\\n24668900,Trazodone;Sertraline;Risperdal,Risperidone;Sertraline Hydrochloride;Olanzapine;Quetiapine;Trazodone Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication;Psychotic Disorder,Toxicity To Various Agents,Serious,Died,Female,-,12/18/2024,Expedited,Not Specified,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,12/3/2024,11/27/2024,CZ,Not Specified,CZ-AUROBINDO-AUR-APL-2024-057051,\"Bursova M, Horak V, Syuparek Z, Yerna I.. Deaths associated with Kratom use. Proceedings. 2024; 93(Military Medicine Science Letters, Suppl. 1, 22nd conference of the military medicine society CLS JEP, - 6 November 2024):5. 2024;SUPPL.. UVN Prague 5. 2024;1:5-6.\",-\\n24703335,Risperdal;Trazodone;Sertraline,Sertraline Hydrochloride;Trazodone Hydrochloride;Risperidone;Herbals\\\\Mitragynine;Quetiapine;Olanzapine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Female,-,12/5/2024,Expedited,Not Specified,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,12/5/2024,12/5/2024,CZ,Not Specified,CZ-JNJFOC-20241212275,\"Bursova M, Cerna I, Horak V, et al. Umrti spojene s uzitim Kratomu. Sbornik. 2024; 93(Military Medicine Science Letters, Suppl. 1, 22. konference spolecnosti vojenske mediciny CLS JEP, UVN Praha 5.-6.11.2024):5.\",-\\n23523065,Paxlovid,Nirmatrelvir\\\\Ritonavir;Herbals\\\\Mitragynine;Quetiapine,Bipolar Disorder;Covid-19 Treatment;Hypertension;Menopausal Symptoms,Serotonin Syndrome;Drug Interaction,Serious,Other Outcomes,Female,-,4/18/2024,Expedited,55,Not Specified,Pfizer,Healthcare Professional,Not Specified,Metoprolol,4/13/2024,2/14/2024,US,Not Specified,US-PFIZER INC-PV202400020037,\"Albert, R.. Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64:S:S72\",-\\n23578072,Paxlovid,Quetiapine;Nirmatrelvir\\\\Ritonavir;Herbals\\\\Mitragynine,Covid-19;Menopausal Symptoms;Phytotherapy;Product Used For Unknown Indication,Serotonin Syndrome;Drug Interaction;Herbal Interaction,Serious,Other Outcomes,Female,-,4/18/2024,Expedited,55,Not Specified,Aurobindo,Healthcare Professional,Not Specified,Metoprolol,4/3/2024,2/29/2024,US,Not Specified,US-AUROBINDO-AUR-APL-2024-008192,\"Albert R, Quraishi S, Ashley K.. Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;64(Supplement):S72\",-\\n23543916,Paxlovid,Nirmatrelvir\\\\Ritonavir;Herbals\\\\Mitragynine;Metoprolol;Quetiapine,Covid-19;Menopausal Symptoms;Product Used For Unknown Indication,Serotonin Syndrome,Serious,Other Outcomes,Female,-,2/29/2024,Expedited,55,Not Specified,Sandoz,Healthcare Professional,Not Specified,-,2/16/2024,2/20/2024,IL,Not Specified,IL-SANDOZ INC.-SDZ2024IL014961,\"Albert R, Quraishi S, Ashley K.. Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. Journal of the Academy of Consultation- Liaison Psychiatry. 64:S72\",-\\n23585473,-,Quetiapine;Herbals\\\\Mitragynine;Nirmatrelvir;Ritonavir,Covid-19;Menopausal Symptoms;Phytotherapy;Product Used For Unknown Indication,Herbal Interaction;Serotonin Syndrome;Drug Interaction,Serious,Other Outcomes,Not Specified,-,3/1/2024,Expedited,Not Specified,Not Specified,Hikma,Healthcare Professional,Not Specified,Metoprolol,2/15/2024,3/1/2024,US,Not Specified,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-24-01483,\"Albert R, Quraishi S, Ashley K.. Albert R, Quraishi S, Ashley K. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom.. Journal of the Academy of Consultation-Liaison Psychiatry.. 2024;64(Supplement)::72\",-\\n23569743,-,Herbals\\\\Mitragynine;Ritonavir;Quetiapine;Nirmatrelvir,Covid-19;Menopausal Symptoms;Phytotherapy;Product Used For Unknown Indication,Serotonin Syndrome;Herbal Interaction;Drug Interaction,Serious,Other Outcomes,Not Specified,-,2/27/2024,Expedited,Not Specified,Not Specified,Macleods,Healthcare Professional,Not Specified,Metoprolol,2/15/2024,2/27/2024,US,Not Specified,US-MACLEODS PHARMACEUTICALS US LTD-MAC2024045997,\"Albert R, Quraishi S, Ashley K.. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;64:S72.\",-\\n23556123,-,Herbals\\\\Mitragynine;Quetiapine Fumarate,Bipolar Disorder;Menopausal Symptoms;Product Used For Unknown Indication,Serotonin Syndrome,Serious,Other Outcomes,Female,-,2/22/2024,Expedited,55,Not Specified,Amneal,Healthcare Professional,Not Specified,Metoprolol,2/13/2024,2/22/2024,IL,Not Specified,IL-AMNEAL PHARMACEUTICALS-2024-AMRX-00591,\"Albert R, Quraishi S, Ashley K.. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. J Acad Consult Liaison Psychiatry. 2023;64:S72\",-\\n23578412,-,Herbals\\\\Mitragynine;Nirmatrelvir;Quetiapine Fumarate;Ritonavir,Covid-19;Menopausal Symptoms;Phytotherapy;Product Used For Unknown Indication,Serotonin Syndrome;Herbal Interaction;Drug Interaction,Serious,Other Outcomes,Female,-,2/29/2024,Expedited,55,Not Specified,Jubilant,Healthcare Professional,Not Specified,Metoprolol,2/15/2024,2/29/2024,US,Not Specified,US-JUBILANT CADISTA PHARMACEUTICALS-2024US000222,\"Albert R, Quraishi S, Ashley K. Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom.. Journal of the Academy of Consultation-Liaison Psychiatry.. 2024;64(Supplement):S72\",-\\n23563823,Paxlovid,Nirmatrelvir\\\\Ritonavir;Herbals\\\\Mitragynine;Quetiapine Fumarate,Covid-19;Menopausal Symptoms;Phytotherapy;Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome;Herbal Interaction,Serious,Other Outcomes,Female,-,2/26/2024,Expedited,55,Not Specified,Lupin,Healthcare Professional,Not Specified,Metoprolol,2/14/2024,2/26/2024,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2024-01273,\"Albert R, Quraishi S, Ashley K. Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64:S72\",-\\n23566169,-,Ritonavir;Quetiapine;Herbals\\\\Mitragynine;Nirmatrelvir,Covid-19;Menopausal Symptoms;Phytotherapy;Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome;Herbal Interaction,Serious,Other Outcomes,Female,-,2/26/2024,Expedited,55,Not Specified,Dr Reddys,Healthcare Professional,Not Specified,Metoprolol,2/15/2024,2/26/2024,US,Not Specified,US-RDY-SPO/USA/24/0003104,\"Albert R, Quraishi S, Ashley K. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;64(Supplement):S72. DOI: 10.1016/j.jaclp.2023.11.616.\",-\\n23569619,-,Ritonavir;Herbals\\\\Mitragynine;Quetiapine;Nirmatrelvir,Covid-19;Menopausal Symptoms;Phytotherapy;Product Used For Unknown Indication,Herbal Interaction;Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes,Female,-,2/27/2024,Expedited,55,Not Specified,Accord,Healthcare Professional,Not Specified,Metoprolol,2/15/2024,2/27/2024,US,Not Specified,US-Accord-408486,\"Albert R, Quraishi S, Ashley K. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;64(Supplement):S72. DOI: 10.1016/j.jaclp.2023.11.616.\",-\\n23561779,Paxlovid,Nirmatrelvir\\\\Ritonavir;Quetiapine;Herbals\\\\Mitragynine,Covid-19;Menopausal Symptoms,Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes,Female,-,2/25/2024,Expedited,55,Not Specified,Prinston Pharmaceutical,Healthcare Professional,Not Specified,Metoprolol,2/14/2024,2/25/2024,US,Not Specified,US-PRINSTON PHARMACEUTICAL INC.-2024PRN00081,\"Albert R, Quraishi S, Ashley K. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. J. Acad. Consul. Liaison. Psychiatry. 2023;(64):S72\",-\\n23616995,Paxlovid,Nirmatrelvir\\\\Ritonavir;Herbals\\\\Mitragynine;Quetiapine,Bipolar Disorder;Covid-19;Hypertension;Menopausal Symptoms,Drug Interaction;Serotonin Syndrome,Serious,Hospitalized,Female,-,3/21/2024,Expedited,55,Not Specified,Teva,Healthcare Professional,Not Specified,Metoprolol,3/13/2024,3/11/2024,US,Not Specified,US-TEVA-VS-3164786,\"Albert R, Quraishi S, Ashley K. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S72 abstr. 146.; Albert R, Quraishi S, Ashley K. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S72 abstr. 146.\",-\\n23552913,Paxlovid,Herbals\\\\Mitragynine;Nirmatrelvir\\\\Ritonavir;Quetiapine,Bipolar Disorder;Covid-19;Hypertension;Menopausal Symptoms,Serotonin Syndrome;Drug Interaction,Serious,Hospitalized,Female,-,2/22/2024,Expedited,55,Not Specified,Mylan,Healthcare Professional,Not Specified,Metoprolol,2/14/2024,2/22/2024,US,Not Specified,US-MYLANLABS-2024M1016323,\"Albert R, Quraishi S, Ashley K. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S72 abstr. 146.\",-\\n23778259,Paxlovid,Nirmatrelvir\\\\Ritonavir;Herbals\\\\Mitragynine;Quetiapine,Bipolar Disorder;Covid-19;Hypertension;Menopausal Symptoms,Drug Interaction;Serotonin Syndrome,Serious,Hospitalized;Other Outcomes,Female,-,4/24/2024,Expedited,55,Not Specified,Sciegen,Healthcare Professional,Not Specified,Metoprolol,4/10/2024,4/24/2024,IL,Not Specified,IL-SCIEGENP-2024SCLIT00244,\"Albert R, et al.Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom.Journal of the Academy of Consultation-Liaison Psychiatry .dec-2023;146:S72\",-\\n24782778,-,Herbals\\\\Mitragynine,-,Road Traffic Accident;Drug Dependence;Personality Change;Seizure,Serious,Hospitalized;Other Outcomes,Male,18-Nov-2024,12/26/2024,Direct,29,67.5 KG,Fda-Ctu,Consumer,Not Specified,Wellbutrin;Melatonin;Lexapro,-,12/26/2024,Not Specified,Not Specified,-,-,-\\n23405586,-,Herbals\\\\Mitragynine,Depression,Product Formulation Issue;Psychotic Disorder;Tremor;Hallucination;Product Measured Potency Issue;Product Advertising Issue;Dependence;Drug Dependence,Serious,Disabled;Required Intervention;Other Outcomes,Male,13-Jan-2024,1/13/2024,Direct,40,72 KG,Fda-Ctu,Consumer,Not Specified,Valium;Lunesta,-,1/13/2024,Not Specified,Y,-,-,-\\n24152665,-,Herbals\\\\Mitragynine,Post-Traumatic Stress Disorder,Seizure;Substance Use;Post-Traumatic Stress Disorder,Serious,Required Intervention;Disabled;Died;Hospitalized;Life Threatening,Male,18-Apr-2024,7/29/2024,Direct,27,99 KG,Fda-Ctu,Consumer,Not Specified,Valium;Benadryl;Gabapentin,-,7/29/2024,Not Specified,Not Specified,-,-,Yes\\n23831162,-,Herbals;Herbals\\\\Mitragynine,Depression,Depression;Weight Decreased;Physical Product Label Issue;Insomnia;Drug Dependence;Substance Use;Temperature Regulation Disorder;Malaise;Withdrawal Syndrome;Restlessness;Alopecia;Nausea;Dependence;Skin Discolouration;Therapy Cessation,Serious,Required Intervention;Other Outcomes,Female,02-May-2024,5/7/2024,Direct,27,58.5 KG,Fda-Ctu,Consumer,Not Specified,Tyrosine;Homeopathics;Vitamin B12;Magnesium Citrate;Melatonin;Vitamin D,-,5/7/2024,Not Specified,Not Specified,-,-,-\\n24613402,-,Herbals\\\\Mitragynine,Anxiety,Restless Legs Syndrome,Serious,Disabled,Male,01-Jan-2023,11/12/2024,Direct,34,58.5 KG,Fda-Ctu,Consumer,Not Specified,Sertraline;Strattera,-,11/12/2024,Not Specified,Not Specified,-,-,-\\n23427626,-,Herbals\\\\Mitragynine,Anxiety,Sudden Death,Serious,Died,Male,-,1/20/2024,Direct,20,58.5 KG,Fda-Ctu,Consumer,Not Specified,Prozac,-,1/20/2024,Not Specified,Not Specified,-,-,-\\n23586351,-,Herbals\\\\Mitragynine,Pain,Hallucination;Psychotic Disorder;Seizure,Serious,Other Outcomes;Hospitalized,Male,09-Feb-2024,3/1/2024,Direct,48,81 KG,Fda-Ctu,Consumer,Not Specified,Prazosin;Keppra;Suboxone;Duloxetine,-,3/1/2024,Not Specified,Not Specified,-,-,-\\n24660433,-,Herbals\\\\Mitragynine,Pain,Weight Decreased;Asthenia;Withdrawal Syndrome,Serious,Other Outcomes,Male,18-Nov-2024,11/24/2024,Direct,53,87.75 KG,Fda-Ctu,Consumer,Not Specified,Levothyroxine;Metoprolol,-,11/24/2024,Not Specified,Not Specified,-,-,-\\n24670817,-,Herbals\\\\Mitragynine,-,Gait Inability;Vision Blurred;Impaired Driving Ability;Pruritus;Initial Insomnia;Abdominal Pain Upper;Ear Discomfort;Dizziness;Euphoric Mood;Nausea;Poisoning,Non-Serious,Non-Serious,Female,23-Nov-2024,11/27/2024,Direct,41,96.75 KG,Fda-Ctu,Consumer,Not Specified,Iron,-,11/27/2024,Not Specified,Not Specified,-,-,-\\n24214282,-,Herbals\\\\Mitragynine,-,Blood Cannabinoids;Maternal Exposure During Pregnancy;Hypertonia Neonatal;Maternal Drugs Affecting Foetus;Agitation Neonatal;Drug Withdrawal Syndrome,Serious,Other Outcomes,Female,01-Aug-2024,8/14/2024,Direct,1 DAY,3.6 KG,Fda-Ctu,Healthcare Professional,Not Specified,Herbals\\\\Tetrahydrocannabinol Unspecified,-,8/14/2024,Not Specified,Not Specified,-,-,-\\n23468572,-,Herbals\\\\Mitragynine,Substance Use,Withdrawal Syndrome;Drug Dependence;Product Complaint,Serious,Disabled;Other Outcomes,Male,26-Jan-2024,2/1/2024,Direct,36,72 KG,Fda-Ctu,Consumer,Not Specified,Herbals\\\\Mitragynine,-,2/1/2024,Not Specified,Not Specified,-,-,-\\n23693637,-,Herbals\\\\Mitragynine,Anxiety,\"Legal Problem;Hallucination, Auditory;Mental Disorder;Illogical Thinking\",Non-Serious,Non-Serious,Female,04-Dec-2023,3/31/2024,Direct,35,74.25 KG,Fda-Ctu,Consumer,Not Specified,Herbals\\\\Mitragynine,-,3/31/2024,Not Specified,Not Specified,-,-,-\\n23718715,-,Herbals\\\\Mitragynine,-,Nausea;Abdominal Pain Upper;Emotional Distress;Vomiting;Tachycardia;Tremor,Non-Serious,Non-Serious,Female,05-Apr-2024,4/7/2024,Direct,21,56.25 KG,Fda-Ctu,Consumer,Not Specified,Gabapentin;Coenzyme Q10;Fish Oil;Clarinex;Prozac;Corlanor,-,4/7/2024,Not Specified,Not Specified,-,-,-\\n23853681,-,Herbals\\\\Mitragynine,Anxiety;Insomnia,Substance Use;Drug Withdrawal Syndrome,Serious,Other Outcomes,Female,22-Apr-2024,5/13/2024,Direct,68,72 KG,Fda-Ctu,Consumer,Not Specified,Fish Oil,-,5/13/2024,Not Specified,Not Specified,-,-,-\\n24570228,-,Herbals\\\\Mitragynine,Product Use Issue,Generalised Tonic-Clonic Seizure;Substance Use,Serious,Other Outcomes;Hospitalized,Male,-,10/30/2024,Direct,24,67.5 KG,Fda-Ctu,Consumer,Not Specified,Creatine;Suboxone,-,10/30/2024,Not Specified,Not Specified,-,-,-\\n24695059,-,Herbals\\\\Mitragynine,Depression,Drug Dependence,Serious,Required Intervention;Other Outcomes,Female,01-Mar-2024,12/4/2024,Direct,40,58.5 KG,Fda-Ctu,Consumer,Not Specified,Clonidine,-,12/4/2024,Not Specified,Not Specified,-,-,-\\n23821555,-,Herbals\\\\Mitragynine,Anxiety;Insomnia,Drug-Induced Liver Injury,Serious,Hospitalized,Male,24-Apr-2024,5/5/2024,Direct,63,74.25 KG,Fda-Ctu,Consumer,Not Specified,Cannabis Sativa Subsp. Indica Top,-,5/5/2024,Not Specified,Y,-,-,-\\n23585410,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died,Male,29-Nov-2023,2/29/2024,Direct,40,77.4 KG,Fda-Ctu,Consumer,Not Specified,Benadryl;Zoloft,-,2/29/2024,Not Specified,Not Specified,-,-,-\\n24096419,-,Herbals\\\\Mitragynine,Drug Dependence,Seizure,Serious,Other Outcomes;Hospitalized,Male,26-Sep-2023,7/15/2024,Direct,49,92.25 KG,Fda-Ctu,Consumer,Not Specified,Alprazolam;Trazodone;Tylenol;Olanzapine;Clonazepam;Ambien,-,7/15/2024,Not Specified,Y,-,-,-\\n24250943,-,Herbals\\\\Mitragynine,Anxiety,Nausea;Diarrhoea;Abnormal Behaviour;Chills;Thinking Abnormal;Abdominal Pain Upper;Cold Sweat;Mood Swings;Tremor;Pain In Extremity;Hyperhidrosis,Serious,Hospitalized;Required Intervention;Disabled,Female,15-May-2024,8/25/2024,Direct,22,54 KG,Fda-Ctu,Consumer,Not Specified,Albuterol;Unspecified Ingredient,-,8/25/2024,Not Specified,Not Specified,-,-,-\\n23394684,-,Herbals\\\\Mitragynine;Tramadol,Product Used For Unknown Indication,Drug Use Disorder;Substance Use Disorder,Serious,Other Outcomes,Female,-,1/12/2024,Expedited,Not Specified,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,1/3/2024,1/12/2024,FR,Not Specified,FR-AUROBINDO-AUR-APL-2024-000826,-,-\\n23405515,Kava,Piper Methysticum Root;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Disorientation;Feeling Abnormal;Lung Disorder;Poisoning;Chest Pain;Product Complaint;Dyspnoea;Product Contamination;Taste Disorder;Diarrhoea,Non-Serious,Non-Serious,Male,01-Dec-2023,1/13/2024,Direct,54,105.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/13/2024,Not Specified,Not Specified,-,-,-\\n23410220,-,Tramadol;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Use Disorder;Substance Use Disorder,Serious,Other Outcomes,Female,-,1/17/2024,Expedited,Not Specified,Not Specified,Mylan,Healthcare Professional,Not Specified,-,1/10/2024,1/17/2024,FR,Not Specified,FR-MYLANLABS-2024M1004418,-,-\\n23448431,-,Pseudoephedrine Hydrochloride;Herbals\\\\Mitragynine;Phenylpropanolamine;Bupropion;Getacatetide Acetate;Citalopram,Product Used For Unknown Indication,Toxicity To Various Agents;Completed Suicide,Serious,Died,Male,-,1/27/2024,Expedited,39,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,1/16/2024,1/27/2024,US,Not Specified,US-JNJFOC-20240152499,-,-\\n23453746,Vivitrol,Naltrexone;Herbals\\\\Mitragynine,Drug Dependence;Product Used For Unknown Indication,Substance Use;Feeling Abnormal,Non-Serious,Non-Serious,Male,-,1/29/2024,Non-Expedited,Not Specified,Not Specified,Alkermes,Consumer,Not Specified,Vitamins Nos;Unspecified Ingredient,1/16/2024,1/29/2024,US,Not Specified,US-ALKERMES INC.-ALK-2024-000103,-,-\\n23508595,-,Acetaminophen\\\\Methocarbamol;Citalopram;Acetaminophen\\\\Codeine Phosphate\\\\Methocarbamol;Diphenhydramine;Ranitidine Hydrochloride;Herbals\\\\Mitragynine;Albuterol;Loratadine,Product Used For Unknown Indication,Maternal Exposure During Pregnancy;Caesarean Section;Live Birth,Serious,Other Outcomes,Female,-,2/9/2024,Expedited,37,Not Specified,Fresenius Kabi,Healthcare Professional,Not Specified,-,2/5/2024,2/9/2024,CA,Not Specified,CA-FreseniusKabi-FK202401977,-,-\\n23523373,Valtrex,Valacyclovir Hydrochloride;Diphenhydramine;Acetaminophen;Ranitidine Hydrochloride;Methocarbamol;Albuterol;Acetaminophen\\\\Codeine Phosphate\\\\Methocarbamol;Herbals\\\\Mitragynine;Loratadine,Product Used For Unknown Indication,Foetal Exposure During Pregnancy;Drug Withdrawal Syndrome Neonatal,Serious,Hospitalized;Other Outcomes,Female,-,2/14/2024,Expedited,Not Specified,3 KG,Fresenius Kabi,Healthcare Professional,Not Specified,Citalopram,2/5/2024,2/14/2024,CA,Not Specified,CA-FreseniusKabi-FK202401978,-,-\\n23557160,Paxlovid,Nirmatrelvir\\\\Ritonavir;Quetiapine;Herbals\\\\Mitragynine,Bipolar Disorder;Covid-19;Menopausal Symptoms;Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome,Serious,Other Outcomes;Hospitalized,Female,-,2/23/2024,Expedited,55,Not Specified,Unichem,Healthcare Professional,Not Specified,Metoprolol,2/9/2024,2/23/2024,Not Specified,Not Specified,IL-Unichem Pharmaceuticals (USA) Inc-UCM202402-000159,-,-\\n23595907,-,Herbals\\\\Mitragynine;Hydromorphone Hydrochloride,Pain,Renal Impairment;Overdose,Serious,Died;Other Outcomes,Male,-,3/5/2024,Expedited,44,Not Specified,Pfizer,Healthcare Professional,Not Specified,Escitalopram Oxalate;Zopiclone;Olanzapine,3/4/2024,3/5/2024,CA,Not Specified,CA-PFIZER INC-202400056459,-,-\\n23699715,Vivitrol,Naltrexone;Herbals\\\\Mitragynine,Alcoholism;Pain In Extremity;Product Used For Unknown Indication,Substance Use,Non-Serious,Non-Serious,Male,-,4/3/2024,Non-Expedited,Not Specified,Not Specified,Alkermes,Healthcare Professional,Not Specified,Trazodone;Fluoxetine,3/20/2024,4/3/2024,US,Not Specified,US-ALKERMES INC.-ALK-2024-000792,-,-\\n23718104,Synthroid,Levothyroxine Sodium;Herbals\\\\Mitragynine,Back Pain,Chromaturia;Faeces Discoloured;Substance Use,Non-Serious,Non-Serious,Female,24-Apr-2023,4/6/2024,Direct,46,65.25 KG,Fda-Ctu,Consumer,Not Specified,Synthroid,-,4/6/2024,Not Specified,Not Specified,-,-,-\\n23705204,Spravato,Esketamine;Herbals\\\\Mitragynine;Hydrocodone;Baclofen,Depression;Product Used For Unknown Indication,Vomiting;Dizziness;Nausea,Serious,Other Outcomes,Male,15-Mar-2024,4/29/2024,Expedited,30,68.1 KG,Johnson And Johnson,Healthcare Professional,Not Specified,-,4/18/2024,4/4/2024,US,Not Specified,US-JNJFOC-20240382704,-,-\\n23906326,Nucynta,Tapentadol Hydrochloride;Clonazepam;Herbals\\\\Mitragynine;Pregabalin;Carisoprodol,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Female,23-Apr-2021,5/28/2024,Expedited,44,Not Specified,Collegium Pharmaceutical,Healthcare Professional,Not Specified,Citalopram Hydrobromide,5/16/2024,5/28/2024,AU,Not Specified,\"AU-COLLEGIUM PHARMACEUTICAL, INC.-20230900738\",-,-\\n23367047,-,Herbals\\\\Mitragynine,-,Drug Ineffective,Non-Serious,Non-Serious,Not Specified,-,1/4/2024,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,1/4/2024,Not Specified,Not Specified,-,-,-\\n23369479,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Loss Of Consciousness;Toxicity To Various Agents;Seizure;Fall,Serious,Died,Male,24-Jul-2023,1/4/2024,Direct,25,78.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/4/2024,Not Specified,Not Specified,-,-,-\\n23392830,-,Herbals\\\\Mitragynine,-,Drug Dependence;Chest Pain;Tremor,Serious,Other Outcomes,Male,-,1/11/2024,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,1/11/2024,Not Specified,Not Specified,-,-,-\\n23405969,-,Herbals\\\\Mitragynine,Disturbance In Attention,Job Dissatisfaction;Fear;Paranoia;Decreased Appetite;Drug Dependence;Dyspepsia;Anxiety;Weight Decreased;Depression;Tremor,Serious,Other Outcomes;Required Intervention;Disabled;Hospitalized,Male,01-Jan-2024,1/14/2024,Direct,20,63 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/14/2024,Not Specified,Y,-,-,-\\n23444436,-,Herbals\\\\Mitragynine,Pain Management,Drug Dependence;Product Formulation Issue;Product Communication Issue;Product Use In Unapproved Indication;Victim Of Crime;Product Advertising Issue,Serious,Disabled;Life Threatening;Hospitalized,Female,06-Jan-2024,1/25/2024,Direct,39,178 LB,Fda-Ctu,Consumer,Not Specified,-,-,1/25/2024,Not Specified,Y,-,-,-\\n24080776,Buspirone,Buspirone Hydrochloride;Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,18-Mar-2024,7/11/2024,Direct,27,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,7/11/2024,Not Specified,Not Specified,-,-,-\\n23466173,-,Herbals\\\\Mitragynine,Osteoarthritis,Nasal Congestion;Constipation;Frustration Tolerance Decreased;Rhinorrhoea;Insomnia;Anxiety;Influenza Like Illness;Drug Dependence;Euphoric Mood,Serious,Other Outcomes,Male,31-Jan-2024,1/31/2024,Direct,62,91 KG,Fda-Ctu,Healthcare Professional,Not Specified,-,-,1/31/2024,Not Specified,Not Specified,-,-,-\\n24105852,-,Diazepam;Methylphenidate Hydrochloride;Etizolam;Herbals\\\\Mitragynine;Cannabidiol,Product Used For Unknown Indication,Toxicity To Various Agents;Accidental Overdose,Serious,Died,Male,25-Mar-2024,7/17/2024,Expedited,28,Not Specified,Johnson And Johnson,Consumer,Not Specified,-,7/15/2024,7/17/2024,AU,Not Specified,AU-JNJFOC-20240737587,-,-\\n23806599,-,Olanzapine;Herbals\\\\Mitragynine;Hydromorphone Hydrochloride,Pain;Product Used For Unknown Indication,Completed Suicide;Toxicity To Various Agents;Overdose;Renal Failure;Renal Impairment;Intentional Overdose;Herbal Interaction,Serious,Died;Other Outcomes,Male,-,7/19/2024,Expedited,44,Not Specified,Teva,Healthcare Professional,Not Specified,Zopiclone;Olanzapine;Escitalopram,7/11/2024,5/2/2024,CA,Not Specified,CA-TEVA-VS-3191473,-,-\\n23493436,-,Herbals\\\\Mitragynine,-,Stress;Drug Dependence;Loss Of Personal Independence In Daily Activities,Serious,Disabled;Other Outcomes;Required Intervention,Male,15-Dec-2023,2/6/2024,Direct,34,76.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,2/6/2024,Not Specified,Y,-,-,-\\n23595917,-,Olanzapine;Herbals\\\\Mitragynine;Hydromorphone Hydrochloride,Pain,Overdose;Completed Suicide;Toxicity To Various Agents;Renal Impairment,Serious,Other Outcomes;Died,Male,-,7/25/2024,Expedited,44,Not Specified,Pfizer,Healthcare Professional,Not Specified,Zopiclone;Escitalopram,7/24/2024,3/5/2024,CA,Not Specified,CA-PFIZER INC-202400056465,-,-\\n23494001,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Therapy Cessation;Withdrawal Syndrome;Drug Dependence,Serious,Required Intervention;Disabled,Female,26-Jan-2024,2/6/2024,Direct,35,58.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,2/6/2024,Not Specified,Not Specified,-,-,-\\n24167027,Adderall,Amphetamine Aspartate\\\\Amphetamine Sulfate\\\\Dextroamphetamine Saccharate\\\\Dextroamphetamine Sulfate;Herbals\\\\Mitragynine,Bone Pain;Humerus Fracture,Drug Dependence;Toxicity To Various Agents;Product Complaint;Cardiac Arrest;Substance Use,Serious,Disabled;Died,Male,23-Jun-2023,8/1/2024,Direct,33,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,8/1/2024,Not Specified,Not Specified,-,-,-\\n24200338,Paxlovid,Nirmatrelvir\\\\Ritonavir;Herbals\\\\Mitragynine;Methocarbamol,Covid-19,Vulvovaginal Pruritus;Dyspnoea;Head Discomfort;Screaming;Crying;Visual Impairment;Dizziness;Abnormal Dreams;Feeling Abnormal;Fear;Headache,Non-Serious,Non-Serious,Female,01-Aug-2024,8/9/2024,Direct,32,59.4 KG,Fda-Ctu,Consumer,Not Specified,Buspirone;Metoprolol;Bupropion;Zofran;Amitriptyline;Ibuprofen;Estrogens;Tylenol;Herbals\\\\Mitragynine,-,8/9/2024,Not Specified,Not Specified,-,-,Yes\\n23496591,-,Herbals\\\\Mitragynine,Substance Use,Insomnia;Night Sweats;Drug Dependence;Product Advertising Issue;Withdrawal Syndrome;Restless Legs Syndrome,Serious,Other Outcomes,Male,30-Jan-2024,2/8/2024,Direct,25,63.5 KG,Fda-Ctu,Not Specified,Not Specified,-,-,2/8/2024,Not Specified,Not Specified,-,-,-\\n23591918,-,Herbals\\\\Mitragynine,-,Seizure;Toxicity To Various Agents;Drug Dependence;Overdose,Serious,Died,Male,19-Mar-2022,3/2/2024,Direct,30,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,3/2/2024,Not Specified,Not Specified,-,-,-\\n24204569,Lybalvi,Olanzapine\\\\Samidorphan L-Malate;Herbals\\\\Mitragynine,Blood Pressure Abnormal;Contraception;Product Used For Unknown Indication,Burning Sensation;Genital Burning Sensation;Hyperhidrosis;Panic Reaction;Substance Use;Dyskinesia;Abdominal Discomfort,Non-Serious,Non-Serious,Female,Aug-2024,8/13/2024,Non-Expedited,Not Specified,Not Specified,Alkermes,Consumer,Not Specified,Unspecified Ingredient,8/3/2024,8/13/2024,US,Not Specified,US-ALKERMES INC.-ALK-2024-002046,-,-\\n23600038,-,Herbals\\\\Mitragynine,-,Vomiting;Toxicity To Various Agents;Abdominal Pain Upper;Diarrhoea,Serious,Hospitalized,Male,16-Feb-2024,3/5/2024,Direct,40,90.72 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/5/2024,Not Specified,Not Specified,-,-,-\\n23616935,-,Herbals\\\\Mitragynine,-,Anger;Drug Dependence;Vomiting;Mood Swings;Nausea;Muscle Twitching,Non-Serious,Non-Serious,Male,-,3/9/2024,Direct,47,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,3/9/2024,Not Specified,Not Specified,-,-,-\\n24020185,Alcohol (Alcohol);Spravato,Esketamine;Cocaine;Alcohol;Fentanyl;Herbals\\\\Mitragynine,Blood Pressure Measurement;Depression;Product Used For Unknown Indication;Sleep Disorder,Poisoning;Depressed Mood,Serious,Died,Male,May-2024,8/23/2024,Expedited,33,90.8 KG,Johnson And Johnson,Healthcare Professional,Not Specified,Rexulti;Trazodone;Lisinopril;Synthroid;Prozac;Auvelity,8/12/2024,6/27/2024,US,Not Specified,US-JNJFOC-20240660098,-,-\\n23617413,-,Herbals\\\\Mitragynine,Spinal Fracture,Skin Burning Sensation;Headache;Insomnia;Psychomotor Hyperactivity;Tremor;Drug Dependence;Drug Withdrawal Syndrome,Serious,Hospitalized;Other Outcomes;Required Intervention,Female,20-Nov-2023,3/10/2024,Direct,33,51.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/10/2024,Not Specified,Not Specified,-,-,-\\n23637450,-,Herbals\\\\Mitragynine,-,Manufacturing Product Shipping Issue;Suspected Counterfeit Product;Manufacturing Facilities Issue,Non-Serious,Non-Serious,Not Specified,-,3/14/2024,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,3/14/2024,Not Specified,Not Specified,-,-,-\\n23647254,-,Herbals\\\\Mitragynine,Asthenia,Skin Exfoliation;Pyrexia;Flushing;Pruritus;Chills;Urticaria,Serious,Life Threatening;Other Outcomes,Male,15-Mar-2024,3/18/2024,Direct,33,104.85 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/18/2024,Not Specified,Not Specified,-,-,-\\n23668375,-,Herbals\\\\Mitragynine,Anxiety;Self-Medication;Stress,Adverse Event;Anger;Psychotic Disorder;Vomiting;Drug Dependence;Sleep Disorder,Serious,Required Intervention;Other Outcomes,Male,20-Mar-2024,3/23/2024,Direct,22,72 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/23/2024,Not Specified,Not Specified,-,-,-\\n24289708,-,Herbals\\\\Mitragynine;Tapentadol;Carisoprodol;Clonazepam;Pregabalin,Product Used For Unknown Indication,Toxicity To Various Agents,Non-Serious,Non-Serious,Female,-,9/6/2024,Expedited,44,Not Specified,Alkem,Healthcare Professional,Not Specified,Citalopram Hydrobromide,5/15/2024,9/6/2024,AU,Not Specified,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2024-10488,-,-\\n23744032,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Withdrawal Syndrome;Drug Dependence,Non-Serious,Non-Serious,Female,28-Feb-2024,4/14/2024,Direct,24,58.5 KG,Fda-Ctu,Healthcare Professional,Not Specified,-,-,4/14/2024,Not Specified,Not Specified,-,-,-\\n23768093,-,Herbals\\\\Mitragynine,-,Muscular Weakness;Dry Skin;Alopecia;Drug Tolerance;Suicidal Ideation;Product Advertising Issue;Drug Dependence,Serious,Required Intervention;Other Outcomes,Female,01-Nov-2023,4/19/2024,Direct,37,65.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/19/2024,Not Specified,Not Specified,-,-,-\\n23768069,-,Herbals\\\\Mitragynine,Substance Use,Drug Dependence;Product Advertising Issue,Serious,Required Intervention,Female,01-Apr-2024,4/19/2024,Direct,30,51.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/19/2024,Not Specified,Not Specified,-,-,-\\n23768089,-,Herbals\\\\Mitragynine,-,Withdrawal Syndrome;Drug Dependence;Product Advertising Issue,Serious,Other Outcomes;Disabled,Male,15-Apr-2024,4/19/2024,Direct,24,67.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/19/2024,Not Specified,Not Specified,-,-,-\\n23768067,-,Herbals\\\\Mitragynine,Drug Dependence,Mental Impairment;Weight Decreased;Drug Dependence;Product Formulation Issue;Skin Disorder;Liver Injury,Serious,Other Outcomes,Female,16-Apr-2024,4/19/2024,Direct,37,67.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/19/2024,Not Specified,Not Specified,-,-,-\\n24409547,-,Herbals\\\\Mitragynine;Methylphenidate Hydrochloride;Diazepam;Etizolam;Cannabidiol,Product Used For Unknown Indication,Accidental Overdose;Toxicity To Various Agents,Serious,Died,Male,25-Mar-2024,10/8/2024,Expedited,28,Not Specified,Sandoz,Consumer,Not Specified,-,7/19/2024,10/8/2024,AU,Not Specified,AU-SANDOZ INC.-SDZ2024AU085433,-,-\\n24417459,-,Inulin;Herbals\\\\Mitragynine,Gastrointestinal Disorder,Agitation;Nightmare;Depression;Nausea;Laboratory Test Abnormal;Fatigue,Serious,Disabled,Female,24-Jun-2024,10/8/2024,Direct,70,101.25 KG,Fda-Ctu,Consumer,Not Specified,Azo,-,10/8/2024,Not Specified,Not Specified,-,-,-\\n23798731,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Sleep Deficit;Therapy Cessation;Pain;Psychotic Disorder;Delirium;Seizure;Mental Status Changes,Serious,Other Outcomes;Hospitalized;Life Threatening;Disabled,Female,25-Jan-2024,4/27/2024,Direct,81,48.15 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/27/2024,Not Specified,Not Specified,-,-,-\\n24446418,Suboxone;Sublocade,Buprenorphine Hydrochloride\\\\Naloxone Hydrochloride;Buprenorphine;Herbals\\\\Mitragynine,Drug Dependence,Dependence;Drug Screen Positive;Drug Half-Life Increased;Anhedonia;Panic Attack;Withdrawal Syndrome;Rebound Effect;Depression,Serious,Hospitalized,Male,30-Aug-2023,10/15/2024,Direct,36,81 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/15/2024,Not Specified,Y,-,-,Yes\\n24446899,-,Diazepam;Cannabidiol;Tramadol;Trimeprazine;Loxapine;Nefopam Hydrochloride;Tropatepine Hydrochloride;Aripiprazole;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Death,Serious,Died,Male,Aug-2024,10/16/2024,Expedited,27,Not Specified,Bausch And Lomb,Healthcare Professional,Not Specified,-,10/13/2024,10/16/2024,FR,Not Specified,FR-BAUSCH-BL-2024-015269,-,-\\n23820739,-,Herbals\\\\Mitragynine,Depression,Death,Serious,Died,Male,-,5/4/2024,Direct,37,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,5/4/2024,Not Specified,Not Specified,-,-,-\\n24563829,-,Tramadol;Tropatepine Hydrochloride;Trimeprazine;Loxapine;Nefopam;Aripiprazole;Cannabidiol;Benzodiazepine;Herbals\\\\Mitragynine;Diazepam,Product Used For Unknown Indication,Death,Serious,Died,Male,Aug-2024,10/30/2024,Expedited,27,Not Specified,Teva,Healthcare Professional,Not Specified,-,10/21/2024,10/30/2024,FR,Not Specified,FR-TEVA-VS-3256806,-,-\\n23831491,-,Herbals\\\\Mitragynine,Anxiety;Pain,Pain;Partner Stress;Drug Dependence;Aggression;Pyrexia;Myalgia;Vomiting;Irritability;Diarrhoea;Withdrawal Syndrome;Somnolence,Serious,Other Outcomes,Male,07-May-2024,5/7/2024,Direct,42,78.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,5/7/2024,Not Specified,Not Specified,-,-,Yes\\n23847716,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Withdrawal Syndrome;Dizziness;Central Nervous System Stimulation;Nausea;Stupor,Serious,Other Outcomes;Disabled;Required Intervention,Male,01-May-2024,5/10/2024,Direct,32,60.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,5/10/2024,Not Specified,Y,-,-,-\\n23890762,-,Herbals\\\\Mitragynine,Substance Use,Drug Dependence;Alcohol Abuse;Drug Abuse;Euphoric Mood,Serious,Hospitalized;Other Outcomes;Required Intervention,Female,-,5/23/2024,Direct,Not Specified,60.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,5/23/2024,Not Specified,Not Specified,-,-,-\\n23896959,-,Herbals\\\\Mitragynine,-,Pain;Colostomy;Product Residue Present;Diverticulitis,Serious,Required Intervention;Hospitalized;Disabled;Other Outcomes;Life Threatening,Male,20-May-2024,5/24/2024,Direct,55,69.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,5/24/2024,Not Specified,Not Specified,-,-,-\\n23919359,-,Herbals\\\\Mitragynine,-,Illness;Substance Use,Serious,Other Outcomes,Male,12-May-2024,5/30/2024,Direct,50,68.04 KG,Fda-Ctu,Not Specified,Not Specified,-,-,5/30/2024,Not Specified,Y,-,-,-\\n24611478,Sertraline;Trazodone;Risperdal,Risperidone;Herbals\\\\Mitragynine;Trazodone Hydrochloride;Olanzapine;Sertraline Hydrochloride;Quetiapine,Psychotic Disorder,Toxicity To Various Agents,Serious,Died,Female,-,11/13/2024,Expedited,Not Specified,Not Specified,Johnson And Johnson,Healthcare Professional,Not Specified,-,11/7/2024,11/13/2024,CZ,Not Specified,CZ-JNJFOC-20241127742,-,-\\n23945485,-,Herbals\\\\Mitragynine,-,Palpitations;Accidental Death;Toxicity To Various Agents,Serious,Died,Not Specified,06-Feb-2024,6/5/2024,Direct,25,78.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,6/5/2024,Not Specified,Not Specified,-,-,-\\n24450876,-,Cannabidiol;Tropatepine Hydrochloride;Aripiprazole;Diazepam;Nefopam;Herbals\\\\Mitragynine;Loxapine;Trimeprazine;Tramadol,Product Used For Unknown Indication,Death,Serious,Other Outcomes;Died,Male,Aug-2024,11/22/2024,Expedited,27,Not Specified,Otsuka,Healthcare Professional,Not Specified,-,11/19/2024,10/17/2024,FR,Not Specified,FR-OTSUKA-2024_028211,-,-\\n23995850,-,Herbals\\\\Mitragynine,Analgesic Therapy,Blood Thyroid Stimulating Hormone Abnormal;Psychotic Disorder;Anger;Hallucination,Serious,Other Outcomes,Female,-,6/19/2024,Direct,40,47.7 KG,Fda-Ctu,Consumer,Not Specified,-,-,6/19/2024,Not Specified,Not Specified,-,-,-\\n24543384,-,Cannabidiol;Loxapine;Aripiprazole;Tropatepine Hydrochloride;Tramadol;Nefopam Hydrochloride;Herbals\\\\Mitragynine;Diazepam;Trimeprazine,Product Used For Unknown Indication,Death,Serious,Died,Not Specified,Aug-2024,11/25/2024,Expedited,Not Specified,Not Specified,Zydus Pharm,Healthcare Professional,Not Specified,-,11/18/2024,10/24/2024,FR,Not Specified,FR-CADILA HEALTHCARE LIMITED-FR-ZYDUS-113782,-,-\\n24669768,-,7-Hydroxymitragynine,Analgesic Therapy,Drug Withdrawal Syndrome;Drug Dependence,Serious,Required Intervention;Hospitalized;Other Outcomes,Male,25-Nov-2024,11/26/2024,Direct,46,90 KG,Fda-Ctu,Consumer,Not Specified,-,-,11/26/2024,Not Specified,Not Specified,-,-,-\\n24046897,-,Herbals\\\\Mitragynine,Pain,Malaise,Serious,Other Outcomes,Female,20-Jun-2024,7/1/2024,Direct,21,54 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/1/2024,Not Specified,Y,-,-,-\\n24538022,-,Trimeprazine;Loxapine;Diazepam;Herbals\\\\Mitragynine;Tropatepine Hydrochloride;Nefopam;Aripiprazole;Tramadol;Cannabidiol,Product Used For Unknown Indication,Death,Serious,Other Outcomes;Died,Male,Aug-2024,11/29/2024,Expedited,27,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,11/16/2024,10/23/2024,FR,Not Specified,FR-AUROBINDO-AUR-APL-2024-051027,-,-\\n24530494,-,Cannabidiol;Tropatepine Hydrochloride;Nefopam;Loxapine;Tramadol;Trimeprazine;Aripiprazole;Diazepam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Death,Serious,Died,Male,Aug-2024,12/3/2024,Expedited,27,Not Specified,Mylan,Healthcare Professional,Not Specified,-,11/26/2024,10/21/2024,FR,Not Specified,FR-MYLANLABS-2024M1094207,-,-\\n24006620,Lybalvi,Olanzapine\\\\Samidorphan L-Malate;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Withdrawal Syndrome;Substance Use,Non-Serious,Non-Serious,Female,-,12/4/2024,Non-Expedited,Not Specified,Not Specified,Alkermes,Healthcare Professional,Not Specified,-,6/9/2024,6/24/2024,US,Not Specified,US-ALKERMES INC.-ALK-2024-001590,-,-\\n24062150,-,Herbals\\\\Mitragynine,Substance Use,Drug Dependence,Serious,Other Outcomes,Male,07-Jul-2024,7/7/2024,Direct,54,117 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/7/2024,Not Specified,Not Specified,-,-,-\\n24129297,-,Herbals\\\\Mitragynine,-,Tremor;Cluster Headache;Dysarthria;Eye Movement Disorder;Drug Dependence;Immobile,Serious,Disabled;Other Outcomes,Female,21-Jul-2024,7/23/2024,Direct,32,71.21 KG,Fda-Ctu,Not Specified,Not Specified,-,-,7/23/2024,Not Specified,Not Specified,-,-,-\\n24200438,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Fear;Paralysis;Irregular Breathing;Poisoning;Gait Inability;Diarrhoea;Chills;Blindness;Toxicity To Various Agents;Hallucination;Product Label Issue;Vomiting,Serious,Hospitalized,Female,04-Aug-2024,8/9/2024,Direct,48,58.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/9/2024,Not Specified,Y,-,-,-\\n24785048,Klonopin,Clonazepam;Herbals\\\\Mitragynine;Lithium;Cannabidiol\\\\Herbals\\\\Tetrahydrocannabinol Unspecified,-,Drug Interaction;Mental Status Changes;Lethargy,Serious,Required Intervention,Female,03-Dec-2024,12/26/2024,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,12/26/2024,Not Specified,Not Specified,-,-,-\\n24200495,-,Herbals\\\\Mitragynine,-,Hypophagia;Insomnia;Impaired Work Ability;Substance Use,Serious,Died,Male,07-Jul-2024,8/10/2024,Direct,32,63 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/10/2024,Not Specified,Not Specified,-,-,Yes\\n24789166,-,Herbals\\\\Mitragynine;Hydromorphone Hydrochloride;Olanzapine,Pain;Product Used For Unknown Indication,Toxicity To Various Agents;Overdose;Completed Suicide;Renal Impairment,Serious,Other Outcomes;Died,Male,-,12/30/2024,Expedited,44,Not Specified,Teva,Healthcare Professional,Not Specified,Zopiclone;Escitalopram,12/23/2024,12/30/2024,CA,Not Specified,CA-TEVA-VS-3280979,-,-\\n24214283,-,Herbals\\\\Mitragynine,-,Suck-Swallow Breathing Coordination Disturbance;Irritability;Drug Screen Positive;High-Pitched Crying;Agitation Neonatal,Serious,Other Outcomes,Female,08-Jun-2024,8/14/2024,Direct,1 DAY,3.54 KG,Fda-Ctu,Healthcare Professional,Not Specified,-,-,8/14/2024,Not Specified,Not Specified,-,-,-\\n24250203,-,Herbals\\\\Mitragynine,Substance Use,Drug Dependence;Alcohol Use;Hepatic Failure,Serious,Died,Male,05-Aug-2024,8/24/2024,Direct,32,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,8/24/2024,Not Specified,Not Specified,-,-,-\\n24278790,-,Herbals\\\\Mitragynine,Anxiety,Road Traffic Accident,Serious,Life Threatening;Hospitalized;Required Intervention;Other Outcomes,Male,08-Jun-2024,8/31/2024,Direct,25,69.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/31/2024,Not Specified,Not Specified,-,-,-\\n24290864,-,Herbals\\\\Mitragynine,Drug Dependence,Photophobia;Pallor;Dry Skin;Vision Blurred;Weight Decreased;Skin Exfoliation;Drug Dependence,Serious,Required Intervention;Life Threatening;Disabled;Other Outcomes,Male,02-Sep-2024,9/5/2024,Direct,46,87.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/5/2024,Not Specified,Not Specified,-,-,-\\n24333729,-,Herbals\\\\Mitragynine,Fatigue,Hyperhidrosis;Anxiety;Pain;Diarrhoea;Substance Use;Restlessness,Serious,Other Outcomes,Female,17-Sep-2024,9/17/2024,Direct,37,69.3 KG,Fda-Ctu,Healthcare Professional,Not Specified,-,-,9/17/2024,Not Specified,Not Specified,-,-,-\\n24344910,-,Herbals\\\\Mitragynine,-,Nausea;Diarrhoea;Vomiting,Serious,Other Outcomes;Required Intervention,Male,14-Sep-2024,9/20/2024,Direct,47,90 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/20/2024,Not Specified,Y,-,-,-\\n24377255,-,Herbals\\\\Mitragynine,Anxiety,Toxicity To Various Agents,Serious,Died,Female,16-Dec-2023,9/28/2024,Direct,34,56.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/28/2024,Not Specified,Not Specified,-,-,-\\n24377559,-,Herbals\\\\Mitragynine,Insomnia,Vision Blurred;Tremor;Nausea;Coordination Abnormal;Cold Sweat;Impaired Driving Ability,Serious,Other Outcomes;Life Threatening,Male,28-Sep-2024,9/28/2024,Direct,27,81 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/28/2024,Not Specified,Not Specified,-,-,-\\n24397937,-,Herbals\\\\Mitragynine,Pain,Overdose;Substance Use,Serious,Died,Male,21-Aug-2024,10/3/2024,Direct,32,98.55 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/3/2024,Not Specified,Not Specified,-,-,-\\n24437297,-,Herbals\\\\Mitragynine,Drug Abuse,Headache;Vomiting;Diarrhoea;Loss Of Personal Independence In Daily Activities;Tachycardia,Serious,Other Outcomes,Male,10-Oct-2024,10/11/2024,Direct,28,76.5 KG,Fda-Ctu,Healthcare Professional,Not Specified,-,-,10/11/2024,Not Specified,Not Specified,-,-,-\\n24535031,-,Herbals\\\\Mitragynine,-,Product Advertising Issue;Withdrawal Syndrome,Serious,Required Intervention,Female,14-Sep-2024,10/21/2024,Direct,33,81 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/21/2024,Not Specified,Not Specified,-,-,-\\n24576225,-,Herbals\\\\Mitragynine,-,Physical Product Label Issue;Lethargy;Nonspecific Reaction;Dizziness;Therapy Non-Responder;Feeling Abnormal,Serious,Other Outcomes,Male,03-Nov-2024,11/3/2024,Direct,79,111.6 KG,Fda-Ctu,Consumer,Not Specified,-,-,11/3/2024,Not Specified,Y,-,-,-\\n24608643,-,Herbals\\\\Mitragynine,-,Vomiting;Substance Use;Drug Withdrawal Syndrome;Cognitive Disorder;Abdominal Distension;Night Sweats;Constipation;Tremor;Irritability;Dependence;Nausea,Serious,Other Outcomes,Male,10-Nov-2024,11/11/2024,Direct,48,220 LB,Fda-Ctu,Healthcare Professional,Not Specified,-,-,11/11/2024,Not Specified,Not Specified,-,-,-\\n24608517,-,Herbals\\\\Mitragynine,Arthritis,Influenza Like Illness;Abdominal Pain Upper;Feeling Cold;Vomiting;Asthenia,Serious,Hospitalized,Female,10-Jun-2023,11/12/2024,Direct,57,94.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,11/12/2024,Not Specified,Not Specified,-,-,-\\n24654444,-,Herbals\\\\Mitragynine,Drug Abuse,Drug Dependence,Serious,Other Outcomes;Required Intervention,Male,21-Nov-2024,11/21/2024,Direct,16,76.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,11/21/2024,Not Specified,Not Specified,-,-,-\\n24726792,-,Herbals\\\\Mitragynine,Arthritis;Asthenia,General Physical Health Deterioration;Nightmare;Asthenia;Hot Flush;Fatigue;Insomnia;Withdrawal Syndrome;Diarrhoea;Pain;Flushing;Depression;Vomiting;Product Complaint;Gastroenteritis Salmonella,Serious,Hospitalized,Female,04-Dec-2024,12/11/2024,Direct,58,96.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,12/11/2024,Not Specified,Not Specified,-,-,-\\n24789696,-,Herbals\\\\Mitragynine,-,Vision Blurred;Withdrawal Syndrome;Insomnia;Hyperhidrosis;Diarrhoea;Drug Dependence;Pyrexia;Chills,Serious,Other Outcomes,Male,25-Dec-2024,12/29/2024,Direct,49,121.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,12/29/2024,Not Specified,Not Specified,-,-,-\\n23819072,Sertraline,Sertraline Hydrochloride;Herbals\\\\Mitragynine,Anxiety;Depression,Electrocardiogram Qt Prolonged;Drug Interaction,Serious,Other Outcomes;Hospitalized,Female,-,4/8/2025,Expedited,17,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,3/31/2025,5/6/2024,US,Not Specified,US-AUROBINDO-AUR-APL-2024-021444,\"Truesdale N, Kaliki V, Fuller KE, Nathani Y. QTc prolongation related to kratom ingestion with underlying SSRI usage. Am-J-Med-Sci. 2024;367 (Suppl. 1):S284\",-\\n26048140,-,Buprenorphine;Clonidine;Herbals\\\\Mitragynine,Drug Withdrawal Syndrome,Vomiting;Drug Withdrawal Syndrome;Nausea;Acute Kidney Injury,Serious,Other Outcomes;Hospitalized,Female,-,11/14/2025,Expedited,54,Not Specified,Purdue,Healthcare Professional,Not Specified,-,11/11/2025,11/14/2025,US,Not Specified,US-PURDUE PHARMA-USA-2025-0322061,\"Sivakumar D, Pascual J, Kennedy M, Clark KT, Mason JM, Walfield AL, Hayes BD, Maldonado G.. The successful use of buprenorphine to manage kratom withdrawal secondary to self-treatment of opioid withdrawal. Clinical Toxicology. 2025;1-2\",-\\n25406123,-,Nitroglycerin;Herbals\\\\Mitragynine;Verapamil Hydrochloride,Product Used For Unknown Indication;Vasospasm,Drug Ineffective,Serious,Other Outcomes,Male,-,6/6/2025,Expedited,52,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,5/22/2025,6/6/2025,US,Not Specified,US-AUROBINDO-AUR-APL-2022-047873,\"Riggs A, Briggs J, Goodrich W, Gardner G.. Intravenous kratom use with peripheral vasospasm. Clin-Toxicol-(Phila). 2022;60 (Suppl. 2):147-148\",-\\n24979676,Valium;Suboxone,Buprenorphine Hydrochloride\\\\Naloxone Hydrochloride;Herbals\\\\Mitragynine;Caffeine;Diazepam;Etizolam;Carisoprodol;Meprobamate,Product Used For Unknown Indication,Toxicity To Various Agents;Impaired Driving Ability;Drug Dependence,Serious,Other Outcomes,Male,-,2/18/2025,Expedited,26,Not Specified,Ranbaxy,Healthcare Professional,Not Specified,-,2/4/2025,2/18/2025,US,Not Specified,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2025R1-494502,\"Papsun DM, Chan-Hosokawa A, Lamb ME, Logan B. Increasing prevalence of designer benzodiazepines in impaired driving: A 5-year analysis from 2017 to 2021. J Anal Toxicol. 2023;47(8):668-679\",-\\n18451955,Sertraline,Sertraline Hydrochloride;Amitriptyline Hydrochloride;Phenethylamine;Herbals\\\\Mitragynine;Bupropion Hydrochloride;Perphenazine,Anxiety;Mood Altered,Metabolic Acidosis;Hypertransaminasaemia;Drug Ineffective;Serotonin Syndrome;Rhabdomyolysis,Serious,Hospitalized,Male,-,6/20/2025,Expedited,20,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/5/2025,11/2/2020,US,Not Specified,US-MYLANLABS-2020M1090641,\"Mantilla B, Vega MV, Solis X, Makram J, Mallah H, Test V.. A DANGEROUS DRUG AND HERBAL MIXTURE.. Chest. 2020;158 (Suppl.)(4):A812 (plus poster).\",-\\n25209681,Promethazine Hydrochloride And Codeine Phosphate;Promethazine,Promethazine Hydrochloride;Herbals\\\\Mitragynine;Codeine Phosphate\\\\Promethazine Hydrochloride;Nordazepam;Pipamperone;Citalopram;Mirtazapine;Ketamine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,4/17/2025,Expedited,19,Not Specified,Quagen Pharmaceuticals,Healthcare Professional,Not Specified,Morphine;Prazepam;Cannabis Sativa Subsp. Indica Top,4/4/2025,4/17/2025,BE,Not Specified,BE-QUAGEN-2025QUALIT00301,Laetitia Breugelmans.A lethal case involving purple drank and Kratom.Toxicologie Analytique & Clinique.2025;37:S17,-\\n25925322,-,Herbals\\\\Mitragynine;Quetiapine,Product Used For Unknown Indication,Toxicity To Various Agents;Neuroleptic Malignant Syndrome;Drug Interaction;Overdose;Accidental Death;Herbal Interaction,Serious,Died;Other Outcomes,Male,-,10/15/2025,Expedited,27,Not Specified,Medicap Laboratories,Healthcare Professional,Not Specified,Valproic Acid,10/4/2025,10/15/2025,US,Not Specified,US-Medicap-000078,Hughes RL. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction. Forensic Sci Med Pathol. 2019 Mar 15(1):110-113. doi: 10.1007/s12024-018-0049-9.,-\\n24973746,Alcohol (Alcohol);Percocet,Acetaminophen\\\\Oxycodone Hydrochloride;Alcohol;Clonazepam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Completed Suicide,Serious,Died,Female,2023,2/17/2025,Expedited,38,Not Specified,Endo,Healthcare Professional,Not Specified,-,1/21/2025,2/17/2025,US,Not Specified,\"US-ENDO USA, INC.-2025-000402\",\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al.. 2023 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 41st Annual Report. Clinical Toxicology. 2024;1-235\",-\\n24828533,-,Cyclobenzaprine;Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Female,-,1/10/2025,Expedited,37,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/6/2025,1/10/2025,US,Not Specified,US-APOTEX-2025AP000265,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C.. 2023 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 41st Annual Report. Clinical Toxicology. 2024;62 (12):793-1027\",-\\n24840161,-,Herbals\\\\Mitragynine;Gabapentin;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/14/2025,Expedited,49,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/6/2025,1/14/2025,US,Not Specified,US-APOTEX-2025AP000336,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C.. 2023 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 41st Annual Report. Clinical Toxicology. 2024;62 (12):793-1027\",-\\n24848465,Salicylates Nos,Unspecified Ingredient;Acetaminophen;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Female,-,1/16/2025,Expedited,65,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/6/2025,1/16/2025,US,Not Specified,US-APOTEX-2025AP000444,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C.. 2023 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 41st Annual Report. Clinical Toxicology. 2024;62 (12):793-1027\",-\\n24853253,-,Oxycodone;Gabapentin;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Female,-,1/17/2025,Expedited,64,Not Specified,Apotex,Healthcare Professional,Not Specified,-,1/6/2025,1/17/2025,US,Not Specified,US-APOTEX-2025AP000914,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C.. 2023 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 41st Annual Report. Clinical Toxicology. 2024;62 (12):793-1027\",-\\n24801330,-,Methamphetamine;Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/2/2025,Expedited,31,Not Specified,Aveva,Healthcare Professional,Not Specified,-,12/24/2024,1/2/2025,US,Not Specified,US-AVEVA-000984,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2023 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers 41st Annual Report. Clin Toxicol (Phila). 2024 Dec 17:1-35. doi: 10.1080/15563650.2024.2412423. Epub ahead of print.\",-\\n24807438,-,Methamphetamine;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/5/2025,Expedited,40,Not Specified,Aveva,Healthcare Professional,Not Specified,-,12/24/2024,1/5/2025,US,Not Specified,US-AVEVA-001197,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2023 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers 41st Annual Report. Clin Toxicol (Phila). 2024 Dec 17:1-35. doi: 10.1080/15563650.2024.2412423. Epub ahead of print.\",-\\n24807325,-,Cyclobenzaprine;Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Female,-,1/5/2025,Expedited,37,Not Specified,Aveva,Healthcare Professional,Not Specified,-,12/24/2024,1/5/2025,US,Not Specified,US-AVEVA-001150,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2023 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers 41st Annual Report. Clin Toxicol (Phila). 2024 Dec 17:1-35. doi: 10.1080/15563650.2024.2412423. Epub ahead of print.\",-\\n24807204,-,Herbals\\\\Mitragynine;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/5/2025,Expedited,35,Not Specified,Aveva,Healthcare Professional,Not Specified,-,12/24/2024,1/5/2025,US,Not Specified,US-AVEVA-001078,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2023 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers 41st Annual Report. Clin Toxicol (Phila). 2024 Dec 17:1-35. doi: 10.1080/15563650.2024.2412423. Epub ahead of print.\",-\\n24810286,-,Herbals\\\\Mitragynine;Gabapentin;Fentanyl,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,1/6/2025,Expedited,49,Not Specified,Aveva,Healthcare Professional,Not Specified,-,12/24/2024,1/6/2025,US,Not Specified,US-AVEVA-001308,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2023 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers 41st Annual Report. Clin Toxicol (Phila). 2024 Dec 17:1-35. doi: 10.1080/15563650.2024.2412423. Epub ahead of print.\",-\\n25188348,-,Fentanyl;Herbals\\\\Mitragynine;Gabapentin,Drug Abuse,Prescription Drug Used Without A Prescription;Drug Abuse,Serious,Died;Other Outcomes,Male,-,4/11/2025,Expedited,49,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2025,4/11/2025,US,Not Specified,US-ALVOGEN-2025096648,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2023 Annual Report of the National Poison Data System (NPDS) from America\\'s Poison Centers: 41st Annual Report. Clinical Toxicology. 2024 Dec 17; doi:https://doi.org/10.1080/15563650.2024.2412423\",-\\n25183604,-,Oxycodone;Gabapentin;Herbals\\\\Mitragynine,Drug Abuse,Drug Abuse,Serious,Died;Other Outcomes,Female,-,4/10/2025,Expedited,64,Not Specified,Alvogen,Healthcare Professional,Not Specified,-,3/27/2025,4/10/2025,US,Not Specified,US-ALVOGEN-2025096994,\"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2023 Annual Report of the National Poison Data System (NPDS) from America?s Poison Centers: 41st Annual Report. Clinical Toxicology. 2024 Dec 17; doi:https://doi.org/10.1080/15563650.2024.2412423\",-\\n24836753,-,Herbals\\\\Mitragynine;Aspirin;Acetaminophen,-,Toxicity To Various Agents;Drug Abuse,Serious,Other Outcomes;Died,Female,-,1/13/2025,Expedited,65,Not Specified,Bayer,Healthcare Professional,Not Specified,-,1/6/2025,1/13/2025,US,Not Specified,US-BAYER-2025A003194,\"Gummin D D, Mowry J B, Beuhler M C, Spyker D A, Rivers L J, Feldman R, Brown K, Pham N P T, Bronstein A C, DesLauriers C.. 2023 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers: 41st Annual Report. Clinical Toxicology. 2024;62:793-1027\",-\\n23455182,Fluoxetine,Fluoxetine Hydrochloride;Fentanyl;Bupropion;Herbals\\\\Mitragynine,Pain,Drug Interaction;Serotonin Syndrome,Serious,Hospitalized,Male,-,3/26/2025,Expedited,68,Not Specified,Teva,Healthcare Professional,Not Specified,-,3/19/2025,1/30/2024,US,Not Specified,US-TEVA-VS-3149311,\"Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Dis-Mon 2023; 69 (6):.; Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Dis-Mon 2023; 69 (6):.\",-\\n25485621,-,Herbals\\\\Mitragynine;Buprenorphine,Anxiety;Dependence;Depressed Mood;Obsessive-Compulsive Disorder,Off Label Use;Dependence;Drug Withdrawal Syndrome;Suicidal Ideation;Wrong Technique In Product Usage Process,Serious,Other Outcomes,Not Specified,Nov-2024,9/2/2025,Expedited,Not Specified,Not Specified,Reckitt Benckiser,Healthcare Professional,Not Specified,-,8/25/2025,6/26/2025,GB,Not Specified,GB-INDIVIOR UK LIMITED-INDV-164864-2025,\"Filipa Teixeira, Oluwatobi Ajewole, Mihai Picior, Emmert Roberts. Treatment of obsessive compulsive disorder and Kratom dependence with buprenorphine and supportive care. BMJ Case Reports. 2025;18:e265834\",-\\n24829679,Buspirone;Trazodone,Buspirone Hydrochloride;Trazodone Hydrochloride;Ziprasidone;Bupropion Hydrochloride;Desvenlafaxine;Herbals\\\\Mitragynine,Depression;Product Used For Unknown Indication,Drug Interaction;Serotonin Syndrome,Serious,Hospitalized;Other Outcomes,Male,-,3/21/2025,Expedited,63,102.5 KG,Graviti Pharmaceuticals,Healthcare Professional,Not Specified,Omeprazole;Amlodipine;Diclofenac;Glimepiride;Metformin;Hydrochlorothiazide;Tizanidine;Gabapentin,3/11/2025,1/10/2025,US,Not Specified,US-GRAVITIPHARMA-GRA-2501-US-LIT-0007,\"Eudaley ST, Brooks SP, Hamilton LA..Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents..J-Pharm-Pract.2022;NA:NA\",-\\n25938723,Alcohol (Alcohol);Librium;Flurazepam;Adderall,Amphetamine Aspartate\\\\Amphetamine Sulfate\\\\Dextroamphetamine Saccharate\\\\Dextroamphetamine Sulfate;Methylphenidate;Lorazepam;Pregabalin;Tianeptine;Flurazepam Hydrochloride;Dextromethorphan;Alprazolam;Herbals\\\\Mitragynine;4-Amino-3-Phenylbutyric Acid;Gabapentin;Clonazepam;Chlordiazepoxide Hydrochloride;Methamphetamine;Alcohol;Lisdexamfetamine;Oxycodone,Product Used For Unknown Indication,Anxiety;Abdominal Tenderness;Drug Abuse;Withdrawal Syndrome;Tremor;Drug Withdrawal Convulsions;Hyperhidrosis;Pancreatitis Acute;Myopia,Serious,Hospitalized;Other Outcomes,Male,-,10/19/2025,Expedited,\"45,994\",Not Specified,Lupin,Healthcare Professional,Not Specified,-,10/6/2025,10/19/2025,US,Not Specified,US-LUPIN PHARMACEUTICALS INC.-2025-09403,\"Butler M, Pirkle J, Carmichael A, Carlson-Dexter P, Rosella T. Successful symptom-based management of active withdrawal from multiple illicit benzodiazepines. BMJ Case Reports. 2025;18 (8):1-3\",-\\n24678645,Trazodone;Sertraline,Sertraline Hydrochloride;Quetiapine;Risperidone;Trazodone Hydrochloride;Olanzapine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Toxicity To Various Agents,Serious,Died,Female,-,4/29/2025,Expedited,Not Specified,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,4/16/2025,11/29/2024,CZ,Not Specified,CZ-AUROBINDO-AUR-APL-2024-057757,\"Bursov M, ern I, Hork V, uprek Z. MRT SPOJEN S UITM KRATOMU. Military medical science list.. 2024;1(93)\",-\\n25743346,Venlafaxine,Venlafaxine Hydrochloride;Quetiapine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Antidepressant Drug Level Above Therapeutic;Electrocardiogram Qt Prolonged;Drug Interaction;Serotonin Syndrome;Herbal Interaction,Serious,Hospitalized;Other Outcomes,Male,-,8/30/2025,Expedited,36,Not Specified,Medicap Laboratories,Healthcare Professional,Not Specified,-,8/18/2025,8/30/2025,US,Not Specified,US-Medicap-000029,\"Brogdon H D, McPhee M M, Paine M F, Cox E J and Burns A G. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J Addict Med. 2022 Sep-Oct:16(5):606-609. Doi: 10.1097/ADM.0000000000000968. Epub 2022 Feb 14.\",-\\n25184025,Promethazine,Promethazine Hydrochloride;Ketamine Hydrochloride;Citalopram;Mirtazapine;Pipamperone;Nordazepam;Herbals\\\\Mitragynine;Codeine,-,Drug Abuse;Toxicity To Various Agents;Overdose,Serious,Died,Male,-,4/10/2025,Expedited,19,Not Specified,Pfizer,Healthcare Professional,Not Specified,-,4/4/2025,4/10/2025,BE,Not Specified,BE-PFIZER INC-202500072887,\"Breugelmans, L.. A lethal case involving purple drank and Kratom.. Toxicologie Analytique & Clinique. 2025;37 (1):S17\",-\\n25189640,Promethazine,Pipamperone;Promethazine Hydrochloride;Mirtazapine;Citalopram;Ketamine;Codeine;Herbals\\\\Mitragynine;Nordazepam,-,Drug Abuse,Serious,Other Outcomes;Died,Male,-,4/11/2025,Expedited,19,Not Specified,Organon,Healthcare Professional,Not Specified,-,4/7/2025,4/11/2025,BE,Not Specified,BE-ORGANON-O2504BEL001065,\"Breugelmans L, Boland A, Fernandez MDMR, Di Fazio V, Wille S.. A lethal case involving purple drank and Kratom.. Toxic-Analyt-Clinique. 2025;37(1):S17\",-\\n25143321,-,Promethazine Hydrochloride;Nordazepam;Citalopram;Herbals\\\\Mitragynine;Codeine;Mirtazapine;Ketamine;Pipamperone,Product Used For Unknown Indication,Drug Abuse,Serious,Other Outcomes;Died,Male,-,4/1/2025,Expedited,19,Not Specified,Strides,Healthcare Professional,Not Specified,-,3/18/2025,4/1/2025,BE,Not Specified,BE-STRIDES ARCOLAB LIMITED-2025SP003986,\"Breugelmans L, Boland A, Fernandez MDMR, Di Fazio V, Wille S.. A lethal case involving purple drank and Kratom. Toxic-Analyt-Clinique. 2025;37 (Suppl.) (1):S17\",-\\n25170437,Promethazine,Pipamperone;Promethazine Hydrochloride;Citalopram;Mirtazapine;Ketamine;Nordazepam;Herbals\\\\Mitragynine;Codeine,Product Used For Unknown Indication,Death;Drug Abuse,Serious,Other Outcomes;Died,Male,-,6/23/2025,Expedited,19,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,6/10/2025,4/8/2025,BE,Not Specified,BE-AUROBINDO-AUR-APL-2025-016637,\"Breugelmans L, Boland A, Fernandez MDMR, Di Fazio V, Wille S. A lethal case involving purple drank and Kratom. Toxic-Analyt-Clinique. 2025;37 (Suppl)(1):S17\",-\\n25122925,Promethazine,Promethazine Hydrochloride;Nordazepam;Codeine;Herbals\\\\Mitragynine;Citalopram;Pipamperone;Ketamine;Mirtazapine,Product Used For Unknown Indication,Drug Abuse,Serious,Died,Male,-,3/26/2025,Expedited,19,Not Specified,Mylan,Healthcare Professional,Not Specified,-,3/18/2025,3/26/2025,BE,Not Specified,BE-MYLANLABS-2025M1024926,\"Breugelmans L, Boland A, Fernandez MDMR, Di Fazio V, Wille S. A lethal case involving purple drank and Kratom. Toxic-Analyt-Clinique 2025; 37 (Suppl.) (1): S17.\",-\\n25147746,Promethazine,Nordazepam;Promethazine Hydrochloride;Ketamine;Herbals\\\\Mitragynine;Mirtazapine;Pipamperone;Codeine;Citalopram,Product Used For Unknown Indication,Drug Abuse,Serious,Died;Other Outcomes,Male,-,4/2/2025,Expedited,19,Not Specified,Natco Pharma,Healthcare Professional,Not Specified,Morphine;Prazepam;Cannabis Sativa Subsp. Indica Top,3/24/2025,4/2/2025,Not Specified,Not Specified,BE-NATCOUSA-2025-NATCOUSA-000273,\"Breugelmans L, Boland A, Fernandez MD, Di Fazio V, Wille S. A lethal case involving purple drank and Kratom. Toxicologie Analytique et Clinique Volume 37, Issue 1, Supplement, March 2025, Page S17.\",-\\n25242427,-,Tramadol;Herbals\\\\Mitragynine;Loperamide,Product Used For Unknown Indication,Accidental Overdose;Loss Of Consciousness;Cardiomegaly;Toxicity To Various Agents;Drug Interaction,Serious,Died;Other Outcomes,Male,-,4/27/2025,Expedited,24,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,4/14/2025,4/27/2025,US,Not Specified,US-AUROBINDO-AUR-APL-2019-077852,\"Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, Winecker RE.. Loperamide-Related Deaths in North Carolina. .. Journal of Analytical Toxicology. 2016;40(8):677-686\",-\\n23355812,Propranolol,Propranolol Hydrochloride;Herbals\\\\Mitragynine;Quinine Sulfate;Citalopram Hydrobromide;Loperamide;Quinidine,Product Used For Unknown Indication,Drug Abuse;Accidental Overdose;Drug Interaction;Toxicity To Various Agents,Serious,Died,Not Specified,-,4/27/2025,Expedited,37,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,4/14/2025,1/2/2024,US,Not Specified,US-AUROBINDO-AUR-APL-2019-077560,\"Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et,al.. Loperamide-Related Deaths in North Carolina.. Journal of Analytical Toxicology.. 2016;40(8):677-686\",-\\n13059359,-,Quinine Sulfate;Loperamide;Herbals\\\\Mitragynine;Quinidine,Product Used For Unknown Indication,Drug Abuse;Toxicity To Various Agents;Drug Interaction;Accidental Overdose,Serious,Died;Other Outcomes,Not Specified,-,4/29/2025,Expedited,33,Not Specified,Aurobindo,Healthcare Professional,Not Specified,-,4/14/2025,12/23/2016,US,Not Specified,US-MYLANLABS-2016M1057187,\"Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et al.. Loperamide-related deaths in North Carolina.. J-Anal-Toxicol. 2016;40(8):677-686\",-\\n24591508,-,Herbals\\\\Mitragynine;Tramadol Hydrochloride,Pain,Cognitive Disorder;Toxicity To Various Agents;Electrocardiogram Qt Prolonged;Drug Interaction;Hypokalaemia;Seizure,Serious,Other Outcomes;Hospitalized,Male,-,3/29/2025,Expedited,Not Specified,Not Specified,Graviti Pharmaceuticals,Healthcare Professional,Not Specified,-,3/20/2025,11/8/2024,US,Not Specified,US-GRAVITIPHARMA-GRA-2410-US-LIT-0570,\"Beresford T, Keffler C, Wasserstein M, Ronan P.(PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report.J-Acad-Consult-Liaison-Psychiatry.2022;63 (Suppl.):S69-S70\",-\\n24903738,-,Lorazepam;Lithium;Quetiapine;Herbals\\\\Mitragynine,Bipolar Disorder;Mania;Toothache,Psychotic Symptom;Mania;Sedation;Treatment Noncompliance;Intentional Product Misuse,Serious,Hospitalized,Female,-,2/13/2025,Expedited,69,Not Specified,Teva,Healthcare Professional,Not Specified,-,2/4/2025,1/30/2025,UA,Not Specified,UA-TEVA-VS-3290374,\"Bachu AK, Singal P, Griffin B, Harbaugh L, Prasad S, Jain L, et al. Kratom use and mental health: A systematic literature review and case example. [Review]. J-Addict-Dis 2024; 42 (4): 301-312.; Bachu AK, Singal P, Griffin B, Harbaugh L, Prasad S, Jain L, et al. Kratom use and mental health: A systematic literature review and case example. [Review]. J-Addict-Dis 2024; 42 (4): 301-312.; Bachu AK, Singal P, Griffin B, Harbaugh L, Prasad S, Jain L, et al. Kratom use and mental health: A systemati...\",-\\n24868050,-,Herbals\\\\Mitragynine,Anxiety;Depression,Seizure,Serious,Other Outcomes,Male,18-Nov-2024,1/20/2025,Direct,29,72 KG,Fda-Ctu,Consumer,Not Specified,Wellbutrin;Lexapro,-,1/20/2025,Not Specified,Not Specified,-,-,-\\n25623069,-,Herbals\\\\Mitragynine,Anxiety,Heart Rate Increased;Hypertension;Palpitations;Dyspnoea,Serious,Other Outcomes,Female,18-Aug-2024,7/30/2025,Direct,50,74.25 KG,Fda-Ctu,Consumer,Not Specified,Vitamins;Krill Oil,-,7/30/2025,Not Specified,Not Specified,-,-,-\\n25509786,-,Herbals\\\\Mitragynine,Asthenia,Drug Dependence;Restless Legs Syndrome;Rebound Psychosis;Withdrawal Syndrome;Depression,Serious,Other Outcomes;Required Intervention,Male,01-May-2024,7/2/2025,Direct,36,99 KG,Fda-Ctu,Consumer,Not Specified,Vitamins,-,7/2/2025,Not Specified,Y,-,-,-\\n25224362,-,Herbals\\\\Mitragynine,Dependence,Malaise;Liver Disorder;Partner Stress;Drug Abuse;Drug Dependence,Serious,Other Outcomes;Required Intervention;Disabled;Life Threatening,Male,19-Apr-2025,4/21/2025,Direct,47,72 KG,Fda-Ctu,Consumer,Not Specified,Viibryd;Lamictal,-,4/21/2025,Not Specified,Not Specified,-,-,-\\n25644082,-,Herbals\\\\Mitragynine,Euphoric Mood;Feeling Of Relaxation,Drug Dependence;Impaired Quality Of Life,Serious,Other Outcomes;Life Threatening;Required Intervention;Hospitalized,Male,28-Dec-2024,8/3/2025,Direct,49,92.25 KG,Fda-Ctu,Consumer,Not Specified,Unspecified Ingredient;Xanax,-,8/3/2025,Not Specified,Not Specified,-,-,-\\n25273355,-,Herbals\\\\Mitragynine,Psoriatic Arthropathy,Herbal Toxicity,Serious,Died,Male,12-Sep-2024,5/5/2025,Direct,40,69.3 KG,Fda-Ctu,Consumer,Not Specified,Stool Softener (Docusate),-,5/5/2025,Not Specified,Not Specified,-,-,-\\n25529119,-,Herbals\\\\Mitragynine,Anxiety;Depression,Toxicity To Various Agents,Serious,Died,Male,20-Apr-2021,7/7/2025,Direct,32,Not Specified,Fda-Ctu,Consumer,Not Specified,Prozac;Celexa;Benadryl,-,7/7/2025,Not Specified,Not Specified,-,-,-\\n25732022,-,Herbals\\\\Mitragynine,Pain,Seizure;Toxicity To Various Agents,Serious,Died,Female,12-Mar-2025,8/27/2025,Direct,39,58.5 KG,Fda-Ctu,Consumer,Not Specified,Methylphenidate;Fluoxetine;Norfluoxetine;Lorazepam,-,8/27/2025,Not Specified,Not Specified,-,-,-\\n25094332,-,Herbals\\\\Mitragynine,Pain,Product Formulation Issue;Withdrawal Syndrome;Quality Of Life Decreased,Serious,Disabled;Required Intervention;Other Outcomes;Life Threatening,Female,01-Mar-2025,3/18/2025,Direct,42,58.5 KG,Fda-Ctu,Consumer,Not Specified,Methocarbamol;Magnesium;Lisinopril;Minerals\\\\Vitamins;Hydroxyzine;Vitamin B1,-,3/18/2025,Not Specified,Not Specified,-,-,-\\n25504578,-,Herbals\\\\Mitragynine,Asthenia,Withdrawal Syndrome;Fatigue;Emotional Disorder;Formication;Feeling Of Body Temperature Change;Sneezing;Insomnia,Serious,Disabled,Male,30-Jun-2025,7/1/2025,Direct,58,87.75 KG,Fda-Ctu,Other,Not Specified,Losartan;Magnesium Citrate;Unspecified Ingredient,-,7/1/2025,Not Specified,Not Specified,-,-,-\\n25504579,-,Herbals\\\\Mitragynine,Anxiety,Seizure;Toxicity To Various Agents,Serious,Died,Male,21-Dec-2024,7/1/2025,Direct,27,67.5 KG,Fda-Ctu,Consumer,Not Specified,Hydrocortisone;Escitalopram,-,7/1/2025,Not Specified,Not Specified,-,-,Yes\\n25461736,-,Herbals\\\\Mitragynine,Anxiety;Pain Management,Withdrawal Syndrome;Depressed Level Of Consciousness;Tachycardia;Drug Dependence;Respiratory Depression;Hyperhidrosis;Diarrhoea,Serious,Other Outcomes,Male,18-Jun-2025,6/19/2025,Direct,42,108 KG,Fda-Ctu,Consumer,Not Specified,Herbals\\\\Mitragynine;Ibuprofen;Klonopin,-,6/19/2025,Not Specified,Not Specified,-,-,-\\n25705804,-,Herbals\\\\Mitragynine,Pain,Delusion;Psychotic Disorder;General Physical Health Deterioration;Withdrawal Syndrome;Tremor;Insomnia;Vomiting;Hyperhidrosis;Loss Of Personal Independence In Daily Activities;Impaired Work Ability;Fatigue;Dependence,Serious,Disabled;Required Intervention,Female,02-Jul-2024,8/19/2025,Direct,54,54 KG,Fda-Ctu,Consumer,Not Specified,Herbals\\\\Mitragynine,-,8/19/2025,Not Specified,Not Specified,-,-,-\\n25375148,-,Herbals\\\\Mitragynine,Anxiety;Headache,Substance Use;Suicidal Ideation;Product Communication Issue;Withdrawal Syndrome;Drug Dependence,Serious,Disabled;Required Intervention;Other Outcomes,Male,08-May-2025,5/29/2025,Direct,69,99 KG,Fda-Ctu,Consumer,Not Specified,Gabapentin;Vitamin D;Paxil;Ibuprofen;Atorvastatin;Klonopin;Herbals\\\\Mitragynine;Xarelto;Clonidine,-,5/29/2025,Not Specified,Not Specified,-,-,-\\n25004799,-,Herbals\\\\Mitragynine,Disturbance In Social Behaviour,Overdose,Serious,Died,Female,03-Aug-2023,2/23/2025,Direct,26,45 KG,Fda-Ctu,Consumer,Not Specified,Cortisone,-,2/23/2025,Not Specified,Not Specified,-,-,-\\n25584861,-,Herbals\\\\Mitragynine,Alcohol Withdrawal Syndrome,Pulmonary Embolism;Substance Use;Cerebrovascular Accident;Blood Pressure Increased;Myocardial Infarction;Intentional Overdose;Thrombosis,Serious,Died,Male,24-Sep-1924,7/17/2025,Direct,37,157.5 KG,Fda-Ctu,Consumer,Not Specified,Benadryl;Losartan,-,7/17/2025,Not Specified,Not Specified,-,-,-\\n25135250,-,Herbals\\\\Mitragynine,-,Drug Dependence;Completed Suicide;Mental Impairment,Serious,Died;Other Outcomes,Male,-,3/27/2025,Direct,41,76.5 KG,Fda-Ctu,Consumer,Not Specified,Albuterol;Trazodone;Tramadol,-,3/27/2025,Not Specified,Not Specified,-,-,-\\n24810217,-,7-Hydroxymitragynine,Disturbance In Attention;Feeling Of Relaxation,Temperature Regulation Disorder;Skin Hyperpigmentation;Adverse Drug Reaction;Dependence;Brain Fog;Insomnia;Withdrawal Syndrome;Depression,Serious,Other Outcomes,Female,04-Jan-2024,1/4/2025,Direct,26,61.2 KG,Fda-Ctu,Consumer,Not Specified,Adderall Xr;Vitamins;Yaz;Xanax;Adderall;Vitamin C,-,1/4/2025,Not Specified,Not Specified,-,-,-\\n24830903,Salicylates Nos,Unspecified Ingredient;Acetaminophen;Herbals\\\\Mitragynine,Drug Abuse;Product Used For Unknown Indication,Exposure To Toxic Agent,Serious,Died,Female,2023,1/10/2025,Expedited,65,Not Specified,Galpharm International,Healthcare Professional,Not Specified,-,1/6/2025,1/10/2025,US,Not Specified,US-PERRIGO-25US000416,-,-\\n24838028,-,7-Hydroxymitragynine,Analgesic Therapy,Drug Tolerance Increased;Drug Dependence;Product Complaint;Drug Withdrawal Syndrome,Non-Serious,Non-Serious,Male,-,1/12/2025,Direct,33,128.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/12/2025,Not Specified,Not Specified,-,-,-\\n24850096,-,Olanzapine;Herbals\\\\Mitragynine;Hydromorphone Hydrochloride,Pain;Product Used For Unknown Indication,Renal Impairment;Overdose;Toxicity To Various Agents;Completed Suicide,Serious,Other Outcomes;Died,Male,-,1/16/2025,Expedited,44,Not Specified,Fresenius Kabi,Healthcare Professional,Not Specified,Zopiclone;Escitalopram,1/6/2025,1/16/2025,CA,Not Specified,CA-FreseniusKabi-FK202500275,-,-\\n24900278,-,7-Hydroxymitragynine,-,Euphoric Mood;Nausea;Dizziness,Serious,Other Outcomes,Female,02-Dec-2024,1/29/2025,Direct,43,55 KG,Fda-Ctu,Not Specified,Not Specified,-,-,1/29/2025,Not Specified,Not Specified,-,-,-\\n23690471,-,Olanzapine;Hydromorphone Hydrochloride;Herbals\\\\Mitragynine,Pain;Product Used For Unknown Indication,Renal Failure;Renal Impairment;Completed Suicide;Herbal Interaction;Overdose;Intentional Overdose;Toxicity To Various Agents;Suspected Suicide,Serious,Other Outcomes;Died,Male,-,2/19/2025,Expedited,44,Not Specified,Sandoz,Healthcare Professional,Not Specified,Zopiclone;Escitalopram;Olanzapine,2/18/2025,4/1/2024,CA,Not Specified,CA-SANDOZ INC.-SDZ2024CA034056,-,-\\n24988534,-,Herbals\\\\Mitragynine;Hydromorphone;Olanzapine,Abdominal Pain;Product Used For Unknown Indication;Schizoaffective Disorder Bipolar Type,Toxicity To Various Agents;Overdose;Renal Impairment,Serious,Died,Male,-,2/20/2025,Expedited,44,Not Specified,Sandoz,Healthcare Professional,Not Specified,Escitalopram;Zopiclone,2/18/2025,2/20/2025,CA,Not Specified,CA-SANDOZ INC.-SDZ2025CA010306,-,-\\n25007716,-,Hydromorphone Hydrochloride;Olanzapine;Herbals\\\\Mitragynine,Pain;Product Used For Unknown Indication,Toxicity To Various Agents;Renal Impairment;Intentional Overdose;Completed Suicide,Serious,Died;Other Outcomes,Male,-,2/25/2025,Expedited,44,Not Specified,Teva,Healthcare Professional,Not Specified,Zopiclone;Escitalopram,2/20/2025,2/25/2025,CA,Not Specified,CA-TEVA-VS-3303137,-,-\\n25011290,-,Hydromorphone;Herbals\\\\Mitragynine;Olanzapine,Abdominal Pain;Product Used For Unknown Indication;Schizoaffective Disorder Bipolar Type,Overdose;Renal Impairment;Toxicity To Various Agents,Serious,Died,Male,-,2/26/2025,Expedited,44,Not Specified,Teva,Healthcare Professional,Not Specified,Escitalopram;Zopiclone,2/20/2025,2/26/2025,CA,Not Specified,CA-TEVA-VS-3303447,-,-\\n25021741,-,Herbals\\\\Mitragynine;Olanzapine;Hydromorphone Hydrochloride,Pain;Product Used For Unknown Indication,Toxicity To Various Agents;Renal Impairment;Completed Suicide;Intentional Overdose,Serious,Other Outcomes;Died,Male,-,2/28/2025,Expedited,44,Not Specified,Sandoz,Healthcare Professional,Not Specified,Escitalopram;Zopiclone,2/26/2025,2/28/2025,CA,Not Specified,CA-SANDOZ INC.-SDZ2025CA012346,-,-\\n25031764,-,7-Hydroxymitragynine,Nutritional Supplementation,Suspected Product Tampering;Affective Disorder;Withdrawal Syndrome;Product Information Content Complaint;Insomnia;Depression;Product Communication Issue;Drug Dependence;Near Death Experience;Substance Abuse;Quality Of Life Decreased;Anxiety;Product Container Seal Issue;Myalgia,Serious,Other Outcomes;Hospitalized,Female,02-Oct-2023,3/2/2025,Direct,35,54 KG,Fda-Ctu,Consumer,Not Specified,Zinc;Biotin;Thyroid;Vitamin D;Cymbalta;Armour Thyroid,-,3/2/2025,Not Specified,Not Specified,-,-,-\\n25051391,Lybalvi,Olanzapine\\\\Samidorphan L-Malate;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Substance Use;Psychotic Disorder,Non-Serious,Non-Serious,Female,-,3/7/2025,Non-Expedited,Not Specified,Not Specified,Alkermes,Healthcare Professional,Not Specified,Zyprexa,2/26/2025,3/7/2025,US,Not Specified,US-ALKERMES INC.-ALK-2025-000501,-,-\\n25104994,Zoloft,Sertraline Hydrochloride;Herbals\\\\Mitragynine;Cyclobenzaprine;Cannabis Sativa Subsp. Indica Top,Pain,Serotonin Syndrome,Serious,Life Threatening;Hospitalized,Male,06-Mar-2025,3/21/2025,Direct,28,103.5 KG,Fda-Ctu,Healthcare Professional,Not Specified,Adderall Xr;Unspecified Ingredient,-,3/21/2025,Not Specified,Not Specified,-,-,-\\n24989322,-,Olanzapine;Hydromorphone;Herbals\\\\Mitragynine,Abdominal Pain;Product Used For Unknown Indication;Schizoaffective Disorder Bipolar Type,Overdose;Renal Impairment;Toxicity To Various Agents,Serious,Died,Male,-,3/21/2025,Expedited,44,Not Specified,Sandoz,Healthcare Professional,Not Specified,Zopiclone;Escitalopram,3/20/2025,2/20/2025,CA,Not Specified,CA-SANDOZ INC.-SDZ2025CA010384,-,-\\n25113537,-,7-Hydroxymitragynine,-,Unevaluable Event;Product Colour Issue,Serious,Life Threatening,Not Specified,04-Mar-2025,3/22/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,3/22/2025,Not Specified,Not Specified,-,-,-\\n24827139,-,Herbals\\\\Mitragynine,Depression;Stress,Toxicity To Various Agents;Drug Dependence,Serious,Died,Male,20-Apr-2020,1/9/2025,Direct,32,74.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/9/2025,Not Specified,Not Specified,-,-,-\\n25141084,-,7-Hydroxymitragynine,Pain Management;Substance Use,Product Communication Issue;Withdrawal Syndrome;Drug Dependence;Product Use In Unapproved Indication,Non-Serious,Non-Serious,Male,19-Dec-2024,3/30/2025,Direct,38,83.7 KG,Fda-Ctu,Consumer,Not Specified,Herbals\\\\Mitragynine;Suboxone,-,3/30/2025,Not Specified,Not Specified,-,-,-\\n25167106,-,7-Hydroxymitragynine;Herbals\\\\Mitragynine,Pain,Drug Dependence,Serious,Disabled,Male,04-Apr-2025,4/4/2025,Direct,33,74.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/4/2025,Not Specified,Y,-,-,-\\n25179701,-,Hydromorphone Hydrochloride;Herbals\\\\Mitragynine;Olanzapine,Abdominal Pain;Product Used For Unknown Indication;Schizoaffective Disorder Bipolar Type,Renal Impairment;Toxicity To Various Agents;Overdose,Serious,Died,Male,-,4/9/2025,Expedited,44,Not Specified,Purdue,Healthcare Professional,Not Specified,Zopiclone;Escitalopram,4/7/2025,4/9/2025,CA,Not Specified,CA-PURDUE-USA-2025-0316666,-,-\\n25186726,-,Olanzapine;Hydromorphone;Herbals\\\\Mitragynine,Abdominal Pain;Product Used For Unknown Indication;Schizoaffective Disorder Bipolar Type,Renal Impairment;Overdose;Toxicity To Various Agents,Serious,Died,Male,-,4/11/2025,Expedited,44,Not Specified,Teva,Healthcare Professional,Not Specified,Escitalopram;Zopiclone,4/3/2025,4/11/2025,CA,Not Specified,CA-TEVA-VS-3320544,-,-\\n25200492,Lybalvi,Olanzapine\\\\Samidorphan L-Malate;Herbals\\\\Mitragynine,Product Used For Unknown Indication;Schizophrenia,Drug Screen Negative;Withdrawal Syndrome;Contraindicated Product Administered,Non-Serious,Non-Serious,Not Specified,-,4/15/2025,Non-Expedited,Not Specified,Not Specified,Alkermes,Healthcare Professional,Not Specified,-,4/7/2025,4/15/2025,US,Not Specified,US-ALKERMES INC.-ALK-2025-000941,-,-\\n24845662,-,Herbals\\\\Mitragynine,-,Illness,Serious,Disabled;Other Outcomes,Female,14-Jan-2025,1/15/2025,Direct,36,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,1/15/2025,Not Specified,Y,-,-,-\\n24849694,-,Herbals\\\\Mitragynine,Insomnia;Pain,Suspected Product Contamination;Illness,Serious,Hospitalized,Not Specified,15-Jan-2025,1/15/2025,Direct,25,54 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/15/2025,Not Specified,Not Specified,-,-,-\\n25209483,-,7-Hydroxymitragynine,-,Irritability;Withdrawal Syndrome;Anxiety;Restlessness;Pain;Fatigue;Cold Sweat;Product Communication Issue,Serious,Other Outcomes;Required Intervention,Not Specified,-,4/17/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,4/17/2025,Not Specified,Not Specified,-,-,-\\n24856780,-,Herbals\\\\Mitragynine,Pain,Substance Use;Near Death Experience,Serious,Disabled;Life Threatening,Female,28-Dec-2024,1/16/2025,Direct,36,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,1/16/2025,Not Specified,Y,-,-,-\\n25220129,-,7-Hydroxymitragynine;Herbals\\\\Mitragynine,Depression;Pain;Substance Use,Muscle Spasms;Constipation;Emotional Disorder;Orthostatic Intolerance;Somnolence;Vomiting;Decreased Appetite;Injury;Drug Dependence;Weight Decreased;Fall;Epistaxis;Retrograde Amnesia;Dyskinesia,Serious,Disabled;Required Intervention,Male,17-Apr-2025,4/19/2025,Direct,66,95.4 KG,Fda-Ctu,Consumer,Not Specified,Trintellix;Losartan;Vitamin D Nos;Nuvigil;Clonidine;Suboxone,-,4/19/2025,Not Specified,Not Specified,-,-,-\\n24850249,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Memory Impairment;Eating Disorder;Withdrawal Syndrome;Loss Of Personal Independence In Daily Activities;Dry Skin;Insomnia;Skin Fissures;Drug Dependence;Incoherent;Vomiting,Serious,Hospitalized;Required Intervention;Disabled;Other Outcomes;Life Threatening,Male,13-Jan-2025,1/16/2025,Direct,42,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,1/16/2025,Not Specified,Not Specified,-,-,-\\n24869696,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents,Serious,Died,Male,-,1/20/2025,Direct,25,74.7 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/20/2025,Not Specified,Not Specified,-,-,-\\n24889954,-,Herbals\\\\Mitragynine,-,Mouth Haemorrhage;Substance Use,Serious,Died,Male,12-Apr-2024,1/24/2025,Direct,27,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,1/24/2025,Not Specified,Not Specified,-,-,-\\n24900535,-,Herbals\\\\Mitragynine,Anxiety,Toxicity To Various Agents,Serious,Died,Female,26-Aug-2024,1/29/2025,Direct,41,48.15 KG,Fda-Ctu,Consumer,Not Specified,-,-,1/29/2025,Not Specified,Not Specified,-,-,-\\n25245489,-,7-Hydroxymitragynine;Herbals\\\\Mitragynine,Alcohol Use;Feeling Of Relaxation;Substance Use,Product Formulation Issue;Dependence;Illness;Anxiety;Depression;Drug Withdrawal Syndrome,Serious,Other Outcomes;Required Intervention;Disabled,Male,-,4/27/2025,Direct,23,75.6 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/27/2025,Not Specified,Not Specified,-,-,-\\n24985527,-,Herbals\\\\Mitragynine,Pain;Weight Decreased,Product Use In Unapproved Indication;Self-Medication;Euphoric Mood;Vomiting;Disturbance In Attention,Non-Serious,Non-Serious,Female,14-Feb-2025,2/17/2025,Direct,39,101.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,2/17/2025,Not Specified,Not Specified,-,-,Yes\\n25014510,-,Herbals\\\\Mitragynine,-,Drug Dependence,Serious,Other Outcomes;Hospitalized;Required Intervention,Male,25-Feb-2025,2/25/2025,Direct,30,72.57 KG,Fda-Ctu,Consumer,Not Specified,-,-,2/25/2025,Not Specified,Not Specified,-,-,-\\n23415519,Suboxone,Buprenorphine Hydrochloride\\\\Naloxone Hydrochloride;Docusate Sodium;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Haematochezia;Dizziness;Loss Of Personal Independence In Daily Activities;Drug Ineffective;Migraine;Discomfort;Vomiting;Pain;Anal Injury;Sleep Disorder;Anal Haemorrhage;Faeces Hard,Serious,Other Outcomes;Disabled,Not Specified,-,5/6/2025,Expedited,Not Specified,Not Specified,Chattem,Consumer,Not Specified,-,1/4/2024,1/18/2024,US,Not Specified,US-CHATTEMPRD-2024OHG000558,-,-\\n25302762,Heroin,Diamorphine;Hydrocodone Bitartrate;Gabapentin;Fentanyl;Diazepam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Overdose;Road Traffic Accident;Toxicity To Various Agents;Impaired Driving Ability;Drug Abuse,Serious,Died;Other Outcomes,Male,20-Jun-2024,5/12/2025,Expedited,33,Not Specified,Purdue,Consumer,Not Specified,-,5/9/2025,5/12/2025,US,Not Specified,US-PURDUE-USA-2025-0317374,-,-\\n25023423,-,Herbals\\\\Mitragynine,Depression;Drug Dependence,Tremor;Seizure;Euphoric Mood;Incorrect Dose Administered;Hypothyroidism;Fall;Thyroxine Decreased;Blood Thyroid Stimulating Hormone Increased,Serious,Hospitalized;Required Intervention;Life Threatening;Disabled;Other Outcomes,Male,15-Nov-2022,2/27/2025,Direct,34,83.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,2/27/2025,Not Specified,Not Specified,-,-,-\\n25079224,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,11-Dec-2021,3/14/2025,Direct,30,101.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/14/2025,Not Specified,Y,-,-,-\\n25323735,-,Herbals\\\\Mitragynine;7-Hydroxymitragynine,Depression;Pain;Plasminogen Activator Inhibitor Polymorphism,Quality Of Life Decreased;Drug Dependence;Somnolence,Serious,Disabled,Male,17-Apr-2025,5/16/2025,Direct,66,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,5/16/2025,Not Specified,Not Specified,-,-,-\\n25094604,-,Herbals\\\\Mitragynine,-,Vertigo;Product Formulation Issue;Nausea;Hypoaesthesia Oral;Vomiting;Dizziness,Serious,Disabled;Other Outcomes,Female,12-Mar-2025,3/18/2025,Direct,30,58.97 KG,Fda-Ctu,Consumer,Not Specified,-,-,3/18/2025,Not Specified,Not Specified,-,-,-\\n25369370,Suboxone,Buprenorphine Hydrochloride\\\\Naloxone Hydrochloride;Hydrocodone Bitartrate;Oxycodone Hydrochloride;Herbals\\\\Mitragynine,Detoxification;Pain,Hypoaesthesia;Drug Dependence;Inadequate Analgesia;Anxiety;Chills;Hyperhidrosis,Serious,Other Outcomes,Male,2019,5/28/2025,Non-Expedited,Not Specified,Not Specified,Purdue,Consumer,Not Specified,-,5/24/2025,5/28/2025,US,Not Specified,US-PURDUE PHARMA-USA-2025-0317721,-,-\\n25113550,-,Herbals\\\\Mitragynine,-,Hypoxia;Mental Status Changes;Pallor,Serious,Life Threatening;Hospitalized,Male,22-Mar-2025,3/22/2025,Direct,2,13.3 KG,Fda-Ctu,Healthcare Professional,Not Specified,-,-,3/22/2025,Not Specified,Not Specified,-,-,-\\n25202828,-,Herbals\\\\Mitragynine,Anxiety;Depression,Drug Dependence;Product Complaint;Quality Of Life Decreased;Compulsive Shopping,Serious,Life Threatening;Hospitalized;Required Intervention,Male,06-Apr-2025,4/15/2025,Direct,46,98.1 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/15/2025,Not Specified,Not Specified,-,-,-\\n25379785,-,Fentanyl;Diazepam;Herbals\\\\Mitragynine;Gabapentin,Product Used For Unknown Indication,Toxicity To Various Agents;Overdose,Serious,Died,Male,-,5/30/2025,Expedited,33,Not Specified,Mylan,Consumer,Not Specified,-,5/27/2025,5/30/2025,US,Not Specified,US-MYLANLABS-2025M1045745,-,-\\n25386228,-,7-Hydroxymitragynine;Herbals\\\\Mitragynine,Back Pain;Pain;Pain In Extremity,Diarrhoea;Vomiting;Product Advertising Issue;Drug Withdrawal Syndrome;Feeling Abnormal;Impaired Work Ability;Middle Insomnia;Restless Legs Syndrome,Serious,Disabled;Required Intervention;Other Outcomes,Male,04-Jan-2025,5/31/2025,Direct,45,80.55 KG,Fda-Ctu,Consumer,Not Specified,Herbals\\\\Mitragynine;Clonazepam,-,5/31/2025,Not Specified,Not Specified,-,-,-\\n25209438,-,Herbals\\\\Mitragynine,-,Quality Of Life Decreased;Product Use In Unapproved Indication;Substance Use,Serious,Required Intervention;Other Outcomes,Male,22-Mar-2024,4/17/2025,Direct,43,78.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/17/2025,Not Specified,Y,-,-,-\\n25460975,-,Herbals\\\\Mitragynine;Tianeptine;Turpentine,-,Drug Withdrawal Syndrome;Drug Dependence;Acetonaemic Vomiting,Non-Serious,Non-Serious,Male,11-Jun-2025,6/18/2025,Direct,35,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,6/18/2025,Not Specified,Not Specified,-,-,-\\n25220629,-,Herbals\\\\Mitragynine,Anxiety;Pain,Drug Dependence;Suicidal Ideation;Withdrawal Syndrome;Blood Pressure Increased;Influenza Like Illness,Serious,Hospitalized,Female,15-Apr-2025,4/19/2025,Direct,46,66.15 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/19/2025,Not Specified,Not Specified,-,-,-\\n25234603,-,Herbals\\\\Mitragynine,-,Plasma Protein Metabolism Disorder;Psychotic Disorder;Substance Use Disorder,Serious,Required Intervention;Disabled;Hospitalized,Male,-,4/24/2025,Direct,Not Specified,83.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/24/2025,Not Specified,Not Specified,-,-,-\\n25462679,-,Cosmetics;.Delta.9-Tetrahydrocannabinol\\\\Herbals;.Delta.8-Tetrahydrocannabinol\\\\Herbals;Herbals\\\\Mitragynine,Weight Control,Product Label Issue;Product Advertising Issue;Headache;Weight Increased,Serious,Disabled,Not Specified,-,6/19/2025,Direct,34,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,6/19/2025,Not Specified,Y,-,-,-\\n25469790,Lybalvi,Olanzapine\\\\Samidorphan L-Malate;Herbals\\\\Mitragynine,Pain;Product Used For Unknown Indication,Pain;Contraindicated Product Administered,Non-Serious,Non-Serious,Not Specified,-,6/23/2025,Non-Expedited,Not Specified,Not Specified,Alkermes,Consumer,Not Specified,-,6/17/2025,6/23/2025,US,Not Specified,US-ALKERMES INC.-ALK-2025-001665,-,-\\n25468427,Lybalvi,Olanzapine\\\\Samidorphan L-Malate;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Contraindicated Product Administered;Withdrawal Syndrome,Non-Serious,Non-Serious,Female,-,6/23/2025,Non-Expedited,Not Specified,Not Specified,Alkermes,Healthcare Professional,Not Specified,Olanzapine,6/17/2025,6/23/2025,US,Not Specified,US-ALKERMES INC.-ALK-2025-001658,-,-\\n25245337,-,Herbals\\\\Mitragynine,-,Cerebral Disorder;Impaired Quality Of Life,Serious,Other Outcomes,Male,20-Apr-2025,4/26/2025,Direct,31,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,4/26/2025,Not Specified,Not Specified,-,-,-\\n25493507,-,7-Hydroxymitragynine,Depression,Drug Dependence;Withdrawal Syndrome,Serious,Required Intervention;Other Outcomes,Male,15-Sep-2024,6/27/2025,Direct,24,81 KG,Fda-Ctu,Consumer,Not Specified,Clonidine;Gabapentin;Pantoprazole;Suboxone,-,6/27/2025,Not Specified,Not Specified,-,-,-\\n25245476,-,Herbals\\\\Mitragynine,Anxiety;Depression;Pain,Drug Dependence;Withdrawal Syndrome,Serious,Other Outcomes,Male,19-Apr-2025,4/27/2025,Direct,40,54 KG,Fda-Ctu,Consumer,Not Specified,-,-,4/27/2025,Not Specified,Not Specified,-,-,-\\n25263508,-,Herbals\\\\Mitragynine,-,Restlessness;Irritability;Withdrawal Syndrome;Chills;Feeling Abnormal;Paranoid Personality Disorder;Fatigue,Serious,Other Outcomes,Male,-,5/1/2025,Direct,33,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,5/1/2025,Not Specified,Not Specified,-,-,-\\n25324294,-,Herbals\\\\Mitragynine,Limb Injury,Communication Disorder;Product Complaint;Mental Disorder,Serious,Disabled;Life Threatening;Required Intervention;Other Outcomes;Hospitalized,Male,06-May-2025,5/15/2025,Direct,46,90 KG,Fda-Ctu,Consumer,Not Specified,-,-,5/15/2025,Not Specified,Not Specified,-,-,-\\n25324201,-,Herbals\\\\Mitragynine,Anxiety,Paranoia;Product Complaint;Hallucination,Serious,Disabled;Hospitalized;Other Outcomes;Life Threatening;Required Intervention,Male,06-May-2025,5/15/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,5/15/2025,Not Specified,Not Specified,-,-,-\\n25504208,-,7-Hydroxymitragynine,Drug Dependence,Dysarthria;Respiratory Arrest;Overdose;Loss Of Consciousness;Anal Incontinence;Anger,Serious,Hospitalized;Other Outcomes;Life Threatening,Male,06-Jun-2025,7/1/2025,Direct,26,113.4 KG,Fda-Ctu,Consumer,Not Specified,Suboxone,-,7/1/2025,Not Specified,Y,-,-,-\\n25341878,-,Herbals\\\\Mitragynine,Stress,Feeling Abnormal;Headache;Bedridden;Nausea;Fatigue;Tongue Pruritus;Heart Rate Decreased;Motor Dysfunction;Sluggishness;Hypoaesthesia Oral,Serious,Other Outcomes,Female,17-May-2025,5/21/2025,Direct,29,46.8 KG,Fda-Ctu,Consumer,Not Specified,-,-,5/21/2025,Not Specified,Not Specified,-,-,-\\n25379995,-,Herbals\\\\Mitragynine,-,Withdrawal Syndrome;Fall;Tremor;Overdose;Vomiting,Serious,Other Outcomes;Died,Male,21-Apr-2025,5/30/2025,Direct,32,72.57 KG,Fda-Ctu,Not Specified,Not Specified,-,-,5/30/2025,Not Specified,Not Specified,-,-,-\\n25438994,-,Herbals\\\\Mitragynine,Alcohol Withdrawal Syndrome,Drug Dependence;Overdose;Substance Use,Serious,Required Intervention;Hospitalized;Life Threatening;Disabled;Other Outcomes,Male,01-Jun-2025,6/14/2025,Direct,35,72 KG,Fda-Ctu,Consumer,Not Specified,-,-,6/14/2025,Not Specified,Not Specified,-,-,-\\n25460702,-,Herbals\\\\Mitragynine,-,Death,Serious,Died,Male,18-Feb-2025,6/18/2025,Direct,38,81 KG,Fda-Ctu,Consumer,Not Specified,-,-,6/18/2025,Not Specified,Not Specified,-,-,-\\n25525749,\"Xanax;Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate\",Amphetamine Aspartate\\\\Amphetamine Sulfate\\\\Dextroamphetamine Saccharate\\\\Dextroamphetamine Sulfate;Fentanyl;Dronabinol;Alprazolam;Cannabis Sativa Subsp. Indica Top;Alprazolam;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Impaired Driving Ability;Drug Diversion;Drug Abuse;Dysarthria;Balance Disorder,Serious,Other Outcomes,Male,-,7/7/2025,Expedited,Not Specified,Not Specified,Purdue,Consumer,Not Specified,-,7/3/2025,7/7/2025,US,Not Specified,US-PURDUE-USA-2025-0318677,-,-\\n25482688,-,Herbals\\\\Mitragynine,Energy Increased,Product Complaint,Serious,Life Threatening,Not Specified,-,6/25/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,6/25/2025,Not Specified,Not Specified,-,-,-\\n25548770,-,Herbals\\\\Mitragynine;7-Hydroxymitragynine,-,Dependence;Adulterated Product;Depression,Serious,Required Intervention;Other Outcomes,Male,29-Aug-2024,7/13/2025,Direct,28,74.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/13/2025,Not Specified,Not Specified,-,-,-\\n25493866,-,Herbals\\\\Mitragynine,-,Anxiety;Product Advertising Issue;Drug Withdrawal Syndrome;Tachycardia;Chest Pain,Serious,Other Outcomes,Male,24-Jun-2025,6/27/2025,Direct,35,74.25 KG,Fda-Ctu,Healthcare Professional,Not Specified,-,-,6/27/2025,Not Specified,Not Specified,-,-,-\\n25496375,-,Herbals\\\\Mitragynine,-,Drug Dependence;Substance Use,Serious,Life Threatening,Male,26-Jun-2025,6/27/2025,Direct,30,185 LB,Fda-Ctu,Healthcare Professional,Not Specified,-,-,6/27/2025,Not Specified,Not Specified,-,-,-\\n25586601,-,7-Hydroxymitragynine,Muscle Spasms,Tremor;Nausea;Impaired Driving Ability;Dizziness;Presyncope;Feeling Drunk;Vomiting,Serious,Disabled;Other Outcomes,Female,20-Jul-2025,7/20/2025,Direct,27,54 KG,Fda-Ctu,Consumer,Not Specified,Prozac;Adderall;Wellbutrin;Vitamin D3,-,7/20/2025,Not Specified,Not Specified,-,-,-\\n25586815,-,7-Hydroxymitragynine,Spinal Pain,Diarrhoea;Withdrawal Syndrome;Vomiting;Heart Rate Increased;Hyperhidrosis,Serious,Required Intervention,Female,16-Jul-2025,7/21/2025,Direct,51,90 KG,Fda-Ctu,Consumer,Not Specified,Melatonin;Prozac;Magnesium;Tolterodine;Wellbutrin Xl,-,7/21/2025,Not Specified,Not Specified,-,-,-\\n25499470,-,Herbals\\\\Mitragynine,-,Substance Use;Drug Dependence,Serious,Life Threatening;Other Outcomes,Not Specified,30-Jun-2025,6/30/2025,Direct,32,175 LB,Fda-Ctu,Healthcare Professional,Not Specified,-,-,6/30/2025,Not Specified,Not Specified,-,-,-\\n25504696,-,Herbals\\\\Mitragynine,Pain,Abnormal Behaviour;Drug Dependence;Suicidal Ideation;Quality Of Life Decreased;Panic Attack;Withdrawal Syndrome;Insomnia;Hyperhidrosis;Vomiting,Serious,Hospitalized;Required Intervention;Other Outcomes;Disabled,Male,29-Jun-2025,7/2/2025,Direct,49,90 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/2/2025,Not Specified,Not Specified,-,-,-\\n25551627,-,Herbals\\\\Mitragynine,Drug Withdrawal Syndrome,Anger;Psychotic Disorder,Serious,Other Outcomes,Male,10-Dec-2023,7/13/2025,Direct,61,72 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/13/2025,Not Specified,Not Specified,-,-,-\\n25566138,-,Herbals\\\\Mitragynine,-,Drug Dependence;Product Formulation Issue;Product Advertising Issue;Ill-Defined Disorder;Withdrawal Syndrome;Emotional Disorder,Serious,Required Intervention;Life Threatening,Male,08-Jul-2025,7/15/2025,Direct,43,99 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/15/2025,Not Specified,Y,-,-,-\\n25596657,-,Herbals\\\\Mitragynine,Drug Dependence;Drug Use Disorder,Detoxification,Serious,Required Intervention,Male,09-Oct-2024,7/22/2025,Direct,41,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,7/22/2025,Not Specified,Not Specified,-,-,-\\n25612923,-,Herbals\\\\Mitragynine,Asthenia,Dyspnoea;Heart Rate Increased;Abdominal Pain Upper;Confusional State,Serious,Life Threatening;Required Intervention,Male,03-Jul-2025,7/26/2025,Direct,36,83.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/26/2025,Not Specified,Y,-,-,-\\n25613316,-,Herbals\\\\Mitragynine,-,Nonspecific Reaction;Dependence,Serious,Hospitalized;Disabled;Other Outcomes;Life Threatening,Male,-,7/27/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,7/27/2025,Not Specified,Not Specified,-,-,-\\n25623554,-,7-Hydroxymitragynine,Cancer Pain,Blood Lead Increased;Product Contamination Physical;Metal Poisoning,Non-Serious,Non-Serious,Not Specified,-,7/30/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,7/30/2025,Not Specified,Not Specified,-,-,-\\n25617090,-,Herbals\\\\Mitragynine,Sleep Disorder,Quality Of Life Decreased;Drug Dependence,Serious,Required Intervention,Male,21-Jul-2025,7/28/2025,Direct,44,81 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/28/2025,Not Specified,Not Specified,-,-,-\\n25623515,-,7-Hydroxymitragynine,Arthritis;Back Pain,Drug Dependence,Serious,Hospitalized,Female,13-Mar-2025,7/30/2025,Direct,42,76.5 KG,Fda-Ctu,Consumer,Not Specified,Duloxetine;Vitamin D3,-,7/30/2025,Not Specified,Not Specified,-,-,-\\n25627100,-,7-Hydroxymitragynine,-,Drug Dependence;Substance Use,Serious,Hospitalized,Female,07-May-2025,7/30/2025,Direct,26,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,7/30/2025,Not Specified,Not Specified,-,-,-\\n25623549,-,7-Hydroxymitragynine,Neuropathy Peripheral,Withdrawal Syndrome;Panic Attack;Product Substitution Issue;Therapy Interrupted,Serious,Other Outcomes,Male,08-Jun-2025,7/30/2025,Direct,55,94.5 KG,Fda-Ctu,Consumer,Not Specified,Metformin;Dietary Supplement;Herbals\\\\Mitragynine;Glipizide;Kava;Herbals\\\\Turmeric;Vitamin B Complex,-,7/30/2025,Not Specified,Not Specified,-,-,-\\n25622686,-,Herbals\\\\Mitragynine,Energy Increased,Constipation;Vomiting;Arthralgia;Bone Pain;Withdrawal Syndrome;Hyperhidrosis;Asthenia;Nausea;Headache;Substance Use;Confusional State,Serious,Hospitalized;Required Intervention,Male,30-Jun-2025,7/29/2025,Direct,52,78.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/29/2025,Not Specified,Not Specified,-,-,-\\n25627154,-,7-Hydroxymitragynine,Anxiety,Tremor;Abdominal Discomfort;Withdrawal Syndrome;Insomnia;Muscle Spasms;Substance Use,Serious,Other Outcomes,Male,29-Jul-2025,7/30/2025,Direct,29,90 KG,Fda-Ctu,Consumer,Not Specified,Fluoxetine;Mirtazapine;Trazodone,-,7/30/2025,Not Specified,Not Specified,-,-,-\\n25634377,-,7-Hydroxymitragynine,Anxiety;Pain,Withdrawal Syndrome;Drug Dependence,Serious,Other Outcomes,Male,01-May-2025,7/31/2025,Direct,49,78.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/31/2025,Not Specified,Not Specified,-,-,-\\n25617799,-,Herbals\\\\Mitragynine,-,Seizure;Cardiac Arrest,Serious,Died,Male,28-Jul-2025,7/29/2025,Direct,31,136.08 KG,Fda-Ctu,Healthcare Professional,Not Specified,-,-,7/29/2025,Not Specified,Not Specified,-,-,-\\n25618818,-,Herbals\\\\Mitragynine,-,Dependence;Partner Stress;Alopecia;Blood Testosterone Decreased;Self Esteem Decreased;Loss Of Employment;Withdrawal Syndrome;Renal Disorder;Dyschezia;Gallbladder Disorder,Serious,Required Intervention,Male,-,7/29/2025,Direct,Not Specified,83.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/29/2025,Not Specified,Not Specified,-,-,-\\n25644366,-,7-Hydroxymitragynine,Substance Use,Vomiting;Body Temperature Increased;Hyperhidrosis;Nausea;Lethargy;Headache;Dizziness,Non-Serious,Non-Serious,Not Specified,02-Aug-2025,8/3/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,8/3/2025,Not Specified,Not Specified,-,-,-\\n25627045,-,Herbals\\\\Mitragynine,Drug Dependence,Job Dissatisfaction;General Physical Health Deterioration;Substance Use;Withdrawal Syndrome,Serious,Other Outcomes;Required Intervention,Male,24-Jul-2025,7/30/2025,Direct,28,103.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,7/30/2025,Not Specified,Not Specified,-,-,-\\n25640731,-,Herbals\\\\Mitragynine,-,Skin Exfoliation;Dependence;Dry Skin;Withdrawal Syndrome,Serious,Hospitalized,Female,04-Nov-2024,8/2/2025,Direct,27,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,8/2/2025,Not Specified,Not Specified,-,-,-\\n25645630,-,Fentanyl;Herbals\\\\Mitragynine,Anxiety;Depression;Pain,Drug Dependence;Illness;Withdrawal Syndrome;Euphoric Mood,Serious,Other Outcomes,Male,01-Nov-2024,8/4/2025,Direct,144,90 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/4/2025,Not Specified,Not Specified,-,-,-\\n25643652,-,Herbals\\\\Mitragynine,Dependence,Dependence;Drug Withdrawal Syndrome,Serious,Required Intervention,Male,02-Aug-2025,8/2/2025,Direct,65,81 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/2/2025,Not Specified,Not Specified,-,-,-\\n25645540,-,Herbals\\\\Tetrahydrocannabiphorol;Herbals\\\\Mitragynine,Anxiety,Insomnia;Decreased Appetite;Confusional State;Schizophrenia;Anxiety;Tremor,Serious,Hospitalized;Required Intervention,Male,26-Jul-2025,8/4/2025,Direct,19,56.7 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/4/2025,Not Specified,Not Specified,-,-,-\\n25645556,-,Lorazepam;Herbals\\\\Mitragynine;Cocaine,-,Substance Abuse;Seizure,Serious,Hospitalized;Life Threatening,Male,03-Aug-2025,8/4/2025,Direct,34,89.5 KG,Fda-Ctu,Healthcare Professional,Not Specified,Alcohol;Lisinopril;Buspirone,-,8/4/2025,Not Specified,Not Specified,-,-,-\\n25645341,-,Herbals\\\\Mitragynine,-,Hordeolum;Dependence;Alopecia;Skin Injury,Serious,Required Intervention,Female,15-Feb-2023,8/4/2025,Direct,28,58.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/4/2025,Not Specified,Not Specified,-,-,-\\n25643805,-,Herbals\\\\Mitragynine,Anxiety,Drug Dependence,Serious,Other Outcomes;Required Intervention,Female,24-Jul-2025,8/4/2025,Direct,14,49.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/4/2025,Not Specified,Not Specified,-,-,-\\n25649556,-,Herbals\\\\Mitragynine,Asthenia,Coma;Death,Serious,Died,Female,09-Oct-2022,8/5/2025,Direct,36,63 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/5/2025,Not Specified,Not Specified,-,-,-\\n25646131,-,Herbals\\\\Mitragynine,Anxiety,Drug Withdrawal Syndrome,Serious,Other Outcomes,Female,05-Aug-2025,8/5/2025,Direct,40,81.9 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/5/2025,Not Specified,Not Specified,-,-,-\\n25656033,-,Herbals\\\\Mitragynine,Self-Medication,Paralysis;Substance Use;Product Measured Potency Issue;Therapeutic Product Effect Variable;Brain Injury;Cardiac Arrest;Circulatory Collapse;Depressed Level Of Consciousness;Oral Discharge;Loss Of Personal Independence In Daily Activities,Serious,Disabled,Male,30-Apr-2022,8/7/2025,Direct,32,79.38 KG,Fda-Ctu,Not Specified,Not Specified,-,-,8/7/2025,Not Specified,Y,-,-,-\\n25676929,-,7-Hydroxymitragynine,Pain;Stress,Loss Of Consciousness;Illness;Pain;Mental Disorder,Serious,Hospitalized,Male,10-Aug-2025,8/13/2025,Direct,11 WEEK,81.9 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/13/2025,Not Specified,Not Specified,-,-,-\\n25658986,-,Herbals\\\\Mitragynine,Asthenia,Nausea;Drug Dependence;Pain;Product Advertising Issue;Withdrawal Syndrome;Product Complaint;Nonspecific Reaction;Headache,Serious,Hospitalized,Female,-,8/7/2025,Direct,45,113.4 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/7/2025,Not Specified,Not Specified,-,-,-\\n25663995,-,Herbals\\\\Mitragynine,-,Loss Of Personal Independence In Daily Activities;Withdrawal Syndrome;Hepatic Pain;Dependence;Drug Dependence;Gastrointestinal Disorder;Physical Deconditioning;Mental Disorder;Depression;Anhedonia,Serious,Required Intervention,Female,08-Aug-2025,8/8/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,8/8/2025,Not Specified,Not Specified,-,-,-\\n25682776,-,Herbals\\\\Mitragynine,Weight Control,Near Death Experience;Drug Dependence;Feeling Abnormal;Anxiety,Serious,Disabled;Hospitalized,Male,24-Jul-2025,8/14/2025,Direct,29,112.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/14/2025,Not Specified,Not Specified,-,-,-\\n25681939,-,Herbals\\\\Mitragynine,-,Drug Dependence;Withdrawal Syndrome,Serious,Required Intervention,Not Specified,-,8/14/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,8/14/2025,Not Specified,Not Specified,-,-,-\\n25690199,-,Herbals\\\\Mitragynine,-,Obsessive-Compulsive Personality Disorder;Acute Psychosis;Paranoia;Delusion,Serious,Hospitalized,Male,03-Feb-2022,8/15/2025,Direct,43,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,8/15/2025,Not Specified,Not Specified,-,-,-\\n25690780,-,7-Hydroxymitragynine,-,Product Complaint;Dependence;Respiratory Depression;Overdose;Product Formulation Issue,Serious,Required Intervention;Life Threatening;Hospitalized,Male,-,8/17/2025,Direct,33,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,8/17/2025,Not Specified,Not Specified,-,-,-\\n25690197,-,Herbals\\\\Mitragynine,-,Drug Tolerance;Drug Dependence;Withdrawal Syndrome;Paranoia;Hallucination;Therapy Cessation,Serious,Other Outcomes,Male,05-Jun-2023,8/15/2025,Direct,30,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,8/15/2025,Not Specified,Not Specified,-,-,-\\n25706627,-,7-Hydroxymitragynine,-,Drug Dependence;Withdrawal Syndrome,Serious,Life Threatening;Other Outcomes,Male,19-Aug-2025,8/19/2025,Direct,31,114.31 KG,Fda-Ctu,Healthcare Professional,Not Specified,-,-,8/19/2025,Not Specified,Not Specified,-,-,-\\n25715392,-,7-Hydroxymitragynine,-,Somnolence;Dizziness;Impaired Work Ability,Non-Serious,Non-Serious,Female,21-Aug-2025,8/21/2025,Direct,26,46.17 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/21/2025,Not Specified,Not Specified,-,-,-\\n25690201,-,Herbals\\\\Mitragynine,-,\"Pain;Paranoia;Anxiety;Hallucination, Auditory;Withdrawal Syndrome;Restless Legs Syndrome;Insomnia;Nausea;Drug Dependence;Depression\",Serious,Other Outcomes,Male,21-Jun-2025,8/15/2025,Direct,35,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,8/15/2025,Not Specified,Not Specified,-,-,-\\n25721295,-,Herbals\\\\Mitragynine,-,Psychotic Disorder;Delusion;Drug Dependence;Crying;Aggression,Serious,Other Outcomes,Male,22-Aug-2025,8/22/2025,Direct,40,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,8/22/2025,Not Specified,Y,-,-,-\\n25726787,-,Herbals\\\\Mitragynine,Alcohol Problem,Abdominal Discomfort;Restlessness;Emotional Disorder;Irritability;Insomnia;Depression;Myalgia;Product Advertising Issue;Anxiety;Drug Dependence;Nausea;Fatigue;Withdrawal Syndrome;Hyperhidrosis;Diarrhoea,Serious,Other Outcomes;Life Threatening;Required Intervention;Disabled,Male,20-Aug-2025,8/25/2025,Direct,29,54 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/25/2025,Not Specified,Not Specified,-,-,-\\n25750030,-,Herbals\\\\Mitragynine,Anxiety,Impaired Work Ability;Seizure,Serious,Hospitalized;Life Threatening,Male,21-Aug-2025,8/30/2025,Direct,40,119.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,8/30/2025,Not Specified,Not Specified,-,-,-\\n25749984,-,7-Hydroxymitragynine,-,Vomiting;Seizure;Abdominal Pain Upper,Serious,Other Outcomes;Hospitalized,Female,28-Aug-2025,8/30/2025,Direct,28,Not Specified,Fda-Ctu,Consumer,Not Specified,Herbals\\\\Mitragynine,-,8/30/2025,Not Specified,Not Specified,-,-,-\\n25749974,-,7-Hydroxymitragynine,-,Drug Dependence,Serious,Hospitalized;Required Intervention,Not Specified,-,8/30/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,8/30/2025,Not Specified,Not Specified,-,-,Yes\\n25766636,-,Herbals\\\\Mitragynine,-,Overdose;Dependence,Serious,Required Intervention;Died;Hospitalized;Life Threatening,Male,01-Jul-2018,9/3/2025,Direct,23,76.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/3/2025,Not Specified,Not Specified,-,-,-\\n25761531,-,Herbals\\\\Mitragynine,-,Dyspnoea;Accidental Exposure To Product,Serious,Other Outcomes,Male,01-Mar-2022,9/3/2025,Direct,48,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,9/3/2025,Not Specified,Not Specified,-,-,-\\n25761592,-,Herbals\\\\Mitragynine,Attention Deficit Hyperactivity Disorder,Dependence,Serious,Other Outcomes,Male,-,9/3/2025,Direct,18,72 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/3/2025,Not Specified,Not Specified,-,-,-\\n25762214,-,7-Hydroxymitragynine,-,Unresponsive To Stimuli,Serious,Died,Male,30-Aug-2025,9/4/2025,Direct,33,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,9/4/2025,Not Specified,Not Specified,-,-,-\\n25766980,-,7-Hydroxymitragynine,-,Product Advertising Issue;Diabetic Ketoacidosis;Withdrawal Syndrome,Serious,Hospitalized,Not Specified,-,9/5/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/5/2025,Not Specified,Not Specified,-,-,-\\n25766915,-,7-Hydroxymitragynine,-,Toxicity To Various Agents,Serious,Died,Not Specified,-,9/5/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Not Specified,Not Specified,-,-,9/5/2025,Not Specified,Not Specified,-,-,-\\n25773864,-,7-Hydroxymitragynine,Pain,Withdrawal Syndrome;Drug Dependence;Therapy Interrupted,Serious,Other Outcomes,Male,30-Aug-2025,9/7/2025,Direct,45,88.2 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/7/2025,Not Specified,Not Specified,-,-,-\\n25778650,-,7-Hydroxymitragynine,Drug Dependence,Unresponsive To Stimuli;Overdose;Hypothermia;Drug Abuse;Organ Failure,Serious,Life Threatening;Required Intervention;Disabled;Hospitalized;Other Outcomes,Male,21-Apr-2025,9/8/2025,Direct,30,67.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/8/2025,Not Specified,Not Specified,-,-,-\\n25779106,-,7-Hydroxymitragynine,Anxiety,Drug Withdrawal Syndrome,Serious,Other Outcomes;Required Intervention,Male,08-Sep-2025,9/8/2025,Direct,58,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,9/8/2025,Not Specified,Not Specified,-,-,-\\n25798167,Vivitrol;Suboxone,Buprenorphine Hydrochloride\\\\Naloxone Hydrochloride;Naltrexone;Herbals\\\\Mitragynine,Drug Dependence;Product Used For Unknown Indication,Pain In Extremity;Drug Withdrawal Syndrome;Feeling Abnormal;Contraindicated Product Administered;Restlessness;Malaise,Non-Serious,Non-Serious,Male,29-Aug-2025,9/12/2025,Non-Expedited,Not Specified,99.773 KG,Alkermes,Consumer,Not Specified,-,8/29/2025,9/12/2025,Not Specified,Not Specified,US-ALKERMES INC.-ALK-2025-002275,-,-\\n25809020,-,Herbals\\\\Mitragynine,-,Drug Dependence;Substance Abuser;Product Advertising Issue,Serious,Died,Female,08-Nov-2024,9/16/2025,Direct,27,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,9/16/2025,Not Specified,Not Specified,-,-,-\\n25809149,Heroin,Diamorphine;Oxycodone Hydrochloride;Methamphetamine;Herbals\\\\Mitragynine,Analgesic Therapy;Product Used For Unknown Indication,Withdrawal Syndrome;Injury;Drug Dependence;Substance Abuse,Serious,Other Outcomes,Female,-,9/16/2025,Expedited,Not Specified,Not Specified,Purdue,Consumer,Not Specified,-,9/13/2025,9/16/2025,US,Not Specified,US-PURDUE PHARMA-USA-2025-0320554,-,-\\n25811385,Brixadi,Buprenorphine;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Nightmare;Drug Withdrawal Syndrome;Myoclonus,Non-Serious,Non-Serious,Female,2025,9/17/2025,Non-Expedited,Not Specified,Not Specified,Braeburn Pharmaceuticals,Consumer,Not Specified,-,8/21/2025,9/17/2025,US,Not Specified,US-BRAEBURN PHARMACEUTICALS-US-BRA-25-000741,-,-\\n25818188,-,Herbals\\\\Mitragynine,-,Product Label Issue,Non-Serious,Non-Serious,Not Specified,-,9/18/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,9/18/2025,Not Specified,Not Specified,-,-,-\\n25823764,-,Herbals\\\\Mitragynine,-,Seizure;Withdrawal Syndrome;Dependence;Substance Use,Serious,Other Outcomes,Male,18-Sep-2025,9/18/2025,Direct,24,54 KG,Fda-Ctu,Healthcare Professional,Not Specified,-,-,9/18/2025,Not Specified,Not Specified,-,-,-\\n25825699,-,Herbals\\\\Mitragynine,-,Somnolence;Depressed Level Of Consciousness;Incorrect Dose Administered,Serious,Died,Male,30-Aug-2025,9/19/2025,Direct,33,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,9/19/2025,Not Specified,Not Specified,-,-,-\\n25831069,-,7-Hydroxymitragynine;Herbals\\\\Mitragynine,-,Withdrawal Syndrome;Impaired Quality Of Life;Diarrhoea;Dependence;Dizziness;Substance Use;Constipation;Illness;Depression;Insomnia;Emotional Disorder;Anxiety,Serious,Disabled;Life Threatening;Other Outcomes,Female,08-Sep-2025,9/20/2025,Direct,37,71.1 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/20/2025,Not Specified,Not Specified,-,-,Yes\\n25836193,-,Herbals\\\\Mitragynine;Mitragynine Pseudoindoxyl;7-Hydroxymitragynine,-,Unresponsive To Stimuli;Drug Abuse,Serious,Died,Female,24-Jul-2025,9/22/2025,Direct,46,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,9/22/2025,Not Specified,Not Specified,-,-,-\\n25832399,Heroin,Diamorphine;Herbals\\\\Mitragynine;Oxycodone Hydrochloride,Product Used For Unknown Indication,Euphoric Mood;Anisocoria;Alopecia;Skin Disorder;Drug Dependence;Panic Attack,Serious,Other Outcomes,Male,-,9/22/2025,Non-Expedited,28,Not Specified,Purdue,Consumer,Not Specified,-,9/19/2025,9/22/2025,US,Not Specified,US-PURDUE PHARMA-USA-2025-0320720,-,-\\n25837588,-,7-Hydroxymitragynine,Sleep Disorder,Coma;Substance Use;Toxicity To Various Agents,Serious,Hospitalized;Required Intervention;Life Threatening,Male,23-Sep-2025,9/23/2025,Direct,20,86.4 KG,Fda-Ctu,Consumer,Not Specified,Keppra,-,9/23/2025,Not Specified,Not Specified,-,-,-\\n25840946,-,Herbals\\\\Mitragynine,-,Family Stress;Drug Dependence;Seizure;Withdrawal Syndrome;Substance Use,Serious,Other Outcomes,Male,-,9/23/2025,Direct,36,300 LB,Fda-Ctu,Not Specified,Not Specified,-,-,9/23/2025,Not Specified,Not Specified,-,-,-\\n25847731,-,Herbals\\\\Mitragynine,-,Toxicity To Various Agents;Seizure,Serious,Died,Male,28-Jul-2025,9/24/2025,Direct,31,126 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/24/2025,Not Specified,Not Specified,-,-,-\\n25859759,-,7-Hydroxymitragynine,Anxiety,Drug Dependence;Drug Withdrawal Syndrome,Serious,Other Outcomes,Male,17-Sep-2025,9/26/2025,Direct,43,81 KG,Fda-Ctu,Consumer,Not Specified,-,-,9/26/2025,Not Specified,Not Specified,-,-,-\\n25860386,Subutex;Keppra;Ativan,Lorazepam;Levetiracetam;7-Hydroxymitragynine;Clonazepam;Buprenorphine Hydrochloride,-,Swelling Face;Anxiety;Swelling;Skin Exfoliation;Chest Pain;Product Use Issue;Anger;Irritability;Hyperhidrosis;Skin Burning Sensation,Serious,Other Outcomes,Female,26-Sep-2025,9/28/2025,Direct,30,92.25 KG,Fda-Ctu,Consumer,Not Specified,Pepcid;Propanol (Propranolol Hydrochloride),-,9/28/2025,Not Specified,Not Specified,-,-,Yes\\n25863951,-,Herbals\\\\Mitragynine,Product Used For Unknown Indication,Liver Injury;Hypoxia;Respiratory Failure,Serious,Hospitalized;Died;Life Threatening,Male,28-Sep-2025,9/29/2025,Direct,55,Not Specified,Fda-Ctu,Healthcare Professional,Not Specified,-,-,9/29/2025,Not Specified,Not Specified,-,-,-\\n25870212,-,7-Hydroxymitragynine,Depression,Blood Follicle Stimulating Hormone Decreased;Negative Thoughts;Self-Injurious Ideation;Cold Sweat;Product Complaint;Anxiety;Pain;Drug Dependence;Sleep Disorder;Drug Withdrawal Syndrome,Serious,Other Outcomes;Life Threatening;Required Intervention,Male,01-Oct-2024,10/1/2025,Direct,35,63 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/1/2025,Not Specified,Not Specified,-,-,-\\n25873438,Dulcolax (Bisacodyl);Suboxone,Buprenorphine Hydrochloride\\\\Naloxone Hydrochloride;Bisacodyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Drug Effect Less Than Expected;Decreased Appetite;Haematochezia;Dizziness;Insomnia;Rectal Haemorrhage;Migraine;Asthenia;Constipation;Vomiting,Non-Serious,Non-Serious,Not Specified,-,10/3/2025,Non-Expedited,Not Specified,Not Specified,Reckitt Benckiser,Healthcare Professional,Not Specified,-,7/19/2025,10/2/2025,US,Not Specified,US-INDIVIOR US-INDV-166579-2025,-,-\\n25883868,-,7-Hydroxymitragynine,Pain Management,Cyanosis;Seizure;Foaming At Mouth,Serious,Hospitalized,Male,29-Sep-2025,10/3/2025,Direct,44,92.25 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/3/2025,Not Specified,Not Specified,-,-,-\\n25887222,-,Herbals\\\\Mitragynine;Oxycodone Hydrochloride;Fentanyl,Product Used For Unknown Indication,Homicide;Product Counterfeit;Drug Diversion,Non-Serious,Non-Serious,Male,Feb-2024,10/6/2025,Non-Expedited,30,Not Specified,Purdue,Consumer,Not Specified,-,10/3/2025,10/6/2025,US,Not Specified,US-PURDUE PHARMA-USA-2025-0321119,-,-\\n25886095,-,Oxycodone Hydrochloride;Fentanyl;Herbals\\\\Mitragynine,Product Used For Unknown Indication,Overdose;Victim Of Homicide;Drug Abuse;Drug Screen Positive;Counterfeit Product Administered,Serious,Other Outcomes;Died,Male,2024,10/6/2025,Expedited,28,Not Specified,Purdue,Consumer,Not Specified,-,10/3/2025,10/6/2025,US,Not Specified,US-PURDUE PHARMA-USA-2025-0321120,-,-\\n25934636,-,Herbals\\\\Mitragynine,-,Epistaxis;Nasal Congestion;Pruritus;Insomnia;Cough;Muscular Weakness;Tremor;Pharyngeal Swelling;Pneumonia;Dyspnoea;Throat Tightness;Product Residue Present;Accidental Exposure To Product,Serious,Disabled;Hospitalized;Other Outcomes,Female,01-Mar-2025,10/16/2025,Direct,27,108 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/16/2025,Not Specified,Y,-,-,-\\n25940912,-,7-Hydroxymitragynine,Pain,Job Dissatisfaction;Withdrawal Syndrome;Weight Decreased;Heart Rate Increased;Drug Dependence;Hypertension;Product Formulation Issue,Serious,Hospitalized;Other Outcomes,Male,28-Aug-2025,10/18/2025,Direct,46,67.5 KG,Fda-Ctu,Consumer,Not Specified,Atorvastatin;Amlodipine;Metoprolol;Singulair;Albuterol,-,10/18/2025,Not Specified,Not Specified,-,-,-\\n25956875,-,Herbals\\\\Mitragynine,-,Overdose,Serious,Required Intervention;Life Threatening;Died,Male,03-Aug-2025,10/23/2025,Direct,32,63 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/23/2025,Not Specified,Not Specified,-,-,-\\n25952897,-,Herbals\\\\Mitragynine,Drug Dependence,Physical Product Label Issue;Mood Altered;Anxiety;Product Use In Unapproved Indication;Substance Use;Withdrawal Syndrome;Drug Dependence,Serious,Required Intervention;Life Threatening;Hospitalized,Male,23-Oct-2025,10/23/2025,Direct,33,72 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/23/2025,Not Specified,Y,-,-,-\\n25961954,-,7-Hydroxymitragynine,-,Suicidal Ideation,Serious,Disabled;Hospitalized;Required Intervention,Not Specified,03-Oct-2025,10/24/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,10/24/2025,Not Specified,Not Specified,-,-,-\\n25974042,-,Herbals\\\\Mitragynine,Disturbance In Attention,Adverse Event,Serious,Life Threatening,Female,12-Oct-2025,10/28/2025,Direct,29,76.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/28/2025,Not Specified,Not Specified,-,-,Yes\\n25979240,-,Herbals\\\\Mitragynine,Supplementation Therapy,Death,Serious,Died,Male,25-Oct-2024,10/29/2025,Direct,45,87.75 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/29/2025,Not Specified,Not Specified,-,-,-\\n25980660,-,7-Hydroxymitragynine,Self-Medication,Pain;Withdrawal Syndrome;Psychotic Disorder;Diarrhoea;Loss Of Personal Independence In Daily Activities;Nausea;Delusion;Substance Use;Insomnia;Hyperhidrosis,Serious,Disabled;Hospitalized;Other Outcomes;Required Intervention,Female,14-Apr-2025,10/30/2025,Direct,56,56.25 KG,Fda-Ctu,Consumer,Not Specified,Subutex;Vitamin E;Vitamin B Complex;Prozac;Seroquel;Dietary Supplement\\\\Herbals\\\\Milk Thistle;Estrogens;Progesterone,-,10/30/2025,Not Specified,Not Specified,-,-,-\\n25984428,-,7-Hydroxymitragynine,Product Used For Unknown Indication,Euphoric Mood;Hypersomnia;Dependence;Dysarthria;Drug Dependence;Impaired Quality Of Life;Loss Of Employment,Serious,Life Threatening;Other Outcomes;Required Intervention;Hospitalized,Male,12-Aug-2025,10/31/2025,Direct,27,103.5 KG,Fda-Ctu,Consumer,Not Specified,-,-,10/31/2025,Not Specified,Not Specified,-,-,Yes\\n26000699,-,7-Hydroxymitragynine,Asthenia;Feeling Of Relaxation,Accidental Overdose;Physical Product Label Issue,Serious,Died,Not Specified,08-Aug-2025,11/4/2025,Direct,33,59.4 KG,Fda-Ctu,Consumer,Not Specified,Ibuprofen,-,11/4/2025,Not Specified,Not Specified,-,-,-\\n25997055,-,7-Hydroxymitragynine,Covid-19;Foot Fracture;Pain,Acute Psychosis;Product Complaint,Serious,Hospitalized,Male,04-Oct-2025,11/4/2025,Direct,40,72 KG,Fda-Ctu,Consumer,Not Specified,Potassium,-,11/4/2025,Not Specified,Not Specified,-,-,-\\n26008750,Contrave,Bupropion Hydrochloride\\\\Naltrexone Hydrochloride;Herbals\\\\Mitragynine,Product Used For Unknown Indication;Supplementation Therapy,Contraindicated Product Administered;Withdrawal Syndrome;Illness;Labelled Drug-Drug Interaction Issue,Non-Serious,Non-Serious,Not Specified,-,11/6/2025,Non-Expedited,Not Specified,Not Specified,Currax Pharmaceuticals,Consumer,Not Specified,-,12/9/2024,11/6/2025,US,Not Specified,US-CURRAX PHARMACEUTICALS LLC-US-2024CUR005153,-,-\\n26007057,-,7-Hydroxymitragynine,-,Product Complaint,Serious,Disabled;Required Intervention,Male,20-Sep-2025,11/6/2025,Direct,Not Specified,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,11/6/2025,Not Specified,Y,-,-,-\\n26054913,-,7-Hydroxymitragynine,Pain,Suspected Product Contamination;Drug Dependence,Serious,Other Outcomes,Male,28-Oct-2025,11/17/2025,Direct,31,99 KG,Fda-Ctu,Consumer,Not Specified,-,-,11/17/2025,Not Specified,Y,-,-,-\\n26070139,-,Mitragynine Pseudoindoxyl;7-Hydroxymitragynine,Anxiety,Constipation;Thinking Abnormal;Nausea;Substance Use;Agitation;Hypophagia;Drug Abuser;Insomnia;Paranoia,Serious,Hospitalized;Disabled;Life Threatening;Required Intervention,Male,25-Sep-2025,11/19/2025,Direct,37,Not Specified,Fda-Ctu,Consumer,Not Specified,-,-,11/19/2025,Not Specified,Not Specified,-,-,-\\n25755184,Humira;Rinvoq;Tylenol;Skyrizi,Risankizumab-Rzaa;Tramadol;Acetaminophen;Upadacitinib;Adalimumab;Herbals\\\\Mitragynine,Abdominal Pain Upper;Anxiety;Crohn\\'s Disease;Pain;Product Used For Unknown Indication,Anal Fistula;Depression;Drug Dependence;Hypersomnia;Suicidal Ideation;Proctalgia;Pain;Faecal Calprotectin Increased;Crohn\\'s Disease;Inflammatory Marker Increased;Abscess;Drainage;Anxiety;Illness;Mental Disorder;Hospitalisation;Rectal Discharge;Fistula;Feeling Of Despair;Fistula Discharge;Drug Ineffective,Serious,Hospitalized;Other Outcomes,Male,Nov-2023,11/21/2025,Expedited,24,79.378 KG,Abbvie,Consumer,Not Specified,Gabapentin;Amjevita;Imodium;Bentyl,11/12/2025,9/3/2025,US,Not Specified,US-ABBVIE-6443000,-,-'"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "## Load Text file for later\n",
    "with open(\"RAW_FAERS_12-5.csv\", \"r\") as text_object:\n",
    "    demo_text = text_object.read()\n",
    "demo_text"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "22267023-8d75-4e37-96be-12dc68848f3b",
   "metadata": {},
   "source": [
    "## Step 3: Covert Text to Table"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "5b5c4ff7-f240-455e-ab37-c1576f4680cb",
   "metadata": {},
   "outputs": [],
   "source": [
    "##import .csv\n",
    "df = pd.read_csv(\"RAW_FAERS_12-5.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "60e5c678-9337-4f3c-b06b-efb8a3260a44",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Shape: (1503, 24)\n",
      "\n",
      "Column names:\n",
      "['Case ID', 'Suspect Product Names', 'Suspect Product Active Ingredients', 'Reason for Use', 'Reactions', 'Serious', 'Outcomes', 'Sex', 'Event Date', 'Latest FDA Received Date', 'Case Priority', 'Patient Age', 'Patient Weight', 'Sender', 'Reporter Type', 'Report Source', 'Concomitant Product Names', 'Latest Manufacturer Received Date', 'Initial FDA Received Date', 'Country where Event occurred', 'Reported to Manufacturer?', 'Manufacturer Control Number', 'Literature Reference', 'Compounded Flag']\n",
      "\n",
      "First 5 rows:\n",
      "   Case ID Suspect Product Names  \\\n",
      "0  6669537                     -   \n",
      "1  6959961                     -   \n",
      "2  7900650          Promethazine   \n",
      "3  8083892           Venlafaxine   \n",
      "4  8121566                     -   \n",
      "\n",
      "                  Suspect Product Active Ingredients  \\\n",
      "0                      Herbals\\Mitragynine;Modafinil   \n",
      "1  Herbals\\Mitragynine;Hydromorphone Hydrochlorid...   \n",
      "2  Promethazine Hydrochloride;Propylhexedrine;Mor...   \n",
      "3  Venlafaxine Hydrochloride;Buprenorphine;Trimep...   \n",
      "4  Trimeprazine Tartrate;Herbals\\Mitragynine;Venl...   \n",
      "\n",
      "                                      Reason for Use  \\\n",
      "0                Drug Withdrawal Syndrome;Somnolence   \n",
      "1  Dependence;Drug Withdrawal Syndrome;Hypervigil...   \n",
      "2                                                  -   \n",
      "3                Product Used For Unknown Indication   \n",
      "4                         Toxicity To Various Agents   \n",
      "\n",
      "                                           Reactions  Serious  \\\n",
      "0  Somnolence;Drug Withdrawal Syndrome;Miosis;Gen...  Serious   \n",
      "1  Incorrect Route Of Product Administration;Drug...  Serious   \n",
      "2    Toxicity To Various Agents;Drug Screen Positive  Serious   \n",
      "3  Overdose;Accidental Death;Brain Oedema;Pulmona...  Serious   \n",
      "4  Pulmonary Congestion;Pulmonary Oedema;Toxicity...  Serious   \n",
      "\n",
      "                      Outcomes   Sex Event Date Latest FDA Received Date  ...  \\\n",
      "0                 Hospitalized  Male          -                 6/3/2008  ...   \n",
      "1  Hospitalized;Other Outcomes  Male          -                 4/3/2009  ...   \n",
      "2          Other Outcomes;Died  Male          -                4/15/2011  ...   \n",
      "3                         Died  Male          -                 8/2/2011  ...   \n",
      "4          Other Outcomes;Died  Male          -                8/24/2011  ...   \n",
      "\n",
      "             Reporter Type                            Report Source  \\\n",
      "0  Healthcare Professional          Health Professional ,Literature   \n",
      "1  Healthcare Professional                      Health Professional   \n",
      "2  Healthcare Professional                      Health Professional   \n",
      "3  Healthcare Professional  Health Professional ,Literature,Foreign   \n",
      "4  Healthcare Professional  Health Professional ,Literature,Foreign   \n",
      "\n",
      "  Concomitant Product Names Latest Manufacturer Received Date  \\\n",
      "0                         -                         5/21/2008   \n",
      "1    Buprenorphine\\Naloxone                         3/30/2009   \n",
      "2                         -                          4/8/2011   \n",
      "3                         -                         7/27/2011   \n",
      "4                         -                          8/9/2011   \n",
      "\n",
      "  Initial FDA Received Date Country where Event occurred  \\\n",
      "0                  6/3/2008                Not Specified   \n",
      "1                  4/3/2009                           US   \n",
      "2                 4/15/2011                           US   \n",
      "3                  8/2/2011                Not Specified   \n",
      "4                 8/24/2011                Not Specified   \n",
      "\n",
      "  Reported to Manufacturer?                   Manufacturer Control Number  \\\n",
      "0             Not Specified                                      US023600   \n",
      "1             Not Specified  US-ROXANE LABORATORIES, INC.-2009-RO-00301RO   \n",
      "2             Not Specified  US-ROXANE LABORATORIES, INC.-2011-RO-00495RO   \n",
      "3             Not Specified                                  2011SP035503   \n",
      "4             Not Specified                                  2011MA011586   \n",
      "\n",
      "  Literature Reference Compounded Flag  \n",
      "0                    -               -  \n",
      "1                    -               -  \n",
      "2                    -               -  \n",
      "3                    -               -  \n",
      "4                    -               -  \n",
      "\n",
      "[5 rows x 24 columns]\n",
      "\n",
      "Initial FDA Received Date sample:\n",
      "0     6/3/2008\n",
      "1     4/3/2009\n",
      "2    4/15/2011\n",
      "3     8/2/2011\n",
      "4    8/24/2011\n",
      "5    8/24/2011\n",
      "6    8/24/2011\n",
      "7    8/24/2011\n",
      "8    8/25/2011\n",
      "9    8/25/2011\n",
      "Name: Initial FDA Received Date, dtype: object\n"
     ]
    }
   ],
   "source": [
    "## make sure all the fields are formatted right\n",
    "\n",
    "print(\"Shape:\", df.shape)\n",
    "print(\"\\nColumn names:\")\n",
    "print(df.columns.tolist())\n",
    "print(\"\\nFirst 5 rows:\")\n",
    "print(df.head())\n",
    "print(\"\\nInitial FDA Received Date sample:\")\n",
    "print(df['Initial FDA Received Date'].head(10))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3e78dace-aa59-4c91-80bf-90d7983ca0f6",
   "metadata": {},
   "source": [
    "## Step 4: Use Pandas to do Quantitative Analysis"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f6166c2b-97ed-45fb-b63c-a253d95fcdec",
   "metadata": {},
   "source": [
    "### Step 4A: Clean Quantitative Fields"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "aa1ed340-c16b-4574-9212-180faaff0289",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " Years: YEAR RECEIVED\n",
      "2008      1\n",
      "2009      1\n",
      "2011      9\n",
      "2014      1\n",
      "2015     10\n",
      "2016     18\n",
      "2017     26\n",
      "2018    217\n",
      "2019    164\n",
      "2020    115\n",
      "2021    127\n",
      "2022    195\n",
      "2023    207\n",
      "2024    207\n",
      "2025    205\n",
      "Name: count, dtype: Int64\n",
      "\n",
      " Age range: 2.0 to 81.0\n",
      "\n",
      " Serious Binary: Serious_Binary\n",
      "1    1401\n",
      "0     102\n",
      "Name: count, dtype: int64\n",
      "\n",
      " Total rows: 1503\n"
     ]
    }
   ],
   "source": [
    "## whoops forgot to import numpy\n",
    "import numpy as np\n",
    "\n",
    "# 1. autodetect format of dates, create year recieved field\n",
    "df['Initial FDA Received Date'] = pd.to_datetime(df['Initial FDA Received Date'], errors='coerce')\n",
    "df['YEAR RECEIVED'] = df['Initial FDA Received Date'].dt.year.astype('Int64')\n",
    "\n",
    "# 2. convert numeric columns and remove errors\n",
    "numeric_cols = ['Patient Age', 'Patient Weight']\n",
    "for col in numeric_cols:\n",
    "    if col in df.columns:\n",
    "        df[col] = pd.to_numeric(df[col], errors='coerce')\n",
    "\n",
    "# 3. clean categorical columns that ill use in quantitative analysis\n",
    "df['Sex'] = df['Sex'].str.strip().replace(['Not Specified', '-', ''], pd.NA)\n",
    "df['Serious'] = df['Serious'].str.strip()\n",
    "\n",
    "# 4. make a binary 'Serious' column for analysis\n",
    "df['Serious_Binary'] = df['Serious'].map({'Serious': 1, 'Non-Serious': 0})\n",
    "\n",
    "# 5.just in case remove any weird ages\n",
    "df.loc[(df['Patient Age'] < 0) | (df['Patient Age'] > 120), 'Patient Age'] = pd.NA\n",
    "\n",
    "# verify all is ok\n",
    "print(\" Years:\", df['YEAR RECEIVED'].value_counts().sort_index())\n",
    "print(\"\\n Age range:\", df['Patient Age'].min(), \"to\", df['Patient Age'].max())\n",
    "print(\"\\n Serious Binary:\", df['Serious_Binary'].value_counts())\n",
    "print(f\"\\n Total rows: {len(df)}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "e6e412c2-6b40-4660-96aa-c4c458484bc8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "               Count    Percent\n",
      "YEAR RECEIVED                  \n",
      "2008               1   0.066534\n",
      "2009               1   0.066534\n",
      "2011               9   0.598802\n",
      "2014               1   0.066534\n",
      "2015              10   0.665336\n",
      "2016              18   1.197605\n",
      "2017              26   1.729874\n",
      "2018             217  14.437791\n",
      "2019             164   10.91151\n",
      "2020             115   7.651364\n",
      "2021             127   8.449767\n",
      "2022             195  12.974052\n",
      "2023             207  13.772455\n",
      "2024             207  13.772455\n",
      "2025             205  13.639388\n"
     ]
    }
   ],
   "source": [
    "\n",
    "year_counts = df['YEAR RECEIVED'].value_counts().sort_index()\n",
    "year_pcts = (year_counts/ len(df)) *100\n",
    "year_summary = pd.DataFrame({\n",
    "    'Count': year_counts,\n",
    "    'Percent': year_pcts\n",
    "})\n",
    "print(year_summary)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "26710d77-2a00-4f63-ba44-160bff78b494",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "36.99761904761905"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Patient Age'].mean()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "716f825e-79f8-4c10-b33c-942a04c3ce1a",
   "metadata": {},
   "source": [
    "<span style=\"color: red; font-size: 24px;\">Average Patient Age</span> \\\n",
    "37"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e7dab85d-0ddd-474a-aae1-976a27ef91e7",
   "metadata": {},
   "source": [
    "<span style=\"color: red; font-size: 24px;\">The last four years of kratom cases make up more than half of all time counts</span> \\\n",
    "Each year between 2022 and 2025 makes up about 13% of all cases reported"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a9da063d-6119-4162-9116-8deaae86b7bc",
   "metadata": {},
   "source": [
    "<span style=\"color: red; font-size: 24px;\">Total case count</span> \\\n",
    "1503 cases all-time \\\n",
    "<span style=\"color: red; font-size: 24px;\">Range of Age in Cases Reported</span> \\\n",
    "Age range: 2.0 to 81.0 \\\n",
    "<span style=\"color: red; font-size: 24px;\">Serious Vs. Non-Serious Cases</span> \\\n",
    "1401 serious, 102 non-serious \\\n",
    "<span style=\"color: red; font-size: 24px;\">Count of Cases by Year</span> \\\n",
    "(2008, 1), (2009, 1), (2011, 9), (2014, 1), (2015, 10), (2016, 18), (2017, 26), (2018, 217), (2019, 164), (2020, 115), (2021, 127), (2022, 195), (2023, 207), (2024, 207), (2025, 205)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "00dc7fc2-780b-4ecd-bd04-4f120b17eef0",
   "metadata": {},
   "outputs": [],
   "source": [
    "## clean qualitative fields and make sure they're read as strings\n",
    "text_columns = ['Reactions', 'Reason for Use', 'Suspect Product Names', 'Concomitant Product Names',\n",
    "                'Suspect Product Active Ingredients', 'Outcomes']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "d1bd1f59-2bda-4d0f-958c-134d93969dc0",
   "metadata": {},
   "outputs": [],
   "source": [
    "## loop through text columns to clean empty/'Not Specified'/'-' fields\n",
    "for col in text_columns:\n",
    "    df[col] = df[col].replace(['-', 'Not Specified', 'Unknown', ''], pd.NA)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9cfd0070-188d-4c9e-8622-0c789d092140",
   "metadata": {},
   "source": [
    "## Step 4B: Serious cases by Year, Serious cases that include \"Herbals/Mitragynine\" vs Serious cases that don't include that \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "b40385ec-55bf-4fdc-9b9f-c53b3a5e52f3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ALL_TIME Serious cases: 93.2%\n"
     ]
    }
   ],
   "source": [
    "serious_pct = (df['Serious_Binary'].sum() / len(df)) * 100\n",
    "print(f\"ALL_TIME Serious cases: {serious_pct:.1f}%\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "d87156df-1479-4d93-ad50-b677ef4bd49e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "               Total_Cases  Serious_Cases  Serious_Rate\n",
      "YEAR RECEIVED                                          \n",
      "2008                     1              1      1.000000\n",
      "2009                     1              1      1.000000\n",
      "2011                     9              9      1.000000\n",
      "2014                     1              1      1.000000\n",
      "2015                    10             10      1.000000\n",
      "2016                    18             18      1.000000\n",
      "2017                    26             25      0.961538\n",
      "2018                   217            202      0.930876\n",
      "2019                   164            151      0.920732\n",
      "2020                   115            112      0.973913\n",
      "2021                   127            119      0.937008\n",
      "2022                   195            182      0.933333\n",
      "2023                   207            190      0.917874\n",
      "2024                   207            192      0.927536\n",
      "2025                   205            188      0.917073\n"
     ]
    }
   ],
   "source": [
    "# Serious cases by year\n",
    "serious_by_year = df.groupby('YEAR RECEIVED')['Serious_Binary'].agg([\n",
    "    ('Total_Cases', 'count'),\n",
    "    ('Serious_Cases', 'sum'),\n",
    "    ('Serious_Rate', 'mean')\n",
    "])\n",
    "print(serious_by_year)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c574bcbf-1381-4916-b595-bf934b7fb53d",
   "metadata": {},
   "source": [
    "<span style=\"color: red; font-size: 24px;\">Serious Cases Don't Vary meaningfully by year</span> "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "1895d56f-42df-4440-b3b9-53e3754d96b8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "734.6153846153845"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "((217-26)/26)*100"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "56ea075c-df08-4487-bd4f-7290bfdec5a7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "YEAR RECEIVED\n",
      "2008     0.066534\n",
      "2009     0.066534\n",
      "2011     0.598802\n",
      "2014     0.066534\n",
      "2015     0.665336\n",
      "2016     1.197605\n",
      "2017     1.729874\n",
      "2018    14.437791\n",
      "2019     10.91151\n",
      "2020     7.651364\n",
      "2021     8.449767\n",
      "2022    12.974052\n",
      "2023    13.772455\n",
      "2024    13.772455\n",
      "2025    13.639388\n",
      "Name: proportion, dtype: Float64\n"
     ]
    }
   ],
   "source": [
    "print(df['YEAR RECEIVED'].value_counts(normalize=True).sort_index() * 100)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0306e76f-b34b-450d-a7a5-33a1a4f915a5",
   "metadata": {},
   "source": [
    "<span style=\"color: red; font-size: 24px;\">Between 2016 and 2018, 734% jump in cases reported</span> \\\n",
    "This was the period where the FDA failed to ban kratom products"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "97df241c-989e-451d-bbba-ee7f68d83914",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Serious_Binary\n",
      "0    37.574074\n",
      "1    36.971808\n",
      "Name: Patient Age, dtype: float64\n"
     ]
    }
   ],
   "source": [
    "print(df.groupby('Serious_Binary')['Patient Age'].mean())"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "040601f9-3819-4578-b056-3097a145eef0",
   "metadata": {},
   "source": [
    "<span style=\"color: red; font-size: 24px;\">There is no direct correlation between serious cases and age</span> "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3a62b2ce-e5d9-4fdf-8c51-dfdfd64d0870",
   "metadata": {},
   "source": [
    "## Step 5: Using Regex extraction, custom functions, fuzzy matching, spaCy NER for Qualitative Data\n",
    "\n",
    "1. Create functions to clean\n",
    "2. Create keyword lists for each analysis goal\n",
    "3. Regex extraction for patterns that my keywords cant capture\n",
    "4. spaCy for NER\n",
    "5. fuzzy matching as supplement if there are incomplete/innacurrate entries\n",
    "6. Run quant analysis to find:\n",
    "\n",
    "<b> Kratom vs. derivatives, other drug use:</b>\n",
    "\n",
    "    - top 20 most co-used drugs (group by category (opioid / benzo / SSRI / stimulant)\n",
    "    - incidence of cases including only kratom (Herbals/mitragynine)\n",
    "    - incidence of cases including kratom derivatives\n",
    "    - incidence of cases using all three\n",
    "    - time trends\n",
    "\n",
    "<b>For reactions:</b>\n",
    "\n",
    "    - most common adverse events\n",
    "\n",
    "    - grouped categories (neurologic, hepatic, cardiovascular)\n",
    "\n",
    "<b>For reasons for use:</b>\n",
    "\n",
    "    - self-treatment for opioid withdrawal\n",
    "\n",
    "    - pain management\n",
    "\n",
    "    - anxiety / depression\n",
    "\n",
    "    - recreational\n",
    "\n",
    "<b>For outcomes:</b>\n",
    "\n",
    "    - hospitalization\n",
    "\n",
    "    - ICU\n",
    "    - death\n",
    "    - continuing substance use disorder\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1aeb8718-f8da-446f-ab37-290d28fac5e6",
   "metadata": {},
   "source": [
    "## Step 5A: Further clean and combine \n",
    "-Since Suspect Product Names, Concomitant Product Names, and Suspect Product Active Ingredients all tell me the same thing (what products are included in the case exposure) and each separate entry varies by entrant/how they listed out substances, combine all into one column call \"All_substances\" \\\n",
    "-This will let me run regex and spaCy only once per row instead of 3x \n",
    "   "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "857528a9-d60c-4509-818c-e690ae0e949a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Reactions',\n",
       " 'Reason for Use',\n",
       " 'Suspect Product Names',\n",
       " 'Concomitant Product Names',\n",
       " 'Suspect Product Active Ingredients',\n",
       " 'Outcomes']"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text_columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "0c8e81ab-f5d9-4a22-a5a2-85683df24d29",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0                   |  | Herbals\\Mitragynine;Modafinil\n",
      "1     | Buprenorphine\\Naloxone | Herbals\\Mitragynin...\n",
      "2    Promethazine |  | Promethazine Hydrochloride;P...\n",
      "3    Venlafaxine |  | Venlafaxine Hydrochloride;Bup...\n",
      "4     |  | Trimeprazine Tartrate;Herbals\\Mitragynin...\n",
      "Name: All_Products, dtype: object\n"
     ]
    }
   ],
   "source": [
    "##merge columns into one using pipe separator so we can still see the diff columns, clean\n",
    "cols_to_merge = ['Suspect Product Names','Concomitant Product Names','Suspect Product Active Ingredients']\n",
    "\n",
    "df['All_Products'] = df[cols_to_merge].fillna('').astype(str).agg(' | '.join, axis=1)\n",
    "\n",
    "# Check result\n",
    "print(df['All_Products'].head())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "6724ec09-038d-40fe-bb04-5c1e4407d719",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0                        Herbals\\Mitragynine;Modafinil\n",
      "1    Buprenorphine\\Naloxone | Herbals\\Mitragynine;H...\n",
      "2    Promethazine | Promethazine Hydrochloride;Prop...\n",
      "3    Venlafaxine | Venlafaxine Hydrochloride;Bupren...\n",
      "4    Trimeprazine Tartrate;Herbals\\Mitragynine;Venl...\n",
      "Name: All_Products_Clean, dtype: object\n"
     ]
    }
   ],
   "source": [
    "##make an even cleaner column without NAs. keep old just in case\n",
    "df['All_Products_Clean'] = df[cols_to_merge].apply(\n",
    "    lambda x: ' | '.join([str(val).strip() for val in x if pd.notna(val) and str(val).strip() not in ['nan', '', 'None', '<NA>', '| <NA> |', '<NA> |']]), \n",
    "    axis=1\n",
    ")\n",
    "df['All_Products_Clean'] = df['All_Products_Clean'].str.replace(r'\\s*\\|\\s*\\|\\s*', ' | ', regex=True)\n",
    "df['All_Products_Clean'] = df['All_Products_Clean'].str.strip(' | ')\n",
    "\n",
    "print(df['All_Products_Clean'].head())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "f4484dbf-d66d-4bce-a05e-1bc84849351c",
   "metadata": {},
   "outputs": [],
   "source": [
    "combined_text_cols = ['Reactions','Reason for Use','Outcomes', 'All_Products_Clean']"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6ca035ee-91db-46af-870a-678da6e05468",
   "metadata": {},
   "source": [
    "<span style=\"background-color: lightblue; padding: 5px;\"><b>*I Used ChatGPT To help me find/group/edit my keyword list for drugs, reactions, etc. below:*</b></span>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "b4f90678-e039-42b0-8d2f-7118c4cf3735",
   "metadata": {
    "jupyter": {
     "source_hidden": true
    }
   },
   "outputs": [],
   "source": [
    "##name the products that I care about comparing/searching for\n",
    "##NOTE: obviously there is overlap btw pharm and street drugs of abuse\n",
    "k_kratom = ['Herbals/Mitragynine', 'Kratom', 'Mitragyna Speciosa']\n",
    "k_sevenOH = ['7-Hydroxymitragynine', '7-OH-Mitragynine', '7-hydroxymitragynine']\n",
    "k_pseudo =['Mitragynine Pseudoindoxyl']\n",
    "pharm_opiods = ['Fentanyl Citrate','Loperamide','Buprenorphine', 'Buprenorphine Hydrochloride/Naloxone Hydrochloride', 'Buprenorphine Hydrochloride', 'Codeine', 'Methadone', 'Hydrocodone', 'Hydromorphone', 'Butorphanol', 'Meperidine','Demerol','Vicodin','Dolophine','Methadose','Dilaudid','Exalgo','OxyContin','Percocet','Percodan','Opana','Oxymorphone','Pentazocine','Talwin','Tapentadol','Nucynta','Tramadol','Morphine', 'Morphine Sulfate', 'MS Contin', 'Kadian', 'Oxycodone', 'Roxicodone','Suboxone','Subutex','Sufentanil', 'Alfentanil', 'Remifentanil','Levorphanol']\n",
    "st_opioids = ['Heroin', 'Fentanyl', 'Carfentanil', 'Diamorphine', 'Acetylfentanyl', 'Furanylfentanyl', 'U-47700', 'Pink', 'Gray Death','Opium']\n",
    "pharm_stimulants = ['Dextroamphetamine', 'Dexedrine', 'Dexamphetamine','Amphetamine', 'Adderall', 'Amphetamine/dextroamphetamine','Methylphenidate','Lisdexamfetamine', 'Modafinil', 'Ephedrine', 'Armodafinil', 'Ritalin', 'Concerta', 'Focalin', 'Vyvanse', 'Phentermine', 'Pseudoephedrine', 'Provigil', 'Nuvigil', 'Desoxyn','Benzphetamine', 'Diethylpropion', 'Phendimetrazine']\n",
    "st_stimulants =['Cocaine', 'Methamphetamine', 'Speed', 'Crack', 'Crack cocaine', 'Meth']\n",
    "benzos = [\n",
    "    'Alprazolam', 'Xanax',\n",
    "    'Lorazepam', 'Ativan',\n",
    "    'Clonazepam', 'Klonopin',\n",
    "    'Diazepam', 'Valium',\n",
    "    'Temazepam', 'Restoril',\n",
    "    'Oxazepam', 'Serax',\n",
    "    'Chlordiazepoxide', 'Librium',\n",
    "    'Clorazepate', 'Tranxene',\n",
    "    'Midazolam', 'Versed',\n",
    "    'Triazolam', 'Halcion',\n",
    "    'Flurazepam', 'Dalmane',\n",
    "    'Estazolam', 'ProSom'\n",
    "]\n",
    "anxiety_other = [\n",
    "    'Buspirone', 'Buspar', \n",
    "    'Hydroxyzine', 'Vistaril', 'Atarax',  \n",
    "    'Propranolol', 'Inderal',  \n",
    "    'Gabapentin', 'Neurontin',  \n",
    "    'Pregabalin', 'Lyrica' ]\n",
    "plant_rec =['Psilocybin', 'Psilocybin mushrooms', 'DMT', 'N,N-Dimethyltryptamine', 'Mescaline', 'Mushrooms','Cannabis Sativa Flowering Top', 'Cannabis', 'Cannabis Sativa Subsp. Indica Top', 'Marijuana', 'THC', 'Tetrahydrocannabinol', 'CBD', 'Cannabidiol','Ayahuasca', 'Peyote', 'San Pedro','Salvia', 'Salvia Divinorum','Khat', 'Cathinone']\n",
    "abuse_other = ['MDMA', 'Molly', 'Ecstasy',  'LSD', 'D-Lysergic Acid Diethylamide', 'Acid', 'Gamma-Hydroxybutyric','Ketamine', 'Esketamine','Phencyclidine', 'PCP', 'Synthetic Cathinones',  'GHB', 'Gamma-Hydroxybutyrate','Bath Salts', 'Flakka', 'Alpha-PVP', 'Spice', 'K2', 'JWH-018', '2C-B', '2C-I', '2C-E','NBOMe', '25I-NBOMe','MXE', 'Methoxetamine','Dextromethorphan']\n",
    "alcohol = ['Alcohol', 'Ethanol', 'Ethyl Alcohol']\n",
    "\n",
    "##look for drugs that can interact with serotonin recpetors (like kratom) can cause serotonin syndrome\n",
    "serotonergic_antidepressants = ['Fluoxetine', 'Prozac',\n",
    "    'Sertraline', 'Zoloft',\n",
    "    'Paroxetine', 'Paxil',\n",
    "    'Citalopram', 'Celexa',\n",
    "    'Escitalopram', 'Lexapro',\n",
    "    'Fluvoxamine', 'Luvox',\n",
    "    'Vilazodone', 'Viibryd',\n",
    "    \n",
    "    # SNRIs\n",
    "    'Venlafaxine', 'Effexor',\n",
    "    'Duloxetine', 'Cymbalta',\n",
    "    'Desvenlafaxine', 'Pristiq',\n",
    "    'Levomilnacipran', 'Fetzima',\n",
    "    'Milnacipran', 'Savella',\n",
    "    \n",
    "    # Tricyclics (affect serotonin + norepinephrine)\n",
    "    'Amitriptyline', 'Elavil',\n",
    "    'Nortriptyline', 'Pamelor',\n",
    "    'Imipramine', 'Tofranil',\n",
    "    'Desipramine', 'Norpramin',\n",
    "    'Doxepin', 'Sinequan',\n",
    "    'Clomipramine', 'Anafranil',\n",
    "    'Trimipramine', 'Surmontil',\n",
    "    'Protriptyline', 'Vivactil',\n",
    "    'Amoxapine', 'Asendin',\n",
    "    \n",
    "    # MAOIs (affect serotonin + others)\n",
    "    'Phenelzine', 'Nardil',\n",
    "    'Tranylcypromine', 'Parnate',\n",
    "    'Isocarboxazid', 'Marplan',\n",
    "    'Selegiline', 'Emsam',\n",
    "    \n",
    "    # Serotonergic Atypicals\n",
    "    'Trazodone', 'Desyrel',  # SARI\n",
    "    'Nefazodone', 'Serzone',  # SARI\n",
    "    'Vortioxetine', 'Trintellix',  # Multimodal serotonin\n",
    "    'Mirtazapine', 'Remeron'  # Also affects serotonin\n",
    "]\n",
    "\n",
    "# BIPOLAR & SCHIZOPHRENIA MEDS (Combined)\n",
    "bipolar_schizo_meds = [\n",
    "    # Mood Stabilizers\n",
    "    'Lithium', 'Lithobid', 'Eskalith',\n",
    "    'Valproic Acid', 'Valproate', 'Divalproex', 'Depakote', 'Depakene',\n",
    "    'Carbamazepine', 'Tegretol', 'Equetro',\n",
    "    'Lamotrigine', 'Lamictal',\n",
    "    'Oxcarbazepine', 'Trileptal',\n",
    "    'Topiramate', 'Topamax',\n",
    "    \n",
    "    # Typical (First-generation) Antipsychotics\n",
    "    'Haloperidol', 'Haldol',\n",
    "    'Chlorpromazine', 'Thorazine',\n",
    "    'Fluphenazine', 'Prolixin',\n",
    "    'Perphenazine', 'Trilafon',\n",
    "    'Thioridazine', 'Mellaril',\n",
    "    'Trifluoperazine', 'Stelazine',\n",
    "    'Thiothixene', 'Navane',\n",
    "    'Loxapine', 'Loxitane',\n",
    "    'Molindone', 'Moban',\n",
    "    'Pimozide', 'Orap',\n",
    "    \n",
    "    # Atypical (Second-generation) Antipsychotics\n",
    "    'Clozapine', 'Clozaril',\n",
    "    'Risperidone', 'Risperdal',\n",
    "    'Olanzapine', 'Zyprexa',\n",
    "    'Quetiapine', 'Seroquel',\n",
    "    'Ziprasidone', 'Geodon',\n",
    "    'Aripiprazole', 'Abilify',\n",
    "    'Paliperidone', 'Invega',\n",
    "    'Iloperidone', 'Fanapt',\n",
    "    'Asenapine', 'Saphris',\n",
    "    'Lurasidone', 'Latuda',\n",
    "    'Brexpiprazole', 'Rexulti',\n",
    "    'Cariprazine', 'Vraylar',\n",
    "    'Lumateperone', 'Caplyta',\n",
    "    'Pimavanserin', 'Nuplazid'\n",
    "]\n",
    "\n",
    "# NON-SEROTONERGIC ANTIDEPRESSANTS (don't primarily work on serotonin)\n",
    "non_serotonergic_antidepressants = [\n",
    "    'Bupropion', 'Wellbutrin', 'Zyban',  # NDRI (dopamine/norepinephrine)\n",
    "    'Brexanolone', 'Zulresso',  # GABA modulator\n",
    "    'Esketamine', 'Spravato'  # NMDA receptor antagonist (if you want to include this)\n",
    "]\n",
    "sleep_meds = [\n",
    "    'Zolpidem', 'Ambien',\n",
    "    'Eszopiclone', 'Lunesta',\n",
    "    'Zaleplon', 'Sonata',\n",
    "    'Ramelteon', 'Rozerem',\n",
    "    'Suvorexant', 'Belsomra',\n",
    "    'Lemborexant', 'Dayvigo',\n",
    "    'Doxepin', 'Silenor',  # Low-dose TCA for sleep\n",
    "    'Trazodone'  # Off-label for sleep\n",
    "]\n",
    "\n",
    "drug_cats = [sleep_meds, k_kratom, k_sevenOH, k_pseudo, pharm_opiods, st_opioids, pharm_stimulants, st_stimulants, benzos, non_serotonergic_antidepressants, bipolar_schizo_meds, serotonergic_antidepressants, alcohol, plant_rec, abuse_other, anxiety_other]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "3cbf3a21-b8b9-4088-bb46-0391e1e3492b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Case ID</th>\n",
       "      <th>Suspect Product Names</th>\n",
       "      <th>Suspect Product Active Ingredients</th>\n",
       "      <th>Reason for Use</th>\n",
       "      <th>Reactions</th>\n",
       "      <th>Serious</th>\n",
       "      <th>Outcomes</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Event Date</th>\n",
       "      <th>Latest FDA Received Date</th>\n",
       "      <th>...</th>\n",
       "      <th>Initial FDA Received Date</th>\n",
       "      <th>Country where Event occurred</th>\n",
       "      <th>Reported to Manufacturer?</th>\n",
       "      <th>Manufacturer Control Number</th>\n",
       "      <th>Literature Reference</th>\n",
       "      <th>Compounded Flag</th>\n",
       "      <th>YEAR RECEIVED</th>\n",
       "      <th>Serious_Binary</th>\n",
       "      <th>All_Products</th>\n",
       "      <th>All_Products_Clean</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>6669537</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Herbals\\Mitragynine;Modafinil</td>\n",
       "      <td>Drug Withdrawal Syndrome;Somnolence</td>\n",
       "      <td>Somnolence;Drug Withdrawal Syndrome;Miosis;Gen...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Hospitalized</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>6/3/2008</td>\n",
       "      <td>...</td>\n",
       "      <td>2008-06-03</td>\n",
       "      <td>Not Specified</td>\n",
       "      <td>Not Specified</td>\n",
       "      <td>US023600</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>2008</td>\n",
       "      <td>1</td>\n",
       "      <td>|  | Herbals\\Mitragynine;Modafinil</td>\n",
       "      <td>Herbals\\Mitragynine;Modafinil</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>6959961</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Herbals\\Mitragynine;Hydromorphone Hydrochlorid...</td>\n",
       "      <td>Dependence;Drug Withdrawal Syndrome;Hypervigil...</td>\n",
       "      <td>Incorrect Route Of Product Administration;Drug...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Hospitalized;Other Outcomes</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>4/3/2009</td>\n",
       "      <td>...</td>\n",
       "      <td>2009-04-03</td>\n",
       "      <td>US</td>\n",
       "      <td>Not Specified</td>\n",
       "      <td>US-ROXANE LABORATORIES, INC.-2009-RO-00301RO</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>2009</td>\n",
       "      <td>1</td>\n",
       "      <td>| Buprenorphine\\Naloxone | Herbals\\Mitragynin...</td>\n",
       "      <td>Buprenorphine\\Naloxone | Herbals\\Mitragynine;H...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7900650</td>\n",
       "      <td>Promethazine</td>\n",
       "      <td>Promethazine Hydrochloride;Propylhexedrine;Mor...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Toxicity To Various Agents;Drug Screen Positive</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Other Outcomes;Died</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>4/15/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>2011-04-15</td>\n",
       "      <td>US</td>\n",
       "      <td>Not Specified</td>\n",
       "      <td>US-ROXANE LABORATORIES, INC.-2011-RO-00495RO</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>2011</td>\n",
       "      <td>1</td>\n",
       "      <td>Promethazine |  | Promethazine Hydrochloride;P...</td>\n",
       "      <td>Promethazine | Promethazine Hydrochloride;Prop...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3 rows  28 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   Case ID Suspect Product Names  \\\n",
       "0  6669537                  <NA>   \n",
       "1  6959961                  <NA>   \n",
       "2  7900650          Promethazine   \n",
       "\n",
       "                  Suspect Product Active Ingredients  \\\n",
       "0                      Herbals\\Mitragynine;Modafinil   \n",
       "1  Herbals\\Mitragynine;Hydromorphone Hydrochlorid...   \n",
       "2  Promethazine Hydrochloride;Propylhexedrine;Mor...   \n",
       "\n",
       "                                      Reason for Use  \\\n",
       "0                Drug Withdrawal Syndrome;Somnolence   \n",
       "1  Dependence;Drug Withdrawal Syndrome;Hypervigil...   \n",
       "2                                               <NA>   \n",
       "\n",
       "                                           Reactions  Serious  \\\n",
       "0  Somnolence;Drug Withdrawal Syndrome;Miosis;Gen...  Serious   \n",
       "1  Incorrect Route Of Product Administration;Drug...  Serious   \n",
       "2    Toxicity To Various Agents;Drug Screen Positive  Serious   \n",
       "\n",
       "                      Outcomes   Sex Event Date Latest FDA Received Date  ...  \\\n",
       "0                 Hospitalized  Male          -                 6/3/2008  ...   \n",
       "1  Hospitalized;Other Outcomes  Male          -                 4/3/2009  ...   \n",
       "2          Other Outcomes;Died  Male          -                4/15/2011  ...   \n",
       "\n",
       "  Initial FDA Received Date  Country where Event occurred  \\\n",
       "0                2008-06-03                 Not Specified   \n",
       "1                2009-04-03                            US   \n",
       "2                2011-04-15                            US   \n",
       "\n",
       "   Reported to Manufacturer?                   Manufacturer Control Number  \\\n",
       "0              Not Specified                                      US023600   \n",
       "1              Not Specified  US-ROXANE LABORATORIES, INC.-2009-RO-00301RO   \n",
       "2              Not Specified  US-ROXANE LABORATORIES, INC.-2011-RO-00495RO   \n",
       "\n",
       "  Literature Reference Compounded Flag YEAR RECEIVED Serious_Binary  \\\n",
       "0                    -               -          2008              1   \n",
       "1                    -               -          2009              1   \n",
       "2                    -               -          2011              1   \n",
       "\n",
       "                                        All_Products  \\\n",
       "0                 |  | Herbals\\Mitragynine;Modafinil   \n",
       "1   | Buprenorphine\\Naloxone | Herbals\\Mitragynin...   \n",
       "2  Promethazine |  | Promethazine Hydrochloride;P...   \n",
       "\n",
       "                                  All_Products_Clean  \n",
       "0                      Herbals\\Mitragynine;Modafinil  \n",
       "1  Buprenorphine\\Naloxone | Herbals\\Mitragynine;H...  \n",
       "2  Promethazine | Promethazine Hydrochloride;Prop...  \n",
       "\n",
       "[3 rows x 28 columns]"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "266ee0cb-f677-4cff-a2cb-4c52863645d2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Reactions',\n",
       " 'Reason for Use',\n",
       " 'Suspect Product Names',\n",
       " 'Concomitant Product Names',\n",
       " 'Suspect Product Active Ingredients',\n",
       " 'Outcomes']"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text_columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "dcd28be3-6904-4e84-b6df-2b8a1a87ecde",
   "metadata": {},
   "outputs": [],
   "source": [
    "drug_cats = [sleep_meds, k_kratom, k_sevenOH, k_pseudo, pharm_opiods, st_opioids, pharm_stimulants, st_stimulants, benzos, \\\n",
    "             non_serotonergic_antidepressants, bipolar_schizo_meds, serotonergic_antidepressants, alcohol, plant_rec, abuse_other, anxiety_other]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "31d61168-831d-493d-a7b2-6fce6115aae3",
   "metadata": {},
   "outputs": [],
   "source": [
    "## make dictionary\n",
    "drug_cat_dict = {\n",
    "    'kratom': k_kratom,\n",
    "    '7O': k_sevenOH,\n",
    "    'pseuomit' : k_pseudo,\n",
    "    'street_opioids': st_opioids,\n",
    "    'pharm_opioids': pharm_opiods,\n",
    "    'street_stimulants': st_stimulants,\n",
    "    'pharm_stimulants': pharm_stimulants,\n",
    "    'benzos': benzos,\n",
    "    'alcohol': alcohol,\n",
    "    'plant_rec': plant_rec,\n",
    "    'bipolar_schizo': bipolar_schizo_meds,\n",
    "    'serotonergic_antidep': serotonergic_antidepressants,\n",
    "    'non_serotonergic_antidep': non_serotonergic_antidepressants,\n",
    "    'non_benzo_anxiety': anxiety_other,\n",
    "    'misc_drugs_abuse': abuse_other,\n",
    "    'sleep' :sleep_meds\n",
    "    \n",
    "}"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a69b232b-efb6-49dd-bf5e-2972d4904516",
   "metadata": {},
   "source": [
    "## Step 5B: Create Custom Pandas Functions for Searching Cases\n",
    "Which categories of other drugs are most commonly used alongside kratom?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "1d5901f4-a9f4-4979-b2c2-1f81c8dc36ff",
   "metadata": {},
   "outputs": [],
   "source": [
    "##create my drug category checker\n",
    "def check_drug_category(text, drug_list):\n",
    "    \"\"\"Check if any drug from the list is in the text\"\"\"\n",
    "    if pd.isna(text):\n",
    "        return False\n",
    "    text_lower = str(text).lower()\n",
    "    return any(drug.lower() in text_lower for drug in drug_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "32586e8a-d678-4508-8e1a-a535d73878d5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "has_serotonergic_antidep        390\n",
      "has_pharm_opioids               306\n",
      "has_bipolar_schizo              223\n",
      "has_benzos                      197\n",
      "has_street_opioids              193\n",
      "has_non_benzo_anxiety           171\n",
      "has_street_stimulants           137\n",
      "has_non_serotonergic_antidep    113\n",
      "has_sleep                        86\n",
      "has_pharm_stimulants             83\n",
      "has_misc_drugs_abuse             71\n",
      "has_alcohol                      68\n",
      "has_7O                           55\n",
      "has_plant_rec                    49\n",
      "has_pseuomit                      2\n",
      "has_kratom                        0\n",
      "dtype: int64\n",
      "has_serotonergic_antidep        0.259481\n",
      "has_pharm_opioids               0.203593\n",
      "has_bipolar_schizo              0.148370\n",
      "has_benzos                      0.131071\n",
      "has_street_opioids              0.128410\n",
      "has_non_benzo_anxiety           0.113772\n",
      "has_street_stimulants           0.091151\n",
      "has_non_serotonergic_antidep    0.075183\n",
      "has_sleep                       0.057219\n",
      "has_pharm_stimulants            0.055223\n",
      "has_misc_drugs_abuse            0.047239\n",
      "has_alcohol                     0.045243\n",
      "has_7O                          0.036593\n",
      "has_plant_rec                   0.032601\n",
      "has_pseuomit                    0.001331\n",
      "has_kratom                      0.000000\n",
      "dtype: float64\n"
     ]
    }
   ],
   "source": [
    "## apply it to all my drug categories and the all_products column\n",
    "for category_name, drug_list in drug_cat_dict.items():\n",
    "    df[f'has_{category_name}'] = df['All_Products_Clean'].apply(\n",
    "        lambda x: check_drug_category(x, drug_list)\n",
    "    )\n",
    "\n",
    "# View all cases by type of co-used drug category\n",
    "category_columns = [col for col in df.columns if col.startswith('has_')]\n",
    "case_drugcat_incidence = df[category_columns].sum().sort_values(ascending=False)\n",
    "pct_drugcat = case_drugcat_incidence/1503\n",
    "print(df[category_columns].sum().sort_values(ascending=False))\n",
    "print(pct_drugcat)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "28cf8876-246e-452a-a754-03b686494a40",
   "metadata": {},
   "source": [
    "<span style=\"color: red; font-size: 24px;\">25% of cases included serotonergic antidepressants, 20% included pharm opioids, 15% included bipolar/schizophrenic disorder meds</span> "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "643d95f1-e439-4651-a5d4-c0c2e1155981",
   "metadata": {},
   "source": [
    "## Step 5C: Move to Text Analysis, Create Regex Functions for top drug categories & top individual drugs,and run kratom variant comparison"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "73564714-c319-473e-9bbd-503e86a04128",
   "metadata": {},
   "outputs": [],
   "source": [
    "from collections import Counter\n",
    "import re"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "b6f099ea-6d7a-4bb0-820f-8fc8156fcc63",
   "metadata": {},
   "outputs": [],
   "source": [
    "#I've already run:\n",
    "##back to SpaCy doc\n",
    "#doc =nlp(demo_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "3717dfbf-298e-44d1-8f98-69054e0187fd",
   "metadata": {},
   "outputs": [],
   "source": [
    "##make general regex function: takes text, applies regex pattern, returns all matches, returns [] if no text\n",
    "def regex_extract(text, pattern):\n",
    "    if pd.isna(text):\n",
    "        return []\n",
    "    regex = re.compile(pattern, flags=re.IGNORECASE)\n",
    "    return regex.findall(text)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "6ff5159c-c52a-4e20-bc8f-d635c67d8357",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Reactions', 'Reason for Use', 'Outcomes', 'All_Products_Clean']"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "combined_text_cols"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "4459899f-27a5-462d-ba17-599cde253341",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "   Case ID Suspect Product Names  \\\n",
      "0  6669537                  <NA>   \n",
      "1  6959961                  <NA>   \n",
      "2  7900650          Promethazine   \n",
      "3  8083892           Venlafaxine   \n",
      "4  8121566                  <NA>   \n",
      "\n",
      "                  Suspect Product Active Ingredients  \\\n",
      "0                      Herbals\\Mitragynine;Modafinil   \n",
      "1  Herbals\\Mitragynine;Hydromorphone Hydrochlorid...   \n",
      "2  Promethazine Hydrochloride;Propylhexedrine;Mor...   \n",
      "3  Venlafaxine Hydrochloride;Buprenorphine;Trimep...   \n",
      "4  Trimeprazine Tartrate;Herbals\\Mitragynine;Venl...   \n",
      "\n",
      "                                      Reason for Use  \\\n",
      "0                Drug Withdrawal Syndrome;Somnolence   \n",
      "1  Dependence;Drug Withdrawal Syndrome;Hypervigil...   \n",
      "2                                               <NA>   \n",
      "3                Product Used For Unknown Indication   \n",
      "4                         Toxicity To Various Agents   \n",
      "\n",
      "                                           Reactions  Serious  \\\n",
      "0  Somnolence;Drug Withdrawal Syndrome;Miosis;Gen...  Serious   \n",
      "1  Incorrect Route Of Product Administration;Drug...  Serious   \n",
      "2    Toxicity To Various Agents;Drug Screen Positive  Serious   \n",
      "3  Overdose;Accidental Death;Brain Oedema;Pulmona...  Serious   \n",
      "4  Pulmonary Congestion;Pulmonary Oedema;Toxicity...  Serious   \n",
      "\n",
      "                      Outcomes   Sex Event Date Latest FDA Received Date  ...  \\\n",
      "0                 Hospitalized  Male          -                 6/3/2008  ...   \n",
      "1  Hospitalized;Other Outcomes  Male          -                 4/3/2009  ...   \n",
      "2          Other Outcomes;Died  Male          -                4/15/2011  ...   \n",
      "3                         Died  Male          -                 8/2/2011  ...   \n",
      "4          Other Outcomes;Died  Male          -                8/24/2011  ...   \n",
      "\n",
      "  has_misc_drugs_abuse  has_sleep  \\\n",
      "0                False      False   \n",
      "1                False      False   \n",
      "2                False      False   \n",
      "3                False      False   \n",
      "4                False      False   \n",
      "\n",
      "                             All_Products_Clean_List  \\\n",
      "0                    [Herbals\\Mitragynine;Modafinil]   \n",
      "1  [Buprenorphine\\Naloxone, Herbals\\Mitragynine;H...   \n",
      "2  [Promethazine, Promethazine Hydrochloride;Prop...   \n",
      "3  [Venlafaxine, Venlafaxine Hydrochloride;Bupren...   \n",
      "4  [Trimeprazine Tartrate;Herbals\\Mitragynine;Ven...   \n",
      "\n",
      "                          All_Products_Clean_Cleaned  \\\n",
      "0                      Herbals\\Mitragynine;Modafinil   \n",
      "1  Buprenorphine\\Naloxone | Herbals\\Mitragynine;H...   \n",
      "2  Promethazine | Promethazine Hydrochloride;Prop...   \n",
      "3  Venlafaxine | Venlafaxine Hydrochloride;Bupren...   \n",
      "4  Trimeprazine Tartrate;Herbals\\Mitragynine;Venl...   \n",
      "\n",
      "                                 Reason for Use_List  \\\n",
      "0              [Drug Withdrawal Syndrome;Somnolence]   \n",
      "1  [Dependence;Drug Withdrawal Syndrome;Hypervigi...   \n",
      "2                                                 []   \n",
      "3              [Product Used For Unknown Indication]   \n",
      "4                       [Toxicity To Various Agents]   \n",
      "\n",
      "                              Reason for Use_Cleaned  \\\n",
      "0                Drug Withdrawal Syndrome;Somnolence   \n",
      "1  Dependence;Drug Withdrawal Syndrome;Hypervigil...   \n",
      "2                                                      \n",
      "3                Product Used For Unknown Indication   \n",
      "4                         Toxicity To Various Agents   \n",
      "\n",
      "                   Outcomes_List             Outcomes_Cleaned  \\\n",
      "0                 [Hospitalized]                 Hospitalized   \n",
      "1  [Hospitalized;Other Outcomes]  Hospitalized;Other Outcomes   \n",
      "2          [Other Outcomes;Died]          Other Outcomes;Died   \n",
      "3                         [Died]                         Died   \n",
      "4          [Other Outcomes;Died]          Other Outcomes;Died   \n",
      "\n",
      "                                      Reactions_List  \\\n",
      "0  [Somnolence;Drug Withdrawal Syndrome;Miosis;Ge...   \n",
      "1  [Incorrect Route Of Product Administration;Dru...   \n",
      "2  [Toxicity To Various Agents;Drug Screen Positive]   \n",
      "3  [Overdose;Accidental Death;Brain Oedema;Pulmon...   \n",
      "4  [Pulmonary Congestion;Pulmonary Oedema;Toxicit...   \n",
      "\n",
      "                                   Reactions_Cleaned  \n",
      "0  Somnolence;Drug Withdrawal Syndrome;Miosis;Gen...  \n",
      "1  Incorrect Route Of Product Administration;Drug...  \n",
      "2    Toxicity To Various Agents;Drug Screen Positive  \n",
      "3  Overdose;Accidental Death;Brain Oedema;Pulmona...  \n",
      "4  Pulmonary Congestion;Pulmonary Oedema;Toxicity...  \n",
      "\n",
      "[5 rows x 52 columns]\n"
     ]
    }
   ],
   "source": [
    "## need to make sure i remove duplicates\n",
    "\n",
    "def clean_list(lst):\n",
    "    ''' \n",
    "    Loop through every item in list, remove leading/trailing white spaces from each string, \n",
    "    include the value if its not empty after stripping whitespace, create new list of clean stripped strings without empty spaces\n",
    "    AND removes duplicates (key)\n",
    "    '''\n",
    "    return sorted(set([x.strip() for x in lst if x.strip() != \"\"])) \n",
    "\n",
    "\n",
    "##run it on my all_products clean and on reactions, reasons for use\n",
    "cols_to_clean = [\"All_Products_Clean\", \"Reason for Use\", \"Outcomes\", \"Reactions\"]\n",
    "\n",
    "for col in cols_to_clean:\n",
    "    df[col + \"_List\"] = df[col].apply(lambda x: clean_list(str(x).split(\" | \")) if pd.notna(x) else [])\n",
    "    df[col + \"_Cleaned\"] = df[col + \"_List\"].apply(lambda lst: \" | \".join(lst))\n",
    "\n",
    "df.to_csv(\"Cleaned_NewCols_FAERS.csv\")\n",
    "print(df.head(5))\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "80185c16-ca8c-42e6-80b7-3b10deb5c44d",
   "metadata": {},
   "source": [
    "### Find All reactions "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "4aa6b9c3-511e-48e9-8e34-05b9eedef761",
   "metadata": {},
   "outputs": [],
   "source": [
    "all_reactions = []\n",
    "\n",
    "for text in df[\"Reactions\"].dropna():\n",
    "    all_reactions.extend(regex_extract(text, r\"[A-Za-z]{6,}\"))\n",
    "\n",
    "    \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "3d99d587-1351-47e5-8488-282306fbfba5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('Toxicity', 331),\n",
       " ('Syndrome', 329),\n",
       " ('Various', 320),\n",
       " ('Agents', 320),\n",
       " ('Dependence', 243),\n",
       " ('Product', 210),\n",
       " ('Withdrawal', 202),\n",
       " ('Interaction', 201),\n",
       " ('Disorder', 159),\n",
       " ('Overdose', 125),\n",
       " ('Arrest', 118),\n",
       " ('Seizure', 115),\n",
       " ('Serotonin', 101),\n",
       " ('Increased', 88),\n",
       " ('Accidental', 88),\n",
       " ('Respiratory', 88),\n",
       " ('Vomiting', 88),\n",
       " ('Decreased', 84),\n",
       " ('Substance', 73),\n",
       " ('Abnormal', 66)]"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "##get counts\n",
    "from collections import Counter\n",
    "Counter(all_reactions).most_common(20)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "de411f5b-f5b4-4ebd-8c1a-c02cd0638534",
   "metadata": {},
   "source": [
    "<span style=\"background-color: lightblue; padding: 5px;\"><b>*I Used ChatGPT To help me find the best pattern and use collections counter*</b></span>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "3bea4cb3-8882-4988-8280-d37b3c9377ca",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('Toxicity To Various Agents', 320),\n",
       " ('Drug Abuse', 199),\n",
       " ('Drug Dependence', 190),\n",
       " ('Drug Interaction', 168),\n",
       " ('Death', 143),\n",
       " ('Withdrawal Syndrome', 126),\n",
       " ('Serotonin Syndrome', 101),\n",
       " ('Seizure', 88),\n",
       " ('Vomiting', 85),\n",
       " ('Overdose', 69),\n",
       " ('Respiratory Arrest', 68),\n",
       " ('Nausea', 60),\n",
       " ('Drug Withdrawal Syndrome', 59),\n",
       " ('Anxiety', 57),\n",
       " ('Substance Use', 57),\n",
       " ('Unresponsive To Stimuli', 54),\n",
       " ('Completed Suicide', 53),\n",
       " ('Dependence', 52),\n",
       " ('Cardiac Arrest', 50),\n",
       " ('Electrocardiogram Qt Prolonged', 45)]"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "##ok that didn't give me enougb specificty. try again with broader pattern\n",
    "all_reactions = []\n",
    "pattern_2 = r\"\\b(?:[A-Za-z]+(?:\\s+[A-Za-z]+){0,3})\\b\"\n",
    "\n",
    "for text in df[\"Reactions\"].dropna():\n",
    "    all_reactions.extend(regex_extract(text,pattern_2))\n",
    "\n",
    "from collections import Counter\n",
    "Counter(all_reactions).most_common(20)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "49bcae7e-5de1-40be-97b4-a974db7ea28a",
   "metadata": {},
   "source": [
    "<span style=\"color: red; font-size: 24px;\">Top reactions are:\n",
    "- Toxicity To Various Agents', 320),\n",
    "- ('Drug Abuse', 199),\n",
    "- ('Drug Dependence', 190),\n",
    "- ('Drug Interaction', 168),\n",
    "- ('Death', 143),\n",
    "- ('Withdrawal Syndrome', 126),\n",
    "- ('Serotonin Syndrome',101\n",
    "  </span> \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "0ecc5cc8-48de-4d0c-a73c-7af88569828a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('Withdrawal Syndrome', 126),\n",
       " ('Serotonin Syndrome', 101),\n",
       " ('Drug Withdrawal', 75),\n",
       " ('Respiratory Arrest', 68),\n",
       " ('Completed Suicide', 53),\n",
       " ('Cardiac Arrest', 50),\n",
       " ('Accidental Death', 44),\n",
       " ('Accidental Overdose', 36),\n",
       " ('Clonic Seizure', 25),\n",
       " ('Intentional Overdose', 20),\n",
       " ('Legs Syndrome', 18),\n",
       " ('Liver Injury', 16),\n",
       " ('Kidney Injury', 15),\n",
       " ('Hepatic Failure', 13),\n",
       " ('Respiratory Depression', 12),\n",
       " ('Herbal Toxicity', 11),\n",
       " ('Brain Death', 7),\n",
       " ('Near Death', 7),\n",
       " ('Suspected Suicide', 7),\n",
       " ('Drug Reaction', 7)]"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "## try another pattern\n",
    "pattern_3 = r\"\\b([A-Za-z]+(?:\\s+(?:failure|injury|arrest|toxicity|overdose|syndrome|reaction|seizure|depression|distress|abnormality|complication|withdrawal|coma|collapse|death|suicide)))\\b\"\n",
    "all_reactions_2 = []\n",
    "\n",
    "for text in df[\"Reactions\"].dropna():\n",
    "    all_reactions_2.extend(regex_extract(text,pattern_3))\n",
    "\n",
    "from collections import Counter\n",
    "Counter(all_reactions_2).most_common(20)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4abb8773-949d-47d2-80b3-2a2ca4f92b3c",
   "metadata": {},
   "source": [
    "### Find All outcomes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "aa629600-fa8d-4de6-9b76-f1994176d43f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0                                            Hospitalized\n",
       "1                             Hospitalized;Other Outcomes\n",
       "2                                     Other Outcomes;Died\n",
       "3                                                    Died\n",
       "4                                     Other Outcomes;Died\n",
       "                              ...                        \n",
       "1498                                          Non-Serious\n",
       "1499                       Disabled;Required Intervention\n",
       "1500                                       Other Outcomes\n",
       "1501    Hospitalized;Disabled;Life Threatening;Require...\n",
       "1502                          Hospitalized;Other Outcomes\n",
       "Name: Outcomes, Length: 1503, dtype: object"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Outcomes']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "71e1a6e7-998e-454e-90b1-c92bf8a6decd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('Died', 719),\n",
       " ('Other Outcomes', 675),\n",
       " ('Hospitalized', 384),\n",
       " ('Life Threatening', 154),\n",
       " ('Disabled', 128),\n",
       " ('Required Intervention', 119),\n",
       " ('Non-Serious', 102),\n",
       " ('Congenital Anomaly', 1)]"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_outcomes = []\n",
    "\n",
    "for text in df[\"Outcomes\"].dropna():\n",
    "    all_outcomes.extend(regex_extract(text, r\"[^;]+\"))\n",
    "\n",
    "\n",
    "##get counts\n",
    "from collections import Counter\n",
    "Counter(all_outcomes).most_common(20)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f5942659-c3af-40b1-87e4-f742fe44ad2d",
   "metadata": {},
   "source": [
    "<span style=\"color: red; font-size: 24px;\">Top outcomes are:\n",
    "- 'Died', 719),\n",
    "- ('Other Outcomes', 675),\n",
    "- ('Hospitalized', 384),\n",
    "- ('Life Threatening', 154),\n",
    "- ('Disabled', 128),\n",
    "- ('Required Intervention', 119),\n",
    "- ('Non-Serious', 102),\n",
    "- ('Congenital Anomaly', 1)]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5e7fbd93-3a54-4d43-8ddc-92b550c07104",
   "metadata": {},
   "source": [
    "## Use SpaCy +regex to compare common reactions across kratom product classes"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4fa5bddd-1c79-4071-9de4-9b3732d18068",
   "metadata": {},
   "source": [
    "<span style=\"background-color: lightblue; padding: 5px;\"><b>*I Used ChatGPT To help me debug the custom functions below:*</b></span>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "eabc95cf-1449-49b2-bc2b-363381086668",
   "metadata": {},
   "outputs": [],
   "source": [
    "##Ok, regex needs some help from spaCy. i need to get a list of the top words and phrases so spacy can use it\n",
    "\n",
    "##REACTIONS\n",
    "\n",
    "def get_top_words_from_list(reaction_list, topn=20):\n",
    "    words = []\n",
    "    for reaction_text in reaction_list:\n",
    "        if not isinstance(reaction_text, str):\n",
    "            continue\n",
    "        terms = [t.strip() for t in reaction_text.split(\";\") if t.strip()]\n",
    "        for t in terms:\n",
    "            words.extend(re.findall(r\"[A-Za-z\\-]+\", t.lower()))\n",
    "    return Counter(words).most_common(topn)\n",
    "\n",
    "\n",
    "def get_top_heads_from_list(reaction_list, topn=20):\n",
    "    heads = []\n",
    "    for reaction_text in reaction_list:\n",
    "        if not isinstance(reaction_text, str):\n",
    "            continue\n",
    "        terms = [t.strip() for t in reaction_text.split(\";\") if t.strip()]\n",
    "        for t in terms:\n",
    "            tokens = re.findall(r\"[A-Za-z\\-]+\", t.lower())\n",
    "            if tokens:\n",
    "                heads.append(tokens[-1])\n",
    "    return Counter(heads).most_common(topn)\n",
    "\n",
    "\n",
    "def get_top_phrases_from_list(reaction_list, topn=20):\n",
    "    phrases = []\n",
    "    for reaction_text in reaction_list:\n",
    "        if not isinstance(reaction_text, str):\n",
    "            continue\n",
    "        terms = [t.strip().lower() for t in reaction_text.split(\";\") if t.strip()]\n",
    "        phrases.extend(terms)\n",
    "    return Counter(phrases).most_common(topn)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "b33a65d9-8172-425c-b45b-8803081eeb04",
   "metadata": {},
   "outputs": [],
   "source": [
    "# EXPOSRES\n",
    "kratom_only_df = df[df[\"All_Products_Clean\"] == \"Herbals\\Mitragynine\"]\n",
    "seven_oh_df   = df[df[\"All_Products_Clean\"] == \"7-Hydroxymitragynine\"]\n",
    "pseudo_df     = df[df[\"All_Products_Clean\"] == \"Mitragynine Pseudoindoxyl\"]\n",
    "\n",
    "# Get top reactions per group using the same list-based functions\n",
    "kratom_top_phrases = get_top_phrases_from_list(kratom_only_df[\"Reactions\"].dropna(), topn=20)\n",
    "seven_oh_top_phrases = get_top_phrases_from_list(seven_oh_df[\"Reactions\"].dropna(), topn=20)\n",
    "pseudo_top_phrases   = get_top_phrases_from_list(pseudo_df[\"Reactions\"].dropna(), topn=20)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "f621f1f2-961c-4b4b-8cf1-44bb2d5181c3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                            kratom   7oh  pseudo\n",
      "drug dependence              116.0  11.0     0.0\n",
      "death                         83.0   0.0     0.0\n",
      "withdrawal syndrome           67.0   5.0     0.0\n",
      "toxicity to various agents    52.0   0.0     0.0\n",
      "vomiting                      49.0   0.0     0.0\n",
      "seizure                       38.0   0.0     0.0\n",
      "nausea                        34.0   2.0     0.0\n",
      "substance use                 28.0   0.0     0.0\n",
      "diarrhoea                     26.0   0.0     0.0\n",
      "anxiety                       26.0   2.0     0.0\n"
     ]
    }
   ],
   "source": [
    "\n",
    "comparison_df = pd.DataFrame({\n",
    "    \"kratom\": dict(kratom_top_phrases),\n",
    "    \"7oh\": dict(seven_oh_top_phrases),\n",
    "    \"pseudo\": dict(pseudo_top_phrases)\n",
    "}).fillna(0)\n",
    "\n",
    "print(comparison_df.head(10))\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3c4a7853-aedb-4b78-b0a6-3133bb0e3355",
   "metadata": {},
   "source": [
    "## Run again for outcomes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "44003e37-52cf-4ae8-bdef-3a834e73efb1",
   "metadata": {},
   "outputs": [],
   "source": [
    "##OUTCOMES PATTERN\n",
    "\n",
    "def get_top_words_from_list_o(reaction_list, topn=20):\n",
    "    words = []\n",
    "    for reaction_text in reaction_list:\n",
    "        if not isinstance(reaction_text, str):\n",
    "            continue\n",
    "        terms = [t.strip() for t in reaction_text.split(\";\") if t.strip()]\n",
    "        for t in terms:\n",
    "            words.extend(re.findall(r\"[^;]+\", t.lower()))\n",
    "    return Counter(words).most_common(topn)\n",
    "\n",
    "\n",
    "def get_top_heads_from_list_o(reaction_list, topn=20):\n",
    "    heads = []\n",
    "    for reaction_text in reaction_list:\n",
    "        if not isinstance(reaction_text, str):\n",
    "            continue\n",
    "        terms = [t.strip() for t in reaction_text.split(\";\") if t.strip()]\n",
    "        for t in terms:\n",
    "            tokens = re.findall(r\"[^;]+\", t.lower())\n",
    "            if tokens:\n",
    "                heads.append(tokens[-1])\n",
    "    return Counter(heads).most_common(topn)\n",
    "\n",
    "\n",
    "def get_top_phrases_from_list_o(reaction_list, topn=20):\n",
    "    phrases = []\n",
    "    for reaction_text in reaction_list:\n",
    "        if not isinstance(reaction_text, str):\n",
    "            continue\n",
    "        terms = [t.strip().lower() for t in reaction_text.split(\";\") if t.strip()]\n",
    "        phrases.extend(terms)\n",
    "    return Counter(phrases).most_common(topn)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "97b30ef8-230d-40d6-aa9d-fc20cfb6cb97",
   "metadata": {},
   "outputs": [],
   "source": [
    "kratom_top_phrases_o = get_top_phrases_from_list_o(kratom_only_df[\"Outcomes\"].dropna(), topn=20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "ef34a57b-4744-42ef-be6d-733729a831c8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                       kratom  7oh  pseudo\n",
      "died                      178    2     0.0\n",
      "other outcomes            147   12     0.0\n",
      "hospitalized              108   10     0.0\n",
      "required intervention      76   10     0.0\n",
      "life threatening           72    6     0.0\n",
      "disabled                   67    3     0.0\n",
      "non-serious                46    4     0.0\n"
     ]
    }
   ],
   "source": [
    "\n",
    "kratom_top_phrases_o = get_top_phrases_from_list_o(kratom_only_df[\"Outcomes\"].dropna(), topn=20)\n",
    "seven_oh_top_phrases_o = get_top_phrases_from_list_o(seven_oh_df[\"Outcomes\"].dropna(), topn=20)\n",
    "pseudo_top_phrases_o = get_top_phrases_from_list_o(pseudo_df[\"Outcomes\"].dropna(), topn=20)\n",
    "\n",
    "comparison_outcomes_df = pd.DataFrame({\n",
    "    \"kratom\": dict(kratom_top_phrases_o),\n",
    "    \"7oh\": dict(seven_oh_top_phrases_o),\n",
    "    \"pseudo\": dict(pseudo_top_phrases_o)\n",
    "}).fillna(0)\n",
    "\n",
    "print(comparison_outcomes_df.head(10))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "93d86519-4c4c-40d1-af2c-61d38e52bda1",
   "metadata": {},
   "source": [
    "## MEGACODE: Use fuzzy matching to expand the standard reactions/reasons for use/ outcomes \n",
    "\n",
    "Normalize and return a more comphrehensive summary for each \n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "98c0a7a1-f537-40f5-b820-fcff31321166",
   "metadata": {},
   "source": [
    "<span style=\"background-color: lightblue; padding: 5px;\"><b>*I Used ChatGPT To help me use .update/.expand/.most_common below:*</b></span>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "4e005c74-481a-4da4-ac6f-163c573ccd18",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Top Reactions: [('toxicity to various agents', 320), ('drug abuse', 199), ('drug dependence', 190), ('drug interaction', 168), ('death', 143), ('withdrawal syndrome', 126), ('serotonin syndrome', 101), ('seizure', 88), ('vomiting', 85), ('overdose', 69), ('nausea', 60), ('drug withdrawal syndrome', 59), ('anxiety', 57), ('substance use', 57), ('unresponsive to stimuli', 54), ('completed suicide', 53), ('dependence', 52), ('cardiac arrest', 50), ('electrocardiogram qt prolonged', 45), ('accidental death', 44)]\n",
      "Top Reason for Use: [('product used for unknown indication', 568), ('anxiety', 132), ('pain', 130), ('depression', 80), ('drug abuse', 44), ('drug dependence', 40), ('substance use', 31), ('back pain', 24), ('asthenia', 20), ('insomnia', 18), ('drug withdrawal syndrome', 15), ('menopausal symptoms', 15), ('covid-19', 15), ('phytotherapy', 14), ('hypertension', 12), ('drug use disorder', 12), ('stress', 11), ('major depression', 11), ('bipolar disorder', 11), ('analgesic therapy', 10)]\n",
      "Top Outcomes: [('died', 719), ('other outcomes', 675), ('hospitalized', 384), ('life threatening', 154), ('disabled', 128), ('required intervention', 119), ('non-serious', 102), ('congenital anomaly', 1)]\n"
     ]
    }
   ],
   "source": [
    "# the outputs\n",
    "from rapidfuzz import process\n",
    "SIMILARITY_THRESHOLD = 85  # fuzzy matching threshold\n",
    "\n",
    "# Starting standard lists (expandable)\n",
    "standard_reactions = [\"Overdose\", \"Death\", \"Nausea\", \"Vomiting\", \"Seizure\", \"Drug Withdrawal Syndrome\"]\n",
    "standard_reasons   = [\"Pain Relief\", \"Recreational\", \"Substance Abuse\", \"Anxiety\"]\n",
    "standard_outcomes  = [\"Died\", \"Life Threatening\", \"Other Outcomes\"]\n",
    "\n",
    "# ------------------------------\n",
    "# Functions\n",
    "# ------------------------------\n",
    "def expand_standard_lists(df, columns_dict):\n",
    "    \"\"\"Automatically expand standard lists from dataset.\"\"\"\n",
    "    expanded_lists = {}\n",
    "    \n",
    "    for col, standard_list in columns_dict.items():\n",
    "        new_phrases = set()\n",
    "        for text in df[col].dropna():\n",
    "            phrases = [t.strip() for t in text.split(\";\") if t.strip()]\n",
    "            new_phrases.update(phrases)\n",
    "        \n",
    "        # Lowercase for consistency\n",
    "        new_phrases = {p.lower() for p in new_phrases}\n",
    "        standard_list_lower = {p.lower() for p in standard_list}\n",
    "        \n",
    "        # Merge and convert back to list\n",
    "        expanded_lists[col] = list(standard_list_lower.union(new_phrases))\n",
    "    \n",
    "    return expanded_lists\n",
    "\n",
    "def extract_phrases(column):\n",
    "    \"\"\"Split semicolon-separated text, lowercase and strip.\"\"\"\n",
    "    all_phrases = []\n",
    "    for text in column.dropna():\n",
    "        phrases = [t.strip().lower() for t in text.split(\";\") if t.strip()]\n",
    "        all_phrases.extend(phrases)\n",
    "    return all_phrases\n",
    "\n",
    "def fuzzy_standardize(phrases, standard_list):\n",
    "    \"\"\"Map phrases to closest match in standard_list using fuzzy matching.\"\"\"\n",
    "    standardized = []\n",
    "    for p in phrases:\n",
    "        match = process.extractOne(p, standard_list)\n",
    "        if match and match[1] >= SIMILARITY_THRESHOLD:\n",
    "            standardized.append(match[0])\n",
    "        else:\n",
    "            standardized.append(p)  # keep original if no good match\n",
    "    return standardized\n",
    "\n",
    "def get_top_counts(df, column, standard_list, topn=20):\n",
    "    \"\"\"Extract top normalized phrases for a column.\"\"\"\n",
    "    phrases = extract_phrases(df[column])\n",
    "    phrases_std = fuzzy_standardize(phrases, standard_list)\n",
    "    return Counter(phrases_std).most_common(topn)\n",
    "\n",
    "\n",
    "columns_dict = {\n",
    "    \"Reactions\": standard_reactions,\n",
    "    \"Reason for Use\": standard_reasons,\n",
    "    \"Outcomes\": standard_outcomes\n",
    "}\n",
    "\n",
    "expanded_lists = expand_standard_lists(df, columns_dict)\n",
    "\n",
    "# Extract top counts\n",
    "\n",
    "top_reactions = get_top_counts(df, \"Reactions\", expanded_lists[\"Reactions\"])\n",
    "top_reasons   = get_top_counts(df, \"Reason for Use\", expanded_lists[\"Reason for Use\"])\n",
    "top_outcomes  = get_top_counts(df, \"Outcomes\", expanded_lists[\"Outcomes\"])\n",
    "\n",
    "# Print summaries\n",
    "\n",
    "print(\"Top Reactions:\", top_reactions)\n",
    "print(\"Top Reason for Use:\", top_reasons)\n",
    "print(\"Top Outcomes:\", top_outcomes)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4410d2e7-af07-4c83-b5e6-0879227e2d9a",
   "metadata": {},
   "source": [
    "## Create expanded list using custom function above"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "977b20c1-0619-4013-8118-ab1096d34a7c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Reactions List: ['toxicity to various agents', 'drug abuse', 'drug dependence', 'drug interaction', 'death', 'withdrawal syndrome', 'serotonin syndrome', 'seizure', 'vomiting', 'overdose', 'nausea', 'drug withdrawal syndrome', 'anxiety', 'substance use', 'unresponsive to stimuli', 'completed suicide', 'dependence', 'cardiac arrest', 'electrocardiogram qt prolonged', 'accidental death']\n",
      "Reasons List: ['product used for unknown indication', 'anxiety', 'pain', 'depression', 'drug abuse', 'drug dependence', 'substance use', 'back pain', 'asthenia', 'insomnia', 'drug withdrawal syndrome', 'menopausal symptoms', 'covid-19', 'phytotherapy', 'hypertension', 'drug use disorder', 'stress', 'major depression', 'bipolar disorder', 'analgesic therapy']\n",
      "Outcomes List: ['died', 'other outcomes', 'hospitalized', 'life threatening', 'disabled', 'required intervention', 'non-serious', 'congenital anomaly']\n"
     ]
    }
   ],
   "source": [
    "# Assuming top_reactions, top_reasons, top_outcomes are lists of tuples like [(phrase, count), ...]\n",
    "reaction_list = [phrase for phrase, count in top_reactions]\n",
    "reason_list   = [phrase for phrase, count in top_reasons]\n",
    "outcome_list  = [phrase for phrase, count in top_outcomes]\n",
    "\n",
    "print(\"Reactions List:\", reaction_list)\n",
    "print(\"Reasons List:\", reason_list)\n",
    "print(\"Outcomes List:\", outcome_list)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ad4da4a5-8c65-483a-8366-0789b5d53f58",
   "metadata": {},
   "source": [
    "<span style=\"color: red; font-size: 24px;\">TOP REACTIONS, REASONS FOR USE, and OUTCOMES using Text Analysis</span>\n",
    "\n",
    "Top Reactions: ['toxicity to various agents', 'drug abuse', 'drug dependence', 'drug interaction', 'death', 'withdrawal syndrome', 'serotonin syndrome', 'seizure', 'vomiting', 'overdose', 'nausea', 'drug withdrawal syndrome', 'anxiety', 'substance use', 'unresponsive to stimuli', 'completed suicide', 'dependence', 'cardiac arrest', 'electrocardiogram qt prolonged', 'accidental death']\n",
    "\n",
    "Top Reason for Use:['product used for unknown indication', 'anxiety', 'pain', 'depression', 'drug abuse', 'drug dependence', 'substance use', 'back pain', 'asthenia', 'insomnia', 'drug withdrawal syndrome', 'menopausal symptoms', 'covid-19', 'phytotherapy', 'hypertension', 'drug use disorder', 'stress', 'major depression', 'bipolar disorder', 'analgesic therapy']\n",
    "\n",
    "\n",
    "Top Outcomes:['died', 'other outcomes', 'hospitalized', 'life threatening', 'disabled', 'required intervention', 'non-serious', 'congenital anomaly']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "82a84346-a2a0-48c0-8f3a-204a46cb652b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Case ID</th>\n",
       "      <th>Suspect Product Names</th>\n",
       "      <th>Suspect Product Active Ingredients</th>\n",
       "      <th>Reason for Use</th>\n",
       "      <th>Reactions</th>\n",
       "      <th>Serious</th>\n",
       "      <th>Outcomes</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Event Date</th>\n",
       "      <th>Latest FDA Received Date</th>\n",
       "      <th>...</th>\n",
       "      <th>has_misc_drugs_abuse</th>\n",
       "      <th>has_sleep</th>\n",
       "      <th>All_Products_Clean_List</th>\n",
       "      <th>All_Products_Clean_Cleaned</th>\n",
       "      <th>Reason for Use_List</th>\n",
       "      <th>Reason for Use_Cleaned</th>\n",
       "      <th>Outcomes_List</th>\n",
       "      <th>Outcomes_Cleaned</th>\n",
       "      <th>Reactions_List</th>\n",
       "      <th>Reactions_Cleaned</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>6669537</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Herbals\\Mitragynine;Modafinil</td>\n",
       "      <td>Drug Withdrawal Syndrome;Somnolence</td>\n",
       "      <td>Somnolence;Drug Withdrawal Syndrome;Miosis;Gen...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Hospitalized</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>6/3/2008</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>[Herbals\\Mitragynine;Modafinil]</td>\n",
       "      <td>Herbals\\Mitragynine;Modafinil</td>\n",
       "      <td>[Drug Withdrawal Syndrome;Somnolence]</td>\n",
       "      <td>Drug Withdrawal Syndrome;Somnolence</td>\n",
       "      <td>[Hospitalized]</td>\n",
       "      <td>Hospitalized</td>\n",
       "      <td>[Somnolence;Drug Withdrawal Syndrome;Miosis;Ge...</td>\n",
       "      <td>Somnolence;Drug Withdrawal Syndrome;Miosis;Gen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>6959961</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Herbals\\Mitragynine;Hydromorphone Hydrochlorid...</td>\n",
       "      <td>Dependence;Drug Withdrawal Syndrome;Hypervigil...</td>\n",
       "      <td>Incorrect Route Of Product Administration;Drug...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Hospitalized;Other Outcomes</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>4/3/2009</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>[Buprenorphine\\Naloxone, Herbals\\Mitragynine;H...</td>\n",
       "      <td>Buprenorphine\\Naloxone | Herbals\\Mitragynine;H...</td>\n",
       "      <td>[Dependence;Drug Withdrawal Syndrome;Hypervigi...</td>\n",
       "      <td>Dependence;Drug Withdrawal Syndrome;Hypervigil...</td>\n",
       "      <td>[Hospitalized;Other Outcomes]</td>\n",
       "      <td>Hospitalized;Other Outcomes</td>\n",
       "      <td>[Incorrect Route Of Product Administration;Dru...</td>\n",
       "      <td>Incorrect Route Of Product Administration;Drug...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7900650</td>\n",
       "      <td>Promethazine</td>\n",
       "      <td>Promethazine Hydrochloride;Propylhexedrine;Mor...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Toxicity To Various Agents;Drug Screen Positive</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Other Outcomes;Died</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>4/15/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>[Promethazine, Promethazine Hydrochloride;Prop...</td>\n",
       "      <td>Promethazine | Promethazine Hydrochloride;Prop...</td>\n",
       "      <td>[]</td>\n",
       "      <td></td>\n",
       "      <td>[Other Outcomes;Died]</td>\n",
       "      <td>Other Outcomes;Died</td>\n",
       "      <td>[Toxicity To Various Agents;Drug Screen Positive]</td>\n",
       "      <td>Toxicity To Various Agents;Drug Screen Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>8083892</td>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Venlafaxine Hydrochloride;Buprenorphine;Trimep...</td>\n",
       "      <td>Product Used For Unknown Indication</td>\n",
       "      <td>Overdose;Accidental Death;Brain Oedema;Pulmona...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Died</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>8/2/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>[Venlafaxine, Venlafaxine Hydrochloride;Bupren...</td>\n",
       "      <td>Venlafaxine | Venlafaxine Hydrochloride;Bupren...</td>\n",
       "      <td>[Product Used For Unknown Indication]</td>\n",
       "      <td>Product Used For Unknown Indication</td>\n",
       "      <td>[Died]</td>\n",
       "      <td>Died</td>\n",
       "      <td>[Overdose;Accidental Death;Brain Oedema;Pulmon...</td>\n",
       "      <td>Overdose;Accidental Death;Brain Oedema;Pulmona...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>8121566</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Trimeprazine Tartrate;Herbals\\Mitragynine;Venl...</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>Pulmonary Congestion;Pulmonary Oedema;Toxicity...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Other Outcomes;Died</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>8/24/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>[Trimeprazine Tartrate;Herbals\\Mitragynine;Ven...</td>\n",
       "      <td>Trimeprazine Tartrate;Herbals\\Mitragynine;Venl...</td>\n",
       "      <td>[Toxicity To Various Agents]</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>[Other Outcomes;Died]</td>\n",
       "      <td>Other Outcomes;Died</td>\n",
       "      <td>[Pulmonary Congestion;Pulmonary Oedema;Toxicit...</td>\n",
       "      <td>Pulmonary Congestion;Pulmonary Oedema;Toxicity...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>8121559</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Tramadol;Zopiclone;Venlafaxine Hydrochloride;U...</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>Cardiac Arrest;Loss Of Consciousness;Respirato...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Life Threatening;Hospitalized;Died</td>\n",
       "      <td>Female</td>\n",
       "      <td>-</td>\n",
       "      <td>8/24/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>[Tramadol;Zopiclone;Venlafaxine Hydrochloride;...</td>\n",
       "      <td>Tramadol;Zopiclone;Venlafaxine Hydrochloride;U...</td>\n",
       "      <td>[Toxicity To Various Agents]</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>[Life Threatening;Hospitalized;Died]</td>\n",
       "      <td>Life Threatening;Hospitalized;Died</td>\n",
       "      <td>[Cardiac Arrest;Loss Of Consciousness;Respirat...</td>\n",
       "      <td>Cardiac Arrest;Loss Of Consciousness;Respirato...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>8121551</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Diazepam;Amphetamine;Olanzapine;Norfluoxetine;...</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>Cardiac Arrest;Toxicity To Various Agents;Pulm...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Died;Other Outcomes</td>\n",
       "      <td>Female</td>\n",
       "      <td>-</td>\n",
       "      <td>8/24/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>[Diazepam;Amphetamine;Olanzapine;Norfluoxetine...</td>\n",
       "      <td>Diazepam;Amphetamine;Olanzapine;Norfluoxetine;...</td>\n",
       "      <td>[Toxicity To Various Agents]</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>[Died;Other Outcomes]</td>\n",
       "      <td>Died;Other Outcomes</td>\n",
       "      <td>[Cardiac Arrest;Toxicity To Various Agents;Pul...</td>\n",
       "      <td>Cardiac Arrest;Toxicity To Various Agents;Pulm...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>8121536</td>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Venlafaxine Hydrochloride;Buprenorphine;Herbal...</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>Cardiac Arrest;Loss Of Consciousness;Pulmonary...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Died;Other Outcomes</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>8/24/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>[Venlafaxine, Venlafaxine Hydrochloride;Bupren...</td>\n",
       "      <td>Venlafaxine | Venlafaxine Hydrochloride;Bupren...</td>\n",
       "      <td>[Toxicity To Various Agents]</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>[Died;Other Outcomes]</td>\n",
       "      <td>Died;Other Outcomes</td>\n",
       "      <td>[Cardiac Arrest;Loss Of Consciousness;Pulmonar...</td>\n",
       "      <td>Cardiac Arrest;Loss Of Consciousness;Pulmonary...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>8132531</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Cannabis Sativa Seed\\Herbals;Citalopram Hydrob...</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>Respiratory Depression;Drug Level Increased;Br...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Died;Hospitalized</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>8/25/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>[Cannabis Sativa Seed\\Herbals;Citalopram Hydro...</td>\n",
       "      <td>Cannabis Sativa Seed\\Herbals;Citalopram Hydrob...</td>\n",
       "      <td>[Toxicity To Various Agents]</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>[Died;Hospitalized]</td>\n",
       "      <td>Died;Hospitalized</td>\n",
       "      <td>[Respiratory Depression;Drug Level Increased;B...</td>\n",
       "      <td>Respiratory Depression;Drug Level Increased;Br...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>8124494</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Alprazolam;Herbals\\Mitragynine;Alcohol;Tramadol</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>Toxicity To Various Agents;Pulmonary Congestion</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Other Outcomes;Died</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>8/25/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>[Alprazolam;Herbals\\Mitragynine;Alcohol;Tramadol]</td>\n",
       "      <td>Alprazolam;Herbals\\Mitragynine;Alcohol;Tramadol</td>\n",
       "      <td>[Toxicity To Various Agents]</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>[Other Outcomes;Died]</td>\n",
       "      <td>Other Outcomes;Died</td>\n",
       "      <td>[Toxicity To Various Agents;Pulmonary Congestion]</td>\n",
       "      <td>Toxicity To Various Agents;Pulmonary Congestion</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>10 rows  52 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   Case ID Suspect Product Names  \\\n",
       "0  6669537                  <NA>   \n",
       "1  6959961                  <NA>   \n",
       "2  7900650          Promethazine   \n",
       "3  8083892           Venlafaxine   \n",
       "4  8121566                  <NA>   \n",
       "5  8121559                  <NA>   \n",
       "6  8121551                  <NA>   \n",
       "7  8121536           Venlafaxine   \n",
       "8  8132531                  <NA>   \n",
       "9  8124494                  <NA>   \n",
       "\n",
       "                  Suspect Product Active Ingredients  \\\n",
       "0                      Herbals\\Mitragynine;Modafinil   \n",
       "1  Herbals\\Mitragynine;Hydromorphone Hydrochlorid...   \n",
       "2  Promethazine Hydrochloride;Propylhexedrine;Mor...   \n",
       "3  Venlafaxine Hydrochloride;Buprenorphine;Trimep...   \n",
       "4  Trimeprazine Tartrate;Herbals\\Mitragynine;Venl...   \n",
       "5  Tramadol;Zopiclone;Venlafaxine Hydrochloride;U...   \n",
       "6  Diazepam;Amphetamine;Olanzapine;Norfluoxetine;...   \n",
       "7  Venlafaxine Hydrochloride;Buprenorphine;Herbal...   \n",
       "8  Cannabis Sativa Seed\\Herbals;Citalopram Hydrob...   \n",
       "9    Alprazolam;Herbals\\Mitragynine;Alcohol;Tramadol   \n",
       "\n",
       "                                      Reason for Use  \\\n",
       "0                Drug Withdrawal Syndrome;Somnolence   \n",
       "1  Dependence;Drug Withdrawal Syndrome;Hypervigil...   \n",
       "2                                               <NA>   \n",
       "3                Product Used For Unknown Indication   \n",
       "4                         Toxicity To Various Agents   \n",
       "5                         Toxicity To Various Agents   \n",
       "6                         Toxicity To Various Agents   \n",
       "7                         Toxicity To Various Agents   \n",
       "8                         Toxicity To Various Agents   \n",
       "9                         Toxicity To Various Agents   \n",
       "\n",
       "                                           Reactions  Serious  \\\n",
       "0  Somnolence;Drug Withdrawal Syndrome;Miosis;Gen...  Serious   \n",
       "1  Incorrect Route Of Product Administration;Drug...  Serious   \n",
       "2    Toxicity To Various Agents;Drug Screen Positive  Serious   \n",
       "3  Overdose;Accidental Death;Brain Oedema;Pulmona...  Serious   \n",
       "4  Pulmonary Congestion;Pulmonary Oedema;Toxicity...  Serious   \n",
       "5  Cardiac Arrest;Loss Of Consciousness;Respirato...  Serious   \n",
       "6  Cardiac Arrest;Toxicity To Various Agents;Pulm...  Serious   \n",
       "7  Cardiac Arrest;Loss Of Consciousness;Pulmonary...  Serious   \n",
       "8  Respiratory Depression;Drug Level Increased;Br...  Serious   \n",
       "9    Toxicity To Various Agents;Pulmonary Congestion  Serious   \n",
       "\n",
       "                             Outcomes     Sex Event Date  \\\n",
       "0                        Hospitalized    Male          -   \n",
       "1         Hospitalized;Other Outcomes    Male          -   \n",
       "2                 Other Outcomes;Died    Male          -   \n",
       "3                                Died    Male          -   \n",
       "4                 Other Outcomes;Died    Male          -   \n",
       "5  Life Threatening;Hospitalized;Died  Female          -   \n",
       "6                 Died;Other Outcomes  Female          -   \n",
       "7                 Died;Other Outcomes    Male          -   \n",
       "8                   Died;Hospitalized    Male          -   \n",
       "9                 Other Outcomes;Died    Male          -   \n",
       "\n",
       "  Latest FDA Received Date  ... has_misc_drugs_abuse  has_sleep  \\\n",
       "0                 6/3/2008  ...                False      False   \n",
       "1                 4/3/2009  ...                False      False   \n",
       "2                4/15/2011  ...                False      False   \n",
       "3                 8/2/2011  ...                False      False   \n",
       "4                8/24/2011  ...                False      False   \n",
       "5                8/24/2011  ...                False      False   \n",
       "6                8/24/2011  ...                False      False   \n",
       "7                8/24/2011  ...                False      False   \n",
       "8                8/25/2011  ...                False      False   \n",
       "9                8/25/2011  ...                False      False   \n",
       "\n",
       "                             All_Products_Clean_List  \\\n",
       "0                    [Herbals\\Mitragynine;Modafinil]   \n",
       "1  [Buprenorphine\\Naloxone, Herbals\\Mitragynine;H...   \n",
       "2  [Promethazine, Promethazine Hydrochloride;Prop...   \n",
       "3  [Venlafaxine, Venlafaxine Hydrochloride;Bupren...   \n",
       "4  [Trimeprazine Tartrate;Herbals\\Mitragynine;Ven...   \n",
       "5  [Tramadol;Zopiclone;Venlafaxine Hydrochloride;...   \n",
       "6  [Diazepam;Amphetamine;Olanzapine;Norfluoxetine...   \n",
       "7  [Venlafaxine, Venlafaxine Hydrochloride;Bupren...   \n",
       "8  [Cannabis Sativa Seed\\Herbals;Citalopram Hydro...   \n",
       "9  [Alprazolam;Herbals\\Mitragynine;Alcohol;Tramadol]   \n",
       "\n",
       "                          All_Products_Clean_Cleaned  \\\n",
       "0                      Herbals\\Mitragynine;Modafinil   \n",
       "1  Buprenorphine\\Naloxone | Herbals\\Mitragynine;H...   \n",
       "2  Promethazine | Promethazine Hydrochloride;Prop...   \n",
       "3  Venlafaxine | Venlafaxine Hydrochloride;Bupren...   \n",
       "4  Trimeprazine Tartrate;Herbals\\Mitragynine;Venl...   \n",
       "5  Tramadol;Zopiclone;Venlafaxine Hydrochloride;U...   \n",
       "6  Diazepam;Amphetamine;Olanzapine;Norfluoxetine;...   \n",
       "7  Venlafaxine | Venlafaxine Hydrochloride;Bupren...   \n",
       "8  Cannabis Sativa Seed\\Herbals;Citalopram Hydrob...   \n",
       "9    Alprazolam;Herbals\\Mitragynine;Alcohol;Tramadol   \n",
       "\n",
       "                                 Reason for Use_List  \\\n",
       "0              [Drug Withdrawal Syndrome;Somnolence]   \n",
       "1  [Dependence;Drug Withdrawal Syndrome;Hypervigi...   \n",
       "2                                                 []   \n",
       "3              [Product Used For Unknown Indication]   \n",
       "4                       [Toxicity To Various Agents]   \n",
       "5                       [Toxicity To Various Agents]   \n",
       "6                       [Toxicity To Various Agents]   \n",
       "7                       [Toxicity To Various Agents]   \n",
       "8                       [Toxicity To Various Agents]   \n",
       "9                       [Toxicity To Various Agents]   \n",
       "\n",
       "                              Reason for Use_Cleaned  \\\n",
       "0                Drug Withdrawal Syndrome;Somnolence   \n",
       "1  Dependence;Drug Withdrawal Syndrome;Hypervigil...   \n",
       "2                                                      \n",
       "3                Product Used For Unknown Indication   \n",
       "4                         Toxicity To Various Agents   \n",
       "5                         Toxicity To Various Agents   \n",
       "6                         Toxicity To Various Agents   \n",
       "7                         Toxicity To Various Agents   \n",
       "8                         Toxicity To Various Agents   \n",
       "9                         Toxicity To Various Agents   \n",
       "\n",
       "                          Outcomes_List                    Outcomes_Cleaned  \\\n",
       "0                        [Hospitalized]                        Hospitalized   \n",
       "1         [Hospitalized;Other Outcomes]         Hospitalized;Other Outcomes   \n",
       "2                 [Other Outcomes;Died]                 Other Outcomes;Died   \n",
       "3                                [Died]                                Died   \n",
       "4                 [Other Outcomes;Died]                 Other Outcomes;Died   \n",
       "5  [Life Threatening;Hospitalized;Died]  Life Threatening;Hospitalized;Died   \n",
       "6                 [Died;Other Outcomes]                 Died;Other Outcomes   \n",
       "7                 [Died;Other Outcomes]                 Died;Other Outcomes   \n",
       "8                   [Died;Hospitalized]                   Died;Hospitalized   \n",
       "9                 [Other Outcomes;Died]                 Other Outcomes;Died   \n",
       "\n",
       "                                      Reactions_List  \\\n",
       "0  [Somnolence;Drug Withdrawal Syndrome;Miosis;Ge...   \n",
       "1  [Incorrect Route Of Product Administration;Dru...   \n",
       "2  [Toxicity To Various Agents;Drug Screen Positive]   \n",
       "3  [Overdose;Accidental Death;Brain Oedema;Pulmon...   \n",
       "4  [Pulmonary Congestion;Pulmonary Oedema;Toxicit...   \n",
       "5  [Cardiac Arrest;Loss Of Consciousness;Respirat...   \n",
       "6  [Cardiac Arrest;Toxicity To Various Agents;Pul...   \n",
       "7  [Cardiac Arrest;Loss Of Consciousness;Pulmonar...   \n",
       "8  [Respiratory Depression;Drug Level Increased;B...   \n",
       "9  [Toxicity To Various Agents;Pulmonary Congestion]   \n",
       "\n",
       "                                   Reactions_Cleaned  \n",
       "0  Somnolence;Drug Withdrawal Syndrome;Miosis;Gen...  \n",
       "1  Incorrect Route Of Product Administration;Drug...  \n",
       "2    Toxicity To Various Agents;Drug Screen Positive  \n",
       "3  Overdose;Accidental Death;Brain Oedema;Pulmona...  \n",
       "4  Pulmonary Congestion;Pulmonary Oedema;Toxicity...  \n",
       "5  Cardiac Arrest;Loss Of Consciousness;Respirato...  \n",
       "6  Cardiac Arrest;Toxicity To Various Agents;Pulm...  \n",
       "7  Cardiac Arrest;Loss Of Consciousness;Pulmonary...  \n",
       "8  Respiratory Depression;Drug Level Increased;Br...  \n",
       "9    Toxicity To Various Agents;Pulmonary Congestion  \n",
       "\n",
       "[10 rows x 52 columns]"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d75220db-fe12-4f1c-98a5-8cdb6d217076",
   "metadata": {},
   "source": [
    "## What substances are most likely to cause a serious event with kratom?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "id": "db902b41-a419-46d5-9de1-48de785480b4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Case ID</th>\n",
       "      <th>Suspect Product Names</th>\n",
       "      <th>Suspect Product Active Ingredients</th>\n",
       "      <th>Reason for Use</th>\n",
       "      <th>Reactions</th>\n",
       "      <th>Serious</th>\n",
       "      <th>Outcomes</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Event Date</th>\n",
       "      <th>Latest FDA Received Date</th>\n",
       "      <th>...</th>\n",
       "      <th>All_Products_Clean_Cleaned</th>\n",
       "      <th>Reason for Use_List</th>\n",
       "      <th>Reason for Use_Cleaned</th>\n",
       "      <th>Outcomes_List</th>\n",
       "      <th>Outcomes_Cleaned</th>\n",
       "      <th>Reactions_List</th>\n",
       "      <th>Reactions_Cleaned</th>\n",
       "      <th>Serious_binary</th>\n",
       "      <th>All_Products_List</th>\n",
       "      <th>serious_flag</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>6669537</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Herbals\\Mitragynine;Modafinil</td>\n",
       "      <td>Drug Withdrawal Syndrome;Somnolence</td>\n",
       "      <td>Somnolence;Drug Withdrawal Syndrome;Miosis;Gen...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Hospitalized</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>6/3/2008</td>\n",
       "      <td>...</td>\n",
       "      <td>Herbals\\Mitragynine;Modafinil</td>\n",
       "      <td>[Drug Withdrawal Syndrome;Somnolence]</td>\n",
       "      <td>Drug Withdrawal Syndrome;Somnolence</td>\n",
       "      <td>[Hospitalized]</td>\n",
       "      <td>Hospitalized</td>\n",
       "      <td>[Somnolence;Drug Withdrawal Syndrome;Miosis;Ge...</td>\n",
       "      <td>Somnolence;Drug Withdrawal Syndrome;Miosis;Gen...</td>\n",
       "      <td>1</td>\n",
       "      <td>[Herbals, Mitragynine, Modafinil]</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>6959961</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Herbals\\Mitragynine;Hydromorphone Hydrochlorid...</td>\n",
       "      <td>Dependence;Drug Withdrawal Syndrome;Hypervigil...</td>\n",
       "      <td>Incorrect Route Of Product Administration;Drug...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Hospitalized;Other Outcomes</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>4/3/2009</td>\n",
       "      <td>...</td>\n",
       "      <td>Buprenorphine\\Naloxone | Herbals\\Mitragynine;H...</td>\n",
       "      <td>[Dependence;Drug Withdrawal Syndrome;Hypervigi...</td>\n",
       "      <td>Dependence;Drug Withdrawal Syndrome;Hypervigil...</td>\n",
       "      <td>[Hospitalized;Other Outcomes]</td>\n",
       "      <td>Hospitalized;Other Outcomes</td>\n",
       "      <td>[Incorrect Route Of Product Administration;Dru...</td>\n",
       "      <td>Incorrect Route Of Product Administration;Drug...</td>\n",
       "      <td>1</td>\n",
       "      <td>[Buprenorphine, Naloxone, Herbals, Mitragynine...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7900650</td>\n",
       "      <td>Promethazine</td>\n",
       "      <td>Promethazine Hydrochloride;Propylhexedrine;Mor...</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Toxicity To Various Agents;Drug Screen Positive</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Other Outcomes;Died</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>4/15/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>Promethazine | Promethazine Hydrochloride;Prop...</td>\n",
       "      <td>[]</td>\n",
       "      <td></td>\n",
       "      <td>[Other Outcomes;Died]</td>\n",
       "      <td>Other Outcomes;Died</td>\n",
       "      <td>[Toxicity To Various Agents;Drug Screen Positive]</td>\n",
       "      <td>Toxicity To Various Agents;Drug Screen Positive</td>\n",
       "      <td>1</td>\n",
       "      <td>[Promethazine, Promethazine Hydrochloride, Pro...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>8083892</td>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Venlafaxine Hydrochloride;Buprenorphine;Trimep...</td>\n",
       "      <td>Product Used For Unknown Indication</td>\n",
       "      <td>Overdose;Accidental Death;Brain Oedema;Pulmona...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Died</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>8/2/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>Venlafaxine | Venlafaxine Hydrochloride;Bupren...</td>\n",
       "      <td>[Product Used For Unknown Indication]</td>\n",
       "      <td>Product Used For Unknown Indication</td>\n",
       "      <td>[Died]</td>\n",
       "      <td>Died</td>\n",
       "      <td>[Overdose;Accidental Death;Brain Oedema;Pulmon...</td>\n",
       "      <td>Overdose;Accidental Death;Brain Oedema;Pulmona...</td>\n",
       "      <td>1</td>\n",
       "      <td>[Venlafaxine, Venlafaxine Hydrochloride, Bupre...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>8121566</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Trimeprazine Tartrate;Herbals\\Mitragynine;Venl...</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>Pulmonary Congestion;Pulmonary Oedema;Toxicity...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Other Outcomes;Died</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>8/24/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>Trimeprazine Tartrate;Herbals\\Mitragynine;Venl...</td>\n",
       "      <td>[Toxicity To Various Agents]</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>[Other Outcomes;Died]</td>\n",
       "      <td>Other Outcomes;Died</td>\n",
       "      <td>[Pulmonary Congestion;Pulmonary Oedema;Toxicit...</td>\n",
       "      <td>Pulmonary Congestion;Pulmonary Oedema;Toxicity...</td>\n",
       "      <td>1</td>\n",
       "      <td>[Trimeprazine Tartrate, Herbals, Mitragynine, ...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>8121559</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Tramadol;Zopiclone;Venlafaxine Hydrochloride;U...</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>Cardiac Arrest;Loss Of Consciousness;Respirato...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Life Threatening;Hospitalized;Died</td>\n",
       "      <td>Female</td>\n",
       "      <td>-</td>\n",
       "      <td>8/24/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>Tramadol;Zopiclone;Venlafaxine Hydrochloride;U...</td>\n",
       "      <td>[Toxicity To Various Agents]</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>[Life Threatening;Hospitalized;Died]</td>\n",
       "      <td>Life Threatening;Hospitalized;Died</td>\n",
       "      <td>[Cardiac Arrest;Loss Of Consciousness;Respirat...</td>\n",
       "      <td>Cardiac Arrest;Loss Of Consciousness;Respirato...</td>\n",
       "      <td>1</td>\n",
       "      <td>[Tramadol, Zopiclone, Venlafaxine Hydrochlorid...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>8121551</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Diazepam;Amphetamine;Olanzapine;Norfluoxetine;...</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>Cardiac Arrest;Toxicity To Various Agents;Pulm...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Died;Other Outcomes</td>\n",
       "      <td>Female</td>\n",
       "      <td>-</td>\n",
       "      <td>8/24/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>Diazepam;Amphetamine;Olanzapine;Norfluoxetine;...</td>\n",
       "      <td>[Toxicity To Various Agents]</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>[Died;Other Outcomes]</td>\n",
       "      <td>Died;Other Outcomes</td>\n",
       "      <td>[Cardiac Arrest;Toxicity To Various Agents;Pul...</td>\n",
       "      <td>Cardiac Arrest;Toxicity To Various Agents;Pulm...</td>\n",
       "      <td>1</td>\n",
       "      <td>[Diazepam, Amphetamine, Olanzapine, Norfluoxet...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>8121536</td>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Venlafaxine Hydrochloride;Buprenorphine;Herbal...</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>Cardiac Arrest;Loss Of Consciousness;Pulmonary...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Died;Other Outcomes</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>8/24/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>Venlafaxine | Venlafaxine Hydrochloride;Bupren...</td>\n",
       "      <td>[Toxicity To Various Agents]</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>[Died;Other Outcomes]</td>\n",
       "      <td>Died;Other Outcomes</td>\n",
       "      <td>[Cardiac Arrest;Loss Of Consciousness;Pulmonar...</td>\n",
       "      <td>Cardiac Arrest;Loss Of Consciousness;Pulmonary...</td>\n",
       "      <td>1</td>\n",
       "      <td>[Venlafaxine, Venlafaxine Hydrochloride, Bupre...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>8132531</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Cannabis Sativa Seed\\Herbals;Citalopram Hydrob...</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>Respiratory Depression;Drug Level Increased;Br...</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Died;Hospitalized</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>8/25/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>Cannabis Sativa Seed\\Herbals;Citalopram Hydrob...</td>\n",
       "      <td>[Toxicity To Various Agents]</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>[Died;Hospitalized]</td>\n",
       "      <td>Died;Hospitalized</td>\n",
       "      <td>[Respiratory Depression;Drug Level Increased;B...</td>\n",
       "      <td>Respiratory Depression;Drug Level Increased;Br...</td>\n",
       "      <td>1</td>\n",
       "      <td>[Cannabis Sativa Seed, Herbals, Citalopram Hyd...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>8124494</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>Alprazolam;Herbals\\Mitragynine;Alcohol;Tramadol</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>Toxicity To Various Agents;Pulmonary Congestion</td>\n",
       "      <td>Serious</td>\n",
       "      <td>Other Outcomes;Died</td>\n",
       "      <td>Male</td>\n",
       "      <td>-</td>\n",
       "      <td>8/25/2011</td>\n",
       "      <td>...</td>\n",
       "      <td>Alprazolam;Herbals\\Mitragynine;Alcohol;Tramadol</td>\n",
       "      <td>[Toxicity To Various Agents]</td>\n",
       "      <td>Toxicity To Various Agents</td>\n",
       "      <td>[Other Outcomes;Died]</td>\n",
       "      <td>Other Outcomes;Died</td>\n",
       "      <td>[Toxicity To Various Agents;Pulmonary Congestion]</td>\n",
       "      <td>Toxicity To Various Agents;Pulmonary Congestion</td>\n",
       "      <td>1</td>\n",
       "      <td>[Alprazolam, Herbals, Mitragynine, Alcohol, Tr...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>10 rows  55 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   Case ID Suspect Product Names  \\\n",
       "0  6669537                  <NA>   \n",
       "1  6959961                  <NA>   \n",
       "2  7900650          Promethazine   \n",
       "3  8083892           Venlafaxine   \n",
       "4  8121566                  <NA>   \n",
       "5  8121559                  <NA>   \n",
       "6  8121551                  <NA>   \n",
       "7  8121536           Venlafaxine   \n",
       "8  8132531                  <NA>   \n",
       "9  8124494                  <NA>   \n",
       "\n",
       "                  Suspect Product Active Ingredients  \\\n",
       "0                      Herbals\\Mitragynine;Modafinil   \n",
       "1  Herbals\\Mitragynine;Hydromorphone Hydrochlorid...   \n",
       "2  Promethazine Hydrochloride;Propylhexedrine;Mor...   \n",
       "3  Venlafaxine Hydrochloride;Buprenorphine;Trimep...   \n",
       "4  Trimeprazine Tartrate;Herbals\\Mitragynine;Venl...   \n",
       "5  Tramadol;Zopiclone;Venlafaxine Hydrochloride;U...   \n",
       "6  Diazepam;Amphetamine;Olanzapine;Norfluoxetine;...   \n",
       "7  Venlafaxine Hydrochloride;Buprenorphine;Herbal...   \n",
       "8  Cannabis Sativa Seed\\Herbals;Citalopram Hydrob...   \n",
       "9    Alprazolam;Herbals\\Mitragynine;Alcohol;Tramadol   \n",
       "\n",
       "                                      Reason for Use  \\\n",
       "0                Drug Withdrawal Syndrome;Somnolence   \n",
       "1  Dependence;Drug Withdrawal Syndrome;Hypervigil...   \n",
       "2                                               <NA>   \n",
       "3                Product Used For Unknown Indication   \n",
       "4                         Toxicity To Various Agents   \n",
       "5                         Toxicity To Various Agents   \n",
       "6                         Toxicity To Various Agents   \n",
       "7                         Toxicity To Various Agents   \n",
       "8                         Toxicity To Various Agents   \n",
       "9                         Toxicity To Various Agents   \n",
       "\n",
       "                                           Reactions  Serious  \\\n",
       "0  Somnolence;Drug Withdrawal Syndrome;Miosis;Gen...  Serious   \n",
       "1  Incorrect Route Of Product Administration;Drug...  Serious   \n",
       "2    Toxicity To Various Agents;Drug Screen Positive  Serious   \n",
       "3  Overdose;Accidental Death;Brain Oedema;Pulmona...  Serious   \n",
       "4  Pulmonary Congestion;Pulmonary Oedema;Toxicity...  Serious   \n",
       "5  Cardiac Arrest;Loss Of Consciousness;Respirato...  Serious   \n",
       "6  Cardiac Arrest;Toxicity To Various Agents;Pulm...  Serious   \n",
       "7  Cardiac Arrest;Loss Of Consciousness;Pulmonary...  Serious   \n",
       "8  Respiratory Depression;Drug Level Increased;Br...  Serious   \n",
       "9    Toxicity To Various Agents;Pulmonary Congestion  Serious   \n",
       "\n",
       "                             Outcomes     Sex Event Date  \\\n",
       "0                        Hospitalized    Male          -   \n",
       "1         Hospitalized;Other Outcomes    Male          -   \n",
       "2                 Other Outcomes;Died    Male          -   \n",
       "3                                Died    Male          -   \n",
       "4                 Other Outcomes;Died    Male          -   \n",
       "5  Life Threatening;Hospitalized;Died  Female          -   \n",
       "6                 Died;Other Outcomes  Female          -   \n",
       "7                 Died;Other Outcomes    Male          -   \n",
       "8                   Died;Hospitalized    Male          -   \n",
       "9                 Other Outcomes;Died    Male          -   \n",
       "\n",
       "  Latest FDA Received Date  ...  \\\n",
       "0                 6/3/2008  ...   \n",
       "1                 4/3/2009  ...   \n",
       "2                4/15/2011  ...   \n",
       "3                 8/2/2011  ...   \n",
       "4                8/24/2011  ...   \n",
       "5                8/24/2011  ...   \n",
       "6                8/24/2011  ...   \n",
       "7                8/24/2011  ...   \n",
       "8                8/25/2011  ...   \n",
       "9                8/25/2011  ...   \n",
       "\n",
       "                          All_Products_Clean_Cleaned  \\\n",
       "0                      Herbals\\Mitragynine;Modafinil   \n",
       "1  Buprenorphine\\Naloxone | Herbals\\Mitragynine;H...   \n",
       "2  Promethazine | Promethazine Hydrochloride;Prop...   \n",
       "3  Venlafaxine | Venlafaxine Hydrochloride;Bupren...   \n",
       "4  Trimeprazine Tartrate;Herbals\\Mitragynine;Venl...   \n",
       "5  Tramadol;Zopiclone;Venlafaxine Hydrochloride;U...   \n",
       "6  Diazepam;Amphetamine;Olanzapine;Norfluoxetine;...   \n",
       "7  Venlafaxine | Venlafaxine Hydrochloride;Bupren...   \n",
       "8  Cannabis Sativa Seed\\Herbals;Citalopram Hydrob...   \n",
       "9    Alprazolam;Herbals\\Mitragynine;Alcohol;Tramadol   \n",
       "\n",
       "                                 Reason for Use_List  \\\n",
       "0              [Drug Withdrawal Syndrome;Somnolence]   \n",
       "1  [Dependence;Drug Withdrawal Syndrome;Hypervigi...   \n",
       "2                                                 []   \n",
       "3              [Product Used For Unknown Indication]   \n",
       "4                       [Toxicity To Various Agents]   \n",
       "5                       [Toxicity To Various Agents]   \n",
       "6                       [Toxicity To Various Agents]   \n",
       "7                       [Toxicity To Various Agents]   \n",
       "8                       [Toxicity To Various Agents]   \n",
       "9                       [Toxicity To Various Agents]   \n",
       "\n",
       "                              Reason for Use_Cleaned  \\\n",
       "0                Drug Withdrawal Syndrome;Somnolence   \n",
       "1  Dependence;Drug Withdrawal Syndrome;Hypervigil...   \n",
       "2                                                      \n",
       "3                Product Used For Unknown Indication   \n",
       "4                         Toxicity To Various Agents   \n",
       "5                         Toxicity To Various Agents   \n",
       "6                         Toxicity To Various Agents   \n",
       "7                         Toxicity To Various Agents   \n",
       "8                         Toxicity To Various Agents   \n",
       "9                         Toxicity To Various Agents   \n",
       "\n",
       "                          Outcomes_List                    Outcomes_Cleaned  \\\n",
       "0                        [Hospitalized]                        Hospitalized   \n",
       "1         [Hospitalized;Other Outcomes]         Hospitalized;Other Outcomes   \n",
       "2                 [Other Outcomes;Died]                 Other Outcomes;Died   \n",
       "3                                [Died]                                Died   \n",
       "4                 [Other Outcomes;Died]                 Other Outcomes;Died   \n",
       "5  [Life Threatening;Hospitalized;Died]  Life Threatening;Hospitalized;Died   \n",
       "6                 [Died;Other Outcomes]                 Died;Other Outcomes   \n",
       "7                 [Died;Other Outcomes]                 Died;Other Outcomes   \n",
       "8                   [Died;Hospitalized]                   Died;Hospitalized   \n",
       "9                 [Other Outcomes;Died]                 Other Outcomes;Died   \n",
       "\n",
       "                                      Reactions_List  \\\n",
       "0  [Somnolence;Drug Withdrawal Syndrome;Miosis;Ge...   \n",
       "1  [Incorrect Route Of Product Administration;Dru...   \n",
       "2  [Toxicity To Various Agents;Drug Screen Positive]   \n",
       "3  [Overdose;Accidental Death;Brain Oedema;Pulmon...   \n",
       "4  [Pulmonary Congestion;Pulmonary Oedema;Toxicit...   \n",
       "5  [Cardiac Arrest;Loss Of Consciousness;Respirat...   \n",
       "6  [Cardiac Arrest;Toxicity To Various Agents;Pul...   \n",
       "7  [Cardiac Arrest;Loss Of Consciousness;Pulmonar...   \n",
       "8  [Respiratory Depression;Drug Level Increased;B...   \n",
       "9  [Toxicity To Various Agents;Pulmonary Congestion]   \n",
       "\n",
       "                                   Reactions_Cleaned Serious_binary  \\\n",
       "0  Somnolence;Drug Withdrawal Syndrome;Miosis;Gen...              1   \n",
       "1  Incorrect Route Of Product Administration;Drug...              1   \n",
       "2    Toxicity To Various Agents;Drug Screen Positive              1   \n",
       "3  Overdose;Accidental Death;Brain Oedema;Pulmona...              1   \n",
       "4  Pulmonary Congestion;Pulmonary Oedema;Toxicity...              1   \n",
       "5  Cardiac Arrest;Loss Of Consciousness;Respirato...              1   \n",
       "6  Cardiac Arrest;Toxicity To Various Agents;Pulm...              1   \n",
       "7  Cardiac Arrest;Loss Of Consciousness;Pulmonary...              1   \n",
       "8  Respiratory Depression;Drug Level Increased;Br...              1   \n",
       "9    Toxicity To Various Agents;Pulmonary Congestion              1   \n",
       "\n",
       "                                   All_Products_List serious_flag  \n",
       "0                  [Herbals, Mitragynine, Modafinil]            1  \n",
       "1  [Buprenorphine, Naloxone, Herbals, Mitragynine...            1  \n",
       "2  [Promethazine, Promethazine Hydrochloride, Pro...            1  \n",
       "3  [Venlafaxine, Venlafaxine Hydrochloride, Bupre...            1  \n",
       "4  [Trimeprazine Tartrate, Herbals, Mitragynine, ...            1  \n",
       "5  [Tramadol, Zopiclone, Venlafaxine Hydrochlorid...            1  \n",
       "6  [Diazepam, Amphetamine, Olanzapine, Norfluoxet...            1  \n",
       "7  [Venlafaxine, Venlafaxine Hydrochloride, Bupre...            1  \n",
       "8  [Cannabis Sativa Seed, Herbals, Citalopram Hyd...            1  \n",
       "9  [Alprazolam, Herbals, Mitragynine, Alcohol, Tr...            1  \n",
       "\n",
       "[10 rows x 55 columns]"
      ]
     },
     "execution_count": 83,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "## convert my \"Serious\" column to a binary\n",
    "\n",
    "df[\"serious_flag\"] = df[\"Serious\"].map({\"Serious\": 1, \"Non-Serious\": 0})\n",
    "\n",
    "df.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "id": "ca823e3a-e579-4fbd-9a56-b7813851fc8d",
   "metadata": {},
   "outputs": [],
   "source": [
    "##split the string of All_Products_clean for each case into a list\n",
    "\n",
    "def split_products(text):\n",
    "    if pd.isna(text):\n",
    "        return []\n",
    "    # Split on | or ; or backslash\n",
    "    items = re.split(r'[|;\\\\]+', text)\n",
    "    return [i.strip() for i in items if i.strip()]\n",
    "\n",
    "df[\"All_Products_List\"] = df[\"All_Products_Clean\"].apply(split_products)\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f2c99d41-004c-4e80-9eff-b4c877b7e3ae",
   "metadata": {},
   "source": [
    "<span style=\"background-color: lightblue; padding: 5px;\"><b>*I Used ChatGPT To help with this, it suggested .explode:*</b></span>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "id": "ade7e304-b098-4d32-be3c-03d85992d0f8",
   "metadata": {},
   "outputs": [],
   "source": [
    "## using the \"explode\" function in pandas, separate out each substance and corresponding case into its own row for analysis\n",
    "df_long = df.explode(\"All_Products_List\")\n",
    "df_long = df_long.rename(columns={\"All_Products_List\": \"Substance\"})\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "id": "2ba4beee-4eca-4885-983f-7362a095f707",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>product_item</th>\n",
       "      <th>serious_rate</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>.Alpha.-Hydroxyetizolam</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>351</th>\n",
       "      <td>Oxycodone</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>367</th>\n",
       "      <td>Pepcid</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>364</th>\n",
       "      <td>Paroxetine Hydrochloride</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>Paroxetine</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>362</th>\n",
       "      <td>Parnate</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>361</th>\n",
       "      <td>Parafluorofentanyl</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>360</th>\n",
       "      <td>Pantoprazole</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>359</th>\n",
       "      <td>Pamelor</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>358</th>\n",
       "      <td>Paliperidone Palmitate</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>357</th>\n",
       "      <td>Paliperidone</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>356</th>\n",
       "      <td>Oxymorphone Hydrochloride</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>355</th>\n",
       "      <td>Oxymorphone</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>354</th>\n",
       "      <td>Oxycontin</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>352</th>\n",
       "      <td>Oxycodone And Acetaminophen</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>350</th>\n",
       "      <td>Oxybate</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>404</th>\n",
       "      <td>Pseudoephedrine Hydrochloride</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>349</th>\n",
       "      <td>Oxazepam</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>348</th>\n",
       "      <td>Ondansetron</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>346</th>\n",
       "      <td>Omega-3 Fatty Acids</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                      product_item  serious_rate\n",
       "0          .Alpha.-Hydroxyetizolam           1.0\n",
       "351                      Oxycodone           1.0\n",
       "367                         Pepcid           1.0\n",
       "364       Paroxetine Hydrochloride           1.0\n",
       "363                     Paroxetine           1.0\n",
       "362                        Parnate           1.0\n",
       "361             Parafluorofentanyl           1.0\n",
       "360                   Pantoprazole           1.0\n",
       "359                        Pamelor           1.0\n",
       "358         Paliperidone Palmitate           1.0\n",
       "357                   Paliperidone           1.0\n",
       "356      Oxymorphone Hydrochloride           1.0\n",
       "355                    Oxymorphone           1.0\n",
       "354                      Oxycontin           1.0\n",
       "352    Oxycodone And Acetaminophen           1.0\n",
       "350                        Oxybate           1.0\n",
       "404  Pseudoephedrine Hydrochloride           1.0\n",
       "349                       Oxazepam           1.0\n",
       "348                    Ondansetron           1.0\n",
       "346            Omega-3 Fatty Acids           1.0"
      ]
     },
     "execution_count": 86,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "## compute seriousness rate per individual substance\n",
    "serious_rate = (\n",
    "    df_long.assign(product_item=df_long[\"Substance\"].apply(lambda x: x[0] if isinstance(x, list) else x))\n",
    "    .groupby(\"product_item\")[\"serious_flag\"]\n",
    "    .mean()\n",
    "    .reset_index(name=\"serious_rate\")\n",
    ")\n",
    "\n",
    "serious_rate.sort_values(\"serious_rate\", ascending=False).head(20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "44c49ebd-dd2f-4de6-8211-05a6c6453131",
   "metadata": {},
   "outputs": [],
   "source": [
    "## ok, because 93% of cases are serious, this is not the right measure for this."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "id": "2b563474-1216-4ea8-943f-b82ab22e88ad",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>serious_rate</th>\n",
       "      <th>case_count</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Substance</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Herbals</th>\n",
       "      <td>0.929860</td>\n",
       "      <td>1497</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Mitragynine</th>\n",
       "      <td>0.931432</td>\n",
       "      <td>1473</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Fentanyl</th>\n",
       "      <td>0.986014</td>\n",
       "      <td>143</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Gabapentin</th>\n",
       "      <td>0.946903</td>\n",
       "      <td>113</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Bupropion</th>\n",
       "      <td>0.986486</td>\n",
       "      <td>74</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sertraline Hydrochloride</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>69</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Alcohol</th>\n",
       "      <td>0.985294</td>\n",
       "      <td>68</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Acetaminophen</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>67</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sertraline</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>62</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Quetiapine</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>62</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Alprazolam</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>59</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Trazodone</th>\n",
       "      <td>0.981818</td>\n",
       "      <td>55</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Oxycodone</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>55</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7-Hydroxymitragynine</th>\n",
       "      <td>0.909091</td>\n",
       "      <td>55</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Clonazepam</th>\n",
       "      <td>0.944444</td>\n",
       "      <td>54</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Olanzapine</th>\n",
       "      <td>0.769231</td>\n",
       "      <td>52</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Tramadol</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>52</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Diphenhydramine</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>50</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Trazodone Hydrochloride</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>47</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Citalopram</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>46</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                          serious_rate  case_count\n",
       "Substance                                         \n",
       "Herbals                       0.929860        1497\n",
       "Mitragynine                   0.931432        1473\n",
       "Fentanyl                      0.986014         143\n",
       "Gabapentin                    0.946903         113\n",
       "Bupropion                     0.986486          74\n",
       "Sertraline Hydrochloride      1.000000          69\n",
       "Alcohol                       0.985294          68\n",
       "Acetaminophen                 1.000000          67\n",
       "Sertraline                    1.000000          62\n",
       "Quetiapine                    1.000000          62\n",
       "Alprazolam                    1.000000          59\n",
       "Trazodone                     0.981818          55\n",
       "Oxycodone                     1.000000          55\n",
       "7-Hydroxymitragynine          0.909091          55\n",
       "Clonazepam                    0.944444          54\n",
       "Olanzapine                    0.769231          52\n",
       "Tramadol                      1.000000          52\n",
       "Diphenhydramine               1.000000          50\n",
       "Trazodone Hydrochloride       1.000000          47\n",
       "Citalopram                    1.000000          46"
      ]
     },
     "execution_count": 88,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "## rank substances by % of serious cases\n",
    "substance_severity = (\n",
    "    df_long.groupby(\"Substance\")[\"serious_flag\"]\n",
    "    .agg(['mean', 'count'])\n",
    "    .rename(columns={'mean': 'serious_rate', 'count': 'case_count'})\n",
    "    .sort_values(\"case_count\", ascending=False)\n",
    ")\n",
    "\n",
    "\n",
    "substance_severity.head(20)\n",
    "\n",
    "##NOTE: im not filtering out small sample sizes because this dataset is not that large"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "id": "f2e169fb-a364-4aca-8821-566056aa6485",
   "metadata": {},
   "outputs": [],
   "source": [
    "substance_severity['Pct_cases'] =substance_severity['case_count']/1503\n",
    "substance_severity.head(10)\n",
    "substance_severity.to_csv(\"Kratom_co-usedrugs_seriousrate.csv\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "156f4bc3-7b79-48cd-af2c-8d750ab3c5c1",
   "metadata": {},
   "source": [
    "\n",
    "<span style=\"color: red; font-size: 24px;\">By count, Fentanyl, Gabapentin, Bupropion, Sertraline Hydrochloride, and Alcohol were the top five substances most likely to produce a serious case when used with kratom</span> \n",
    "- See substance_severity for full list "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "id": "f5437550-ae79-4343-a183-dcd8d9ed96f2",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['-',\n",
       "       'Neerman, M.F., Frost, R.E., Deking, J.. A Drug Fatality Involving Kratom. Journal of forensic sciences. 2013;58 (S1):S278-S279',\n",
       "       'Mowry JB; Spyker DA, Cantilena Jr. LR, McMillan N, Ford M. 2013 Annual Report of the American Association of Poison Control Centers \\x92 National Poison Data System (NPDS):31st Annual Report. CLINICAL TOXICOLOGY. 2014;52:1032-1283',\n",
       "       'Mowry J.B., Spyker D.A., Cantilena L.R., Mcmillan N, Ford M. 2013Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 31st Annual Report. Clinical Toxicology. 2014;52:1032-1283',\n",
       "       \"Mowry J.B., Spyker D.A., Cantilena JR L.R., Mcmillan N., Ford M.. 2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st Annual Report. Clinical Toxicology. 2014;52 (10):1032-1283\",\n",
       "       'McIntyre IM, Trochta A, Stolberg S, Campman SC. Mitragynine kratom related fatality: a case report with postmortem concentrations. Journal of Analytical Toxicology 2015;39(2):152-155.',\n",
       "       \"McIntyre IM, Trochta A, Stolberg S, Campman SC. Mitragynine 'Kratom' Related Fatality: A Case Report with Postmortem Concentrations. Journal of Analytical Toxicology. 2014;0:1-4\",\n",
       "       'McIntyre I M.. Mitragynine \"Kratom\\' Related Fatality: A Case Report with Postmortem Concentrations. Journal of Analytical Toxicology. 2015;39 (2):152-155',\n",
       "       'Bishop-Freeman SC, Feaster MS, beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-related deaths in North Carolina.. JOURNAL OF ANALYTICAL TOXICOLOGY. 2016;40(8):677-86',\n",
       "       'Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-Related Deaths in North Carolina. Journal of Analytical Toxicology 2016;40/8:677-686.',\n",
       "       'Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-Related Deaths in North Carolina. Journal of Analytical Toxicology 2016;40(8):677-686.',\n",
       "       'Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et al. Loperamide-related deaths in North Carolina. J-Anal-Toxicol 2016;40(8):677-686.',\n",
       "       \"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report. Clin Toxicol (Phila). 2017 Dec; 55(10):1072-1252.\",\n",
       "       'Domingo O, Roider G, Stover A, Graw M, Musshoff F, Sachs H, et al.. Mitragynine concentrations in two fatalities. FORENSIC SCIENCE INTERNATIONAL. 2017;271:e1-e7',\n",
       "       'Domingo O, Roider G, Stover A, Graw M, Musshoff F, Sachs H, et al. Mitragynine concentrations in two fatalities. Forensic-Sci-Int 2017;271:e1-e7.',\n",
       "       'Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO et al. Loperamide-related deaths in North Carolina. J Anal Toxicol. 2016;40(8):677-686',\n",
       "       'Noori M, Hendrickson R, Hatten B.. Kratom: Natural painkiller or herbal enemy?. Clinical Toxicology. 2018;56(6):574',\n",
       "       'Noori M, Hendrickson R, Hatten B. Kratom: Natural painkiller or herbal enemy?. Clinical Toxicology. 2018;56(6):574. DOI: 10.1080/15563650.2018.1457818.',\n",
       "       'Monica Noori, Robert Hendrickson, Benjamin Hatten et al.. Kratom: Natural painkiller or herbal enemy?.. Clinical Toxicology. 122',\n",
       "       'Mitchell-Mata C, Thomas B, Peterson B, Couper F.. Two fatal intoxications involving 3-methoxyphencyclidine. Journal of Analytical Toxicology.. 2017;41(6):503-7',\n",
       "       'Mitchell-Mata C, Thomas B, Peterson B, Couper F.. Two fatal intoxications involving 3-methoxyphencyclidine. Journal of Analytical Toxicology. 2017;41(6):503-507',\n",
       "       'Mitchell-Mata C, Thomas B, Peterson B, Couper F.. Two fatal intoxications involving 3-methoxyphencyclidine. doi: 10.1093/jat/bkx048. Journal of Analytical Toxicology. 2017;41(6):503-507',\n",
       "       'Mitchell-Mata C, Thomas B, Peterson B, Couper F. Two fatal intoxications involving 3-methoxyphencyclidine.. Journal of Analytical Toxicology. 2017;41(6):503-507',\n",
       "       'Mitchell-Mata C, Thomas B, Peterson B, Couper F. Two fatal intoxications involving 3-methoxyphencyclidine. Journal of Analytical Toxicology. 2017;41(6):503-507; doi: 10.1093/jat/bkx048',\n",
       "       'Mitchell-Mata C, Thomas B, Peterson B, Couper F. Two fatal intoxications involving 3-methoxyphencyclidine. JOURNAL OF ANALYTICAL TOXICOLOGY. 2017;41(6):503-507',\n",
       "       'Mitchell-Mata C, Thomas B, Peterson B, Couper F. Two fatal intoxications involving 3-methoxyphencyclidine. J Anal Toxicol. 2017;41(6):503-507',\n",
       "       'Mitchell-Mata C, Thomas B, Peterson B, Couper F. Two Fatal Intoxications Involving 3-Methoxyphencyclidine. J Anal Toxicol. 2017 Jul 1;41(6):503-507.',\n",
       "       'Hughes RL.. Fatal combination of Mitragynine and Quetiapine - a case report with discussion of a potential herb-drug interaction.. Forensic Science, Medicine and Pathology. 2018;UNK:1-4',\n",
       "       'Hughes RL. Fatal combination of mitragynine and quetiapine-a case report with discussion of a potential herb-drug interaction. DOI: 10.1007/s12024-018-0049-9. Forensic Science, Medicine and Pathology. 2018',\n",
       "       \"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W.. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS):34th Annual Report. Clinical Toxicology. 2017;55(10):1072\\x961254\",\n",
       "       \"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report. Clinical toxicology. 2017;1 to 181\",\n",
       "       \"Gummin D D, Mowry J B, Spyker D A, Brooks D E, Fraser M O, Banner W.. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report. Clinical Toxicology. 2017;55 (10):1072-1254\",\n",
       "       'Fagiola M, Hahn T, Avella J. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS). JOURNAL OF ANALYTICAL TOXICOLOGY. 2018;42:562-9',\n",
       "       'Fagiola M, Hahn T, Avella J. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS). Journal of Analytical Toxicology. 2018;42 (8):562 - 569',\n",
       "       'Wright TH. Suspected Driving Under the Influence Case Involving Mitragynine. J-Anal-Toxicol 2018;42(7):e65-e68.',\n",
       "       'Tiscione NB, Alford IK, Miller R, Shan X, Yeatman DT. Driving Under the Influence of Drugs: When the Law Misses the Mark. Journal of Analytical Toxicology 2019;43:138-143.',\n",
       "       'Tiscione NB, Alford IK, Miller R, Shan X, Yeatman DT. Driving Under the Influence of Drugs: When the Law Misses the Mark. Journal of Analytical Toxicology 01-Oct-2018;2019;43:138-143.',\n",
       "       'Tiscione NB, Alford IK, Miller R, Shan X, Yeatman DT. Driving Under the Influence of Drugs: When the Law Misses the Mark. J Anal Toxicol. 2019;43:138-143',\n",
       "       'Tiscione N.B., Alford I.K., Miller R., Shan X., Yeatman D.T.. Driving under the Influence of Drugs: When the Law Misses the Mark. Journal of Analytical Toxicology. 2019;43:138-143',\n",
       "       'Scoccimarro A, Marino R, Shulman J. A case of etizolam withdrawal syndrome. Clinical Toxicology.. 2019;57 (6):427',\n",
       "       'Rhome L. Hughes et.al.,;Fatal combination of mitragynine and quetiapine-a case report with discussion of a potential herb-drug interaction;Forensic Science Medicine and Pathology;29-NOV-2018;;',\n",
       "       'Osborne CS, Overstreet AN, Rockey DC, Schreiner AD. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic. J-Investig-Med-High-Impact-Case-Rep 2019;.',\n",
       "       'Osborne CS, Overstreet AN, Rockey DC, Schreiner AD. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic. J-Investig-Med-High-Impact-Case-Rep 2019;:.',\n",
       "       'Osborne CS, Overstreet AN, Rockey DC, Schreiner AD. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic. J Investig Med High Impact Case Rep. 2019;7:1-5',\n",
       "       'Osborne CS, Overstreet AN, Rockey DC and Schreiner AD.. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic.. Journal of Investigative Medicine High Impact Case Reports.. 2019;7:1-5',\n",
       "       'Osborne Caroline Stokes, Overstreet Amanda N, Rockey Don C, Schreiner Andrew D. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic. Journal of Investigative Medicine High Impact Case Reports. 2019',\n",
       "       'Murthy P, Clark D. An unusual cause for neonatal abstinence syndrome. Paediatrics and Child Health (Canada). 2019;24:1:12-14',\n",
       "       'Monte AA. Kratom-Only Deaths In Colorado Are Not Kratom Only. Academic Emergency Medicine. 2019;26(S1):S282',\n",
       "       'Journal: Forensic science, medicine, and pathology\\n Author: Hughes RL\\n Title: Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction Volume: 15 (1) Year: 2019 Pages: 110-3',\n",
       "       'Hughes RL.. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction.. Journal Forensic Science, Medicine and Pathology. 2018',\n",
       "       'Hughes RL.. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction.. Forensic Sci Med Pathol.. 2018',\n",
       "       'Hughes RL. Fatal combination of mitragynine and quetiapine-a case report with discussion of a potential herb-drug interaction. Forensic Sci Med Pathol. 2019;15(1):110-113',\n",
       "       'Hughes RL. Fatal combination of mitragynine and quetiapine-a case report with discussion of a potential herb-drug interaction. Forensic Sci Med Pathol. 2019; 15(1): 110-3.',\n",
       "       'Hughes RL. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction. Journal Forensic Science, Medicine and Pathology. 2019;15:110-113',\n",
       "       'Hughes RL. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction. FORENSIC SCIENCE, MEDICINE, AND PATHOLOGY. 2019;15(1):110-3',\n",
       "       'Hughes RL. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction. Forensic Science, Medicine, and Pathology. 2019;15(1):110-113',\n",
       "       'Hughes RL. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction. Forensic Sci Med Pathol. 2018 Nov 29.',\n",
       "       'Hughes R. Fatal combination of mitragynine and quetiapine \\x96 a case report with discussion of a potential herb-drug interaction. Forensic Sci Med Pathol. 2019;15(1):110-113',\n",
       "       'Hughes R L. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction. Forensic science, medicine, and pathology. 2019;15 (1):110-113',\n",
       "       \"Gummin, David D; Mowry, James B; Spyker, Daniel A; Brooks, Daniel E; Osterthaler, Krista M; Banner, William. 2017 Annual Report of the American Association of Poison Control Centers' National Poison Data System. Clinical Toxicology. 2018;prepub:1-203\",\n",
       "       \"Gummin, D.. 2017 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th Annual Report. CLINICAL TOXICOLOGY. 2018;10.1080/15563650.2018.1533727\",\n",
       "       \"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W.. 2017 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th Annual Report. Doi.org/10.1080/15563650.2018.1533727. Clinical Toxicology. 2018;1-203\",\n",
       "       'Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W. 2017 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 35th Annual Report. CLINICAL TOXICOLOGY. 2018;56:12:1213-1415',\n",
       "       'Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al.. Deaths in Colorado attributed to Kratom. N-Engl-J-Med. 2019;380(1):97-98',\n",
       "       'Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med. 2019;380(1):97-98',\n",
       "       'Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, et al. Deaths in Colorado attributed to Kratom. N-Engl-J-Med 2019;380(1):97-98.',\n",
       "       'Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R et al. Deaths in Colorado Attributed to Kratom. N Engl J Med. 2019;380(1):97-98',\n",
       "       'Fels H, Lottner-Nau S, Sax T, Roider G, Graw M, Auwrter V et. al.. Postmortem concentrations of the synthetic opioid U-47700 in 26 fatalities associated with the drug. Forensic Sci Int.. 2019',\n",
       "       'Fels H, Lottner-Nau S, Sax T, Roider G, Graw M, Auwarter V et al. Postmortem concentrations of the synthetic opioid U-47700 in 26 fatalities associated with the drug. Forensic Science International. 2019;301:E20-E28',\n",
       "       'Fagiola M, Hahn T, Avella J.. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS).. J-Anal-Toxicol. 2018;42(8):562-569',\n",
       "       'Fagiola M, Hahn T, Avella J. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS). J-Anal-Toxicol. 2018;42(8):562-569',\n",
       "       'Fagiola M, Hahn T, Avella J, et,al.. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS).. Journal of Analytical Toxicology. 2018;42 (8):562-69',\n",
       "       'Fagiola M, Hahn T, Avella J, et,al.. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS).. Journal of Analytical Toxicology. 2018;42 (8):562-59',\n",
       "       'David D. Gummin MD, James B. Mowry PharmD, Daniel A. Spyker PhD, MDd, Daniel E. Brooks MD. 2017 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 35th Annual Report. Clinical Toxicology. CLINICAL TOXICOLOGY. 2018;56:12:1213-1415',\n",
       "       'Castillo A, Payne JD, Nugent K. Posterior reversible leukoencephalopathy syndrome after kratom ingestion. BAYLOR UNIV MED CENT PROC. 2017;30(3):355-357',\n",
       "       'Buresh M.. Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance;DOI:10.1097/ADM.0000000000000428. Journal of Addiction Medicine. 2018;12:481-483',\n",
       "       'Bourgine, J.. Fatal intoxication with Kratom: A case report. Toxicologie Analytique et Clinique. 2019;31 (Suppl 2):S36-S37',\n",
       "       'Bourgine J, Garnier-Jardin C, Chretien B, Le Boisselier R, Loilier M, Lelong-Boulouard V, et al.. Fatal intoxication with Kratom: A case report. Toxicologie Analytique et Clinique. 2019 MAY;VOL. 31:S36-S37.',\n",
       "       'Mantilla B, Vega MV, Solis X, Makram J, Mallah H, Test V. A Dangerous Drug and Herbal Mixture. Chest. 2020;Oct 18-21:812A',\n",
       "       'Mantilla B, Vega MV, Solis X, Makram J, Mallah H, Test V. A DANGEROUS DRUG AND HERBAL MIXTURE. Chest 2020;158 (Suppl.)(4):A812 (plus poster).',\n",
       "       \"Gummin, D.. 2018 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57 (12):1220-1413\",\n",
       "       'Gummin DD; Mowry JB; Spyker DA; Brooks DE; Beuhler MC; Rivers LJ; Hashem HA; Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers. National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;54:12:1220-1413',\n",
       "       'Gummin DD, Spyker DA, Brooks DE, Beuhler MC, Mowry JB, Rivers LJ et al.. 2018 Annual Report of the American Association of Poison Control Centers National Poison Data: 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413',\n",
       "       'Gummin DD, Spyker DA, Brooks DE, Beuhler MC, Mowry JB, Rivers LJ et al.. 2018 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 36th Annual Report.. Clinical Toxicology. 2019;57(12):1220-1413',\n",
       "       'Gummin DD, Spyker DA, Brooks DE, Beuhler MC, Mowry JB, Rivers LJ et al.. 2018 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413',\n",
       "       'Gummin DD, Spyker DA, Brooks DE, Beuhler MC, Mowry JB, Rivers LJ et al.. 2018 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413',\n",
       "       \"Gummin DD, Spyker DA, Brooks DE, Banner W, Mowry JB, Osterthaler KM. 2017 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th Annual Report.. CLINICAL TOXICOLOGY. 2018;56(12):1213-1415\",\n",
       "       'Gummin DD, MowryJB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, Hashem HA, Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers\\x92 National Poison Data System (NPDS): 36th Annual Report. DOI: 10.1080/15563650.2019.1677022. Clinical Toxicology. 2019;57 (12):1220-1413',\n",
       "       \"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W.. 2017 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th Annual Report.. CLINICAL TOXICOLOGY. 2018;56(12):1213-1415\",\n",
       "       \"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, Hashem HA, Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 36 Annual Report. Clinical Toxicology. 2019;57 (12):1220-1413\",\n",
       "       \"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, et al.. 2018 Annual report of the american association of poison control centers' national poison data system (npds): 36th annual report.. Clinical Toxicology. 2019;57(12:1220-1413\",\n",
       "       \"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, et al.. 2018 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413\",\n",
       "       \"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, et al. 2018 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila). 2019 Dec;57(12):1220-1413.\",\n",
       "       'Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ et al.. 2018 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413',\n",
       "       'Gummin D. 2018 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57(12):1220-1413.',\n",
       "       \"Gummin D, Mowry J, Spyker D, Brooks D, Beuhler M, Rivers L, Hashem H, Ryan M. 2018 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019 NOV 21;57(12):1220-1413. doi:10.1080/15563650.2019.1677022\",\n",
       "       'Fishburn SJ, Mullins ME.. Kratom (mitragynine speciosa) induced acute liver failure.. Journal of Medical Toxicology. 2020;16(2):143-144',\n",
       "       'Fishburn SJ, Mullins ME.. Kratom (mitragynine speciosa) induced acute liver failure.. J-Med-Toxicol.. 2020;16(2):143-144',\n",
       "       'Fishburn SJ, Mullins ME. Kratom (Mitragynine speciosa) Induced Acute Liver Failure. Journal of Medical Toxicology. 2020;16:143-144',\n",
       "       'Fishburn SJ, Mullins ME. Kratom (mitragynine speciosa) induced acute liver failure. J-Med-Toxicol 2020;16(2):143-144 (plus poster) abstr. 094.',\n",
       "       'Fishburn SJ, Mullins ME. Kratom (mitragynine speciosa) induced acute liver failure. J Med Toxicol. 2020;16(2):143-144',\n",
       "       'Fishburn S.J., Mullins M.E.. Kratom (mitragynine speciosa) induced acute liver failure. J Med Toxicol.. 2020;16(2):143-144',\n",
       "       'Fels H, Lottner-Nau S, Sax T, Roider G, Graw M, Auwarter V et al.. Postmortem concentrations of the synthetic opioid U-47700 in 26 fatalities associated with the drug. FORENSIC SCI. INT.. 2019',\n",
       "       'Eudaley ST, Hamilton LA. Case report: Successful treatment of suspected kratominduced serotonin syndrome. JACCP Journal of the American College of Clinical Pharmacy. 2020;3(1):347',\n",
       "       \"Davidson L, Rawat M, Stojanovski S, and Chandrasekharan P Natural drugs, not so natural effects: Neonatal abstinence syndrome secondary to 'kratom'. Journal of Neonatal-Perinatal Medicine 2019;12 (1):109-112.\",\n",
       "       \"Davidson L, Rawat M, Stojanovski S and Chandrasekharan P Natural drugs, not so natural effects: Neonatal abstinence syndrome secondary to 'kratom'. Journal of Neonatal-Perinatal Medicine 2019;12 (1):109-112.\",\n",
       "       'Bourgine J, Garnier Jardin C, Chretien B, Le Boisselier R, Loilier M, Lelong Boulouard V, et al. Fatal intoxication with Kratom: A case report. Fundam Clin Pharmacol. 2019;33 (Suppl. 1):72 (PS2-013)',\n",
       "       'Bishop freeman SC, Fox L, Winecker RE, Hudson JS. Death from Poppy Tea Consumption. Journal of Analytical Toxicology. 2020;44:734-740',\n",
       "       'Baumgartner K.T, Mullins M.E. A case of Kratom poisoning causing cardiotoxicity. J. Med. Toxicol. 2020;16(2):165-6',\n",
       "       'Yeh M, Krotulski A, Therriault C, Eisenstat MD, Nguyen H, Papsun D, et al.. Acute opioid overdose following nasal atomization of a novel designer opioid, 2-methyl AP-237, with potentiation of designer benzodiazepines, pyrazolam and clonazolam.. J-Med-Toxicol. 2021;17:123',\n",
       "       'Solbeck P, Woodall KL, Martin TL.. Strategic Decision-Making by a Forensic Toxicology Laboratory in Response to an Emerging NPS: Detection, Quantitation, and Interpretation of Carfentanil in Death Investigations in Ontario, Canada, July 2017 to June 2018.. Journal of Analytical Toxicology. 2021',\n",
       "       'Papson, D.. Flualprazolam Blood Concentrations in 197 Forensic Investigation Cases.. Journal of analytical toxicology. 2021;45 (3):226-232',\n",
       "       \"Natarajan, V.. A DRUG ADDICT'S KRYPTONITE. Chest. 2021;160(4 Suppl):685A\",\n",
       "       'Krotulski AJ, Papsun DM, Chronister CW, Homan J, Crosby MM, Hoyer J et al. Eutylone intoxications-An emerging synthetic stimulant in forensic investigations. Journal of Analytical Toxicology. 2021;45:8-20',\n",
       "       'Kalin S, Dakhlalla S, Bhardwaj S.. Treatment for kratom abuse in a contingency-management-based MAT setting: A case series.. J-Opioid-Manag. 2020;16(5):391-394',\n",
       "       'Kalin S, Dakhlalla S, Bhardwaj S. Treatment for kratom abuse in a contingency-management-based MAT setting: A case series. Journal of Opioid Management. 2020;16(5):391-394',\n",
       "       'Kalin S, Dakhlalla S, Bhardwaj S. Treatment for kratom abuse in a contingency-management-based MAT setting: A case series. J-Opioid-Manag 2020;16(5):391-394.',\n",
       "       'Jittasopa W, Srisont S.. The Causes of Death and Pathological Findings of Kratom Users: A 5-Year Retrospective Analysis. Am J Forensic Med Pathol. 2021;42:33534',\n",
       "       \"Gummin, D.. 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58 (12):1360-1541\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW; et al.. 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58 (12):1360\\x961541\",\n",
       "       'Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, Rivers LJ, Pham NPT, Ryan ML. 2019 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58 (12):1360\\x961541',\n",
       "       'Gummin D. 2019 Annual Report of the American Association of Poison Control Centers National Poison Data Systems (NPDS): 37th Annual Report. Clinical Toxicology. 2020 DEC;58(12):1360-1541.',\n",
       "       \"Gummin D, Mowry J, Beuhler M, Spyker D, Bronstein A, Rivers L, Pham N, Weber J. 2020 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021 DEC 10;59 (12):1282-1501. doi:10.1080/15563650.2021.1989785\",\n",
       "       'Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R et al. Deaths in Colorado Attributed to Kratom. N Engl J Med. 2019;JAN 380 1:1-2',\n",
       "       'Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R et al. Deaths in Colorado Attributed to Kratom. N Engl J Med. 2019;3Jan:380(1):1-2',\n",
       "       'Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R et al. Deaths in Colorado Attributed to Kratom. N Engl J Med. 2019;3Jan: 380(1):1-2',\n",
       "       'Fagiola M, Hahn T, Avella J. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS). J Anal Toxicol. 2018;42:562-569',\n",
       "       'Bowe A, Kerr PL.. A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management. JOURNAL OF PSYCHOACTIVE DRUGS. 2020;52(5):447-452',\n",
       "       'Bowe A, Kerr PL. A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management. J-Psychoactive-Drugs 2020;52(5):447-452.',\n",
       "       'Bishop-Freeman, S.. Death from poppy tea consumption. Journal of Analytical Toxicology. 2020;44(7):734-740',\n",
       "       'Bishop-Freeman SC, Fox L, Winecker RE, Hudson JS.. Death from poppy tea consumption.. Journal of Analytical Toxicology. 2020;44(7):734-740',\n",
       "       'Bishop-Freeman SC, Fox L, Winecker RE, Hudson JS. Death from Poppy Tea Consumption. Journal of Analytical Toxicology. 2020;44(7):734-740',\n",
       "       'Bishop-Freeman SC, Fox L, Winecker RE, Hudson JS. Death from poppy tea consumption. JOURNAL OF ANALYTICAL TOXICOLOGY. 2020;44:734-40',\n",
       "       'Bishop-Freeman SC, Fox L, Winecker RE, Hudson JS. Death from poppy tea consumption. Journal of Analytical Toxicology. 2020;44 (7):734-40',\n",
       "       'Zoucha K, Moore C. Kratom Use in Pregnancy. J-Addict-Med 2022;16(5):e331-e332.',\n",
       "       'Zoucha K, Moore C. Kratom Use in Pregnancy. J Addict Med. 2022;Sep-Oct;16(5):e331-e332',\n",
       "       'Zoucha K, Moore C. Kratom Use in Pregnancy. J Addict Med. 2022;16(5):e331-e332',\n",
       "       'Thomas Beresford, Carrie Keffler, Mitzi Wasserstein, et.al. Kratom tramadol toxicity with seizure, hypokalemia, marked Q-T prolongation, and cognitive impairment: A case report. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63:S69-S70',\n",
       "       'Theegala V., K Solanki K., S Grover B.. Cardiac arrest in a middle-aged woman from combined use of kratom and amphetamine. Chest. 2022;162:4',\n",
       "       'Theegala V, Solanki KK, Grover BS. Cardiac arrest in a middle-aged woman from combined use of kratom and amphetamine. Chest. 2022;162(4):A776',\n",
       "       'McPhee MM, Paine MF, Cox EJ, Burns AG.. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone.. Journal of addiction medicine. 2022',\n",
       "       'LeSaint, K.. Acute Renal Insufficiency Associated With Consumption of Hydrocodone- and Morphine-Adulterated Kratom (Mitragyna Speciosa). Journal of Emergency Medicine. 2022;10.1016/j.jemermed.2022.02.004',\n",
       "       'Hamilton L, Eudaley S, Brooks S. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. J Pharm Pract. 2022;UNKNOWN:1-5. doi:10.1177/08971900221116009',\n",
       "       'Hall A, Hall D. Kratom Ingestion and Emergency Care: Summary and a Case Report. J-Emerg-Nurs 2021;47(4):551-556.e1.',\n",
       "       \"Gummin, D.. 2020 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):1282-1501\",\n",
       "       \"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report. Clinical Toxicology. 2017;55(10):1072-1252\",\n",
       "       \"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, Hashem HA, Ryan ML. 2018 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 36th Annual Report. Clinical Toxicology. 2019;57 (12):1220-1413\",\n",
       "       'Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J.. 2020 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 38th Annual Report.. Clinical Toxicology.. 2021;59 (12):1282-1501',\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59 (12):12821501\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol (Phila). 2021 Dec;59(12):1282-1501. doi: 10.1080/15563650.2021.1989785.\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ et al. 2020 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59(12):1282-501\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brinstein AC, Rivers LJ, et al.. 2020 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 38th Annual Report. Clinical toxicology. 2021;59(12):1282-1501\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brinstein AC, Rivers LJ, et al.. 2020 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 38th Annual Report. Clinical Toxicology. 2021;59(12):1282-1501\",\n",
       "       'Gummin D. 2020 Annual Report of the American Association of Poison Control Centers National Poison Data Systems (NPDS) 38th Annual Report. Clinical Toxicology. 2021 DEC 10;59(12):1282-1501.',\n",
       "       'Eudaley ST, Hamilton LA. Case report: Successful treatment of suspected kratominduced serotonin syndrome.. JACCP Journal of the American College of Clinical Pharmacy. 2020;3 (1):347',\n",
       "       'Eudaley ST, Hamilton LA. Case report: Successful treatment of suspected kratominduced serotonin syndrome. J-Am-Coll-Clin-Pharm. 2020;3(1)347:450',\n",
       "       'Eudaley ST, Hamilton LA. Case report: Successful treatment of suspected kratom-induced serotonin syndrome. JOURNAL OF AMERICAN COLLEGE OF CLINICAL PHARMACY. 2020;3(1):347',\n",
       "       'Eudaley ST, Hamilton LA. Case report: Successful treatment of suspected kratom induced serotonin syndrome. Journal of the American College of Clinical Pharmacy. 2020;3:347',\n",
       "       'Eudaley ST, Hamilton LA, Brooks SP. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. Journal of Pharmacy Practice. 2022;1 to 5',\n",
       "       'Eudaley ST, Brooks SP, Hamilton LA.. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. Journal of pharmacy practice. 2022;1-5',\n",
       "       'Eudaley ST, Brooks SP, Hamilton LA. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. Journal of Pharmacy Practice. 2022 Jul 15:08971900221116009.',\n",
       "       'Eudaley ST, Brooks SP, Hamilton LA. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. J Pharm Pract. 2022 Jul 15:8971900221116009. doi: 10.1177/08971900221116009. Epub ahead of print. PMID: 35840540.',\n",
       "       'Eudaley ST, Brooks SP, Hamilton LA. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. J Pharm Pract. 2022 Jul 15:8971900221116009.',\n",
       "       'Eudaley S, Hamilton L. Case report: Successful treatment of suspected kratominduced serotonin syndrome. JACCP Journal of the American College of Clinical Pharmacy. 2020;3(1):347-347. doi:10.1002/jac5.1204',\n",
       "       'Eudaley S, Brooks S, Hamilton L.. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. Journal of Pharmacy Practice. 2022',\n",
       "       'Burns A. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine Naloxone. Journal of Addiction Medicine. 2022 SEP;16(5):606-609.',\n",
       "       'Burns A, Brogdon H, McPhee M, Paine M, Cox E. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J Addict Med. 2022;UNK:UNK-UNK. doi:10.1097/ADM.0000000000000968',\n",
       "       'Brogdon, H. D., McPhee, M. M., Paine, M. F., Cox, E. J., & Burns, A. G. (2022). A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. Journal of addiction medicine, 10.1097/ADM.0000000000000968. Advance online publication. https://doi.org/10.1097/ADM.0000000000000968',\n",
       "       'Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG.. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone.. Journal of addiction medicine. 2022',\n",
       "       'Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone.. J Addict Med. 2022;00',\n",
       "       'Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J-Addict-Med 2022;null:null.',\n",
       "       'Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J-Addict-Med 2022;:.',\n",
       "       'Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J Addict Med. 2022 Feb 14.',\n",
       "       'Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J Addict Med. 2022',\n",
       "       'Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. American Society of Addiction Medicine. 2022;00:00',\n",
       "       'Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A case of potential pharmacokinetic kratom-drug interactions resulting in toxicity and subsequent treatment of kratom use disorder with buprenorphine/naloxone. American Society of Addiction Medicine. 2022',\n",
       "       'Brogdon H.D.; McPhee M.M.; Paine M.F.; Cox E.J.; Burns A.G.. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. Journal of addiction medicine 2022;',\n",
       "       'Brogdon H, McPhee M, Paine M, Cox E, Burns A. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. Journal of Addiction Medicine. 2022;1-4. doi:1097/ADM.0000000000000968',\n",
       "       'Bowe A, Kerr PL. A complex case of kratom dependence, depression, and chronic pain in opioid use disorder: effects of buprenorphine in clinical management. Journal of Psychoactive Drugs. 2020;52(5):447-452',\n",
       "       'Beresford T., Keffler C., Wasserstein M., Ronan P.. Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63:S:S69',\n",
       "       'Beresford T, Keffler C, Wasserstein M, Ronan P.. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report.. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63Supplement:S69-70',\n",
       "       'Beresford T, Keffler C, Wasserstein M, Ronan P.. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report.. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63:S69-S70',\n",
       "       'Beresford T, Keffler C, Wasserstein M, Ronan P.. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report.. J-Acad-Consult-Liaison-Psychiatry. 2022;63 (Suppl.):S69-S70 abstr. PO-152.',\n",
       "       'Beresford T, Keffler C, Wasserstein M, Ronan P. Kratom Tramadol toxicity with seizure, hypokalemia, marked q-t prolongation, and cognitive impairment: A case report. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63:S69-S70',\n",
       "       'Beresford T, Keffler C, Wasserstein M, Ronan P. Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report. J Acad Consult Liaison Psychiatry. 2022;63 (Suppl.):S69-70(Abstract ID:PO-152)',\n",
       "       'Beresford T, Keffler C, Wasserstein M, Ronan P. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report. Journal of the Academy of Consultation-Liaison Psychiatry. 2022;63:S69-70',\n",
       "       'Beresford T, Keffler C, Wasserstein M, Ronan P. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report. Journal of the Academy of Consultation-Liaison Psychiatry 63 (Suppl.): S69-S70 abstr. PO-152, May 2022. URL: http://doi.org/10.1016/j.jaclp.2022.03.145',\n",
       "       'Beresford T, Keffler C, Wasserstein M, Ronan P. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report. J-Acad-Consult-Liaison-Psychiatry. 2022;63 (Suppl.:S69-S70 abstr. PO-152',\n",
       "       'Beresford T, Keffler C, Wasserstein M, Ronan P. (PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report. J-Acad-Consult-Liaison-Psychiatry 2022;63 (Suppl.):S69-S70 abstr. PO-152.',\n",
       "       'Zoucha K, Moore C. Kratom Use in Pregnancy. J Addict Med. 2022;Sep/Oct; 16(5):e331-e332',\n",
       "       'Shi T, Shea JL. A case of fatal overdose involving both hydromorphone and kratom. J Forensic Sci. 2023 Sep 27.',\n",
       "       'Shi T, Shea JL. A case of fatal overdose involving both hydromorphone and kratom. J Forensic Sci. 2023 Sep 27',\n",
       "       'Shi T, Shea J.L. A case of fatal overdose involving both hydromorphone and kratom. Journal of forensic sciences. 2023;00:1-4',\n",
       "       'Salas, J.. Concentrations of para-Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations. Journal of Analytical Toxicology. 2022;46 (4):358-373',\n",
       "       'Salas JR, Krotulski AJ, Newman R, Thogmartin JR, Mohr ALA, Logan BK. Concentrations of para-Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations. J Anal Toxicol. 2022;46:358-373',\n",
       "       'Rodriguez Salas J, Krotulski AJ, Newman R, Thogmartin JR, Mohr ALA, Logan BK.. Concentrations of para-Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations.. J-Anal-Toxicol. 2022;46(4):358-373',\n",
       "       'Rodriguez Salas J, Krotulski AJ, Newman R, Thogmartin JR, Mohr ALA, Logan BK. Concentrations of para-Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations. J-Anal-Toxicol 2022;46(4):358-373.',\n",
       "       'Papsun M D, Krotulski A J, Logan B K. Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances. Am J Forensic Med Pathol. 2022;43:315-327',\n",
       "       'Palungwachira.P., Yeh.M, Whitworth.B, Rushton.W and Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 20162020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11:2',\n",
       "       'Palungwachira, P.. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11 (2):10.4303/jdar/236162',\n",
       "       'Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z.. ported to the Georgia and Alabama Poison Control Centers from 20162020: A Retrospective Review. J-Drug-Alcohol-Res. 2022;11No. 2.',\n",
       "       'Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z.. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 20162020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11(2):1-10',\n",
       "       'Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z.. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review.. Journal of Drug and Alcohol Research.. 2022;11(2):1-10',\n",
       "       'Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z.. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review.. Journal of Drug and Alcohol Research.. 2022;11 (2):1-10',\n",
       "       'Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z.. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review.. J-Drug-Alcohol-Res. 2022;11 (2).',\n",
       "       'Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11 (2):1-10',\n",
       "       'Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J-Drug-Alcohol-Res. 2022;11No:2',\n",
       "       'Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J-Drug-Alcohol-Res 2022;11:No. 2.',\n",
       "       'Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J Drug Alcohol Res. 2022;11(2):236162',\n",
       "       'Palungwachira P, Yeh M, Whitworth B, Rushton W, Kazzi Z. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 2016-2020: A Retrospective Review. J Drug Alcohol Res. 2022;11(2):1-10',\n",
       "       'P. Palungwachira, M. Yeh, B. Whitworth, W. Rushton and Z. Kazzi. Clinical Characteristics of Kratom Exposures Reported to the Georgia and Alabama Poison Control Centers from 20162020: A Retrospective Review. Journal of Drug and Alcohol Research. 2022;11:2',\n",
       "       'Nunez T, Meyerson G, Alani M, Elahi S, Vargas E. Supersensitivity Psychosis with Acute Dystonia. HCA Healthc J Med. 2023 Feb 28;4(1):57-60.',\n",
       "       'Nasser, N.. Serotonin Syndrome Precipitated by Paxlovid Initiation. Cureus. 2023',\n",
       "       'LeSaint KT, Yin S, Sharma A, Avery BA, McCurdy CR, Waksman JC. Acute renal insufficiency associated with consumption of hydrocodone- and morphine-adulterated Kratom (Mitragyna Speciosa). Journal of Emergency Medicine. 2022;63(1):e28-30',\n",
       "       'Lefkovich E, Downing M, Zouridis S. Over-The-Counter Overdose: Toxicity Secondary to an Herbal Pain Supplement. 2023 RESIDENT AND MEDICAL STUDENT FORUM - NEW YORK CHAPTER OF THEAMERICAN COLLEGE OF PHYSICIANS (NYACP) 2023;',\n",
       "       'Karinen R, Fosen J, Rogde S, Vindenes V.. An accidental poisoning with mitragynine. Forensic Science International. 2014;245:E29-E32',\n",
       "       'Karinen R, Fosen J, Rogde S, Vindenes V. An accidental poisoning with mitragynine. Forensic Sci Int. 2014;245:E29-E32.',\n",
       "       \"Gummin, D.. 2021 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60 (12):1381-1643\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al. 2022 Annual report of the national poison data system (NPDS) from america's poison Centers: 40th annual report. Clinical toxicology. 2023;61(10):717-939\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NP , Bronstein AC, Weber J.. 2021 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 39th Annual Report.. Clinical toxicity. 2023Jan05;60(12):1381-1643. doi:10.1080/15563650.2021.1989785\",\n",
       "       'Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NP , Bronstein AC, Weber J. 2021 Annual Report of the National Poison Data System (NPDS) from America?s Poison Centers: 39th Annual Report. Clinical toxicity. 2023Jan05;60:1381-1643. doi:10.1080/15563650.2021.1989785',\n",
       "       'Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NP , Bronstein AC, Weber J. 2021 Annual Report of the National Poison Data System (NPDS) from America?s Poison Centers: 39th Annual Report. Clinical toxicity. 2023Jan05;60:1381-1643. doi: https://doi.org/10.1080/15563650.2022.2132768',\n",
       "       'Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA.. 2021 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers: 39th Annual Report.. Clinical Toxicology.. 2022;60 (12):1381-1643',\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA.2021 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 39th Annual Report.Clinical toxicology (Philadelphia).DEC-2022;60(12):1381-1643\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA.. 2021 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 39th Annual Report.. Clinical toxicology. 2023Jan05;60(12):1381-1643. doi:10.1080/15563650.2022.2132768\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA.. 2021 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 39th Annual Report.. Clinical toxicity. 2023Jan05;60(12):1381-1643. doi:10.1080/15563650.2021.1989785\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA.. 2021 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 39th Annual Report. Clinical Toxicology. 2023 Jan 05;60(12):1381-1643. doi:10.1080/15563650.2022.2132768\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA.. 2021 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 39th Annual Report. Clinical Toxicology. 05Jan2023;60(12):1381-1643 . doi:https://doi.org/10.1080/15563650.2022.2132768\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 39th Annual Report . Clinical Toxicology. 2023-Jan-05;60 (12):1381-1643. doi:https://doi.org/10.1080/15563650.2022.2132768\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 39th Annual Report. Clinical Toxicology. 2023Jan05;60(12):1381-1643. https://doi:10.1080/15563650.2022.2132768\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 39th Annual Report. Clinical Toxicology. 2023 Jan 05;60(12):1381-1643. doi:10.1080/15563650.2022.2132768\",\n",
       "       'Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America?s Poison Centers: 39th Annual Report. Clinical Toxicology. 2023-Jan-05;60 (12):1381-1643. doi: https://doi.org/10.1080/15563650.2022.2132768',\n",
       "       'Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R et al. 2021 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60(12):1381-643',\n",
       "       \"Gummin D, Mowry J, Beuhler M, Spyker D, Rivers L, Feldman R, Brown K, Pham N, Bronstein A, Weber J. 2021 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 39th Annual Report. Clinical Toxicology. 2023 JAN 05;60 (12):1381-1643. doi:10.1080/15563650.2022.2132768\",\n",
       "       \"Gummin D, Mowry J, Beuhler M, Spyker D, Rivers L, Feldman R, Brown K, Pham N, Bronstein A, DesLauriers C. 2022 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 40th Annual Report. Clinical Toxicology. 2023 DEC 12;61(10):717-939. doi:10.1080/15563650.2023.2268981\",\n",
       "       \"Gummin D D; Mowry J B; Beuhler C; Spyker D A; Rivers L J; Feldman R; Brown K; Pham Nathanuek; Bronsteun A C; Weber J A. 2021 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 39th Annual Repor. Clinical Toxicology. 2022;60:12:1381-1643\",\n",
       "       'Fels H, Lottner-Nau S, Sax T, Roider G, Graw M, Auwrter V, Musshoff F. Postmortem concentrations of the synthetic opioid U-47700 in 26 fatalities associated with the drug. Forensic Science International. 2019;S0379-0738(19):30141-0',\n",
       "       'Eudaley, S.. Case report: Successful treatment of suspected kratom-induced serotonin syndrome. Journal of the American College of Clinical Pharmacy. 2020;3 (1):347',\n",
       "       'Eudaley ST, Hamilton LA. Case report: Successful treatment of suspected kratominduced serotonin syndrome. J-Am-Coll-Clin-Pharm 2020;3(1):347 abstr. 450.',\n",
       "       'Eudaley ST, Brooks SP, Hamilton LA.. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. Journal of Pharmacy Practice. 2023;36(6):15231527',\n",
       "       'Eudaley ST, Brooks SP, Hamilton LA.. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. Journal of Pharmacy Practice. 2023;36(6):1523-1527',\n",
       "       'Eudaley S T, Brooks S P, Hamilton L A. Case Report: Possible Serotonin Syndrome in a Patient Taking Serotonergic Agents. journal of Pharmacy Practice. 2023;36(6):1523?1527. doi:10.1177/08971900221116009',\n",
       "       'Donna M. Papsun, Ayako Chan-Hosokawa, Laura Friederich, Justin Brower, Kristopher Graf and Barry Logan. The Trouble With Kratom: Analytical and Interpretative Issues Involving Mitragynine. Journal of Analytical Toxicology. 2019;43:615-629',\n",
       "       \"Domanski K, Fleming SW, Maag H, Raley EB, DeBord J, Wright B, et al. A Psychonaut's Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis. Journal of psychoactive drugs. 2022;54(4):319-323. DOI: 10.1080/02791072.2021.2006373.\",\n",
       "       \"Domanski k, Fleming SW, Maag H, Raley E, Debord J, Wright B, et al.. A Psychonaut's Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis.. J-Psychoactive-Drugs. 2022;54(4):319-323\",\n",
       "       \"Domanski k, Fleming SW, Maag H, Raley E, Debord J, Wright B, et al. A Psychonaut's experience of intoxication with multiple classes of drugs including novel psychoactive substance 2-fluorodeschloroketamine: Case report and urinary analysis. Journal Of Psychoactive Drugs. 2022;54(4):319323\",\n",
       "       'Brogdon HD.A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone.Journal of Addiction Medicine.14-FEB-2022',\n",
       "       'Behonick, G.. Two Single-Drug Fatal Intoxications by Mitragynine. Journal of Analytical Toxicology. 2022;46(5):E110-E114',\n",
       "       'Yu J, Diekhans K, Tsang A, Rodda L.N. Fluorofentanyl and novel synthetic opioids in accidental overdose deaths. Journal of Analytical Toxicology. 2024;48(8):573-581',\n",
       "       'Unknown. Unknown. Unknown',\n",
       "       'Truesdale N, Kaliki V, Fuller KE, Nathani Y. QTc prolongation related to Kratom ingestion with underlying SSRI usage. The American Journal of the Medical Sciences. 2024;367(S1):S284',\n",
       "       'Truesdale N, Kaliki V, Fuller KE, Nathani Y. QTc prolongation related to kratom ingestion with underlying SSRI usage. Am-J-Med-Sci 2024; 367 (Suppl. 1) S284 abstr. 472.',\n",
       "       'Truesdale N, et al.QTc prolongation related to kratom ingestion with underlying SSRI usage.American Journal of the Medical Sciences.feb-2024;367 (1):S284',\n",
       "       'Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D.. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report.. Frontiers in Psychiatry. 2024;14:1332999 (01-04)',\n",
       "       'Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Frontiers in Psychiatry. 2024 Jan 10;14: 1332999: doi:10.3389/fpsyt.2023.1332999',\n",
       "       'Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front. Psychiatry. 2024 Jan 10;14:1332999: doi:doi: 10.3389/fpsyt.2023.1332999',\n",
       "       'Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front. Psychiatry. 2024 Jan 10;14:1332999: doi:10.3389/fpsyt.2023.1332999',\n",
       "       'Torrico T, Patel K, Nikolov N, Salam MT, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Front Psychiatry, 2024 Jan 10;14:1332999. doi: 10.3389/fpsyt.2023.1332999.',\n",
       "       'Torrico T, Patel K, Nikolov N, Salam M.T, Padhy R, Weinstein D. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report. Frontiers in Psychiatry. 2023;14 (1332999):1-4',\n",
       "       'Spungen, H.. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy.. Journal of Medical Toxicology. 2024;1-6',\n",
       "       'Spungen, H.. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. Journal of Medical Toxicology. 2024;1-6',\n",
       "       'Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J-Med-Toxicol 2024;.; Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J-Med-Toxicol 2024;.; Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J-Med-Toxicol 2024;.',\n",
       "       'Spungen HH, Mody K, Micetic B, Wade C, Kang AM. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy. J Med Toxicol. 2024, doi: 10.1007/s13181-024-01016-x. PMID: 38839731.',\n",
       "       'Source document (Full text)',\n",
       "       'Shi T, Shea LJ.. A case of fatal overdose involving both hydromorphone and kratom. J Forensic Sci. 2023',\n",
       "       'Shi T, Shea LJ. A case of fatal overdose involving both hydromorphone and kratom. J Forensic Sci. 2023;Sep 27; 69:355-358',\n",
       "       'Shi T, Shea JL. A case of fatal overdose involving both hydromorphone and kratom. J-Forensic-Sci 2023; 69 355-358.; Shi T, Shea JL. A case of fatal overdose involving both hydromorphone and kratom. J-Forensic-Sci 2023; 69 355-358.; Shi T, Shea JL. A case of fatal overdose involving both hydromorphone and kratom. J-Forensic-Sci 2023; 69 355-358.',\n",
       "       'Sablaban IM, Gautam M. Kratom and Stimulant Co-Addiction: A Case Series and Brief Review. Journal of Addictive Diseases: The Official Journal of the ASAM, American Society of Addiction Medicine. 2023 Jan;41(2): 181-184. doi:10.1080/10550887.2022.2066459.',\n",
       "       'Sablaban IM, Gautam M. Kratom & Stimulant Co-Addiction: A Case Series and Brief Review. [Review]. J-Addict-Dis 2023; 41 (2): 181-184.',\n",
       "       'Saber M.; Zichichi A.; Ammar M.. SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY. Crit. Care Med.. 2024;52:1 (S1):S642',\n",
       "       'Saber M., Zichichi A., Ammar M. SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT. Y. Critical Care Medicine. 2024;52:1',\n",
       "       'Saber M, Zichichi A, Ammar M.. SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY. Critical Care Medicine. 2024;52(1):S642',\n",
       "       'Saber M, Zichichi A, Ammar M. SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY. Critical Care Medicine. 2024;52 (Suppl 1):S642',\n",
       "       'Saber M, Zichichi A, Ammar M. Serotonin syndrome due to kratom and antidepressant interaction: A case study. Critical care medicine. 2024;52 (1):S642 abstr. 1342',\n",
       "       'Saber M, Zichichi A, Ammar M. Serotonin Syndrome Due To Kratom And Antidepressant Interaction: A Case Study. Critical Care Medicine. 2024;52 (1):S642',\n",
       "       'Saber M, Zichichi A, Ammar M. SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY. Critical Care Medicine. 2024;52 (1):S642',\n",
       "       'Saber M, Zichichi A, Ammar M. SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY. Critical Care Medicine. 2024 Jan; 52(Suppl 1): S642; abstract 1342.',\n",
       "       'Perez J. Kratom and opioid use disorder in the perioperative period: A case report on the expanding role of buprenorphine. J-Opioid-Manag 2023;19(1):91-93.; Perez J. Kratom and opioid use disorder in the perioperative period: A case report on the expanding role of buprenorphine. J-Opioid-Manag 2023;19(1):91-93.',\n",
       "       'Papsun DM, Krotulski AJ, Homan J, Temporal KDH, Logan BK. Flualprazolam Blood Concentrations in 197 Forensic Investigation Cases. Journal of Analytical Toxicology. 2021;45:226 to 232',\n",
       "       'Papsun D.M., Chan-Hosokawa A., Lamb M.E., Logan B.. Increasing prevalence of designer benzodiazepines in impaired driving: a 5-year analysis from 2017 to 2021. J. Anal. Toxicol.. 2023;47:8:668 - 679',\n",
       "       'N Truesdale.QTc prolongation related to kratom ingestion with underlying SSRI usage.American Journal of the Medical Sciences.FEB-2024;367 (Suppl. 1):S284 abstr',\n",
       "       'Marissa Saber.SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY.Critical Care Medicine.JAN-2024;52:S642',\n",
       "       'Marissa Saber.SEROTONIN SYNDROME DUE TO KRATOM AND ANTIDEPRESSANT INTERACTION: A CASE STUDY..Critical Care Medicine.JAN-2024;52:S642',\n",
       "       'Kedzierski N, Mata D. Mitragynine in the Orange County DUID population. Journal of Analytical Toxicology. 2023;47(8):770-85',\n",
       "       'Karinen R, Fosen JT, Rogde S, Vindenes V. An accidental poisoning with mitragynine. Forensic Sci Int. 2014;245:e29-32',\n",
       "       'Initial',\n",
       "       \"Gummin, D.. 2022 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 40th Annual Report. Clinical Toxicology. 2023;61 (10):717-939\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al.. 2022 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 40th Annual Report. Clinical Toxicology. 2023;61 (10):717-939\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C.. 2022 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 40th Annual Report. Clinical Toxicology. 2023;61(10):717-939\",\n",
       "       'Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2022 Annual Report of the National Poison Data System (NPDS) from America?s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023 Dec 12;61 (10):717-939. doi:https://doi.org/10.1080/15563650.2023.2268981',\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R et al. 2023 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 41st Annual Report. Clinical Toxicology. 2024;2-235\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, et al.. 2022 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 40th Annual Report. Clinical Toxicology. 2022;61(10):717-939\",\n",
       "       'Grundmann O.Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits.DM Disease a Month.JAN-2023;69',\n",
       "       'Grundmann O.Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits.DM Disease a Month .JAN-2023;69 (6)',\n",
       "       'Grundmann O,Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Dis Mon. 2023;69 (6):1-13',\n",
       "       'Grundmann O,Hendrickson R G,Greenberg M I. Kratom: History, pharmacology, current user trends, adversehealth effects and potential benefits. Disease-a-Month. 2023;69',\n",
       "       'Grundmann O, Hendrickson RG, Greenberg MI.Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits.Dis-Mon.2023;69:6',\n",
       "       'Grundmann O, Hendrickson RG, Greenberg MI.. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits.. Dis-Mon. 2023;69 No. 6.',\n",
       "       'Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits.. Dis-Mon. 2023;69 (6)',\n",
       "       'Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. DM Disease a Month. 2023 Jan;69(6): doi:10.1016/j.disamonth.2022.101442.',\n",
       "       'Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Disease-a-Month. 2023;69:6',\n",
       "       'Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Disease-a-Month. 2023;69 (6):1-13',\n",
       "       'Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Disease-a-Month. 2023;69 (6) 101442:1-13',\n",
       "       'Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Disease-a-Month. 2023;(69(6)): 1-13. doi:https://doi.org/10.1016/j.disamonth.2022.101442.',\n",
       "       'Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Dis-Mon 2023; 69 (6):.',\n",
       "       'Grundmann O, et al..Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits.DM Disease a Month.jun-2023;69 (6):1-13',\n",
       "       'Eudaley ST, Hamilton LA, Brooks S P.. Case report: Successful treatment of suspected kratominduced serotonin syndrome.. J-Am-Coll-Ciin-Pharm. 2020;3(1):347',\n",
       "       'Eudaley ST, Brooks SP, Hamilton LA.. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents.. Journal of pharmacy practice. 2022;1-5',\n",
       "       'Eudaley ST, Brooks SP, Hamilton LA. Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents. J Pharm Pract. 2023;36(6):1523-1527',\n",
       "       \"David D. Gummin, James B. Mowry, Michael C. Beuhler, Daniel A. Spyker, Laura J. Rivers, Ryan Feldman, Kaitlyn Brown, Nathaniel P.T. Pham, Alvin C. Bronstein &amp; Carol DesLauriers (2023) 2022 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers : 40th Annual Report, Clinical Toxicology, 61:10, 717-939.\",\n",
       "       \"David D. Gummin, James B. Mowry, Michael C. Beuhler, Daniel A. Spyker, Laura J. Rivers, Ryan Feldman, Kaitlyn Brown, Nathaniel P.T. Pham, Alvin C. Bronstein &amp; Carol DesLauriers (2023) 2022 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers : 40th Annual Report, Clinical Toxicology, 61:10, 717-939\",\n",
       "       \"D'Orazio AL, Mohr AL, Chan-Hosokawa A, Harper C, Huestis MA, Limoges JF et al. Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities-2021 update. Journal of Analytical Toxicology. 2021;45(6):529-36\",\n",
       "       'Bursova M, Horak V, Syuparek Z, Yerna I.. Deaths associated with Kratom use. Proceedings. 22nd conference of the military medicine society CLS JEP. 2024;1 (93):5-6',\n",
       "       'Bursova M, Horak V, Syuparek Z, Yerna I.. Deaths associated with Kratom use. Proceedings. 2024; 93(Military Medicine Science Letters, Suppl. 1, 22nd conference of the military medicine society CLS JEP, - 6 November 2024):5. 2024;SUPPL.. UVN Prague 5. 2024;1:5-6.',\n",
       "       'Bursova M, Cerna I, Horak V, et al. Umrti spojene s uzitim Kratomu. Sbornik. 2024; 93(Military Medicine Science Letters, Suppl. 1, 22. konference spolecnosti vojenske mediciny CLS JEP, UVN Praha 5.-6.11.2024):5.',\n",
       "       'Albert, R.. Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64:S:S72',\n",
       "       'Albert R, Quraishi S, Ashley K.. Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;64(Supplement):S72',\n",
       "       'Albert R, Quraishi S, Ashley K.. Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. Journal of the Academy of Consultation- Liaison Psychiatry. 64:S72',\n",
       "       'Albert R, Quraishi S, Ashley K.. Albert R, Quraishi S, Ashley K. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom.. Journal of the Academy of Consultation-Liaison Psychiatry.. 2024;64(Supplement)::72',\n",
       "       'Albert R, Quraishi S, Ashley K.. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;64:S72.',\n",
       "       'Albert R, Quraishi S, Ashley K.. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. J Acad Consult Liaison Psychiatry. 2023;64:S72',\n",
       "       'Albert R, Quraishi S, Ashley K. Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom.. Journal of the Academy of Consultation-Liaison Psychiatry.. 2024;64(Supplement):S72',\n",
       "       'Albert R, Quraishi S, Ashley K. Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. Journal of the Academy of Consultation-Liaison Psychiatry. 2023;64:S72',\n",
       "       'Albert R, Quraishi S, Ashley K. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. Journal of the Academy of Consultation-Liaison Psychiatry. 2024;64(Supplement):S72. DOI: 10.1016/j.jaclp.2023.11.616.',\n",
       "       'Albert R, Quraishi S, Ashley K. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. J. Acad. Consul. Liaison. Psychiatry. 2023;(64):S72',\n",
       "       'Albert R, Quraishi S, Ashley K. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S72 abstr. 146.; Albert R, Quraishi S, Ashley K. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S72 abstr. 146.',\n",
       "       'Albert R, Quraishi S, Ashley K. (146) Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom. J-Acad-Consult-Liaison-Psychiatry 2023; 64 (Suppl.) S72 abstr. 146.',\n",
       "       'Albert R, et al.Serotonin Syndrome in COVID-19: Polypharmacy with Paxlovid and Kratom.Journal of the Academy of Consultation-Liaison Psychiatry .dec-2023;146:S72',\n",
       "       'Truesdale N, Kaliki V, Fuller KE, Nathani Y. QTc prolongation related to kratom ingestion with underlying SSRI usage. Am-J-Med-Sci. 2024;367 (Suppl. 1):S284',\n",
       "       'Sivakumar D, Pascual J, Kennedy M, Clark KT, Mason JM, Walfield AL, Hayes BD, Maldonado G.. The successful use of buprenorphine to manage kratom withdrawal secondary to self-treatment of opioid withdrawal. Clinical Toxicology. 2025;1-2',\n",
       "       'Riggs A, Briggs J, Goodrich W, Gardner G.. Intravenous kratom use with peripheral vasospasm. Clin-Toxicol-(Phila). 2022;60 (Suppl. 2):147-148',\n",
       "       'Papsun DM, Chan-Hosokawa A, Lamb ME, Logan B. Increasing prevalence of designer benzodiazepines in impaired driving: A 5-year analysis from 2017 to 2021. J Anal Toxicol. 2023;47(8):668-679',\n",
       "       'Mantilla B, Vega MV, Solis X, Makram J, Mallah H, Test V.. A DANGEROUS DRUG AND HERBAL MIXTURE.. Chest. 2020;158 (Suppl.)(4):A812 (plus poster).',\n",
       "       'Laetitia Breugelmans.A lethal case involving purple drank and Kratom.Toxicologie Analytique & Clinique.2025;37:S17',\n",
       "       'Hughes RL. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction. Forensic Sci Med Pathol. 2019 Mar 15(1):110-113. doi: 10.1007/s12024-018-0049-9.',\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al.. 2023 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 41st Annual Report. Clinical Toxicology. 2024;1-235\",\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C.. 2023 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 41st Annual Report. Clinical Toxicology. 2024;62 (12):793-1027\",\n",
       "       'Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2023 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers 41st Annual Report. Clin Toxicol (Phila). 2024 Dec 17:1-35. doi: 10.1080/15563650.2024.2412423. Epub ahead of print.',\n",
       "       \"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2023 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 41st Annual Report. Clinical Toxicology. 2024 Dec 17; doi:https://doi.org/10.1080/15563650.2024.2412423\",\n",
       "       'Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham NPT, Bronstein AC, DesLauriers C. 2023 Annual Report of the National Poison Data System (NPDS) from America?s Poison Centers: 41st Annual Report. Clinical Toxicology. 2024 Dec 17; doi:https://doi.org/10.1080/15563650.2024.2412423',\n",
       "       'Gummin D D, Mowry J B, Beuhler M C, Spyker D A, Rivers L J, Feldman R, Brown K, Pham N P T, Bronstein A C, DesLauriers C.. 2023 Annual Report of the National Poison Data System (NPDS) from Americas Poison Centers: 41st Annual Report. Clinical Toxicology. 2024;62:793-1027',\n",
       "       'Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Dis-Mon 2023; 69 (6):.; Grundmann O, Hendrickson RG, Greenberg MI. Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Dis-Mon 2023; 69 (6):.',\n",
       "       'Filipa Teixeira, Oluwatobi Ajewole, Mihai Picior, Emmert Roberts. Treatment of obsessive compulsive disorder and Kratom dependence with buprenorphine and supportive care. BMJ Case Reports. 2025;18:e265834',\n",
       "       'Eudaley ST, Brooks SP, Hamilton LA..Case Report: Possible Serotonin Syndrome in a Patient Taking Kratom and Multiple Serotonergic Agents..J-Pharm-Pract.2022;NA:NA',\n",
       "       'Butler M, Pirkle J, Carmichael A, Carlson-Dexter P, Rosella T. Successful symptom-based management of active withdrawal from multiple illicit benzodiazepines. BMJ Case Reports. 2025;18 (8):1-3',\n",
       "       'Bursov M, ern I, Hork V, uprek Z. MRT SPOJEN S UITM KRATOMU. Military medical science list.. 2024;1(93)',\n",
       "       'Brogdon H D, McPhee M M, Paine M F, Cox E J and Burns A G. A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. J Addict Med. 2022 Sep-Oct:16(5):606-609. Doi: 10.1097/ADM.0000000000000968. Epub 2022 Feb 14.',\n",
       "       'Breugelmans, L.. A lethal case involving purple drank and Kratom.. Toxicologie Analytique & Clinique. 2025;37 (1):S17',\n",
       "       'Breugelmans L, Boland A, Fernandez MDMR, Di Fazio V, Wille S.. A lethal case involving purple drank and Kratom.. Toxic-Analyt-Clinique. 2025;37(1):S17',\n",
       "       'Breugelmans L, Boland A, Fernandez MDMR, Di Fazio V, Wille S.. A lethal case involving purple drank and Kratom. Toxic-Analyt-Clinique. 2025;37 (Suppl.) (1):S17',\n",
       "       'Breugelmans L, Boland A, Fernandez MDMR, Di Fazio V, Wille S. A lethal case involving purple drank and Kratom. Toxic-Analyt-Clinique. 2025;37 (Suppl)(1):S17',\n",
       "       'Breugelmans L, Boland A, Fernandez MDMR, Di Fazio V, Wille S. A lethal case involving purple drank and Kratom. Toxic-Analyt-Clinique 2025; 37 (Suppl.) (1): S17.',\n",
       "       'Breugelmans L, Boland A, Fernandez MD, Di Fazio V, Wille S. A lethal case involving purple drank and Kratom. Toxicologie Analytique et Clinique Volume 37, Issue 1, Supplement, March 2025, Page S17.',\n",
       "       'Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, Winecker RE.. Loperamide-Related Deaths in North Carolina. .. Journal of Analytical Toxicology. 2016;40(8):677-686',\n",
       "       'Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et,al.. Loperamide-Related Deaths in North Carolina.. Journal of Analytical Toxicology.. 2016;40(8):677-686',\n",
       "       'Bishop-Freeman SC, Feaster MS, Beal J, Miller A, Hargrove RL, Brower JO, et al.. Loperamide-related deaths in North Carolina.. J-Anal-Toxicol. 2016;40(8):677-686',\n",
       "       'Beresford T, Keffler C, Wasserstein M, Ronan P.(PO-152) Kratom Tramadol Toxicity With Seizure, Hypokalemia, Marked Q-T Prolongation, and Cognitive Impairment: A Case Report.J-Acad-Consult-Liaison-Psychiatry.2022;63 (Suppl.):S69-S70',\n",
       "       'Bachu AK, Singal P, Griffin B, Harbaugh L, Prasad S, Jain L, et al. Kratom use and mental health: A systematic literature review and case example. [Review]. J-Addict-Dis 2024; 42 (4): 301-312.; Bachu AK, Singal P, Griffin B, Harbaugh L, Prasad S, Jain L, et al. Kratom use and mental health: A systematic literature review and case example. [Review]. J-Addict-Dis 2024; 42 (4): 301-312.; Bachu AK, Singal P, Griffin B, Harbaugh L, Prasad S, Jain L, et al. Kratom use and mental health: A systemati...'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 93,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_refs = pd.read_csv(\"Cleaned_NewCols_FAERS.csv\")\n",
    "df_refs['Literature Reference'].unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "id": "9ec1ceab-7d91-4bac-bdbb-60250bb17acb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Literature Reference</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Neerman, M.F., Frost, R.E., Deking, J.. A Drug...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Mowry JB; Spyker DA, Cantilena Jr. LR, McMilla...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>McIntyre IM, Trochta A, Stolberg S, Campman SC...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>McIntyre I M.. Mitragynine \"Kratom' Related Fa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>151</th>\n",
       "      <td>Bursov M, ern I, Hork V, uprek Z. MRT...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>152</th>\n",
       "      <td>Brogdon H D, McPhee M M, Paine M F, Cox E J an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>Breugelmans L, Boland A, Fernandez MDMR, Di Fa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>Breugelmans L, Boland A, Fernandez MD, Di Fazi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>Bachu AK, Singal P, Griffin B, Harbaugh L, Pra...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>156 rows  1 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                  Literature Reference\n",
       "0                                                    -\n",
       "1    Neerman, M.F., Frost, R.E., Deking, J.. A Drug...\n",
       "2    Mowry JB; Spyker DA, Cantilena Jr. LR, McMilla...\n",
       "3    McIntyre IM, Trochta A, Stolberg S, Campman SC...\n",
       "4    McIntyre I M.. Mitragynine \"Kratom' Related Fa...\n",
       "..                                                 ...\n",
       "151  Bursov M, ern I, Hork V, uprek Z. MRT...\n",
       "152  Brogdon H D, McPhee M M, Paine M F, Cox E J an...\n",
       "153  Breugelmans L, Boland A, Fernandez MDMR, Di Fa...\n",
       "154  Breugelmans L, Boland A, Fernandez MD, Di Fazi...\n",
       "155  Bachu AK, Singal P, Griffin B, Harbaugh L, Pra...\n",
       "\n",
       "[156 rows x 1 columns]"
      ]
     },
     "execution_count": 97,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Install the necessary library if you haven't already\n",
    "# !pip install fuzzywuzzy python-Levenshtein  # or !pip install rapidfuzz\n",
    "\n",
    "from rapidfuzz import fuzz, process\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "references = df_refs['Literature Reference'].dropna().tolist()\n",
    "unique_refs = []\n",
    "duplicate_indices = []\n",
    "\n",
    "# Set a similarity threshold (adjust as needed)\n",
    "threshold = 90\n",
    "\n",
    "for i, ref1 in enumerate(references):\n",
    "    if i in duplicate_indices:\n",
    "        continue\n",
    "        \n",
    "    unique_refs.append(ref1)\n",
    "    \n",
    "    # Compare with remaining references\n",
    "    for j in range(i+1, len(references)):\n",
    "        ref2 = references[j]\n",
    "        # Calculate similarity ratio\n",
    "        similarity = fuzz.ratio(ref1.lower(), ref2.lower())\n",
    "        \n",
    "        if similarity >= threshold:\n",
    "            duplicate_indices.append(j)\n",
    "\n",
    "# Create a new DataFrame with only unique references\n",
    "unique_references = pd.DataFrame({'Literature Reference': unique_refs})\n",
    "unique_references"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a2456d62-e24d-46d6-8ba2-6a59a71b85f6",
   "metadata": {},
   "source": [
    "### NOTE FOR SANDEEP: I'm going to keep going with this analysis but I am going to stop for now! More to do on the references/correlations/demographics that could be useful\n",
    "---"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c61789cd-3262-4283-8d8c-b5f608e22150",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python [conda env:st-env] *",
   "language": "python",
   "name": "conda-env-st-env-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.18"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
